data_1d1r_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1d1r _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 121.298 0.571 . . . . 0.0 109.53 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.446 ' HA2' ' HB3' ' A' ' 55' ' ' ASP . . . 147.67 126.45 1.64 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.403 ' O ' ' CG2' ' A' ' 33' ' ' VAL . 19.1 m -133.8 121.26 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.318 -1.107 . . . . 0.0 109.42 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.412 ' CG1' HD13 ' A' ' 97' ' ' LEU . 77.9 t -96.42 135.78 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.218 -0.926 . . . . 0.0 109.493 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.461 ' O ' ' HG3' ' A' ' 35' ' ' ARG . 0.1 OUTLIER -130.08 124.45 32.82 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.187 -0.946 . . . . 0.0 109.519 -179.992 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.431 ' CG2' ' HG ' ' A' ' 93' ' ' LEU . 3.9 mp -110.08 126.11 67.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.233 -0.917 . . . . 0.0 109.449 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -121.69 160.65 24.05 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.272 -0.892 . . . . 0.0 109.502 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.413 ' HG3' ' O ' ' A' ' 38' ' ' ARG . 12.0 ptt180 -131.87 104.75 7.04 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.292 -0.88 . . . . 0.0 109.402 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -88.33 80.72 7.43 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.226 -0.921 . . . . 0.0 109.49 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 43.6 p . . . . . 0 N--CA 1.489 1.523 0 O-C-N 121.245 -0.909 . . . . 0.0 109.463 179.994 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 79.1 tttt . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 121.283 0.563 . . . . 0.0 109.572 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -118.99 149.61 18.13 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 27.6 m -126.43 158.13 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.232 -1.158 . . . . 0.0 109.487 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -129.42 124.23 33.6 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.267 -0.896 . . . . 0.0 109.48 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.1 mt -115.34 124.26 50.81 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.233 -0.917 . . . . 0.0 109.39 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.469 ' HB ' ' HB ' ' A' ' 83' ' ' ILE . 6.7 mm -107.28 119.28 56.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.231 -0.918 . . . . 0.0 109.595 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.453 HG23 ' O ' ' A' ' 81' ' ' GLY . 1.3 m -158.86 158.72 33.99 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.267 -0.896 . . . . 0.0 109.426 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.487 ' O ' ' N ' ' A' ' 55' ' ' ASP . . . 109.09 -23.86 22.37 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 21.3 t -49.02 94.17 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.311 -1.111 . . . . 0.0 109.424 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.487 ' N ' ' O ' ' A' ' 53' ' ' GLY . 13.3 t0 -79.78 85.92 5.4 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.234 -0.916 . . . . 0.0 109.527 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.402 ' O ' ' C ' ' A' ' 57' ' ' ASP . 35.2 mt -146.16 167.52 23.24 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.322 -0.861 . . . . 0.0 109.355 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.402 ' C ' ' O ' ' A' ' 56' ' ' LEU . 0.2 OUTLIER -45.47 150.47 0.47 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.224 -0.923 . . . . 0.0 109.392 179.888 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -60.33 -53.35 58.62 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.187 -0.945 . . . . 0.0 109.656 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.12 -39.02 71.59 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.283 -0.886 . . . . 0.0 109.733 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.41 -39.41 93.19 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.174 -0.954 . . . . 0.0 109.671 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.9 -42.95 90.81 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.213 -0.929 . . . . 0.0 109.602 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -61.36 -33.44 73.64 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.309 -0.87 . . . . 0.0 109.638 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -71.58 -34.89 70.31 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.235 -0.915 . . . . 0.0 109.605 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.99 -59.77 3.5 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.189 -0.944 . . . . 0.0 109.577 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.464 ' HB3' HG12 ' A' ' 83' ' ' ILE . . . -56.99 -34.17 67.86 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.278 -0.889 . . . . 0.0 109.628 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.46 ' HA ' ' HG2' ' A' ' 69' ' ' LYS . . . -66.36 -33.82 76.58 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.274 -0.891 . . . . 0.0 109.768 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -70.17 -44.31 69.05 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.204 -0.935 . . . . 0.0 109.723 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.448 ' O ' ' HB2' ' A' ' 72' ' ' CYS . 9.7 mt -63.99 -39.85 95.07 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.231 -0.918 . . . . 0.0 109.629 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.46 ' HG2' ' HA ' ' A' ' 66' ' ' ALA . 12.9 ptmt -75.23 -2.11 26.47 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.321 -0.862 . . . . 0.0 109.854 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 10.3 tttt -76.83 -49.22 16.3 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.096 -1.003 . . . . 0.0 109.993 -179.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.54 64.63 1.43 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.079 -1.013 . . . . 0.0 109.768 -179.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . 0.448 ' HB2' ' O ' ' A' ' 68' ' ' LEU . 5.7 m -128.64 -15.36 4.47 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.192 -0.942 . . . . 0.0 110.078 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.672 ' O ' ' CB ' ' A' ' 74' ' ' CYS . . . 96.35 78.29 1.4 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.672 ' CB ' ' O ' ' A' ' 73' ' ' GLY . 34.7 t 112.02 110.62 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.19 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 -179.527 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.456 ' HA2' ' HB2' ' A' ' 69' ' ' LYS . . . -67.06 111.61 4.25 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -84.1 148.93 24.74 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -107.25 168.34 9.29 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.194 -1.18 . . . . 0.0 109.783 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.454 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 85.0 t -106.46 162.26 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.42 -0.8 . . . . 0.0 109.347 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.449 ' HB2' ' O ' ' A' ' 82' ' ' VAL . 6.6 mttt -149.27 82.27 1.42 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.222 -0.924 . . . . 0.0 109.521 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 46.15 66.87 0.85 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.373 -0.829 . . . . 0.0 109.728 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.453 ' O ' HG23 ' A' ' 52' ' ' THR . . . 74.84 8.88 82.91 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 179.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.449 ' O ' ' HB2' ' A' ' 79' ' ' LYS . 3.3 t -124.62 98.57 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.084 -1.245 . . . . 0.0 109.585 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.469 ' HB ' ' HB ' ' A' ' 51' ' ' ILE . 6.2 mt -93.15 124.37 45.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.228 -0.92 . . . . 0.0 109.481 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -91.87 124.55 36.07 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.324 -0.86 . . . . 0.0 109.578 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 34.1 mm -127.76 115.1 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.268 -0.895 . . . . 0.0 109.221 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.73 105.46 16.97 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.254 -0.904 . . . . 0.0 109.619 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 162.2 137.69 2.25 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -97.01 64.36 1.98 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.174 -1.192 . . . . 0.0 109.429 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 76.2 mttt -112.06 36.48 3.32 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.278 -0.889 . . . . 0.0 109.471 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 17.7 ttm180 -44.27 -35.8 2.46 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.261 -0.9 . . . . 0.0 109.476 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -56.39 -52.28 65.2 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.242 -0.911 . . . . 0.0 109.498 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.43 -26.88 68.17 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.291 -0.881 . . . . 0.0 109.47 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.459 ' HA ' ' CD2' ' A' ' 96' ' ' LEU . 3.2 mm? -63.23 -46.08 88.61 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.309 -0.869 . . . . 0.0 109.459 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 72.3 tttt -61.67 -29.95 70.41 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.228 -0.92 . . . . 0.0 109.534 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 17.5 t -69.83 -68.7 0.4 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.253 -0.905 . . . . 0.0 109.449 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.459 ' CD2' ' HA ' ' A' ' 93' ' ' LEU . 2.5 pp -44.86 -35.36 2.75 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.242 -0.911 . . . . 0.0 109.42 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.445 ' CD1' HG12 ' A' ' 104' ' ' VAL . 0.5 OUTLIER -64.63 -47.94 76.69 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.23 -0.919 . . . . 0.0 109.487 179.939 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -67.18 -9.26 38.21 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.234 -0.916 . . . . 0.0 109.488 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -70.44 -33.16 70.99 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.233 -0.917 . . . . 0.0 109.482 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 4.8 mtmm -84.98 -25.87 27.48 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.209 -0.932 . . . . 0.0 109.506 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 92.5 16.01 50.99 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 4.2 mtm -87.69 -174.42 4.76 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.266 -1.138 . . . . 0.0 109.464 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 24.5 mttt -91.42 163.5 14.16 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.262 -0.899 . . . . 0.0 109.487 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.445 HG12 ' CD1' ' A' ' 97' ' ' LEU . 19.2 t -139.82 158.99 27.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.245 -0.909 . . . . 0.0 109.456 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.452 ' O ' ' N ' ' A' ' 107' ' ' ALA . 17.3 tttt -130.25 61.42 1.59 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.215 -0.928 . . . . 0.0 109.474 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.41 ' C ' ' O ' ' A' ' 105' ' ' LYS . 3.7 tp -44.9 98.49 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.26 -0.9 . . . . 0.0 109.494 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.452 ' N ' ' O ' ' A' ' 105' ' ' LYS . . . . . . . . 0 N--CA 1.49 1.526 0 O-C-N 121.206 -0.934 . . . . 0.0 109.488 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 14.9 t70 . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -86.37 161.08 33.75 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.473 HG13 ' CB ' ' A' ' 103' ' ' LYS . 18.9 m -142.98 97.51 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.189 -1.183 . . . . 0.0 109.506 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.475 HG22 ' CE ' ' A' ' 102' ' ' MET . 38.6 t -97.06 145.45 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.186 -0.946 . . . . 0.0 109.444 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 58.5 mtt180 -127.45 131.13 50.26 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.265 -0.897 . . . . 0.0 109.493 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.485 HG21 ' CD2' ' A' ' 93' ' ' LEU . 3.0 mp -125.68 106.31 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.293 -0.879 . . . . 0.0 109.476 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.501 ' HA ' ' CB ' ' A' ' 107' ' ' ALA . 20.4 pt20 -113.49 -175.01 2.57 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.265 -0.897 . . . . 0.0 109.443 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.413 ' O ' ' CG ' ' A' ' 38' ' ' ARG . 3.9 ptt180 -133.22 117.85 17.9 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.237 -0.914 . . . . 0.0 109.498 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -95.05 132.63 39.73 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.237 -0.915 . . . . 0.0 109.47 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.537 0 O-C-N 121.248 -0.908 . . . . 0.0 109.523 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 90.1 mttt . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -166.12 156.86 29.06 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -130.22 165.01 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.276 -1.132 . . . . 0.0 109.454 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 3.5 m -133.82 134.59 43.01 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.245 -0.91 . . . . 0.0 109.515 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -111.18 139.25 46.71 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.261 -0.899 . . . . 0.0 109.489 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.463 HG12 ' CG1' ' A' ' 36' ' ' ILE . 15.3 mt -127.95 107.8 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.246 -0.909 . . . . 0.0 109.468 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 15.8 m -152.47 158.82 43.13 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.237 -0.914 . . . . 0.0 109.426 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 104.36 16.42 18.31 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.431 ' CG1' HD22 ' A' ' 61' ' ' LEU . 21.8 t -74.6 130.42 36.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.198 -1.177 . . . . 0.0 109.46 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -104.44 86.85 2.59 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.232 -0.918 . . . . 0.0 109.45 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.486 ' HB2' ' CD1' ' A' ' 61' ' ' LEU . 5.1 mt -133.38 -170.63 2.52 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.247 -0.908 . . . . 0.0 109.537 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -73.89 -69.89 0.41 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.191 -0.943 . . . . 0.0 109.481 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 174.12 -63.13 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.171 -0.956 . . . . 0.0 109.521 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.68 -30.89 71.92 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.242 -0.911 . . . . 0.0 109.583 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -66.01 -35.49 80.71 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.182 -0.949 . . . . 0.0 109.478 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.486 ' CD1' ' HB2' ' A' ' 56' ' ' LEU . 0.3 OUTLIER -63.95 -38.61 91.7 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.27 -0.894 . . . . 0.0 109.548 179.995 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 23.8 m -59.75 -49.64 76.92 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.234 -0.916 . . . . 0.0 109.47 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 58.5 tttt -59.7 -36.88 77.41 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.255 -0.903 . . . . 0.0 109.492 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.459 ' CD1' HD21 ' A' ' 68' ' ' LEU . 0.1 OUTLIER -59.29 -53.69 55.37 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.209 -0.932 . . . . 0.0 109.527 -179.926 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.15 -32.28 69.73 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.271 -0.893 . . . . 0.0 109.541 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.88 -42.29 94.93 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.238 -0.914 . . . . 0.0 109.401 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -75.64 -19.83 58.93 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.273 -0.892 . . . . 0.0 109.403 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.459 HD21 ' CD1' ' A' ' 64' ' ' LEU . 0.7 OUTLIER -72.17 -53.69 11.93 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.32 -0.863 . . . . 0.0 109.548 -179.956 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.463 ' HA ' ' HB2' ' A' ' 72' ' ' CYS . 1.3 ptpt -65.8 -21.41 66.49 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.323 -0.861 . . . . 0.0 109.694 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 9.3 mttt -58.57 -34.61 71.25 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.321 -0.862 . . . . 0.0 110.042 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 59.7 tttt -120.12 24.03 10.67 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.045 -1.034 . . . . 0.0 110.066 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . 0.463 ' HB2' ' HA ' ' A' ' 69' ' ' LYS . 0.5 OUTLIER -107.37 -27.13 10.65 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.069 -1.019 . . . . 0.0 109.548 179.827 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.436 ' O ' ' HB3' ' A' ' 74' ' ' CYS . . . 61.38 54.09 38.95 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.646 -1.381 . . . . 0.0 109.646 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.436 ' HB3' ' O ' ' A' ' 73' ' ' GLY . 27.0 p 177.66 125.33 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.283 -1.128 . . . . 0.0 109.49 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -114.06 82.27 0.31 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -75.91 -52.88 6.08 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.774 -1.331 . . . . 0.0 109.774 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 176.78 124.42 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.171 -1.194 . . . . 0.0 109.508 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 38.5 t -127.29 122.53 59.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.261 -0.9 . . . . 0.0 109.554 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -131.5 143.81 50.67 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.24 -0.912 . . . . 0.0 109.593 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.63 109.72 0.85 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.157 -0.964 . . . . 0.0 109.36 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 119.68 -38.39 2.81 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 87.8 t -140.26 133.13 33.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.329 -1.1 . . . . 0.0 109.412 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 12.1 mt -122.55 148.4 26.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.247 -0.908 . . . . 0.0 109.4 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -135.41 134.96 40.23 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.175 -0.953 . . . . 0.0 109.686 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 27.8 mm -118.15 148.52 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.236 -0.915 . . . . 0.0 109.332 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.38 122.06 46.55 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.204 -0.935 . . . . 0.0 109.478 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 130.43 161.28 10.32 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -103.66 108.93 20.42 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.231 -1.159 . . . . 0.0 109.458 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 30.6 mttt -158.73 31.39 0.22 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.235 -0.916 . . . . 0.0 109.462 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 50.8 ttp180 -53.48 -27.78 27.09 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.249 -0.907 . . . . 0.0 109.485 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 50.0 t0 -60.05 -51.77 68.2 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.259 -0.901 . . . . 0.0 109.456 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.7 tt -70.75 -23.95 62.52 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.21 -0.931 . . . . 0.0 109.438 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.485 ' CD2' HG21 ' A' ' 36' ' ' ILE . 1.3 mt -63.51 -47.87 79.93 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.193 -0.942 . . . . 0.0 109.424 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.497 ' HD2' ' CD2' ' A' ' 106' ' ' LEU . 78.2 tttt -61.98 -23.07 66.17 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.244 -0.91 . . . . 0.0 109.451 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 6.6 t -76.56 -65.37 0.94 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.277 -0.889 . . . . 0.0 109.491 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.446 ' CD1' ' N ' ' A' ' 97' ' ' LEU . 2.9 pp -47.73 -36.04 10.74 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.256 -0.903 . . . . 0.0 109.419 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.472 ' CD2' HG11 ' A' ' 104' ' ' VAL . 1.4 tp -69.52 -44.25 71.41 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.225 -0.922 . . . . 0.0 109.456 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 68.4 tt0 -61.21 -20.26 62.58 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.285 -0.884 . . . . 0.0 109.477 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -62.77 -32.28 73.4 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.229 -0.919 . . . . 0.0 109.476 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -84.36 -18.07 37.37 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.229 -0.919 . . . . 0.0 109.495 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 75.47 24.66 69.98 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' MET . . . . . 0.475 ' CE ' HG22 ' A' ' 34' ' ' VAL . 1.1 mtm -79.07 179.34 7.41 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.29 -1.124 . . . . 0.0 109.495 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.473 ' CB ' HG13 ' A' ' 33' ' ' VAL . 13.0 mttt -97.21 88.32 4.43 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.308 -0.87 . . . . 0.0 109.447 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.472 HG11 ' CD2' ' A' ' 97' ' ' LEU . 2.1 t -81.62 165.08 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.227 -0.92 . . . . 0.0 109.494 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.401 ' O ' ' C ' ' A' ' 106' ' ' LEU . 41.7 tttt -128.88 28.2 5.37 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.263 -0.898 . . . . 0.0 109.446 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.497 ' CD2' ' HD2' ' A' ' 94' ' ' LYS . 0.2 OUTLIER 44.24 -157.82 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.243 -0.911 . . . . 0.0 109.456 179.954 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.501 ' CB ' ' HA ' ' A' ' 37' ' ' GLN . . . . . . . . 0 N--CA 1.49 1.541 0 O-C-N 121.213 -0.929 . . . . 0.0 109.479 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.4 ' C ' ' CG2' ' A' ' 33' ' ' VAL . . . 163.2 128.12 0.93 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.4 ' CG2' ' C ' ' A' ' 32' ' ' GLY . 1.9 t -149.61 151.64 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.248 -1.149 . . . . 0.0 109.546 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.47 ' HB ' ' CD1' ' A' ' 97' ' ' LEU . 72.7 t -138.1 121.68 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.312 -0.867 . . . . 0.0 109.392 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.419 ' CG ' ' HA3' ' A' ' 53' ' ' GLY . 62.3 mtt180 -88.11 111.22 21.34 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.244 -0.91 . . . . 0.0 109.516 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.448 ' CG2' HD12 ' A' ' 93' ' ' LEU . 7.5 mt -115.66 108.51 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.263 -0.898 . . . . 0.0 109.408 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -131.72 -160.12 1.02 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.21 -0.931 . . . . 0.0 109.548 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 11.9 ptm180 -130.79 132.09 45.06 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.297 -0.877 . . . . 0.0 109.447 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -125.81 77.47 1.67 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.254 -0.904 . . . . 0.0 109.484 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' THR . . . . . 0.403 ' OG1' ' O ' ' A' ' 40' ' ' THR . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.576 0 O-C-N 121.3 -0.875 . . . . 0.0 109.472 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 93.3 mttt . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 176.96 144.52 5.31 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 16.0 m -135.02 159.05 41.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.275 -1.132 . . . . 0.0 109.373 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -111.9 110.02 20.13 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.247 -0.908 . . . . 0.0 109.531 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.47 ' CD1' ' HG3' ' A' ' 84' ' ' GLU . 8.5 tp -93.83 129.29 40.28 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.225 -0.922 . . . . 0.0 109.44 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 11.1 mm -120.91 114.74 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.295 -0.878 . . . . 0.0 109.439 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.43 ' O ' HG23 ' A' ' 52' ' ' THR . 8.6 m -141.6 13.28 2.13 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.307 -0.871 . . . . 0.0 109.496 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.419 ' HA3' ' CG ' ' A' ' 35' ' ' ARG . . . -97.41 19.02 56.37 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.579 -1.409 . . . . 0.0 109.579 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 60.0 t -82.95 105.65 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.267 -1.137 . . . . 0.0 109.452 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -100.19 87.73 3.52 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.187 -0.946 . . . . 0.0 109.522 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 19.2 mt -129.15 -169.23 2.05 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.269 -0.894 . . . . 0.0 109.403 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -81.87 -65.33 1.02 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.235 -0.916 . . . . 0.0 109.446 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.4 t0 179.76 -50.34 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.23 -0.918 . . . . 0.0 109.402 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.6 -34.71 65.18 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.24 -0.913 . . . . 0.0 109.437 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -70.2 -28.15 65.06 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.261 -0.899 . . . . 0.0 109.413 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.437 HD21 ' CD1' ' A' ' 83' ' ' ILE . 0.4 OUTLIER -66.55 -55.46 15.38 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.263 -0.898 . . . . 0.0 109.476 179.951 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 8.2 t -59.81 -37.73 79.99 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.26 -0.9 . . . . 0.0 109.551 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -57.74 -62.39 1.83 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.206 -0.934 . . . . 0.0 109.535 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.5 tt -49.82 -48.43 50.81 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.258 -0.901 . . . . 0.0 109.612 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -50.08 -41.61 48.47 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.29 -0.881 . . . . 0.0 109.659 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.8 -34.92 76.34 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.213 -0.93 . . . . 0.0 109.657 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -67.18 -30.26 70.17 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.222 -0.924 . . . . 0.0 109.584 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -79.62 -33.93 41.06 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.293 -0.88 . . . . 0.0 109.454 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.443 ' HA ' ' HB3' ' A' ' 72' ' ' CYS . 6.8 ttpt -77.04 -9.58 58.81 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.267 -0.895 . . . . 0.0 109.377 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -68.51 -41.58 79.77 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.187 -0.946 . . . . 0.0 109.46 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 39.6 mttt -103.83 5.44 35.91 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.267 -0.896 . . . . 0.0 109.493 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . 0.443 ' HB3' ' HA ' ' A' ' 69' ' ' LYS . 31.9 t -81.4 -64.44 1.19 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.217 -0.927 . . . . 0.0 109.615 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 91.38 19.65 41.02 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.291 -1.524 . . . . 0.0 109.291 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 17.4 t -174.92 90.95 0.06 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.364 -1.08 . . . . 0.0 109.304 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -95.89 157.99 21.81 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -117.98 -87.57 1.21 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -134.07 127.99 33.33 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.187 -1.184 . . . . 0.0 109.288 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.45 HG13 HG22 ' A' ' 83' ' ' ILE . 84.0 t -128.03 82.64 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.152 -0.967 . . . . 0.0 109.682 -179.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 65.4 mttt -94.09 155.69 16.96 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.268 -0.895 . . . . 0.0 109.255 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -63.72 104.97 0.73 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.24 -0.912 . . . . 0.0 109.575 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 129.67 -26.32 4.32 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 90.9 t -149.79 151.9 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.207 -1.172 . . . . 0.0 109.726 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.45 HG22 HG13 ' A' ' 78' ' ' VAL . 15.8 mt -143.7 120.58 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.389 -0.819 . . . . 0.0 109.249 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.47 ' HG3' ' CD1' ' A' ' 50' ' ' LEU . 1.7 tt0 -112.56 130.28 56.07 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.219 -0.925 . . . . 0.0 109.638 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.401 HD12 ' HA ' ' A' ' 85' ' ' ILE . 25.7 mm -126.39 145.85 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.262 -0.899 . . . . 0.0 109.335 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.53 112.23 24.47 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.231 -0.918 . . . . 0.0 109.543 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -161.03 -40.07 0.02 OUTLIER Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 27.7 t70 53.36 60.83 3.46 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.314 -1.11 . . . . 0.0 109.478 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 16.8 mttt -152.15 65.98 0.84 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.288 -0.883 . . . . 0.0 109.466 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 4.1 ptt-85 -56.79 -28.92 62.15 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.218 -0.927 . . . . 0.0 109.478 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -55.28 -52.63 62.82 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.242 -0.911 . . . . 0.0 109.455 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.5 tt -70.02 -42.07 73.45 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.25 -0.906 . . . . 0.0 109.511 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.448 HD12 ' CG2' ' A' ' 36' ' ' ILE . 2.3 mt -54.28 -26.27 28.16 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.196 -0.94 . . . . 0.0 109.484 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -64.48 -64.33 0.91 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.259 -0.901 . . . . 0.0 109.412 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -63.51 -13.93 45.98 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.276 -0.89 . . . . 0.0 109.435 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.459 ' CD2' ' C ' ' A' ' 96' ' ' LEU . 4.1 tt -71.16 -56.9 5.13 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.287 -0.883 . . . . 0.0 109.429 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.514 ' HB3' ' CG2' ' A' ' 104' ' ' VAL . 0.2 OUTLIER -70.91 -30.54 66.91 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.306 -0.871 . . . . 0.0 109.437 -179.966 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -64.71 -18.09 64.7 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.261 -0.899 . . . . 0.0 109.458 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.95 -37.24 86.99 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.292 -0.88 . . . . 0.0 109.484 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 11.2 mtpp -82.63 -34.91 27.39 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.266 -0.896 . . . . 0.0 109.444 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 107.99 17.85 10.54 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 1.5 mtm -91.28 167.85 12.01 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.261 -1.141 . . . . 0.0 109.45 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.14 157.76 22.65 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.245 -0.91 . . . . 0.0 109.44 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.514 ' CG2' ' HB3' ' A' ' 97' ' ' LEU . 87.3 t -136.19 123.0 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.312 -0.867 . . . . 0.0 109.423 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.84 88.63 4.34 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.239 -0.913 . . . . 0.0 109.49 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 30.9 mt -44.24 -36.11 2.57 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.339 -0.85 . . . . 0.0 109.465 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.54 0 O-C-N 121.248 -0.908 . . . . 0.0 109.455 179.984 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 76.92 117.58 0.16 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.49 ' CG1' ' O ' ' A' ' 103' ' ' LYS . 82.2 t -143.68 122.55 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.261 -1.14 . . . . 0.0 109.483 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 44.5 t -101.77 135.17 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.257 -0.902 . . . . 0.0 109.462 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 13.4 ttt180 -102.89 123.35 46.36 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.231 -0.918 . . . . 0.0 109.521 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.485 HG23 ' CD1' ' A' ' 93' ' ' LEU . 4.0 mt -128.87 112.49 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.195 -0.94 . . . . 0.0 109.537 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 3.3 pm0 -136.3 110.9 8.61 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.277 -0.889 . . . . 0.0 109.49 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.431 ' HG3' ' O ' ' A' ' 38' ' ' ARG . 0.0 OUTLIER -69.83 109.64 4.54 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.277 -0.89 . . . . 0.0 109.433 -179.949 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -96.17 138.99 32.97 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.304 -0.872 . . . . 0.0 109.507 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 8.9 m . . . . . 0 N--CA 1.49 1.547 0 O-C-N 121.25 -0.906 . . . . 0.0 109.446 -179.989 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 12.5 tttt . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.416 ' O ' HG11 ' A' ' 48' ' ' VAL . . . 169.26 139.53 2.74 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.416 HG11 ' O ' ' A' ' 47' ' ' GLY . 16.0 m -146.71 151.16 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.201 -1.176 . . . . 0.0 109.475 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -111.04 126.01 54.36 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.302 -0.874 . . . . 0.0 109.444 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.2 mp -112.99 104.77 12.73 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.254 -0.904 . . . . 0.0 109.578 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.437 ' HB ' ' HB ' ' A' ' 83' ' ' ILE . 8.2 mm -82.83 119.67 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.251 -0.905 . . . . 0.0 109.39 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 9.8 t -159.93 169.59 23.17 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.211 -0.93 . . . . 0.0 109.5 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 84.33 24.13 48.56 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.3 t -91.59 126.68 44.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.25 -1.147 . . . . 0.0 109.495 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -113.55 78.73 1.17 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.271 -0.893 . . . . 0.0 109.43 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 84.7 mt -137.21 -170.44 2.72 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.244 -0.91 . . . . 0.0 109.429 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.444 ' HB3' ' HB2' ' A' ' 60' ' ' GLU . 6.7 t0 -57.92 151.42 18.26 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.257 -0.902 . . . . 0.0 109.484 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.87 -54.25 49.25 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.237 -0.914 . . . . 0.0 109.513 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.57 -21.76 62.65 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.191 -0.943 . . . . 0.0 109.604 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.444 ' HB2' ' HB3' ' A' ' 57' ' ' ASP . 19.0 tt0 -61.99 -41.74 98.38 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.201 -0.937 . . . . 0.0 109.597 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.8 mp -61.08 -56.7 17.82 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.225 -0.922 . . . . 0.0 109.579 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 86.6 m -47.87 -36.69 12.51 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.15 -0.969 . . . . 0.0 109.492 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.408 ' O ' ' C ' ' A' ' 64' ' ' LEU . 15.4 tttt -61.84 -64.76 0.84 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.265 -0.897 . . . . 0.0 109.437 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.408 ' C ' ' O ' ' A' ' 63' ' ' LYS . 0.5 OUTLIER -44.55 -41.51 6.53 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.281 -0.887 . . . . 0.0 109.751 -179.862 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -56.83 -59.09 5.55 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.242 -0.911 . . . . 0.0 109.702 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.3 -17.08 17.01 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.292 -0.88 . . . . 0.0 109.81 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -76.65 -44.16 35.13 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.162 -0.961 . . . . 0.0 110.042 -179.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.457 ' N ' ' CD2' ' A' ' 68' ' ' LEU . 4.4 mm? -79.58 -26.52 41.28 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.073 -1.017 . . . . 0.0 110.201 -179.413 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.1 ttmt -71.18 -5.84 34.92 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.056 -1.028 . . . . 0.0 109.593 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -60.22 -42.23 94.72 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.251 -0.905 . . . . 0.0 109.196 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.52 43.48 0.75 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.313 -0.867 . . . . 0.0 109.688 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -77.78 -28.35 50.48 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.345 -0.847 . . . . 0.0 108.944 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.477 ' O ' ' HB2' ' A' ' 74' ' ' CYS . . . 124.75 -27.98 5.31 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 108.839 -1.705 . . . . 0.0 108.839 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.477 ' HB2' ' O ' ' A' ' 73' ' ' GLY . 4.5 t 165.36 97.42 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.554 -0.968 . . . . 0.0 108.695 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -76.52 116.29 4.64 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.444 -1.463 . . . . 0.0 109.444 -179.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -63.4 -88.47 0.04 OUTLIER Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.496 -1.441 . . . . 0.0 109.496 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -133.09 160.6 36.71 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.341 -1.093 . . . . 0.0 109.559 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 39.5 t -132.0 140.75 47.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.277 -0.89 . . . . 0.0 109.413 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 48.5 mttt -148.18 141.68 25.38 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.287 -0.883 . . . . 0.0 109.414 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -60.71 91.49 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.153 -0.967 . . . . 0.0 109.516 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.401 ' C ' HG22 ' A' ' 82' ' ' VAL . . . 134.93 -37.33 1.95 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.401 HG22 ' C ' ' A' ' 81' ' ' GLY . 90.8 t -139.86 135.18 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.266 -1.138 . . . . 0.0 109.341 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.437 ' HB ' ' HB ' ' A' ' 51' ' ' ILE . 41.4 mt -130.99 133.92 62.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.227 -0.92 . . . . 0.0 109.612 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 -104.33 120.62 41.59 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.263 -0.898 . . . . 0.0 109.43 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.412 HD12 ' HA ' ' A' ' 85' ' ' ILE . 20.4 mm -122.44 91.4 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.209 -0.932 . . . . 0.0 109.46 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -55.2 129.99 40.4 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.211 -0.931 . . . . 0.0 109.505 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 161.74 -155.16 26.32 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -177.79 70.38 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.203 -1.175 . . . . 0.0 109.475 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 55.1 mttt -143.51 49.44 1.41 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.276 -0.89 . . . . 0.0 109.537 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.442 ' HA ' HD11 ' A' ' 93' ' ' LEU . 0.9 OUTLIER -48.44 -28.76 3.48 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.27 -0.894 . . . . 0.0 109.426 179.998 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -60.77 -55.16 36.48 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.196 -0.94 . . . . 0.0 109.433 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.7 tt -64.49 -29.2 70.24 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.24 -0.913 . . . . 0.0 109.477 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.485 ' CD1' HG23 ' A' ' 36' ' ' ILE . 0.3 OUTLIER -61.86 -44.04 97.64 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.21 -0.931 . . . . 0.0 109.474 -179.979 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -63.21 -30.31 71.48 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.291 -0.881 . . . . 0.0 109.438 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.404 ' O ' ' C ' ' A' ' 96' ' ' LEU . 46.8 t -70.32 -68.95 0.39 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.284 -0.885 . . . . 0.0 109.469 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.482 ' CD2' ' HA ' ' A' ' 93' ' ' LEU . 3.8 pp -45.42 -35.39 3.67 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.224 -0.923 . . . . 0.0 109.493 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.516 ' CD2' ' HB ' ' A' ' 104' ' ' VAL . 2.5 tt -62.54 -52.67 62.51 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.292 -0.88 . . . . 0.0 109.431 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -62.25 -17.52 58.66 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.248 -0.908 . . . . 0.0 109.441 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -62.18 -37.2 84.38 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.303 -0.873 . . . . 0.0 109.466 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -84.23 -23.47 30.43 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.196 -0.94 . . . . 0.0 109.477 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 93.58 14.8 52.31 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 2.6 mtm -85.42 152.79 22.96 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.194 -1.18 . . . . 0.0 109.49 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.49 ' O ' ' CG1' ' A' ' 33' ' ' VAL . 16.2 mttt -81.31 149.35 28.97 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.264 -0.898 . . . . 0.0 109.436 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.516 ' HB ' ' CD2' ' A' ' 97' ' ' LEU . 12.9 p -136.87 153.59 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.259 -0.901 . . . . 0.0 109.454 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 69.6 mttt -120.93 85.83 2.47 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.248 -0.907 . . . . 0.0 109.431 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -50.52 101.33 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.263 -0.898 . . . . 0.0 109.521 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.546 0 O-C-N 121.236 -0.915 . . . . 0.0 109.493 -179.985 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 121.274 0.559 . . . . 0.0 109.515 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.402 ' C ' ' HE1' ' A' ' 102' ' ' MET . . . -117.09 133.43 10.62 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.8 m -154.43 145.48 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.217 -1.166 . . . . 0.0 109.493 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.412 ' HB ' HD23 ' A' ' 97' ' ' LEU . 45.0 t -127.73 147.36 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.286 -0.884 . . . . 0.0 109.436 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.458 ' HB2' ' HA3' ' A' ' 53' ' ' GLY . 3.2 ttm180 -103.18 99.56 9.43 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.224 -0.922 . . . . 0.0 109.487 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 11.0 mt -104.87 107.58 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.236 -0.915 . . . . 0.0 109.457 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.4 ' HB3' ' CB ' ' A' ' 107' ' ' ALA . 1.5 pt20 -137.64 138.44 39.47 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.255 -0.903 . . . . 0.0 109.47 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 10.1 ptt85 -92.63 127.63 38.2 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.232 -0.917 . . . . 0.0 109.532 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -115.06 81.88 1.65 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.266 -0.896 . . . . 0.0 109.384 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 4.2 p . . . . . 0 N--CA 1.49 1.559 0 O-C-N 121.215 -0.928 . . . . 0.0 109.504 -179.955 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 12.7 tttt . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -103.29 130.35 10.21 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 35.2 m -144.09 154.08 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.312 -1.111 . . . . 0.0 109.459 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -125.65 125.31 42.89 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.166 -0.959 . . . . 0.0 109.54 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.5 mp -106.29 111.07 23.51 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.253 -0.904 . . . . 0.0 109.485 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.441 ' HB ' ' HB ' ' A' ' 83' ' ' ILE . 5.4 mm -98.64 117.76 44.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.233 -0.917 . . . . 0.0 109.481 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.0 m -154.82 25.89 0.44 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.207 -0.933 . . . . 0.0 109.491 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.458 ' HA3' ' HB2' ' A' ' 35' ' ' ARG . . . -119.68 28.51 6.43 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.431 HG12 HD11 ' A' ' 61' ' ' LEU . 17.5 t -88.28 127.83 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.224 -1.162 . . . . 0.0 109.462 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -115.95 82.71 1.82 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.262 -0.899 . . . . 0.0 109.442 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.6 mt -146.21 -172.65 3.98 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.247 -0.908 . . . . 0.0 109.465 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.418 ' HB2' ' HB2' ' A' ' 60' ' ' GLU . 2.9 m-20 -59.37 167.04 2.02 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.265 -0.897 . . . . 0.0 109.396 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -76.16 -50.58 14.2 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.251 -0.906 . . . . 0.0 109.329 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.24 -27.9 65.86 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.294 -0.879 . . . . 0.0 109.301 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.418 ' HB2' ' HB2' ' A' ' 57' ' ' ASP . 18.3 tt0 -70.47 -37.07 74.21 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.274 -0.891 . . . . 0.0 109.391 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.431 HD11 HG12 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -66.27 -35.41 80.33 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.301 -0.874 . . . . 0.0 109.49 179.957 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.5 m -66.85 -31.05 71.41 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.294 -0.879 . . . . 0.0 109.583 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 43.8 mttt -72.5 -49.31 33.93 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.274 -0.891 . . . . 0.0 109.616 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.4 tp -55.24 -48.34 74.11 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.244 -0.91 . . . . 0.0 109.419 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.444 ' HA ' ' CD1' ' A' ' 68' ' ' LEU . . . -61.74 -36.13 80.1 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.309 -0.869 . . . . 0.0 109.394 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.08 -47.44 85.89 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.274 -0.891 . . . . 0.0 109.528 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -72.24 -19.77 61.65 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.215 -0.928 . . . . 0.0 109.545 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.444 ' CD1' ' HA ' ' A' ' 65' ' ' ALA . 7.1 mt -70.29 -63.88 1.0 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.201 -0.937 . . . . 0.0 109.12 179.563 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.31 -12.0 12.04 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.457 -0.777 . . . . 0.0 109.631 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.5 -50.79 62.09 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.15 -0.969 . . . . 0.0 109.369 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -111.36 31.43 6.11 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.195 -0.941 . . . . 0.0 109.724 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 42.5 t -96.7 -12.31 23.96 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.106 -0.996 . . . . 0.0 109.657 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 90.51 -32.96 4.77 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 9.9 t 179.15 112.07 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.981 -1.305 . . . . 0.0 109.537 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -91.77 -150.15 25.1 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 110.034 -1.227 . . . . 0.0 110.034 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -157.94 -83.3 0.04 OUTLIER Glycine 0 N--CA 1.493 2.456 0 O-C-N 121.228 -1.16 . . . . 0.0 110.257 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -113.9 118.0 32.96 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.06 -1.259 . . . . 0.0 109.851 -179.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 97.7 t -109.69 120.35 60.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.256 -0.903 . . . . 0.0 109.731 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.6 mtmt -154.16 149.96 27.61 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.299 -0.876 . . . . 0.0 109.239 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -70.58 97.03 1.26 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.156 -0.965 . . . . 0.0 109.523 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.424 ' O ' ' CG2' ' A' ' 82' ' ' VAL . . . 125.52 -11.42 7.54 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.424 ' CG2' ' O ' ' A' ' 81' ' ' GLY . 57.3 t -156.88 108.33 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.055 -1.262 . . . . 0.0 109.413 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.441 ' HB ' ' HB ' ' A' ' 51' ' ' ILE . 4.1 mt -118.74 104.85 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.208 -0.932 . . . . 0.0 109.52 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -92.92 112.28 24.18 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.295 -0.878 . . . . 0.0 109.615 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 49.5 mm -99.07 89.95 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.229 -0.919 . . . . 0.0 109.29 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -60.13 104.69 0.33 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.224 -0.922 . . . . 0.0 109.548 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 156.57 152.27 6.23 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -112.05 96.83 6.27 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.288 -1.124 . . . . 0.0 109.515 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 16.2 mttt -141.3 48.37 1.67 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.296 -0.878 . . . . 0.0 109.5 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.476 ' HA ' ' CD1' ' A' ' 93' ' ' LEU . 39.2 ptt180 -49.38 -32.01 10.67 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.231 -0.918 . . . . 0.0 109.659 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.41 ' N ' ' HG3' ' A' ' 90' ' ' ARG . 67.8 t0 -62.21 -60.39 3.65 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.228 -0.92 . . . . 0.0 109.572 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.1 tp -59.25 -22.67 61.47 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.167 -0.958 . . . . 0.0 109.351 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.476 ' CD1' ' HA ' ' A' ' 90' ' ' ARG . 35.4 mt -69.11 -46.29 68.07 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.312 -0.868 . . . . 0.0 109.471 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 77.0 tttt -61.73 -25.76 67.64 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.196 -0.94 . . . . 0.0 109.46 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 8.7 t -76.05 -61.05 2.07 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.229 -0.919 . . . . 0.0 109.564 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.5 ' CD1' ' N ' ' A' ' 97' ' ' LEU . 4.2 pp -52.91 -29.72 30.13 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.246 -0.909 . . . . 0.0 109.537 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.5 ' N ' ' CD1' ' A' ' 96' ' ' LEU . 0.2 OUTLIER -72.34 -48.55 41.08 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.22 -0.925 . . . . 0.0 109.491 -179.955 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -68.74 -12.74 61.81 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.244 -0.91 . . . . 0.0 109.465 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -61.97 -33.11 73.7 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.226 -0.921 . . . . 0.0 109.469 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.73 -22.04 27.97 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.22 -0.925 . . . . 0.0 109.491 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 77.89 24.6 64.1 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' MET . . . . . 0.402 ' HE1' ' C ' ' A' ' 32' ' ' GLY . 0.6 OUTLIER -99.09 -158.88 0.7 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.255 -1.144 . . . . 0.0 109.479 -179.991 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 23.3 mttt -104.06 165.06 11.29 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.206 -0.934 . . . . 0.0 109.492 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.447 HG22 ' N ' ' A' ' 105' ' ' LYS . 11.4 p -145.03 158.25 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.24 -0.912 . . . . 0.0 109.458 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.447 ' N ' HG22 ' A' ' 104' ' ' VAL . 33.9 tttt -119.61 68.47 0.82 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.262 -0.899 . . . . 0.0 109.471 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -50.39 96.61 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.212 -0.93 . . . . 0.0 109.478 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.422 ' N ' ' O ' ' A' ' 105' ' ' LYS . . . . . . . . 0 N--CA 1.49 1.568 0 O-C-N 121.325 -0.86 . . . . 0.0 109.509 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 125.61 59.67 0.16 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 73.3 t -108.89 111.29 35.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.263 -1.139 . . . . 0.0 109.423 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 39.8 t -87.65 145.13 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.275 -0.891 . . . . 0.0 109.522 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 31.9 ttm180 -111.55 103.53 11.86 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.228 -0.92 . . . . 0.0 109.437 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.409 ' CD1' HG22 ' A' ' 104' ' ' VAL . 4.7 mt -102.07 106.22 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.196 -0.94 . . . . 0.0 109.538 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.422 ' HB3' ' O ' ' A' ' 106' ' ' LEU . 1.7 pp0? -142.66 136.58 29.22 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.227 -0.921 . . . . 0.0 109.412 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.65 167.03 11.37 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.235 -0.915 . . . . 0.0 109.501 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -150.17 154.29 37.75 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.243 -0.91 . . . . 0.0 109.467 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.555 0 O-C-N 121.298 -0.876 . . . . 0.0 109.468 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 90.7 mttt . . . . . 0 N--CA 1.489 1.513 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.62 85.85 0.65 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 27.7 m -123.69 168.33 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.242 -1.152 . . . . 0.0 109.452 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 2.1 t -140.72 132.51 27.43 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.223 -0.923 . . . . 0.0 109.429 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.09 154.56 39.78 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.265 -0.897 . . . . 0.0 109.449 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.48 HG23 ' CG2' ' A' ' 54' ' ' VAL . 4.5 mm -122.15 117.83 53.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.246 -0.909 . . . . 0.0 109.463 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.1 m -141.84 14.01 2.1 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.261 -0.9 . . . . 0.0 109.525 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.442 ' O ' ' N ' ' A' ' 55' ' ' ASP . . . -105.5 -16.69 15.27 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.48 ' CG2' HG23 ' A' ' 51' ' ' ILE . 18.6 t -44.93 98.9 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.214 -1.168 . . . . 0.0 109.494 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.442 ' N ' ' O ' ' A' ' 53' ' ' GLY . 41.0 t0 -87.34 88.28 7.64 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.201 -0.937 . . . . 0.0 109.459 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.448 ' HB2' HD12 ' A' ' 61' ' ' LEU . 12.9 mt -151.42 -169.95 3.52 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.281 -0.887 . . . . 0.0 109.487 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -74.76 178.49 5.43 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.259 -0.901 . . . . 0.0 109.441 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.53 -30.31 46.95 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.286 -0.884 . . . . 0.0 109.444 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -75.79 -48.66 20.77 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.213 -0.929 . . . . 0.0 109.464 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -62.06 -32.16 72.66 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.276 -0.89 . . . . 0.0 109.466 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.493 ' CD2' ' HA2' ' A' ' 81' ' ' GLY . 0.2 OUTLIER -65.36 -45.83 82.55 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.225 -0.922 . . . . 0.0 109.435 -179.994 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 51.5 p -63.78 -33.88 76.65 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.218 -0.926 . . . . 0.0 109.47 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.423 ' O ' ' HB1' ' A' ' 66' ' ' ALA . 32.6 mttp -65.65 -46.73 78.06 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.29 -0.882 . . . . 0.0 109.469 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.29 -57.65 12.08 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.339 -0.851 . . . . 0.0 109.527 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.55 -23.63 58.87 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.273 -0.892 . . . . 0.0 109.534 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.423 ' HB1' ' O ' ' A' ' 63' ' ' LYS . . . -69.72 -41.49 75.26 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.241 -0.912 . . . . 0.0 109.582 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -76.99 -29.21 55.4 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.203 -0.936 . . . . 0.0 109.566 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.441 ' CD2' HD11 ' A' ' 96' ' ' LEU . 9.8 mt -67.7 -52.22 40.32 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.242 -0.911 . . . . 0.0 109.47 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.46 -12.55 57.85 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.295 -0.878 . . . . 0.0 109.504 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -74.97 -42.11 58.26 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.197 -0.939 . . . . 0.0 109.507 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 5.7 tttp -67.1 -19.86 65.7 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.304 -0.873 . . . . 0.0 109.654 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 43.7 t -88.14 -43.52 11.59 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.193 -0.942 . . . . 0.0 109.552 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.42 ' O ' ' HB2' ' A' ' 74' ' ' CYS . . . 100.62 -19.87 50.63 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.42 ' HB2' ' O ' ' A' ' 73' ' ' GLY . 0.1 OUTLIER 172.08 134.97 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.169 -1.195 . . . . 0.0 109.532 -179.981 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 126.73 -34.45 3.15 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -69.31 98.76 0.59 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -108.9 134.52 51.46 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.305 -1.114 . . . . 0.0 109.17 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.436 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 26.8 m -101.02 160.49 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.269 -0.894 . . . . 0.0 109.817 -179.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.438 ' HB2' ' O ' ' A' ' 82' ' ' VAL . 0.2 OUTLIER -142.05 65.82 1.36 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.362 -0.836 . . . . 0.0 109.208 179.747 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 25.4 t70 50.76 68.7 0.73 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.362 -0.836 . . . . 0.0 109.545 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.493 ' HA2' ' CD2' ' A' ' 61' ' ' LEU . . . 90.3 -28.57 7.32 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.438 ' O ' ' HB2' ' A' ' 79' ' ' LYS . 40.2 t -91.59 90.74 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.161 -1.199 . . . . 0.0 109.559 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.445 HD13 ' HB ' ' A' ' 51' ' ' ILE . 11.7 mt -82.04 155.86 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.276 -0.89 . . . . 0.0 109.437 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -149.56 113.33 5.07 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.2 -0.937 . . . . 0.0 109.436 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 23.8 mt -130.9 107.62 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.215 -0.928 . . . . 0.0 109.511 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -53.74 148.52 9.84 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.235 -0.916 . . . . 0.0 109.397 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 143.55 152.84 5.73 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -133.91 84.14 2.1 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.252 -1.146 . . . . 0.0 109.429 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 84.7 mttt -148.21 52.22 1.02 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.282 -0.886 . . . . 0.0 109.478 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 11.8 ptt-85 -46.58 -31.95 3.13 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.25 -0.906 . . . . 0.0 109.472 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -55.78 -55.21 35.03 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.236 -0.915 . . . . 0.0 109.465 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 8.2 tt -63.16 -49.32 74.77 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.176 -0.952 . . . . 0.0 109.491 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -47.87 -31.04 4.61 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.229 -0.919 . . . . 0.0 109.481 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 34.4 tttt -60.63 -62.77 1.62 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.241 -0.912 . . . . 0.0 109.53 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.57 -16.83 58.28 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.247 -0.908 . . . . 0.0 109.495 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.441 HD11 ' CD2' ' A' ' 68' ' ' LEU . 5.4 tt -72.62 -43.92 62.64 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.287 -0.883 . . . . 0.0 109.513 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -74.1 -38.41 63.86 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.287 -0.883 . . . . 0.0 109.484 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -69.73 -20.9 63.51 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.281 -0.887 . . . . 0.0 109.475 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -55.62 -29.93 60.03 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.262 -0.899 . . . . 0.0 109.497 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.43 -25.37 21.54 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.281 -0.887 . . . . 0.0 109.492 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 95.26 28.44 9.81 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 31.4 mtm -109.5 179.93 4.0 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.226 -1.161 . . . . 0.0 109.471 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 8.7 mmtt -88.85 162.16 16.31 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.259 -0.901 . . . . 0.0 109.456 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.409 HG22 ' CD1' ' A' ' 36' ' ' ILE . 3.2 p -154.39 135.79 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.218 -0.926 . . . . 0.0 109.464 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 12.5 mttt -108.56 104.41 13.72 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.253 -0.904 . . . . 0.0 109.464 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.422 ' O ' ' HB3' ' A' ' 37' ' ' GLN . 1.1 tp -47.86 -24.45 1.01 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.25 -0.906 . . . . 0.0 109.453 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.409 ' C ' ' O ' ' A' ' 106' ' ' LEU . . . . . . . . 0 N--CA 1.489 1.511 0 O-C-N 121.215 -0.928 . . . . 0.0 109.475 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 19.0 t70 . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.428 ' HA3' ' SD ' ' A' ' 102' ' ' MET . . . 112.61 125.9 4.53 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 93.7 t -143.16 93.95 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.252 -1.146 . . . . 0.0 109.478 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.44 HG11 HG21 ' A' ' 51' ' ' ILE . 70.5 t -93.23 109.46 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.289 -0.882 . . . . 0.0 109.454 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.425 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 71.9 mtt180 -92.34 131.8 37.24 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.24 -0.913 . . . . 0.0 109.545 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.402 ' CG1' HG12 ' A' ' 51' ' ' ILE . 7.0 mt -125.55 127.22 71.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.219 -0.926 . . . . 0.0 109.421 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.476 ' HA ' ' CB ' ' A' ' 107' ' ' ALA . 1.7 pt20 -151.03 -167.89 2.94 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.176 -0.953 . . . . 0.0 109.526 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.406 ' HG3' ' O ' ' A' ' 38' ' ' ARG . 5.4 ptt180 -137.11 118.8 14.99 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.229 -0.919 . . . . 0.0 109.504 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -91.36 118.63 30.69 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.183 -0.948 . . . . 0.0 109.442 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 29.0 p . . . . . 0 N--CA 1.49 1.533 0 O-C-N 121.263 -0.898 . . . . 0.0 109.428 179.922 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 51.9 mttt . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -141.93 -163.93 9.83 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.586 -1.405 . . . . 0.0 109.586 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 22.9 m -154.58 146.11 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.269 -1.136 . . . . 0.0 109.521 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -90.04 131.27 36.01 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.288 -0.883 . . . . 0.0 109.435 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.1 115.86 25.68 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.255 -0.903 . . . . 0.0 109.46 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.442 HD12 HG13 ' A' ' 85' ' ' ILE . 8.1 mt -120.37 110.5 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.212 -0.93 . . . . 0.0 109.458 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 9.8 t -142.95 162.89 34.27 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.238 -0.914 . . . . 0.0 109.637 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.49 22.24 13.09 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.611 -1.395 . . . . 0.0 109.611 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.456 ' HB ' HD23 ' A' ' 61' ' ' LEU . 61.7 t -78.41 112.71 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.22 -1.165 . . . . 0.0 109.443 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -97.15 70.48 2.37 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.294 -0.879 . . . . 0.0 109.541 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.449 HD12 HG12 ' A' ' 54' ' ' VAL . 10.3 mt -136.87 172.7 12.62 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.167 -0.958 . . . . 0.0 109.524 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -47.75 170.71 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.218 -0.926 . . . . 0.0 109.45 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -76.55 -39.8 51.73 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.232 -0.917 . . . . 0.0 109.468 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.09 -31.01 72.04 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.243 -0.91 . . . . 0.0 109.496 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -62.03 -45.92 91.47 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.269 -0.894 . . . . 0.0 109.543 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.456 HD23 ' HB ' ' A' ' 54' ' ' VAL . 8.4 mt -53.04 -42.69 65.98 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.249 -0.907 . . . . 0.0 109.472 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 52.2 m -71.9 -26.28 62.26 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.264 -0.898 . . . . 0.0 109.425 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.2 tttt -63.49 -59.91 4.04 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.256 -0.902 . . . . 0.0 109.393 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.9 mt -64.7 -31.55 72.82 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.281 -0.887 . . . . 0.0 109.538 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -57.5 -49.63 75.68 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.272 -0.892 . . . . 0.0 109.662 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -71.81 -28.04 63.33 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.244 -0.91 . . . . 0.0 109.628 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -64.45 -33.08 75.05 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.219 -0.926 . . . . 0.0 109.907 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 6.0 mt -88.04 -34.52 17.96 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.102 -0.999 . . . . 0.0 109.921 -179.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.8 mttt -63.24 -16.9 61.66 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.139 -0.975 . . . . 0.0 109.778 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 13.5 tttt -75.28 -28.15 59.67 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.18 -0.95 . . . . 0.0 109.707 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 7.2 mtpp -72.42 -67.84 0.52 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.169 -0.957 . . . . 0.0 109.243 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -64.63 -56.72 12.03 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.19 -0.944 . . . . 0.0 109.195 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.468 ' O ' ' HB2' ' A' ' 74' ' ' CYS . . . 84.31 12.88 75.07 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.468 ' HB2' ' O ' ' A' ' 73' ' ' GLY . 4.7 t 166.46 126.73 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.478 -1.013 . . . . 0.0 108.994 -179.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 113.86 -5.95 24.02 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -110.08 125.63 7.61 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.194 -1.563 . . . . 0.0 109.194 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -110.15 121.41 45.21 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.169 -1.194 . . . . 0.0 109.939 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 36.9 t -86.92 124.34 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.276 -0.89 . . . . 0.0 109.122 179.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -120.41 145.7 46.94 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.209 -0.932 . . . . 0.0 109.201 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.0 101.17 1.08 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.289 -0.882 . . . . 0.0 109.493 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 103.53 -11.53 54.03 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 65.0 t -142.85 121.29 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.323 -1.104 . . . . 0.0 109.426 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 26.8 mm -104.3 121.18 55.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.226 -0.921 . . . . 0.0 109.589 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -105.68 120.33 41.41 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.315 -0.866 . . . . 0.0 109.401 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.442 HG13 HD12 ' A' ' 51' ' ' ILE . 14.8 mm -117.6 164.4 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.176 -0.952 . . . . 0.0 109.517 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -124.69 132.89 53.36 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.311 -0.868 . . . . 0.0 109.583 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 136.87 168.31 11.37 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -135.62 82.11 1.93 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.29 -1.124 . . . . 0.0 109.559 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 43.7 mttt -142.88 51.68 1.41 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.217 -0.927 . . . . 0.0 109.478 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.64 -25.95 0.81 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.24 -0.912 . . . . 0.0 109.447 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -64.85 -58.33 6.47 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.244 -0.91 . . . . 0.0 109.373 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.0 tt -58.13 -49.08 78.24 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.245 -0.909 . . . . 0.0 109.308 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.452 ' O ' ' HB3' ' A' ' 96' ' ' LEU . 3.4 mt -52.1 -33.63 40.53 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.278 -0.889 . . . . 0.0 109.408 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.429 ' CG ' ' CD1' ' A' ' 106' ' ' LEU . 0.1 OUTLIER -60.53 -58.49 8.25 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.292 -0.88 . . . . 0.0 109.388 179.923 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 3.2 t -65.79 -11.76 48.63 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.213 -0.929 . . . . 0.0 109.447 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.452 ' HB3' ' O ' ' A' ' 93' ' ' LEU . 3.1 tt -74.9 -59.2 2.84 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.24 -0.913 . . . . 0.0 109.423 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.498 ' CD1' ' HB2' ' A' ' 102' ' ' MET . 0.1 OUTLIER -69.56 -23.29 63.54 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.286 -0.883 . . . . 0.0 109.49 179.975 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -73.39 -26.46 61.0 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.282 -0.886 . . . . 0.0 109.516 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -71.03 -22.26 62.17 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.252 -0.905 . . . . 0.0 109.489 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 4.0 mtmt -94.29 8.0 43.37 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.231 -0.918 . . . . 0.0 109.508 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 46.32 33.29 5.65 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' MET . . . . . 0.498 ' HB2' ' CD1' ' A' ' 97' ' ' LEU . 0.1 OUTLIER -86.93 -173.43 4.46 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.268 -1.137 . . . . 0.0 109.471 -179.993 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 16.8 mttt -101.16 72.06 1.43 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.262 -0.899 . . . . 0.0 109.459 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 8.3 p -88.68 145.69 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.232 -0.918 . . . . 0.0 109.532 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.403 ' O ' ' C ' ' A' ' 106' ' ' LEU . 21.5 tttt -110.79 30.27 7.0 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.277 -0.889 . . . . 0.0 109.446 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.429 ' CD1' ' CG ' ' A' ' 94' ' ' LYS . 3.5 tp 44.6 -154.28 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.251 -0.905 . . . . 0.0 109.487 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.476 ' CB ' ' HA ' ' A' ' 37' ' ' GLN . . . . . . . . 0 N--CA 1.49 1.545 0 O-C-N 121.221 -0.924 . . . . 0.0 109.463 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 16.1 t0 . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 121.252 0.549 . . . . 0.0 109.531 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -160.33 148.1 15.95 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.8 m -131.68 145.41 35.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.271 -1.135 . . . . 0.0 109.491 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.4 t -111.28 164.71 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.23 -0.919 . . . . 0.0 109.442 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -141.57 112.24 7.14 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.237 -0.915 . . . . 0.0 109.444 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 4.5 mt -125.78 117.1 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.259 -0.901 . . . . 0.0 109.483 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.71 98.16 2.93 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.303 -0.873 . . . . 0.0 109.449 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.2 ptt180 -56.38 125.68 23.04 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.284 -0.885 . . . . 0.0 109.515 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -110.78 79.14 1.17 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.208 -0.932 . . . . 0.0 109.494 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 33.7 p . . . . . 0 N--CA 1.49 1.552 0 O-C-N 121.209 -0.932 . . . . 0.0 109.476 -179.96 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 10.8 tttt . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -144.75 152.58 24.54 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 34.5 m -106.01 167.88 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.233 -1.157 . . . . 0.0 109.428 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -128.88 113.1 14.83 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.187 -0.946 . . . . 0.0 109.477 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -89.04 143.78 26.61 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.198 -0.939 . . . . 0.0 109.528 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 6.4 mm -127.33 108.32 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.207 -0.933 . . . . 0.0 109.414 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -155.14 154.58 32.55 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.274 -0.891 . . . . 0.0 109.494 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 115.5 -28.72 7.67 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 24.2 t -45.76 109.84 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.311 -1.111 . . . . 0.0 109.457 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -90.73 75.89 6.49 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.284 -0.885 . . . . 0.0 109.466 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -114.12 -171.5 1.92 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.259 -0.9 . . . . 0.0 109.485 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -72.5 -69.72 0.39 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.258 -0.901 . . . . 0.0 109.473 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -178.93 -43.03 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.256 -0.903 . . . . 0.0 109.465 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.406 ' O ' ' OG1' ' A' ' 62' ' ' THR . . . -76.92 -30.58 56.18 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.247 -0.908 . . . . 0.0 109.525 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -59.1 -45.48 90.75 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.223 -0.923 . . . . 0.0 109.523 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -50.89 -52.8 38.35 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.238 -0.914 . . . . 0.0 109.42 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.406 ' OG1' ' O ' ' A' ' 59' ' ' ALA . 34.0 p -57.57 -40.66 79.46 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.304 -0.872 . . . . 0.0 109.405 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 7.7 tttt -54.57 -45.04 73.44 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.3 -0.875 . . . . 0.0 109.536 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.0 -46.01 86.44 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.24 -0.912 . . . . 0.0 109.509 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -49.72 -43.83 47.9 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.199 -0.938 . . . . 0.0 109.548 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -69.37 -35.96 76.35 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.272 -0.892 . . . . 0.0 109.577 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -65.44 -21.61 66.67 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.211 -0.931 . . . . 0.0 109.627 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 5.4 mt -87.25 -44.4 11.47 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.305 -0.872 . . . . 0.0 109.673 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.449 ' O ' ' HG2' ' A' ' 69' ' ' LYS . 10.0 tttt -64.59 -22.7 67.04 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.259 -0.901 . . . . 0.0 109.801 -179.686 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.24 -15.52 47.58 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.178 -0.951 . . . . 0.0 110.004 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.8 23.87 1.09 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.057 -1.027 . . . . 0.0 109.656 -179.589 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -105.39 -24.56 12.63 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.303 -0.873 . . . . 0.0 109.551 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.43 ' O ' ' SG ' ' A' ' 74' ' ' CYS . . . 94.03 -10.74 71.65 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 -179.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.43 ' SG ' ' O ' ' A' ' 73' ' ' GLY . 0.7 OUTLIER 174.07 134.86 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.325 -1.103 . . . . 0.0 109.281 179.983 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -72.66 -80.49 0.41 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 120.66 -109.34 1.54 Allowed Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -106.0 131.39 53.35 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.153 -1.204 . . . . 0.0 109.417 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 90.4 t -136.33 97.37 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.23 -0.919 . . . . 0.0 109.83 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.2 146.71 27.59 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.194 -0.941 . . . . 0.0 108.761 179.321 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -63.27 94.43 0.08 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.112 -0.992 . . . . 0.0 109.609 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 129.88 -25.95 4.33 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.444 ' O ' HG13 ' A' ' 83' ' ' ILE . 1.6 m -143.59 157.79 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.182 -1.187 . . . . 0.0 109.673 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.493 HG23 ' N ' ' A' ' 84' ' ' GLU . 4.2 mp -143.71 146.74 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.223 -0.923 . . . . 0.0 109.467 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.493 ' N ' HG23 ' A' ' 83' ' ' ILE . 3.4 mt-10 -130.28 125.96 36.08 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.238 -0.914 . . . . 0.0 109.423 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.44 HG23 ' N ' ' A' ' 86' ' ' GLN . 28.1 mm -114.69 157.18 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.215 -0.928 . . . . 0.0 109.5 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . 0.44 ' N ' HG23 ' A' ' 85' ' ' ILE . 0.0 OUTLIER -115.9 86.02 2.4 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.206 -0.934 . . . . 0.0 109.469 -179.963 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -164.48 166.85 38.07 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -119.38 49.22 1.38 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.246 -1.149 . . . . 0.0 109.482 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 31.4 mttt -105.52 37.0 2.32 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.211 -0.931 . . . . 0.0 109.459 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 7.3 ttt180 -46.81 -36.85 7.83 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.26 -0.9 . . . . 0.0 109.474 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -58.03 -53.66 55.75 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.242 -0.912 . . . . 0.0 109.547 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.11 -17.8 64.94 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.231 -0.918 . . . . 0.0 109.526 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.434 ' HA ' ' CD2' ' A' ' 96' ' ' LEU . 2.1 mt -72.56 -44.85 61.53 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.302 -0.874 . . . . 0.0 109.494 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 61.6 tttt -65.96 -32.98 74.78 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.224 -0.923 . . . . 0.0 109.477 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 14.3 t -67.54 -62.69 1.3 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.25 -0.906 . . . . 0.0 109.448 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.532 ' CD1' ' N ' ' A' ' 97' ' ' LEU . 4.2 pp -51.64 -31.61 26.1 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.195 -0.941 . . . . 0.0 109.471 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.532 ' N ' ' CD1' ' A' ' 96' ' ' LEU . 0.2 OUTLIER -65.14 -47.01 78.6 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.223 -0.923 . . . . 0.0 109.494 179.968 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 72.4 tt0 -69.19 -14.26 62.88 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.298 -0.876 . . . . 0.0 109.455 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -73.42 -13.93 61.17 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.212 -0.93 . . . . 0.0 109.434 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.35 -31.28 11.4 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.262 -0.899 . . . . 0.0 109.441 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 100.68 15.8 28.25 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 1.5 mtm -88.2 156.12 19.4 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.192 -1.181 . . . . 0.0 109.49 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 27.2 mttt -86.17 97.61 10.44 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.285 -0.885 . . . . 0.0 109.468 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.407 HG22 HD13 ' A' ' 106' ' ' LEU . 12.5 p -81.43 140.66 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.226 -0.921 . . . . 0.0 109.46 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.47 ' O ' ' N ' ' A' ' 107' ' ' ALA . 0.7 OUTLIER -111.41 77.41 1.04 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.224 -0.923 . . . . 0.0 109.469 -179.994 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.407 HD13 HG22 ' A' ' 104' ' ' VAL . 1.5 mp -46.54 96.44 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.185 -0.947 . . . . 0.0 109.471 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.47 ' N ' ' O ' ' A' ' 105' ' ' LYS . . . . . . . . 0 N--CA 1.49 1.552 0 O-C-N 121.265 -0.897 . . . . 0.0 109.488 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 23.0 t0 . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.414 ' O ' ' HB2' ' A' ' 103' ' ' LYS . . . -138.64 123.45 2.61 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.41 HG23 ' CB ' ' A' ' 103' ' ' LYS . 73.2 t -146.91 104.5 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.242 -1.152 . . . . 0.0 109.454 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.415 HG21 HD13 ' A' ' 97' ' ' LEU . 21.4 t -92.88 151.09 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.253 -0.904 . . . . 0.0 109.432 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 2.0 ttt180 -121.82 112.4 18.3 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.25 -0.906 . . . . 0.0 109.487 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.445 HG21 ' HB3' ' A' ' 93' ' ' LEU . 2.2 mp -123.44 114.54 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.266 -0.896 . . . . 0.0 109.406 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -150.59 -162.13 1.49 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.212 -0.93 . . . . 0.0 109.446 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 30.8 mtm180 -123.77 139.19 54.22 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.233 -0.917 . . . . 0.0 109.452 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.488 ' CB ' HD13 ' A' ' 50' ' ' LEU . 13.5 tt0 -116.05 60.17 0.72 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.247 -0.908 . . . . 0.0 109.472 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.6 p . . . . . 0 N--CA 1.491 1.589 0 O-C-N 121.261 -0.9 . . . . 0.0 109.438 -179.965 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 19.6 mttt . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 121.265 0.555 . . . . 0.0 109.547 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -109.11 149.05 17.06 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.9 m -119.57 145.74 25.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.307 -1.113 . . . . 0.0 109.468 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 2.3 t -111.46 139.79 46.59 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.269 -0.894 . . . . 0.0 109.437 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.488 HD13 ' CB ' ' A' ' 39' ' ' GLN . 2.1 mp -130.35 119.91 23.51 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.246 -0.909 . . . . 0.0 109.516 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.422 ' HB ' HD11 ' A' ' 83' ' ' ILE . 3.1 mm -101.19 124.7 55.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.229 -0.919 . . . . 0.0 109.379 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -159.63 159.52 33.2 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.199 -0.938 . . . . 0.0 109.491 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.412 ' O ' ' C ' ' A' ' 54' ' ' VAL . . . 105.76 -29.06 11.93 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.412 ' C ' ' O ' ' A' ' 53' ' ' GLY . 62.5 t -45.22 117.75 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.213 -1.169 . . . . 0.0 109.421 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -111.95 72.24 0.77 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.26 -0.9 . . . . 0.0 109.511 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.7 mt -126.04 -170.31 2.17 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.216 -0.928 . . . . 0.0 109.456 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -56.03 147.77 19.19 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.242 -0.911 . . . . 0.0 109.475 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.94 -33.49 73.25 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.274 -0.891 . . . . 0.0 109.518 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -77.27 -29.06 53.69 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.231 -0.918 . . . . 0.0 109.385 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -69.27 -30.51 68.64 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.303 -0.873 . . . . 0.0 109.45 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.7 mt -66.21 -58.35 5.59 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.271 -0.893 . . . . 0.0 109.496 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -57.68 -19.4 26.71 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.197 -0.939 . . . . 0.0 109.376 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 9.3 mttt -76.68 -44.33 34.16 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.309 -0.869 . . . . 0.0 109.558 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.88 -29.0 64.98 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.209 -0.932 . . . . 0.0 109.508 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -72.25 -52.38 16.67 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.245 -0.909 . . . . 0.0 109.382 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.9 -48.78 80.21 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.237 -0.915 . . . . 0.0 109.551 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -54.0 -46.27 71.72 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.196 -0.94 . . . . 0.0 109.331 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -59.5 -36.54 76.24 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.277 -0.889 . . . . 0.0 109.238 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 7.9 tmtt? -61.54 -37.96 85.68 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.333 -0.855 . . . . 0.0 109.286 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 11.3 mttt -58.05 -25.46 61.24 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.234 -0.916 . . . . 0.0 108.955 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 1.7 mtmp? -122.0 50.19 1.48 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.513 -0.742 . . . . 0.0 109.217 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 23.4 t -133.72 -63.51 0.74 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.178 -0.951 . . . . 0.0 109.686 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.47 ' O ' ' HB2' ' A' ' 74' ' ' CYS . . . 120.17 10.25 7.53 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -179.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.47 ' HB2' ' O ' ' A' ' 73' ' ' GLY . 4.6 t 168.3 127.92 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.325 -1.103 . . . . 0.0 109.193 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -94.53 101.58 2.75 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -66.99 -109.01 0.02 OUTLIER Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -111.75 121.77 46.0 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.205 -1.173 . . . . 0.0 109.302 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 22.9 t -116.43 78.12 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.21 -0.931 . . . . 0.0 109.808 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -88.28 145.62 25.76 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.243 -0.911 . . . . 0.0 109.201 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -65.0 91.42 0.09 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.201 -0.937 . . . . 0.0 109.507 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 129.07 -24.34 4.79 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.0 t -139.04 137.86 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.152 -1.205 . . . . 0.0 109.582 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.422 HD11 ' HB ' ' A' ' 51' ' ' ILE . 4.2 mt -132.01 135.34 58.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.353 -0.842 . . . . 0.0 109.55 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 68.1 mt-10 -132.25 116.47 16.97 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.302 -0.874 . . . . 0.0 109.207 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 56.1 mt -148.36 146.72 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.225 -0.922 . . . . 0.0 109.621 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -72.74 141.58 48.14 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.24 -0.912 . . . . 0.0 109.309 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 167.7 122.33 0.61 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -106.96 51.61 0.74 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.321 -1.105 . . . . 0.0 109.538 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 85.5 mttt -131.9 53.42 2.0 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.252 -0.905 . . . . 0.0 109.478 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 32.5 ptt180 -53.13 -27.48 21.1 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.24 -0.912 . . . . 0.0 109.358 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 48.1 t0 -65.41 -53.33 44.76 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.29 -0.881 . . . . 0.0 109.393 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.9 tt -58.71 -48.35 81.43 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.274 -0.891 . . . . 0.0 109.424 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.445 ' HB3' HG21 ' A' ' 36' ' ' ILE . 5.9 mt -53.93 -38.97 65.45 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.252 -0.905 . . . . 0.0 109.429 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.1 ttmt -68.26 -31.26 70.6 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.253 -0.904 . . . . 0.0 109.494 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 21.8 t -67.54 -64.03 0.94 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.236 -0.915 . . . . 0.0 109.471 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.489 HD13 ' N ' ' A' ' 97' ' ' LEU . 2.6 pp -50.62 -38.27 44.98 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.277 -0.889 . . . . 0.0 109.499 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.489 ' N ' HD13 ' A' ' 96' ' ' LEU . 0.2 OUTLIER -59.44 -45.13 92.46 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.218 -0.926 . . . . 0.0 109.485 179.978 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -69.68 -17.07 63.46 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.257 -0.902 . . . . 0.0 109.444 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.41 ' HB1' ' O ' ' A' ' 96' ' ' LEU . . . -67.98 -27.47 66.6 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.251 -0.905 . . . . 0.0 109.459 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.492 ' HD2' ' N ' ' A' ' 100' ' ' LYS . 6.7 mptt -85.13 -16.35 40.77 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.228 -0.92 . . . . 0.0 109.442 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 88.73 23.96 34.4 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' MET . . . . . 0.41 ' HB2' ' CD1' ' A' ' 97' ' ' LEU . 1.2 mtm -97.77 171.17 8.49 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.265 -1.138 . . . . 0.0 109.467 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.414 ' HB2' ' O ' ' A' ' 32' ' ' GLY . 8.7 mttt -84.62 165.74 17.71 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.231 -0.918 . . . . 0.0 109.484 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.8 t -147.91 124.16 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.275 -0.891 . . . . 0.0 109.485 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 5.9 mttt -109.38 79.07 1.18 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.256 -0.903 . . . . 0.0 109.468 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 6.2 mt -46.18 105.53 0.06 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.297 -0.877 . . . . 0.0 109.482 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.56 0 O-C-N 121.277 -0.89 . . . . 0.0 109.466 -179.994 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 149.54 130.98 1.89 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.5 p -160.03 131.26 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.265 -1.138 . . . . 0.0 109.449 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.507 ' CG1' HG21 ' A' ' 51' ' ' ILE . 75.6 t -105.54 153.65 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.261 -0.899 . . . . 0.0 109.468 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.406 ' HB3' ' O ' ' A' ' 52' ' ' THR . 24.6 ttt180 -129.65 100.89 5.68 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.192 -0.942 . . . . 0.0 109.513 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.517 HG21 ' CD1' ' A' ' 93' ' ' LEU . 1.2 mp -102.81 125.75 57.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.232 -0.918 . . . . 0.0 109.397 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -122.63 -166.81 1.48 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.235 -0.916 . . . . 0.0 109.468 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 14.1 ptt180 -152.54 132.7 13.51 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.197 -0.939 . . . . 0.0 109.476 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -118.13 110.37 17.52 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.23 -0.919 . . . . 0.0 109.488 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 5.7 t . . . . . 0 N--CA 1.49 1.558 0 O-C-N 121.275 -0.89 . . . . 0.0 109.453 -179.962 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 12.4 ttmt . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 121.284 0.564 . . . . 0.0 109.515 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -178.35 131.26 1.71 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.402 ' O ' HG23 ' A' ' 48' ' ' VAL . 21.2 m -131.49 147.26 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.245 -1.15 . . . . 0.0 109.528 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 1.8 m -125.01 118.34 26.0 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.269 -0.895 . . . . 0.0 109.494 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -113.1 138.93 49.19 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.218 -0.926 . . . . 0.0 109.503 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.559 ' CD1' ' N ' ' A' ' 51' ' ' ILE . 2.7 mp -108.37 122.62 63.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.234 -0.916 . . . . 0.0 109.394 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.406 ' O ' ' HB3' ' A' ' 35' ' ' ARG . 0.5 OUTLIER -146.25 156.53 43.45 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.287 -0.883 . . . . 0.0 109.534 -179.898 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 93.89 23.14 23.81 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 10.1 t -80.55 115.38 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.304 -1.115 . . . . 0.0 109.552 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -94.14 76.91 4.05 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.265 -0.897 . . . . 0.0 109.443 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -144.9 177.75 8.51 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.263 -0.898 . . . . 0.0 109.409 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -56.97 158.35 4.97 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.216 -0.927 . . . . 0.0 109.519 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.72 -48.35 59.82 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.32 -0.862 . . . . 0.0 109.495 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.92 -33.69 70.85 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.279 -0.888 . . . . 0.0 109.411 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.421 ' O ' ' C ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -59.47 -54.05 51.05 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.232 -0.917 . . . . 0.0 109.418 179.951 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.421 ' C ' ' O ' ' A' ' 60' ' ' GLU . 0.3 OUTLIER -44.58 -42.75 7.59 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.239 -0.913 . . . . 0.0 109.196 179.844 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 60.9 m -58.54 -50.63 73.08 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.263 -0.898 . . . . 0.0 109.166 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -52.5 -30.39 29.96 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.26 -0.9 . . . . 0.0 109.137 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -68.81 -53.48 21.31 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.344 -0.847 . . . . 0.0 109.485 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -52.68 -33.76 48.88 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.242 -0.911 . . . . 0.0 109.308 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -71.98 -41.88 67.16 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.278 -0.889 . . . . 0.0 109.284 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -65.11 -19.79 66.15 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.22 -0.925 . . . . 0.0 109.357 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -84.02 -57.3 3.25 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.229 -0.919 . . . . 0.0 109.447 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 6.2 mttt -60.11 -22.75 63.19 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.281 -0.887 . . . . 0.0 109.412 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.8 -42.67 47.44 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.262 -0.899 . . . . 0.0 109.496 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 2.1 ptmt -129.14 70.17 1.41 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.271 -0.893 . . . . 0.0 109.332 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -144.33 -42.7 0.26 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.311 -0.868 . . . . 0.0 109.424 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.466 ' O ' ' HB2' ' A' ' 74' ' ' CYS . . . 119.49 -62.09 0.48 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.466 ' HB2' ' O ' ' A' ' 73' ' ' GLY . 17.0 t 172.31 107.49 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.344 -1.092 . . . . 0.0 109.323 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 160.38 50.77 0.01 OUTLIER Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -117.97 116.92 3.58 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -104.05 110.25 22.35 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.337 -1.096 . . . . 0.0 109.004 179.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.2 t -85.16 84.22 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.214 -0.929 . . . . 0.0 109.814 -179.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.442 ' HB3' ' HB ' ' A' ' 82' ' ' VAL . 20.3 mmtt -90.9 169.18 11.13 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.287 -0.883 . . . . 0.0 108.955 179.505 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -60.63 112.75 2.12 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.113 -0.992 . . . . 0.0 109.578 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 51.99 27.78 22.92 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.442 ' HB ' ' HB3' ' A' ' 79' ' ' LYS . 43.4 t -141.65 88.19 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.152 -1.205 . . . . 0.0 109.536 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 4.7 mm -83.53 102.12 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.246 -0.908 . . . . 0.0 109.306 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -82.92 126.66 32.73 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.284 -0.885 . . . . 0.0 109.73 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 18.6 mm -133.96 110.62 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.265 -0.897 . . . . 0.0 109.406 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -72.77 128.95 37.06 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.263 -0.898 . . . . 0.0 109.573 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 145.04 136.56 3.03 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -95.89 89.56 5.29 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.251 -1.147 . . . . 0.0 109.445 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 3.1 mttt -144.55 53.23 1.25 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.205 -0.934 . . . . 0.0 109.5 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 51.2 ttt180 -64.02 -40.73 96.98 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.251 -0.906 . . . . 0.0 109.483 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -53.82 -44.06 69.92 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.211 -0.931 . . . . 0.0 109.46 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 3.6 tt -75.11 -26.63 59.4 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.267 -0.896 . . . . 0.0 109.532 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.517 ' CD1' HG21 ' A' ' 36' ' ' ILE . 22.8 mt -61.63 -42.86 99.47 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.263 -0.898 . . . . 0.0 109.474 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 17.3 tttt -67.03 -26.74 66.92 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.24 -0.913 . . . . 0.0 109.592 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 1.2 t -70.72 -62.34 1.43 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.224 -0.922 . . . . 0.0 109.534 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.485 ' CD1' ' N ' ' A' ' 97' ' ' LEU . 4.6 pp -54.93 -31.43 60.3 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.228 -0.92 . . . . 0.0 109.534 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.485 ' N ' ' CD1' ' A' ' 96' ' ' LEU . 0.2 OUTLIER -67.64 -47.4 69.69 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.183 -0.948 . . . . 0.0 109.559 -179.917 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.53 -15.36 63.23 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.223 -0.923 . . . . 0.0 109.589 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -69.79 -12.75 61.87 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.222 -0.924 . . . . 0.0 109.464 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.19 -37.49 20.07 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.246 -0.908 . . . . 0.0 109.497 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 101.45 22.96 9.89 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -119.6 -172.89 2.41 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.198 -1.177 . . . . 0.0 109.466 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 6.6 tttt -86.54 162.01 18.26 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.252 -0.905 . . . . 0.0 109.484 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.459 ' CG2' ' HG ' ' A' ' 97' ' ' LEU . 12.7 p -152.32 153.47 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.262 -0.899 . . . . 0.0 109.429 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 6.0 mttt -131.64 90.12 2.8 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.212 -0.93 . . . . 0.0 109.494 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.494 ' O ' ' CB ' ' A' ' 107' ' ' ALA . 4.6 mm? -54.85 -30.13 56.93 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.259 -0.901 . . . . 0.0 109.476 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.494 ' CB ' ' O ' ' A' ' 106' ' ' LEU . . . . . . . . 0 N--CA 1.49 1.555 0 O-C-N 121.265 -0.897 . . . . 0.0 109.433 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 27.4 t0 . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 171.72 120.36 0.55 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.5 m -132.17 115.48 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.307 -1.114 . . . . 0.0 109.463 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.455 HG21 ' HE3' ' A' ' 102' ' ' MET . 97.0 t -80.62 159.84 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.273 -0.892 . . . . 0.0 109.513 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 4.5 mtp180 -145.59 127.76 15.7 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.282 -0.887 . . . . 0.0 109.441 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.473 HG22 ' CD1' ' A' ' 93' ' ' LEU . 2.7 mp -132.48 109.18 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.274 -0.891 . . . . 0.0 109.497 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.442 ' CB ' ' HB1' ' A' ' 107' ' ' ALA . 2.6 pt20 -140.02 157.39 45.74 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.294 -0.879 . . . . 0.0 109.467 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.42 ' HG2' ' HD3' ' A' ' 90' ' ' ARG . 7.8 ptt180 -96.15 135.96 37.24 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.249 -0.907 . . . . 0.0 109.433 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -108.39 95.41 5.65 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.26 -0.9 . . . . 0.0 109.458 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.565 0 O-C-N 121.226 -0.921 . . . . 0.0 109.461 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 21.8 mttt . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -95.03 177.13 35.09 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.7 m -151.46 154.36 8.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.258 -1.142 . . . . 0.0 109.477 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 6.9 t -119.34 110.64 17.21 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.261 -0.9 . . . . 0.0 109.493 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -97.12 131.7 43.63 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.29 -0.881 . . . . 0.0 109.411 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 63.6 mt -125.36 114.95 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.229 -0.919 . . . . 0.0 109.533 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -151.84 170.35 20.02 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.252 -0.905 . . . . 0.0 109.435 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.19 -15.91 58.66 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 53.4 t -56.92 108.47 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.269 -1.136 . . . . 0.0 109.474 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -86.16 78.16 9.43 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.296 -0.878 . . . . 0.0 109.471 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -134.53 159.03 42.42 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.247 -0.908 . . . . 0.0 109.46 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.448 ' O ' ' O ' ' A' ' 58' ' ' ASP . 0.2 OUTLIER -76.61 157.02 32.27 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.203 -0.936 . . . . 0.0 109.501 179.963 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.522 ' O ' ' CB ' ' A' ' 59' ' ' ALA . 0.2 OUTLIER -50.73 -179.48 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.298 -0.876 . . . . 0.0 109.523 -179.963 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.522 ' CB ' ' O ' ' A' ' 58' ' ' ASP . . . 76.98 -78.9 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.313 -0.867 . . . . 0.0 109.501 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -55.1 -36.77 66.03 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.236 -0.915 . . . . 0.0 109.543 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -58.76 -48.29 81.73 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.181 -0.95 . . . . 0.0 109.478 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -61.85 -28.11 69.26 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.211 -0.931 . . . . 0.0 109.463 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -68.67 -51.54 40.79 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.276 -0.89 . . . . 0.0 109.388 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.59 -33.59 72.95 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.218 -0.926 . . . . 0.0 109.309 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -64.17 -52.1 60.6 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.262 -0.899 . . . . 0.0 109.371 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.67 -22.31 66.95 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.238 -0.914 . . . . 0.0 109.322 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.99 -55.19 13.58 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.256 -0.902 . . . . 0.0 109.425 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.3 mp -69.36 -22.47 63.74 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.186 -0.946 . . . . 0.0 109.415 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.93 -37.38 72.87 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.275 -0.891 . . . . 0.0 109.504 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 19.7 tttt -68.82 -12.85 61.97 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.248 -0.907 . . . . 0.0 109.414 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 20.3 mttm -75.47 -22.47 57.22 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.318 -0.864 . . . . 0.0 109.818 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -103.66 -34.39 8.63 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.185 -0.947 . . . . 0.0 110.008 -179.428 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.446 ' O ' ' CB ' ' A' ' 74' ' ' CYS . . . 76.21 32.09 53.17 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 108.764 -1.734 . . . . 0.0 108.764 -179.437 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.446 ' CB ' ' O ' ' A' ' 73' ' ' GLY . 0.0 OUTLIER 167.35 152.05 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.475 -1.015 . . . . 0.0 109.126 -179.695 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 67.6 123.94 0.02 OUTLIER Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -173.89 92.59 0.09 OUTLIER Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -104.07 123.31 47.02 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.221 -1.164 . . . . 0.0 109.081 179.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 33.7 m -110.49 170.24 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.141 -0.974 . . . . 0.0 109.541 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.415 ' CB ' ' HB ' ' A' ' 82' ' ' VAL . 11.4 mttp -159.19 166.74 30.77 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.299 -0.876 . . . . 0.0 109.352 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -64.13 100.8 0.35 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.202 -0.936 . . . . 0.0 109.567 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 74.7 2.97 65.78 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.415 ' HB ' ' CB ' ' A' ' 79' ' ' LYS . 87.5 t -129.6 141.71 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.116 -1.226 . . . . 0.0 109.595 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 58.1 mt -131.89 158.69 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.326 -0.859 . . . . 0.0 109.456 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -148.03 139.14 23.35 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.217 -0.927 . . . . 0.0 109.548 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 53.6 mt -149.69 102.7 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.218 -0.926 . . . . 0.0 109.377 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -52.8 110.07 0.48 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.214 -0.929 . . . . 0.0 109.506 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -154.85 -175.75 26.3 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -154.39 47.82 0.59 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.267 -1.137 . . . . 0.0 109.446 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 60.3 mttt -137.82 45.95 2.12 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.283 -0.886 . . . . 0.0 109.467 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.469 ' HG3' ' N ' ' A' ' 91' ' ' ASP . 36.1 ptt180 -50.93 -40.15 56.43 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.246 -0.909 . . . . 0.0 109.467 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.469 ' N ' ' HG3' ' A' ' 90' ' ' ARG . 8.1 p-10 -51.05 -45.54 61.37 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.27 -0.894 . . . . 0.0 109.467 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 4.4 tt -68.4 -47.18 68.0 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.267 -0.896 . . . . 0.0 109.495 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.473 ' CD1' HG22 ' A' ' 36' ' ' ILE . 17.9 mt -54.32 -24.67 20.08 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.223 -0.923 . . . . 0.0 109.477 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -61.39 -65.42 0.7 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.297 -0.877 . . . . 0.0 109.465 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 11.4 t -64.48 -17.38 63.81 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.272 -0.893 . . . . 0.0 109.465 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.502 ' CD2' HD22 ' A' ' 97' ' ' LEU . 3.1 tt -66.42 -55.83 13.91 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.288 -0.883 . . . . 0.0 109.482 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.502 HD22 ' CD2' ' A' ' 96' ' ' LEU . 0.2 OUTLIER -69.97 -38.24 76.02 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.293 -0.879 . . . . 0.0 109.504 -179.979 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -64.27 -19.11 65.18 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.243 -0.91 . . . . 0.0 109.497 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -66.53 -31.74 72.64 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.273 -0.892 . . . . 0.0 109.441 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? -80.21 -14.9 58.07 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.239 -0.913 . . . . 0.0 109.474 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 101.44 -13.16 58.37 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' MET . . . . . 0.455 ' HE3' HG21 ' A' ' 34' ' ' VAL . 2.7 mtm -65.64 147.89 52.65 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.278 -1.13 . . . . 0.0 109.431 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 16.6 mttt -81.85 115.79 21.22 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.284 -0.885 . . . . 0.0 109.473 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 4.6 p -109.72 155.0 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.221 -0.924 . . . . 0.0 109.523 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.429 ' O ' ' N ' ' A' ' 107' ' ' ALA . 0.5 OUTLIER -122.18 90.39 3.3 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.212 -0.93 . . . . 0.0 109.468 -179.958 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 19.5 tp -54.2 93.09 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.253 -0.904 . . . . 0.0 109.486 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.442 ' HB1' ' CB ' ' A' ' 37' ' ' GLN . . . . . . . . 0 N--CA 1.491 1.593 0 O-C-N 121.28 -0.887 . . . . 0.0 109.475 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.45 ' OD1' ' N ' ' A' ' 31' ' ' ASP . 18.8 p30 . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -60.3 153.24 35.96 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.447 ' O ' ' CG2' ' A' ' 33' ' ' VAL . 34.7 m -142.39 101.17 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.279 -1.13 . . . . 0.0 109.452 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 9.7 t -88.85 150.04 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.268 -0.895 . . . . 0.0 109.501 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 53.0 mtt180 -127.05 119.25 26.13 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.231 -0.918 . . . . 0.0 109.458 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.413 HD11 HD12 ' A' ' 97' ' ' LEU . 1.5 mp -118.1 118.41 58.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.237 -0.914 . . . . 0.0 109.507 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -153.89 175.54 13.23 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.258 -0.901 . . . . 0.0 109.479 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.78 140.04 38.68 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.223 -0.923 . . . . 0.0 109.453 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -124.91 57.6 1.27 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.282 -0.886 . . . . 0.0 109.486 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 15.1 t . . . . . 0 N--CA 1.49 1.546 0 O-C-N 121.246 -0.909 . . . . 0.0 109.448 -179.988 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.4 ptmt . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 121.325 0.583 . . . . 0.0 109.539 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -171.16 147.75 10.62 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.426 HG11 ' HG3' ' A' ' 86' ' ' GLN . 14.1 m -119.77 158.03 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.205 -1.173 . . . . 0.0 109.504 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 1.4 t -121.11 120.51 35.52 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.229 -0.919 . . . . 0.0 109.422 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -111.58 149.25 31.72 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.234 -0.916 . . . . 0.0 109.539 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 16.7 mt -134.26 126.43 49.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.269 -0.895 . . . . 0.0 109.46 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -151.59 166.67 30.5 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.228 -0.92 . . . . 0.0 109.48 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 92.57 15.57 52.43 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.8 t -75.86 106.9 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.231 -1.158 . . . . 0.0 109.489 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -94.62 84.57 4.3 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.279 -0.888 . . . . 0.0 109.476 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -144.95 -172.87 3.93 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.194 -0.941 . . . . 0.0 109.483 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -68.67 150.22 48.19 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.262 -0.899 . . . . 0.0 109.464 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.427 ' O ' ' HB2' ' A' ' 61' ' ' LEU . 19.6 m-20 -52.72 -46.26 67.3 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.246 -0.909 . . . . 0.0 109.549 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.437 ' O ' HG23 ' A' ' 62' ' ' THR . . . -58.72 -44.73 90.48 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.23 -0.919 . . . . 0.0 109.558 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -51.36 -34.73 35.31 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.151 -0.968 . . . . 0.0 109.488 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.427 ' HB2' ' O ' ' A' ' 58' ' ' ASP . 39.7 mt -56.8 -54.81 42.11 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.233 -0.917 . . . . 0.0 109.505 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.437 HG23 ' O ' ' A' ' 59' ' ' ALA . 9.5 t -63.66 -17.82 63.32 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.233 -0.917 . . . . 0.0 109.588 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.417 ' N ' HG23 ' A' ' 62' ' ' THR . 0.1 OUTLIER -73.65 -68.76 0.48 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.265 -0.897 . . . . 0.0 109.459 179.965 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -51.77 -34.61 40.3 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.273 -0.892 . . . . 0.0 109.371 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.48 -59.47 5.19 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.267 -0.896 . . . . 0.0 109.426 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -55.07 -24.93 27.66 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.279 -0.888 . . . . 0.0 109.447 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -66.68 -62.46 1.44 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.256 -0.903 . . . . 0.0 109.482 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -67.33 -13.5 62.06 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.193 -0.942 . . . . 0.0 109.545 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 17.8 tttt -69.77 -36.35 75.68 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.189 -0.944 . . . . 0.0 109.428 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -73.27 -19.74 60.99 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.279 -0.888 . . . . 0.0 109.276 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 63.7 mttt -66.29 -29.88 70.19 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.3 -0.875 . . . . 0.0 109.319 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 62.7 m -89.17 -30.06 18.85 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.315 -0.866 . . . . 0.0 109.316 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.455 ' O ' ' HB2' ' A' ' 74' ' ' CYS . . . 91.87 -19.74 46.78 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.455 ' HB2' ' O ' ' A' ' 73' ' ' GLY . 52.8 t 177.55 94.41 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.232 -1.158 . . . . 0.0 109.364 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 148.83 151.03 5.36 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.394 -1.483 . . . . 0.0 109.394 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 159.41 -176.46 36.19 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -179.36 114.12 0.06 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.252 -1.146 . . . . 0.0 109.624 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.5 p -120.01 148.59 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.256 -0.903 . . . . 0.0 109.136 179.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.439 ' CB ' ' HB ' ' A' ' 82' ' ' VAL . 0.0 OUTLIER -150.21 77.7 1.31 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.17 -0.956 . . . . 0.0 109.774 -179.735 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 60.3 t0 49.25 69.03 0.63 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.336 -0.852 . . . . 0.0 109.956 179.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 83.27 -11.56 54.65 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 179.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.439 ' HB ' ' CB ' ' A' ' 79' ' ' LYS . 58.5 t -97.97 89.79 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.094 -1.239 . . . . 0.0 109.523 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 52.3 mt -99.68 154.15 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.228 -0.92 . . . . 0.0 109.374 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -149.26 104.11 3.37 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.242 -0.911 . . . . 0.0 109.612 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 62.2 mt -125.76 125.04 67.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.334 -0.853 . . . . 0.0 109.357 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . 0.426 ' HG3' HG11 ' A' ' 48' ' ' VAL . 8.3 tt0 -66.8 155.98 36.79 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.261 -0.899 . . . . 0.0 109.462 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 141.7 140.32 3.78 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -112.61 52.28 0.78 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.19 -1.182 . . . . 0.0 109.511 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 6.6 mttp -121.13 41.37 3.34 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.208 -0.933 . . . . 0.0 109.452 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.404 ' HA ' ' HB2' ' A' ' 93' ' ' LEU . 7.6 ptt85 -56.44 -27.76 57.59 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.251 -0.906 . . . . 0.0 109.494 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -57.89 -47.09 83.81 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.209 -0.932 . . . . 0.0 109.481 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 4.2 tt -74.28 -33.38 63.24 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.199 -0.938 . . . . 0.0 109.511 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.409 ' O ' ' HB3' ' A' ' 96' ' ' LEU . 1.5 mm? -55.9 -38.72 70.6 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.272 -0.892 . . . . 0.0 109.458 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 13.1 tttt -53.41 -49.29 67.61 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.205 -0.934 . . . . 0.0 109.451 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 3.2 t -68.35 -29.36 68.07 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.28 -0.888 . . . . 0.0 109.437 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.409 ' HB3' ' O ' ' A' ' 93' ' ' LEU . 4.1 tt -58.06 -51.85 67.96 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.238 -0.914 . . . . 0.0 109.434 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.469 ' CD2' ' HB ' ' A' ' 104' ' ' VAL . 0.4 OUTLIER -72.19 -32.35 66.74 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.261 -0.899 . . . . 0.0 109.428 179.983 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -71.69 -14.49 62.05 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.232 -0.918 . . . . 0.0 109.456 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.08 -31.42 72.6 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.213 -0.929 . . . . 0.0 109.422 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 7.3 mttm -94.0 -19.83 20.52 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.266 -0.896 . . . . 0.0 109.473 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 100.17 13.1 37.34 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' MET . . . . . 0.409 ' HE1' HG22 ' A' ' 34' ' ' VAL . 4.0 mtm -79.3 156.99 27.8 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.287 -1.125 . . . . 0.0 109.5 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 28.3 tttt -81.98 132.55 35.26 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.224 -0.923 . . . . 0.0 109.472 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.469 ' HB ' ' CD2' ' A' ' 97' ' ' LEU . 11.6 p -133.86 141.5 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.248 -0.908 . . . . 0.0 109.457 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 2.1 tttt -115.85 98.13 6.49 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.238 -0.914 . . . . 0.0 109.488 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 25.5 tp -45.92 -26.59 0.72 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.238 -0.914 . . . . 0.0 109.477 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.512 0 O-C-N 121.223 -0.923 . . . . 0.0 109.5 -179.998 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 140.48 119.33 1.59 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.544 -1.423 . . . . 0.0 109.544 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 18.2 t -123.84 94.6 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.211 -1.17 . . . . 0.0 109.458 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 22.0 t -86.54 162.39 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.23 -0.919 . . . . 0.0 109.491 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.419 ' O ' HG13 ' A' ' 36' ' ' ILE . 0.0 OUTLIER -144.91 140.56 28.38 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.206 -0.934 . . . . 0.0 109.491 179.928 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.51 HD12 ' CG2' ' A' ' 104' ' ' VAL . 3.8 mp -141.52 124.4 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.233 -0.917 . . . . 0.0 109.491 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.514 ' HB3' ' CB ' ' A' ' 107' ' ' ALA . 5.5 pt20 -147.59 118.98 7.86 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.25 -0.906 . . . . 0.0 109.471 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 5.4 tmm_? -45.81 116.0 1.1 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.249 -0.907 . . . . 0.0 109.426 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 2.1 tm0? -85.01 126.95 33.97 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.253 -0.904 . . . . 0.0 109.465 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 8.8 t . . . . . 0 N--CA 1.49 1.558 0 O-C-N 121.243 -0.911 . . . . 0.0 109.459 -179.987 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 31.0 mttt . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.451 ' O ' ' CG1' ' A' ' 48' ' ' VAL . . . -103.54 -156.96 24.63 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.451 ' CG1' ' O ' ' A' ' 47' ' ' GLY . 35.9 m -156.5 160.34 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.281 -1.129 . . . . 0.0 109.481 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -95.35 117.56 30.54 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.191 -0.943 . . . . 0.0 109.494 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -103.56 98.17 8.09 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.27 -0.894 . . . . 0.0 109.471 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 3.1 mp -96.05 125.87 48.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.232 -0.918 . . . . 0.0 109.485 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.7 -152.82 0.43 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.224 -0.923 . . . . 0.0 109.538 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 52.07 51.44 40.85 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.441 ' O ' ' N ' ' A' ' 56' ' ' LEU . 2.1 t -115.72 46.33 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.212 -1.17 . . . . 0.0 109.477 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -55.71 90.89 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.229 -0.919 . . . . 0.0 109.423 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.441 ' N ' ' O ' ' A' ' 54' ' ' VAL . 0.4 OUTLIER -149.98 157.07 42.79 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.283 -0.886 . . . . 0.0 109.509 -179.925 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.34 157.75 19.05 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.286 -0.884 . . . . 0.0 109.452 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.553 ' O ' ' CB ' ' A' ' 59' ' ' ALA . 0.4 OUTLIER -56.17 172.46 0.21 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.183 -0.948 . . . . 0.0 109.455 179.995 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.553 ' CB ' ' O ' ' A' ' 58' ' ' ASP . . . 83.05 -43.03 0.11 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.676 -0.64 . . . . 0.0 109.83 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.41 -63.14 1.35 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.08 -1.012 . . . . 0.0 109.52 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -56.63 -27.92 59.4 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.233 -0.917 . . . . 0.0 109.476 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 46.0 p -72.72 -33.4 66.41 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.232 -0.918 . . . . 0.0 109.421 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 44.4 mttt -73.87 -51.73 15.25 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.269 -0.894 . . . . 0.0 109.469 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.453 ' O ' HD11 ' A' ' 68' ' ' LEU . 1.0 OUTLIER -56.69 -48.38 77.8 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.315 -0.866 . . . . 0.0 109.526 179.995 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.415 ' O ' ' C ' ' A' ' 66' ' ' ALA . . . -59.13 -61.02 2.95 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.323 -0.861 . . . . 0.0 109.686 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.415 ' C ' ' O ' ' A' ' 65' ' ' ALA . . . -43.26 -40.58 3.53 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.307 -0.871 . . . . 0.0 109.722 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -60.78 -52.22 66.0 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.21 -0.931 . . . . 0.0 109.542 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.453 HD11 ' O ' ' A' ' 64' ' ' LEU . 0.9 OUTLIER -60.72 -21.43 62.94 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.214 -0.929 . . . . 0.0 109.652 -179.879 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -65.44 -40.06 92.81 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.176 -0.952 . . . . 0.0 109.478 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 45.7 mttt -69.11 -23.29 63.98 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.209 -0.932 . . . . 0.0 109.444 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 15.7 mtpt -64.28 -29.07 70.18 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.406 -0.808 . . . . 0.0 110.032 -179.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.2 m -99.05 -43.03 6.83 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.049 -1.032 . . . . 0.0 109.672 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.47 ' O ' ' HB2' ' A' ' 74' ' ' CYS . . . 103.08 -22.68 35.92 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.47 ' HB2' ' O ' ' A' ' 73' ' ' GLY . 30.2 t 173.62 104.17 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.279 -1.13 . . . . 0.0 109.499 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 155.18 -61.4 0.37 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -47.49 119.38 4.83 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -110.41 150.35 28.95 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.26 -1.141 . . . . 0.0 109.234 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 41.8 t -102.38 152.22 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.253 -0.904 . . . . 0.0 109.715 -179.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -138.77 151.97 47.53 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.331 -0.856 . . . . 0.0 109.243 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.429 ' N ' ' OD1' ' A' ' 80' ' ' ASP . 1.0 OUTLIER -69.91 90.97 0.64 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.242 -0.911 . . . . 0.0 109.626 -179.817 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 109.07 -8.46 33.39 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.771 -1.331 . . . . 0.0 109.771 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 75.9 t -142.26 153.02 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.129 -1.218 . . . . 0.0 109.566 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 2.0 mm -136.53 129.25 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.289 -0.882 . . . . 0.0 109.226 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -117.4 125.68 51.38 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.211 -0.931 . . . . 0.0 109.66 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 17.8 mm -137.42 116.65 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.269 -0.894 . . . . 0.0 109.417 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -69.77 157.56 37.1 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.247 -0.908 . . . . 0.0 109.521 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 148.74 -39.22 0.96 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.504 -1.439 . . . . 0.0 109.504 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 21.1 t0 57.33 53.77 7.3 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.223 -1.163 . . . . 0.0 109.452 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 19.8 mttt -134.96 54.52 1.94 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.24 -0.913 . . . . 0.0 109.451 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 38.5 ptt180 -47.31 -27.14 1.46 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.244 -0.91 . . . . 0.0 109.54 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -61.2 -58.61 7.62 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.248 -0.907 . . . . 0.0 109.464 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -64.87 -20.72 66.57 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.265 -0.897 . . . . 0.0 109.494 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.467 ' HG ' ' CG2' ' A' ' 36' ' ' ILE . 2.1 mm? -65.81 -52.76 48.0 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.213 -0.93 . . . . 0.0 109.462 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.426 ' HG2' ' CG1' ' A' ' 104' ' ' VAL . 0.0 OUTLIER -62.83 -19.76 64.41 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.27 -0.893 . . . . 0.0 109.439 -179.98 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.94 -55.25 6.39 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.299 -0.876 . . . . 0.0 109.446 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.442 ' HG ' ' O ' ' A' ' 93' ' ' LEU . 2.6 pp -64.82 -27.82 69.14 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.204 -0.935 . . . . 0.0 109.473 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.51 ' HB3' ' CG1' ' A' ' 104' ' ' VAL . 0.8 OUTLIER -68.12 -51.71 43.2 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.228 -0.92 . . . . 0.0 109.468 179.996 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -70.08 -16.65 63.16 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.267 -0.895 . . . . 0.0 109.44 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -67.22 -21.28 65.76 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.296 -0.878 . . . . 0.0 109.506 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -99.08 -17.18 18.36 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.269 -0.894 . . . . 0.0 109.453 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 103.59 -11.13 53.71 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 2.2 mtp -65.9 145.59 55.75 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.263 -1.14 . . . . 0.0 109.439 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.8 mttt -86.53 92.79 8.99 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.246 -0.908 . . . . 0.0 109.456 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.51 ' CG2' HD12 ' A' ' 36' ' ' ILE . 9.3 p -88.99 147.79 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.266 -0.896 . . . . 0.0 109.49 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.487 ' N ' HG21 ' A' ' 104' ' ' VAL . 1.5 mttt -116.29 111.41 20.09 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.227 -0.92 . . . . 0.0 109.476 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.503 ' O ' ' CB ' ' A' ' 107' ' ' ALA . 2.8 mt -45.69 -84.6 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.194 -0.941 . . . . 0.0 109.48 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.514 ' CB ' ' HB3' ' A' ' 37' ' ' GLN . . . . . . . . 0 N--CA 1.49 1.547 0 O-C-N 121.282 -0.886 . . . . 0.0 109.486 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.3 t70 . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -120.21 152.16 17.07 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.413 HG22 ' O ' ' A' ' 33' ' ' VAL . 4.6 m -156.14 106.52 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.255 -1.144 . . . . 0.0 109.482 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.443 HG23 ' CE ' ' A' ' 102' ' ' MET . 3.0 t -89.75 140.66 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.221 -0.924 . . . . 0.0 109.48 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 17.0 ttm180 -106.71 108.01 19.31 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.262 -0.899 . . . . 0.0 109.435 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 22.2 mt -101.36 126.23 55.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.203 -0.935 . . . . 0.0 109.473 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.432 ' HB3' ' HB2' ' A' ' 107' ' ' ALA . 18.1 pt20 -146.59 -178.37 6.13 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.239 -0.913 . . . . 0.0 109.475 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 10.9 ttm180 -134.89 114.34 12.46 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.246 -0.909 . . . . 0.0 109.462 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.514 ' HB2' ' CD1' ' A' ' 50' ' ' LEU . 5.5 tp60 -87.78 127.5 35.32 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.245 -0.909 . . . . 0.0 109.438 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.523 0 O-C-N 121.267 -0.896 . . . . 0.0 109.518 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.411 ' C ' HG12 ' A' ' 48' ' ' VAL . . . -109.15 144.52 16.51 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.411 HG12 ' C ' ' A' ' 47' ' ' GLY . 29.5 m -144.45 151.99 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.258 -1.142 . . . . 0.0 109.458 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -109.52 116.66 32.2 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.226 -0.921 . . . . 0.0 109.483 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.514 ' CD1' ' HB2' ' A' ' 39' ' ' GLN . 1.3 mp -96.99 147.73 23.7 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.251 -0.906 . . . . 0.0 109.53 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.428 ' O ' HG11 ' A' ' 82' ' ' VAL . 3.8 mm -136.08 125.87 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.293 -0.879 . . . . 0.0 109.387 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.4 t -158.16 168.46 26.99 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.186 -0.946 . . . . 0.0 109.508 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.35 -24.78 25.75 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.418 ' CG1' ' O ' ' A' ' 54' ' ' VAL . 8.0 p -49.55 106.97 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.255 -1.144 . . . . 0.0 109.496 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -100.48 78.85 2.05 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.195 -0.941 . . . . 0.0 109.462 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 16.4 mt -137.73 -173.57 3.53 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.231 -0.918 . . . . 0.0 109.455 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -68.0 138.26 55.74 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.24 -0.913 . . . . 0.0 109.446 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -50.08 -31.3 12.85 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.277 -0.89 . . . . 0.0 109.493 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.74 -43.42 93.44 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.249 -0.907 . . . . 0.0 109.5 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -66.18 -35.22 79.89 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.273 -0.892 . . . . 0.0 109.528 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.63 -46.27 89.49 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.203 -0.935 . . . . 0.0 109.454 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 39.5 p -71.06 -22.2 62.15 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.268 -0.895 . . . . 0.0 109.426 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.5 mmtp -71.77 -42.26 67.37 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.296 -0.877 . . . . 0.0 109.41 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -74.81 -34.64 62.41 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.203 -0.936 . . . . 0.0 109.285 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.63 -54.47 42.38 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.277 -0.889 . . . . 0.0 109.271 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.7 -39.2 93.24 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.274 -0.891 . . . . 0.0 109.213 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -54.89 -38.35 67.46 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.296 -0.878 . . . . 0.0 109.367 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 13.2 mt -82.17 -23.03 35.75 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.302 -0.874 . . . . 0.0 109.435 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 42.2 tttt -70.44 -22.93 62.65 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.22 -0.925 . . . . 0.0 109.268 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 4.6 mmtt -76.95 1.12 18.63 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.257 -0.902 . . . . 0.0 109.572 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 11.2 tttt -118.02 16.44 14.19 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.224 -0.922 . . . . 0.0 109.484 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -113.78 -33.04 5.93 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.201 -0.937 . . . . 0.0 109.544 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 87.72 -43.52 3.18 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 7.5 t -157.05 113.33 2.97 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.207 -1.172 . . . . 0.0 109.544 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 126.0 177.55 14.94 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 115.56 111.5 2.79 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -123.16 121.01 34.91 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.218 -1.166 . . . . 0.0 109.704 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.5 p -109.48 139.59 31.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.266 -0.896 . . . . 0.0 109.199 179.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.472 ' O ' ' N ' ' A' ' 81' ' ' GLY . 50.1 mttt -130.01 136.26 49.21 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.163 -0.961 . . . . 0.0 109.716 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -55.22 89.52 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.287 -0.883 . . . . 0.0 109.437 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.472 ' N ' ' O ' ' A' ' 79' ' ' LYS . . . 137.45 -44.78 1.11 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.428 HG11 ' O ' ' A' ' 51' ' ' ILE . 2.3 t -137.18 151.79 27.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.179 -1.189 . . . . 0.0 109.488 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 2.4 mp -124.66 140.63 47.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.209 -0.932 . . . . 0.0 109.555 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -128.92 139.0 52.32 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.315 -0.866 . . . . 0.0 109.372 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 17.8 mt -155.08 135.18 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.215 -0.928 . . . . 0.0 109.55 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -82.3 112.27 19.13 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.304 -0.872 . . . . 0.0 109.552 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -136.29 -39.78 0.14 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.461 -1.455 . . . . 0.0 109.461 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 46.28 36.61 3.42 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.227 -1.161 . . . . 0.0 109.521 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 5.4 mttp -137.91 53.7 1.82 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.261 -0.9 . . . . 0.0 109.473 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 1.9 mtm105 -49.64 -25.68 3.06 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.26 -0.9 . . . . 0.0 109.434 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -57.31 -53.34 59.17 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.255 -0.903 . . . . 0.0 109.443 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.6 tt -72.63 -33.4 66.62 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.262 -0.899 . . . . 0.0 109.471 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 48.0 mt -60.35 -27.42 67.36 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.263 -0.898 . . . . 0.0 109.406 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 75.4 tttt -64.65 -65.2 0.71 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.261 -0.9 . . . . 0.0 109.507 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -63.07 -15.42 56.52 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.228 -0.92 . . . . 0.0 109.468 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 5.0 tt -71.22 -57.57 4.36 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.261 -0.899 . . . . 0.0 109.431 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.508 ' CD1' ' HB2' ' A' ' 102' ' ' MET . 0.1 OUTLIER -65.29 -32.38 74.0 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.252 -0.905 . . . . 0.0 109.469 179.993 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 56.5 mm-40 -67.8 -27.97 67.19 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.275 -0.891 . . . . 0.0 109.465 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.38 -32.21 73.73 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.295 -0.878 . . . . 0.0 109.441 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 17.2 mttt -80.52 -14.68 58.03 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.19 -0.944 . . . . 0.0 109.476 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 79.55 11.66 84.56 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' MET . . . . . 0.508 ' HB2' ' CD1' ' A' ' 97' ' ' LEU . 4.5 mtm -86.64 156.73 19.89 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.221 -1.164 . . . . 0.0 109.499 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.404 ' CB ' HG13 ' A' ' 33' ' ' VAL . 2.1 mmtt -80.69 108.44 14.34 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.242 -0.911 . . . . 0.0 109.445 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 34' ' ' VAL . 13.1 p -102.39 151.73 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.281 -0.887 . . . . 0.0 109.496 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.401 ' O ' ' N ' ' A' ' 107' ' ' ALA . 0.3 OUTLIER -115.32 79.21 1.25 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.243 -0.91 . . . . 0.0 109.472 179.993 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 5.2 tt -46.74 100.45 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.247 -0.908 . . . . 0.0 109.463 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.432 ' HB2' ' HB3' ' A' ' 37' ' ' GLN . . . . . . . . 0 N--CA 1.491 1.581 0 O-C-N 121.259 -0.901 . . . . 0.0 109.494 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 16.6 t0 . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -169.46 107.4 0.27 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.0 m -121.86 144.96 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.281 -1.129 . . . . 0.0 109.426 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.402 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 72.2 t -119.88 133.32 67.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.264 -0.898 . . . . 0.0 109.5 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 5.5 mtt180 -108.17 98.05 7.65 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.202 -0.937 . . . . 0.0 109.474 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.9 mt -98.63 145.42 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.251 -0.905 . . . . 0.0 109.432 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.443 ' O ' ' HG3' ' A' ' 37' ' ' GLN . 0.0 OUTLIER -179.46 122.46 0.08 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.253 -0.905 . . . . 0.0 109.473 179.977 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.5 132.51 44.78 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.23 -0.919 . . . . 0.0 109.462 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -121.45 149.21 43.36 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.279 -0.888 . . . . 0.0 109.506 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 11.2 p . . . . . 0 N--CA 1.49 1.572 0 O-C-N 121.269 -0.894 . . . . 0.0 109.444 -179.988 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 25.3 mttt . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 127.39 83.99 0.46 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 28.1 m -113.69 157.02 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.225 -1.162 . . . . 0.0 109.434 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 5.4 t -105.71 123.56 48.13 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.237 -0.914 . . . . 0.0 109.485 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.4 mt -116.39 108.61 16.27 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.237 -0.914 . . . . 0.0 109.433 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 3.5 mm -96.13 121.22 46.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.268 -0.895 . . . . 0.0 109.533 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.6 -169.32 2.37 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.264 -0.897 . . . . 0.0 109.497 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 63.35 46.42 92.82 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.8 t -95.94 122.63 47.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.216 -1.167 . . . . 0.0 109.491 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -105.24 77.61 1.32 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.218 -0.926 . . . . 0.0 109.496 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 37.7 mt -135.89 165.93 24.49 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.24 -0.912 . . . . 0.0 109.481 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -65.79 -73.59 0.13 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.303 -0.873 . . . . 0.0 109.454 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -173.45 -52.09 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.229 -0.919 . . . . 0.0 109.479 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.41 -33.42 74.75 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.221 -0.924 . . . . 0.0 109.495 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -69.73 -30.15 67.7 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.222 -0.924 . . . . 0.0 109.434 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.5 tt -70.54 -45.95 64.51 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.225 -0.922 . . . . 0.0 109.4 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -61.35 -43.97 97.97 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.255 -0.903 . . . . 0.0 109.45 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 76.8 tttt -60.56 -52.14 66.46 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.273 -0.892 . . . . 0.0 109.433 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -48.01 -47.48 33.33 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.169 -0.957 . . . . 0.0 109.316 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.03 -42.14 84.69 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.293 -0.879 . . . . 0.0 109.297 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.35 -24.26 67.2 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.289 -0.882 . . . . 0.0 109.343 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -75.39 -38.62 59.83 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.34 -0.85 . . . . 0.0 109.431 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 9.5 mt -68.17 -42.57 79.79 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.246 -0.909 . . . . 0.0 109.314 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 17.2 tttt -56.81 -43.9 81.44 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.281 -0.887 . . . . 0.0 109.341 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 10.5 mttt -52.66 -33.19 45.99 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.21 -0.931 . . . . 0.0 109.459 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 34.4 mttt -116.61 54.78 0.84 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.169 -0.957 . . . . 0.0 109.836 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -140.36 -37.95 0.45 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.091 -1.006 . . . . 0.0 109.559 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.487 ' O ' ' CB ' ' A' ' 74' ' ' CYS . . . 91.28 -24.1 21.03 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 -179.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.487 ' CB ' ' O ' ' A' ' 73' ' ' GLY . 1.6 p 165.62 133.14 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.3 -1.117 . . . . 0.0 109.392 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.7 114.31 3.63 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 178.25 76.22 0.06 OUTLIER Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.446 ' HB1' ' HB2' ' A' ' 84' ' ' GLU . . . -83.95 151.33 25.12 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.297 -1.119 . . . . 0.0 109.473 -179.833 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 37.5 t -119.6 142.95 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.263 -0.898 . . . . 0.0 109.269 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.418 ' HB2' ' O ' ' A' ' 82' ' ' VAL . 16.3 mttt -147.33 171.18 15.84 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.267 -0.896 . . . . 0.0 109.496 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -63.8 102.62 0.48 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.344 -0.848 . . . . 0.0 109.718 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.455 ' O ' HG22 ' A' ' 82' ' ' VAL . . . 63.18 25.9 68.73 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 179.725 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.455 HG22 ' O ' ' A' ' 81' ' ' GLY . 40.8 t -146.21 123.26 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.232 -1.158 . . . . 0.0 109.414 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 34.9 mt -117.86 139.59 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.223 -0.923 . . . . 0.0 109.508 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.446 ' HB2' ' HB1' ' A' ' 77' ' ' ALA . 1.3 mt-10 -115.09 131.2 57.0 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.195 -0.94 . . . . 0.0 109.325 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 47.3 mm -128.82 137.33 57.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.203 -0.935 . . . . 0.0 109.583 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -96.39 109.35 21.89 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.28 -0.888 . . . . 0.0 109.449 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 165.68 166.96 25.55 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -129.2 62.8 1.51 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.266 -1.138 . . . . 0.0 109.47 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 76.0 mttt -127.27 52.19 1.83 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.214 -0.929 . . . . 0.0 109.473 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.412 ' HG3' ' N ' ' A' ' 91' ' ' ASP . 6.6 ptt180 -52.25 -36.11 51.67 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.32 -0.863 . . . . 0.0 109.442 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.412 ' N ' ' HG3' ' A' ' 90' ' ' ARG . 21.9 m-20 -60.21 -43.22 96.15 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.274 -0.891 . . . . 0.0 109.519 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.45 -34.6 77.51 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.23 -0.919 . . . . 0.0 109.484 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.516 ' HA ' ' CD2' ' A' ' 96' ' ' LEU . 0.3 OUTLIER -62.15 -39.83 93.94 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.286 -0.884 . . . . 0.0 109.504 179.983 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 76.1 tttt -63.76 -27.07 68.94 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.242 -0.911 . . . . 0.0 109.427 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 20.7 t -75.61 -60.67 2.21 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.273 -0.892 . . . . 0.0 109.504 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.566 ' CD1' ' N ' ' A' ' 97' ' ' LEU . 4.0 pp -52.36 -33.16 41.79 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.271 -0.893 . . . . 0.0 109.479 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.566 ' N ' ' CD1' ' A' ' 96' ' ' LEU . 0.1 OUTLIER -68.89 -54.15 17.18 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.276 -0.89 . . . . 0.0 109.508 179.978 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -64.78 -12.52 48.46 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.286 -0.884 . . . . 0.0 109.523 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.28 -28.32 69.24 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.238 -0.914 . . . . 0.0 109.469 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 33.6 mttm -95.86 -24.92 16.22 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.263 -0.898 . . . . 0.0 109.445 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 103.04 13.92 27.88 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -76.62 147.98 37.22 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.254 -1.144 . . . . 0.0 109.488 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.47 87.16 5.7 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.254 -0.904 . . . . 0.0 109.434 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' A' ' 34' ' ' VAL . 11.7 p -85.88 133.19 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.225 -0.922 . . . . 0.0 109.475 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.417 ' O ' ' N ' ' A' ' 107' ' ' ALA . 5.3 mttt -102.33 86.18 2.77 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.285 -0.885 . . . . 0.0 109.469 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 4.7 tp -52.27 95.89 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.192 -0.942 . . . . 0.0 109.483 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.417 ' N ' ' O ' ' A' ' 105' ' ' LYS . . . . . . . . 0 N--CA 1.49 1.542 0 O-C-N 121.281 -0.887 . . . . 0.0 109.468 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -108.4 167.3 13.16 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.462 ' CG2' ' O ' ' A' ' 103' ' ' LYS . 3.3 p -150.41 94.47 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.233 -1.157 . . . . 0.0 109.504 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.42 ' HB ' ' CD2' ' A' ' 97' ' ' LEU . 69.6 t -85.14 107.42 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.251 -0.905 . . . . 0.0 109.484 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 82.6 mtt180 -83.45 120.81 26.36 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.268 -0.895 . . . . 0.0 109.445 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.489 ' CD1' HD21 ' A' ' 93' ' ' LEU . 5.6 mt -120.14 116.31 49.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.196 -0.94 . . . . 0.0 109.524 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.462 ' HB3' ' HB3' ' A' ' 107' ' ' ALA . 28.2 pt20 -143.76 151.25 39.75 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.207 -0.933 . . . . 0.0 109.454 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.461 ' HG3' ' O ' ' A' ' 38' ' ' ARG . 11.9 ptt180 -95.47 122.59 38.36 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.221 -0.924 . . . . 0.0 109.439 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 7.2 tp60 -83.04 -37.2 24.22 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.3 -0.875 . . . . 0.0 109.484 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.541 0 O-C-N 121.234 -0.916 . . . . 0.0 109.448 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 12.6 mttt . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.7 173.32 31.02 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 16.0 m -143.22 156.92 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.261 -1.14 . . . . 0.0 109.416 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -118.21 110.89 18.11 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.241 -0.912 . . . . 0.0 109.471 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 56.5 mt -93.79 123.83 37.39 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.273 -0.892 . . . . 0.0 109.514 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 4.7 mm -109.4 110.94 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.28 -0.888 . . . . 0.0 109.453 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -158.48 152.68 24.03 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.269 -0.894 . . . . 0.0 109.448 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.36 51.8 1.2 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 6.1 t -116.53 100.17 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.255 -1.144 . . . . 0.0 109.497 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -77.36 102.49 6.81 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.223 -0.923 . . . . 0.0 109.505 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.401 HD21 ' CB ' ' A' ' 60' ' ' GLU . 0.1 OUTLIER -150.8 -157.43 0.81 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.252 -0.905 . . . . 0.0 109.481 179.991 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -76.58 -86.56 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.27 -0.894 . . . . 0.0 109.473 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -177.84 -47.33 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.307 -0.87 . . . . 0.0 109.36 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.8 -23.12 52.84 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.289 -0.882 . . . . 0.0 109.364 179.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.401 ' CB ' HD21 ' A' ' 56' ' ' LEU . 1.9 mm-40 -68.25 -28.07 66.89 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.267 -0.895 . . . . 0.0 109.437 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.95 -32.94 74.52 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.215 -0.928 . . . . 0.0 109.348 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -71.14 -40.7 71.22 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.275 -0.89 . . . . 0.0 109.391 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -66.79 -37.55 84.78 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.201 -0.937 . . . . 0.0 109.365 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 53.4 tp -65.35 -50.96 63.6 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.267 -0.896 . . . . 0.0 109.356 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.95 -26.96 69.07 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.306 -0.871 . . . . 0.0 109.295 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -74.21 -34.51 63.73 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.328 -0.858 . . . . 0.0 109.34 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -76.75 -26.71 54.86 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.254 -0.904 . . . . 0.0 109.39 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -77.9 -37.01 48.91 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.267 -0.895 . . . . 0.0 109.437 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 7.3 ttpt -67.61 -24.04 65.43 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.283 -0.886 . . . . 0.0 109.422 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.9 -29.71 60.43 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.288 -0.883 . . . . 0.0 109.536 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 4.0 mtmt -132.08 52.63 2.06 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.257 -0.902 . . . . 0.0 109.492 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . 0.412 ' SG ' HG22 ' A' ' 85' ' ' ILE . 9.1 t -110.13 -28.68 8.55 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.274 -0.891 . . . . 0.0 109.49 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.403 ' O ' ' HB2' ' A' ' 74' ' ' CYS . . . 77.73 6.19 86.82 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.403 ' HB2' ' O ' ' A' ' 73' ' ' GLY . 23.2 t 177.37 125.31 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.241 -1.152 . . . . 0.0 109.455 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -102.85 139.11 14.29 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -114.5 -100.86 2.37 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -117.78 133.36 56.01 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.211 -1.17 . . . . 0.0 109.333 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.0 t -124.85 99.13 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.19 -0.944 . . . . 0.0 109.669 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 61.4 mttm -115.29 141.47 47.99 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.272 -0.893 . . . . 0.0 109.322 179.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -60.39 99.84 0.09 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.207 -0.933 . . . . 0.0 109.391 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.413 ' C ' HG21 ' A' ' 82' ' ' VAL . . . 121.17 -33.03 4.51 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.413 HG21 ' C ' ' A' ' 81' ' ' GLY . 30.9 t -132.84 117.53 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.294 -1.121 . . . . 0.0 109.361 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 7.6 mt -123.13 123.71 68.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.291 -0.881 . . . . 0.0 109.556 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 53.6 tt0 -106.1 124.79 50.13 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.166 -0.959 . . . . 0.0 109.422 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.412 HG22 ' SG ' ' A' ' 72' ' ' CYS . 45.2 mm -115.2 143.44 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.228 -0.92 . . . . 0.0 109.555 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -112.68 113.64 25.86 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.301 -0.874 . . . . 0.0 109.501 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 178.74 -140.37 4.45 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.544 -1.423 . . . . 0.0 109.544 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.464 ' O ' ' CG ' ' A' ' 89' ' ' LYS . 17.6 t0 -177.35 79.9 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.261 -1.141 . . . . 0.0 109.514 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.464 ' CG ' ' O ' ' A' ' 88' ' ' ASP . 90.4 mttt -156.89 40.27 0.33 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.291 -0.881 . . . . 0.0 109.473 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 68.4 ttt180 -47.55 -31.5 4.46 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.282 -0.886 . . . . 0.0 109.527 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -57.46 -53.56 56.72 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.243 -0.91 . . . . 0.0 109.493 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 3.3 tp -63.82 -31.71 72.97 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.218 -0.926 . . . . 0.0 109.502 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.489 HD21 ' CD1' ' A' ' 36' ' ' ILE . 0.6 OUTLIER -59.09 -41.68 88.65 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.242 -0.911 . . . . 0.0 109.493 179.964 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -64.72 -27.04 68.64 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.272 -0.893 . . . . 0.0 109.519 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 1.1 t -73.94 -62.42 1.51 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.228 -0.92 . . . . 0.0 109.487 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.515 ' CD1' ' N ' ' A' ' 97' ' ' LEU . 4.1 pp -51.96 -31.11 27.66 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.237 -0.914 . . . . 0.0 109.526 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.515 ' N ' ' CD1' ' A' ' 96' ' ' LEU . 0.2 OUTLIER -70.03 -50.1 44.65 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.235 -0.916 . . . . 0.0 109.459 -179.927 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -65.49 -14.48 61.09 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.189 -0.945 . . . . 0.0 109.505 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -73.19 -27.94 61.92 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.252 -0.905 . . . . 0.0 109.489 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.8 mptt -87.65 -13.13 43.46 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.284 -0.885 . . . . 0.0 109.484 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 74.13 31.17 59.92 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 2.0 mtm -98.06 167.02 11.15 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.265 -1.138 . . . . 0.0 109.468 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.462 ' O ' ' CG2' ' A' ' 33' ' ' VAL . 2.3 mttm -86.53 93.34 9.15 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.292 -0.88 . . . . 0.0 109.457 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.453 HG21 ' HG ' ' A' ' 97' ' ' LEU . 7.5 p -83.31 136.43 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.241 -0.912 . . . . 0.0 109.5 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.9 90.25 3.33 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.302 -0.874 . . . . 0.0 109.456 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 45.3 mt -57.04 94.02 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.238 -0.914 . . . . 0.0 109.509 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.462 ' HB3' ' HB3' ' A' ' 37' ' ' GLN . . . . . . . . 0 N--CA 1.49 1.555 0 O-C-N 121.277 -0.889 . . . . 0.0 109.454 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -126.86 119.06 3.2 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.2 m -125.65 90.62 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.273 -1.134 . . . . 0.0 109.443 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.43 HG12 ' N ' ' A' ' 35' ' ' ARG . 44.9 t -97.59 163.21 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.241 -0.912 . . . . 0.0 109.459 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.43 ' N ' HG12 ' A' ' 34' ' ' VAL . 69.5 mtt180 -147.79 121.66 9.34 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.248 -0.908 . . . . 0.0 109.458 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.508 ' CD1' HG22 ' A' ' 104' ' ' VAL . 1.1 mp -116.21 94.54 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.24 -0.913 . . . . 0.0 109.493 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -106.97 -176.02 2.96 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.258 -0.901 . . . . 0.0 109.473 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 18.4 mtp180 -122.02 142.12 50.65 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.291 -0.881 . . . . 0.0 109.464 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -105.62 102.54 11.99 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.185 -0.947 . . . . 0.0 109.473 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 3.0 t . . . . . 0 N--CA 1.491 1.584 0 O-C-N 121.247 -0.908 . . . . 0.0 109.444 -179.946 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 92.2 mttt . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 121.301 0.572 . . . . 0.0 109.475 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 114.76 146.34 9.05 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 5.6 m -138.71 162.75 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.241 -1.152 . . . . 0.0 109.581 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 92.2 m -112.37 138.22 49.42 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.277 -0.889 . . . . 0.0 109.39 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -132.26 113.36 13.15 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.243 -0.91 . . . . 0.0 109.493 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.443 HG13 HG21 ' A' ' 36' ' ' ILE . 3.7 mp -85.91 131.01 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.208 -0.933 . . . . 0.0 109.503 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.0 p -142.15 -174.54 4.13 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.236 -0.915 . . . . 0.0 109.453 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 52.04 51.36 41.08 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.6 t -97.13 110.69 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.289 -1.124 . . . . 0.0 109.41 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -97.43 78.18 2.67 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.258 -0.901 . . . . 0.0 109.488 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -115.86 -167.7 1.3 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.228 -0.92 . . . . 0.0 109.49 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -96.57 -61.03 1.48 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.257 -0.902 . . . . 0.0 109.47 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 175.74 -54.59 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.308 -0.87 . . . . 0.0 109.394 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -75.55 -23.05 56.57 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.252 -0.905 . . . . 0.0 109.435 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -75.29 -33.48 61.21 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.289 -0.882 . . . . 0.0 109.441 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.0 -44.42 84.86 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.266 -0.897 . . . . 0.0 109.374 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 57.2 m -69.02 -29.77 68.01 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.266 -0.896 . . . . 0.0 109.514 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -70.67 -35.48 72.85 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.232 -0.918 . . . . 0.0 109.49 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.45 -59.83 2.53 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.214 -0.929 . . . . 0.0 109.494 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -48.39 -45.39 35.84 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.278 -0.889 . . . . 0.0 109.473 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.18 -41.37 99.21 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.262 -0.899 . . . . 0.0 109.465 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -59.35 -32.62 70.27 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.212 -0.93 . . . . 0.0 109.534 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.5 mt -82.89 -22.28 33.99 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.265 -0.897 . . . . 0.0 109.405 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.98 -21.08 59.37 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.302 -0.873 . . . . 0.0 109.758 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.6 -14.18 61.14 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.274 -0.891 . . . . 0.0 110.264 -179.412 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.02 37.88 1.17 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.053 -1.029 . . . . 0.0 109.584 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . 0.418 ' SG ' HG21 ' A' ' 85' ' ' ILE . 0.1 OUTLIER -99.06 -64.79 1.01 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.269 -0.894 . . . . 0.0 109.566 -179.958 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.479 ' O ' ' CB ' ' A' ' 74' ' ' CYS . . . 116.21 18.81 5.72 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.479 ' CB ' ' O ' ' A' ' 73' ' ' GLY . 0.5 OUTLIER 164.93 93.06 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.275 -1.132 . . . . 0.0 109.438 -179.961 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -57.27 100.71 0.13 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -77.38 -159.09 10.44 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -74.2 146.57 43.27 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.128 -1.219 . . . . 0.0 109.314 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 57.9 t -135.18 93.77 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.176 -0.952 . . . . 0.0 109.695 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.04 156.35 18.85 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.332 -0.855 . . . . 0.0 109.333 179.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -71.58 101.45 2.5 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.173 -0.954 . . . . 0.0 109.54 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.404 ' C ' ' CG2' ' A' ' 82' ' ' VAL . . . 117.44 -11.93 14.06 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.404 ' CG2' ' C ' ' A' ' 81' ' ' GLY . 3.3 t -152.72 117.75 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.297 -1.12 . . . . 0.0 109.357 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 15.2 mt -122.76 123.68 68.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.189 -0.944 . . . . 0.0 109.744 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -92.14 136.06 33.49 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.308 -0.87 . . . . 0.0 109.27 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.418 HG21 ' SG ' ' A' ' 72' ' ' CYS . 13.1 mm -131.9 95.93 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.171 -0.956 . . . . 0.0 109.521 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -56.56 133.85 53.84 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.296 -0.877 . . . . 0.0 109.407 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 143.9 173.72 15.59 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -139.92 81.32 1.81 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.28 -1.13 . . . . 0.0 109.419 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 13.7 pttt -145.55 49.03 1.24 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.261 -0.9 . . . . 0.0 109.456 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 7.1 ptt180 -47.69 -37.53 13.21 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.258 -0.901 . . . . 0.0 109.516 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -56.15 -49.66 73.33 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.261 -0.899 . . . . 0.0 109.438 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.444 HD13 ' O ' ' A' ' 92' ' ' LEU . 0.2 OUTLIER -60.15 -44.13 95.2 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.268 -0.895 . . . . 0.0 109.501 -179.992 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.443 ' O ' ' HB3' ' A' ' 96' ' ' LEU . 4.3 mm? -56.15 -35.13 66.82 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.237 -0.914 . . . . 0.0 109.42 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 67.9 tttt -60.87 -62.07 2.12 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.25 -0.906 . . . . 0.0 109.491 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -62.82 -14.1 41.47 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.216 -0.928 . . . . 0.0 109.421 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.446 ' CD2' ' N ' ' A' ' 97' ' ' LEU . 4.7 tt -72.78 -62.08 1.58 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.231 -0.918 . . . . 0.0 109.473 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.511 ' CD2' ' HB ' ' A' ' 104' ' ' VAL . 0.1 OUTLIER -61.78 -31.9 72.15 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.266 -0.896 . . . . 0.0 109.444 -179.983 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -71.86 -25.56 62.0 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.277 -0.889 . . . . 0.0 109.506 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -68.79 -26.82 65.4 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.209 -0.932 . . . . 0.0 109.474 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -85.78 -39.31 17.25 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.244 -0.91 . . . . 0.0 109.504 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 117.65 14.46 6.82 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 19.0 mtp -96.62 154.12 17.46 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.293 -1.122 . . . . 0.0 109.451 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 11.1 mptt -81.19 118.94 22.99 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.282 -0.886 . . . . 0.0 109.512 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.511 ' HB ' ' CD2' ' A' ' 97' ' ' LEU . 12.1 p -115.32 135.06 56.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.265 -0.897 . . . . 0.0 109.456 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 71.6 tttt -102.28 97.56 7.82 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.273 -0.892 . . . . 0.0 109.465 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 23.9 tp -45.59 -30.35 1.47 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.285 -0.884 . . . . 0.0 109.497 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.55 0 O-C-N 121.232 -0.918 . . . . 0.0 109.48 179.98 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -122.94 145.45 16.21 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 16.3 m -132.21 137.71 53.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.29 -1.124 . . . . 0.0 109.45 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.468 HG21 ' CE ' ' A' ' 102' ' ' MET . 60.3 t -106.6 162.29 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.196 -0.94 . . . . 0.0 109.478 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 4.4 ttt180 -135.62 108.07 7.37 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.243 -0.911 . . . . 0.0 109.48 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.429 HD12 HD23 ' A' ' 93' ' ' LEU . 3.2 mt -116.53 128.11 73.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.208 -0.933 . . . . 0.0 109.429 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -156.07 153.88 30.1 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.258 -0.901 . . . . 0.0 109.477 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.1 143.14 34.66 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.248 -0.908 . . . . 0.0 109.487 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 20.2 tt0 -109.55 71.2 0.76 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.203 -0.936 . . . . 0.0 109.47 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 3.3 t . . . . . 0 N--CA 1.491 1.579 0 O-C-N 121.29 -0.881 . . . . 0.0 109.485 179.954 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 12.3 tttt . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -96.16 123.27 7.64 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 15.6 m -121.44 143.31 34.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.239 -1.154 . . . . 0.0 109.328 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -125.37 133.92 52.36 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.211 -0.93 . . . . 0.0 109.53 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.421 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -123.29 120.52 33.34 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.264 -0.898 . . . . 0.0 109.41 179.951 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 3.2 mm -90.91 119.61 38.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.232 -0.917 . . . . 0.0 109.441 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.92 159.4 44.58 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.273 -0.892 . . . . 0.0 109.455 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 108.05 -31.21 8.13 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 57.0 t -45.02 113.05 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.221 -1.164 . . . . 0.0 109.419 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -114.34 76.8 1.01 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.234 -0.916 . . . . 0.0 109.478 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 31.3 mt -130.06 -156.33 0.75 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.255 -0.903 . . . . 0.0 109.439 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -67.34 143.28 56.46 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.278 -0.889 . . . . 0.0 109.446 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -58.08 -36.02 72.24 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.248 -0.907 . . . . 0.0 109.66 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.434 ' O ' HG21 ' A' ' 62' ' ' THR . . . -75.25 -32.55 61.12 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.182 -0.949 . . . . 0.0 109.531 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -71.95 -26.3 62.22 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.278 -0.889 . . . . 0.0 109.534 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.87 -56.87 4.94 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.219 -0.925 . . . . 0.0 109.549 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.434 HG21 ' O ' ' A' ' 59' ' ' ALA . 4.5 t -56.45 -24.36 44.96 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.266 -0.896 . . . . 0.0 109.453 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 79.2 mttt -75.54 -46.17 33.66 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.259 -0.9 . . . . 0.0 109.515 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.73 -46.02 92.04 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.188 -0.945 . . . . 0.0 109.359 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.456 ' HB3' HG21 ' A' ' 83' ' ' ILE . . . -65.78 -38.09 88.08 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.271 -0.893 . . . . 0.0 109.381 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.82 -36.98 75.39 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.227 -0.921 . . . . 0.0 109.413 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -75.55 -35.99 60.53 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.231 -0.918 . . . . 0.0 109.445 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -56.55 -53.17 60.65 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.347 -0.846 . . . . 0.0 109.605 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 15.4 pttp -66.16 -34.02 77.1 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.277 -0.889 . . . . 0.0 109.494 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -59.7 -21.83 61.16 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.316 -0.865 . . . . 0.0 109.71 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -85.07 -36.72 21.01 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.221 -0.925 . . . . 0.0 109.75 -179.655 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.2 m -94.42 -64.95 1.02 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.219 -0.925 . . . . 0.0 109.574 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 118.23 5.2 13.33 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 -179.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 46.8 t -160.15 121.87 3.19 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.307 -1.114 . . . . 0.0 109.258 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -129.35 -106.81 1.25 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 -179.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -172.84 -47.07 0.04 OUTLIER Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -178.55 119.52 0.08 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.291 -1.123 . . . . 0.0 109.56 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.417 HG23 ' HB3' ' A' ' 65' ' ' ALA . 77.9 t -100.98 97.82 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.312 -0.868 . . . . 0.0 109.292 179.837 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -106.34 141.34 37.82 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.213 -0.929 . . . . 0.0 109.814 -179.698 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -57.82 96.16 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.329 -0.857 . . . . 0.0 109.44 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 127.45 -40.78 1.7 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 23.5 t -132.93 122.51 46.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.179 -1.189 . . . . 0.0 109.58 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.456 HG21 ' HB3' ' A' ' 65' ' ' ALA . 2.9 mp -120.6 132.33 70.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.316 -0.865 . . . . 0.0 109.241 179.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -110.25 137.14 48.39 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.236 -0.915 . . . . 0.0 109.583 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 31.2 mm -132.59 123.18 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.299 -0.876 . . . . 0.0 109.563 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -91.78 104.95 17.34 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.204 -0.935 . . . . 0.0 109.438 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 178.6 -162.9 30.42 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -153.5 70.78 0.86 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.243 -1.151 . . . . 0.0 109.47 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 77.3 mttt -136.57 50.0 2.05 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.263 -0.898 . . . . 0.0 109.578 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 24.5 ptt180 -60.21 -34.04 73.09 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.227 -0.92 . . . . 0.0 109.478 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 30.5 t0 -55.74 -56.14 23.97 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.242 -0.911 . . . . 0.0 109.416 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.38 -31.03 71.63 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.249 -0.907 . . . . 0.0 109.398 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.433 ' HA ' ' CD2' ' A' ' 96' ' ' LEU . 0.4 OUTLIER -58.9 -45.16 90.96 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.31 -0.868 . . . . 0.0 109.442 179.961 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -61.91 -31.86 72.2 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.28 -0.887 . . . . 0.0 109.562 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.415 ' O ' ' C ' ' A' ' 96' ' ' LEU . 1.5 t -68.9 -69.76 0.31 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.216 -0.928 . . . . 0.0 109.499 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.57 ' CD1' ' N ' ' A' ' 97' ' ' LEU . 4.1 pp -43.78 -37.56 2.8 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.272 -0.892 . . . . 0.0 109.532 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.57 ' N ' ' CD1' ' A' ' 96' ' ' LEU . 10.6 tp -63.04 -47.24 83.87 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.213 -0.929 . . . . 0.0 109.46 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -69.2 -15.62 63.43 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.285 -0.884 . . . . 0.0 109.481 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -69.99 -28.34 65.44 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.22 -0.925 . . . . 0.0 109.472 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.433 ' HD3' ' N ' ' A' ' 100' ' ' LYS . 0.3 OUTLIER -85.77 -16.24 39.49 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.23 -0.919 . . . . 0.0 109.466 -179.951 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 84.94 14.38 69.8 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' MET . . . . . 0.468 ' CE ' HG21 ' A' ' 34' ' ' VAL . 1.4 mtm -87.29 171.89 10.28 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.243 -1.151 . . . . 0.0 109.43 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.43 164.93 22.68 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.238 -0.913 . . . . 0.0 109.452 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.494 ' CG1' HD23 ' A' ' 97' ' ' LEU . 4.8 t -139.49 125.88 23.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.215 -0.928 . . . . 0.0 109.48 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.427 ' O ' ' C ' ' A' ' 106' ' ' LEU . 2.5 mttt -106.5 64.46 0.66 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.189 -0.944 . . . . 0.0 109.491 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.427 ' C ' ' O ' ' A' ' 105' ' ' LYS . 3.6 tp -43.93 102.55 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.28 -0.887 . . . . 0.0 109.494 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.568 0 O-C-N 121.23 -0.919 . . . . 0.0 109.456 -179.997 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 65.9 t0 . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -99.53 139.33 14.37 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 18.8 m -143.89 121.56 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.213 -1.169 . . . . 0.0 109.459 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.437 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 2.4 t -98.94 152.8 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.281 -0.887 . . . . 0.0 109.474 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.411 ' HG2' ' C ' ' A' ' 34' ' ' VAL . 4.4 mtt180 -139.01 118.56 12.95 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.314 -0.866 . . . . 0.0 109.461 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.441 ' CG2' ' HG ' ' A' ' 93' ' ' LEU . 2.6 mp -125.64 116.91 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.218 -0.926 . . . . 0.0 109.45 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -146.96 174.24 11.7 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.186 -0.946 . . . . 0.0 109.504 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 9.1 ttm180 -102.1 149.74 23.96 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.221 -0.924 . . . . 0.0 109.469 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -136.27 108.04 7.05 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.233 -0.917 . . . . 0.0 109.405 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 40.5 p . . . . . 0 N--CA 1.489 1.518 0 O-C-N 121.264 -0.898 . . . . 0.0 109.493 179.96 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -107.28 135.09 12.55 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 18.6 m -133.06 168.75 23.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.252 -1.146 . . . . 0.0 109.461 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -119.83 116.98 26.97 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.184 -0.947 . . . . 0.0 109.54 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -92.69 129.51 38.59 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.254 -0.904 . . . . 0.0 109.425 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 21.9 mt -110.07 111.62 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.256 -0.903 . . . . 0.0 109.562 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.411 HG22 HG23 ' A' ' 82' ' ' VAL . 60.2 p -137.98 176.25 8.86 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.243 -0.91 . . . . 0.0 109.452 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.89 -15.11 59.81 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.432 HG11 ' HG ' ' A' ' 61' ' ' LEU . 18.6 t -56.67 122.01 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.248 -1.148 . . . . 0.0 109.466 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -124.45 72.12 1.18 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.255 -0.903 . . . . 0.0 109.486 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.3 mt -113.15 -173.36 2.24 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.28 -0.887 . . . . 0.0 109.466 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.61 -83.6 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.269 -0.895 . . . . 0.0 109.536 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -156.24 -61.09 0.1 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.22 -0.925 . . . . 0.0 109.452 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -65.33 -26.6 68.11 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.235 -0.916 . . . . 0.0 109.45 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -62.58 -42.5 99.6 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.253 -0.904 . . . . 0.0 109.481 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.432 ' HG ' HG11 ' A' ' 54' ' ' VAL . 0.4 OUTLIER -56.03 -59.15 5.32 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.212 -0.93 . . . . 0.0 109.403 179.895 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 8.8 t -59.46 -20.6 56.43 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.281 -0.887 . . . . 0.0 109.506 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.2 tttt -70.94 -71.06 0.27 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.215 -0.928 . . . . 0.0 109.522 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.452 ' O ' HD11 ' A' ' 64' ' ' LEU . 0.2 OUTLIER -48.25 -32.24 6.95 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.3 -0.875 . . . . 0.0 109.761 -179.869 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.42 -49.86 61.91 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.123 -0.986 . . . . 0.0 109.902 -179.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.404 ' O ' ' HG3' ' A' ' 70' ' ' LYS . . . -60.01 -28.99 68.18 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.089 -1.007 . . . . 0.0 109.891 -179.652 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.448 ' O ' ' HB2' ' A' ' 70' ' ' LYS . 2.6 tt0 -76.71 -33.83 58.18 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.127 -0.983 . . . . 0.0 109.835 -179.709 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 29.7 mt -71.62 -42.79 67.2 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.155 -0.965 . . . . 0.0 109.624 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 18.7 mtmt -72.34 -4.51 30.32 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.171 -0.956 . . . . 0.0 109.461 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.448 ' HB2' ' O ' ' A' ' 67' ' ' GLU . 4.3 mttt -74.0 -21.8 59.84 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.131 -0.981 . . . . 0.0 109.955 -179.509 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.93 59.3 1.54 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.12 -0.988 . . . . 0.0 109.579 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 4.9 t -134.31 -3.76 2.71 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.17 -0.956 . . . . 0.0 110.029 -179.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.13 2.68 54.13 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -163.54 -169.12 1.84 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.157 -1.202 . . . . 0.0 109.512 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -140.81 -116.18 1.27 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 144.1 -172.36 25.26 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -87.26 126.14 34.64 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.231 -1.158 . . . . 0.0 109.464 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 18.8 m -99.39 88.43 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.186 -0.946 . . . . 0.0 109.565 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.47 148.23 22.45 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.208 -0.933 . . . . 0.0 109.351 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -70.83 89.89 0.78 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.193 -0.942 . . . . 0.0 109.555 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.426 ' O ' ' CG2' ' A' ' 82' ' ' VAL . . . 123.85 -11.19 8.34 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.426 ' CG2' ' O ' ' A' ' 81' ' ' GLY . 73.2 t -156.18 121.41 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.299 -1.118 . . . . 0.0 109.356 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 11.3 mt -119.45 126.61 75.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.203 -0.935 . . . . 0.0 109.659 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -92.5 120.73 33.26 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.277 -0.889 . . . . 0.0 109.318 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 48.1 mm -127.45 70.72 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.28 -0.887 . . . . 0.0 109.561 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -50.43 160.92 0.35 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.256 -0.902 . . . . 0.0 109.416 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 126.59 -159.81 20.88 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -151.82 93.82 1.9 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.239 -1.153 . . . . 0.0 109.539 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 63.5 mttt -152.55 29.03 0.54 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.278 -0.889 . . . . 0.0 109.437 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.414 ' HB3' HD22 ' A' ' 106' ' ' LEU . 26.4 mtp180 -49.53 -38.42 30.59 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.219 -0.926 . . . . 0.0 109.465 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -55.36 -57.19 12.87 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.228 -0.92 . . . . 0.0 109.477 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.77 -21.48 65.88 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.285 -0.884 . . . . 0.0 109.467 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.441 ' HG ' ' CG2' ' A' ' 36' ' ' ILE . 0.9 OUTLIER -68.94 -42.4 76.77 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.248 -0.907 . . . . 0.0 109.472 179.995 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 18.3 tttt -68.84 -23.67 64.27 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.282 -0.886 . . . . 0.0 109.482 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -74.68 -62.44 1.53 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.173 -0.955 . . . . 0.0 109.437 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.442 HD12 HD23 ' A' ' 97' ' ' LEU . 2.6 pp -53.92 -35.88 62.15 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.235 -0.916 . . . . 0.0 109.439 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.442 HD23 HD12 ' A' ' 96' ' ' LEU . 0.2 OUTLIER -63.23 -52.58 61.6 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.281 -0.887 . . . . 0.0 109.483 179.976 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -63.04 -16.54 60.19 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.276 -0.89 . . . . 0.0 109.441 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.76 -35.92 82.09 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.248 -0.908 . . . . 0.0 109.505 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.7 mptp? -81.05 -38.5 27.3 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.245 -0.909 . . . . 0.0 109.508 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 108.99 14.58 14.73 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 8.1 mtm -89.77 158.83 17.34 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.25 -1.147 . . . . 0.0 109.466 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 20.4 mttt -80.93 120.04 24.23 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.269 -0.895 . . . . 0.0 109.428 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.437 ' HA ' ' O ' ' A' ' 34' ' ' VAL . 3.0 p -115.82 143.11 26.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.218 -0.926 . . . . 0.0 109.455 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.418 ' O ' ' C ' ' A' ' 106' ' ' LEU . 26.6 tttt -114.1 83.19 1.83 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.263 -0.898 . . . . 0.0 109.481 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.418 ' C ' ' O ' ' A' ' 105' ' ' LYS . 0.6 OUTLIER -44.67 -26.81 0.42 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.207 -0.933 . . . . 0.0 109.473 179.993 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.55 0 O-C-N 121.249 -0.907 . . . . 0.0 109.48 180.0 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 19.1 p-10 . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 178.02 130.21 1.37 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.447 ' O ' ' CG2' ' A' ' 33' ' ' VAL . 19.3 m -152.1 115.12 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.259 -1.142 . . . . 0.0 109.5 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 4.7 t -90.81 142.32 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.253 -0.904 . . . . 0.0 109.486 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 67.8 ttt180 -117.6 109.55 16.82 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.236 -0.915 . . . . 0.0 109.496 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.452 ' CD1' ' CD1' ' A' ' 97' ' ' LEU . 2.4 mp -108.22 93.7 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.266 -0.896 . . . . 0.0 109.473 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.79 179.96 7.44 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.273 -0.892 . . . . 0.0 109.425 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.71 102.67 3.96 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.254 -0.904 . . . . 0.0 109.446 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -88.44 128.83 35.54 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.285 -0.885 . . . . 0.0 109.478 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 74.1 p . . . . . 0 N--CA 1.49 1.554 0 O-C-N 121.279 -0.888 . . . . 0.0 109.481 179.965 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 41.6 pttt . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -161.49 145.1 10.46 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 34.1 m -137.08 153.01 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.229 -1.159 . . . . 0.0 109.444 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -130.63 130.53 44.08 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.212 -0.93 . . . . 0.0 109.52 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 4.2 mp -118.74 109.51 16.17 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.235 -0.916 . . . . 0.0 109.468 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 4.0 mp -99.58 122.25 51.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.192 -0.943 . . . . 0.0 109.492 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 8.8 t -158.47 167.59 29.23 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.289 -0.882 . . . . 0.0 109.496 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 83.44 48.09 5.45 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 18.3 t -103.57 117.45 49.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.22 -1.165 . . . . 0.0 109.506 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -83.55 81.13 8.87 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.178 -0.951 . . . . 0.0 109.437 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 19.0 mt -151.35 174.02 13.82 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.256 -0.902 . . . . 0.0 109.467 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -56.85 166.5 0.97 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.245 -0.91 . . . . 0.0 109.509 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -73.74 -35.87 65.09 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.283 -0.885 . . . . 0.0 109.422 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.03 -29.43 58.07 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.256 -0.903 . . . . 0.0 109.395 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -67.43 -34.66 77.67 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.24 -0.912 . . . . 0.0 109.388 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.79 -44.62 80.82 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.229 -0.919 . . . . 0.0 109.286 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 54.9 m -60.82 -44.31 97.09 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.319 -0.863 . . . . 0.0 109.206 179.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 74.4 tttt -57.52 -49.54 76.0 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.342 -0.849 . . . . 0.0 109.363 179.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -55.95 -41.03 74.05 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.256 -0.902 . . . . 0.0 109.505 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.55 -37.01 84.46 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.242 -0.911 . . . . 0.0 109.578 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -70.81 -31.59 68.4 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.272 -0.893 . . . . 0.0 109.548 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 82.8 mt-10 -71.66 -37.67 70.78 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.181 -0.95 . . . . 0.0 109.433 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 11.2 mt -68.48 -55.45 11.74 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.253 -0.904 . . . . 0.0 109.531 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 19.8 ttmt -52.84 -40.18 63.13 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.258 -0.902 . . . . 0.0 109.41 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 61.4 tttt -47.81 -47.77 30.92 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.177 -0.952 . . . . 0.0 109.322 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 14.7 mttt -108.09 57.86 0.62 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.372 -0.83 . . . . 0.0 109.301 179.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.5 m -129.69 -75.97 0.55 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.265 -0.897 . . . . 0.0 109.736 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.658 ' O ' ' CB ' ' A' ' 74' ' ' CYS . . . 125.95 49.77 0.18 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.07 -1.612 . . . . 0.0 109.07 -179.582 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.658 ' CB ' ' O ' ' A' ' 73' ' ' GLY . 49.3 t 112.44 104.57 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.237 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -179.499 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -83.8 142.54 20.92 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -86.54 -80.71 1.18 Allowed Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -129.62 124.16 33.03 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.133 -1.216 . . . . 0.0 109.6 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 95.1 t -125.81 95.44 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.303 -0.873 . . . . 0.0 109.298 179.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 18.0 mttt -122.27 142.12 50.8 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.239 -0.913 . . . . 0.0 109.705 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -54.21 94.82 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.283 -0.886 . . . . 0.0 109.491 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 148.02 -46.24 0.71 Allowed Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 42.7 t -143.13 160.94 17.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.233 -1.157 . . . . 0.0 109.47 -179.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 4.8 mp -138.32 149.43 24.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.246 -0.909 . . . . 0.0 109.43 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -147.14 120.25 8.85 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.252 -0.905 . . . . 0.0 109.473 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 36.3 mm -119.53 117.75 54.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.171 -0.956 . . . . 0.0 109.443 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.57 114.37 10.63 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.234 -0.916 . . . . 0.0 109.481 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 172.2 -137.97 4.54 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.556 -1.417 . . . . 0.0 109.556 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -177.08 53.24 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.238 -1.154 . . . . 0.0 109.452 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 19.8 mttt -106.14 39.45 1.8 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.234 -0.916 . . . . 0.0 109.499 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 5.4 ttm180 -49.59 -35.28 20.28 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.205 -0.934 . . . . 0.0 109.501 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.93 -43.96 91.26 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.241 -0.912 . . . . 0.0 109.439 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.84 -20.32 58.23 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.231 -0.918 . . . . 0.0 109.427 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.436 HD11 HG23 ' A' ' 36' ' ' ILE . 19.5 mt -69.33 -43.46 73.66 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.234 -0.916 . . . . 0.0 109.45 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -67.69 -24.07 65.36 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.274 -0.892 . . . . 0.0 109.446 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -74.98 -60.86 2.1 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.205 -0.935 . . . . 0.0 109.491 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.42 ' CD2' ' HA ' ' A' ' 93' ' ' LEU . 3.6 pp -54.08 -34.53 60.41 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.254 -0.904 . . . . 0.0 109.505 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.462 ' CD2' ' HB ' ' A' ' 104' ' ' VAL . 0.4 OUTLIER -67.33 -47.04 71.68 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.315 -0.866 . . . . 0.0 109.453 179.981 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -65.91 -16.42 63.84 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.29 -0.881 . . . . 0.0 109.466 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -67.3 -36.37 81.38 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.264 -0.897 . . . . 0.0 109.437 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.94 -37.78 23.65 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.266 -0.896 . . . . 0.0 109.48 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 106.19 21.5 8.43 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.96 158.92 16.0 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.253 -1.145 . . . . 0.0 109.485 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 11.5 mttm -82.85 107.28 15.35 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.249 -0.907 . . . . 0.0 109.469 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.462 ' HB ' ' CD2' ' A' ' 97' ' ' LEU . 7.5 p -84.65 144.47 9.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.226 -0.921 . . . . 0.0 109.471 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 11.0 mttt -113.92 83.76 1.92 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.25 -0.906 . . . . 0.0 109.462 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.1 tp -45.09 -27.98 0.66 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.235 -0.916 . . . . 0.0 109.425 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.552 0 O-C-N 121.276 -0.89 . . . . 0.0 109.492 -179.959 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 7.5 tttt . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -166.61 -62.74 0.03 OUTLIER Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 65.84 73.29 0.39 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.302 -1.116 . . . . 0.0 109.53 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.446 ' HA2' ' HB3' ' A' ' 55' ' ' ASP . . . 147.67 126.45 1.64 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.403 ' O ' ' CG2' ' A' ' 33' ' ' VAL . 19.1 m -133.8 121.26 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.318 -1.107 . . . . 0.0 109.42 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.412 ' CG1' HD13 ' A' ' 97' ' ' LEU . 77.9 t -96.42 135.78 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.218 -0.926 . . . . 0.0 109.493 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.461 ' O ' ' HG3' ' A' ' 35' ' ' ARG . 0.1 OUTLIER -130.08 124.45 32.82 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.187 -0.946 . . . . 0.0 109.519 -179.992 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.431 ' CG2' ' HG ' ' A' ' 93' ' ' LEU . 3.9 mp -110.08 126.11 67.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.233 -0.917 . . . . 0.0 109.449 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -121.69 160.65 24.05 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.272 -0.892 . . . . 0.0 109.502 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.413 ' HG3' ' O ' ' A' ' 38' ' ' ARG . 12.0 ptt180 -131.87 104.75 7.04 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.292 -0.88 . . . . 0.0 109.402 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -88.33 80.72 7.43 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.226 -0.921 . . . . 0.0 109.49 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 43.6 p -77.75 -173.24 2.95 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.245 -0.909 . . . . 0.0 109.463 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 22.6 t -139.12 22.65 2.59 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.226 -0.921 . . . . 0.0 109.484 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 158.15 -157.03 27.92 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 19.2 mtt-85 -71.24 -74.08 0.16 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.25 -1.147 . . . . 0.0 109.495 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 76.3 mttt -139.48 115.78 10.49 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.251 -0.906 . . . . 0.0 109.413 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -173.04 -39.83 0.04 OUTLIER Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -168.37 110.48 0.56 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.205 -1.174 . . . . 0.0 109.572 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -118.99 149.61 18.13 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 27.6 m -126.43 158.13 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.232 -1.158 . . . . 0.0 109.487 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -129.42 124.23 33.6 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.267 -0.896 . . . . 0.0 109.48 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.1 mt -115.34 124.26 50.81 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.233 -0.917 . . . . 0.0 109.39 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.469 ' HB ' ' HB ' ' A' ' 83' ' ' ILE . 6.7 mm -107.28 119.28 56.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.231 -0.918 . . . . 0.0 109.595 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.453 HG23 ' O ' ' A' ' 81' ' ' GLY . 1.3 m -158.86 158.72 33.99 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.267 -0.896 . . . . 0.0 109.426 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.487 ' O ' ' N ' ' A' ' 55' ' ' ASP . . . 109.09 -23.86 22.37 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 21.3 t -49.02 94.17 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.311 -1.111 . . . . 0.0 109.424 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.487 ' N ' ' O ' ' A' ' 53' ' ' GLY . 13.3 t0 -79.78 85.92 5.4 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.234 -0.916 . . . . 0.0 109.527 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.402 ' O ' ' C ' ' A' ' 57' ' ' ASP . 35.2 mt -146.16 167.52 23.24 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.322 -0.861 . . . . 0.0 109.355 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.402 ' C ' ' O ' ' A' ' 56' ' ' LEU . 0.2 OUTLIER -45.47 150.47 0.47 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.224 -0.923 . . . . 0.0 109.392 179.888 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -60.33 -53.35 58.62 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.187 -0.945 . . . . 0.0 109.656 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.12 -39.02 71.59 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.283 -0.886 . . . . 0.0 109.733 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.41 -39.41 93.19 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.174 -0.954 . . . . 0.0 109.671 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.9 -42.95 90.81 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.213 -0.929 . . . . 0.0 109.602 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -61.36 -33.44 73.64 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.309 -0.87 . . . . 0.0 109.638 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -71.58 -34.89 70.31 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.235 -0.915 . . . . 0.0 109.605 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.99 -59.77 3.5 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.189 -0.944 . . . . 0.0 109.577 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.464 ' HB3' HG12 ' A' ' 83' ' ' ILE . . . -56.99 -34.17 67.86 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.278 -0.889 . . . . 0.0 109.628 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.46 ' HA ' ' HG2' ' A' ' 69' ' ' LYS . . . -66.36 -33.82 76.58 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.274 -0.891 . . . . 0.0 109.768 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -70.17 -44.31 69.05 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.204 -0.935 . . . . 0.0 109.723 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.448 ' O ' ' HB2' ' A' ' 72' ' ' CYS . 9.7 mt -63.99 -39.85 95.07 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.231 -0.918 . . . . 0.0 109.629 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.46 ' HG2' ' HA ' ' A' ' 66' ' ' ALA . 12.9 ptmt -75.23 -2.11 26.47 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.321 -0.862 . . . . 0.0 109.854 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 10.3 tttt -76.83 -49.22 16.3 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.096 -1.003 . . . . 0.0 109.993 -179.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.54 64.63 1.43 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.079 -1.013 . . . . 0.0 109.768 -179.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . 0.448 ' HB2' ' O ' ' A' ' 68' ' ' LEU . 5.7 m -128.64 -15.36 4.47 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.192 -0.942 . . . . 0.0 110.078 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.672 ' O ' ' CB ' ' A' ' 74' ' ' CYS . . . 96.35 78.29 1.4 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.672 ' CB ' ' O ' ' A' ' 73' ' ' GLY . 34.7 t 112.02 110.62 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.19 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 -179.527 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.456 ' HA2' ' HB2' ' A' ' 69' ' ' LYS . . . -67.06 111.61 4.25 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -84.1 148.93 24.74 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -107.25 168.34 9.29 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.194 -1.18 . . . . 0.0 109.783 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.454 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 85.0 t -106.46 162.26 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.42 -0.8 . . . . 0.0 109.347 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.449 ' HB2' ' O ' ' A' ' 82' ' ' VAL . 6.6 mttt -149.27 82.27 1.42 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.222 -0.924 . . . . 0.0 109.521 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 46.15 66.87 0.85 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.373 -0.829 . . . . 0.0 109.728 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.453 ' O ' HG23 ' A' ' 52' ' ' THR . . . 74.84 8.88 82.91 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 179.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.449 ' O ' ' HB2' ' A' ' 79' ' ' LYS . 3.3 t -124.62 98.57 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.084 -1.245 . . . . 0.0 109.585 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.469 ' HB ' ' HB ' ' A' ' 51' ' ' ILE . 6.2 mt -93.15 124.37 45.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.228 -0.92 . . . . 0.0 109.481 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -91.87 124.55 36.07 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.324 -0.86 . . . . 0.0 109.578 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 34.1 mm -127.76 115.1 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.268 -0.895 . . . . 0.0 109.221 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.73 105.46 16.97 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.254 -0.904 . . . . 0.0 109.619 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 162.2 137.69 2.25 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -97.01 64.36 1.98 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.174 -1.192 . . . . 0.0 109.429 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 76.2 mttt -112.06 36.48 3.32 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.278 -0.889 . . . . 0.0 109.471 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 17.7 ttm180 -44.27 -35.8 2.46 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.261 -0.9 . . . . 0.0 109.476 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -56.39 -52.28 65.2 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.242 -0.911 . . . . 0.0 109.498 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.43 -26.88 68.17 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.291 -0.881 . . . . 0.0 109.47 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.459 ' HA ' ' CD2' ' A' ' 96' ' ' LEU . 3.2 mm? -63.23 -46.08 88.61 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.309 -0.869 . . . . 0.0 109.459 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 72.3 tttt -61.67 -29.95 70.41 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.228 -0.92 . . . . 0.0 109.534 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 17.5 t -69.83 -68.7 0.4 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.253 -0.905 . . . . 0.0 109.449 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.459 ' CD2' ' HA ' ' A' ' 93' ' ' LEU . 2.5 pp -44.86 -35.36 2.75 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.242 -0.911 . . . . 0.0 109.42 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.445 ' CD1' HG12 ' A' ' 104' ' ' VAL . 0.5 OUTLIER -64.63 -47.94 76.69 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.23 -0.919 . . . . 0.0 109.487 179.939 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -67.18 -9.26 38.21 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.234 -0.916 . . . . 0.0 109.488 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -70.44 -33.16 70.99 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.233 -0.917 . . . . 0.0 109.482 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 4.8 mtmm -84.98 -25.87 27.48 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.209 -0.932 . . . . 0.0 109.506 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 92.5 16.01 50.99 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 4.2 mtm -87.69 -174.42 4.76 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.266 -1.138 . . . . 0.0 109.464 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 24.5 mttt -91.42 163.5 14.16 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.262 -0.899 . . . . 0.0 109.487 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.445 HG12 ' CD1' ' A' ' 97' ' ' LEU . 19.2 t -139.82 158.99 27.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.245 -0.909 . . . . 0.0 109.456 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.452 ' O ' ' N ' ' A' ' 107' ' ' ALA . 17.3 tttt -130.25 61.42 1.59 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.215 -0.928 . . . . 0.0 109.474 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.41 ' C ' ' O ' ' A' ' 105' ' ' LYS . 3.7 tp -44.9 98.49 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.26 -0.9 . . . . 0.0 109.494 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.452 ' N ' ' O ' ' A' ' 105' ' ' LYS . . . -69.06 164.94 21.29 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.206 -0.934 . . . . 0.0 109.488 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 178.2 -168.68 40.07 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 151.65 161.69 10.28 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -110.77 124.4 51.93 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.27 -1.135 . . . . 0.0 109.467 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 117.994 -1.003 . . . . 0.0 109.452 -179.957 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 93.3 mttt . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -178.44 78.57 0.07 OUTLIER Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -92.72 130.32 38.38 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.302 -1.117 . . . . 0.0 109.453 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -86.37 161.08 33.75 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.473 HG13 ' CB ' ' A' ' 103' ' ' LYS . 18.9 m -142.98 97.51 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.189 -1.183 . . . . 0.0 109.506 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.475 HG22 ' CE ' ' A' ' 102' ' ' MET . 38.6 t -97.06 145.45 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.186 -0.946 . . . . 0.0 109.444 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 58.5 mtt180 -127.45 131.13 50.26 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.265 -0.897 . . . . 0.0 109.493 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.485 HG21 ' CD2' ' A' ' 93' ' ' LEU . 3.0 mp -125.68 106.31 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.293 -0.879 . . . . 0.0 109.476 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.501 ' HA ' ' CB ' ' A' ' 107' ' ' ALA . 20.4 pt20 -113.49 -175.01 2.57 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.265 -0.897 . . . . 0.0 109.443 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.413 ' O ' ' CG ' ' A' ' 38' ' ' ARG . 3.9 ptt180 -133.22 117.85 17.9 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.237 -0.914 . . . . 0.0 109.498 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -95.05 132.63 39.73 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.237 -0.915 . . . . 0.0 109.47 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -117.45 150.79 38.33 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.248 -0.908 . . . . 0.0 109.523 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.35 23.57 14.31 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.246 -0.909 . . . . 0.0 109.449 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 139.47 177.47 15.64 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 61.8 mtt180 -68.79 116.17 8.98 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.202 -1.175 . . . . 0.0 109.522 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 55.2 pttt -168.3 161.04 11.9 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.254 -0.904 . . . . 0.0 109.445 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -78.11 -39.07 24.53 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -57.08 158.59 4.94 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.26 -1.141 . . . . 0.0 109.48 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -166.12 156.86 29.06 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -130.22 165.01 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.276 -1.132 . . . . 0.0 109.454 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 3.5 m -133.82 134.59 43.01 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.245 -0.91 . . . . 0.0 109.515 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -111.18 139.25 46.71 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.261 -0.899 . . . . 0.0 109.489 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.463 HG12 ' CG1' ' A' ' 36' ' ' ILE . 15.3 mt -127.95 107.8 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.246 -0.909 . . . . 0.0 109.468 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 15.8 m -152.47 158.82 43.13 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.237 -0.914 . . . . 0.0 109.426 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 104.36 16.42 18.31 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.431 ' CG1' HD22 ' A' ' 61' ' ' LEU . 21.8 t -74.6 130.42 36.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.198 -1.177 . . . . 0.0 109.46 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -104.44 86.85 2.59 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.232 -0.918 . . . . 0.0 109.45 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.486 ' HB2' ' CD1' ' A' ' 61' ' ' LEU . 5.1 mt -133.38 -170.63 2.52 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.247 -0.908 . . . . 0.0 109.537 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -73.89 -69.89 0.41 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.191 -0.943 . . . . 0.0 109.481 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 174.12 -63.13 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.171 -0.956 . . . . 0.0 109.521 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.68 -30.89 71.92 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.242 -0.911 . . . . 0.0 109.583 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -66.01 -35.49 80.71 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.182 -0.949 . . . . 0.0 109.478 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.486 ' CD1' ' HB2' ' A' ' 56' ' ' LEU . 0.3 OUTLIER -63.95 -38.61 91.7 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.27 -0.894 . . . . 0.0 109.548 179.995 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 23.8 m -59.75 -49.64 76.92 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.234 -0.916 . . . . 0.0 109.47 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 58.5 tttt -59.7 -36.88 77.41 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.255 -0.903 . . . . 0.0 109.492 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.459 ' CD1' HD21 ' A' ' 68' ' ' LEU . 0.1 OUTLIER -59.29 -53.69 55.37 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.209 -0.932 . . . . 0.0 109.527 -179.926 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.15 -32.28 69.73 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.271 -0.893 . . . . 0.0 109.541 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.88 -42.29 94.93 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.238 -0.914 . . . . 0.0 109.401 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -75.64 -19.83 58.93 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.273 -0.892 . . . . 0.0 109.403 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.459 HD21 ' CD1' ' A' ' 64' ' ' LEU . 0.7 OUTLIER -72.17 -53.69 11.93 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.32 -0.863 . . . . 0.0 109.548 -179.956 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.463 ' HA ' ' HB2' ' A' ' 72' ' ' CYS . 1.3 ptpt -65.8 -21.41 66.49 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.323 -0.861 . . . . 0.0 109.694 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 9.3 mttt -58.57 -34.61 71.25 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.321 -0.862 . . . . 0.0 110.042 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 59.7 tttt -120.12 24.03 10.67 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.045 -1.034 . . . . 0.0 110.066 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . 0.463 ' HB2' ' HA ' ' A' ' 69' ' ' LYS . 0.5 OUTLIER -107.37 -27.13 10.65 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.069 -1.019 . . . . 0.0 109.548 179.827 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.436 ' O ' ' HB3' ' A' ' 74' ' ' CYS . . . 61.38 54.09 38.95 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.646 -1.381 . . . . 0.0 109.646 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.436 ' HB3' ' O ' ' A' ' 73' ' ' GLY . 27.0 p 177.66 125.33 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.283 -1.128 . . . . 0.0 109.49 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -114.06 82.27 0.31 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -75.91 -52.88 6.08 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.774 -1.331 . . . . 0.0 109.774 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 176.78 124.42 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.171 -1.194 . . . . 0.0 109.508 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 38.5 t -127.29 122.53 59.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.261 -0.9 . . . . 0.0 109.554 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -131.5 143.81 50.67 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.24 -0.912 . . . . 0.0 109.593 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.63 109.72 0.85 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.157 -0.964 . . . . 0.0 109.36 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 119.68 -38.39 2.81 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 87.8 t -140.26 133.13 33.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.329 -1.1 . . . . 0.0 109.412 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 12.1 mt -122.55 148.4 26.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.247 -0.908 . . . . 0.0 109.4 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -135.41 134.96 40.23 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.175 -0.953 . . . . 0.0 109.686 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 27.8 mm -118.15 148.52 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.236 -0.915 . . . . 0.0 109.332 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.38 122.06 46.55 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.204 -0.935 . . . . 0.0 109.478 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 130.43 161.28 10.32 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -103.66 108.93 20.42 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.231 -1.159 . . . . 0.0 109.458 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 30.6 mttt -158.73 31.39 0.22 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.235 -0.916 . . . . 0.0 109.462 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 50.8 ttp180 -53.48 -27.78 27.09 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.249 -0.907 . . . . 0.0 109.485 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 50.0 t0 -60.05 -51.77 68.2 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.259 -0.901 . . . . 0.0 109.456 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.7 tt -70.75 -23.95 62.52 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.21 -0.931 . . . . 0.0 109.438 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.485 ' CD2' HG21 ' A' ' 36' ' ' ILE . 1.3 mt -63.51 -47.87 79.93 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.193 -0.942 . . . . 0.0 109.424 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.497 ' HD2' ' CD2' ' A' ' 106' ' ' LEU . 78.2 tttt -61.98 -23.07 66.17 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.244 -0.91 . . . . 0.0 109.451 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 6.6 t -76.56 -65.37 0.94 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.277 -0.889 . . . . 0.0 109.491 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.446 ' CD1' ' N ' ' A' ' 97' ' ' LEU . 2.9 pp -47.73 -36.04 10.74 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.256 -0.903 . . . . 0.0 109.419 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.472 ' CD2' HG11 ' A' ' 104' ' ' VAL . 1.4 tp -69.52 -44.25 71.41 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.225 -0.922 . . . . 0.0 109.456 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 68.4 tt0 -61.21 -20.26 62.58 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.285 -0.884 . . . . 0.0 109.477 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -62.77 -32.28 73.4 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.229 -0.919 . . . . 0.0 109.476 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -84.36 -18.07 37.37 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.229 -0.919 . . . . 0.0 109.495 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 75.47 24.66 69.98 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' MET . . . . . 0.475 ' CE ' HG22 ' A' ' 34' ' ' VAL . 1.1 mtm -79.07 179.34 7.41 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.29 -1.124 . . . . 0.0 109.495 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.473 ' CB ' HG13 ' A' ' 33' ' ' VAL . 13.0 mttt -97.21 88.32 4.43 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.308 -0.87 . . . . 0.0 109.447 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.472 HG11 ' CD2' ' A' ' 97' ' ' LEU . 2.1 t -81.62 165.08 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.227 -0.92 . . . . 0.0 109.494 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.401 ' O ' ' C ' ' A' ' 106' ' ' LEU . 41.7 tttt -128.88 28.2 5.37 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.263 -0.898 . . . . 0.0 109.446 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.497 ' CD2' ' HD2' ' A' ' 94' ' ' LYS . 0.2 OUTLIER 44.24 -157.82 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.243 -0.911 . . . . 0.0 109.456 179.954 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.501 ' CB ' ' HA ' ' A' ' 37' ' ' GLN . . . -98.46 -32.88 11.25 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.213 -0.929 . . . . 0.0 109.479 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -132.93 127.22 4.69 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -113.52 -23.93 4.9 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.4 mt -140.33 112.69 7.85 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.272 -1.134 . . . . 0.0 109.472 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 . . . . . 0 N--CA 1.489 1.52 0 CA-C-O 118.025 -0.988 . . . . 0.0 109.519 -179.975 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 176.09 66.58 0.06 OUTLIER Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -116.45 -63.78 1.4 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.28 -1.13 . . . . 0.0 109.434 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.4 ' C ' ' CG2' ' A' ' 33' ' ' VAL . . . 163.2 128.12 0.93 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.4 ' CG2' ' C ' ' A' ' 32' ' ' GLY . 1.9 t -149.61 151.64 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.248 -1.149 . . . . 0.0 109.546 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.47 ' HB ' ' CD1' ' A' ' 97' ' ' LEU . 72.7 t -138.1 121.68 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.312 -0.867 . . . . 0.0 109.392 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.419 ' CG ' ' HA3' ' A' ' 53' ' ' GLY . 62.3 mtt180 -88.11 111.22 21.34 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.244 -0.91 . . . . 0.0 109.516 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.448 ' CG2' HD12 ' A' ' 93' ' ' LEU . 7.5 mt -115.66 108.51 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.263 -0.898 . . . . 0.0 109.408 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -131.72 -160.12 1.02 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.21 -0.931 . . . . 0.0 109.548 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 11.9 ptm180 -130.79 132.09 45.06 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.297 -0.877 . . . . 0.0 109.447 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -125.81 77.47 1.67 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.254 -0.904 . . . . 0.0 109.484 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.403 ' OG1' ' O ' ' A' ' 40' ' ' THR . 0.1 OUTLIER -106.05 17.23 23.88 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.3 -0.875 . . . . 0.0 109.472 -179.99 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.88 150.38 7.72 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.28 -0.888 . . . . 0.0 109.481 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 68.32 159.65 1.55 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 45.8 mtt180 -95.7 111.5 23.44 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.312 -1.111 . . . . 0.0 109.468 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 50.7 tttt -174.09 31.66 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.244 -0.91 . . . . 0.0 109.51 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 153.34 158.31 8.5 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -71.07 -45.58 63.52 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.269 -1.136 . . . . 0.0 109.447 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 176.96 144.52 5.31 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 16.0 m -135.02 159.05 41.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.275 -1.132 . . . . 0.0 109.373 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -111.9 110.02 20.13 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.247 -0.908 . . . . 0.0 109.531 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.47 ' CD1' ' HG3' ' A' ' 84' ' ' GLU . 8.5 tp -93.83 129.29 40.28 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.225 -0.922 . . . . 0.0 109.44 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 11.1 mm -120.91 114.74 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.295 -0.878 . . . . 0.0 109.439 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.43 ' O ' HG23 ' A' ' 52' ' ' THR . 8.6 m -141.6 13.28 2.13 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.307 -0.871 . . . . 0.0 109.496 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.419 ' HA3' ' CG ' ' A' ' 35' ' ' ARG . . . -97.41 19.02 56.37 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.579 -1.409 . . . . 0.0 109.579 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 60.0 t -82.95 105.65 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.267 -1.137 . . . . 0.0 109.452 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -100.19 87.73 3.52 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.187 -0.946 . . . . 0.0 109.522 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 19.2 mt -129.15 -169.23 2.05 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.269 -0.894 . . . . 0.0 109.403 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -81.87 -65.33 1.02 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.235 -0.916 . . . . 0.0 109.446 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.4 t0 179.76 -50.34 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.23 -0.918 . . . . 0.0 109.402 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.6 -34.71 65.18 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.24 -0.913 . . . . 0.0 109.437 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -70.2 -28.15 65.06 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.261 -0.899 . . . . 0.0 109.413 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.437 HD21 ' CD1' ' A' ' 83' ' ' ILE . 0.4 OUTLIER -66.55 -55.46 15.38 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.263 -0.898 . . . . 0.0 109.476 179.951 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 8.2 t -59.81 -37.73 79.99 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.26 -0.9 . . . . 0.0 109.551 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -57.74 -62.39 1.83 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.206 -0.934 . . . . 0.0 109.535 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.5 tt -49.82 -48.43 50.81 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.258 -0.901 . . . . 0.0 109.612 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -50.08 -41.61 48.47 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.29 -0.881 . . . . 0.0 109.659 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.8 -34.92 76.34 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.213 -0.93 . . . . 0.0 109.657 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -67.18 -30.26 70.17 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.222 -0.924 . . . . 0.0 109.584 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -79.62 -33.93 41.06 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.293 -0.88 . . . . 0.0 109.454 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.443 ' HA ' ' HB3' ' A' ' 72' ' ' CYS . 6.8 ttpt -77.04 -9.58 58.81 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.267 -0.895 . . . . 0.0 109.377 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -68.51 -41.58 79.77 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.187 -0.946 . . . . 0.0 109.46 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 39.6 mttt -103.83 5.44 35.91 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.267 -0.896 . . . . 0.0 109.493 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . 0.443 ' HB3' ' HA ' ' A' ' 69' ' ' LYS . 31.9 t -81.4 -64.44 1.19 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.217 -0.927 . . . . 0.0 109.615 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 91.38 19.65 41.02 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.291 -1.524 . . . . 0.0 109.291 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 17.4 t -174.92 90.95 0.06 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.364 -1.08 . . . . 0.0 109.304 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -95.89 157.99 21.81 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -117.98 -87.57 1.21 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -134.07 127.99 33.33 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.187 -1.184 . . . . 0.0 109.288 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.45 HG13 HG22 ' A' ' 83' ' ' ILE . 84.0 t -128.03 82.64 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.152 -0.967 . . . . 0.0 109.682 -179.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 65.4 mttt -94.09 155.69 16.96 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.268 -0.895 . . . . 0.0 109.255 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -63.72 104.97 0.73 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.24 -0.912 . . . . 0.0 109.575 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 129.67 -26.32 4.32 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 90.9 t -149.79 151.9 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.207 -1.172 . . . . 0.0 109.726 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.45 HG22 HG13 ' A' ' 78' ' ' VAL . 15.8 mt -143.7 120.58 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.389 -0.819 . . . . 0.0 109.249 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.47 ' HG3' ' CD1' ' A' ' 50' ' ' LEU . 1.7 tt0 -112.56 130.28 56.07 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.219 -0.925 . . . . 0.0 109.638 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.401 HD12 ' HA ' ' A' ' 85' ' ' ILE . 25.7 mm -126.39 145.85 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.262 -0.899 . . . . 0.0 109.335 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.53 112.23 24.47 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.231 -0.918 . . . . 0.0 109.543 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -161.03 -40.07 0.02 OUTLIER Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 27.7 t70 53.36 60.83 3.46 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.314 -1.11 . . . . 0.0 109.478 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 16.8 mttt -152.15 65.98 0.84 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.288 -0.883 . . . . 0.0 109.466 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 4.1 ptt-85 -56.79 -28.92 62.15 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.218 -0.927 . . . . 0.0 109.478 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -55.28 -52.63 62.82 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.242 -0.911 . . . . 0.0 109.455 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.5 tt -70.02 -42.07 73.45 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.25 -0.906 . . . . 0.0 109.511 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.448 HD12 ' CG2' ' A' ' 36' ' ' ILE . 2.3 mt -54.28 -26.27 28.16 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.196 -0.94 . . . . 0.0 109.484 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -64.48 -64.33 0.91 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.259 -0.901 . . . . 0.0 109.412 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -63.51 -13.93 45.98 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.276 -0.89 . . . . 0.0 109.435 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.459 ' CD2' ' C ' ' A' ' 96' ' ' LEU . 4.1 tt -71.16 -56.9 5.13 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.287 -0.883 . . . . 0.0 109.429 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.514 ' HB3' ' CG2' ' A' ' 104' ' ' VAL . 0.2 OUTLIER -70.91 -30.54 66.91 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.306 -0.871 . . . . 0.0 109.437 -179.966 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -64.71 -18.09 64.7 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.261 -0.899 . . . . 0.0 109.458 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.95 -37.24 86.99 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.292 -0.88 . . . . 0.0 109.484 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 11.2 mtpp -82.63 -34.91 27.39 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.266 -0.896 . . . . 0.0 109.444 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 107.99 17.85 10.54 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 1.5 mtm -91.28 167.85 12.01 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.261 -1.141 . . . . 0.0 109.45 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.14 157.76 22.65 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.245 -0.91 . . . . 0.0 109.44 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.514 ' CG2' ' HB3' ' A' ' 97' ' ' LEU . 87.3 t -136.19 123.0 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.312 -0.867 . . . . 0.0 109.423 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.84 88.63 4.34 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.239 -0.913 . . . . 0.0 109.49 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 30.9 mt -44.24 -36.11 2.57 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.339 -0.85 . . . . 0.0 109.465 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . 68.1 83.6 0.16 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.248 -0.908 . . . . 0.0 109.455 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -173.53 102.54 0.17 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.569 -1.413 . . . . 0.0 109.569 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 72.01 174.46 22.48 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.3 pp -149.48 144.97 26.64 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.305 -1.115 . . . . 0.0 109.469 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.507 -180.0 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 56.3 mttp . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -132.76 165.59 23.8 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -178.68 110.5 0.05 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.275 -1.132 . . . . 0.0 109.455 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 76.92 117.58 0.16 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.49 ' CG1' ' O ' ' A' ' 103' ' ' LYS . 82.2 t -143.68 122.55 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.261 -1.14 . . . . 0.0 109.483 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 44.5 t -101.77 135.17 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.257 -0.902 . . . . 0.0 109.462 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 13.4 ttt180 -102.89 123.35 46.36 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.231 -0.918 . . . . 0.0 109.521 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.485 HG23 ' CD1' ' A' ' 93' ' ' LEU . 4.0 mt -128.87 112.49 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.195 -0.94 . . . . 0.0 109.537 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 3.3 pm0 -136.3 110.9 8.61 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.277 -0.889 . . . . 0.0 109.49 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.431 ' HG3' ' O ' ' A' ' 38' ' ' ARG . 0.0 OUTLIER -69.83 109.64 4.54 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.277 -0.89 . . . . 0.0 109.433 -179.949 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -96.17 138.99 32.97 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.304 -0.872 . . . . 0.0 109.507 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 8.9 m -111.24 163.34 14.04 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.25 -0.906 . . . . 0.0 109.446 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.5 t -119.99 -29.3 4.96 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.275 -0.891 . . . . 0.0 109.438 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.418 ' O ' ' CB ' ' A' ' 43' ' ' ARG . . . 169.65 150.56 6.87 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.418 ' CB ' ' O ' ' A' ' 42' ' ' GLY . 4.6 ttm180 70.32 160.02 0.2 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.274 -1.133 . . . . 0.0 109.45 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -99.9 27.29 5.59 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.22 -0.925 . . . . 0.0 109.468 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -116.39 -25.95 3.31 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 12.5 tttt -86.62 162.16 18.11 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.3 -1.118 . . . . 0.0 109.48 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.416 ' O ' HG11 ' A' ' 48' ' ' VAL . . . 169.26 139.53 2.74 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.416 HG11 ' O ' ' A' ' 47' ' ' GLY . 16.0 m -146.71 151.16 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.201 -1.176 . . . . 0.0 109.475 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -111.04 126.01 54.36 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.302 -0.874 . . . . 0.0 109.444 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.2 mp -112.99 104.77 12.73 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.254 -0.904 . . . . 0.0 109.578 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.437 ' HB ' ' HB ' ' A' ' 83' ' ' ILE . 8.2 mm -82.83 119.67 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.251 -0.905 . . . . 0.0 109.39 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 9.8 t -159.93 169.59 23.17 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.211 -0.93 . . . . 0.0 109.5 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 84.33 24.13 48.56 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.3 t -91.59 126.68 44.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.25 -1.147 . . . . 0.0 109.495 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -113.55 78.73 1.17 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.271 -0.893 . . . . 0.0 109.43 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 84.7 mt -137.21 -170.44 2.72 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.244 -0.91 . . . . 0.0 109.429 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.444 ' HB3' ' HB2' ' A' ' 60' ' ' GLU . 6.7 t0 -57.92 151.42 18.26 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.257 -0.902 . . . . 0.0 109.484 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.87 -54.25 49.25 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.237 -0.914 . . . . 0.0 109.513 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.57 -21.76 62.65 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.191 -0.943 . . . . 0.0 109.604 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.444 ' HB2' ' HB3' ' A' ' 57' ' ' ASP . 19.0 tt0 -61.99 -41.74 98.38 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.201 -0.937 . . . . 0.0 109.597 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.8 mp -61.08 -56.7 17.82 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.225 -0.922 . . . . 0.0 109.579 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 86.6 m -47.87 -36.69 12.51 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.15 -0.969 . . . . 0.0 109.492 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.408 ' O ' ' C ' ' A' ' 64' ' ' LEU . 15.4 tttt -61.84 -64.76 0.84 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.265 -0.897 . . . . 0.0 109.437 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.408 ' C ' ' O ' ' A' ' 63' ' ' LYS . 0.5 OUTLIER -44.55 -41.51 6.53 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.281 -0.887 . . . . 0.0 109.751 -179.862 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -56.83 -59.09 5.55 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.242 -0.911 . . . . 0.0 109.702 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.3 -17.08 17.01 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.292 -0.88 . . . . 0.0 109.81 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -76.65 -44.16 35.13 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.162 -0.961 . . . . 0.0 110.042 -179.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.457 ' CD2' ' N ' ' A' ' 68' ' ' LEU . 4.4 mm? -79.58 -26.52 41.28 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.073 -1.017 . . . . 0.0 110.201 -179.413 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.1 ttmt -71.18 -5.84 34.92 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.056 -1.028 . . . . 0.0 109.593 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -60.22 -42.23 94.72 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.251 -0.905 . . . . 0.0 109.196 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.52 43.48 0.75 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.313 -0.867 . . . . 0.0 109.688 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -77.78 -28.35 50.48 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.345 -0.847 . . . . 0.0 108.944 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.477 ' O ' ' HB2' ' A' ' 74' ' ' CYS . . . 124.75 -27.98 5.31 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 108.839 -1.705 . . . . 0.0 108.839 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.477 ' HB2' ' O ' ' A' ' 73' ' ' GLY . 4.5 t 165.36 97.42 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.554 -0.968 . . . . 0.0 108.695 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -76.52 116.29 4.64 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.444 -1.463 . . . . 0.0 109.444 -179.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -63.4 -88.47 0.04 OUTLIER Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.496 -1.441 . . . . 0.0 109.496 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -133.09 160.6 36.71 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.341 -1.093 . . . . 0.0 109.559 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 39.5 t -132.0 140.75 47.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.277 -0.89 . . . . 0.0 109.413 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 48.5 mttt -148.18 141.68 25.38 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.287 -0.883 . . . . 0.0 109.414 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -60.71 91.49 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.153 -0.967 . . . . 0.0 109.516 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.401 ' C ' HG22 ' A' ' 82' ' ' VAL . . . 134.93 -37.33 1.95 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.401 HG22 ' C ' ' A' ' 81' ' ' GLY . 90.8 t -139.86 135.18 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.266 -1.138 . . . . 0.0 109.341 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.437 ' HB ' ' HB ' ' A' ' 51' ' ' ILE . 41.4 mt -130.99 133.92 62.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.227 -0.92 . . . . 0.0 109.612 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 -104.33 120.62 41.59 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.263 -0.898 . . . . 0.0 109.43 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.412 HD12 ' HA ' ' A' ' 85' ' ' ILE . 20.4 mm -122.44 91.4 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.209 -0.932 . . . . 0.0 109.46 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -55.2 129.99 40.4 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.211 -0.931 . . . . 0.0 109.505 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 161.74 -155.16 26.32 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -177.79 70.38 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.203 -1.175 . . . . 0.0 109.475 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 55.1 mttt -143.51 49.44 1.41 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.276 -0.89 . . . . 0.0 109.537 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.442 ' HA ' HD11 ' A' ' 93' ' ' LEU . 0.9 OUTLIER -48.44 -28.76 3.48 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.27 -0.894 . . . . 0.0 109.426 179.998 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -60.77 -55.16 36.48 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.196 -0.94 . . . . 0.0 109.433 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.7 tt -64.49 -29.2 70.24 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.24 -0.913 . . . . 0.0 109.477 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.485 ' CD1' HG23 ' A' ' 36' ' ' ILE . 0.3 OUTLIER -61.86 -44.04 97.64 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.21 -0.931 . . . . 0.0 109.474 -179.979 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -63.21 -30.31 71.48 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.291 -0.881 . . . . 0.0 109.438 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.404 ' O ' ' C ' ' A' ' 96' ' ' LEU . 46.8 t -70.32 -68.95 0.39 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.284 -0.885 . . . . 0.0 109.469 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.482 ' CD2' ' HA ' ' A' ' 93' ' ' LEU . 3.8 pp -45.42 -35.39 3.67 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.224 -0.923 . . . . 0.0 109.493 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.516 ' CD2' ' HB ' ' A' ' 104' ' ' VAL . 2.5 tt -62.54 -52.67 62.51 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.292 -0.88 . . . . 0.0 109.431 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -62.25 -17.52 58.66 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.248 -0.908 . . . . 0.0 109.441 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -62.18 -37.2 84.38 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.303 -0.873 . . . . 0.0 109.466 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -84.23 -23.47 30.43 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.196 -0.94 . . . . 0.0 109.477 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 93.58 14.8 52.31 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 2.6 mtm -85.42 152.79 22.96 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.194 -1.18 . . . . 0.0 109.49 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.49 ' O ' ' CG1' ' A' ' 33' ' ' VAL . 16.2 mttt -81.31 149.35 28.97 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.264 -0.898 . . . . 0.0 109.436 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.516 ' HB ' ' CD2' ' A' ' 97' ' ' LEU . 12.9 p -136.87 153.59 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.259 -0.901 . . . . 0.0 109.454 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 69.6 mttt -120.93 85.83 2.47 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.248 -0.907 . . . . 0.0 109.431 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -50.52 101.33 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.263 -0.898 . . . . 0.0 109.521 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -89.16 175.4 7.39 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.236 -0.915 . . . . 0.0 109.493 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 156.81 -146.86 14.52 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 159.58 118.97 0.53 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -101.45 -27.35 13.18 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.249 -1.148 . . . . 0.0 109.463 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.43 ' O ' ' HG2' ' A' ' 111' ' ' GLU . 77.7 tt0 . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 118.0 -1.0 . . . . 0.0 109.418 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 23.8 mtpt . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -136.49 58.11 0.66 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -106.64 104.87 14.66 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.286 -1.126 . . . . 0.0 109.515 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.402 ' C ' ' HE1' ' A' ' 102' ' ' MET . . . -117.09 133.43 10.62 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.8 m -154.43 145.48 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.217 -1.166 . . . . 0.0 109.493 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.412 ' HB ' HD23 ' A' ' 97' ' ' LEU . 45.0 t -127.73 147.36 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.286 -0.884 . . . . 0.0 109.436 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.458 ' HB2' ' HA3' ' A' ' 53' ' ' GLY . 3.2 ttm180 -103.18 99.56 9.43 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.224 -0.922 . . . . 0.0 109.487 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 11.0 mt -104.87 107.58 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.236 -0.915 . . . . 0.0 109.457 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.4 ' HB3' ' CB ' ' A' ' 107' ' ' ALA . 1.5 pt20 -137.64 138.44 39.47 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.255 -0.903 . . . . 0.0 109.47 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 10.1 ptt85 -92.63 127.63 38.2 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.232 -0.917 . . . . 0.0 109.532 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -115.06 81.88 1.65 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.266 -0.896 . . . . 0.0 109.384 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 4.2 p -50.57 162.14 0.27 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.215 -0.928 . . . . 0.0 109.504 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -148.92 37.55 0.8 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.28 -0.888 . . . . 0.0 109.458 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 152.55 169.52 17.96 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -105.73 49.0 0.82 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.272 -1.134 . . . . 0.0 109.391 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 74.1 mttt -130.83 49.43 2.32 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.279 -0.888 . . . . 0.0 109.531 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 54.75 42.17 77.46 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 12.7 tttt -100.07 87.35 3.45 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.244 -1.15 . . . . 0.0 109.424 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -103.29 130.35 10.21 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 35.2 m -144.09 154.08 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.312 -1.111 . . . . 0.0 109.459 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -125.65 125.31 42.89 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.166 -0.959 . . . . 0.0 109.54 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.5 mp -106.29 111.07 23.51 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.253 -0.904 . . . . 0.0 109.485 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.441 ' HB ' ' HB ' ' A' ' 83' ' ' ILE . 5.4 mm -98.64 117.76 44.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.233 -0.917 . . . . 0.0 109.481 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.0 m -154.82 25.89 0.44 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.207 -0.933 . . . . 0.0 109.491 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.458 ' HA3' ' HB2' ' A' ' 35' ' ' ARG . . . -119.68 28.51 6.43 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.431 HG12 HD11 ' A' ' 61' ' ' LEU . 17.5 t -88.28 127.83 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.224 -1.162 . . . . 0.0 109.462 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -115.95 82.71 1.82 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.262 -0.899 . . . . 0.0 109.442 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.6 mt -146.21 -172.65 3.98 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.247 -0.908 . . . . 0.0 109.465 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.418 ' HB2' ' HB2' ' A' ' 60' ' ' GLU . 2.9 m-20 -59.37 167.04 2.02 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.265 -0.897 . . . . 0.0 109.396 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -76.16 -50.58 14.2 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.251 -0.906 . . . . 0.0 109.329 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.24 -27.9 65.86 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.294 -0.879 . . . . 0.0 109.301 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.418 ' HB2' ' HB2' ' A' ' 57' ' ' ASP . 18.3 tt0 -70.47 -37.07 74.21 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.274 -0.891 . . . . 0.0 109.391 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.431 HD11 HG12 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -66.27 -35.41 80.33 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.301 -0.874 . . . . 0.0 109.49 179.957 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.5 m -66.85 -31.05 71.41 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.294 -0.879 . . . . 0.0 109.583 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 43.8 mttt -72.5 -49.31 33.93 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.274 -0.891 . . . . 0.0 109.616 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.4 tp -55.24 -48.34 74.11 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.244 -0.91 . . . . 0.0 109.419 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.444 ' HA ' ' CD1' ' A' ' 68' ' ' LEU . . . -61.74 -36.13 80.1 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.309 -0.869 . . . . 0.0 109.394 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.08 -47.44 85.89 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.274 -0.891 . . . . 0.0 109.528 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -72.24 -19.77 61.65 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.215 -0.928 . . . . 0.0 109.545 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.444 ' CD1' ' HA ' ' A' ' 65' ' ' ALA . 7.1 mt -70.29 -63.88 1.0 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.201 -0.937 . . . . 0.0 109.12 179.563 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.31 -12.0 12.04 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.457 -0.777 . . . . 0.0 109.631 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.5 -50.79 62.09 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.15 -0.969 . . . . 0.0 109.369 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -111.36 31.43 6.11 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.195 -0.941 . . . . 0.0 109.724 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 42.5 t -96.7 -12.31 23.96 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.106 -0.996 . . . . 0.0 109.657 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 90.51 -32.96 4.77 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 9.9 t 179.15 112.07 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.981 -1.305 . . . . 0.0 109.537 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -91.77 -150.15 25.1 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 110.034 -1.227 . . . . 0.0 110.034 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -157.94 -83.3 0.04 OUTLIER Glycine 0 N--CA 1.493 2.456 0 O-C-N 121.228 -1.16 . . . . 0.0 110.257 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -113.9 118.0 32.96 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.06 -1.259 . . . . 0.0 109.851 -179.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 97.7 t -109.69 120.35 60.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.256 -0.903 . . . . 0.0 109.731 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.6 mtmt -154.16 149.96 27.61 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.299 -0.876 . . . . 0.0 109.239 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -70.58 97.03 1.26 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.156 -0.965 . . . . 0.0 109.523 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.424 ' O ' ' CG2' ' A' ' 82' ' ' VAL . . . 125.52 -11.42 7.54 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.424 ' CG2' ' O ' ' A' ' 81' ' ' GLY . 57.3 t -156.88 108.33 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.055 -1.262 . . . . 0.0 109.413 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.441 ' HB ' ' HB ' ' A' ' 51' ' ' ILE . 4.1 mt -118.74 104.85 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.208 -0.932 . . . . 0.0 109.52 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -92.92 112.28 24.18 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.295 -0.878 . . . . 0.0 109.615 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 49.5 mm -99.07 89.95 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.229 -0.919 . . . . 0.0 109.29 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -60.13 104.69 0.33 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.224 -0.922 . . . . 0.0 109.548 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 156.57 152.27 6.23 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -112.05 96.83 6.27 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.288 -1.124 . . . . 0.0 109.515 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 16.2 mttt -141.3 48.37 1.67 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.296 -0.878 . . . . 0.0 109.5 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.476 ' HA ' ' CD1' ' A' ' 93' ' ' LEU . 39.2 ptt180 -49.38 -32.01 10.67 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.231 -0.918 . . . . 0.0 109.659 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.41 ' N ' ' HG3' ' A' ' 90' ' ' ARG . 67.8 t0 -62.21 -60.39 3.65 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.228 -0.92 . . . . 0.0 109.572 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.1 tp -59.25 -22.67 61.47 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.167 -0.958 . . . . 0.0 109.351 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.476 ' CD1' ' HA ' ' A' ' 90' ' ' ARG . 35.4 mt -69.11 -46.29 68.07 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.312 -0.868 . . . . 0.0 109.471 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 77.0 tttt -61.73 -25.76 67.64 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.196 -0.94 . . . . 0.0 109.46 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 8.7 t -76.05 -61.05 2.07 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.229 -0.919 . . . . 0.0 109.564 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.5 ' CD1' ' N ' ' A' ' 97' ' ' LEU . 4.2 pp -52.91 -29.72 30.13 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.246 -0.909 . . . . 0.0 109.537 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.5 ' N ' ' CD1' ' A' ' 96' ' ' LEU . 0.2 OUTLIER -72.34 -48.55 41.08 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.22 -0.925 . . . . 0.0 109.491 -179.955 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -68.74 -12.74 61.81 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.244 -0.91 . . . . 0.0 109.465 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -61.97 -33.11 73.7 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.226 -0.921 . . . . 0.0 109.469 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.73 -22.04 27.97 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.22 -0.925 . . . . 0.0 109.491 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 77.89 24.6 64.1 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' MET . . . . . 0.402 ' HE1' ' C ' ' A' ' 32' ' ' GLY . 0.6 OUTLIER -99.09 -158.88 0.7 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.255 -1.144 . . . . 0.0 109.479 -179.991 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 23.3 mttt -104.06 165.06 11.29 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.206 -0.934 . . . . 0.0 109.492 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.447 HG22 ' N ' ' A' ' 105' ' ' LYS . 11.4 p -145.03 158.25 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.24 -0.912 . . . . 0.0 109.458 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.447 ' N ' HG22 ' A' ' 104' ' ' VAL . 33.9 tttt -119.61 68.47 0.82 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.262 -0.899 . . . . 0.0 109.471 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -50.39 96.61 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.212 -0.93 . . . . 0.0 109.478 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.422 ' N ' ' O ' ' A' ' 105' ' ' LYS . . . -89.05 140.06 29.83 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.325 -0.86 . . . . 0.0 109.509 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 117.73 174.62 16.75 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -168.94 -177.82 40.0 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -77.6 115.58 17.47 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.253 -1.146 . . . . 0.0 109.469 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.429 ' HG2' ' O ' ' A' ' 111' ' ' GLU . 74.0 tt0 . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.442 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 88.3 mttt . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -171.57 130.32 1.93 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -142.64 72.43 1.37 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.209 -1.171 . . . . 0.0 109.512 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 125.61 59.67 0.16 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 73.3 t -108.89 111.29 35.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.263 -1.139 . . . . 0.0 109.423 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 39.8 t -87.65 145.13 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.275 -0.891 . . . . 0.0 109.522 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 31.9 ttm180 -111.55 103.53 11.86 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.228 -0.92 . . . . 0.0 109.437 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.409 ' CD1' HG22 ' A' ' 104' ' ' VAL . 4.7 mt -102.07 106.22 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.196 -0.94 . . . . 0.0 109.538 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.422 ' HB3' ' O ' ' A' ' 106' ' ' LEU . 1.7 pp0? -142.66 136.58 29.22 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.227 -0.921 . . . . 0.0 109.412 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.65 167.03 11.37 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.235 -0.915 . . . . 0.0 109.501 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -150.17 154.29 37.75 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.243 -0.91 . . . . 0.0 109.467 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.46 76.79 1.03 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.298 -0.876 . . . . 0.0 109.468 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -147.13 104.01 3.64 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.247 -0.908 . . . . 0.0 109.465 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 153.61 138.25 2.63 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.536 -1.425 . . . . 0.0 109.536 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 91.2 mtt180 -96.34 23.35 6.79 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.253 -1.146 . . . . 0.0 109.497 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 25.3 mttt -129.05 29.35 5.19 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.287 -0.883 . . . . 0.0 109.441 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 159.71 137.5 2.24 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -113.0 120.01 39.9 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.219 -1.166 . . . . 0.0 109.485 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.62 85.85 0.65 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 27.7 m -123.69 168.33 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.242 -1.152 . . . . 0.0 109.452 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 2.1 t -140.72 132.51 27.43 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.223 -0.923 . . . . 0.0 109.429 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.09 154.56 39.78 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.265 -0.897 . . . . 0.0 109.449 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.48 HG23 ' CG2' ' A' ' 54' ' ' VAL . 4.5 mm -122.15 117.83 53.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.246 -0.909 . . . . 0.0 109.463 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.1 m -141.84 14.01 2.1 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.261 -0.9 . . . . 0.0 109.525 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.442 ' O ' ' N ' ' A' ' 55' ' ' ASP . . . -105.5 -16.69 15.27 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.48 ' CG2' HG23 ' A' ' 51' ' ' ILE . 18.6 t -44.93 98.9 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.214 -1.168 . . . . 0.0 109.494 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.442 ' N ' ' O ' ' A' ' 53' ' ' GLY . 41.0 t0 -87.34 88.28 7.64 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.201 -0.937 . . . . 0.0 109.459 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.448 ' HB2' HD12 ' A' ' 61' ' ' LEU . 12.9 mt -151.42 -169.95 3.52 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.281 -0.887 . . . . 0.0 109.487 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -74.76 178.49 5.43 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.259 -0.901 . . . . 0.0 109.441 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.53 -30.31 46.95 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.286 -0.884 . . . . 0.0 109.444 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -75.79 -48.66 20.77 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.213 -0.929 . . . . 0.0 109.464 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -62.06 -32.16 72.66 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.276 -0.89 . . . . 0.0 109.466 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.493 ' CD2' ' HA2' ' A' ' 81' ' ' GLY . 0.2 OUTLIER -65.36 -45.83 82.55 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.225 -0.922 . . . . 0.0 109.435 -179.994 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 51.5 p -63.78 -33.88 76.65 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.218 -0.926 . . . . 0.0 109.47 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.423 ' O ' ' HB1' ' A' ' 66' ' ' ALA . 32.6 mttp -65.65 -46.73 78.06 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.29 -0.882 . . . . 0.0 109.469 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.29 -57.65 12.08 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.339 -0.851 . . . . 0.0 109.527 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.55 -23.63 58.87 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.273 -0.892 . . . . 0.0 109.534 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.423 ' HB1' ' O ' ' A' ' 63' ' ' LYS . . . -69.72 -41.49 75.26 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.241 -0.912 . . . . 0.0 109.582 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -76.99 -29.21 55.4 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.203 -0.936 . . . . 0.0 109.566 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.441 ' CD2' HD11 ' A' ' 96' ' ' LEU . 9.8 mt -67.7 -52.22 40.32 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.242 -0.911 . . . . 0.0 109.47 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.46 -12.55 57.85 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.295 -0.878 . . . . 0.0 109.504 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -74.97 -42.11 58.26 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.197 -0.939 . . . . 0.0 109.507 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 5.7 tttp -67.1 -19.86 65.7 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.304 -0.873 . . . . 0.0 109.654 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 43.7 t -88.14 -43.52 11.59 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.193 -0.942 . . . . 0.0 109.552 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.42 ' O ' ' HB2' ' A' ' 74' ' ' CYS . . . 100.62 -19.87 50.63 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.42 ' HB2' ' O ' ' A' ' 73' ' ' GLY . 0.1 OUTLIER 172.08 134.97 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.169 -1.195 . . . . 0.0 109.532 -179.981 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 126.73 -34.45 3.15 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -69.31 98.76 0.59 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -108.9 134.52 51.46 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.305 -1.114 . . . . 0.0 109.17 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.436 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 26.8 m -101.02 160.49 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.269 -0.894 . . . . 0.0 109.817 -179.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.438 ' HB2' ' O ' ' A' ' 82' ' ' VAL . 0.2 OUTLIER -142.05 65.82 1.36 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.362 -0.836 . . . . 0.0 109.208 179.747 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 25.4 t70 50.76 68.7 0.73 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.362 -0.836 . . . . 0.0 109.545 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.493 ' HA2' ' CD2' ' A' ' 61' ' ' LEU . . . 90.3 -28.57 7.32 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.438 ' O ' ' HB2' ' A' ' 79' ' ' LYS . 40.2 t -91.59 90.74 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.161 -1.199 . . . . 0.0 109.559 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.445 HD13 ' HB ' ' A' ' 51' ' ' ILE . 11.7 mt -82.04 155.86 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.276 -0.89 . . . . 0.0 109.437 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -149.56 113.33 5.07 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.2 -0.937 . . . . 0.0 109.436 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 23.8 mt -130.9 107.62 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.215 -0.928 . . . . 0.0 109.511 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -53.74 148.52 9.84 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.235 -0.916 . . . . 0.0 109.397 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 143.55 152.84 5.73 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -133.91 84.14 2.1 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.252 -1.146 . . . . 0.0 109.429 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 84.7 mttt -148.21 52.22 1.02 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.282 -0.886 . . . . 0.0 109.478 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 11.8 ptt-85 -46.58 -31.95 3.13 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.25 -0.906 . . . . 0.0 109.472 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -55.78 -55.21 35.03 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.236 -0.915 . . . . 0.0 109.465 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 8.2 tt -63.16 -49.32 74.77 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.176 -0.952 . . . . 0.0 109.491 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -47.87 -31.04 4.61 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.229 -0.919 . . . . 0.0 109.481 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 34.4 tttt -60.63 -62.77 1.62 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.241 -0.912 . . . . 0.0 109.53 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.57 -16.83 58.28 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.247 -0.908 . . . . 0.0 109.495 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.441 HD11 ' CD2' ' A' ' 68' ' ' LEU . 5.4 tt -72.62 -43.92 62.64 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.287 -0.883 . . . . 0.0 109.513 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -74.1 -38.41 63.86 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.287 -0.883 . . . . 0.0 109.484 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -69.73 -20.9 63.51 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.281 -0.887 . . . . 0.0 109.475 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -55.62 -29.93 60.03 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.262 -0.899 . . . . 0.0 109.497 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.43 -25.37 21.54 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.281 -0.887 . . . . 0.0 109.492 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 95.26 28.44 9.81 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 31.4 mtm -109.5 179.93 4.0 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.226 -1.161 . . . . 0.0 109.471 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 8.7 mmtt -88.85 162.16 16.31 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.259 -0.901 . . . . 0.0 109.456 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.409 HG22 ' CD1' ' A' ' 36' ' ' ILE . 3.2 p -154.39 135.79 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.218 -0.926 . . . . 0.0 109.464 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 12.5 mttt -108.56 104.41 13.72 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.253 -0.904 . . . . 0.0 109.464 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.422 ' O ' ' HB3' ' A' ' 37' ' ' GLN . 1.1 tp -47.86 -24.45 1.01 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.25 -0.906 . . . . 0.0 109.453 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.409 ' C ' ' O ' ' A' ' 106' ' ' LEU . . . 44.74 67.23 0.73 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.215 -0.928 . . . . 0.0 109.475 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -109.38 -170.57 20.51 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 142.9 166.06 10.91 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.432 ' O ' ' HB2' ' A' ' 111' ' ' GLU . 13.4 mt 59.48 86.42 0.09 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.276 -1.132 . . . . 0.0 109.469 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.432 ' HB2' ' O ' ' A' ' 110' ' ' LEU . 81.5 tt0 . . . . . 0 N--CA 1.49 1.525 0 CA-C-O 117.99 -1.005 . . . . 0.0 109.489 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.7 mttt . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -178.94 154.51 14.25 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -152.23 50.82 0.78 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.232 -1.158 . . . . 0.0 109.484 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.428 ' HA3' ' SD ' ' A' ' 102' ' ' MET . . . 112.61 125.9 4.53 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 93.7 t -143.16 93.95 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.252 -1.146 . . . . 0.0 109.478 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.44 HG11 HG21 ' A' ' 51' ' ' ILE . 70.5 t -93.23 109.46 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.289 -0.882 . . . . 0.0 109.454 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.425 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 71.9 mtt180 -92.34 131.8 37.24 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.24 -0.913 . . . . 0.0 109.545 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.402 ' CG1' HG12 ' A' ' 51' ' ' ILE . 7.0 mt -125.55 127.22 71.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.219 -0.926 . . . . 0.0 109.421 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.476 ' HA ' ' CB ' ' A' ' 107' ' ' ALA . 1.7 pt20 -151.03 -167.89 2.94 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.176 -0.953 . . . . 0.0 109.526 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.406 ' HG3' ' O ' ' A' ' 38' ' ' ARG . 5.4 ptt180 -137.11 118.8 14.99 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.229 -0.919 . . . . 0.0 109.504 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -91.36 118.63 30.69 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.183 -0.948 . . . . 0.0 109.442 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 29.0 p -106.13 -171.05 1.83 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.263 -0.898 . . . . 0.0 109.428 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -177.63 -51.0 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.185 -0.947 . . . . 0.0 109.54 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -110.68 -173.61 20.12 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -139.5 55.25 1.68 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.246 -1.15 . . . . 0.0 109.445 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 31.4 pttt -161.11 30.31 0.14 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.284 -0.885 . . . . 0.0 109.481 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -158.1 -123.85 0.75 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 51.9 mttt -132.98 -153.36 0.54 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.206 -1.173 . . . . 0.0 109.478 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -141.93 -163.93 9.83 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.586 -1.405 . . . . 0.0 109.586 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 22.9 m -154.58 146.11 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.269 -1.136 . . . . 0.0 109.521 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -90.04 131.27 36.01 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.288 -0.883 . . . . 0.0 109.435 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.1 115.86 25.68 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.255 -0.903 . . . . 0.0 109.46 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.442 HD12 HG13 ' A' ' 85' ' ' ILE . 8.1 mt -120.37 110.5 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.212 -0.93 . . . . 0.0 109.458 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 9.8 t -142.95 162.89 34.27 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.238 -0.914 . . . . 0.0 109.637 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.49 22.24 13.09 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.611 -1.395 . . . . 0.0 109.611 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.456 ' HB ' HD23 ' A' ' 61' ' ' LEU . 61.7 t -78.41 112.71 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.22 -1.165 . . . . 0.0 109.443 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -97.15 70.48 2.37 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.294 -0.879 . . . . 0.0 109.541 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.449 HD12 HG12 ' A' ' 54' ' ' VAL . 10.3 mt -136.87 172.7 12.62 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.167 -0.958 . . . . 0.0 109.524 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -47.75 170.71 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.218 -0.926 . . . . 0.0 109.45 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -76.55 -39.8 51.73 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.232 -0.917 . . . . 0.0 109.468 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.09 -31.01 72.04 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.243 -0.91 . . . . 0.0 109.496 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -62.03 -45.92 91.47 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.269 -0.894 . . . . 0.0 109.543 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.456 HD23 ' HB ' ' A' ' 54' ' ' VAL . 8.4 mt -53.04 -42.69 65.98 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.249 -0.907 . . . . 0.0 109.472 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 52.2 m -71.9 -26.28 62.26 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.264 -0.898 . . . . 0.0 109.425 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.2 tttt -63.49 -59.91 4.04 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.256 -0.902 . . . . 0.0 109.393 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.9 mt -64.7 -31.55 72.82 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.281 -0.887 . . . . 0.0 109.538 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -57.5 -49.63 75.68 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.272 -0.892 . . . . 0.0 109.662 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -71.81 -28.04 63.33 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.244 -0.91 . . . . 0.0 109.628 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -64.45 -33.08 75.05 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.219 -0.926 . . . . 0.0 109.907 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 6.0 mt -88.04 -34.52 17.96 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.102 -0.999 . . . . 0.0 109.921 -179.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.8 mttt -63.24 -16.9 61.66 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.139 -0.975 . . . . 0.0 109.778 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 13.5 tttt -75.28 -28.15 59.67 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.18 -0.95 . . . . 0.0 109.707 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 7.2 mtpp -72.42 -67.84 0.52 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.169 -0.957 . . . . 0.0 109.243 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -64.63 -56.72 12.03 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.19 -0.944 . . . . 0.0 109.195 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.468 ' O ' ' HB2' ' A' ' 74' ' ' CYS . . . 84.31 12.88 75.07 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.468 ' HB2' ' O ' ' A' ' 73' ' ' GLY . 4.7 t 166.46 126.73 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.478 -1.013 . . . . 0.0 108.994 -179.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 113.86 -5.95 24.02 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -110.08 125.63 7.61 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.194 -1.563 . . . . 0.0 109.194 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -110.15 121.41 45.21 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.169 -1.194 . . . . 0.0 109.939 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 36.9 t -86.92 124.34 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.276 -0.89 . . . . 0.0 109.122 179.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -120.41 145.7 46.94 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.209 -0.932 . . . . 0.0 109.201 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.0 101.17 1.08 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.289 -0.882 . . . . 0.0 109.493 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 103.53 -11.53 54.03 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 65.0 t -142.85 121.29 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.323 -1.104 . . . . 0.0 109.426 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 26.8 mm -104.3 121.18 55.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.226 -0.921 . . . . 0.0 109.589 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -105.68 120.33 41.41 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.315 -0.866 . . . . 0.0 109.401 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.442 HG13 HD12 ' A' ' 51' ' ' ILE . 14.8 mm -117.6 164.4 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.176 -0.952 . . . . 0.0 109.517 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -124.69 132.89 53.36 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.311 -0.868 . . . . 0.0 109.583 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 136.87 168.31 11.37 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -135.62 82.11 1.93 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.29 -1.124 . . . . 0.0 109.559 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 43.7 mttt -142.88 51.68 1.41 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.217 -0.927 . . . . 0.0 109.478 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.64 -25.95 0.81 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.24 -0.912 . . . . 0.0 109.447 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -64.85 -58.33 6.47 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.244 -0.91 . . . . 0.0 109.373 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.0 tt -58.13 -49.08 78.24 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.245 -0.909 . . . . 0.0 109.308 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.452 ' O ' ' HB3' ' A' ' 96' ' ' LEU . 3.4 mt -52.1 -33.63 40.53 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.278 -0.889 . . . . 0.0 109.408 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.429 ' CG ' ' CD1' ' A' ' 106' ' ' LEU . 0.1 OUTLIER -60.53 -58.49 8.25 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.292 -0.88 . . . . 0.0 109.388 179.923 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 3.2 t -65.79 -11.76 48.63 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.213 -0.929 . . . . 0.0 109.447 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.452 ' HB3' ' O ' ' A' ' 93' ' ' LEU . 3.1 tt -74.9 -59.2 2.84 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.24 -0.913 . . . . 0.0 109.423 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.498 ' CD1' ' HB2' ' A' ' 102' ' ' MET . 0.1 OUTLIER -69.56 -23.29 63.54 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.286 -0.883 . . . . 0.0 109.49 179.975 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -73.39 -26.46 61.0 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.282 -0.886 . . . . 0.0 109.516 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -71.03 -22.26 62.17 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.252 -0.905 . . . . 0.0 109.489 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 4.0 mtmt -94.29 8.0 43.37 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.231 -0.918 . . . . 0.0 109.508 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 46.32 33.29 5.65 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' MET . . . . . 0.498 ' HB2' ' CD1' ' A' ' 97' ' ' LEU . 0.1 OUTLIER -86.93 -173.43 4.46 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.268 -1.137 . . . . 0.0 109.471 -179.993 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 16.8 mttt -101.16 72.06 1.43 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.262 -0.899 . . . . 0.0 109.459 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 8.3 p -88.68 145.69 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.232 -0.918 . . . . 0.0 109.532 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.403 ' O ' ' C ' ' A' ' 106' ' ' LEU . 21.5 tttt -110.79 30.27 7.0 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.277 -0.889 . . . . 0.0 109.446 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.429 ' CD1' ' CG ' ' A' ' 94' ' ' LYS . 3.5 tp 44.6 -154.28 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.251 -0.905 . . . . 0.0 109.487 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.476 ' CB ' ' HA ' ' A' ' 37' ' ' GLN . . . -105.26 63.61 0.7 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.221 -0.924 . . . . 0.0 109.463 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -68.72 168.65 43.07 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -170.53 162.5 35.6 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -177.05 67.62 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.292 -1.122 . . . . 0.0 109.416 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.427 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 85.7 mttt . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -77.01 111.68 3.33 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -119.04 -35.67 3.58 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.22 -1.165 . . . . 0.0 109.531 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -160.33 148.1 15.95 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.8 m -131.68 145.41 35.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.271 -1.135 . . . . 0.0 109.491 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.4 t -111.28 164.71 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.23 -0.919 . . . . 0.0 109.442 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -141.57 112.24 7.14 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.237 -0.915 . . . . 0.0 109.444 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 4.5 mt -125.78 117.1 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.259 -0.901 . . . . 0.0 109.483 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.71 98.16 2.93 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.303 -0.873 . . . . 0.0 109.449 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.2 ptt180 -56.38 125.68 23.04 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.284 -0.885 . . . . 0.0 109.515 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -110.78 79.14 1.17 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.208 -0.932 . . . . 0.0 109.494 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 33.7 p -50.28 149.22 3.06 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.209 -0.932 . . . . 0.0 109.476 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.2 t -103.34 -12.56 17.15 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.265 -0.897 . . . . 0.0 109.449 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -135.4 160.35 24.41 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -61.36 119.36 8.36 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.194 -1.18 . . . . 0.0 109.456 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 27.4 tttt 53.73 -175.9 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.232 -0.918 . . . . 0.0 109.474 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 97.49 -143.41 16.71 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 10.8 tttt -88.26 161.54 17.13 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.29 -1.124 . . . . 0.0 109.506 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -144.75 152.58 24.54 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 34.5 m -106.01 167.88 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.233 -1.157 . . . . 0.0 109.428 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -128.88 113.1 14.83 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.187 -0.946 . . . . 0.0 109.477 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -89.04 143.78 26.61 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.198 -0.939 . . . . 0.0 109.528 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 6.4 mm -127.33 108.32 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.207 -0.933 . . . . 0.0 109.414 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -155.14 154.58 32.55 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.274 -0.891 . . . . 0.0 109.494 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 115.5 -28.72 7.67 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 24.2 t -45.76 109.84 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.311 -1.111 . . . . 0.0 109.457 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -90.73 75.89 6.49 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.284 -0.885 . . . . 0.0 109.466 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -114.12 -171.5 1.92 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.259 -0.9 . . . . 0.0 109.485 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -72.5 -69.72 0.39 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.258 -0.901 . . . . 0.0 109.473 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -178.93 -43.03 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.256 -0.903 . . . . 0.0 109.465 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.406 ' O ' ' OG1' ' A' ' 62' ' ' THR . . . -76.92 -30.58 56.18 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.247 -0.908 . . . . 0.0 109.525 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -59.1 -45.48 90.75 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.223 -0.923 . . . . 0.0 109.523 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -50.89 -52.8 38.35 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.238 -0.914 . . . . 0.0 109.42 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.406 ' OG1' ' O ' ' A' ' 59' ' ' ALA . 34.0 p -57.57 -40.66 79.46 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.304 -0.872 . . . . 0.0 109.405 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 7.7 tttt -54.57 -45.04 73.44 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.3 -0.875 . . . . 0.0 109.536 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.0 -46.01 86.44 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.24 -0.912 . . . . 0.0 109.509 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -49.72 -43.83 47.9 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.199 -0.938 . . . . 0.0 109.548 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -69.37 -35.96 76.35 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.272 -0.892 . . . . 0.0 109.577 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -65.44 -21.61 66.67 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.211 -0.931 . . . . 0.0 109.627 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 5.4 mt -87.25 -44.4 11.47 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.305 -0.872 . . . . 0.0 109.673 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.449 ' O ' ' HG2' ' A' ' 69' ' ' LYS . 10.0 tttt -64.59 -22.7 67.04 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.259 -0.901 . . . . 0.0 109.801 -179.686 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.24 -15.52 47.58 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.178 -0.951 . . . . 0.0 110.004 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.8 23.87 1.09 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.057 -1.027 . . . . 0.0 109.656 -179.589 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -105.39 -24.56 12.63 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.303 -0.873 . . . . 0.0 109.551 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.43 ' O ' ' SG ' ' A' ' 74' ' ' CYS . . . 94.03 -10.74 71.65 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 -179.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.43 ' SG ' ' O ' ' A' ' 73' ' ' GLY . 0.7 OUTLIER 174.07 134.86 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.325 -1.103 . . . . 0.0 109.281 179.983 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -72.66 -80.49 0.41 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 120.66 -109.34 1.54 Allowed Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -106.0 131.39 53.35 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.153 -1.204 . . . . 0.0 109.417 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 90.4 t -136.33 97.37 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.23 -0.919 . . . . 0.0 109.83 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.2 146.71 27.59 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.194 -0.941 . . . . 0.0 108.761 179.321 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -63.27 94.43 0.08 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.112 -0.992 . . . . 0.0 109.609 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 129.88 -25.95 4.33 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.444 ' O ' HG13 ' A' ' 83' ' ' ILE . 1.6 m -143.59 157.79 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.182 -1.187 . . . . 0.0 109.673 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.493 HG23 ' N ' ' A' ' 84' ' ' GLU . 4.2 mp -143.71 146.74 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.223 -0.923 . . . . 0.0 109.467 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.493 ' N ' HG23 ' A' ' 83' ' ' ILE . 3.4 mt-10 -130.28 125.96 36.08 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.238 -0.914 . . . . 0.0 109.423 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.44 HG23 ' N ' ' A' ' 86' ' ' GLN . 28.1 mm -114.69 157.18 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.215 -0.928 . . . . 0.0 109.5 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.44 ' N ' HG23 ' A' ' 85' ' ' ILE . 0.0 OUTLIER -115.9 86.02 2.4 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.206 -0.934 . . . . 0.0 109.469 -179.963 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -164.48 166.85 38.07 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -119.38 49.22 1.38 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.246 -1.149 . . . . 0.0 109.482 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 31.4 mttt -105.52 37.0 2.32 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.211 -0.931 . . . . 0.0 109.459 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 7.3 ttt180 -46.81 -36.85 7.83 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.26 -0.9 . . . . 0.0 109.474 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -58.03 -53.66 55.75 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.242 -0.912 . . . . 0.0 109.547 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.11 -17.8 64.94 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.231 -0.918 . . . . 0.0 109.526 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.434 ' HA ' ' CD2' ' A' ' 96' ' ' LEU . 2.1 mt -72.56 -44.85 61.53 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.302 -0.874 . . . . 0.0 109.494 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 61.6 tttt -65.96 -32.98 74.78 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.224 -0.923 . . . . 0.0 109.477 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 14.3 t -67.54 -62.69 1.3 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.25 -0.906 . . . . 0.0 109.448 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.532 ' CD1' ' N ' ' A' ' 97' ' ' LEU . 4.2 pp -51.64 -31.61 26.1 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.195 -0.941 . . . . 0.0 109.471 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.532 ' N ' ' CD1' ' A' ' 96' ' ' LEU . 0.2 OUTLIER -65.14 -47.01 78.6 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.223 -0.923 . . . . 0.0 109.494 179.968 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 72.4 tt0 -69.19 -14.26 62.88 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.298 -0.876 . . . . 0.0 109.455 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -73.42 -13.93 61.17 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.212 -0.93 . . . . 0.0 109.434 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.35 -31.28 11.4 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.262 -0.899 . . . . 0.0 109.441 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 100.68 15.8 28.25 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 1.5 mtm -88.2 156.12 19.4 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.192 -1.181 . . . . 0.0 109.49 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 27.2 mttt -86.17 97.61 10.44 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.285 -0.885 . . . . 0.0 109.468 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.407 HG22 HD13 ' A' ' 106' ' ' LEU . 12.5 p -81.43 140.66 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.226 -0.921 . . . . 0.0 109.46 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.47 ' O ' ' N ' ' A' ' 107' ' ' ALA . 0.7 OUTLIER -111.41 77.41 1.04 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.224 -0.923 . . . . 0.0 109.469 -179.994 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.407 HD13 HG22 ' A' ' 104' ' ' VAL . 1.5 mp -46.54 96.44 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.185 -0.947 . . . . 0.0 109.471 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.47 ' N ' ' O ' ' A' ' 105' ' ' LYS . . . -90.2 97.36 11.14 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.265 -0.897 . . . . 0.0 109.488 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -178.71 161.91 28.7 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -157.82 168.86 34.51 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.7 98.87 8.61 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.217 -1.167 . . . . 0.0 109.458 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 118.016 -0.993 . . . . 0.0 109.428 -179.987 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 23.3 mttt . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -96.52 -62.49 0.94 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -133.03 86.51 2.31 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.266 -1.138 . . . . 0.0 109.462 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.414 ' O ' ' HB2' ' A' ' 103' ' ' LYS . . . -138.64 123.45 2.61 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.41 HG23 ' CB ' ' A' ' 103' ' ' LYS . 73.2 t -146.91 104.5 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.242 -1.152 . . . . 0.0 109.454 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.415 HG21 HD13 ' A' ' 97' ' ' LEU . 21.4 t -92.88 151.09 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.253 -0.904 . . . . 0.0 109.432 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 2.0 ttt180 -121.82 112.4 18.3 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.25 -0.906 . . . . 0.0 109.487 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.445 HG21 ' HB3' ' A' ' 93' ' ' LEU . 2.2 mp -123.44 114.54 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.266 -0.896 . . . . 0.0 109.406 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -150.59 -162.13 1.49 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.212 -0.93 . . . . 0.0 109.446 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 30.8 mtm180 -123.77 139.19 54.22 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.233 -0.917 . . . . 0.0 109.452 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.488 ' CB ' HD13 ' A' ' 50' ' ' LEU . 13.5 tt0 -116.05 60.17 0.72 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.247 -0.908 . . . . 0.0 109.472 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.6 p -60.05 142.51 53.91 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.261 -0.9 . . . . 0.0 109.438 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 20.0 m -114.28 -73.59 0.65 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.245 -0.909 . . . . 0.0 109.47 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 149.36 75.85 0.02 OUTLIER Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 5.1 ttt180 179.52 -58.28 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.314 -1.109 . . . . 0.0 109.491 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -60.42 -57.12 14.12 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.296 -0.878 . . . . 0.0 109.451 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 119.96 -54.6 0.64 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.561 -1.415 . . . . 0.0 109.561 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 19.6 mttt -69.17 -174.41 0.63 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.274 -1.133 . . . . 0.0 109.547 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -109.11 149.05 17.06 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.9 m -119.57 145.74 25.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.307 -1.113 . . . . 0.0 109.468 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 2.3 t -111.46 139.79 46.59 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.269 -0.894 . . . . 0.0 109.437 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.488 HD13 ' CB ' ' A' ' 39' ' ' GLN . 2.1 mp -130.35 119.91 23.51 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.246 -0.909 . . . . 0.0 109.516 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.422 ' HB ' HD11 ' A' ' 83' ' ' ILE . 3.1 mm -101.19 124.7 55.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.229 -0.919 . . . . 0.0 109.379 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -159.63 159.52 33.2 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.199 -0.938 . . . . 0.0 109.491 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.412 ' O ' ' C ' ' A' ' 54' ' ' VAL . . . 105.76 -29.06 11.93 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.412 ' C ' ' O ' ' A' ' 53' ' ' GLY . 62.5 t -45.22 117.75 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.213 -1.169 . . . . 0.0 109.421 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -111.95 72.24 0.77 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.26 -0.9 . . . . 0.0 109.511 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.7 mt -126.04 -170.31 2.17 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.216 -0.928 . . . . 0.0 109.456 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -56.03 147.77 19.19 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.242 -0.911 . . . . 0.0 109.475 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.94 -33.49 73.25 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.274 -0.891 . . . . 0.0 109.518 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -77.27 -29.06 53.69 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.231 -0.918 . . . . 0.0 109.385 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -69.27 -30.51 68.64 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.303 -0.873 . . . . 0.0 109.45 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.7 mt -66.21 -58.35 5.59 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.271 -0.893 . . . . 0.0 109.496 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -57.68 -19.4 26.71 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.197 -0.939 . . . . 0.0 109.376 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 9.3 mttt -76.68 -44.33 34.16 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.309 -0.869 . . . . 0.0 109.558 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.88 -29.0 64.98 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.209 -0.932 . . . . 0.0 109.508 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -72.25 -52.38 16.67 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.245 -0.909 . . . . 0.0 109.382 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.9 -48.78 80.21 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.237 -0.915 . . . . 0.0 109.551 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -54.0 -46.27 71.72 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.196 -0.94 . . . . 0.0 109.331 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -59.5 -36.54 76.24 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.277 -0.889 . . . . 0.0 109.238 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 7.9 tmtt? -61.54 -37.96 85.68 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.333 -0.855 . . . . 0.0 109.286 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 11.3 mttt -58.05 -25.46 61.24 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.234 -0.916 . . . . 0.0 108.955 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 1.7 mtmp? -122.0 50.19 1.48 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.513 -0.742 . . . . 0.0 109.217 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 23.4 t -133.72 -63.51 0.74 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.178 -0.951 . . . . 0.0 109.686 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.47 ' O ' ' HB2' ' A' ' 74' ' ' CYS . . . 120.17 10.25 7.53 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -179.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.47 ' HB2' ' O ' ' A' ' 73' ' ' GLY . 4.6 t 168.3 127.92 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.325 -1.103 . . . . 0.0 109.193 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -94.53 101.58 2.75 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -66.99 -109.01 0.02 OUTLIER Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -111.75 121.77 46.0 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.205 -1.173 . . . . 0.0 109.302 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 22.9 t -116.43 78.12 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.21 -0.931 . . . . 0.0 109.808 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -88.28 145.62 25.76 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.243 -0.911 . . . . 0.0 109.201 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -65.0 91.42 0.09 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.201 -0.937 . . . . 0.0 109.507 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 129.07 -24.34 4.79 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.0 t -139.04 137.86 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.152 -1.205 . . . . 0.0 109.582 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.422 HD11 ' HB ' ' A' ' 51' ' ' ILE . 4.2 mt -132.01 135.34 58.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.353 -0.842 . . . . 0.0 109.55 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 68.1 mt-10 -132.25 116.47 16.97 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.302 -0.874 . . . . 0.0 109.207 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 56.1 mt -148.36 146.72 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.225 -0.922 . . . . 0.0 109.621 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -72.74 141.58 48.14 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.24 -0.912 . . . . 0.0 109.309 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 167.7 122.33 0.61 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -106.96 51.61 0.74 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.321 -1.105 . . . . 0.0 109.538 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 85.5 mttt -131.9 53.42 2.0 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.252 -0.905 . . . . 0.0 109.478 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 32.5 ptt180 -53.13 -27.48 21.1 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.24 -0.912 . . . . 0.0 109.358 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 48.1 t0 -65.41 -53.33 44.76 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.29 -0.881 . . . . 0.0 109.393 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.9 tt -58.71 -48.35 81.43 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.274 -0.891 . . . . 0.0 109.424 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.445 ' HB3' HG21 ' A' ' 36' ' ' ILE . 5.9 mt -53.93 -38.97 65.45 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.252 -0.905 . . . . 0.0 109.429 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.1 ttmt -68.26 -31.26 70.6 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.253 -0.904 . . . . 0.0 109.494 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 21.8 t -67.54 -64.03 0.94 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.236 -0.915 . . . . 0.0 109.471 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.489 HD13 ' N ' ' A' ' 97' ' ' LEU . 2.6 pp -50.62 -38.27 44.98 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.277 -0.889 . . . . 0.0 109.499 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.489 ' N ' HD13 ' A' ' 96' ' ' LEU . 0.2 OUTLIER -59.44 -45.13 92.46 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.218 -0.926 . . . . 0.0 109.485 179.978 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -69.68 -17.07 63.46 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.257 -0.902 . . . . 0.0 109.444 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.41 ' HB1' ' O ' ' A' ' 96' ' ' LEU . . . -67.98 -27.47 66.6 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.251 -0.905 . . . . 0.0 109.459 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.492 ' HD2' ' N ' ' A' ' 100' ' ' LYS . 6.7 mptt -85.13 -16.35 40.77 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.228 -0.92 . . . . 0.0 109.442 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 88.73 23.96 34.4 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' MET . . . . . 0.41 ' HB2' ' CD1' ' A' ' 97' ' ' LEU . 1.2 mtm -97.77 171.17 8.49 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.265 -1.138 . . . . 0.0 109.467 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.414 ' HB2' ' O ' ' A' ' 32' ' ' GLY . 8.7 mttt -84.62 165.74 17.71 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.231 -0.918 . . . . 0.0 109.484 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.8 t -147.91 124.16 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.275 -0.891 . . . . 0.0 109.485 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 5.9 mttt -109.38 79.07 1.18 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.256 -0.903 . . . . 0.0 109.468 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 6.2 mt -46.18 105.53 0.06 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.297 -0.877 . . . . 0.0 109.482 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -102.5 163.5 12.19 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.277 -0.89 . . . . 0.0 109.466 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -178.46 -150.04 8.5 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -63.71 -145.96 0.02 OUTLIER Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 13.4 mt -127.78 -65.39 0.92 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.263 -1.14 . . . . 0.0 109.473 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 117.956 -1.021 . . . . 0.0 109.426 -179.974 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 92.9 mttt . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 142.79 164.41 10.15 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -135.71 51.77 2.03 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.208 -1.172 . . . . 0.0 109.454 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 149.54 130.98 1.89 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.5 p -160.03 131.26 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.265 -1.138 . . . . 0.0 109.449 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.507 ' CG1' HG21 ' A' ' 51' ' ' ILE . 75.6 t -105.54 153.65 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.261 -0.899 . . . . 0.0 109.468 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.406 ' HB3' ' O ' ' A' ' 52' ' ' THR . 24.6 ttt180 -129.65 100.89 5.68 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.192 -0.942 . . . . 0.0 109.513 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.517 HG21 ' CD1' ' A' ' 93' ' ' LEU . 1.2 mp -102.81 125.75 57.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.232 -0.918 . . . . 0.0 109.397 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -122.63 -166.81 1.48 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.235 -0.916 . . . . 0.0 109.468 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 14.1 ptt180 -152.54 132.7 13.51 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.197 -0.939 . . . . 0.0 109.476 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -118.13 110.37 17.52 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.23 -0.919 . . . . 0.0 109.488 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 5.7 t -109.18 166.5 10.8 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.275 -0.89 . . . . 0.0 109.453 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -148.99 21.24 0.98 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.251 -0.906 . . . . 0.0 109.471 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 179.33 -147.97 7.92 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 39.4 ptt180 -150.87 -177.36 5.96 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.238 -1.154 . . . . 0.0 109.469 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 77.2 tttt 62.27 25.68 15.36 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.23 -0.919 . . . . 0.0 109.442 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.456 ' O ' ' O ' ' A' ' 46' ' ' LYS . . . 129.93 -158.43 22.29 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.456 ' O ' ' O ' ' A' ' 45' ' ' GLY . 12.4 ttmt 58.15 112.2 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.248 -1.148 . . . . 0.0 109.515 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -178.35 131.26 1.71 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.402 ' O ' HG23 ' A' ' 48' ' ' VAL . 21.2 m -131.49 147.26 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.245 -1.15 . . . . 0.0 109.528 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 1.8 m -125.01 118.34 26.0 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.269 -0.895 . . . . 0.0 109.494 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -113.1 138.93 49.19 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.218 -0.926 . . . . 0.0 109.503 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.559 ' CD1' ' N ' ' A' ' 51' ' ' ILE . 2.7 mp -108.37 122.62 63.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.234 -0.916 . . . . 0.0 109.394 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.406 ' O ' ' HB3' ' A' ' 35' ' ' ARG . 0.5 OUTLIER -146.25 156.53 43.45 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.287 -0.883 . . . . 0.0 109.534 -179.898 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 93.89 23.14 23.81 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 10.1 t -80.55 115.38 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.304 -1.115 . . . . 0.0 109.552 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -94.14 76.91 4.05 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.265 -0.897 . . . . 0.0 109.443 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -144.9 177.75 8.51 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.263 -0.898 . . . . 0.0 109.409 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -56.97 158.35 4.97 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.216 -0.927 . . . . 0.0 109.519 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.72 -48.35 59.82 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.32 -0.862 . . . . 0.0 109.495 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.92 -33.69 70.85 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.279 -0.888 . . . . 0.0 109.411 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.421 ' O ' ' C ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -59.47 -54.05 51.05 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.232 -0.917 . . . . 0.0 109.418 179.951 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.421 ' C ' ' O ' ' A' ' 60' ' ' GLU . 0.3 OUTLIER -44.58 -42.75 7.59 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.239 -0.913 . . . . 0.0 109.196 179.844 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 60.9 m -58.54 -50.63 73.08 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.263 -0.898 . . . . 0.0 109.166 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -52.5 -30.39 29.96 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.26 -0.9 . . . . 0.0 109.137 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -68.81 -53.48 21.31 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.344 -0.847 . . . . 0.0 109.485 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -52.68 -33.76 48.88 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.242 -0.911 . . . . 0.0 109.308 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -71.98 -41.88 67.16 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.278 -0.889 . . . . 0.0 109.284 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -65.11 -19.79 66.15 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.22 -0.925 . . . . 0.0 109.357 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -84.02 -57.3 3.25 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.229 -0.919 . . . . 0.0 109.447 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 6.2 mttt -60.11 -22.75 63.19 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.281 -0.887 . . . . 0.0 109.412 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.8 -42.67 47.44 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.262 -0.899 . . . . 0.0 109.496 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 2.1 ptmt -129.14 70.17 1.41 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.271 -0.893 . . . . 0.0 109.332 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -144.33 -42.7 0.26 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.311 -0.868 . . . . 0.0 109.424 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.466 ' O ' ' HB2' ' A' ' 74' ' ' CYS . . . 119.49 -62.09 0.48 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.466 ' HB2' ' O ' ' A' ' 73' ' ' GLY . 17.0 t 172.31 107.49 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.344 -1.092 . . . . 0.0 109.323 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 160.38 50.77 0.01 OUTLIER Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -117.97 116.92 3.58 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -104.05 110.25 22.35 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.337 -1.096 . . . . 0.0 109.004 179.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.2 t -85.16 84.22 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.214 -0.929 . . . . 0.0 109.814 -179.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.442 ' HB3' ' HB ' ' A' ' 82' ' ' VAL . 20.3 mmtt -90.9 169.18 11.13 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.287 -0.883 . . . . 0.0 108.955 179.505 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -60.63 112.75 2.12 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.113 -0.992 . . . . 0.0 109.578 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 51.99 27.78 22.92 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.442 ' HB ' ' HB3' ' A' ' 79' ' ' LYS . 43.4 t -141.65 88.19 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.152 -1.205 . . . . 0.0 109.536 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 4.7 mm -83.53 102.12 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.246 -0.908 . . . . 0.0 109.306 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -82.92 126.66 32.73 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.284 -0.885 . . . . 0.0 109.73 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 18.6 mm -133.96 110.62 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.265 -0.897 . . . . 0.0 109.406 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -72.77 128.95 37.06 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.263 -0.898 . . . . 0.0 109.573 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 145.04 136.56 3.03 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -95.89 89.56 5.29 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.251 -1.147 . . . . 0.0 109.445 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 3.1 mttt -144.55 53.23 1.25 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.205 -0.934 . . . . 0.0 109.5 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 51.2 ttt180 -64.02 -40.73 96.98 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.251 -0.906 . . . . 0.0 109.483 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -53.82 -44.06 69.92 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.211 -0.931 . . . . 0.0 109.46 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 3.6 tt -75.11 -26.63 59.4 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.267 -0.896 . . . . 0.0 109.532 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.517 ' CD1' HG21 ' A' ' 36' ' ' ILE . 22.8 mt -61.63 -42.86 99.47 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.263 -0.898 . . . . 0.0 109.474 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 17.3 tttt -67.03 -26.74 66.92 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.24 -0.913 . . . . 0.0 109.592 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 1.2 t -70.72 -62.34 1.43 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.224 -0.922 . . . . 0.0 109.534 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.485 ' CD1' ' N ' ' A' ' 97' ' ' LEU . 4.6 pp -54.93 -31.43 60.3 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.228 -0.92 . . . . 0.0 109.534 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.485 ' N ' ' CD1' ' A' ' 96' ' ' LEU . 0.2 OUTLIER -67.64 -47.4 69.69 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.183 -0.948 . . . . 0.0 109.559 -179.917 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.53 -15.36 63.23 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.223 -0.923 . . . . 0.0 109.589 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -69.79 -12.75 61.87 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.222 -0.924 . . . . 0.0 109.464 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.19 -37.49 20.07 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.246 -0.908 . . . . 0.0 109.497 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 101.45 22.96 9.89 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -119.6 -172.89 2.41 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.198 -1.177 . . . . 0.0 109.466 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 6.6 tttt -86.54 162.01 18.26 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.252 -0.905 . . . . 0.0 109.484 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.459 ' CG2' ' HG ' ' A' ' 97' ' ' LEU . 12.7 p -152.32 153.47 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.262 -0.899 . . . . 0.0 109.429 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 6.0 mttt -131.64 90.12 2.8 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.212 -0.93 . . . . 0.0 109.494 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.494 ' O ' ' CB ' ' A' ' 107' ' ' ALA . 4.6 mm? -54.85 -30.13 56.93 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.259 -0.901 . . . . 0.0 109.476 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.494 ' CB ' ' O ' ' A' ' 106' ' ' LEU . . . 75.25 86.23 0.09 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.265 -0.897 . . . . 0.0 109.433 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -115.04 70.39 0.25 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -84.57 -168.03 43.7 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -156.54 153.66 29.05 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.239 -1.154 . . . . 0.0 109.456 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 118.028 -0.986 . . . . 0.0 109.483 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.6 mttt . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 179.82 164.71 32.58 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -160.17 69.48 0.4 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.26 -1.141 . . . . 0.0 109.483 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 171.72 120.36 0.55 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.5 m -132.17 115.48 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.307 -1.114 . . . . 0.0 109.463 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.455 HG21 ' HE3' ' A' ' 102' ' ' MET . 97.0 t -80.62 159.84 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.273 -0.892 . . . . 0.0 109.513 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 4.5 mtp180 -145.59 127.76 15.7 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.282 -0.887 . . . . 0.0 109.441 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.473 HG22 ' CD1' ' A' ' 93' ' ' LEU . 2.7 mp -132.48 109.18 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.274 -0.891 . . . . 0.0 109.497 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.442 ' CB ' ' HB1' ' A' ' 107' ' ' ALA . 2.6 pt20 -140.02 157.39 45.74 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.294 -0.879 . . . . 0.0 109.467 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.42 ' HG2' ' HD3' ' A' ' 90' ' ' ARG . 7.8 ptt180 -96.15 135.96 37.24 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.249 -0.907 . . . . 0.0 109.433 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -108.39 95.41 5.65 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.26 -0.9 . . . . 0.0 109.458 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.25 171.01 14.41 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.226 -0.921 . . . . 0.0 109.461 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -176.33 82.87 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.297 -0.877 . . . . 0.0 109.479 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 129.71 -168.19 21.26 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 1.4 mtt180 -111.79 -69.25 0.88 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.254 -1.145 . . . . 0.0 109.474 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 66.9 mttt -94.9 86.66 4.73 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.226 -0.921 . . . . 0.0 109.501 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -152.49 -164.0 12.05 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 21.8 mttt -107.7 158.77 17.0 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.201 -1.176 . . . . 0.0 109.481 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -95.03 177.13 35.09 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.7 m -151.46 154.36 8.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.258 -1.142 . . . . 0.0 109.477 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 6.9 t -119.34 110.64 17.21 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.261 -0.9 . . . . 0.0 109.493 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -97.12 131.7 43.63 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.29 -0.881 . . . . 0.0 109.411 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 63.6 mt -125.36 114.95 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.229 -0.919 . . . . 0.0 109.533 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -151.84 170.35 20.02 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.252 -0.905 . . . . 0.0 109.435 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.19 -15.91 58.66 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 53.4 t -56.92 108.47 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.269 -1.136 . . . . 0.0 109.474 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -86.16 78.16 9.43 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.296 -0.878 . . . . 0.0 109.471 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -134.53 159.03 42.42 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.247 -0.908 . . . . 0.0 109.46 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.448 ' O ' ' O ' ' A' ' 58' ' ' ASP . 0.2 OUTLIER -76.61 157.02 32.27 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.203 -0.936 . . . . 0.0 109.501 179.963 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.522 ' O ' ' CB ' ' A' ' 59' ' ' ALA . 0.2 OUTLIER -50.73 -179.48 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.298 -0.876 . . . . 0.0 109.523 -179.963 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.522 ' CB ' ' O ' ' A' ' 58' ' ' ASP . . . 76.98 -78.9 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.313 -0.867 . . . . 0.0 109.501 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -55.1 -36.77 66.03 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.236 -0.915 . . . . 0.0 109.543 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -58.76 -48.29 81.73 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.181 -0.95 . . . . 0.0 109.478 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -61.85 -28.11 69.26 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.211 -0.931 . . . . 0.0 109.463 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -68.67 -51.54 40.79 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.276 -0.89 . . . . 0.0 109.388 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.59 -33.59 72.95 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.218 -0.926 . . . . 0.0 109.309 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -64.17 -52.1 60.6 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.262 -0.899 . . . . 0.0 109.371 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.67 -22.31 66.95 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.238 -0.914 . . . . 0.0 109.322 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.99 -55.19 13.58 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.256 -0.902 . . . . 0.0 109.425 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.3 mp -69.36 -22.47 63.74 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.186 -0.946 . . . . 0.0 109.415 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.93 -37.38 72.87 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.275 -0.891 . . . . 0.0 109.504 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 19.7 tttt -68.82 -12.85 61.97 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.248 -0.907 . . . . 0.0 109.414 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 20.3 mttm -75.47 -22.47 57.22 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.318 -0.864 . . . . 0.0 109.818 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -103.66 -34.39 8.63 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.185 -0.947 . . . . 0.0 110.008 -179.428 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.446 ' O ' ' CB ' ' A' ' 74' ' ' CYS . . . 76.21 32.09 53.17 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 108.764 -1.734 . . . . 0.0 108.764 -179.437 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.446 ' CB ' ' O ' ' A' ' 73' ' ' GLY . 0.0 OUTLIER 167.35 152.05 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.475 -1.015 . . . . 0.0 109.126 -179.695 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 67.6 123.94 0.02 OUTLIER Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -173.89 92.59 0.09 OUTLIER Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -104.07 123.31 47.02 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.221 -1.164 . . . . 0.0 109.081 179.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 33.7 m -110.49 170.24 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.141 -0.974 . . . . 0.0 109.541 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.415 ' CB ' ' HB ' ' A' ' 82' ' ' VAL . 11.4 mttp -159.19 166.74 30.77 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.299 -0.876 . . . . 0.0 109.352 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -64.13 100.8 0.35 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.202 -0.936 . . . . 0.0 109.567 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 74.7 2.97 65.78 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.415 ' HB ' ' CB ' ' A' ' 79' ' ' LYS . 87.5 t -129.6 141.71 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.116 -1.226 . . . . 0.0 109.595 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 58.1 mt -131.89 158.69 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.326 -0.859 . . . . 0.0 109.456 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -148.03 139.14 23.35 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.217 -0.927 . . . . 0.0 109.548 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 53.6 mt -149.69 102.7 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.218 -0.926 . . . . 0.0 109.377 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -52.8 110.07 0.48 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.214 -0.929 . . . . 0.0 109.506 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -154.85 -175.75 26.3 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -154.39 47.82 0.59 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.267 -1.137 . . . . 0.0 109.446 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 60.3 mttt -137.82 45.95 2.12 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.283 -0.886 . . . . 0.0 109.467 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.469 ' HG3' ' N ' ' A' ' 91' ' ' ASP . 36.1 ptt180 -50.93 -40.15 56.43 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.246 -0.909 . . . . 0.0 109.467 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.469 ' N ' ' HG3' ' A' ' 90' ' ' ARG . 8.1 p-10 -51.05 -45.54 61.37 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.27 -0.894 . . . . 0.0 109.467 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 4.4 tt -68.4 -47.18 68.0 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.267 -0.896 . . . . 0.0 109.495 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.473 ' CD1' HG22 ' A' ' 36' ' ' ILE . 17.9 mt -54.32 -24.67 20.08 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.223 -0.923 . . . . 0.0 109.477 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -61.39 -65.42 0.7 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.297 -0.877 . . . . 0.0 109.465 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 11.4 t -64.48 -17.38 63.81 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.272 -0.893 . . . . 0.0 109.465 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.502 ' CD2' HD22 ' A' ' 97' ' ' LEU . 3.1 tt -66.42 -55.83 13.91 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.288 -0.883 . . . . 0.0 109.482 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.502 HD22 ' CD2' ' A' ' 96' ' ' LEU . 0.2 OUTLIER -69.97 -38.24 76.02 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.293 -0.879 . . . . 0.0 109.504 -179.979 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -64.27 -19.11 65.18 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.243 -0.91 . . . . 0.0 109.497 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -66.53 -31.74 72.64 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.273 -0.892 . . . . 0.0 109.441 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? -80.21 -14.9 58.07 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.239 -0.913 . . . . 0.0 109.474 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 101.44 -13.16 58.37 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' MET . . . . . 0.455 ' HE3' HG21 ' A' ' 34' ' ' VAL . 2.7 mtm -65.64 147.89 52.65 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.278 -1.13 . . . . 0.0 109.431 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 16.6 mttt -81.85 115.79 21.22 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.284 -0.885 . . . . 0.0 109.473 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 4.6 p -109.72 155.0 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.221 -0.924 . . . . 0.0 109.523 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.429 ' O ' ' N ' ' A' ' 107' ' ' ALA . 0.5 OUTLIER -122.18 90.39 3.3 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.212 -0.93 . . . . 0.0 109.468 -179.958 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 19.5 tp -54.2 93.09 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.253 -0.904 . . . . 0.0 109.486 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.442 ' HB1' ' CB ' ' A' ' 37' ' ' GLN . . . -73.87 -161.93 0.12 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.28 -0.887 . . . . 0.0 109.475 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 88.79 108.44 1.1 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 69.3 66.24 2.32 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -171.91 -59.89 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.212 -1.169 . . . . 0.0 109.471 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 118.055 -0.974 . . . . 0.0 109.48 -179.983 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 83.5 mttt . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 155.33 151.23 5.8 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.45 ' OD1' ' N ' ' A' ' 31' ' ' ASP . 18.8 p30 -55.81 98.21 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.251 -1.146 . . . . 0.0 109.414 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -60.3 153.24 35.96 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.447 ' O ' ' CG2' ' A' ' 33' ' ' VAL . 34.7 m -142.39 101.17 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.279 -1.13 . . . . 0.0 109.452 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 9.7 t -88.85 150.04 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.268 -0.895 . . . . 0.0 109.501 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 53.0 mtt180 -127.05 119.25 26.13 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.231 -0.918 . . . . 0.0 109.458 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.413 HD11 HD12 ' A' ' 97' ' ' LEU . 1.5 mp -118.1 118.41 58.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.237 -0.914 . . . . 0.0 109.507 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -153.89 175.54 13.23 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.258 -0.901 . . . . 0.0 109.479 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.78 140.04 38.68 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.223 -0.923 . . . . 0.0 109.453 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -124.91 57.6 1.27 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.282 -0.886 . . . . 0.0 109.486 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 15.1 t -76.05 165.21 25.28 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.246 -0.909 . . . . 0.0 109.448 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -176.53 138.37 0.3 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.265 -0.897 . . . . 0.0 109.486 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.61 -53.59 0.73 Allowed Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 22.0 ttt180 -168.18 159.07 10.63 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.23 -1.159 . . . . 0.0 109.515 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 30.0 tttt -83.08 125.39 31.43 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.275 -0.891 . . . . 0.0 109.422 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 168.23 -44.79 0.23 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.4 ptmt -129.27 179.51 5.74 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.209 -1.171 . . . . 0.0 109.539 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -171.16 147.75 10.62 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.426 HG11 ' HG3' ' A' ' 86' ' ' GLN . 14.1 m -119.77 158.03 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.205 -1.173 . . . . 0.0 109.504 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 1.4 t -121.11 120.51 35.52 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.229 -0.919 . . . . 0.0 109.422 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -111.58 149.25 31.72 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.234 -0.916 . . . . 0.0 109.539 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 16.7 mt -134.26 126.43 49.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.269 -0.895 . . . . 0.0 109.46 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -151.59 166.67 30.5 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.228 -0.92 . . . . 0.0 109.48 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 92.57 15.57 52.43 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.8 t -75.86 106.9 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.231 -1.158 . . . . 0.0 109.489 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -94.62 84.57 4.3 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.279 -0.888 . . . . 0.0 109.476 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -144.95 -172.87 3.93 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.194 -0.941 . . . . 0.0 109.483 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -68.67 150.22 48.19 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.262 -0.899 . . . . 0.0 109.464 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.427 ' O ' ' HB2' ' A' ' 61' ' ' LEU . 19.6 m-20 -52.72 -46.26 67.3 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.246 -0.909 . . . . 0.0 109.549 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.437 ' O ' HG23 ' A' ' 62' ' ' THR . . . -58.72 -44.73 90.48 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.23 -0.919 . . . . 0.0 109.558 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -51.36 -34.73 35.31 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.151 -0.968 . . . . 0.0 109.488 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.427 ' HB2' ' O ' ' A' ' 58' ' ' ASP . 39.7 mt -56.8 -54.81 42.11 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.233 -0.917 . . . . 0.0 109.505 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.437 HG23 ' O ' ' A' ' 59' ' ' ALA . 9.5 t -63.66 -17.82 63.32 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.233 -0.917 . . . . 0.0 109.588 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.417 ' N ' HG23 ' A' ' 62' ' ' THR . 0.1 OUTLIER -73.65 -68.76 0.48 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.265 -0.897 . . . . 0.0 109.459 179.965 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -51.77 -34.61 40.3 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.273 -0.892 . . . . 0.0 109.371 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.48 -59.47 5.19 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.267 -0.896 . . . . 0.0 109.426 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -55.07 -24.93 27.66 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.279 -0.888 . . . . 0.0 109.447 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -66.68 -62.46 1.44 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.256 -0.903 . . . . 0.0 109.482 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -67.33 -13.5 62.06 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.193 -0.942 . . . . 0.0 109.545 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 17.8 tttt -69.77 -36.35 75.68 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.189 -0.944 . . . . 0.0 109.428 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -73.27 -19.74 60.99 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.279 -0.888 . . . . 0.0 109.276 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 63.7 mttt -66.29 -29.88 70.19 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.3 -0.875 . . . . 0.0 109.319 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 62.7 m -89.17 -30.06 18.85 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.315 -0.866 . . . . 0.0 109.316 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.455 ' O ' ' HB2' ' A' ' 74' ' ' CYS . . . 91.87 -19.74 46.78 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.455 ' HB2' ' O ' ' A' ' 73' ' ' GLY . 52.8 t 177.55 94.41 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.232 -1.158 . . . . 0.0 109.364 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 148.83 151.03 5.36 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.394 -1.483 . . . . 0.0 109.394 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 159.41 -176.46 36.19 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -179.36 114.12 0.06 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.252 -1.146 . . . . 0.0 109.624 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.5 p -120.01 148.59 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.256 -0.903 . . . . 0.0 109.136 179.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.439 ' CB ' ' HB ' ' A' ' 82' ' ' VAL . 0.0 OUTLIER -150.21 77.7 1.31 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.17 -0.956 . . . . 0.0 109.774 -179.735 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 60.3 t0 49.25 69.03 0.63 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.336 -0.852 . . . . 0.0 109.956 179.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 83.27 -11.56 54.65 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 179.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.439 ' HB ' ' CB ' ' A' ' 79' ' ' LYS . 58.5 t -97.97 89.79 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.094 -1.239 . . . . 0.0 109.523 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 52.3 mt -99.68 154.15 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.228 -0.92 . . . . 0.0 109.374 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -149.26 104.11 3.37 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.242 -0.911 . . . . 0.0 109.612 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 62.2 mt -125.76 125.04 67.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.334 -0.853 . . . . 0.0 109.357 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.426 ' HG3' HG11 ' A' ' 48' ' ' VAL . 8.3 tt0 -66.8 155.98 36.79 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.261 -0.899 . . . . 0.0 109.462 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 141.7 140.32 3.78 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -112.61 52.28 0.78 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.19 -1.182 . . . . 0.0 109.511 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 6.6 mttp -121.13 41.37 3.34 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.208 -0.933 . . . . 0.0 109.452 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.404 ' HA ' ' HB2' ' A' ' 93' ' ' LEU . 7.6 ptt85 -56.44 -27.76 57.59 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.251 -0.906 . . . . 0.0 109.494 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -57.89 -47.09 83.81 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.209 -0.932 . . . . 0.0 109.481 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 4.2 tt -74.28 -33.38 63.24 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.199 -0.938 . . . . 0.0 109.511 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.409 ' O ' ' HB3' ' A' ' 96' ' ' LEU . 1.5 mm? -55.9 -38.72 70.6 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.272 -0.892 . . . . 0.0 109.458 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 13.1 tttt -53.41 -49.29 67.61 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.205 -0.934 . . . . 0.0 109.451 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 3.2 t -68.35 -29.36 68.07 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.28 -0.888 . . . . 0.0 109.437 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.409 ' HB3' ' O ' ' A' ' 93' ' ' LEU . 4.1 tt -58.06 -51.85 67.96 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.238 -0.914 . . . . 0.0 109.434 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.469 ' CD2' ' HB ' ' A' ' 104' ' ' VAL . 0.4 OUTLIER -72.19 -32.35 66.74 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.261 -0.899 . . . . 0.0 109.428 179.983 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -71.69 -14.49 62.05 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.232 -0.918 . . . . 0.0 109.456 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.08 -31.42 72.6 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.213 -0.929 . . . . 0.0 109.422 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 7.3 mttm -94.0 -19.83 20.52 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.266 -0.896 . . . . 0.0 109.473 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 100.17 13.1 37.34 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' MET . . . . . 0.409 ' HE1' HG22 ' A' ' 34' ' ' VAL . 4.0 mtm -79.3 156.99 27.8 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.287 -1.125 . . . . 0.0 109.5 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 28.3 tttt -81.98 132.55 35.26 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.224 -0.923 . . . . 0.0 109.472 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.469 ' HB ' ' CD2' ' A' ' 97' ' ' LEU . 11.6 p -133.86 141.5 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.248 -0.908 . . . . 0.0 109.457 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 2.1 tttt -115.85 98.13 6.49 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.238 -0.914 . . . . 0.0 109.488 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 25.5 tp -45.92 -26.59 0.72 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.238 -0.914 . . . . 0.0 109.477 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . 65.66 68.52 0.47 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.223 -0.923 . . . . 0.0 109.5 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -50.38 -62.28 5.24 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.44 ' O ' ' CB ' ' A' ' 110' ' ' LEU . . . 78.04 167.1 29.76 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.44 ' CB ' ' O ' ' A' ' 109' ' ' GLY . 0.4 OUTLIER 72.0 161.58 0.24 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.241 -1.152 . . . . 0.0 109.485 179.99 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.463 -179.99 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 66.5 mttt . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 174.71 164.24 29.22 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -179.61 85.81 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.242 -1.152 . . . . 0.0 109.449 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 140.48 119.33 1.59 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.544 -1.423 . . . . 0.0 109.544 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 18.2 t -123.84 94.6 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.211 -1.17 . . . . 0.0 109.458 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 22.0 t -86.54 162.39 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.23 -0.919 . . . . 0.0 109.491 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.419 ' O ' HG13 ' A' ' 36' ' ' ILE . 0.0 OUTLIER -144.91 140.56 28.38 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.206 -0.934 . . . . 0.0 109.491 179.928 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.51 HD12 ' CG2' ' A' ' 104' ' ' VAL . 3.8 mp -141.52 124.4 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.233 -0.917 . . . . 0.0 109.491 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.514 ' HB3' ' CB ' ' A' ' 107' ' ' ALA . 5.5 pt20 -147.59 118.98 7.86 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.25 -0.906 . . . . 0.0 109.471 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 5.4 tmm_? -45.81 116.0 1.1 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.249 -0.907 . . . . 0.0 109.426 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 2.1 tm0? -85.01 126.95 33.97 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.253 -0.904 . . . . 0.0 109.465 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.416 ' O ' ' CB ' ' A' ' 41' ' ' SER . 8.8 t -96.25 173.66 7.28 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.243 -0.911 . . . . 0.0 109.459 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.416 ' CB ' ' O ' ' A' ' 40' ' ' THR . 1.4 t 169.57 81.53 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.271 -0.893 . . . . 0.0 109.436 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.41 161.04 30.23 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 10.6 ptt180 -123.15 59.42 1.08 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.214 -1.168 . . . . 0.0 109.495 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 85.8 mttt -147.17 27.78 1.03 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.25 -0.906 . . . . 0.0 109.512 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -177.86 -176.31 45.76 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 31.0 mttt -83.05 177.44 8.6 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.275 -1.132 . . . . 0.0 109.469 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.451 ' O ' ' CG1' ' A' ' 48' ' ' VAL . . . -103.54 -156.96 24.63 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.451 ' CG1' ' O ' ' A' ' 47' ' ' GLY . 35.9 m -156.5 160.34 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.281 -1.129 . . . . 0.0 109.481 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -95.35 117.56 30.54 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.191 -0.943 . . . . 0.0 109.494 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -103.56 98.17 8.09 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.27 -0.894 . . . . 0.0 109.471 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 3.1 mp -96.05 125.87 48.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.232 -0.918 . . . . 0.0 109.485 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.7 -152.82 0.43 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.224 -0.923 . . . . 0.0 109.538 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 52.07 51.44 40.85 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.441 ' O ' ' N ' ' A' ' 56' ' ' LEU . 2.1 t -115.72 46.33 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.212 -1.17 . . . . 0.0 109.477 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -55.71 90.89 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.229 -0.919 . . . . 0.0 109.423 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.441 ' N ' ' O ' ' A' ' 54' ' ' VAL . 0.4 OUTLIER -149.98 157.07 42.79 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.283 -0.886 . . . . 0.0 109.509 -179.925 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.34 157.75 19.05 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.286 -0.884 . . . . 0.0 109.452 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.553 ' O ' ' CB ' ' A' ' 59' ' ' ALA . 0.4 OUTLIER -56.17 172.46 0.21 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.183 -0.948 . . . . 0.0 109.455 179.995 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.553 ' CB ' ' O ' ' A' ' 58' ' ' ASP . . . 83.05 -43.03 0.11 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.676 -0.64 . . . . 0.0 109.83 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.41 -63.14 1.35 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.08 -1.012 . . . . 0.0 109.52 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -56.63 -27.92 59.4 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.233 -0.917 . . . . 0.0 109.476 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 46.0 p -72.72 -33.4 66.41 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.232 -0.918 . . . . 0.0 109.421 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 44.4 mttt -73.87 -51.73 15.25 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.269 -0.894 . . . . 0.0 109.469 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.453 ' O ' HD11 ' A' ' 68' ' ' LEU . 1.0 OUTLIER -56.69 -48.38 77.8 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.315 -0.866 . . . . 0.0 109.526 179.995 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.415 ' O ' ' C ' ' A' ' 66' ' ' ALA . . . -59.13 -61.02 2.95 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.323 -0.861 . . . . 0.0 109.686 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.415 ' C ' ' O ' ' A' ' 65' ' ' ALA . . . -43.26 -40.58 3.53 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.307 -0.871 . . . . 0.0 109.722 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -60.78 -52.22 66.0 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.21 -0.931 . . . . 0.0 109.542 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.453 HD11 ' O ' ' A' ' 64' ' ' LEU . 0.9 OUTLIER -60.72 -21.43 62.94 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.214 -0.929 . . . . 0.0 109.652 -179.879 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -65.44 -40.06 92.81 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.176 -0.952 . . . . 0.0 109.478 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 45.7 mttt -69.11 -23.29 63.98 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.209 -0.932 . . . . 0.0 109.444 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 15.7 mtpt -64.28 -29.07 70.18 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.406 -0.808 . . . . 0.0 110.032 -179.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.2 m -99.05 -43.03 6.83 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.049 -1.032 . . . . 0.0 109.672 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.47 ' O ' ' HB2' ' A' ' 74' ' ' CYS . . . 103.08 -22.68 35.92 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.47 ' HB2' ' O ' ' A' ' 73' ' ' GLY . 30.2 t 173.62 104.17 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.279 -1.13 . . . . 0.0 109.499 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 155.18 -61.4 0.37 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -47.49 119.38 4.83 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -110.41 150.35 28.95 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.26 -1.141 . . . . 0.0 109.234 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 41.8 t -102.38 152.22 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.253 -0.904 . . . . 0.0 109.715 -179.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -138.77 151.97 47.53 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.331 -0.856 . . . . 0.0 109.243 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.429 ' N ' ' OD1' ' A' ' 80' ' ' ASP . 1.0 OUTLIER -69.91 90.97 0.64 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.242 -0.911 . . . . 0.0 109.626 -179.817 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 109.07 -8.46 33.39 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.771 -1.331 . . . . 0.0 109.771 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 75.9 t -142.26 153.02 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.129 -1.218 . . . . 0.0 109.566 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 2.0 mm -136.53 129.25 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.289 -0.882 . . . . 0.0 109.226 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -117.4 125.68 51.38 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.211 -0.931 . . . . 0.0 109.66 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 17.8 mm -137.42 116.65 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.269 -0.894 . . . . 0.0 109.417 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -69.77 157.56 37.1 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.247 -0.908 . . . . 0.0 109.521 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 148.74 -39.22 0.96 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.504 -1.439 . . . . 0.0 109.504 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 21.1 t0 57.33 53.77 7.3 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.223 -1.163 . . . . 0.0 109.452 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 19.8 mttt -134.96 54.52 1.94 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.24 -0.913 . . . . 0.0 109.451 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 38.5 ptt180 -47.31 -27.14 1.46 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.244 -0.91 . . . . 0.0 109.54 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -61.2 -58.61 7.62 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.248 -0.907 . . . . 0.0 109.464 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -64.87 -20.72 66.57 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.265 -0.897 . . . . 0.0 109.494 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.467 ' HG ' ' CG2' ' A' ' 36' ' ' ILE . 2.1 mm? -65.81 -52.76 48.0 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.213 -0.93 . . . . 0.0 109.462 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.426 ' HG2' ' CG1' ' A' ' 104' ' ' VAL . 0.0 OUTLIER -62.83 -19.76 64.41 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.27 -0.893 . . . . 0.0 109.439 -179.98 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.94 -55.25 6.39 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.299 -0.876 . . . . 0.0 109.446 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.442 ' HG ' ' O ' ' A' ' 93' ' ' LEU . 2.6 pp -64.82 -27.82 69.14 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.204 -0.935 . . . . 0.0 109.473 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.51 ' HB3' ' CG1' ' A' ' 104' ' ' VAL . 0.8 OUTLIER -68.12 -51.71 43.2 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.228 -0.92 . . . . 0.0 109.468 179.996 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -70.08 -16.65 63.16 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.267 -0.895 . . . . 0.0 109.44 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -67.22 -21.28 65.76 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.296 -0.878 . . . . 0.0 109.506 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -99.08 -17.18 18.36 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.269 -0.894 . . . . 0.0 109.453 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 103.59 -11.13 53.71 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 2.2 mtp -65.9 145.59 55.75 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.263 -1.14 . . . . 0.0 109.439 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.8 mttt -86.53 92.79 8.99 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.246 -0.908 . . . . 0.0 109.456 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.51 ' CG2' HD12 ' A' ' 36' ' ' ILE . 9.3 p -88.99 147.79 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.266 -0.896 . . . . 0.0 109.49 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.487 ' N ' HG21 ' A' ' 104' ' ' VAL . 1.5 mttt -116.29 111.41 20.09 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.227 -0.92 . . . . 0.0 109.476 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.503 ' O ' ' CB ' ' A' ' 107' ' ' ALA . 2.8 mt -45.69 -84.6 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.194 -0.941 . . . . 0.0 109.48 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.514 ' CB ' ' HB3' ' A' ' 37' ' ' GLN . . . 165.33 -49.63 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.282 -0.886 . . . . 0.0 109.486 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 112.08 -127.34 8.03 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 126.72 168.04 12.49 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.511 -1.435 . . . . 0.0 109.511 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -175.88 -175.79 0.77 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.229 -1.159 . . . . 0.0 109.495 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 118.009 -0.996 . . . . 0.0 109.504 179.965 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 15.1 mttm . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 171.25 178.1 41.49 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -177.69 -37.88 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.254 -1.145 . . . . 0.0 109.511 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -120.21 152.16 17.07 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.413 HG22 ' O ' ' A' ' 33' ' ' VAL . 4.6 m -156.14 106.52 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.255 -1.144 . . . . 0.0 109.482 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.443 HG23 ' CE ' ' A' ' 102' ' ' MET . 3.0 t -89.75 140.66 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.221 -0.924 . . . . 0.0 109.48 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 17.0 ttm180 -106.71 108.01 19.31 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.262 -0.899 . . . . 0.0 109.435 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 22.2 mt -101.36 126.23 55.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.203 -0.935 . . . . 0.0 109.473 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.432 ' HB3' ' HB2' ' A' ' 107' ' ' ALA . 18.1 pt20 -146.59 -178.37 6.13 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.239 -0.913 . . . . 0.0 109.475 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 10.9 ttm180 -134.89 114.34 12.46 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.246 -0.909 . . . . 0.0 109.462 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.514 ' HB2' ' CD1' ' A' ' 50' ' ' LEU . 5.5 tp60 -87.78 127.5 35.32 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.245 -0.909 . . . . 0.0 109.438 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -87.64 159.63 18.46 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.267 -0.896 . . . . 0.0 109.518 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 45.2 t -153.58 30.69 0.47 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.193 -0.942 . . . . 0.0 109.475 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 148.9 141.93 3.53 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.42 79.87 9.27 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.276 -1.132 . . . . 0.0 109.473 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 2.3 mttp -172.55 -54.78 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.259 -0.9 . . . . 0.0 109.463 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -171.77 -131.02 1.3 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 51.28 74.53 0.24 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.229 -1.16 . . . . 0.0 109.443 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.411 ' C ' HG12 ' A' ' 48' ' ' VAL . . . -109.15 144.52 16.51 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.411 HG12 ' C ' ' A' ' 47' ' ' GLY . 29.5 m -144.45 151.99 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.258 -1.142 . . . . 0.0 109.458 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -109.52 116.66 32.2 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.226 -0.921 . . . . 0.0 109.483 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.514 ' CD1' ' HB2' ' A' ' 39' ' ' GLN . 1.3 mp -96.99 147.73 23.7 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.251 -0.906 . . . . 0.0 109.53 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.428 ' O ' HG11 ' A' ' 82' ' ' VAL . 3.8 mm -136.08 125.87 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.293 -0.879 . . . . 0.0 109.387 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.4 t -158.16 168.46 26.99 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.186 -0.946 . . . . 0.0 109.508 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.35 -24.78 25.75 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.418 ' CG1' ' O ' ' A' ' 54' ' ' VAL . 8.0 p -49.55 106.97 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.255 -1.144 . . . . 0.0 109.496 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -100.48 78.85 2.05 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.195 -0.941 . . . . 0.0 109.462 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 16.4 mt -137.73 -173.57 3.53 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.231 -0.918 . . . . 0.0 109.455 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -68.0 138.26 55.74 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.24 -0.913 . . . . 0.0 109.446 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -50.08 -31.3 12.85 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.277 -0.89 . . . . 0.0 109.493 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.74 -43.42 93.44 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.249 -0.907 . . . . 0.0 109.5 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -66.18 -35.22 79.89 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.273 -0.892 . . . . 0.0 109.528 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.63 -46.27 89.49 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.203 -0.935 . . . . 0.0 109.454 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 39.5 p -71.06 -22.2 62.15 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.268 -0.895 . . . . 0.0 109.426 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.5 mmtp -71.77 -42.26 67.37 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.296 -0.877 . . . . 0.0 109.41 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -74.81 -34.64 62.41 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.203 -0.936 . . . . 0.0 109.285 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.63 -54.47 42.38 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.277 -0.889 . . . . 0.0 109.271 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.7 -39.2 93.24 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.274 -0.891 . . . . 0.0 109.213 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -54.89 -38.35 67.46 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.296 -0.878 . . . . 0.0 109.367 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 13.2 mt -82.17 -23.03 35.75 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.302 -0.874 . . . . 0.0 109.435 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 42.2 tttt -70.44 -22.93 62.65 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.22 -0.925 . . . . 0.0 109.268 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 4.6 mmtt -76.95 1.12 18.63 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.257 -0.902 . . . . 0.0 109.572 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 11.2 tttt -118.02 16.44 14.19 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.224 -0.922 . . . . 0.0 109.484 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -113.78 -33.04 5.93 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.201 -0.937 . . . . 0.0 109.544 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 87.72 -43.52 3.18 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 7.5 t -157.05 113.33 2.97 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.207 -1.172 . . . . 0.0 109.544 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 126.0 177.55 14.94 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 115.56 111.5 2.79 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -123.16 121.01 34.91 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.218 -1.166 . . . . 0.0 109.704 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.5 p -109.48 139.59 31.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.266 -0.896 . . . . 0.0 109.199 179.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.472 ' O ' ' N ' ' A' ' 81' ' ' GLY . 50.1 mttt -130.01 136.26 49.21 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.163 -0.961 . . . . 0.0 109.716 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -55.22 89.52 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.287 -0.883 . . . . 0.0 109.437 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.472 ' N ' ' O ' ' A' ' 79' ' ' LYS . . . 137.45 -44.78 1.11 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.428 HG11 ' O ' ' A' ' 51' ' ' ILE . 2.3 t -137.18 151.79 27.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.179 -1.189 . . . . 0.0 109.488 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 2.4 mp -124.66 140.63 47.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.209 -0.932 . . . . 0.0 109.555 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -128.92 139.0 52.32 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.315 -0.866 . . . . 0.0 109.372 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 17.8 mt -155.08 135.18 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.215 -0.928 . . . . 0.0 109.55 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -82.3 112.27 19.13 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.304 -0.872 . . . . 0.0 109.552 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -136.29 -39.78 0.14 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.461 -1.455 . . . . 0.0 109.461 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 46.28 36.61 3.42 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.227 -1.161 . . . . 0.0 109.521 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 5.4 mttp -137.91 53.7 1.82 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.261 -0.9 . . . . 0.0 109.473 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 1.9 mtm105 -49.64 -25.68 3.06 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.26 -0.9 . . . . 0.0 109.434 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -57.31 -53.34 59.17 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.255 -0.903 . . . . 0.0 109.443 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.6 tt -72.63 -33.4 66.62 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.262 -0.899 . . . . 0.0 109.471 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 48.0 mt -60.35 -27.42 67.36 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.263 -0.898 . . . . 0.0 109.406 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 75.4 tttt -64.65 -65.2 0.71 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.261 -0.9 . . . . 0.0 109.507 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -63.07 -15.42 56.52 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.228 -0.92 . . . . 0.0 109.468 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 5.0 tt -71.22 -57.57 4.36 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.261 -0.899 . . . . 0.0 109.431 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.508 ' CD1' ' HB2' ' A' ' 102' ' ' MET . 0.1 OUTLIER -65.29 -32.38 74.0 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.252 -0.905 . . . . 0.0 109.469 179.993 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 56.5 mm-40 -67.8 -27.97 67.19 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.275 -0.891 . . . . 0.0 109.465 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.38 -32.21 73.73 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.295 -0.878 . . . . 0.0 109.441 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 17.2 mttt -80.52 -14.68 58.03 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.19 -0.944 . . . . 0.0 109.476 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 79.55 11.66 84.56 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' MET . . . . . 0.508 ' HB2' ' CD1' ' A' ' 97' ' ' LEU . 4.5 mtm -86.64 156.73 19.89 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.221 -1.164 . . . . 0.0 109.499 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.404 ' CB ' HG13 ' A' ' 33' ' ' VAL . 2.1 mmtt -80.69 108.44 14.34 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.242 -0.911 . . . . 0.0 109.445 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 34' ' ' VAL . 13.1 p -102.39 151.73 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.281 -0.887 . . . . 0.0 109.496 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.401 ' O ' ' N ' ' A' ' 107' ' ' ALA . 0.3 OUTLIER -115.32 79.21 1.25 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.243 -0.91 . . . . 0.0 109.472 179.993 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 5.2 tt -46.74 100.45 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.247 -0.908 . . . . 0.0 109.463 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.432 ' HB2' ' HB3' ' A' ' 37' ' ' GLN . . . -98.71 130.93 45.21 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.259 -0.901 . . . . 0.0 109.494 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -128.28 -80.4 0.28 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.489 ' O ' ' CB ' ' A' ' 110' ' ' LEU . . . 106.05 -81.68 0.31 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.489 ' CB ' ' O ' ' A' ' 109' ' ' GLY . 6.8 tp 74.83 38.91 0.44 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.233 -1.157 . . . . 0.0 109.483 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 76.9 tt0 . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 117.981 -1.009 . . . . 0.0 109.451 -179.951 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 92.7 mttt . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 176.25 67.09 0.06 OUTLIER Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -94.4 46.83 1.16 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.247 -1.149 . . . . 0.0 109.507 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -169.46 107.4 0.27 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.0 m -121.86 144.96 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.281 -1.129 . . . . 0.0 109.426 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.402 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 72.2 t -119.88 133.32 67.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.264 -0.898 . . . . 0.0 109.5 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 5.5 mtt180 -108.17 98.05 7.65 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.202 -0.937 . . . . 0.0 109.474 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.9 mt -98.63 145.42 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.251 -0.905 . . . . 0.0 109.432 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.443 ' O ' ' HG3' ' A' ' 37' ' ' GLN . 0.0 OUTLIER -179.46 122.46 0.08 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.253 -0.905 . . . . 0.0 109.473 179.977 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.5 132.51 44.78 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.23 -0.919 . . . . 0.0 109.462 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -121.45 149.21 43.36 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.279 -0.888 . . . . 0.0 109.506 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 11.2 p -86.45 143.06 27.96 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.269 -0.894 . . . . 0.0 109.444 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.3 m -102.98 -57.35 2.06 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.218 -0.926 . . . . 0.0 109.437 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 113.4 -19.69 19.38 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 46.7 mtt180 -105.19 -76.31 0.61 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.255 -1.144 . . . . 0.0 109.422 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 47.7 mttt -123.65 98.34 5.78 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.237 -0.914 . . . . 0.0 109.469 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 152.52 -57.98 0.42 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 25.3 mttt 55.18 31.42 16.38 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.214 -1.168 . . . . 0.0 109.513 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 127.39 83.99 0.46 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 28.1 m -113.69 157.02 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.225 -1.162 . . . . 0.0 109.434 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 5.4 t -105.71 123.56 48.13 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.237 -0.914 . . . . 0.0 109.485 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.4 mt -116.39 108.61 16.27 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.237 -0.914 . . . . 0.0 109.433 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 3.5 mm -96.13 121.22 46.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.268 -0.895 . . . . 0.0 109.533 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.6 -169.32 2.37 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.264 -0.897 . . . . 0.0 109.497 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 63.35 46.42 92.82 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.8 t -95.94 122.63 47.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.216 -1.167 . . . . 0.0 109.491 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -105.24 77.61 1.32 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.218 -0.926 . . . . 0.0 109.496 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 37.7 mt -135.89 165.93 24.49 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.24 -0.912 . . . . 0.0 109.481 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -65.79 -73.59 0.13 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.303 -0.873 . . . . 0.0 109.454 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -173.45 -52.09 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.229 -0.919 . . . . 0.0 109.479 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.41 -33.42 74.75 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.221 -0.924 . . . . 0.0 109.495 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -69.73 -30.15 67.7 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.222 -0.924 . . . . 0.0 109.434 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.5 tt -70.54 -45.95 64.51 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.225 -0.922 . . . . 0.0 109.4 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -61.35 -43.97 97.97 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.255 -0.903 . . . . 0.0 109.45 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 76.8 tttt -60.56 -52.14 66.46 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.273 -0.892 . . . . 0.0 109.433 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -48.01 -47.48 33.33 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.169 -0.957 . . . . 0.0 109.316 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.03 -42.14 84.69 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.293 -0.879 . . . . 0.0 109.297 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.35 -24.26 67.2 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.289 -0.882 . . . . 0.0 109.343 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -75.39 -38.62 59.83 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.34 -0.85 . . . . 0.0 109.431 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 9.5 mt -68.17 -42.57 79.79 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.246 -0.909 . . . . 0.0 109.314 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 17.2 tttt -56.81 -43.9 81.44 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.281 -0.887 . . . . 0.0 109.341 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 10.5 mttt -52.66 -33.19 45.99 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.21 -0.931 . . . . 0.0 109.459 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 34.4 mttt -116.61 54.78 0.84 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.169 -0.957 . . . . 0.0 109.836 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -140.36 -37.95 0.45 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.091 -1.006 . . . . 0.0 109.559 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.487 ' O ' ' CB ' ' A' ' 74' ' ' CYS . . . 91.28 -24.1 21.03 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 -179.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.487 ' CB ' ' O ' ' A' ' 73' ' ' GLY . 1.6 p 165.62 133.14 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.3 -1.117 . . . . 0.0 109.392 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.7 114.31 3.63 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 178.25 76.22 0.06 OUTLIER Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.446 ' HB1' ' HB2' ' A' ' 84' ' ' GLU . . . -83.95 151.33 25.12 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.297 -1.119 . . . . 0.0 109.473 -179.833 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 37.5 t -119.6 142.95 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.263 -0.898 . . . . 0.0 109.269 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.418 ' HB2' ' O ' ' A' ' 82' ' ' VAL . 16.3 mttt -147.33 171.18 15.84 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.267 -0.896 . . . . 0.0 109.496 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -63.8 102.62 0.48 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.344 -0.848 . . . . 0.0 109.718 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.455 ' O ' HG22 ' A' ' 82' ' ' VAL . . . 63.18 25.9 68.73 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 179.725 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.455 HG22 ' O ' ' A' ' 81' ' ' GLY . 40.8 t -146.21 123.26 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.232 -1.158 . . . . 0.0 109.414 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 34.9 mt -117.86 139.59 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.223 -0.923 . . . . 0.0 109.508 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.446 ' HB2' ' HB1' ' A' ' 77' ' ' ALA . 1.3 mt-10 -115.09 131.2 57.0 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.195 -0.94 . . . . 0.0 109.325 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 47.3 mm -128.82 137.33 57.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.203 -0.935 . . . . 0.0 109.583 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -96.39 109.35 21.89 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.28 -0.888 . . . . 0.0 109.449 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 165.68 166.96 25.55 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -129.2 62.8 1.51 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.266 -1.138 . . . . 0.0 109.47 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 76.0 mttt -127.27 52.19 1.83 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.214 -0.929 . . . . 0.0 109.473 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.412 ' HG3' ' N ' ' A' ' 91' ' ' ASP . 6.6 ptt180 -52.25 -36.11 51.67 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.32 -0.863 . . . . 0.0 109.442 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.412 ' N ' ' HG3' ' A' ' 90' ' ' ARG . 21.9 m-20 -60.21 -43.22 96.15 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.274 -0.891 . . . . 0.0 109.519 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.45 -34.6 77.51 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.23 -0.919 . . . . 0.0 109.484 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.516 ' HA ' ' CD2' ' A' ' 96' ' ' LEU . 0.3 OUTLIER -62.15 -39.83 93.94 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.286 -0.884 . . . . 0.0 109.504 179.983 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 76.1 tttt -63.76 -27.07 68.94 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.242 -0.911 . . . . 0.0 109.427 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 20.7 t -75.61 -60.67 2.21 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.273 -0.892 . . . . 0.0 109.504 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.566 ' CD1' ' N ' ' A' ' 97' ' ' LEU . 4.0 pp -52.36 -33.16 41.79 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.271 -0.893 . . . . 0.0 109.479 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.566 ' N ' ' CD1' ' A' ' 96' ' ' LEU . 0.1 OUTLIER -68.89 -54.15 17.18 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.276 -0.89 . . . . 0.0 109.508 179.978 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -64.78 -12.52 48.46 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.286 -0.884 . . . . 0.0 109.523 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.28 -28.32 69.24 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.238 -0.914 . . . . 0.0 109.469 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 33.6 mttm -95.86 -24.92 16.22 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.263 -0.898 . . . . 0.0 109.445 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 103.04 13.92 27.88 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -76.62 147.98 37.22 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.254 -1.144 . . . . 0.0 109.488 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.47 87.16 5.7 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.254 -0.904 . . . . 0.0 109.434 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' A' ' 34' ' ' VAL . 11.7 p -85.88 133.19 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.225 -0.922 . . . . 0.0 109.475 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.417 ' O ' ' N ' ' A' ' 107' ' ' ALA . 5.3 mttt -102.33 86.18 2.77 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.285 -0.885 . . . . 0.0 109.469 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 4.7 tp -52.27 95.89 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.192 -0.942 . . . . 0.0 109.483 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.417 ' N ' ' O ' ' A' ' 105' ' ' LYS . . . -95.37 144.73 25.67 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.281 -0.887 . . . . 0.0 109.468 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -146.96 -79.86 0.03 OUTLIER Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -86.9 -157.85 31.33 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -172.61 168.42 5.26 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.203 -1.175 . . . . 0.0 109.459 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 118.051 -0.976 . . . . 0.0 109.459 179.995 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -178.32 78.0 0.07 OUTLIER Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -93.95 114.82 27.1 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.307 -1.113 . . . . 0.0 109.518 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -108.4 167.3 13.16 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.462 ' CG2' ' O ' ' A' ' 103' ' ' LYS . 3.3 p -150.41 94.47 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.233 -1.157 . . . . 0.0 109.504 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.42 ' HB ' ' CD2' ' A' ' 97' ' ' LEU . 69.6 t -85.14 107.42 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.251 -0.905 . . . . 0.0 109.484 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 82.6 mtt180 -83.45 120.81 26.36 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.268 -0.895 . . . . 0.0 109.445 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.489 ' CD1' HD21 ' A' ' 93' ' ' LEU . 5.6 mt -120.14 116.31 49.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.196 -0.94 . . . . 0.0 109.524 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.462 ' HB3' ' HB3' ' A' ' 107' ' ' ALA . 28.2 pt20 -143.76 151.25 39.75 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.207 -0.933 . . . . 0.0 109.454 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.461 ' HG3' ' O ' ' A' ' 38' ' ' ARG . 11.9 ptt180 -95.47 122.59 38.36 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.221 -0.924 . . . . 0.0 109.439 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 7.2 tp60 -83.04 -37.2 24.22 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.3 -0.875 . . . . 0.0 109.484 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 55.05 54.65 8.64 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.234 -0.916 . . . . 0.0 109.448 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 30.2 t -113.1 118.01 33.58 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.201 -0.937 . . . . 0.0 109.481 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 118.37 178.19 17.02 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 2.4 ttp180 -144.11 38.25 1.29 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.277 -1.131 . . . . 0.0 109.422 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.73 23.09 13.85 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.254 -0.904 . . . . 0.0 109.524 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -172.9 -83.44 0.05 OUTLIER Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 12.6 mttt -179.09 -60.8 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.25 -1.147 . . . . 0.0 109.492 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.7 173.32 31.02 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 16.0 m -143.22 156.92 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.261 -1.14 . . . . 0.0 109.416 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -118.21 110.89 18.11 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.241 -0.912 . . . . 0.0 109.471 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 56.5 mt -93.79 123.83 37.39 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.273 -0.892 . . . . 0.0 109.514 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 4.7 mm -109.4 110.94 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.28 -0.888 . . . . 0.0 109.453 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -158.48 152.68 24.03 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.269 -0.894 . . . . 0.0 109.448 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.36 51.8 1.2 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 6.1 t -116.53 100.17 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.255 -1.144 . . . . 0.0 109.497 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -77.36 102.49 6.81 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.223 -0.923 . . . . 0.0 109.505 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.401 HD21 ' CB ' ' A' ' 60' ' ' GLU . 0.1 OUTLIER -150.8 -157.43 0.81 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.252 -0.905 . . . . 0.0 109.481 179.991 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -76.58 -86.56 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.27 -0.894 . . . . 0.0 109.473 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -177.84 -47.33 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.307 -0.87 . . . . 0.0 109.36 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.8 -23.12 52.84 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.289 -0.882 . . . . 0.0 109.364 179.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.401 ' CB ' HD21 ' A' ' 56' ' ' LEU . 1.9 mm-40 -68.25 -28.07 66.89 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.267 -0.895 . . . . 0.0 109.437 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.95 -32.94 74.52 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.215 -0.928 . . . . 0.0 109.348 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -71.14 -40.7 71.22 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.275 -0.89 . . . . 0.0 109.391 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -66.79 -37.55 84.78 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.201 -0.937 . . . . 0.0 109.365 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 53.4 tp -65.35 -50.96 63.6 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.267 -0.896 . . . . 0.0 109.356 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.95 -26.96 69.07 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.306 -0.871 . . . . 0.0 109.295 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -74.21 -34.51 63.73 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.328 -0.858 . . . . 0.0 109.34 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -76.75 -26.71 54.86 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.254 -0.904 . . . . 0.0 109.39 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -77.9 -37.01 48.91 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.267 -0.895 . . . . 0.0 109.437 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 7.3 ttpt -67.61 -24.04 65.43 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.283 -0.886 . . . . 0.0 109.422 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.9 -29.71 60.43 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.288 -0.883 . . . . 0.0 109.536 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 4.0 mtmt -132.08 52.63 2.06 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.257 -0.902 . . . . 0.0 109.492 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . 0.412 ' SG ' HG22 ' A' ' 85' ' ' ILE . 9.1 t -110.13 -28.68 8.55 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.274 -0.891 . . . . 0.0 109.49 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.403 ' O ' ' HB2' ' A' ' 74' ' ' CYS . . . 77.73 6.19 86.82 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.403 ' HB2' ' O ' ' A' ' 73' ' ' GLY . 23.2 t 177.37 125.31 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.241 -1.152 . . . . 0.0 109.455 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -102.85 139.11 14.29 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -114.5 -100.86 2.37 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -117.78 133.36 56.01 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.211 -1.17 . . . . 0.0 109.333 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.0 t -124.85 99.13 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.19 -0.944 . . . . 0.0 109.669 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 61.4 mttm -115.29 141.47 47.99 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.272 -0.893 . . . . 0.0 109.322 179.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -60.39 99.84 0.09 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.207 -0.933 . . . . 0.0 109.391 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.413 ' C ' HG21 ' A' ' 82' ' ' VAL . . . 121.17 -33.03 4.51 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.413 HG21 ' C ' ' A' ' 81' ' ' GLY . 30.9 t -132.84 117.53 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.294 -1.121 . . . . 0.0 109.361 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 7.6 mt -123.13 123.71 68.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.291 -0.881 . . . . 0.0 109.556 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 53.6 tt0 -106.1 124.79 50.13 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.166 -0.959 . . . . 0.0 109.422 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.412 HG22 ' SG ' ' A' ' 72' ' ' CYS . 45.2 mm -115.2 143.44 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.228 -0.92 . . . . 0.0 109.555 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -112.68 113.64 25.86 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.301 -0.874 . . . . 0.0 109.501 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 178.74 -140.37 4.45 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.544 -1.423 . . . . 0.0 109.544 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.464 ' O ' ' CG ' ' A' ' 89' ' ' LYS . 17.6 t0 -177.35 79.9 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.261 -1.141 . . . . 0.0 109.514 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.464 ' CG ' ' O ' ' A' ' 88' ' ' ASP . 90.4 mttt -156.89 40.27 0.33 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.291 -0.881 . . . . 0.0 109.473 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 68.4 ttt180 -47.55 -31.5 4.46 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.282 -0.886 . . . . 0.0 109.527 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -57.46 -53.56 56.72 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.243 -0.91 . . . . 0.0 109.493 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 3.3 tp -63.82 -31.71 72.97 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.218 -0.926 . . . . 0.0 109.502 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.489 HD21 ' CD1' ' A' ' 36' ' ' ILE . 0.6 OUTLIER -59.09 -41.68 88.65 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.242 -0.911 . . . . 0.0 109.493 179.964 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -64.72 -27.04 68.64 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.272 -0.893 . . . . 0.0 109.519 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 1.1 t -73.94 -62.42 1.51 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.228 -0.92 . . . . 0.0 109.487 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.515 ' CD1' ' N ' ' A' ' 97' ' ' LEU . 4.1 pp -51.96 -31.11 27.66 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.237 -0.914 . . . . 0.0 109.526 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.515 ' N ' ' CD1' ' A' ' 96' ' ' LEU . 0.2 OUTLIER -70.03 -50.1 44.65 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.235 -0.916 . . . . 0.0 109.459 -179.927 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -65.49 -14.48 61.09 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.189 -0.945 . . . . 0.0 109.505 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -73.19 -27.94 61.92 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.252 -0.905 . . . . 0.0 109.489 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.8 mptt -87.65 -13.13 43.46 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.284 -0.885 . . . . 0.0 109.484 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 74.13 31.17 59.92 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 2.0 mtm -98.06 167.02 11.15 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.265 -1.138 . . . . 0.0 109.468 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.462 ' O ' ' CG2' ' A' ' 33' ' ' VAL . 2.3 mttm -86.53 93.34 9.15 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.292 -0.88 . . . . 0.0 109.457 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.453 HG21 ' HG ' ' A' ' 97' ' ' LEU . 7.5 p -83.31 136.43 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.241 -0.912 . . . . 0.0 109.5 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.9 90.25 3.33 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.302 -0.874 . . . . 0.0 109.456 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 45.3 mt -57.04 94.02 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.238 -0.914 . . . . 0.0 109.509 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.462 ' HB3' ' HB3' ' A' ' 37' ' ' GLN . . . -82.72 118.47 23.38 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.277 -0.889 . . . . 0.0 109.454 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -155.75 -166.44 15.8 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 162.53 161.48 12.24 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.559 -1.417 . . . . 0.0 109.559 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 2.0 pp -168.02 152.56 6.45 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.266 -1.138 . . . . 0.0 109.45 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.468 -179.998 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 98.9 mttt . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 152.09 -174.24 31.12 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -177.51 143.13 0.35 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.267 -1.137 . . . . 0.0 109.443 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -126.86 119.06 3.2 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.2 m -125.65 90.62 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.273 -1.134 . . . . 0.0 109.443 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.43 HG12 ' N ' ' A' ' 35' ' ' ARG . 44.9 t -97.59 163.21 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.241 -0.912 . . . . 0.0 109.459 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.43 ' N ' HG12 ' A' ' 34' ' ' VAL . 69.5 mtt180 -147.79 121.66 9.34 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.248 -0.908 . . . . 0.0 109.458 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.508 ' CD1' HG22 ' A' ' 104' ' ' VAL . 1.1 mp -116.21 94.54 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.24 -0.913 . . . . 0.0 109.493 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -106.97 -176.02 2.96 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.258 -0.901 . . . . 0.0 109.473 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 18.4 mtp180 -122.02 142.12 50.65 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.291 -0.881 . . . . 0.0 109.464 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -105.62 102.54 11.99 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.185 -0.947 . . . . 0.0 109.473 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 3.0 t -126.23 139.34 53.41 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.247 -0.908 . . . . 0.0 109.444 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -171.3 143.01 1.8 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.191 -0.943 . . . . 0.0 109.461 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 69.73 -175.14 34.73 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.408 ' O ' ' CB ' ' A' ' 44' ' ' LYS . 40.9 ptt180 -104.65 178.36 4.58 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.247 -1.149 . . . . 0.0 109.512 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.408 ' CB ' ' O ' ' A' ' 43' ' ' ARG . 56.0 tttt 69.0 67.08 0.28 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.244 -0.91 . . . . 0.0 109.497 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 179.4 146.4 6.75 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -99.43 -26.84 14.0 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.228 -1.16 . . . . 0.0 109.475 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 114.76 146.34 9.05 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 5.6 m -138.71 162.75 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.241 -1.152 . . . . 0.0 109.581 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 92.2 m -112.37 138.22 49.42 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.277 -0.889 . . . . 0.0 109.39 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -132.26 113.36 13.15 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.243 -0.91 . . . . 0.0 109.493 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.443 HG13 HG21 ' A' ' 36' ' ' ILE . 3.7 mp -85.91 131.01 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.208 -0.933 . . . . 0.0 109.503 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.0 p -142.15 -174.54 4.13 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.236 -0.915 . . . . 0.0 109.453 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 52.04 51.36 41.08 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.6 t -97.13 110.69 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.289 -1.124 . . . . 0.0 109.41 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -97.43 78.18 2.67 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.258 -0.901 . . . . 0.0 109.488 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -115.86 -167.7 1.3 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.228 -0.92 . . . . 0.0 109.49 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -96.57 -61.03 1.48 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.257 -0.902 . . . . 0.0 109.47 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 175.74 -54.59 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.308 -0.87 . . . . 0.0 109.394 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -75.55 -23.05 56.57 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.252 -0.905 . . . . 0.0 109.435 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -75.29 -33.48 61.21 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.289 -0.882 . . . . 0.0 109.441 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.0 -44.42 84.86 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.266 -0.897 . . . . 0.0 109.374 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 57.2 m -69.02 -29.77 68.01 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.266 -0.896 . . . . 0.0 109.514 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -70.67 -35.48 72.85 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.232 -0.918 . . . . 0.0 109.49 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.45 -59.83 2.53 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.214 -0.929 . . . . 0.0 109.494 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -48.39 -45.39 35.84 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.278 -0.889 . . . . 0.0 109.473 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.18 -41.37 99.21 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.262 -0.899 . . . . 0.0 109.465 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -59.35 -32.62 70.27 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.212 -0.93 . . . . 0.0 109.534 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.5 mt -82.89 -22.28 33.99 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.265 -0.897 . . . . 0.0 109.405 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.98 -21.08 59.37 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.302 -0.873 . . . . 0.0 109.758 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.6 -14.18 61.14 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.274 -0.891 . . . . 0.0 110.264 -179.412 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.02 37.88 1.17 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.053 -1.029 . . . . 0.0 109.584 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . 0.418 ' SG ' HG21 ' A' ' 85' ' ' ILE . 0.1 OUTLIER -99.06 -64.79 1.01 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.269 -0.894 . . . . 0.0 109.566 -179.958 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.479 ' O ' ' CB ' ' A' ' 74' ' ' CYS . . . 116.21 18.81 5.72 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.479 ' CB ' ' O ' ' A' ' 73' ' ' GLY . 0.5 OUTLIER 164.93 93.06 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.275 -1.132 . . . . 0.0 109.438 -179.961 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -57.27 100.71 0.13 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -77.38 -159.09 10.44 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -74.2 146.57 43.27 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.128 -1.219 . . . . 0.0 109.314 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 57.9 t -135.18 93.77 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.176 -0.952 . . . . 0.0 109.695 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.04 156.35 18.85 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.332 -0.855 . . . . 0.0 109.333 179.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -71.58 101.45 2.5 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.173 -0.954 . . . . 0.0 109.54 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.404 ' C ' ' CG2' ' A' ' 82' ' ' VAL . . . 117.44 -11.93 14.06 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.404 ' CG2' ' C ' ' A' ' 81' ' ' GLY . 3.3 t -152.72 117.75 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.297 -1.12 . . . . 0.0 109.357 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 15.2 mt -122.76 123.68 68.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.189 -0.944 . . . . 0.0 109.744 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -92.14 136.06 33.49 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.308 -0.87 . . . . 0.0 109.27 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.418 HG21 ' SG ' ' A' ' 72' ' ' CYS . 13.1 mm -131.9 95.93 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.171 -0.956 . . . . 0.0 109.521 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -56.56 133.85 53.84 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.296 -0.877 . . . . 0.0 109.407 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 143.9 173.72 15.59 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -139.92 81.32 1.81 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.28 -1.13 . . . . 0.0 109.419 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 13.7 pttt -145.55 49.03 1.24 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.261 -0.9 . . . . 0.0 109.456 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 7.1 ptt180 -47.69 -37.53 13.21 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.258 -0.901 . . . . 0.0 109.516 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -56.15 -49.66 73.33 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.261 -0.899 . . . . 0.0 109.438 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.444 HD13 ' O ' ' A' ' 92' ' ' LEU . 0.2 OUTLIER -60.15 -44.13 95.2 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.268 -0.895 . . . . 0.0 109.501 -179.992 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.443 ' O ' ' HB3' ' A' ' 96' ' ' LEU . 4.3 mm? -56.15 -35.13 66.82 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.237 -0.914 . . . . 0.0 109.42 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 67.9 tttt -60.87 -62.07 2.12 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.25 -0.906 . . . . 0.0 109.491 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -62.82 -14.1 41.47 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.216 -0.928 . . . . 0.0 109.421 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.446 ' CD2' ' N ' ' A' ' 97' ' ' LEU . 4.7 tt -72.78 -62.08 1.58 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.231 -0.918 . . . . 0.0 109.473 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.511 ' CD2' ' HB ' ' A' ' 104' ' ' VAL . 0.1 OUTLIER -61.78 -31.9 72.15 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.266 -0.896 . . . . 0.0 109.444 -179.983 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -71.86 -25.56 62.0 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.277 -0.889 . . . . 0.0 109.506 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -68.79 -26.82 65.4 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.209 -0.932 . . . . 0.0 109.474 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -85.78 -39.31 17.25 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.244 -0.91 . . . . 0.0 109.504 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 117.65 14.46 6.82 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 19.0 mtp -96.62 154.12 17.46 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.293 -1.122 . . . . 0.0 109.451 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 11.1 mptt -81.19 118.94 22.99 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.282 -0.886 . . . . 0.0 109.512 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.511 ' HB ' ' CD2' ' A' ' 97' ' ' LEU . 12.1 p -115.32 135.06 56.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.265 -0.897 . . . . 0.0 109.456 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 71.6 tttt -102.28 97.56 7.82 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.273 -0.892 . . . . 0.0 109.465 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 23.9 tp -45.59 -30.35 1.47 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.285 -0.884 . . . . 0.0 109.497 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . 62.67 -178.39 0.14 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.232 -0.918 . . . . 0.0 109.48 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.404 ' O ' ' C ' ' A' ' 109' ' ' GLY . . . 148.25 -139.36 7.61 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.404 ' C ' ' O ' ' A' ' 108' ' ' GLY . . . -44.83 129.66 7.77 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.0 tt -174.03 119.65 0.27 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.281 -1.129 . . . . 0.0 109.47 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 118.017 -0.992 . . . . 0.0 109.483 179.979 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 57.6 tttt . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 177.57 -71.77 0.08 OUTLIER Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -92.86 149.33 21.34 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.239 -1.154 . . . . 0.0 109.453 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -122.94 145.45 16.21 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 16.3 m -132.21 137.71 53.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.29 -1.124 . . . . 0.0 109.45 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.468 HG21 ' CE ' ' A' ' 102' ' ' MET . 60.3 t -106.6 162.29 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.196 -0.94 . . . . 0.0 109.478 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 4.4 ttt180 -135.62 108.07 7.37 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.243 -0.911 . . . . 0.0 109.48 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.429 HD12 HD23 ' A' ' 93' ' ' LEU . 3.2 mt -116.53 128.11 73.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.208 -0.933 . . . . 0.0 109.429 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -156.07 153.88 30.1 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.258 -0.901 . . . . 0.0 109.477 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.1 143.14 34.66 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.248 -0.908 . . . . 0.0 109.487 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 20.2 tt0 -109.55 71.2 0.76 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.203 -0.936 . . . . 0.0 109.47 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 3.3 t -56.5 151.87 12.68 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.29 -0.881 . . . . 0.0 109.485 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -152.52 56.29 0.81 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.3 -0.875 . . . . 0.0 109.509 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 153.43 163.49 11.83 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 27.9 mtp85 -84.22 113.64 21.24 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.215 -1.167 . . . . 0.0 109.452 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 81.8 tttt 47.94 63.7 1.93 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.201 -0.937 . . . . 0.0 109.436 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -116.88 -55.48 0.31 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 12.3 tttt -174.18 131.5 0.39 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.193 -1.18 . . . . 0.0 109.406 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -96.16 123.27 7.64 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 15.6 m -121.44 143.31 34.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.239 -1.154 . . . . 0.0 109.328 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -125.37 133.92 52.36 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.211 -0.93 . . . . 0.0 109.53 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.421 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -123.29 120.52 33.34 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.264 -0.898 . . . . 0.0 109.41 179.951 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 3.2 mm -90.91 119.61 38.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.232 -0.917 . . . . 0.0 109.441 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.92 159.4 44.58 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.273 -0.892 . . . . 0.0 109.455 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 108.05 -31.21 8.13 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 57.0 t -45.02 113.05 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.221 -1.164 . . . . 0.0 109.419 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -114.34 76.8 1.01 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.234 -0.916 . . . . 0.0 109.478 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 31.3 mt -130.06 -156.33 0.75 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.255 -0.903 . . . . 0.0 109.439 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -67.34 143.28 56.46 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.278 -0.889 . . . . 0.0 109.446 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -58.08 -36.02 72.24 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.248 -0.907 . . . . 0.0 109.66 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.434 ' O ' HG21 ' A' ' 62' ' ' THR . . . -75.25 -32.55 61.12 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.182 -0.949 . . . . 0.0 109.531 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -71.95 -26.3 62.22 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.278 -0.889 . . . . 0.0 109.534 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.87 -56.87 4.94 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.219 -0.925 . . . . 0.0 109.549 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.434 HG21 ' O ' ' A' ' 59' ' ' ALA . 4.5 t -56.45 -24.36 44.96 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.266 -0.896 . . . . 0.0 109.453 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 79.2 mttt -75.54 -46.17 33.66 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.259 -0.9 . . . . 0.0 109.515 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.73 -46.02 92.04 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.188 -0.945 . . . . 0.0 109.359 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.456 ' HB3' HG21 ' A' ' 83' ' ' ILE . . . -65.78 -38.09 88.08 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.271 -0.893 . . . . 0.0 109.381 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.82 -36.98 75.39 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.227 -0.921 . . . . 0.0 109.413 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -75.55 -35.99 60.53 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.231 -0.918 . . . . 0.0 109.445 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -56.55 -53.17 60.65 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.347 -0.846 . . . . 0.0 109.605 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 15.4 pttp -66.16 -34.02 77.1 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.277 -0.889 . . . . 0.0 109.494 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -59.7 -21.83 61.16 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.316 -0.865 . . . . 0.0 109.71 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -85.07 -36.72 21.01 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.221 -0.925 . . . . 0.0 109.75 -179.655 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.2 m -94.42 -64.95 1.02 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.219 -0.925 . . . . 0.0 109.574 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 118.23 5.2 13.33 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 -179.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 46.8 t -160.15 121.87 3.19 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.307 -1.114 . . . . 0.0 109.258 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -129.35 -106.81 1.25 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 -179.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -172.84 -47.07 0.04 OUTLIER Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -178.55 119.52 0.08 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.291 -1.123 . . . . 0.0 109.56 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.417 HG23 ' HB3' ' A' ' 65' ' ' ALA . 77.9 t -100.98 97.82 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.312 -0.868 . . . . 0.0 109.292 179.837 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -106.34 141.34 37.82 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.213 -0.929 . . . . 0.0 109.814 -179.698 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -57.82 96.16 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.329 -0.857 . . . . 0.0 109.44 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 127.45 -40.78 1.7 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 23.5 t -132.93 122.51 46.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.179 -1.189 . . . . 0.0 109.58 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.456 HG21 ' HB3' ' A' ' 65' ' ' ALA . 2.9 mp -120.6 132.33 70.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.316 -0.865 . . . . 0.0 109.241 179.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -110.25 137.14 48.39 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.236 -0.915 . . . . 0.0 109.583 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 31.2 mm -132.59 123.18 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.299 -0.876 . . . . 0.0 109.563 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -91.78 104.95 17.34 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.204 -0.935 . . . . 0.0 109.438 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 178.6 -162.9 30.42 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -153.5 70.78 0.86 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.243 -1.151 . . . . 0.0 109.47 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 77.3 mttt -136.57 50.0 2.05 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.263 -0.898 . . . . 0.0 109.578 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 24.5 ptt180 -60.21 -34.04 73.09 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.227 -0.92 . . . . 0.0 109.478 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 30.5 t0 -55.74 -56.14 23.97 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.242 -0.911 . . . . 0.0 109.416 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.38 -31.03 71.63 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.249 -0.907 . . . . 0.0 109.398 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.433 ' HA ' ' CD2' ' A' ' 96' ' ' LEU . 0.4 OUTLIER -58.9 -45.16 90.96 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.31 -0.868 . . . . 0.0 109.442 179.961 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -61.91 -31.86 72.2 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.28 -0.887 . . . . 0.0 109.562 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.415 ' O ' ' C ' ' A' ' 96' ' ' LEU . 1.5 t -68.9 -69.76 0.31 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.216 -0.928 . . . . 0.0 109.499 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.57 ' CD1' ' N ' ' A' ' 97' ' ' LEU . 4.1 pp -43.78 -37.56 2.8 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.272 -0.892 . . . . 0.0 109.532 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.57 ' N ' ' CD1' ' A' ' 96' ' ' LEU . 10.6 tp -63.04 -47.24 83.87 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.213 -0.929 . . . . 0.0 109.46 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -69.2 -15.62 63.43 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.285 -0.884 . . . . 0.0 109.481 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -69.99 -28.34 65.44 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.22 -0.925 . . . . 0.0 109.472 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.433 ' HD3' ' N ' ' A' ' 100' ' ' LYS . 0.3 OUTLIER -85.77 -16.24 39.49 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.23 -0.919 . . . . 0.0 109.466 -179.951 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 84.94 14.38 69.8 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' MET . . . . . 0.468 ' CE ' HG21 ' A' ' 34' ' ' VAL . 1.4 mtm -87.29 171.89 10.28 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.243 -1.151 . . . . 0.0 109.43 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.43 164.93 22.68 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.238 -0.913 . . . . 0.0 109.452 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.494 ' CG1' HD23 ' A' ' 97' ' ' LEU . 4.8 t -139.49 125.88 23.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.215 -0.928 . . . . 0.0 109.48 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.427 ' O ' ' C ' ' A' ' 106' ' ' LEU . 2.5 mttt -106.5 64.46 0.66 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.189 -0.944 . . . . 0.0 109.491 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.427 ' C ' ' O ' ' A' ' 105' ' ' LYS . 3.6 tp -43.93 102.55 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.28 -0.887 . . . . 0.0 109.494 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -96.0 -11.65 26.18 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.23 -0.919 . . . . 0.0 109.456 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -102.72 137.27 13.3 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 146.74 148.68 4.81 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -102.41 157.41 16.93 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.267 -1.137 . . . . 0.0 109.445 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 117.996 -1.002 . . . . 0.0 109.479 179.952 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 36.8 tttt . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -176.18 -59.31 0.06 OUTLIER Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 65.9 t0 50.45 68.3 0.79 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.201 -1.176 . . . . 0.0 109.477 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -99.53 139.33 14.37 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 18.8 m -143.89 121.56 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.213 -1.169 . . . . 0.0 109.459 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.437 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 2.4 t -98.94 152.8 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.281 -0.887 . . . . 0.0 109.474 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.411 ' HG2' ' C ' ' A' ' 34' ' ' VAL . 4.4 mtt180 -139.01 118.56 12.95 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.314 -0.866 . . . . 0.0 109.461 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.441 ' CG2' ' HG ' ' A' ' 93' ' ' LEU . 2.6 mp -125.64 116.91 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.218 -0.926 . . . . 0.0 109.45 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -146.96 174.24 11.7 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.186 -0.946 . . . . 0.0 109.504 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 9.1 ttm180 -102.1 149.74 23.96 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.221 -0.924 . . . . 0.0 109.469 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -136.27 108.04 7.05 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.233 -0.917 . . . . 0.0 109.405 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 40.5 p -69.15 -179.47 1.57 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.264 -0.898 . . . . 0.0 109.493 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -149.15 -54.29 0.18 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.221 -0.924 . . . . 0.0 109.463 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -89.08 -110.51 1.19 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 86.7 mtt180 -127.31 -47.9 1.45 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.288 -1.124 . . . . 0.0 109.468 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 30.0 pttt -138.55 156.47 47.46 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.285 -0.884 . . . . 0.0 109.484 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 60.55 -173.3 5.7 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 58.29 49.01 11.68 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.235 -1.156 . . . . 0.0 109.432 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -107.28 135.09 12.55 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 18.6 m -133.06 168.75 23.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.252 -1.146 . . . . 0.0 109.461 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -119.83 116.98 26.97 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.184 -0.947 . . . . 0.0 109.54 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -92.69 129.51 38.59 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.254 -0.904 . . . . 0.0 109.425 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 21.9 mt -110.07 111.62 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.256 -0.903 . . . . 0.0 109.562 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.411 HG22 HG23 ' A' ' 82' ' ' VAL . 60.2 p -137.98 176.25 8.86 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.243 -0.91 . . . . 0.0 109.452 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.89 -15.11 59.81 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.432 HG11 ' HG ' ' A' ' 61' ' ' LEU . 18.6 t -56.67 122.01 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.248 -1.148 . . . . 0.0 109.466 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -124.45 72.12 1.18 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.255 -0.903 . . . . 0.0 109.486 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.3 mt -113.15 -173.36 2.24 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.28 -0.887 . . . . 0.0 109.466 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.61 -83.6 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.269 -0.895 . . . . 0.0 109.536 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -156.24 -61.09 0.1 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.22 -0.925 . . . . 0.0 109.452 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -65.33 -26.6 68.11 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.235 -0.916 . . . . 0.0 109.45 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -62.58 -42.5 99.6 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.253 -0.904 . . . . 0.0 109.481 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.432 ' HG ' HG11 ' A' ' 54' ' ' VAL . 0.4 OUTLIER -56.03 -59.15 5.32 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.212 -0.93 . . . . 0.0 109.403 179.895 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 8.8 t -59.46 -20.6 56.43 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.281 -0.887 . . . . 0.0 109.506 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.2 tttt -70.94 -71.06 0.27 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.215 -0.928 . . . . 0.0 109.522 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.452 ' O ' HD11 ' A' ' 64' ' ' LEU . 0.2 OUTLIER -48.25 -32.24 6.95 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.3 -0.875 . . . . 0.0 109.761 -179.869 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.42 -49.86 61.91 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.123 -0.986 . . . . 0.0 109.902 -179.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.404 ' O ' ' HG3' ' A' ' 70' ' ' LYS . . . -60.01 -28.99 68.18 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.089 -1.007 . . . . 0.0 109.891 -179.652 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.448 ' O ' ' HB2' ' A' ' 70' ' ' LYS . 2.6 tt0 -76.71 -33.83 58.18 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.127 -0.983 . . . . 0.0 109.835 -179.709 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 29.7 mt -71.62 -42.79 67.2 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.155 -0.965 . . . . 0.0 109.624 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 18.7 mtmt -72.34 -4.51 30.32 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.171 -0.956 . . . . 0.0 109.461 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.448 ' HB2' ' O ' ' A' ' 67' ' ' GLU . 4.3 mttt -74.0 -21.8 59.84 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.131 -0.981 . . . . 0.0 109.955 -179.509 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.93 59.3 1.54 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.12 -0.988 . . . . 0.0 109.579 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 4.9 t -134.31 -3.76 2.71 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.17 -0.956 . . . . 0.0 110.029 -179.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.13 2.68 54.13 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -163.54 -169.12 1.84 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.157 -1.202 . . . . 0.0 109.512 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -140.81 -116.18 1.27 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 144.1 -172.36 25.26 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -87.26 126.14 34.64 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.231 -1.158 . . . . 0.0 109.464 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 18.8 m -99.39 88.43 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.186 -0.946 . . . . 0.0 109.565 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.47 148.23 22.45 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.208 -0.933 . . . . 0.0 109.351 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -70.83 89.89 0.78 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.193 -0.942 . . . . 0.0 109.555 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.426 ' O ' ' CG2' ' A' ' 82' ' ' VAL . . . 123.85 -11.19 8.34 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.426 ' CG2' ' O ' ' A' ' 81' ' ' GLY . 73.2 t -156.18 121.41 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.299 -1.118 . . . . 0.0 109.356 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 11.3 mt -119.45 126.61 75.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.203 -0.935 . . . . 0.0 109.659 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -92.5 120.73 33.26 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.277 -0.889 . . . . 0.0 109.318 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 48.1 mm -127.45 70.72 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.28 -0.887 . . . . 0.0 109.561 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -50.43 160.92 0.35 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.256 -0.902 . . . . 0.0 109.416 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 126.59 -159.81 20.88 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -151.82 93.82 1.9 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.239 -1.153 . . . . 0.0 109.539 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 63.5 mttt -152.55 29.03 0.54 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.278 -0.889 . . . . 0.0 109.437 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.414 ' HB3' HD22 ' A' ' 106' ' ' LEU . 26.4 mtp180 -49.53 -38.42 30.59 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.219 -0.926 . . . . 0.0 109.465 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -55.36 -57.19 12.87 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.228 -0.92 . . . . 0.0 109.477 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.77 -21.48 65.88 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.285 -0.884 . . . . 0.0 109.467 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.441 ' HG ' ' CG2' ' A' ' 36' ' ' ILE . 0.9 OUTLIER -68.94 -42.4 76.77 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.248 -0.907 . . . . 0.0 109.472 179.995 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 18.3 tttt -68.84 -23.67 64.27 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.282 -0.886 . . . . 0.0 109.482 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -74.68 -62.44 1.53 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.173 -0.955 . . . . 0.0 109.437 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.442 HD12 HD23 ' A' ' 97' ' ' LEU . 2.6 pp -53.92 -35.88 62.15 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.235 -0.916 . . . . 0.0 109.439 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.442 HD23 HD12 ' A' ' 96' ' ' LEU . 0.2 OUTLIER -63.23 -52.58 61.6 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.281 -0.887 . . . . 0.0 109.483 179.976 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -63.04 -16.54 60.19 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.276 -0.89 . . . . 0.0 109.441 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.76 -35.92 82.09 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.248 -0.908 . . . . 0.0 109.505 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.7 mptp? -81.05 -38.5 27.3 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.245 -0.909 . . . . 0.0 109.508 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 108.99 14.58 14.73 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 8.1 mtm -89.77 158.83 17.34 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.25 -1.147 . . . . 0.0 109.466 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 20.4 mttt -80.93 120.04 24.23 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.269 -0.895 . . . . 0.0 109.428 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.437 ' HA ' ' O ' ' A' ' 34' ' ' VAL . 3.0 p -115.82 143.11 26.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.218 -0.926 . . . . 0.0 109.455 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.418 ' O ' ' C ' ' A' ' 106' ' ' LEU . 26.6 tttt -114.1 83.19 1.83 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.263 -0.898 . . . . 0.0 109.481 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.418 ' C ' ' O ' ' A' ' 105' ' ' LYS . 0.6 OUTLIER -44.67 -26.81 0.42 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.207 -0.933 . . . . 0.0 109.473 179.993 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . 66.21 -169.89 0.2 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.249 -0.907 . . . . 0.0 109.48 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 116.94 -166.21 12.42 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 160.38 -171.39 36.58 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.4 tp -53.94 102.14 0.05 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.312 -1.11 . . . . 0.0 109.436 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 63.8 tt0 . . . . . 0 N--CA 1.489 1.52 0 CA-C-O 117.986 -1.007 . . . . 0.0 109.502 179.976 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 75.0 mttt . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -149.26 141.7 9.16 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 19.1 p-10 -174.92 -171.51 0.54 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.222 -1.163 . . . . 0.0 109.458 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 178.02 130.21 1.37 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.447 ' O ' ' CG2' ' A' ' 33' ' ' VAL . 19.3 m -152.1 115.12 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.259 -1.142 . . . . 0.0 109.5 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 4.7 t -90.81 142.32 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.253 -0.904 . . . . 0.0 109.486 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 67.8 ttt180 -117.6 109.55 16.82 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.236 -0.915 . . . . 0.0 109.496 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.452 ' CD1' ' CD1' ' A' ' 97' ' ' LEU . 2.4 mp -108.22 93.7 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.266 -0.896 . . . . 0.0 109.473 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.79 179.96 7.44 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.273 -0.892 . . . . 0.0 109.425 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.71 102.67 3.96 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.254 -0.904 . . . . 0.0 109.446 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -88.44 128.83 35.54 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.285 -0.885 . . . . 0.0 109.478 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 74.1 p -130.49 147.75 52.22 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.279 -0.888 . . . . 0.0 109.481 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.3 t -113.2 144.19 43.11 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.284 -0.885 . . . . 0.0 109.467 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 49.32 -158.75 1.13 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -95.52 118.42 32.19 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.259 -1.142 . . . . 0.0 109.438 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 21.7 tttt 45.97 -165.89 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.292 -0.88 . . . . 0.0 109.463 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 104.46 -29.87 11.14 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 41.6 pttt -173.11 174.52 3.41 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.302 -1.116 . . . . 0.0 109.472 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -161.49 145.1 10.46 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 34.1 m -137.08 153.01 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.229 -1.159 . . . . 0.0 109.444 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -130.63 130.53 44.08 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.212 -0.93 . . . . 0.0 109.52 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 4.2 mp -118.74 109.51 16.17 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.235 -0.916 . . . . 0.0 109.468 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 4.0 mp -99.58 122.25 51.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.192 -0.943 . . . . 0.0 109.492 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 8.8 t -158.47 167.59 29.23 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.289 -0.882 . . . . 0.0 109.496 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 83.44 48.09 5.45 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 18.3 t -103.57 117.45 49.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.22 -1.165 . . . . 0.0 109.506 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -83.55 81.13 8.87 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.178 -0.951 . . . . 0.0 109.437 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 19.0 mt -151.35 174.02 13.82 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.256 -0.902 . . . . 0.0 109.467 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -56.85 166.5 0.97 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.245 -0.91 . . . . 0.0 109.509 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -73.74 -35.87 65.09 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.283 -0.885 . . . . 0.0 109.422 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.03 -29.43 58.07 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.256 -0.903 . . . . 0.0 109.395 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -67.43 -34.66 77.67 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.24 -0.912 . . . . 0.0 109.388 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.79 -44.62 80.82 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.229 -0.919 . . . . 0.0 109.286 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 54.9 m -60.82 -44.31 97.09 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.319 -0.863 . . . . 0.0 109.206 179.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 74.4 tttt -57.52 -49.54 76.0 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.342 -0.849 . . . . 0.0 109.363 179.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -55.95 -41.03 74.05 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.256 -0.902 . . . . 0.0 109.505 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.55 -37.01 84.46 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.242 -0.911 . . . . 0.0 109.578 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -70.81 -31.59 68.4 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.272 -0.893 . . . . 0.0 109.548 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 82.8 mt-10 -71.66 -37.67 70.78 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.181 -0.95 . . . . 0.0 109.433 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 11.2 mt -68.48 -55.45 11.74 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.253 -0.904 . . . . 0.0 109.531 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 19.8 ttmt -52.84 -40.18 63.13 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.258 -0.902 . . . . 0.0 109.41 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 61.4 tttt -47.81 -47.77 30.92 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.177 -0.952 . . . . 0.0 109.322 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 14.7 mttt -108.09 57.86 0.62 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.372 -0.83 . . . . 0.0 109.301 179.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.5 m -129.69 -75.97 0.55 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.265 -0.897 . . . . 0.0 109.736 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.658 ' O ' ' CB ' ' A' ' 74' ' ' CYS . . . 125.95 49.77 0.18 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.07 -1.612 . . . . 0.0 109.07 -179.582 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.658 ' CB ' ' O ' ' A' ' 73' ' ' GLY . 49.3 t 112.44 104.57 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.237 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -179.499 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -83.8 142.54 20.92 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -86.54 -80.71 1.18 Allowed Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -129.62 124.16 33.03 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.133 -1.216 . . . . 0.0 109.6 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 95.1 t -125.81 95.44 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.303 -0.873 . . . . 0.0 109.298 179.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 18.0 mttt -122.27 142.12 50.8 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.239 -0.913 . . . . 0.0 109.705 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -54.21 94.82 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.283 -0.886 . . . . 0.0 109.491 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 148.02 -46.24 0.71 Allowed Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 42.7 t -143.13 160.94 17.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.233 -1.157 . . . . 0.0 109.47 -179.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 4.8 mp -138.32 149.43 24.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.246 -0.909 . . . . 0.0 109.43 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -147.14 120.25 8.85 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.252 -0.905 . . . . 0.0 109.473 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 36.3 mm -119.53 117.75 54.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.171 -0.956 . . . . 0.0 109.443 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.57 114.37 10.63 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.234 -0.916 . . . . 0.0 109.481 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 172.2 -137.97 4.54 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.556 -1.417 . . . . 0.0 109.556 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -177.08 53.24 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.238 -1.154 . . . . 0.0 109.452 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 19.8 mttt -106.14 39.45 1.8 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.234 -0.916 . . . . 0.0 109.499 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 5.4 ttm180 -49.59 -35.28 20.28 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.205 -0.934 . . . . 0.0 109.501 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.93 -43.96 91.26 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.241 -0.912 . . . . 0.0 109.439 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.84 -20.32 58.23 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.231 -0.918 . . . . 0.0 109.427 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.436 HD11 HG23 ' A' ' 36' ' ' ILE . 19.5 mt -69.33 -43.46 73.66 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.234 -0.916 . . . . 0.0 109.45 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -67.69 -24.07 65.36 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.274 -0.892 . . . . 0.0 109.446 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -74.98 -60.86 2.1 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.205 -0.935 . . . . 0.0 109.491 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.42 ' CD2' ' HA ' ' A' ' 93' ' ' LEU . 3.6 pp -54.08 -34.53 60.41 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.254 -0.904 . . . . 0.0 109.505 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.462 ' CD2' ' HB ' ' A' ' 104' ' ' VAL . 0.4 OUTLIER -67.33 -47.04 71.68 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.315 -0.866 . . . . 0.0 109.453 179.981 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -65.91 -16.42 63.84 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.29 -0.881 . . . . 0.0 109.466 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -67.3 -36.37 81.38 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.264 -0.897 . . . . 0.0 109.437 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.94 -37.78 23.65 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.266 -0.896 . . . . 0.0 109.48 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 106.19 21.5 8.43 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.96 158.92 16.0 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.253 -1.145 . . . . 0.0 109.485 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 11.5 mttm -82.85 107.28 15.35 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.249 -0.907 . . . . 0.0 109.469 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.462 ' HB ' ' CD2' ' A' ' 97' ' ' LEU . 7.5 p -84.65 144.47 9.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.226 -0.921 . . . . 0.0 109.471 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 11.0 mttt -113.92 83.76 1.92 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.25 -0.906 . . . . 0.0 109.462 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.1 tp -45.09 -27.98 0.66 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.235 -0.916 . . . . 0.0 109.425 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . 59.05 77.89 0.29 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.276 -0.89 . . . . 0.0 109.492 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -159.59 175.9 36.41 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 167.88 -169.6 41.4 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 5.0 mt -62.49 143.56 57.0 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.276 -1.132 . . . . 0.0 109.485 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 50.4 tt0 . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.486 -179.983 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 121.298 0.571 . . . . 0.0 109.53 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.467 ' HA2' ' HB3' ' A' ' 55' ' ' ASP . . . 147.67 126.45 1.64 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.585 HG23 ' O ' ' A' ' 33' ' ' VAL . 19.1 m -133.8 121.26 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.318 -1.107 . . . . 0.0 109.42 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.954 HG22 HG22 ' A' ' 54' ' ' VAL . 77.9 t -96.42 135.78 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.218 -0.926 . . . . 0.0 109.493 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.471 ' O ' ' HG3' ' A' ' 35' ' ' ARG . 0.1 OUTLIER -130.08 124.45 32.82 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.187 -0.946 . . . . 0.0 109.519 -179.992 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.877 HG21 ' HG ' ' A' ' 93' ' ' LEU . 3.9 mp -110.08 126.11 67.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.233 -0.917 . . . . 0.0 109.449 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -121.69 160.65 24.05 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.272 -0.892 . . . . 0.0 109.502 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.405 ' O ' ' HG3' ' A' ' 38' ' ' ARG . 12.0 ptt180 -131.87 104.75 7.04 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.292 -0.88 . . . . 0.0 109.402 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -88.33 80.72 7.43 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.226 -0.921 . . . . 0.0 109.49 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 43.6 p . . . . . 0 N--CA 1.489 1.523 0 O-C-N 121.245 -0.909 . . . . 0.0 109.463 179.994 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 79.1 tttt . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 121.283 0.563 . . . . 0.0 109.572 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -118.99 149.61 18.13 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 27.6 m -126.43 158.13 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.232 -1.158 . . . . 0.0 109.487 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -129.42 124.23 33.6 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.267 -0.896 . . . . 0.0 109.48 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.1 mt -115.34 124.26 50.81 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.233 -0.917 . . . . 0.0 109.39 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.49 ' HB ' ' HB ' ' A' ' 83' ' ' ILE . 6.7 mm -107.28 119.28 56.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.231 -0.918 . . . . 0.0 109.595 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.987 HG23 ' O ' ' A' ' 81' ' ' GLY . 1.3 m -158.86 158.72 33.99 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.267 -0.896 . . . . 0.0 109.426 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.487 ' O ' ' N ' ' A' ' 55' ' ' ASP . . . 109.09 -23.86 22.37 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.954 HG22 HG22 ' A' ' 34' ' ' VAL . 21.3 t -49.02 94.17 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.311 -1.111 . . . . 0.0 109.424 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.487 ' N ' ' O ' ' A' ' 53' ' ' GLY . 13.3 t0 -79.78 85.92 5.4 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.234 -0.916 . . . . 0.0 109.527 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.493 HD13 ' OE1' ' A' ' 60' ' ' GLU . 35.2 mt -146.16 167.52 23.24 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.322 -0.861 . . . . 0.0 109.355 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.402 ' C ' ' O ' ' A' ' 56' ' ' LEU . 0.2 OUTLIER -45.47 150.47 0.47 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.224 -0.923 . . . . 0.0 109.392 179.888 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -60.33 -53.35 58.62 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.187 -0.945 . . . . 0.0 109.656 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.12 -39.02 71.59 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.283 -0.886 . . . . 0.0 109.733 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.493 ' OE1' HD13 ' A' ' 56' ' ' LEU . 0.3 OUTLIER -62.41 -39.41 93.19 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.174 -0.954 . . . . 0.0 109.671 -179.801 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.531 HD21 ' HB ' ' A' ' 54' ' ' VAL . 0.2 OUTLIER -58.9 -42.95 90.81 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.213 -0.929 . . . . 0.0 109.602 -179.894 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -61.36 -33.44 73.64 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.309 -0.87 . . . . 0.0 109.638 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -71.58 -34.89 70.31 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.235 -0.915 . . . . 0.0 109.605 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.49 ' HA ' HD22 ' A' ' 64' ' ' LEU . 0.2 OUTLIER -65.99 -59.77 3.5 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.189 -0.944 . . . . 0.0 109.577 -179.973 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -56.99 -34.17 67.86 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.278 -0.889 . . . . 0.0 109.628 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.477 ' HA ' ' HG2' ' A' ' 69' ' ' LYS . . . -66.36 -33.82 76.58 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.274 -0.891 . . . . 0.0 109.768 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -70.17 -44.31 69.05 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.204 -0.935 . . . . 0.0 109.723 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.645 ' CD2' HD22 ' A' ' 96' ' ' LEU . 9.7 mt -63.99 -39.85 95.07 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.231 -0.918 . . . . 0.0 109.629 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.485 ' HB2' ' HA2' ' A' ' 75' ' ' GLY . 12.9 ptmt -75.23 -2.11 26.47 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.321 -0.862 . . . . 0.0 109.854 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 10.3 tttt -76.83 -49.22 16.3 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.096 -1.003 . . . . 0.0 109.993 -179.569 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.54 64.63 1.43 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.079 -1.013 . . . . 0.0 109.768 -179.586 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' CYS . . . . . 0.437 ' HB2' ' O ' ' A' ' 68' ' ' LEU . 5.7 m -128.64 -15.36 4.47 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.192 -0.942 . . . . 0.0 110.078 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.672 ' O ' ' CB ' ' A' ' 74' ' ' CYS . . . 96.35 78.29 1.4 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.672 ' CB ' ' O ' ' A' ' 73' ' ' GLY . 34.7 t 112.02 110.62 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.19 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 -179.527 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.485 ' HA2' ' HB2' ' A' ' 69' ' ' LYS . . . -67.06 111.61 4.25 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -84.1 148.93 24.74 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -107.25 168.34 9.29 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.194 -1.18 . . . . 0.0 109.783 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.947 HG22 HG12 ' A' ' 83' ' ' ILE . 85.0 t -106.46 162.26 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.42 -0.8 . . . . 0.0 109.347 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.541 ' N ' HG12 ' A' ' 78' ' ' VAL . 6.6 mttt -149.27 82.27 1.42 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.222 -0.924 . . . . 0.0 109.521 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 46.15 66.87 0.85 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.373 -0.829 . . . . 0.0 109.728 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.987 ' O ' HG23 ' A' ' 52' ' ' THR . . . 74.84 8.88 82.91 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 179.608 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.459 ' O ' ' HB2' ' A' ' 79' ' ' LYS . 3.3 t -124.62 98.57 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.084 -1.245 . . . . 0.0 109.585 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.947 HG12 HG22 ' A' ' 78' ' ' VAL . 6.2 mt -93.15 124.37 45.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.228 -0.92 . . . . 0.0 109.481 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -91.87 124.55 36.07 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.324 -0.86 . . . . 0.0 109.578 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.413 HD13 ' HA ' ' A' ' 85' ' ' ILE . 34.1 mm -127.76 115.1 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.268 -0.895 . . . . 0.0 109.221 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.73 105.46 16.97 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.254 -0.904 . . . . 0.0 109.619 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 162.2 137.69 2.25 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -97.01 64.36 1.98 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.174 -1.192 . . . . 0.0 109.429 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 76.2 mttt -112.06 36.48 3.32 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.278 -0.889 . . . . 0.0 109.471 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 17.7 ttm180 -44.27 -35.8 2.46 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.261 -0.9 . . . . 0.0 109.476 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -56.39 -52.28 65.2 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.242 -0.911 . . . . 0.0 109.498 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.43 -26.88 68.17 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.291 -0.881 . . . . 0.0 109.47 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.877 ' HG ' HG21 ' A' ' 36' ' ' ILE . 3.2 mm? -63.23 -46.08 88.61 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.309 -0.869 . . . . 0.0 109.459 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 72.3 tttt -61.67 -29.95 70.41 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.228 -0.92 . . . . 0.0 109.534 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 17.5 t -69.83 -68.7 0.4 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.253 -0.905 . . . . 0.0 109.449 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.827 HD21 HD13 ' A' ' 93' ' ' LEU . 2.5 pp -44.86 -35.36 2.75 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.242 -0.911 . . . . 0.0 109.42 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.881 HD22 HG22 ' A' ' 104' ' ' VAL . 0.5 OUTLIER -64.63 -47.94 76.69 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.23 -0.919 . . . . 0.0 109.487 179.939 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -67.18 -9.26 38.21 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.234 -0.916 . . . . 0.0 109.488 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.417 ' HB3' ' O ' ' A' ' 96' ' ' LEU . . . -70.44 -33.16 70.99 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.233 -0.917 . . . . 0.0 109.482 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 4.8 mtmm -84.98 -25.87 27.48 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.209 -0.932 . . . . 0.0 109.506 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 92.5 16.01 50.99 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 4.2 mtm -87.69 -174.42 4.76 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.266 -1.138 . . . . 0.0 109.464 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 24.5 mttt -91.42 163.5 14.16 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.262 -0.899 . . . . 0.0 109.487 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.881 HG22 HD22 ' A' ' 97' ' ' LEU . 19.2 t -139.82 158.99 27.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.245 -0.909 . . . . 0.0 109.456 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.452 ' O ' ' N ' ' A' ' 107' ' ' ALA . 17.3 tttt -130.25 61.42 1.59 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.215 -0.928 . . . . 0.0 109.474 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.41 ' C ' ' O ' ' A' ' 105' ' ' LYS . 3.7 tp -44.9 98.49 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.26 -0.9 . . . . 0.0 109.494 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.452 ' N ' ' O ' ' A' ' 105' ' ' LYS . . . . . . . . 0 N--CA 1.49 1.526 0 O-C-N 121.206 -0.934 . . . . 0.0 109.488 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 14.9 t70 . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -86.37 161.08 33.75 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.806 HG12 ' HB3' ' A' ' 103' ' ' LYS . 18.9 m -142.98 97.51 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.189 -1.183 . . . . 0.0 109.506 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.634 ' HB ' HD21 ' A' ' 97' ' ' LEU . 38.6 t -97.06 145.45 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.186 -0.946 . . . . 0.0 109.444 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 58.5 mtt180 -127.45 131.13 50.26 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.265 -0.897 . . . . 0.0 109.493 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.773 ' CD1' HD22 ' A' ' 97' ' ' LEU . 3.0 mp -125.68 106.31 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.293 -0.879 . . . . 0.0 109.476 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.66 ' HA ' ' HB2' ' A' ' 107' ' ' ALA . 20.4 pt20 -113.49 -175.01 2.57 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.265 -0.897 . . . . 0.0 109.443 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.413 ' O ' ' CG ' ' A' ' 38' ' ' ARG . 3.9 ptt180 -133.22 117.85 17.9 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.237 -0.914 . . . . 0.0 109.498 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -95.05 132.63 39.73 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.237 -0.915 . . . . 0.0 109.47 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.537 0 O-C-N 121.248 -0.908 . . . . 0.0 109.523 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 90.1 mttt . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -166.12 156.86 29.06 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -130.22 165.01 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.276 -1.132 . . . . 0.0 109.454 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 3.5 m -133.82 134.59 43.01 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.245 -0.91 . . . . 0.0 109.515 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -111.18 139.25 46.71 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.261 -0.899 . . . . 0.0 109.489 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.481 HG12 ' CG1' ' A' ' 36' ' ' ILE . 15.3 mt -127.95 107.8 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.246 -0.909 . . . . 0.0 109.468 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 15.8 m -152.47 158.82 43.13 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.237 -0.914 . . . . 0.0 109.426 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 104.36 16.42 18.31 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.781 ' HB ' HD21 ' A' ' 61' ' ' LEU . 21.8 t -74.6 130.42 36.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.198 -1.177 . . . . 0.0 109.46 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -104.44 86.85 2.59 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.232 -0.918 . . . . 0.0 109.45 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.628 ' HB2' HD11 ' A' ' 61' ' ' LEU . 5.1 mt -133.38 -170.63 2.52 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.247 -0.908 . . . . 0.0 109.537 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -73.89 -69.89 0.41 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.191 -0.943 . . . . 0.0 109.481 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 174.12 -63.13 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.171 -0.956 . . . . 0.0 109.521 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.68 -30.89 71.92 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.242 -0.911 . . . . 0.0 109.583 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -66.01 -35.49 80.71 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.182 -0.949 . . . . 0.0 109.478 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.781 HD21 ' HB ' ' A' ' 54' ' ' VAL . 0.3 OUTLIER -63.95 -38.61 91.7 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.27 -0.894 . . . . 0.0 109.548 179.995 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 23.8 m -59.75 -49.64 76.92 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.234 -0.916 . . . . 0.0 109.47 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 58.5 tttt -59.7 -36.88 77.41 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.255 -0.903 . . . . 0.0 109.492 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.46 ' CD1' HD23 ' A' ' 68' ' ' LEU . 0.1 OUTLIER -59.29 -53.69 55.37 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.209 -0.932 . . . . 0.0 109.527 -179.926 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.559 ' HB1' HG11 ' A' ' 78' ' ' VAL . . . -59.15 -32.28 69.73 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.271 -0.893 . . . . 0.0 109.541 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.88 -42.29 94.93 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.238 -0.914 . . . . 0.0 109.401 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -75.64 -19.83 58.93 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.273 -0.892 . . . . 0.0 109.403 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.463 ' HA ' HD13 ' A' ' 68' ' ' LEU . 0.7 OUTLIER -72.17 -53.69 11.93 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.32 -0.863 . . . . 0.0 109.548 -179.956 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.496 ' HA ' ' HB2' ' A' ' 72' ' ' CYS . 1.3 ptpt -65.8 -21.41 66.49 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.323 -0.861 . . . . 0.0 109.694 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 9.3 mttt -58.57 -34.61 71.25 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.321 -0.862 . . . . 0.0 110.042 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 59.7 tttt -120.12 24.03 10.67 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.045 -1.034 . . . . 0.0 110.066 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' CYS . . . . . 0.496 ' HB2' ' HA ' ' A' ' 69' ' ' LYS . 0.5 OUTLIER -107.37 -27.13 10.65 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.069 -1.019 . . . . 0.0 109.548 179.827 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.424 ' O ' ' HB3' ' A' ' 74' ' ' CYS . . . 61.38 54.09 38.95 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.646 -1.381 . . . . 0.0 109.646 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.424 ' HB3' ' O ' ' A' ' 73' ' ' GLY . 27.0 p 177.66 125.33 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.283 -1.128 . . . . 0.0 109.49 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -114.06 82.27 0.31 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.479 ' O ' ' HB2' ' A' ' 77' ' ' ALA . . . -75.91 -52.88 6.08 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.774 -1.331 . . . . 0.0 109.774 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.479 ' HB2' ' O ' ' A' ' 76' ' ' GLY . . . 176.78 124.42 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.171 -1.194 . . . . 0.0 109.508 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.559 HG11 ' HB1' ' A' ' 65' ' ' ALA . 38.5 t -127.29 122.53 59.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.261 -0.9 . . . . 0.0 109.554 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -131.5 143.81 50.67 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.24 -0.912 . . . . 0.0 109.593 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.63 109.72 0.85 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.157 -0.964 . . . . 0.0 109.36 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 119.68 -38.39 2.81 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 87.8 t -140.26 133.13 33.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.329 -1.1 . . . . 0.0 109.412 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.414 HG12 HG13 ' A' ' 78' ' ' VAL . 12.1 mt -122.55 148.4 26.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.247 -0.908 . . . . 0.0 109.4 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.458 ' O ' HD13 ' A' ' 85' ' ' ILE . 6.9 tt0 -135.41 134.96 40.23 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.175 -0.953 . . . . 0.0 109.686 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.458 HD13 ' O ' ' A' ' 84' ' ' GLU . 27.8 mm -118.15 148.52 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.236 -0.915 . . . . 0.0 109.332 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -109.38 122.06 46.55 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.204 -0.935 . . . . 0.0 109.478 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 130.43 161.28 10.32 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -103.66 108.93 20.42 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.231 -1.159 . . . . 0.0 109.458 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 30.6 mttt -158.73 31.39 0.22 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.235 -0.916 . . . . 0.0 109.462 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.589 ' HA ' HD12 ' A' ' 93' ' ' LEU . 50.8 ttp180 -53.48 -27.78 27.09 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.249 -0.907 . . . . 0.0 109.485 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 50.0 t0 -60.05 -51.77 68.2 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.259 -0.901 . . . . 0.0 109.456 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.621 HD23 HD23 ' A' ' 96' ' ' LEU . 1.7 tt -70.75 -23.95 62.52 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.21 -0.931 . . . . 0.0 109.438 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.769 HD22 HG21 ' A' ' 36' ' ' ILE . 1.3 mt -63.51 -47.87 79.93 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.193 -0.942 . . . . 0.0 109.424 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.946 ' HD2' HD21 ' A' ' 106' ' ' LEU . 78.2 tttt -61.98 -23.07 66.17 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.244 -0.91 . . . . 0.0 109.451 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 6.6 t -76.56 -65.37 0.94 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.277 -0.889 . . . . 0.0 109.491 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.848 HD12 ' N ' ' A' ' 97' ' ' LEU . 2.9 pp -47.73 -36.04 10.74 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.256 -0.903 . . . . 0.0 109.419 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.848 ' N ' HD12 ' A' ' 96' ' ' LEU . 1.4 tp -69.52 -44.25 71.41 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.225 -0.922 . . . . 0.0 109.456 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 68.4 tt0 -61.21 -20.26 62.58 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.285 -0.884 . . . . 0.0 109.477 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -62.77 -32.28 73.4 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.229 -0.919 . . . . 0.0 109.476 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -84.36 -18.07 37.37 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.229 -0.919 . . . . 0.0 109.495 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 75.47 24.66 69.98 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 1.1 mtm -79.07 179.34 7.41 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.29 -1.124 . . . . 0.0 109.495 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.806 ' HB3' HG12 ' A' ' 33' ' ' VAL . 13.0 mttt -97.21 88.32 4.43 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.308 -0.87 . . . . 0.0 109.447 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.693 ' CG2' HD23 ' A' ' 97' ' ' LEU . 2.1 t -81.62 165.08 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.227 -0.92 . . . . 0.0 109.494 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.401 ' O ' ' C ' ' A' ' 106' ' ' LEU . 41.7 tttt -128.88 28.2 5.37 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.263 -0.898 . . . . 0.0 109.446 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.946 HD21 ' HD2' ' A' ' 94' ' ' LYS . 0.2 OUTLIER 44.24 -157.82 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.243 -0.911 . . . . 0.0 109.456 179.954 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.66 ' HB2' ' HA ' ' A' ' 37' ' ' GLN . . . . . . . . 0 N--CA 1.49 1.541 0 O-C-N 121.213 -0.929 . . . . 0.0 109.479 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.4 ' C ' ' CG2' ' A' ' 33' ' ' VAL . . . 163.2 128.12 0.93 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.4 ' CG2' ' C ' ' A' ' 32' ' ' GLY . 1.9 t -149.61 151.64 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.248 -1.149 . . . . 0.0 109.546 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.547 ' HB ' HD11 ' A' ' 97' ' ' LEU . 72.7 t -138.1 121.68 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.312 -0.867 . . . . 0.0 109.392 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.436 ' CG ' ' HA3' ' A' ' 53' ' ' GLY . 62.3 mtt180 -88.11 111.22 21.34 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.244 -0.91 . . . . 0.0 109.516 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.93 HD11 HD13 ' A' ' 97' ' ' LEU . 7.5 mt -115.66 108.51 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.263 -0.898 . . . . 0.0 109.408 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.758 ' HB3' ' HB3' ' A' ' 107' ' ' ALA . 3.4 pt20 -131.72 -160.12 1.02 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.21 -0.931 . . . . 0.0 109.548 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 11.9 ptm180 -130.79 132.09 45.06 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.297 -0.877 . . . . 0.0 109.447 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -125.81 77.47 1.67 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.254 -0.904 . . . . 0.0 109.484 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.576 0 O-C-N 121.3 -0.875 . . . . 0.0 109.472 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 93.3 mttt . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 176.96 144.52 5.31 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 16.0 m -135.02 159.05 41.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.275 -1.132 . . . . 0.0 109.373 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -111.9 110.02 20.13 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.247 -0.908 . . . . 0.0 109.531 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.899 HD12 ' HG3' ' A' ' 84' ' ' GLU . 8.5 tp -93.83 129.29 40.28 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.225 -0.922 . . . . 0.0 109.44 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.402 HG23 HD12 ' A' ' 51' ' ' ILE . 11.1 mm -120.91 114.74 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.295 -0.878 . . . . 0.0 109.439 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.444 ' O ' HG22 ' A' ' 52' ' ' THR . 8.6 m -141.6 13.28 2.13 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.307 -0.871 . . . . 0.0 109.496 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.436 ' HA3' ' CG ' ' A' ' 35' ' ' ARG . . . -97.41 19.02 56.37 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.579 -1.409 . . . . 0.0 109.579 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.639 HG11 ' HG ' ' A' ' 61' ' ' LEU . 60.0 t -82.95 105.65 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.267 -1.137 . . . . 0.0 109.452 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -100.19 87.73 3.52 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.187 -0.946 . . . . 0.0 109.522 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.594 HD12 ' CG1' ' A' ' 54' ' ' VAL . 19.2 mt -129.15 -169.23 2.05 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.269 -0.894 . . . . 0.0 109.403 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -81.87 -65.33 1.02 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.235 -0.916 . . . . 0.0 109.446 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.4 t0 179.76 -50.34 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.23 -0.918 . . . . 0.0 109.402 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.6 -34.71 65.18 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.24 -0.913 . . . . 0.0 109.437 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -70.2 -28.15 65.06 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.261 -0.899 . . . . 0.0 109.413 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.639 ' HG ' HG11 ' A' ' 54' ' ' VAL . 0.4 OUTLIER -66.55 -55.46 15.38 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.263 -0.898 . . . . 0.0 109.476 179.951 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.449 HG23 ' N ' ' A' ' 63' ' ' LYS . 8.2 t -59.81 -37.73 79.99 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.26 -0.9 . . . . 0.0 109.551 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.449 ' N ' HG23 ' A' ' 62' ' ' THR . 0.7 OUTLIER -57.74 -62.39 1.83 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.206 -0.934 . . . . 0.0 109.535 -179.947 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.5 tt -49.82 -48.43 50.81 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.258 -0.901 . . . . 0.0 109.612 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -50.08 -41.61 48.47 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.29 -0.881 . . . . 0.0 109.659 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.8 -34.92 76.34 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.213 -0.93 . . . . 0.0 109.657 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -67.18 -30.26 70.17 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.222 -0.924 . . . . 0.0 109.584 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -79.62 -33.93 41.06 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.293 -0.88 . . . . 0.0 109.454 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.476 ' HA ' ' HB3' ' A' ' 72' ' ' CYS . 6.8 ttpt -77.04 -9.58 58.81 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.267 -0.895 . . . . 0.0 109.377 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -68.51 -41.58 79.77 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.187 -0.946 . . . . 0.0 109.46 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 39.6 mttt -103.83 5.44 35.91 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.267 -0.896 . . . . 0.0 109.493 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' CYS . . . . . 0.476 ' HB3' ' HA ' ' A' ' 69' ' ' LYS . 31.9 t -81.4 -64.44 1.19 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.217 -0.927 . . . . 0.0 109.615 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 91.38 19.65 41.02 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.291 -1.524 . . . . 0.0 109.291 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 17.4 t -174.92 90.95 0.06 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.364 -1.08 . . . . 0.0 109.304 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -95.89 157.99 21.81 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -117.98 -87.57 1.21 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -134.07 127.99 33.33 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.187 -1.184 . . . . 0.0 109.288 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.701 HG22 HG23 ' A' ' 83' ' ' ILE . 84.0 t -128.03 82.64 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.152 -0.967 . . . . 0.0 109.682 -179.723 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 65.4 mttt -94.09 155.69 16.96 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.268 -0.895 . . . . 0.0 109.255 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -63.72 104.97 0.73 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.24 -0.912 . . . . 0.0 109.575 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 129.67 -26.32 4.32 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 90.9 t -149.79 151.9 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.207 -1.172 . . . . 0.0 109.726 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.701 HG23 HG22 ' A' ' 78' ' ' VAL . 15.8 mt -143.7 120.58 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.389 -0.819 . . . . 0.0 109.249 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.899 ' HG3' HD12 ' A' ' 50' ' ' LEU . 1.7 tt0 -112.56 130.28 56.07 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.219 -0.925 . . . . 0.0 109.638 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.402 HD13 ' HA ' ' A' ' 85' ' ' ILE . 25.7 mm -126.39 145.85 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.262 -0.899 . . . . 0.0 109.335 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.53 112.23 24.47 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.231 -0.918 . . . . 0.0 109.543 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -161.03 -40.07 0.02 OUTLIER Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 27.7 t70 53.36 60.83 3.46 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.314 -1.11 . . . . 0.0 109.478 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 16.8 mttt -152.15 65.98 0.84 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.288 -0.883 . . . . 0.0 109.466 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 4.1 ptt-85 -56.79 -28.92 62.15 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.218 -0.927 . . . . 0.0 109.478 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -55.28 -52.63 62.82 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.242 -0.911 . . . . 0.0 109.455 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.5 tt -70.02 -42.07 73.45 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.25 -0.906 . . . . 0.0 109.511 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.653 HD13 ' CG2' ' A' ' 36' ' ' ILE . 2.3 mt -54.28 -26.27 28.16 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.196 -0.94 . . . . 0.0 109.484 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -64.48 -64.33 0.91 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.259 -0.901 . . . . 0.0 109.412 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -63.51 -13.93 45.98 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.276 -0.89 . . . . 0.0 109.435 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.827 HD23 ' N ' ' A' ' 97' ' ' LEU . 4.1 tt -71.16 -56.9 5.13 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.287 -0.883 . . . . 0.0 109.429 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.956 HD22 HG22 ' A' ' 104' ' ' VAL . 0.2 OUTLIER -70.91 -30.54 66.91 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.306 -0.871 . . . . 0.0 109.437 -179.966 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -64.71 -18.09 64.7 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.261 -0.899 . . . . 0.0 109.458 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.95 -37.24 86.99 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.292 -0.88 . . . . 0.0 109.484 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 11.2 mtpp -82.63 -34.91 27.39 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.266 -0.896 . . . . 0.0 109.444 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 107.99 17.85 10.54 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 1.5 mtm -91.28 167.85 12.01 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.261 -1.141 . . . . 0.0 109.45 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.14 157.76 22.65 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.245 -0.91 . . . . 0.0 109.44 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.956 HG22 HD22 ' A' ' 97' ' ' LEU . 87.3 t -136.19 123.0 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.312 -0.867 . . . . 0.0 109.423 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.84 88.63 4.34 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.239 -0.913 . . . . 0.0 109.49 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.556 ' O ' ' HB3' ' A' ' 107' ' ' ALA . 30.9 mt -44.24 -36.11 2.57 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.339 -0.85 . . . . 0.0 109.465 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.758 ' HB3' ' HB3' ' A' ' 37' ' ' GLN . . . . . . . . 0 N--CA 1.49 1.54 0 O-C-N 121.248 -0.908 . . . . 0.0 109.455 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.581 ' CA ' HD21 ' A' ' 56' ' ' LEU . . . 76.92 117.58 0.16 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.976 HG13 ' O ' ' A' ' 103' ' ' LYS . 82.2 t -143.68 122.55 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.261 -1.14 . . . . 0.0 109.483 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.778 ' O ' HG23 ' A' ' 104' ' ' VAL . 44.5 t -101.77 135.17 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.257 -0.902 . . . . 0.0 109.462 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 13.4 ttt180 -102.89 123.35 46.36 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.231 -0.918 . . . . 0.0 109.521 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.772 HG21 HD13 ' A' ' 93' ' ' LEU . 4.0 mt -128.87 112.49 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.195 -0.94 . . . . 0.0 109.537 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.704 ' HB3' ' HB3' ' A' ' 107' ' ' ALA . 3.3 pm0 -136.3 110.9 8.61 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.277 -0.889 . . . . 0.0 109.49 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.412 ' O ' ' HG3' ' A' ' 38' ' ' ARG . 0.0 OUTLIER -69.83 109.64 4.54 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.277 -0.89 . . . . 0.0 109.433 -179.949 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -96.17 138.99 32.97 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.304 -0.872 . . . . 0.0 109.507 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 8.9 m . . . . . 0 N--CA 1.49 1.547 0 O-C-N 121.25 -0.906 . . . . 0.0 109.446 -179.989 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 12.5 tttt . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 169.26 139.53 2.74 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 16.0 m -146.71 151.16 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.201 -1.176 . . . . 0.0 109.475 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -111.04 126.01 54.36 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.302 -0.874 . . . . 0.0 109.444 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.2 mp -112.99 104.77 12.73 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.254 -0.904 . . . . 0.0 109.578 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.454 ' HB ' ' HB ' ' A' ' 83' ' ' ILE . 8.2 mm -82.83 119.67 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.251 -0.905 . . . . 0.0 109.39 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 9.8 t -159.93 169.59 23.17 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.211 -0.93 . . . . 0.0 109.5 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 84.33 24.13 48.56 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.559 ' HB ' HD21 ' A' ' 61' ' ' LEU . 3.3 t -91.59 126.68 44.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.25 -1.147 . . . . 0.0 109.495 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -113.55 78.73 1.17 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.271 -0.893 . . . . 0.0 109.43 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.581 HD21 ' CA ' ' A' ' 32' ' ' GLY . 84.7 mt -137.21 -170.44 2.72 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.244 -0.91 . . . . 0.0 109.429 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.491 ' HB3' ' HB2' ' A' ' 60' ' ' GLU . 6.7 t0 -57.92 151.42 18.26 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.257 -0.902 . . . . 0.0 109.484 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.87 -54.25 49.25 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.237 -0.914 . . . . 0.0 109.513 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.57 -21.76 62.65 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.191 -0.943 . . . . 0.0 109.604 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.491 ' HB2' ' HB3' ' A' ' 57' ' ' ASP . 19.0 tt0 -61.99 -41.74 98.38 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.201 -0.937 . . . . 0.0 109.597 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.559 HD21 ' HB ' ' A' ' 54' ' ' VAL . 1.8 mp -61.08 -56.7 17.82 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.225 -0.922 . . . . 0.0 109.579 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 86.6 m -47.87 -36.69 12.51 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.15 -0.969 . . . . 0.0 109.492 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.408 ' O ' ' C ' ' A' ' 64' ' ' LEU . 15.4 tttt -61.84 -64.76 0.84 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.265 -0.897 . . . . 0.0 109.437 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.421 HD23 HD23 ' A' ' 68' ' ' LEU . 0.5 OUTLIER -44.55 -41.51 6.53 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.281 -0.887 . . . . 0.0 109.751 -179.862 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -56.83 -59.09 5.55 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.242 -0.911 . . . . 0.0 109.702 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.3 -17.08 17.01 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.292 -0.88 . . . . 0.0 109.81 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -76.65 -44.16 35.13 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.162 -0.961 . . . . 0.0 110.042 -179.606 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.481 ' N ' HD22 ' A' ' 68' ' ' LEU . 4.4 mm? -79.58 -26.52 41.28 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.073 -1.017 . . . . 0.0 110.201 -179.413 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.1 ttmt -71.18 -5.84 34.92 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.056 -1.028 . . . . 0.0 109.593 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -60.22 -42.23 94.72 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.251 -0.905 . . . . 0.0 109.196 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.52 43.48 0.75 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.313 -0.867 . . . . 0.0 109.688 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -77.78 -28.35 50.48 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.345 -0.847 . . . . 0.0 108.944 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.488 ' O ' ' HB2' ' A' ' 74' ' ' CYS . . . 124.75 -27.98 5.31 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 108.839 -1.705 . . . . 0.0 108.839 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.488 ' HB2' ' O ' ' A' ' 73' ' ' GLY . 4.5 t 165.36 97.42 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.554 -0.968 . . . . 0.0 108.695 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -76.52 116.29 4.64 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.444 -1.463 . . . . 0.0 109.444 -179.696 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -63.4 -88.47 0.04 OUTLIER Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.496 -1.441 . . . . 0.0 109.496 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -133.09 160.6 36.71 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.341 -1.093 . . . . 0.0 109.559 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 39.5 t -132.0 140.75 47.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.277 -0.89 . . . . 0.0 109.413 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 48.5 mttt -148.18 141.68 25.38 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.287 -0.883 . . . . 0.0 109.414 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -60.71 91.49 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.153 -0.967 . . . . 0.0 109.516 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 134.93 -37.33 1.95 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 90.8 t -139.86 135.18 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.266 -1.138 . . . . 0.0 109.341 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.454 ' HB ' ' HB ' ' A' ' 51' ' ' ILE . 41.4 mt -130.99 133.92 62.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.227 -0.92 . . . . 0.0 109.612 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 -104.33 120.62 41.59 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.263 -0.898 . . . . 0.0 109.43 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.438 HD13 ' HA ' ' A' ' 85' ' ' ILE . 20.4 mm -122.44 91.4 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.209 -0.932 . . . . 0.0 109.46 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -55.2 129.99 40.4 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.211 -0.931 . . . . 0.0 109.505 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 161.74 -155.16 26.32 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -177.79 70.38 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.203 -1.175 . . . . 0.0 109.475 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 55.1 mttt -143.51 49.44 1.41 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.276 -0.89 . . . . 0.0 109.537 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -48.44 -28.76 3.48 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.27 -0.894 . . . . 0.0 109.426 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -60.77 -55.16 36.48 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.196 -0.94 . . . . 0.0 109.433 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.506 HD23 HD23 ' A' ' 96' ' ' LEU . 2.7 tt -64.49 -29.2 70.24 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.24 -0.913 . . . . 0.0 109.477 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.772 HD13 HG21 ' A' ' 36' ' ' ILE . 0.3 OUTLIER -61.86 -44.04 97.64 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.21 -0.931 . . . . 0.0 109.474 -179.979 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -63.21 -30.31 71.48 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.291 -0.881 . . . . 0.0 109.438 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.404 ' O ' ' C ' ' A' ' 96' ' ' LEU . 46.8 t -70.32 -68.95 0.39 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.284 -0.885 . . . . 0.0 109.469 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.719 HD12 ' N ' ' A' ' 97' ' ' LEU . 3.8 pp -45.42 -35.39 3.67 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.224 -0.923 . . . . 0.0 109.493 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.719 ' N ' HD12 ' A' ' 96' ' ' LEU . 2.5 tt -62.54 -52.67 62.51 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.292 -0.88 . . . . 0.0 109.431 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -62.25 -17.52 58.66 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.248 -0.908 . . . . 0.0 109.441 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.488 ' HB3' ' O ' ' A' ' 96' ' ' LEU . . . -62.18 -37.2 84.38 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.303 -0.873 . . . . 0.0 109.466 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -84.23 -23.47 30.43 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.196 -0.94 . . . . 0.0 109.477 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 93.58 14.8 52.31 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' MET . . . . . 0.606 ' CE ' HG23 ' A' ' 34' ' ' VAL . 2.6 mtm -85.42 152.79 22.96 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.194 -1.18 . . . . 0.0 109.49 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.976 ' O ' HG13 ' A' ' 33' ' ' VAL . 16.2 mttt -81.31 149.35 28.97 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.264 -0.898 . . . . 0.0 109.436 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.778 HG23 ' O ' ' A' ' 34' ' ' VAL . 12.9 p -136.87 153.59 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.259 -0.901 . . . . 0.0 109.454 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 69.6 mttt -120.93 85.83 2.47 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.248 -0.907 . . . . 0.0 109.431 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -50.52 101.33 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.263 -0.898 . . . . 0.0 109.521 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.704 ' HB3' ' HB3' ' A' ' 37' ' ' GLN . . . . . . . . 0 N--CA 1.49 1.546 0 O-C-N 121.236 -0.915 . . . . 0.0 109.493 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 121.274 0.559 . . . . 0.0 109.515 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.444 ' O ' HG13 ' A' ' 33' ' ' VAL . . . -117.09 133.43 10.62 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.444 HG13 ' O ' ' A' ' 32' ' ' GLY . 5.8 m -154.43 145.48 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.217 -1.166 . . . . 0.0 109.493 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.518 HG13 HG22 ' A' ' 54' ' ' VAL . 45.0 t -127.73 147.36 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.286 -0.884 . . . . 0.0 109.436 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.481 ' HB2' ' HA3' ' A' ' 53' ' ' GLY . 3.2 ttm180 -103.18 99.56 9.43 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.224 -0.922 . . . . 0.0 109.487 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.8 ' CG2' HD13 ' A' ' 93' ' ' LEU . 11.0 mt -104.87 107.58 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.236 -0.915 . . . . 0.0 109.457 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.923 ' HB3' ' HB3' ' A' ' 107' ' ' ALA . 1.5 pt20 -137.64 138.44 39.47 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.255 -0.903 . . . . 0.0 109.47 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 10.1 ptt85 -92.63 127.63 38.2 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.232 -0.917 . . . . 0.0 109.532 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -115.06 81.88 1.65 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.266 -0.896 . . . . 0.0 109.384 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 4.2 p . . . . . 0 N--CA 1.49 1.559 0 O-C-N 121.215 -0.928 . . . . 0.0 109.504 -179.955 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 12.7 tttt . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -103.29 130.35 10.21 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 35.2 m -144.09 154.08 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.312 -1.111 . . . . 0.0 109.459 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -125.65 125.31 42.89 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.166 -0.959 . . . . 0.0 109.54 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.5 mp -106.29 111.07 23.51 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.253 -0.904 . . . . 0.0 109.485 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.458 ' HB ' ' HB ' ' A' ' 83' ' ' ILE . 5.4 mm -98.64 117.76 44.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.233 -0.917 . . . . 0.0 109.481 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.0 m -154.82 25.89 0.44 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.207 -0.933 . . . . 0.0 109.491 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.481 ' HA3' ' HB2' ' A' ' 35' ' ' ARG . . . -119.68 28.51 6.43 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.758 ' HB ' HD21 ' A' ' 61' ' ' LEU . 17.5 t -88.28 127.83 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.224 -1.162 . . . . 0.0 109.462 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -115.95 82.71 1.82 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.262 -0.899 . . . . 0.0 109.442 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.6 mt -146.21 -172.65 3.98 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.247 -0.908 . . . . 0.0 109.465 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.464 ' HB2' ' HB2' ' A' ' 60' ' ' GLU . 2.9 m-20 -59.37 167.04 2.02 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.265 -0.897 . . . . 0.0 109.396 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -76.16 -50.58 14.2 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.251 -0.906 . . . . 0.0 109.329 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.24 -27.9 65.86 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.294 -0.879 . . . . 0.0 109.301 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.464 ' HB2' ' HB2' ' A' ' 57' ' ' ASP . 18.3 tt0 -70.47 -37.07 74.21 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.274 -0.891 . . . . 0.0 109.391 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.758 HD21 ' HB ' ' A' ' 54' ' ' VAL . 0.0 OUTLIER -66.27 -35.41 80.33 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.301 -0.874 . . . . 0.0 109.49 179.957 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.5 m -66.85 -31.05 71.41 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.294 -0.879 . . . . 0.0 109.583 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 43.8 mttt -72.5 -49.31 33.93 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.274 -0.891 . . . . 0.0 109.616 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.441 HD11 ' HE2' ' A' ' 100' ' ' LYS . 1.4 tp -55.24 -48.34 74.11 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.244 -0.91 . . . . 0.0 109.419 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.828 ' HA ' HD12 ' A' ' 68' ' ' LEU . . . -61.74 -36.13 80.1 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.309 -0.869 . . . . 0.0 109.394 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.08 -47.44 85.89 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.274 -0.891 . . . . 0.0 109.528 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -72.24 -19.77 61.65 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.215 -0.928 . . . . 0.0 109.545 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.828 HD12 ' HA ' ' A' ' 65' ' ' ALA . 7.1 mt -70.29 -63.88 1.0 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.201 -0.937 . . . . 0.0 109.12 179.563 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.31 -12.0 12.04 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.457 -0.777 . . . . 0.0 109.631 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.5 -50.79 62.09 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.15 -0.969 . . . . 0.0 109.369 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -111.36 31.43 6.11 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.195 -0.941 . . . . 0.0 109.724 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 42.5 t -96.7 -12.31 23.96 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.106 -0.996 . . . . 0.0 109.657 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 90.51 -32.96 4.77 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 9.9 t 179.15 112.07 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.981 -1.305 . . . . 0.0 109.537 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -91.77 -150.15 25.1 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 110.034 -1.227 . . . . 0.0 110.034 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -157.94 -83.3 0.04 OUTLIER Glycine 0 N--CA 1.493 2.456 0 O-C-N 121.228 -1.16 . . . . 0.0 110.257 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -113.9 118.0 32.96 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.06 -1.259 . . . . 0.0 109.851 -179.48 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 97.7 t -109.69 120.35 60.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.256 -0.903 . . . . 0.0 109.731 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.6 mtmt -154.16 149.96 27.61 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.299 -0.876 . . . . 0.0 109.239 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -70.58 97.03 1.26 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.156 -0.965 . . . . 0.0 109.523 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.501 ' O ' HG23 ' A' ' 82' ' ' VAL . . . 125.52 -11.42 7.54 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.501 HG23 ' O ' ' A' ' 81' ' ' GLY . 57.3 t -156.88 108.33 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.055 -1.262 . . . . 0.0 109.413 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.458 ' HB ' ' HB ' ' A' ' 51' ' ' ILE . 4.1 mt -118.74 104.85 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.208 -0.932 . . . . 0.0 109.52 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -92.92 112.28 24.18 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.295 -0.878 . . . . 0.0 109.615 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 49.5 mm -99.07 89.95 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.229 -0.919 . . . . 0.0 109.29 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -60.13 104.69 0.33 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.224 -0.922 . . . . 0.0 109.548 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 156.57 152.27 6.23 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -112.05 96.83 6.27 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.288 -1.124 . . . . 0.0 109.515 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 16.2 mttt -141.3 48.37 1.67 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.296 -0.878 . . . . 0.0 109.5 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.947 ' HA ' HD12 ' A' ' 93' ' ' LEU . 39.2 ptt180 -49.38 -32.01 10.67 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.231 -0.918 . . . . 0.0 109.659 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.425 ' N ' ' HG3' ' A' ' 90' ' ' ARG . 67.8 t0 -62.21 -60.39 3.65 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.228 -0.92 . . . . 0.0 109.572 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.1 tp -59.25 -22.67 61.47 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.167 -0.958 . . . . 0.0 109.351 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.947 HD12 ' HA ' ' A' ' 90' ' ' ARG . 35.4 mt -69.11 -46.29 68.07 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.312 -0.868 . . . . 0.0 109.471 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 77.0 tttt -61.73 -25.76 67.64 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.196 -0.94 . . . . 0.0 109.46 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 8.7 t -76.05 -61.05 2.07 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.229 -0.919 . . . . 0.0 109.564 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.902 HD12 ' N ' ' A' ' 97' ' ' LEU . 4.2 pp -52.91 -29.72 30.13 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.246 -0.909 . . . . 0.0 109.537 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.902 ' N ' HD12 ' A' ' 96' ' ' LEU . 0.2 OUTLIER -72.34 -48.55 41.08 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.22 -0.925 . . . . 0.0 109.491 -179.955 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -68.74 -12.74 61.81 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.244 -0.91 . . . . 0.0 109.465 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -61.97 -33.11 73.7 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.226 -0.921 . . . . 0.0 109.469 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.441 ' HE2' HD11 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -85.73 -22.04 27.97 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.22 -0.925 . . . . 0.0 109.491 179.986 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 77.89 24.6 64.1 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -99.09 -158.88 0.7 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.255 -1.144 . . . . 0.0 109.479 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 23.3 mttt -104.06 165.06 11.29 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.206 -0.934 . . . . 0.0 109.492 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.418 HG22 ' N ' ' A' ' 105' ' ' LYS . 11.4 p -145.03 158.25 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.24 -0.912 . . . . 0.0 109.458 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.422 ' O ' ' N ' ' A' ' 107' ' ' ALA . 33.9 tttt -119.61 68.47 0.82 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.262 -0.899 . . . . 0.0 109.471 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -50.39 96.61 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.212 -0.93 . . . . 0.0 109.478 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.923 ' HB3' ' HB3' ' A' ' 37' ' ' GLN . . . . . . . . 0 N--CA 1.49 1.568 0 O-C-N 121.325 -0.86 . . . . 0.0 109.509 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 125.61 59.67 0.16 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.474 HG22 ' HB2' ' A' ' 103' ' ' LYS . 73.3 t -108.89 111.29 35.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.263 -1.139 . . . . 0.0 109.423 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.913 HG13 HG22 ' A' ' 54' ' ' VAL . 39.8 t -87.65 145.13 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.275 -0.891 . . . . 0.0 109.522 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 31.9 ttm180 -111.55 103.53 11.86 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.228 -0.92 . . . . 0.0 109.437 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.976 HD11 HD23 ' A' ' 97' ' ' LEU . 4.7 mt -102.07 106.22 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.196 -0.94 . . . . 0.0 109.538 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.872 ' HB3' ' HB3' ' A' ' 107' ' ' ALA . 1.7 pp0? -142.66 136.58 29.22 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.227 -0.921 . . . . 0.0 109.412 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.65 167.03 11.37 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.235 -0.915 . . . . 0.0 109.501 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -150.17 154.29 37.75 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.243 -0.91 . . . . 0.0 109.467 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.555 0 O-C-N 121.298 -0.876 . . . . 0.0 109.468 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 90.7 mttt . . . . . 0 N--CA 1.489 1.513 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.62 85.85 0.65 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 27.7 m -123.69 168.33 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.242 -1.152 . . . . 0.0 109.452 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 2.1 t -140.72 132.51 27.43 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.223 -0.923 . . . . 0.0 109.429 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.668 ' O ' HD13 ' A' ' 51' ' ' ILE . 0.2 OUTLIER -124.09 154.56 39.78 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.265 -0.897 . . . . 0.0 109.449 -179.979 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.697 ' HB ' HD12 ' A' ' 83' ' ' ILE . 4.5 mm -122.15 117.83 53.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.246 -0.909 . . . . 0.0 109.463 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.1 m -141.84 14.01 2.1 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.261 -0.9 . . . . 0.0 109.525 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.442 ' O ' ' N ' ' A' ' 55' ' ' ASP . . . -105.5 -16.69 15.27 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.913 HG22 HG13 ' A' ' 34' ' ' VAL . 18.6 t -44.93 98.9 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.214 -1.168 . . . . 0.0 109.494 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.442 ' N ' ' O ' ' A' ' 53' ' ' GLY . 41.0 t0 -87.34 88.28 7.64 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.201 -0.937 . . . . 0.0 109.459 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.495 HD23 ' HA ' ' A' ' 56' ' ' LEU . 12.9 mt -151.42 -169.95 3.52 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.281 -0.887 . . . . 0.0 109.487 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -74.76 178.49 5.43 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.259 -0.901 . . . . 0.0 109.441 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.53 -30.31 46.95 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.286 -0.884 . . . . 0.0 109.444 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -75.79 -48.66 20.77 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.213 -0.929 . . . . 0.0 109.464 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -62.06 -32.16 72.66 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.276 -0.89 . . . . 0.0 109.466 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.525 HD23 ' HA2' ' A' ' 81' ' ' GLY . 0.2 OUTLIER -65.36 -45.83 82.55 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.225 -0.922 . . . . 0.0 109.435 -179.994 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 51.5 p -63.78 -33.88 76.65 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.218 -0.926 . . . . 0.0 109.47 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 32.6 mttp -65.65 -46.73 78.06 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.29 -0.882 . . . . 0.0 109.469 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.29 -57.65 12.08 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.339 -0.851 . . . . 0.0 109.527 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.789 ' HA ' HD12 ' A' ' 68' ' ' LEU . . . -58.55 -23.63 58.87 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.273 -0.892 . . . . 0.0 109.534 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -69.72 -41.49 75.26 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.241 -0.912 . . . . 0.0 109.582 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -76.99 -29.21 55.4 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.203 -0.936 . . . . 0.0 109.566 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.789 HD12 ' HA ' ' A' ' 65' ' ' ALA . 9.8 mt -67.7 -52.22 40.32 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.242 -0.911 . . . . 0.0 109.47 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.414 ' HB3' ' HA3' ' A' ' 76' ' ' GLY . 0.0 OUTLIER -66.46 -12.55 57.85 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.295 -0.878 . . . . 0.0 109.504 -179.929 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -74.97 -42.11 58.26 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.197 -0.939 . . . . 0.0 109.507 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 5.7 tttp -67.1 -19.86 65.7 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.304 -0.873 . . . . 0.0 109.654 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 43.7 t -88.14 -43.52 11.59 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.193 -0.942 . . . . 0.0 109.552 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.403 ' O ' ' HB2' ' A' ' 74' ' ' CYS . . . 100.62 -19.87 50.63 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.403 ' HB2' ' O ' ' A' ' 73' ' ' GLY . 0.1 OUTLIER 172.08 134.97 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.169 -1.195 . . . . 0.0 109.532 -179.981 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 126.73 -34.45 3.15 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.414 ' HA3' ' HB3' ' A' ' 69' ' ' LYS . . . -69.31 98.76 0.59 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -108.9 134.52 51.46 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.305 -1.114 . . . . 0.0 109.17 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.455 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 26.8 m -101.02 160.49 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.269 -0.894 . . . . 0.0 109.817 -179.617 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.443 ' HB2' ' O ' ' A' ' 82' ' ' VAL . 0.2 OUTLIER -142.05 65.82 1.36 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.362 -0.836 . . . . 0.0 109.208 179.747 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 25.4 t70 50.76 68.7 0.73 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.362 -0.836 . . . . 0.0 109.545 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.525 ' HA2' HD23 ' A' ' 61' ' ' LEU . . . 90.3 -28.57 7.32 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.443 ' O ' ' HB2' ' A' ' 79' ' ' LYS . 40.2 t -91.59 90.74 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.161 -1.199 . . . . 0.0 109.559 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.697 HD12 ' HB ' ' A' ' 51' ' ' ILE . 11.7 mt -82.04 155.86 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.276 -0.89 . . . . 0.0 109.437 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -149.56 113.33 5.07 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.2 -0.937 . . . . 0.0 109.436 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.403 HG12 ' HA2' ' A' ' 76' ' ' GLY . 23.8 mt -130.9 107.62 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.215 -0.928 . . . . 0.0 109.511 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -53.74 148.52 9.84 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.235 -0.916 . . . . 0.0 109.397 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 143.55 152.84 5.73 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -133.91 84.14 2.1 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.252 -1.146 . . . . 0.0 109.429 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 84.7 mttt -148.21 52.22 1.02 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.282 -0.886 . . . . 0.0 109.478 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 11.8 ptt-85 -46.58 -31.95 3.13 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.25 -0.906 . . . . 0.0 109.472 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -55.78 -55.21 35.03 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.236 -0.915 . . . . 0.0 109.465 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.556 HD23 ' C ' ' A' ' 92' ' ' LEU . 8.2 tt -63.16 -49.32 74.77 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.176 -0.952 . . . . 0.0 109.491 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.649 ' HB3' HG21 ' A' ' 36' ' ' ILE . 3.7 mm? -47.87 -31.04 4.61 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.229 -0.919 . . . . 0.0 109.481 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 34.4 tttt -60.63 -62.77 1.62 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.241 -0.912 . . . . 0.0 109.53 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.57 -16.83 58.28 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.247 -0.908 . . . . 0.0 109.495 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.587 ' C ' HD23 ' A' ' 96' ' ' LEU . 5.4 tt -72.62 -43.92 62.64 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.287 -0.883 . . . . 0.0 109.513 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.976 HD23 HD11 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -74.1 -38.41 63.86 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.287 -0.883 . . . . 0.0 109.484 179.959 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -69.73 -20.9 63.51 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.281 -0.887 . . . . 0.0 109.475 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -55.62 -29.93 60.03 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.262 -0.899 . . . . 0.0 109.497 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.43 -25.37 21.54 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.281 -0.887 . . . . 0.0 109.492 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 95.26 28.44 9.81 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 31.4 mtm -109.5 179.93 4.0 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.226 -1.161 . . . . 0.0 109.471 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.474 ' HB2' HG22 ' A' ' 33' ' ' VAL . 8.7 mmtt -88.85 162.16 16.31 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.259 -0.901 . . . . 0.0 109.456 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.463 ' CG2' HD12 ' A' ' 36' ' ' ILE . 3.2 p -154.39 135.79 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.218 -0.926 . . . . 0.0 109.464 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 12.5 mttt -108.56 104.41 13.72 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.253 -0.904 . . . . 0.0 109.464 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.442 ' O ' ' HB3' ' A' ' 37' ' ' GLN . 1.1 tp -47.86 -24.45 1.01 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.25 -0.906 . . . . 0.0 109.453 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.872 ' HB3' ' HB3' ' A' ' 37' ' ' GLN . . . . . . . . 0 N--CA 1.489 1.511 0 O-C-N 121.215 -0.928 . . . . 0.0 109.475 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 19.0 t70 . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.429 ' HA3' ' SD ' ' A' ' 102' ' ' MET . . . 112.61 125.9 4.53 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.624 HG13 ' O ' ' A' ' 103' ' ' LYS . 93.7 t -143.16 93.95 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.252 -1.146 . . . . 0.0 109.478 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.933 ' O ' HG23 ' A' ' 104' ' ' VAL . 70.5 t -93.23 109.46 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.289 -0.882 . . . . 0.0 109.454 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.522 ' O ' HG23 ' A' ' 51' ' ' ILE . 71.9 mtt180 -92.34 131.8 37.24 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.24 -0.913 . . . . 0.0 109.545 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.744 HG21 HD22 ' A' ' 93' ' ' LEU . 7.0 mt -125.55 127.22 71.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.219 -0.926 . . . . 0.0 109.421 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.673 ' HA ' ' HB2' ' A' ' 107' ' ' ALA . 1.7 pt20 -151.03 -167.89 2.94 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.176 -0.953 . . . . 0.0 109.526 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.419 ' O ' ' HG3' ' A' ' 38' ' ' ARG . 5.4 ptt180 -137.11 118.8 14.99 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.229 -0.919 . . . . 0.0 109.504 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.513 ' OE1' HD13 ' A' ' 50' ' ' LEU . 8.6 tt0 -91.36 118.63 30.69 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.183 -0.948 . . . . 0.0 109.442 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 29.0 p . . . . . 0 N--CA 1.49 1.533 0 O-C-N 121.263 -0.898 . . . . 0.0 109.428 179.922 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 51.9 mttt . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -141.93 -163.93 9.83 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.586 -1.405 . . . . 0.0 109.586 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 22.9 m -154.58 146.11 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.269 -1.136 . . . . 0.0 109.521 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -90.04 131.27 36.01 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.288 -0.883 . . . . 0.0 109.435 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.513 HD13 ' OE1' ' A' ' 39' ' ' GLN . 0.0 OUTLIER -118.1 115.86 25.68 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.255 -0.903 . . . . 0.0 109.46 -179.917 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.522 HG23 ' O ' ' A' ' 35' ' ' ARG . 8.1 mt -120.37 110.5 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.212 -0.93 . . . . 0.0 109.458 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 9.8 t -142.95 162.89 34.27 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.238 -0.914 . . . . 0.0 109.637 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.49 22.24 13.09 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.611 -1.395 . . . . 0.0 109.611 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.577 ' HB ' HD21 ' A' ' 61' ' ' LEU . 61.7 t -78.41 112.71 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.22 -1.165 . . . . 0.0 109.443 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -97.15 70.48 2.37 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.294 -0.879 . . . . 0.0 109.541 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.549 HD22 ' OE2' ' A' ' 60' ' ' GLU . 10.3 mt -136.87 172.7 12.62 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.167 -0.958 . . . . 0.0 109.524 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -47.75 170.71 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.218 -0.926 . . . . 0.0 109.45 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -76.55 -39.8 51.73 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.232 -0.917 . . . . 0.0 109.468 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.09 -31.01 72.04 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.243 -0.91 . . . . 0.0 109.496 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.549 ' OE2' HD22 ' A' ' 56' ' ' LEU . 2.9 mt-10 -62.03 -45.92 91.47 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.269 -0.894 . . . . 0.0 109.543 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.577 HD21 ' HB ' ' A' ' 54' ' ' VAL . 8.4 mt -53.04 -42.69 65.98 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.249 -0.907 . . . . 0.0 109.472 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 52.2 m -71.9 -26.28 62.26 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.264 -0.898 . . . . 0.0 109.425 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.2 tttt -63.49 -59.91 4.04 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.256 -0.902 . . . . 0.0 109.393 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.9 mt -64.7 -31.55 72.82 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.281 -0.887 . . . . 0.0 109.538 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.506 ' HB1' ' CG2' ' A' ' 78' ' ' VAL . . . -57.5 -49.63 75.68 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.272 -0.892 . . . . 0.0 109.662 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -71.81 -28.04 63.33 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.244 -0.91 . . . . 0.0 109.628 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -64.45 -33.08 75.05 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.219 -0.926 . . . . 0.0 109.907 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 6.0 mt -88.04 -34.52 17.96 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.102 -0.999 . . . . 0.0 109.921 -179.669 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.8 mttt -63.24 -16.9 61.66 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.139 -0.975 . . . . 0.0 109.778 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 13.5 tttt -75.28 -28.15 59.67 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.18 -0.95 . . . . 0.0 109.707 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 7.2 mtpp -72.42 -67.84 0.52 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.169 -0.957 . . . . 0.0 109.243 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -64.63 -56.72 12.03 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.19 -0.944 . . . . 0.0 109.195 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.482 ' O ' ' HB2' ' A' ' 74' ' ' CYS . . . 84.31 12.88 75.07 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.482 ' HB2' ' O ' ' A' ' 73' ' ' GLY . 4.7 t 166.46 126.73 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.478 -1.013 . . . . 0.0 108.994 -179.733 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 113.86 -5.95 24.02 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -110.08 125.63 7.61 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.194 -1.563 . . . . 0.0 109.194 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -110.15 121.41 45.21 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.169 -1.194 . . . . 0.0 109.939 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.506 ' CG2' ' HB1' ' A' ' 65' ' ' ALA . 36.9 t -86.92 124.34 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.276 -0.89 . . . . 0.0 109.122 179.534 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -120.41 145.7 46.94 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.209 -0.932 . . . . 0.0 109.201 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.0 101.17 1.08 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.289 -0.882 . . . . 0.0 109.493 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 103.53 -11.53 54.03 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 65.0 t -142.85 121.29 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.323 -1.104 . . . . 0.0 109.426 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 26.8 mm -104.3 121.18 55.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.226 -0.921 . . . . 0.0 109.589 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -105.68 120.33 41.41 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.315 -0.866 . . . . 0.0 109.401 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.494 HG13 HD12 ' A' ' 51' ' ' ILE . 14.8 mm -117.6 164.4 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.176 -0.952 . . . . 0.0 109.517 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.478 ' N ' HG22 ' A' ' 85' ' ' ILE . 5.4 mt-30 -124.69 132.89 53.36 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.311 -0.868 . . . . 0.0 109.583 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 136.87 168.31 11.37 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -135.62 82.11 1.93 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.29 -1.124 . . . . 0.0 109.559 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 43.7 mttt -142.88 51.68 1.41 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.217 -0.927 . . . . 0.0 109.478 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.64 -25.95 0.81 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.24 -0.912 . . . . 0.0 109.447 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -64.85 -58.33 6.47 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.244 -0.91 . . . . 0.0 109.373 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.0 tt -58.13 -49.08 78.24 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.245 -0.909 . . . . 0.0 109.308 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.744 HD22 HG21 ' A' ' 36' ' ' ILE . 3.4 mt -52.1 -33.63 40.53 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.278 -0.889 . . . . 0.0 109.408 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.594 ' CG ' HD11 ' A' ' 106' ' ' LEU . 0.1 OUTLIER -60.53 -58.49 8.25 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.292 -0.88 . . . . 0.0 109.388 179.923 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 3.2 t -65.79 -11.76 48.63 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.213 -0.929 . . . . 0.0 109.447 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.609 HD23 ' N ' ' A' ' 97' ' ' LEU . 3.1 tt -74.9 -59.2 2.84 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.24 -0.913 . . . . 0.0 109.423 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.683 HD23 HD11 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -69.56 -23.29 63.54 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.286 -0.883 . . . . 0.0 109.49 179.975 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -73.39 -26.46 61.0 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.282 -0.886 . . . . 0.0 109.516 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -71.03 -22.26 62.17 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.252 -0.905 . . . . 0.0 109.489 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 4.0 mtmt -94.29 8.0 43.37 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.231 -0.918 . . . . 0.0 109.508 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 46.32 33.29 5.65 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' MET . . . . . 0.519 ' HB2' ' CD1' ' A' ' 97' ' ' LEU . 0.1 OUTLIER -86.93 -173.43 4.46 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.268 -1.137 . . . . 0.0 109.471 -179.993 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.624 ' O ' HG13 ' A' ' 33' ' ' VAL . 16.8 mttt -101.16 72.06 1.43 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.262 -0.899 . . . . 0.0 109.459 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.933 HG23 ' O ' ' A' ' 34' ' ' VAL . 8.3 p -88.68 145.69 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.232 -0.918 . . . . 0.0 109.532 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.403 ' O ' ' C ' ' A' ' 106' ' ' LEU . 21.5 tttt -110.79 30.27 7.0 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.277 -0.889 . . . . 0.0 109.446 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.594 HD11 ' CG ' ' A' ' 94' ' ' LYS . 3.5 tp 44.6 -154.28 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.251 -0.905 . . . . 0.0 109.487 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.673 ' HB2' ' HA ' ' A' ' 37' ' ' GLN . . . . . . . . 0 N--CA 1.49 1.545 0 O-C-N 121.221 -0.924 . . . . 0.0 109.463 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 16.1 t0 . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 121.252 0.549 . . . . 0.0 109.531 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -160.33 148.1 15.95 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.504 HG12 ' HB2' ' A' ' 103' ' ' LYS . 34.8 m -131.68 145.41 35.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.271 -1.135 . . . . 0.0 109.491 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.576 HG11 HD21 ' A' ' 97' ' ' LEU . 5.4 t -111.28 164.71 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.23 -0.919 . . . . 0.0 109.442 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.424 ' N ' HG12 ' A' ' 34' ' ' VAL . 0.1 OUTLIER -141.57 112.24 7.14 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.237 -0.915 . . . . 0.0 109.444 -179.985 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.715 HG21 HD13 ' A' ' 93' ' ' LEU . 4.5 mt -125.78 117.1 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.259 -0.901 . . . . 0.0 109.483 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.71 98.16 2.93 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.303 -0.873 . . . . 0.0 109.449 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.2 ptt180 -56.38 125.68 23.04 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.284 -0.885 . . . . 0.0 109.515 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -110.78 79.14 1.17 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.208 -0.932 . . . . 0.0 109.494 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 33.7 p . . . . . 0 N--CA 1.49 1.552 0 O-C-N 121.209 -0.932 . . . . 0.0 109.476 -179.96 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 10.8 tttt . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -144.75 152.58 24.54 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 34.5 m -106.01 167.88 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.233 -1.157 . . . . 0.0 109.428 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -128.88 113.1 14.83 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.187 -0.946 . . . . 0.0 109.477 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.783 ' O ' HD13 ' A' ' 51' ' ' ILE . 0.8 OUTLIER -89.04 143.78 26.61 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.198 -0.939 . . . . 0.0 109.528 179.955 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.783 HD13 ' O ' ' A' ' 50' ' ' LEU . 6.4 mm -127.33 108.32 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.207 -0.933 . . . . 0.0 109.414 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.403 ' HB ' HG12 ' A' ' 82' ' ' VAL . 0.0 OUTLIER -155.14 154.58 32.55 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.274 -0.891 . . . . 0.0 109.494 179.995 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 115.5 -28.72 7.67 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.452 HG12 HD23 ' A' ' 56' ' ' LEU . 24.2 t -45.76 109.84 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.311 -1.111 . . . . 0.0 109.457 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -90.73 75.89 6.49 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.284 -0.885 . . . . 0.0 109.466 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.486 ' HA ' HD13 ' A' ' 56' ' ' LEU . 1.4 mm? -114.12 -171.5 1.92 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.259 -0.9 . . . . 0.0 109.485 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -72.5 -69.72 0.39 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.258 -0.901 . . . . 0.0 109.473 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -178.93 -43.03 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.256 -0.903 . . . . 0.0 109.465 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.92 -30.58 56.18 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.247 -0.908 . . . . 0.0 109.525 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -59.1 -45.48 90.75 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.223 -0.923 . . . . 0.0 109.523 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.566 HD23 HD11 ' A' ' 83' ' ' ILE . 0.1 OUTLIER -50.89 -52.8 38.35 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.238 -0.914 . . . . 0.0 109.42 179.988 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 34.0 p -57.57 -40.66 79.46 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.304 -0.872 . . . . 0.0 109.405 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 7.7 tttt -54.57 -45.04 73.44 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.3 -0.875 . . . . 0.0 109.536 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.472 ' HA ' HD22 ' A' ' 64' ' ' LEU . 0.1 OUTLIER -64.0 -46.01 86.44 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.24 -0.912 . . . . 0.0 109.509 -179.945 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -49.72 -43.83 47.9 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.199 -0.938 . . . . 0.0 109.548 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -69.37 -35.96 76.35 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.272 -0.892 . . . . 0.0 109.577 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -65.44 -21.61 66.67 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.211 -0.931 . . . . 0.0 109.627 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 5.4 mt -87.25 -44.4 11.47 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.305 -0.872 . . . . 0.0 109.673 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.446 ' O ' ' HG2' ' A' ' 69' ' ' LYS . 10.0 tttt -64.59 -22.7 67.04 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.259 -0.901 . . . . 0.0 109.801 -179.686 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.24 -15.52 47.58 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.178 -0.951 . . . . 0.0 110.004 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.8 23.87 1.09 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.057 -1.027 . . . . 0.0 109.656 -179.589 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -105.39 -24.56 12.63 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.303 -0.873 . . . . 0.0 109.551 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.43 ' O ' ' SG ' ' A' ' 74' ' ' CYS . . . 94.03 -10.74 71.65 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 -179.621 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.43 ' SG ' ' O ' ' A' ' 73' ' ' GLY . 0.7 OUTLIER 174.07 134.86 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.325 -1.103 . . . . 0.0 109.281 179.983 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -72.66 -80.49 0.41 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 120.66 -109.34 1.54 Allowed Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -106.0 131.39 53.35 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.153 -1.204 . . . . 0.0 109.417 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 90.4 t -136.33 97.37 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.23 -0.919 . . . . 0.0 109.83 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.2 146.71 27.59 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.194 -0.941 . . . . 0.0 108.761 179.321 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -63.27 94.43 0.08 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.112 -0.992 . . . . 0.0 109.609 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 129.88 -25.95 4.33 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.433 ' O ' HG13 ' A' ' 83' ' ' ILE . 1.6 m -143.59 157.79 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.182 -1.187 . . . . 0.0 109.673 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.566 HD11 HD23 ' A' ' 61' ' ' LEU . 4.2 mp -143.71 146.74 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.223 -0.923 . . . . 0.0 109.467 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -130.28 125.96 36.08 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.238 -0.914 . . . . 0.0 109.423 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.432 HG22 ' N ' ' A' ' 86' ' ' GLN . 28.1 mm -114.69 157.18 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.215 -0.928 . . . . 0.0 109.5 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.432 ' N ' HG22 ' A' ' 85' ' ' ILE . 0.0 OUTLIER -115.9 86.02 2.4 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.206 -0.934 . . . . 0.0 109.469 -179.963 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -164.48 166.85 38.07 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -119.38 49.22 1.38 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.246 -1.149 . . . . 0.0 109.482 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 31.4 mttt -105.52 37.0 2.32 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.211 -0.931 . . . . 0.0 109.459 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.413 ' HA ' HD12 ' A' ' 93' ' ' LEU . 7.3 ttt180 -46.81 -36.85 7.83 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.26 -0.9 . . . . 0.0 109.474 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -58.03 -53.66 55.75 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.242 -0.912 . . . . 0.0 109.547 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.11 -17.8 64.94 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.231 -0.918 . . . . 0.0 109.526 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.715 HD13 HG21 ' A' ' 36' ' ' ILE . 2.1 mt -72.56 -44.85 61.53 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.302 -0.874 . . . . 0.0 109.494 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 61.6 tttt -65.96 -32.98 74.78 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.224 -0.923 . . . . 0.0 109.477 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 14.3 t -67.54 -62.69 1.3 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.25 -0.906 . . . . 0.0 109.448 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.939 HD12 ' N ' ' A' ' 97' ' ' LEU . 4.2 pp -51.64 -31.61 26.1 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.195 -0.941 . . . . 0.0 109.471 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.939 ' N ' HD12 ' A' ' 96' ' ' LEU . 0.2 OUTLIER -65.14 -47.01 78.6 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.223 -0.923 . . . . 0.0 109.494 179.968 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 72.4 tt0 -69.19 -14.26 62.88 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.298 -0.876 . . . . 0.0 109.455 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -73.42 -13.93 61.17 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.212 -0.93 . . . . 0.0 109.434 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.35 -31.28 11.4 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.262 -0.899 . . . . 0.0 109.441 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 100.68 15.8 28.25 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 1.5 mtm -88.2 156.12 19.4 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.192 -1.181 . . . . 0.0 109.49 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.504 ' HB2' HG12 ' A' ' 33' ' ' VAL . 27.2 mttt -86.17 97.61 10.44 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.285 -0.885 . . . . 0.0 109.468 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 12.5 p -81.43 140.66 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.226 -0.921 . . . . 0.0 109.46 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.47 ' O ' ' N ' ' A' ' 107' ' ' ALA . 0.7 OUTLIER -111.41 77.41 1.04 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.224 -0.923 . . . . 0.0 109.469 -179.994 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.5 mp -46.54 96.44 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.185 -0.947 . . . . 0.0 109.471 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.47 ' N ' ' O ' ' A' ' 105' ' ' LYS . . . . . . . . 0 N--CA 1.49 1.552 0 O-C-N 121.265 -0.897 . . . . 0.0 109.488 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 23.0 t0 . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.425 ' O ' ' HB2' ' A' ' 103' ' ' LYS . . . -138.64 123.45 2.61 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.403 HG22 ' CB ' ' A' ' 103' ' ' LYS . 73.2 t -146.91 104.5 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.242 -1.152 . . . . 0.0 109.454 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.745 HG13 ' CG2' ' A' ' 54' ' ' VAL . 21.4 t -92.88 151.09 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.253 -0.904 . . . . 0.0 109.432 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 2.0 ttt180 -121.82 112.4 18.3 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.25 -0.906 . . . . 0.0 109.487 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.785 HG21 ' HB3' ' A' ' 93' ' ' LEU . 2.2 mp -123.44 114.54 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.266 -0.896 . . . . 0.0 109.406 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.5 ' CD ' ' HB3' ' A' ' 107' ' ' ALA . 7.0 pt20 -150.59 -162.13 1.49 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.212 -0.93 . . . . 0.0 109.446 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 30.8 mtm180 -123.77 139.19 54.22 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.233 -0.917 . . . . 0.0 109.452 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.694 ' HB2' HD13 ' A' ' 50' ' ' LEU . 13.5 tt0 -116.05 60.17 0.72 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.247 -0.908 . . . . 0.0 109.472 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.6 p . . . . . 0 N--CA 1.491 1.589 0 O-C-N 121.261 -0.9 . . . . 0.0 109.438 -179.965 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 19.6 mttt . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 121.265 0.555 . . . . 0.0 109.547 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -109.11 149.05 17.06 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.9 m -119.57 145.74 25.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.307 -1.113 . . . . 0.0 109.468 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 2.3 t -111.46 139.79 46.59 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.269 -0.894 . . . . 0.0 109.437 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.694 HD13 ' HB2' ' A' ' 39' ' ' GLN . 2.1 mp -130.35 119.91 23.51 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.246 -0.909 . . . . 0.0 109.516 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.801 ' HB ' HD12 ' A' ' 83' ' ' ILE . 3.1 mm -101.19 124.7 55.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.229 -0.919 . . . . 0.0 109.379 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -159.63 159.52 33.2 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.199 -0.938 . . . . 0.0 109.491 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.412 ' O ' ' C ' ' A' ' 54' ' ' VAL . . . 105.76 -29.06 11.93 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.745 ' CG2' HG13 ' A' ' 34' ' ' VAL . 62.5 t -45.22 117.75 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.213 -1.169 . . . . 0.0 109.421 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -111.95 72.24 0.77 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.26 -0.9 . . . . 0.0 109.511 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.503 HD11 ' SD ' ' A' ' 102' ' ' MET . 2.7 mt -126.04 -170.31 2.17 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.216 -0.928 . . . . 0.0 109.456 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -56.03 147.77 19.19 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.242 -0.911 . . . . 0.0 109.475 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.94 -33.49 73.25 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.274 -0.891 . . . . 0.0 109.518 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -77.27 -29.06 53.69 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.231 -0.918 . . . . 0.0 109.385 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -69.27 -30.51 68.64 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.303 -0.873 . . . . 0.0 109.45 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.416 HD21 ' HB ' ' A' ' 54' ' ' VAL . 1.7 mt -66.21 -58.35 5.59 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.271 -0.893 . . . . 0.0 109.496 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -57.68 -19.4 26.71 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.197 -0.939 . . . . 0.0 109.376 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 9.3 mttt -76.68 -44.33 34.16 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.309 -0.869 . . . . 0.0 109.558 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.409 HD22 ' HA ' ' A' ' 64' ' ' LEU . 0.3 OUTLIER -70.88 -29.0 64.98 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.209 -0.932 . . . . 0.0 109.508 -179.997 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.451 ' HB1' HG13 ' A' ' 78' ' ' VAL . . . -72.25 -52.38 16.67 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.245 -0.909 . . . . 0.0 109.382 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.9 -48.78 80.21 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.237 -0.915 . . . . 0.0 109.551 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -54.0 -46.27 71.72 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.196 -0.94 . . . . 0.0 109.331 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -59.5 -36.54 76.24 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.277 -0.889 . . . . 0.0 109.238 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 7.9 tmtt? -61.54 -37.96 85.68 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.333 -0.855 . . . . 0.0 109.286 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 11.3 mttt -58.05 -25.46 61.24 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.234 -0.916 . . . . 0.0 108.955 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 1.7 mtmp? -122.0 50.19 1.48 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.513 -0.742 . . . . 0.0 109.217 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 23.4 t -133.72 -63.51 0.74 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.178 -0.951 . . . . 0.0 109.686 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.482 ' O ' ' HB2' ' A' ' 74' ' ' CYS . . . 120.17 10.25 7.53 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -179.701 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.482 ' HB2' ' O ' ' A' ' 73' ' ' GLY . 4.6 t 168.3 127.92 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.325 -1.103 . . . . 0.0 109.193 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -94.53 101.58 2.75 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -66.99 -109.01 0.02 OUTLIER Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -111.75 121.77 46.0 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.205 -1.173 . . . . 0.0 109.302 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.451 HG13 ' HB1' ' A' ' 65' ' ' ALA . 22.9 t -116.43 78.12 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.21 -0.931 . . . . 0.0 109.808 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -88.28 145.62 25.76 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.243 -0.911 . . . . 0.0 109.201 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -65.0 91.42 0.09 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.201 -0.937 . . . . 0.0 109.507 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 129.07 -24.34 4.79 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.0 t -139.04 137.86 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.152 -1.205 . . . . 0.0 109.582 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.801 HD12 ' HB ' ' A' ' 51' ' ' ILE . 4.2 mt -132.01 135.34 58.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.353 -0.842 . . . . 0.0 109.55 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 68.1 mt-10 -132.25 116.47 16.97 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.302 -0.874 . . . . 0.0 109.207 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 56.1 mt -148.36 146.72 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.225 -0.922 . . . . 0.0 109.621 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -72.74 141.58 48.14 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.24 -0.912 . . . . 0.0 109.309 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 167.7 122.33 0.61 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -106.96 51.61 0.74 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.321 -1.105 . . . . 0.0 109.538 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 85.5 mttt -131.9 53.42 2.0 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.252 -0.905 . . . . 0.0 109.478 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 32.5 ptt180 -53.13 -27.48 21.1 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.24 -0.912 . . . . 0.0 109.358 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 48.1 t0 -65.41 -53.33 44.76 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.29 -0.881 . . . . 0.0 109.393 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.9 tt -58.71 -48.35 81.43 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.274 -0.891 . . . . 0.0 109.424 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.785 ' HB3' HG21 ' A' ' 36' ' ' ILE . 5.9 mt -53.93 -38.97 65.45 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.252 -0.905 . . . . 0.0 109.429 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.521 ' HE3' HD11 ' A' ' 106' ' ' LEU . 3.1 ttmt -68.26 -31.26 70.6 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.253 -0.904 . . . . 0.0 109.494 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 21.8 t -67.54 -64.03 0.94 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.236 -0.915 . . . . 0.0 109.471 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.796 HD12 ' N ' ' A' ' 97' ' ' LEU . 2.6 pp -50.62 -38.27 44.98 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.277 -0.889 . . . . 0.0 109.499 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.796 ' N ' HD12 ' A' ' 96' ' ' LEU . 0.2 OUTLIER -59.44 -45.13 92.46 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.218 -0.926 . . . . 0.0 109.485 179.978 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -69.68 -17.07 63.46 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.257 -0.902 . . . . 0.0 109.444 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -67.98 -27.47 66.6 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.251 -0.905 . . . . 0.0 109.459 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.494 ' HD2' ' N ' ' A' ' 100' ' ' LYS . 6.7 mptt -85.13 -16.35 40.77 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.228 -0.92 . . . . 0.0 109.442 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 88.73 23.96 34.4 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' MET . . . . . 0.503 ' SD ' HD11 ' A' ' 56' ' ' LEU . 1.2 mtm -97.77 171.17 8.49 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.265 -1.138 . . . . 0.0 109.467 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.425 ' HB2' ' O ' ' A' ' 32' ' ' GLY . 8.7 mttt -84.62 165.74 17.71 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.231 -0.918 . . . . 0.0 109.484 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.8 t -147.91 124.16 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.275 -0.891 . . . . 0.0 109.485 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 5.9 mttt -109.38 79.07 1.18 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.256 -0.903 . . . . 0.0 109.468 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.521 HD11 ' HE3' ' A' ' 94' ' ' LYS . 6.2 mt -46.18 105.53 0.06 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.297 -0.877 . . . . 0.0 109.482 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.5 ' HB3' ' CD ' ' A' ' 37' ' ' GLN . . . . . . . . 0 N--CA 1.49 1.56 0 O-C-N 121.277 -0.89 . . . . 0.0 109.466 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 149.54 130.98 1.89 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.5 p -160.03 131.26 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.265 -1.138 . . . . 0.0 109.449 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.629 HG23 ' CE ' ' A' ' 102' ' ' MET . 75.6 t -105.54 153.65 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.261 -0.899 . . . . 0.0 109.468 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.431 ' HB3' ' O ' ' A' ' 52' ' ' THR . 24.6 ttt180 -129.65 100.89 5.68 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.192 -0.942 . . . . 0.0 109.513 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.85 HG23 HG13 ' A' ' 51' ' ' ILE . 1.2 mp -102.81 125.75 57.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.232 -0.918 . . . . 0.0 109.397 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -122.63 -166.81 1.48 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.235 -0.916 . . . . 0.0 109.468 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 14.1 ptt180 -152.54 132.7 13.51 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.197 -0.939 . . . . 0.0 109.476 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -118.13 110.37 17.52 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.23 -0.919 . . . . 0.0 109.488 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 5.7 t . . . . . 0 N--CA 1.49 1.558 0 O-C-N 121.275 -0.89 . . . . 0.0 109.453 -179.962 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 12.4 ttmt . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 121.284 0.564 . . . . 0.0 109.515 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -178.35 131.26 1.71 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.2 m -131.49 147.26 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.245 -1.15 . . . . 0.0 109.528 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 1.8 m -125.01 118.34 26.0 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.269 -0.895 . . . . 0.0 109.494 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.563 ' C ' HD12 ' A' ' 51' ' ' ILE . 0.4 OUTLIER -113.1 138.93 49.19 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.218 -0.926 . . . . 0.0 109.503 -179.94 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.85 HG13 HG23 ' A' ' 36' ' ' ILE . 2.7 mp -108.37 122.62 63.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.234 -0.916 . . . . 0.0 109.394 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.431 ' O ' ' HB3' ' A' ' 35' ' ' ARG . 0.5 OUTLIER -146.25 156.53 43.45 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.287 -0.883 . . . . 0.0 109.534 -179.898 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 93.89 23.14 23.81 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.438 HG12 HD12 ' A' ' 56' ' ' LEU . 10.1 t -80.55 115.38 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.304 -1.115 . . . . 0.0 109.552 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -94.14 76.91 4.05 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.265 -0.897 . . . . 0.0 109.443 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.438 HD12 HG12 ' A' ' 54' ' ' VAL . 0.4 OUTLIER -144.9 177.75 8.51 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.263 -0.898 . . . . 0.0 109.409 179.955 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -56.97 158.35 4.97 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.216 -0.927 . . . . 0.0 109.519 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.72 -48.35 59.82 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.32 -0.862 . . . . 0.0 109.495 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.92 -33.69 70.85 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.279 -0.888 . . . . 0.0 109.411 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.421 ' O ' ' C ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -59.47 -54.05 51.05 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.232 -0.917 . . . . 0.0 109.418 179.951 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.421 ' C ' ' O ' ' A' ' 60' ' ' GLU . 0.3 OUTLIER -44.58 -42.75 7.59 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.239 -0.913 . . . . 0.0 109.196 179.844 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 60.9 m -58.54 -50.63 73.08 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.263 -0.898 . . . . 0.0 109.166 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -52.5 -30.39 29.96 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.26 -0.9 . . . . 0.0 109.137 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -68.81 -53.48 21.31 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.344 -0.847 . . . . 0.0 109.485 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -52.68 -33.76 48.88 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.242 -0.911 . . . . 0.0 109.308 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -71.98 -41.88 67.16 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.278 -0.889 . . . . 0.0 109.284 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -65.11 -19.79 66.15 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.22 -0.925 . . . . 0.0 109.357 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.463 ' HA ' HD13 ' A' ' 68' ' ' LEU . 3.3 mm? -84.02 -57.3 3.25 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.229 -0.919 . . . . 0.0 109.447 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 6.2 mttt -60.11 -22.75 63.19 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.281 -0.887 . . . . 0.0 109.412 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.8 -42.67 47.44 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.262 -0.899 . . . . 0.0 109.496 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 2.1 ptmt -129.14 70.17 1.41 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.271 -0.893 . . . . 0.0 109.332 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -144.33 -42.7 0.26 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.311 -0.868 . . . . 0.0 109.424 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.474 ' O ' ' HB2' ' A' ' 74' ' ' CYS . . . 119.49 -62.09 0.48 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.474 ' HB2' ' O ' ' A' ' 73' ' ' GLY . 17.0 t 172.31 107.49 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.344 -1.092 . . . . 0.0 109.323 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 160.38 50.77 0.01 OUTLIER Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -117.97 116.92 3.58 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.501 ' HB3' ' HB3' ' A' ' 84' ' ' GLU . . . -104.05 110.25 22.35 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.337 -1.096 . . . . 0.0 109.004 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.2 t -85.16 84.22 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.214 -0.929 . . . . 0.0 109.814 -179.544 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.476 ' HB3' ' HB ' ' A' ' 82' ' ' VAL . 20.3 mmtt -90.9 169.18 11.13 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.287 -0.883 . . . . 0.0 108.955 179.505 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -60.63 112.75 2.12 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.113 -0.992 . . . . 0.0 109.578 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 51.99 27.78 22.92 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.494 ' O ' HG12 ' A' ' 82' ' ' VAL . 43.4 t -141.65 88.19 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.152 -1.205 . . . . 0.0 109.536 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.494 ' N ' HD13 ' A' ' 83' ' ' ILE . 4.7 mm -83.53 102.12 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.246 -0.908 . . . . 0.0 109.306 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.501 ' HB3' ' HB3' ' A' ' 77' ' ' ALA . 0.5 OUTLIER -82.92 126.66 32.73 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.284 -0.885 . . . . 0.0 109.73 -179.845 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 18.6 mm -133.96 110.62 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.265 -0.897 . . . . 0.0 109.406 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -72.77 128.95 37.06 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.263 -0.898 . . . . 0.0 109.573 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 145.04 136.56 3.03 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -95.89 89.56 5.29 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.251 -1.147 . . . . 0.0 109.445 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 3.1 mttt -144.55 53.23 1.25 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.205 -0.934 . . . . 0.0 109.5 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.842 ' HA ' HD12 ' A' ' 93' ' ' LEU . 51.2 ttt180 -64.02 -40.73 96.98 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.251 -0.906 . . . . 0.0 109.483 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -53.82 -44.06 69.92 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.211 -0.931 . . . . 0.0 109.46 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 3.6 tt -75.11 -26.63 59.4 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.267 -0.896 . . . . 0.0 109.532 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.842 HD12 ' HA ' ' A' ' 90' ' ' ARG . 22.8 mt -61.63 -42.86 99.47 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.263 -0.898 . . . . 0.0 109.474 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 17.3 tttt -67.03 -26.74 66.92 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.24 -0.913 . . . . 0.0 109.592 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 1.2 t -70.72 -62.34 1.43 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.224 -0.922 . . . . 0.0 109.534 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.865 HD12 ' N ' ' A' ' 97' ' ' LEU . 4.6 pp -54.93 -31.43 60.3 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.228 -0.92 . . . . 0.0 109.534 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.865 ' N ' HD12 ' A' ' 96' ' ' LEU . 0.2 OUTLIER -67.64 -47.4 69.69 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.183 -0.948 . . . . 0.0 109.559 -179.917 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.53 -15.36 63.23 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.223 -0.923 . . . . 0.0 109.589 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -69.79 -12.75 61.87 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.222 -0.924 . . . . 0.0 109.464 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.19 -37.49 20.07 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.246 -0.908 . . . . 0.0 109.497 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 101.45 22.96 9.89 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' MET . . . . . 0.629 ' CE ' HG23 ' A' ' 34' ' ' VAL . 0.3 OUTLIER -119.6 -172.89 2.41 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.198 -1.177 . . . . 0.0 109.466 -179.996 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 6.6 tttt -86.54 162.01 18.26 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.252 -0.905 . . . . 0.0 109.484 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.582 ' HB ' HD12 ' A' ' 97' ' ' LEU . 12.7 p -152.32 153.47 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.262 -0.899 . . . . 0.0 109.429 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 6.0 mttt -131.64 90.12 2.8 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.212 -0.93 . . . . 0.0 109.494 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.68 ' O ' ' HB3' ' A' ' 107' ' ' ALA . 4.6 mm? -54.85 -30.13 56.93 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.259 -0.901 . . . . 0.0 109.476 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.68 ' HB3' ' O ' ' A' ' 106' ' ' LEU . . . . . . . . 0 N--CA 1.49 1.555 0 O-C-N 121.265 -0.897 . . . . 0.0 109.433 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 27.4 t0 . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 171.72 120.36 0.55 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.595 HG23 ' O ' ' A' ' 33' ' ' VAL . 35.5 m -132.17 115.48 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.307 -1.114 . . . . 0.0 109.463 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.729 HG22 HG22 ' A' ' 54' ' ' VAL . 97.0 t -80.62 159.84 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.273 -0.892 . . . . 0.0 109.513 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.484 ' N ' HG12 ' A' ' 34' ' ' VAL . 4.5 mtp180 -145.59 127.76 15.7 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.282 -0.887 . . . . 0.0 109.441 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.833 HG21 HD13 ' A' ' 93' ' ' LEU . 2.7 mp -132.48 109.18 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.274 -0.891 . . . . 0.0 109.497 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.878 ' HB3' ' HB3' ' A' ' 107' ' ' ALA . 2.6 pt20 -140.02 157.39 45.74 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.294 -0.879 . . . . 0.0 109.467 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.44 ' HG2' ' HD3' ' A' ' 90' ' ' ARG . 7.8 ptt180 -96.15 135.96 37.24 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.249 -0.907 . . . . 0.0 109.433 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -108.39 95.41 5.65 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.26 -0.9 . . . . 0.0 109.458 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.565 0 O-C-N 121.226 -0.921 . . . . 0.0 109.461 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 21.8 mttt . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -95.03 177.13 35.09 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.7 m -151.46 154.36 8.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.258 -1.142 . . . . 0.0 109.477 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 6.9 t -119.34 110.64 17.21 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.261 -0.9 . . . . 0.0 109.493 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -97.12 131.7 43.63 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.29 -0.881 . . . . 0.0 109.411 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 63.6 mt -125.36 114.95 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.229 -0.919 . . . . 0.0 109.533 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -151.84 170.35 20.02 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.252 -0.905 . . . . 0.0 109.435 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.19 -15.91 58.66 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.729 HG22 HG22 ' A' ' 34' ' ' VAL . 53.4 t -56.92 108.47 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.269 -1.136 . . . . 0.0 109.474 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.468 ' O ' HD22 ' A' ' 56' ' ' LEU . 18.3 t0 -86.16 78.16 9.43 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.296 -0.878 . . . . 0.0 109.471 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.468 HD22 ' O ' ' A' ' 55' ' ' ASP . 0.2 OUTLIER -134.53 159.03 42.42 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.247 -0.908 . . . . 0.0 109.46 179.986 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.448 ' O ' ' O ' ' A' ' 58' ' ' ASP . 0.2 OUTLIER -76.61 157.02 32.27 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.203 -0.936 . . . . 0.0 109.501 179.963 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.709 ' O ' ' HB3' ' A' ' 59' ' ' ALA . 0.2 OUTLIER -50.73 -179.48 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.298 -0.876 . . . . 0.0 109.523 -179.963 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.709 ' HB3' ' O ' ' A' ' 58' ' ' ASP . . . 76.98 -78.9 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.313 -0.867 . . . . 0.0 109.501 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -55.1 -36.77 66.03 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.236 -0.915 . . . . 0.0 109.543 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -58.76 -48.29 81.73 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.181 -0.95 . . . . 0.0 109.478 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -61.85 -28.11 69.26 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.211 -0.931 . . . . 0.0 109.463 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -68.67 -51.54 40.79 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.276 -0.89 . . . . 0.0 109.388 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.59 -33.59 72.95 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.218 -0.926 . . . . 0.0 109.309 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -64.17 -52.1 60.6 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.262 -0.899 . . . . 0.0 109.371 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.67 -22.31 66.95 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.238 -0.914 . . . . 0.0 109.322 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.99 -55.19 13.58 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.256 -0.902 . . . . 0.0 109.425 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.3 mp -69.36 -22.47 63.74 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.186 -0.946 . . . . 0.0 109.415 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.93 -37.38 72.87 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.275 -0.891 . . . . 0.0 109.504 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 19.7 tttt -68.82 -12.85 61.97 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.248 -0.907 . . . . 0.0 109.414 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 20.3 mttm -75.47 -22.47 57.22 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.318 -0.864 . . . . 0.0 109.818 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -103.66 -34.39 8.63 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.185 -0.947 . . . . 0.0 110.008 -179.428 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.446 ' O ' ' CB ' ' A' ' 74' ' ' CYS . . . 76.21 32.09 53.17 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 108.764 -1.734 . . . . 0.0 108.764 -179.437 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.446 ' CB ' ' O ' ' A' ' 73' ' ' GLY . 0.0 OUTLIER 167.35 152.05 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.475 -1.015 . . . . 0.0 109.126 -179.695 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 67.6 123.94 0.02 OUTLIER Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -173.89 92.59 0.09 OUTLIER Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -104.07 123.31 47.02 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.221 -1.164 . . . . 0.0 109.081 179.603 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 33.7 m -110.49 170.24 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.141 -0.974 . . . . 0.0 109.541 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.423 ' CB ' ' HB ' ' A' ' 82' ' ' VAL . 11.4 mttp -159.19 166.74 30.77 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.299 -0.876 . . . . 0.0 109.352 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -64.13 100.8 0.35 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.202 -0.936 . . . . 0.0 109.567 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 74.7 2.97 65.78 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.423 ' HB ' ' CB ' ' A' ' 79' ' ' LYS . 87.5 t -129.6 141.71 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.116 -1.226 . . . . 0.0 109.595 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.431 HG22 ' N ' ' A' ' 84' ' ' GLU . 58.1 mt -131.89 158.69 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.326 -0.859 . . . . 0.0 109.456 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.431 ' N ' HG22 ' A' ' 83' ' ' ILE . 19.1 tt0 -148.03 139.14 23.35 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.217 -0.927 . . . . 0.0 109.548 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 53.6 mt -149.69 102.7 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.218 -0.926 . . . . 0.0 109.377 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -52.8 110.07 0.48 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.214 -0.929 . . . . 0.0 109.506 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -154.85 -175.75 26.3 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -154.39 47.82 0.59 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.267 -1.137 . . . . 0.0 109.446 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 60.3 mttt -137.82 45.95 2.12 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.283 -0.886 . . . . 0.0 109.467 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.59 ' HA ' HD12 ' A' ' 93' ' ' LEU . 36.1 ptt180 -50.93 -40.15 56.43 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.246 -0.909 . . . . 0.0 109.467 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.486 ' N ' ' HG3' ' A' ' 90' ' ' ARG . 8.1 p-10 -51.05 -45.54 61.37 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.27 -0.894 . . . . 0.0 109.467 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.404 HD23 ' N ' ' A' ' 93' ' ' LEU . 4.4 tt -68.4 -47.18 68.0 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.267 -0.896 . . . . 0.0 109.495 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.833 HD13 HG21 ' A' ' 36' ' ' ILE . 17.9 mt -54.32 -24.67 20.08 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.223 -0.923 . . . . 0.0 109.477 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -61.39 -65.42 0.7 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.297 -0.877 . . . . 0.0 109.465 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 11.4 t -64.48 -17.38 63.81 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.272 -0.893 . . . . 0.0 109.465 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.636 HD23 ' N ' ' A' ' 97' ' ' LEU . 3.1 tt -66.42 -55.83 13.91 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.288 -0.883 . . . . 0.0 109.482 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.636 ' N ' HD23 ' A' ' 96' ' ' LEU . 0.2 OUTLIER -69.97 -38.24 76.02 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.293 -0.879 . . . . 0.0 109.504 -179.979 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -64.27 -19.11 65.18 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.243 -0.91 . . . . 0.0 109.497 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -66.53 -31.74 72.64 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.273 -0.892 . . . . 0.0 109.441 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? -80.21 -14.9 58.07 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.239 -0.913 . . . . 0.0 109.474 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 101.44 -13.16 58.37 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 2.7 mtm -65.64 147.89 52.65 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.278 -1.13 . . . . 0.0 109.431 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 16.6 mttt -81.85 115.79 21.22 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.284 -0.885 . . . . 0.0 109.473 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.418 HG22 ' N ' ' A' ' 105' ' ' LYS . 4.6 p -109.72 155.0 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.221 -0.924 . . . . 0.0 109.523 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.429 ' O ' ' N ' ' A' ' 107' ' ' ALA . 0.5 OUTLIER -122.18 90.39 3.3 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.212 -0.93 . . . . 0.0 109.468 -179.958 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 19.5 tp -54.2 93.09 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.253 -0.904 . . . . 0.0 109.486 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.878 ' HB3' ' HB3' ' A' ' 37' ' ' GLN . . . . . . . . 0 N--CA 1.491 1.593 0 O-C-N 121.28 -0.887 . . . . 0.0 109.475 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.45 ' N ' ' OD1' ' A' ' 31' ' ' ASP . 18.8 p30 . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -60.3 153.24 35.96 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.708 HG23 ' O ' ' A' ' 33' ' ' VAL . 34.7 m -142.39 101.17 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.279 -1.13 . . . . 0.0 109.452 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.571 HG13 HG22 ' A' ' 54' ' ' VAL . 9.7 t -88.85 150.04 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.268 -0.895 . . . . 0.0 109.501 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 53.0 mtt180 -127.05 119.25 26.13 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.231 -0.918 . . . . 0.0 109.458 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.511 HD11 HD13 ' A' ' 97' ' ' LEU . 1.5 mp -118.1 118.41 58.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.237 -0.914 . . . . 0.0 109.507 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -153.89 175.54 13.23 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.258 -0.901 . . . . 0.0 109.479 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.78 140.04 38.68 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.223 -0.923 . . . . 0.0 109.453 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -124.91 57.6 1.27 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.282 -0.886 . . . . 0.0 109.486 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 15.1 t . . . . . 0 N--CA 1.49 1.546 0 O-C-N 121.246 -0.909 . . . . 0.0 109.448 -179.988 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.4 ptmt . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 121.325 0.583 . . . . 0.0 109.539 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -171.16 147.75 10.62 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.405 HG12 ' HG3' ' A' ' 86' ' ' GLN . 14.1 m -119.77 158.03 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.205 -1.173 . . . . 0.0 109.504 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 1.4 t -121.11 120.51 35.52 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.229 -0.919 . . . . 0.0 109.422 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -111.58 149.25 31.72 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.234 -0.916 . . . . 0.0 109.539 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.493 ' CG1' HG23 ' A' ' 36' ' ' ILE . 16.7 mt -134.26 126.43 49.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.269 -0.895 . . . . 0.0 109.46 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.463 HG23 ' O ' ' A' ' 81' ' ' GLY . 0.2 OUTLIER -151.59 166.67 30.5 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.228 -0.92 . . . . 0.0 109.48 179.98 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 92.57 15.57 52.43 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.571 HG22 HG13 ' A' ' 34' ' ' VAL . 8.8 t -75.86 106.9 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.231 -1.158 . . . . 0.0 109.489 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -94.62 84.57 4.3 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.279 -0.888 . . . . 0.0 109.476 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -144.95 -172.87 3.93 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.194 -0.941 . . . . 0.0 109.483 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -68.67 150.22 48.19 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.262 -0.899 . . . . 0.0 109.464 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.418 ' O ' ' HB2' ' A' ' 61' ' ' LEU . 19.6 m-20 -52.72 -46.26 67.3 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.246 -0.909 . . . . 0.0 109.549 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.808 ' O ' HG22 ' A' ' 62' ' ' THR . . . -58.72 -44.73 90.48 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.23 -0.919 . . . . 0.0 109.558 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -51.36 -34.73 35.31 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.151 -0.968 . . . . 0.0 109.488 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.461 HD23 ' HA ' ' A' ' 61' ' ' LEU . 39.7 mt -56.8 -54.81 42.11 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.233 -0.917 . . . . 0.0 109.505 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.808 HG22 ' O ' ' A' ' 59' ' ' ALA . 9.5 t -63.66 -17.82 63.32 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.233 -0.917 . . . . 0.0 109.588 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.65 -68.76 0.48 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.265 -0.897 . . . . 0.0 109.459 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -51.77 -34.61 40.3 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.273 -0.892 . . . . 0.0 109.371 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.48 -59.47 5.19 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.267 -0.896 . . . . 0.0 109.426 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -55.07 -24.93 27.66 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.279 -0.888 . . . . 0.0 109.447 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -66.68 -62.46 1.44 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.256 -0.903 . . . . 0.0 109.482 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -67.33 -13.5 62.06 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.193 -0.942 . . . . 0.0 109.545 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 17.8 tttt -69.77 -36.35 75.68 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.189 -0.944 . . . . 0.0 109.428 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -73.27 -19.74 60.99 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.279 -0.888 . . . . 0.0 109.276 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 63.7 mttt -66.29 -29.88 70.19 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.3 -0.875 . . . . 0.0 109.319 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 62.7 m -89.17 -30.06 18.85 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.315 -0.866 . . . . 0.0 109.316 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.457 ' O ' ' HB2' ' A' ' 74' ' ' CYS . . . 91.87 -19.74 46.78 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.457 ' HB2' ' O ' ' A' ' 73' ' ' GLY . 52.8 t 177.55 94.41 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.232 -1.158 . . . . 0.0 109.364 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 148.83 151.03 5.36 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.394 -1.483 . . . . 0.0 109.394 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 159.41 -176.46 36.19 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -179.36 114.12 0.06 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.252 -1.146 . . . . 0.0 109.624 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.5 p -120.01 148.59 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.256 -0.903 . . . . 0.0 109.136 179.669 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.448 ' CB ' ' HB ' ' A' ' 82' ' ' VAL . 0.0 OUTLIER -150.21 77.7 1.31 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.17 -0.956 . . . . 0.0 109.774 -179.735 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 60.3 t0 49.25 69.03 0.63 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.336 -0.852 . . . . 0.0 109.956 179.527 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.463 ' O ' HG23 ' A' ' 52' ' ' THR . . . 83.27 -11.56 54.65 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 179.514 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.448 ' HB ' ' CB ' ' A' ' 79' ' ' LYS . 58.5 t -97.97 89.79 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.094 -1.239 . . . . 0.0 109.523 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 52.3 mt -99.68 154.15 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.228 -0.92 . . . . 0.0 109.374 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -149.26 104.11 3.37 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.242 -0.911 . . . . 0.0 109.612 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 62.2 mt -125.76 125.04 67.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.334 -0.853 . . . . 0.0 109.357 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.405 ' HG3' HG12 ' A' ' 48' ' ' VAL . 8.3 tt0 -66.8 155.98 36.79 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.261 -0.899 . . . . 0.0 109.462 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 141.7 140.32 3.78 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -112.61 52.28 0.78 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.19 -1.182 . . . . 0.0 109.511 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 6.6 mttp -121.13 41.37 3.34 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.208 -0.933 . . . . 0.0 109.452 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.48 HH11 HD21 ' A' ' 106' ' ' LEU . 7.6 ptt85 -56.44 -27.76 57.59 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.251 -0.906 . . . . 0.0 109.494 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -57.89 -47.09 83.81 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.209 -0.932 . . . . 0.0 109.481 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 4.2 tt -74.28 -33.38 63.24 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.199 -0.938 . . . . 0.0 109.511 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.482 ' HG ' HG21 ' A' ' 36' ' ' ILE . 1.5 mm? -55.9 -38.72 70.6 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.272 -0.892 . . . . 0.0 109.458 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 13.1 tttt -53.41 -49.29 67.61 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.205 -0.934 . . . . 0.0 109.451 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 3.2 t -68.35 -29.36 68.07 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.28 -0.888 . . . . 0.0 109.437 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.558 HD23 ' N ' ' A' ' 97' ' ' LEU . 4.1 tt -58.06 -51.85 67.96 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.238 -0.914 . . . . 0.0 109.434 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.558 ' N ' HD23 ' A' ' 96' ' ' LEU . 0.4 OUTLIER -72.19 -32.35 66.74 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.261 -0.899 . . . . 0.0 109.428 179.983 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -71.69 -14.49 62.05 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.232 -0.918 . . . . 0.0 109.456 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.08 -31.42 72.6 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.213 -0.929 . . . . 0.0 109.422 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 7.3 mttm -94.0 -19.83 20.52 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.266 -0.896 . . . . 0.0 109.473 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 100.17 13.1 37.34 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 4.0 mtm -79.3 156.99 27.8 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.287 -1.125 . . . . 0.0 109.5 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.697 ' HB3' HG12 ' A' ' 33' ' ' VAL . 28.3 tttt -81.98 132.55 35.26 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.224 -0.923 . . . . 0.0 109.472 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.476 ' HB ' ' CD2' ' A' ' 97' ' ' LEU . 11.6 p -133.86 141.5 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.248 -0.908 . . . . 0.0 109.457 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 2.1 tttt -115.85 98.13 6.49 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.238 -0.914 . . . . 0.0 109.488 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.521 ' O ' ' HB3' ' A' ' 107' ' ' ALA . 25.5 tp -45.92 -26.59 0.72 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.238 -0.914 . . . . 0.0 109.477 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.521 ' HB3' ' O ' ' A' ' 106' ' ' LEU . . . . . . . . 0 N--CA 1.489 1.512 0 O-C-N 121.223 -0.923 . . . . 0.0 109.5 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 140.48 119.33 1.59 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.544 -1.423 . . . . 0.0 109.544 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 18.2 t -123.84 94.6 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.211 -1.17 . . . . 0.0 109.458 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.467 HG12 ' N ' ' A' ' 35' ' ' ARG . 22.0 t -86.54 162.39 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.23 -0.919 . . . . 0.0 109.491 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.467 ' N ' HG12 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -144.91 140.56 28.38 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.206 -0.934 . . . . 0.0 109.491 179.928 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.903 HG21 ' HG ' ' A' ' 93' ' ' LEU . 3.8 mp -141.52 124.4 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.233 -0.917 . . . . 0.0 109.491 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.862 ' HB3' ' HB2' ' A' ' 107' ' ' ALA . 5.5 pt20 -147.59 118.98 7.86 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.25 -0.906 . . . . 0.0 109.471 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 5.4 tmm_? -45.81 116.0 1.1 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.249 -0.907 . . . . 0.0 109.426 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 2.1 tm0? -85.01 126.95 33.97 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.253 -0.904 . . . . 0.0 109.465 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 8.8 t . . . . . 0 N--CA 1.49 1.558 0 O-C-N 121.243 -0.911 . . . . 0.0 109.459 -179.987 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 31.0 mttt . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.456 ' C ' HG13 ' A' ' 48' ' ' VAL . . . -103.54 -156.96 24.63 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.456 HG13 ' C ' ' A' ' 47' ' ' GLY . 35.9 m -156.5 160.34 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.281 -1.129 . . . . 0.0 109.481 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.4 ' HB2' ' O ' ' A' ' 85' ' ' ILE . 0.1 OUTLIER -95.35 117.56 30.54 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.191 -0.943 . . . . 0.0 109.494 179.989 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -103.56 98.17 8.09 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.27 -0.894 . . . . 0.0 109.471 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.694 HG13 HG23 ' A' ' 36' ' ' ILE . 3.1 mp -96.05 125.87 48.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.232 -0.918 . . . . 0.0 109.485 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.7 -152.82 0.43 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.224 -0.923 . . . . 0.0 109.538 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 52.07 51.44 40.85 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.441 ' O ' ' N ' ' A' ' 56' ' ' LEU . 2.1 t -115.72 46.33 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.212 -1.17 . . . . 0.0 109.477 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -55.71 90.89 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.229 -0.919 . . . . 0.0 109.423 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.441 ' N ' ' O ' ' A' ' 54' ' ' VAL . 0.4 OUTLIER -149.98 157.07 42.79 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.283 -0.886 . . . . 0.0 109.509 -179.925 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.34 157.75 19.05 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.286 -0.884 . . . . 0.0 109.452 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.719 ' O ' ' HB3' ' A' ' 59' ' ' ALA . 0.4 OUTLIER -56.17 172.46 0.21 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.183 -0.948 . . . . 0.0 109.455 179.995 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.719 ' HB3' ' O ' ' A' ' 58' ' ' ASP . . . 83.05 -43.03 0.11 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.676 -0.64 . . . . 0.0 109.83 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.41 -63.14 1.35 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.08 -1.012 . . . . 0.0 109.52 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -56.63 -27.92 59.4 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.233 -0.917 . . . . 0.0 109.476 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 46.0 p -72.72 -33.4 66.41 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.232 -0.918 . . . . 0.0 109.421 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 44.4 mttt -73.87 -51.73 15.25 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.269 -0.894 . . . . 0.0 109.469 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.693 ' O ' HD12 ' A' ' 68' ' ' LEU . 1.0 OUTLIER -56.69 -48.38 77.8 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.315 -0.866 . . . . 0.0 109.526 179.995 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.696 ' HB1' HG22 ' A' ' 78' ' ' VAL . . . -59.13 -61.02 2.95 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.323 -0.861 . . . . 0.0 109.686 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.415 ' C ' ' O ' ' A' ' 65' ' ' ALA . . . -43.26 -40.58 3.53 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.307 -0.871 . . . . 0.0 109.722 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -60.78 -52.22 66.0 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.21 -0.931 . . . . 0.0 109.542 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.693 HD12 ' O ' ' A' ' 64' ' ' LEU . 0.9 OUTLIER -60.72 -21.43 62.94 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.214 -0.929 . . . . 0.0 109.652 -179.879 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -65.44 -40.06 92.81 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.176 -0.952 . . . . 0.0 109.478 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 45.7 mttt -69.11 -23.29 63.98 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.209 -0.932 . . . . 0.0 109.444 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 15.7 mtpt -64.28 -29.07 70.18 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.406 -0.808 . . . . 0.0 110.032 -179.547 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.2 m -99.05 -43.03 6.83 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.049 -1.032 . . . . 0.0 109.672 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.474 ' O ' ' HB2' ' A' ' 74' ' ' CYS . . . 103.08 -22.68 35.92 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.474 ' HB2' ' O ' ' A' ' 73' ' ' GLY . 30.2 t 173.62 104.17 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.279 -1.13 . . . . 0.0 109.499 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 155.18 -61.4 0.37 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -47.49 119.38 4.83 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -110.41 150.35 28.95 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.26 -1.141 . . . . 0.0 109.234 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.696 HG22 ' HB1' ' A' ' 65' ' ' ALA . 41.8 t -102.38 152.22 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.253 -0.904 . . . . 0.0 109.715 -179.779 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -138.77 151.97 47.53 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.331 -0.856 . . . . 0.0 109.243 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.429 ' N ' ' OD1' ' A' ' 80' ' ' ASP . 1.0 OUTLIER -69.91 90.97 0.64 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.242 -0.911 . . . . 0.0 109.626 -179.817 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 109.07 -8.46 33.39 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.771 -1.331 . . . . 0.0 109.771 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.913 ' O ' HD13 ' A' ' 83' ' ' ILE . 75.9 t -142.26 153.02 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.129 -1.218 . . . . 0.0 109.566 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.913 HD13 ' O ' ' A' ' 82' ' ' VAL . 2.0 mm -136.53 129.25 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.289 -0.882 . . . . 0.0 109.226 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.515 ' O ' HD13 ' A' ' 85' ' ' ILE . 2.2 mt-10 -117.4 125.68 51.38 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.211 -0.931 . . . . 0.0 109.66 -179.844 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.515 HD13 ' O ' ' A' ' 84' ' ' GLU . 17.8 mm -137.42 116.65 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.269 -0.894 . . . . 0.0 109.417 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -69.77 157.56 37.1 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.247 -0.908 . . . . 0.0 109.521 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 148.74 -39.22 0.96 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.504 -1.439 . . . . 0.0 109.504 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 21.1 t0 57.33 53.77 7.3 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.223 -1.163 . . . . 0.0 109.452 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 19.8 mttt -134.96 54.52 1.94 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.24 -0.913 . . . . 0.0 109.451 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.414 ' HA ' ' HB2' ' A' ' 93' ' ' LEU . 38.5 ptt180 -47.31 -27.14 1.46 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.244 -0.91 . . . . 0.0 109.54 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -61.2 -58.61 7.62 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.248 -0.907 . . . . 0.0 109.464 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.484 HD23 ' O ' ' A' ' 92' ' ' LEU . 0.7 OUTLIER -64.87 -20.72 66.57 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.265 -0.897 . . . . 0.0 109.494 -179.975 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.903 ' HG ' HG21 ' A' ' 36' ' ' ILE . 2.1 mm? -65.81 -52.76 48.0 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.213 -0.93 . . . . 0.0 109.462 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.441 ' HG2' ' CG1' ' A' ' 104' ' ' VAL . 0.0 OUTLIER -62.83 -19.76 64.41 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.27 -0.893 . . . . 0.0 109.439 -179.98 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.94 -55.25 6.39 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.299 -0.876 . . . . 0.0 109.446 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.676 HD21 HD13 ' A' ' 93' ' ' LEU . 2.6 pp -64.82 -27.82 69.14 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.204 -0.935 . . . . 0.0 109.473 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.529 ' HB3' ' CG1' ' A' ' 104' ' ' VAL . 0.8 OUTLIER -68.12 -51.71 43.2 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.228 -0.92 . . . . 0.0 109.468 179.996 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -70.08 -16.65 63.16 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.267 -0.895 . . . . 0.0 109.44 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -67.22 -21.28 65.76 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.296 -0.878 . . . . 0.0 109.506 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -99.08 -17.18 18.36 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.269 -0.894 . . . . 0.0 109.453 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 103.59 -11.13 53.71 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 2.2 mtp -65.9 145.59 55.75 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.263 -1.14 . . . . 0.0 109.439 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.8 mttt -86.53 92.79 8.99 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.246 -0.908 . . . . 0.0 109.456 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.542 ' CG2' HD12 ' A' ' 36' ' ' ILE . 9.3 p -88.99 147.79 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.266 -0.896 . . . . 0.0 109.49 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 1.5 mttt -116.29 111.41 20.09 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.227 -0.92 . . . . 0.0 109.476 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.684 ' O ' ' HB2' ' A' ' 107' ' ' ALA . 2.8 mt -45.69 -84.6 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.194 -0.941 . . . . 0.0 109.48 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.862 ' HB2' ' HB3' ' A' ' 37' ' ' GLN . . . . . . . . 0 N--CA 1.49 1.547 0 O-C-N 121.282 -0.886 . . . . 0.0 109.486 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.3 t70 . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.499 ' O ' HG13 ' A' ' 33' ' ' VAL . . . -120.21 152.16 17.07 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.678 HG12 ' CB ' ' A' ' 103' ' ' LYS . 4.6 m -156.14 106.52 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.255 -1.144 . . . . 0.0 109.482 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.556 HG23 ' HE3' ' A' ' 102' ' ' MET . 3.0 t -89.75 140.66 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.221 -0.924 . . . . 0.0 109.48 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 17.0 ttm180 -106.71 108.01 19.31 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.262 -0.899 . . . . 0.0 109.435 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.761 ' CG2' HD13 ' A' ' 93' ' ' LEU . 22.2 mt -101.36 126.23 55.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.203 -0.935 . . . . 0.0 109.473 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.967 ' HB3' ' HB3' ' A' ' 107' ' ' ALA . 18.1 pt20 -146.59 -178.37 6.13 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.239 -0.913 . . . . 0.0 109.475 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 10.9 ttm180 -134.89 114.34 12.46 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.246 -0.909 . . . . 0.0 109.462 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.538 ' HB2' ' CD1' ' A' ' 50' ' ' LEU . 5.5 tp60 -87.78 127.5 35.32 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.245 -0.909 . . . . 0.0 109.438 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.523 0 O-C-N 121.267 -0.896 . . . . 0.0 109.518 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -109.15 144.52 16.51 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 29.5 m -144.45 151.99 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.258 -1.142 . . . . 0.0 109.458 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -109.52 116.66 32.2 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.226 -0.921 . . . . 0.0 109.483 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.691 ' O ' HD13 ' A' ' 51' ' ' ILE . 1.3 mp -96.99 147.73 23.7 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.251 -0.906 . . . . 0.0 109.53 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.691 HD13 ' O ' ' A' ' 50' ' ' LEU . 3.8 mm -136.08 125.87 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.293 -0.879 . . . . 0.0 109.387 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.406 ' HB ' HG13 ' A' ' 82' ' ' VAL . 1.4 t -158.16 168.46 26.99 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.186 -0.946 . . . . 0.0 109.508 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.35 -24.78 25.75 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.658 HG13 ' O ' ' A' ' 54' ' ' VAL . 8.0 p -49.55 106.97 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.255 -1.144 . . . . 0.0 109.496 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -100.48 78.85 2.05 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.195 -0.941 . . . . 0.0 109.462 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.456 HD23 ' HA ' ' A' ' 56' ' ' LEU . 16.4 mt -137.73 -173.57 3.53 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.231 -0.918 . . . . 0.0 109.455 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -68.0 138.26 55.74 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.24 -0.913 . . . . 0.0 109.446 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -50.08 -31.3 12.85 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.277 -0.89 . . . . 0.0 109.493 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.74 -43.42 93.44 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.249 -0.907 . . . . 0.0 109.5 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -66.18 -35.22 79.89 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.273 -0.892 . . . . 0.0 109.528 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.94 HD23 HD11 ' A' ' 83' ' ' ILE . 0.1 OUTLIER -59.63 -46.27 89.49 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.203 -0.935 . . . . 0.0 109.454 -179.955 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 39.5 p -71.06 -22.2 62.15 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.268 -0.895 . . . . 0.0 109.426 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.5 mmtp -71.77 -42.26 67.37 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.296 -0.877 . . . . 0.0 109.41 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -74.81 -34.64 62.41 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.203 -0.936 . . . . 0.0 109.285 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.63 -54.47 42.38 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.277 -0.889 . . . . 0.0 109.271 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.7 -39.2 93.24 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.274 -0.891 . . . . 0.0 109.213 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -54.89 -38.35 67.46 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.296 -0.878 . . . . 0.0 109.367 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 13.2 mt -82.17 -23.03 35.75 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.302 -0.874 . . . . 0.0 109.435 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 42.2 tttt -70.44 -22.93 62.65 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.22 -0.925 . . . . 0.0 109.268 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 4.6 mmtt -76.95 1.12 18.63 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.257 -0.902 . . . . 0.0 109.572 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 11.2 tttt -118.02 16.44 14.19 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.224 -0.922 . . . . 0.0 109.484 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -113.78 -33.04 5.93 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.201 -0.937 . . . . 0.0 109.544 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 87.72 -43.52 3.18 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 7.5 t -157.05 113.33 2.97 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.207 -1.172 . . . . 0.0 109.544 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 126.0 177.55 14.94 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 115.56 111.5 2.79 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -123.16 121.01 34.91 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.218 -1.166 . . . . 0.0 109.704 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.5 p -109.48 139.59 31.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.266 -0.896 . . . . 0.0 109.199 179.744 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.472 ' O ' ' N ' ' A' ' 81' ' ' GLY . 50.1 mttt -130.01 136.26 49.21 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.163 -0.961 . . . . 0.0 109.716 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -55.22 89.52 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.287 -0.883 . . . . 0.0 109.437 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.472 ' N ' ' O ' ' A' ' 79' ' ' LYS . . . 137.45 -44.78 1.11 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.406 HG13 ' HB ' ' A' ' 52' ' ' THR . 2.3 t -137.18 151.79 27.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.179 -1.189 . . . . 0.0 109.488 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.94 HD11 HD23 ' A' ' 61' ' ' LEU . 2.4 mp -124.66 140.63 47.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.209 -0.932 . . . . 0.0 109.555 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -128.92 139.0 52.32 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.315 -0.866 . . . . 0.0 109.372 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 17.8 mt -155.08 135.18 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.215 -0.928 . . . . 0.0 109.55 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -82.3 112.27 19.13 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.304 -0.872 . . . . 0.0 109.552 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -136.29 -39.78 0.14 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.461 -1.455 . . . . 0.0 109.461 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 46.28 36.61 3.42 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.227 -1.161 . . . . 0.0 109.521 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 5.4 mttp -137.91 53.7 1.82 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.261 -0.9 . . . . 0.0 109.473 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.562 ' HA ' HD12 ' A' ' 93' ' ' LEU . 1.9 mtm105 -49.64 -25.68 3.06 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.26 -0.9 . . . . 0.0 109.434 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -57.31 -53.34 59.17 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.255 -0.903 . . . . 0.0 109.443 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.6 tt -72.63 -33.4 66.62 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.262 -0.899 . . . . 0.0 109.471 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.761 HD13 ' CG2' ' A' ' 36' ' ' ILE . 48.0 mt -60.35 -27.42 67.36 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.263 -0.898 . . . . 0.0 109.406 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 75.4 tttt -64.65 -65.2 0.71 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.261 -0.9 . . . . 0.0 109.507 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -63.07 -15.42 56.52 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.228 -0.92 . . . . 0.0 109.468 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.766 HD23 ' N ' ' A' ' 97' ' ' LEU . 5.0 tt -71.22 -57.57 4.36 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.261 -0.899 . . . . 0.0 109.431 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.766 ' N ' HD23 ' A' ' 96' ' ' LEU . 0.1 OUTLIER -65.29 -32.38 74.0 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.252 -0.905 . . . . 0.0 109.469 179.993 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 56.5 mm-40 -67.8 -27.97 67.19 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.275 -0.891 . . . . 0.0 109.465 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.38 -32.21 73.73 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.295 -0.878 . . . . 0.0 109.441 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 17.2 mttt -80.52 -14.68 58.03 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.19 -0.944 . . . . 0.0 109.476 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 79.55 11.66 84.56 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' MET . . . . . 0.556 ' HE3' HG23 ' A' ' 34' ' ' VAL . 4.5 mtm -86.64 156.73 19.89 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.221 -1.164 . . . . 0.0 109.499 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.678 ' CB ' HG12 ' A' ' 33' ' ' VAL . 2.1 mmtt -80.69 108.44 14.34 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.242 -0.911 . . . . 0.0 109.445 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 34' ' ' VAL . 13.1 p -102.39 151.73 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.281 -0.887 . . . . 0.0 109.496 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.401 ' O ' ' N ' ' A' ' 107' ' ' ALA . 0.3 OUTLIER -115.32 79.21 1.25 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.243 -0.91 . . . . 0.0 109.472 179.993 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.488 HD23 ' C ' ' A' ' 106' ' ' LEU . 5.2 tt -46.74 100.45 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.247 -0.908 . . . . 0.0 109.463 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.967 ' HB3' ' HB3' ' A' ' 37' ' ' GLN . . . . . . . . 0 N--CA 1.491 1.581 0 O-C-N 121.259 -0.901 . . . . 0.0 109.494 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 16.6 t0 . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -169.46 107.4 0.27 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.546 HG12 ' HB2' ' A' ' 103' ' ' LYS . 27.0 m -121.86 144.96 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.281 -1.129 . . . . 0.0 109.426 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.54 ' O ' HG23 ' A' ' 104' ' ' VAL . 72.2 t -119.88 133.32 67.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.264 -0.898 . . . . 0.0 109.5 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 5.5 mtt180 -108.17 98.05 7.65 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.202 -0.937 . . . . 0.0 109.474 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.649 HG12 HD22 ' A' ' 93' ' ' LEU . 3.9 mt -98.63 145.42 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.251 -0.905 . . . . 0.0 109.432 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.425 ' O ' ' HG3' ' A' ' 37' ' ' GLN . 0.0 OUTLIER -179.46 122.46 0.08 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.253 -0.905 . . . . 0.0 109.473 179.977 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.5 132.51 44.78 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.23 -0.919 . . . . 0.0 109.462 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -121.45 149.21 43.36 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.279 -0.888 . . . . 0.0 109.506 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 11.2 p . . . . . 0 N--CA 1.49 1.572 0 O-C-N 121.269 -0.894 . . . . 0.0 109.444 -179.988 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 25.3 mttt . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 127.39 83.99 0.46 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 28.1 m -113.69 157.02 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.225 -1.162 . . . . 0.0 109.434 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.518 ' SG ' HD11 ' A' ' 51' ' ' ILE . 5.4 t -105.71 123.56 48.13 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.237 -0.914 . . . . 0.0 109.485 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.41 ' C ' HD13 ' A' ' 51' ' ' ILE . 1.4 mt -116.39 108.61 16.27 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.237 -0.914 . . . . 0.0 109.433 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.518 HD11 ' SG ' ' A' ' 49' ' ' CYS . 3.5 mm -96.13 121.22 46.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.268 -0.895 . . . . 0.0 109.533 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.505 HG22 ' H ' ' A' ' 53' ' ' GLY . 0.2 OUTLIER -135.6 -169.32 2.37 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.264 -0.897 . . . . 0.0 109.497 179.938 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.505 ' H ' HG22 ' A' ' 52' ' ' THR . . . 63.35 46.42 92.82 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.8 t -95.94 122.63 47.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.216 -1.167 . . . . 0.0 109.491 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -105.24 77.61 1.32 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.218 -0.926 . . . . 0.0 109.496 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 37.7 mt -135.89 165.93 24.49 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.24 -0.912 . . . . 0.0 109.481 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -65.79 -73.59 0.13 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.303 -0.873 . . . . 0.0 109.454 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -173.45 -52.09 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.229 -0.919 . . . . 0.0 109.479 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.41 -33.42 74.75 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.221 -0.924 . . . . 0.0 109.495 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -69.73 -30.15 67.7 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.222 -0.924 . . . . 0.0 109.434 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.5 tt -70.54 -45.95 64.51 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.225 -0.922 . . . . 0.0 109.4 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -61.35 -43.97 97.97 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.255 -0.903 . . . . 0.0 109.45 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 76.8 tttt -60.56 -52.14 66.46 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.273 -0.892 . . . . 0.0 109.433 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.47 ' HA ' HD22 ' A' ' 64' ' ' LEU . 0.2 OUTLIER -48.01 -47.48 33.33 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.169 -0.957 . . . . 0.0 109.316 179.96 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.03 -42.14 84.69 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.293 -0.879 . . . . 0.0 109.297 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.35 -24.26 67.2 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.289 -0.882 . . . . 0.0 109.343 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -75.39 -38.62 59.83 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.34 -0.85 . . . . 0.0 109.431 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 9.5 mt -68.17 -42.57 79.79 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.246 -0.909 . . . . 0.0 109.314 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 17.2 tttt -56.81 -43.9 81.44 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.281 -0.887 . . . . 0.0 109.341 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 10.5 mttt -52.66 -33.19 45.99 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.21 -0.931 . . . . 0.0 109.459 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 34.4 mttt -116.61 54.78 0.84 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.169 -0.957 . . . . 0.0 109.836 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -140.36 -37.95 0.45 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.091 -1.006 . . . . 0.0 109.559 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.487 ' O ' ' CB ' ' A' ' 74' ' ' CYS . . . 91.28 -24.1 21.03 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 -179.843 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.487 ' CB ' ' O ' ' A' ' 73' ' ' GLY . 1.6 p 165.62 133.14 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.3 -1.117 . . . . 0.0 109.392 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.7 114.31 3.63 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 178.25 76.22 0.06 OUTLIER Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.564 ' HB3' ' HB2' ' A' ' 84' ' ' GLU . . . -83.95 151.33 25.12 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.297 -1.119 . . . . 0.0 109.473 -179.833 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 37.5 t -119.6 142.95 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.263 -0.898 . . . . 0.0 109.269 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.422 ' HB2' ' O ' ' A' ' 82' ' ' VAL . 16.3 mttt -147.33 171.18 15.84 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.267 -0.896 . . . . 0.0 109.496 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -63.8 102.62 0.48 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.344 -0.848 . . . . 0.0 109.718 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 63.18 25.9 68.73 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 179.725 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.422 ' O ' ' HB2' ' A' ' 79' ' ' LYS . 40.8 t -146.21 123.26 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.232 -1.158 . . . . 0.0 109.414 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 34.9 mt -117.86 139.59 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.223 -0.923 . . . . 0.0 109.508 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.564 ' HB2' ' HB3' ' A' ' 77' ' ' ALA . 1.3 mt-10 -115.09 131.2 57.0 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.195 -0.94 . . . . 0.0 109.325 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.415 HD13 ' HA ' ' A' ' 85' ' ' ILE . 47.3 mm -128.82 137.33 57.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.203 -0.935 . . . . 0.0 109.583 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -96.39 109.35 21.89 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.28 -0.888 . . . . 0.0 109.449 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 165.68 166.96 25.55 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -129.2 62.8 1.51 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.266 -1.138 . . . . 0.0 109.47 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 76.0 mttt -127.27 52.19 1.83 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.214 -0.929 . . . . 0.0 109.473 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.431 ' HG3' ' N ' ' A' ' 91' ' ' ASP . 6.6 ptt180 -52.25 -36.11 51.67 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.32 -0.863 . . . . 0.0 109.442 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.431 ' N ' ' HG3' ' A' ' 90' ' ' ARG . 21.9 m-20 -60.21 -43.22 96.15 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.274 -0.891 . . . . 0.0 109.519 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.45 -34.6 77.51 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.23 -0.919 . . . . 0.0 109.484 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.681 ' HA ' HD21 ' A' ' 96' ' ' LEU . 0.3 OUTLIER -62.15 -39.83 93.94 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.286 -0.884 . . . . 0.0 109.504 179.983 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 76.1 tttt -63.76 -27.07 68.94 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.242 -0.911 . . . . 0.0 109.427 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 20.7 t -75.61 -60.67 2.21 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.273 -0.892 . . . . 0.0 109.504 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.999 HD12 ' N ' ' A' ' 97' ' ' LEU . 4.0 pp -52.36 -33.16 41.79 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.271 -0.893 . . . . 0.0 109.479 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.999 ' N ' HD12 ' A' ' 96' ' ' LEU . 0.1 OUTLIER -68.89 -54.15 17.18 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.276 -0.89 . . . . 0.0 109.508 179.978 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -64.78 -12.52 48.46 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.286 -0.884 . . . . 0.0 109.523 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.28 -28.32 69.24 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.238 -0.914 . . . . 0.0 109.469 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 33.6 mttm -95.86 -24.92 16.22 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.263 -0.898 . . . . 0.0 109.445 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 103.04 13.92 27.88 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -76.62 147.98 37.22 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.254 -1.144 . . . . 0.0 109.488 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.546 ' HB2' HG12 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -80.47 87.16 5.7 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.254 -0.904 . . . . 0.0 109.434 -179.999 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.54 HG23 ' O ' ' A' ' 34' ' ' VAL . 11.7 p -85.88 133.19 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.225 -0.922 . . . . 0.0 109.475 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.417 ' O ' ' N ' ' A' ' 107' ' ' ALA . 5.3 mttt -102.33 86.18 2.77 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.285 -0.885 . . . . 0.0 109.469 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 4.7 tp -52.27 95.89 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.192 -0.942 . . . . 0.0 109.483 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.417 ' N ' ' O ' ' A' ' 105' ' ' LYS . . . . . . . . 0 N--CA 1.49 1.542 0 O-C-N 121.281 -0.887 . . . . 0.0 109.468 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -108.4 167.3 13.16 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.941 HG23 ' O ' ' A' ' 103' ' ' LYS . 3.3 p -150.41 94.47 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.233 -1.157 . . . . 0.0 109.504 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.91 ' HB ' HD21 ' A' ' 97' ' ' LEU . 69.6 t -85.14 107.42 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.251 -0.905 . . . . 0.0 109.484 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 82.6 mtt180 -83.45 120.81 26.36 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.268 -0.895 . . . . 0.0 109.445 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.767 HG21 HD13 ' A' ' 93' ' ' LEU . 5.6 mt -120.14 116.31 49.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.196 -0.94 . . . . 0.0 109.524 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.934 ' HB3' ' HB3' ' A' ' 107' ' ' ALA . 28.2 pt20 -143.76 151.25 39.75 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.207 -0.933 . . . . 0.0 109.454 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.455 ' O ' ' HG3' ' A' ' 38' ' ' ARG . 11.9 ptt180 -95.47 122.59 38.36 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.221 -0.924 . . . . 0.0 109.439 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 7.2 tp60 -83.04 -37.2 24.22 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.3 -0.875 . . . . 0.0 109.484 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.541 0 O-C-N 121.234 -0.916 . . . . 0.0 109.448 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 12.6 mttt . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.7 173.32 31.02 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 16.0 m -143.22 156.92 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.261 -1.14 . . . . 0.0 109.416 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -118.21 110.89 18.11 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.241 -0.912 . . . . 0.0 109.471 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.453 ' C ' HD13 ' A' ' 51' ' ' ILE . 56.5 mt -93.79 123.83 37.39 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.273 -0.892 . . . . 0.0 109.514 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.453 HD13 ' C ' ' A' ' 50' ' ' LEU . 4.7 mm -109.4 110.94 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.28 -0.888 . . . . 0.0 109.453 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -158.48 152.68 24.03 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.269 -0.894 . . . . 0.0 109.448 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.443 ' O ' HG13 ' A' ' 33' ' ' VAL . . . 100.36 51.8 1.2 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 6.1 t -116.53 100.17 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.255 -1.144 . . . . 0.0 109.497 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -77.36 102.49 6.81 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.223 -0.923 . . . . 0.0 109.505 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.439 HD23 ' H ' ' A' ' 57' ' ' ASP . 0.1 OUTLIER -150.8 -157.43 0.81 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.252 -0.905 . . . . 0.0 109.481 179.991 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.439 ' H ' HD23 ' A' ' 56' ' ' LEU . 5.5 m-20 -76.58 -86.56 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.27 -0.894 . . . . 0.0 109.473 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -177.84 -47.33 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.307 -0.87 . . . . 0.0 109.36 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.8 -23.12 52.84 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.289 -0.882 . . . . 0.0 109.364 179.866 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.402 ' CB ' HD22 ' A' ' 56' ' ' LEU . 1.9 mm-40 -68.25 -28.07 66.89 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.267 -0.895 . . . . 0.0 109.437 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.95 -32.94 74.52 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.215 -0.928 . . . . 0.0 109.348 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -71.14 -40.7 71.22 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.275 -0.89 . . . . 0.0 109.391 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -66.79 -37.55 84.78 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.201 -0.937 . . . . 0.0 109.365 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.489 HD21 HG21 ' A' ' 34' ' ' VAL . 53.4 tp -65.35 -50.96 63.6 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.267 -0.896 . . . . 0.0 109.356 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.95 -26.96 69.07 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.306 -0.871 . . . . 0.0 109.295 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -74.21 -34.51 63.73 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.328 -0.858 . . . . 0.0 109.34 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -76.75 -26.71 54.86 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.254 -0.904 . . . . 0.0 109.39 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.489 ' HA ' HD13 ' A' ' 68' ' ' LEU . 0.5 OUTLIER -77.9 -37.01 48.91 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.267 -0.895 . . . . 0.0 109.437 -179.978 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 7.3 ttpt -67.61 -24.04 65.43 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.283 -0.886 . . . . 0.0 109.422 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.9 -29.71 60.43 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.288 -0.883 . . . . 0.0 109.536 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 4.0 mtmt -132.08 52.63 2.06 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.257 -0.902 . . . . 0.0 109.492 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' CYS . . . . . 0.581 ' SG ' HG23 ' A' ' 85' ' ' ILE . 9.1 t -110.13 -28.68 8.55 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.274 -0.891 . . . . 0.0 109.49 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.408 ' O ' ' HB2' ' A' ' 74' ' ' CYS . . . 77.73 6.19 86.82 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.408 ' HB2' ' O ' ' A' ' 73' ' ' GLY . 23.2 t 177.37 125.31 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.241 -1.152 . . . . 0.0 109.455 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -102.85 139.11 14.29 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -114.5 -100.86 2.37 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -117.78 133.36 56.01 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.211 -1.17 . . . . 0.0 109.333 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.0 t -124.85 99.13 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.19 -0.944 . . . . 0.0 109.669 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 61.4 mttm -115.29 141.47 47.99 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.272 -0.893 . . . . 0.0 109.322 179.822 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -60.39 99.84 0.09 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.207 -0.933 . . . . 0.0 109.391 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 121.17 -33.03 4.51 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 30.9 t -132.84 117.53 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.294 -1.121 . . . . 0.0 109.361 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 7.6 mt -123.13 123.71 68.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.291 -0.881 . . . . 0.0 109.556 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 53.6 tt0 -106.1 124.79 50.13 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.166 -0.959 . . . . 0.0 109.422 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.581 HG23 ' SG ' ' A' ' 72' ' ' CYS . 45.2 mm -115.2 143.44 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.228 -0.92 . . . . 0.0 109.555 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -112.68 113.64 25.86 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.301 -0.874 . . . . 0.0 109.501 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 178.74 -140.37 4.45 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.544 -1.423 . . . . 0.0 109.544 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.464 ' O ' ' CG ' ' A' ' 89' ' ' LYS . 17.6 t0 -177.35 79.9 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.261 -1.141 . . . . 0.0 109.514 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.464 ' CG ' ' O ' ' A' ' 88' ' ' ASP . 90.4 mttt -156.89 40.27 0.33 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.291 -0.881 . . . . 0.0 109.473 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 68.4 ttt180 -47.55 -31.5 4.46 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.282 -0.886 . . . . 0.0 109.527 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -57.46 -53.56 56.72 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.243 -0.91 . . . . 0.0 109.493 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 3.3 tp -63.82 -31.71 72.97 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.218 -0.926 . . . . 0.0 109.502 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.767 HD13 HG21 ' A' ' 36' ' ' ILE . 0.6 OUTLIER -59.09 -41.68 88.65 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.242 -0.911 . . . . 0.0 109.493 179.964 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -64.72 -27.04 68.64 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.272 -0.893 . . . . 0.0 109.519 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 1.1 t -73.94 -62.42 1.51 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.228 -0.92 . . . . 0.0 109.487 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.943 HD12 ' N ' ' A' ' 97' ' ' LEU . 4.1 pp -51.96 -31.11 27.66 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.237 -0.914 . . . . 0.0 109.526 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.943 ' N ' HD12 ' A' ' 96' ' ' LEU . 0.2 OUTLIER -70.03 -50.1 44.65 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.235 -0.916 . . . . 0.0 109.459 -179.927 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -65.49 -14.48 61.09 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.189 -0.945 . . . . 0.0 109.505 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -73.19 -27.94 61.92 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.252 -0.905 . . . . 0.0 109.489 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.8 mptt -87.65 -13.13 43.46 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.284 -0.885 . . . . 0.0 109.484 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 74.13 31.17 59.92 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 2.0 mtm -98.06 167.02 11.15 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.265 -1.138 . . . . 0.0 109.468 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.941 ' O ' HG23 ' A' ' 33' ' ' VAL . 2.3 mttm -86.53 93.34 9.15 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.292 -0.88 . . . . 0.0 109.457 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.641 ' HB ' HD12 ' A' ' 97' ' ' LEU . 7.5 p -83.31 136.43 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.241 -0.912 . . . . 0.0 109.5 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.9 90.25 3.33 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.302 -0.874 . . . . 0.0 109.456 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 45.3 mt -57.04 94.02 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.238 -0.914 . . . . 0.0 109.509 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.934 ' HB3' ' HB3' ' A' ' 37' ' ' GLN . . . . . . . . 0 N--CA 1.49 1.555 0 O-C-N 121.277 -0.889 . . . . 0.0 109.454 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -126.86 119.06 3.2 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 33' ' ' VAL . 5.2 m -125.65 90.62 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.273 -1.134 . . . . 0.0 109.443 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.506 HG12 ' N ' ' A' ' 35' ' ' ARG . 44.9 t -97.59 163.21 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.241 -0.912 . . . . 0.0 109.459 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.506 ' N ' HG12 ' A' ' 34' ' ' VAL . 69.5 mtt180 -147.79 121.66 9.34 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.248 -0.908 . . . . 0.0 109.458 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.776 HD11 HD13 ' A' ' 97' ' ' LEU . 1.1 mp -116.21 94.54 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.24 -0.913 . . . . 0.0 109.493 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.415 ' HB3' ' HB3' ' A' ' 107' ' ' ALA . 7.8 pt20 -106.97 -176.02 2.96 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.258 -0.901 . . . . 0.0 109.473 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 18.4 mtp180 -122.02 142.12 50.65 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.291 -0.881 . . . . 0.0 109.464 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -105.62 102.54 11.99 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.185 -0.947 . . . . 0.0 109.473 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 3.0 t . . . . . 0 N--CA 1.491 1.584 0 O-C-N 121.247 -0.908 . . . . 0.0 109.444 -179.946 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 92.2 mttt . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 121.301 0.572 . . . . 0.0 109.475 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 114.76 146.34 9.05 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 5.6 m -138.71 162.75 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.241 -1.152 . . . . 0.0 109.581 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 92.2 m -112.37 138.22 49.42 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.277 -0.889 . . . . 0.0 109.39 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.415 HD23 ' N ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -132.26 113.36 13.15 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.243 -0.91 . . . . 0.0 109.493 -179.972 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.682 HG13 HG23 ' A' ' 36' ' ' ILE . 3.7 mp -85.91 131.01 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.208 -0.933 . . . . 0.0 109.503 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.0 p -142.15 -174.54 4.13 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.236 -0.915 . . . . 0.0 109.453 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 52.04 51.36 41.08 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.6 t -97.13 110.69 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.289 -1.124 . . . . 0.0 109.41 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -97.43 78.18 2.67 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.258 -0.901 . . . . 0.0 109.488 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.647 HD12 ' CB ' ' A' ' 60' ' ' GLU . 1.8 mm? -115.86 -167.7 1.3 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.228 -0.92 . . . . 0.0 109.49 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -96.57 -61.03 1.48 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.257 -0.902 . . . . 0.0 109.47 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 175.74 -54.59 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.308 -0.87 . . . . 0.0 109.394 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -75.55 -23.05 56.57 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.252 -0.905 . . . . 0.0 109.435 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.647 ' CB ' HD12 ' A' ' 56' ' ' LEU . 0.4 OUTLIER -75.29 -33.48 61.21 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.289 -0.882 . . . . 0.0 109.441 179.986 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.0 -44.42 84.86 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.266 -0.897 . . . . 0.0 109.374 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 57.2 m -69.02 -29.77 68.01 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.266 -0.896 . . . . 0.0 109.514 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -70.67 -35.48 72.85 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.232 -0.918 . . . . 0.0 109.49 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.419 HD22 ' HA ' ' A' ' 64' ' ' LEU . 0.1 OUTLIER -72.45 -59.83 2.53 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.214 -0.929 . . . . 0.0 109.494 179.986 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -48.39 -45.39 35.84 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.278 -0.889 . . . . 0.0 109.473 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.18 -41.37 99.21 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.262 -0.899 . . . . 0.0 109.465 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -59.35 -32.62 70.27 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.212 -0.93 . . . . 0.0 109.534 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.533 HD21 ' CD1' ' A' ' 96' ' ' LEU . 3.5 mt -82.89 -22.28 33.99 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.265 -0.897 . . . . 0.0 109.405 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.98 -21.08 59.37 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.302 -0.873 . . . . 0.0 109.758 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.6 -14.18 61.14 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.274 -0.891 . . . . 0.0 110.264 -179.412 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.02 37.88 1.17 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.053 -1.029 . . . . 0.0 109.584 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' CYS . . . . . 0.638 ' SG ' HD12 ' A' ' 85' ' ' ILE . 0.1 OUTLIER -99.06 -64.79 1.01 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.269 -0.894 . . . . 0.0 109.566 -179.958 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.479 ' O ' ' CB ' ' A' ' 74' ' ' CYS . . . 116.21 18.81 5.72 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.479 ' CB ' ' O ' ' A' ' 73' ' ' GLY . 0.5 OUTLIER 164.93 93.06 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.275 -1.132 . . . . 0.0 109.438 -179.961 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -57.27 100.71 0.13 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -77.38 -159.09 10.44 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -74.2 146.57 43.27 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.128 -1.219 . . . . 0.0 109.314 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 57.9 t -135.18 93.77 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.176 -0.952 . . . . 0.0 109.695 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.04 156.35 18.85 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.332 -0.855 . . . . 0.0 109.333 179.821 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -71.58 101.45 2.5 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.173 -0.954 . . . . 0.0 109.54 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.404 ' C ' ' CG2' ' A' ' 82' ' ' VAL . . . 117.44 -11.93 14.06 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.404 ' CG2' ' C ' ' A' ' 81' ' ' GLY . 3.3 t -152.72 117.75 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.297 -1.12 . . . . 0.0 109.357 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 15.2 mt -122.76 123.68 68.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.189 -0.944 . . . . 0.0 109.744 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -92.14 136.06 33.49 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.308 -0.87 . . . . 0.0 109.27 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.638 HD12 ' SG ' ' A' ' 72' ' ' CYS . 13.1 mm -131.9 95.93 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.171 -0.956 . . . . 0.0 109.521 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -56.56 133.85 53.84 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.296 -0.877 . . . . 0.0 109.407 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 143.9 173.72 15.59 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -139.92 81.32 1.81 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.28 -1.13 . . . . 0.0 109.419 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 13.7 pttt -145.55 49.03 1.24 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.261 -0.9 . . . . 0.0 109.456 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 7.1 ptt180 -47.69 -37.53 13.21 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.258 -0.901 . . . . 0.0 109.516 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -56.15 -49.66 73.33 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.261 -0.899 . . . . 0.0 109.438 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.498 ' HA ' HD22 ' A' ' 92' ' ' LEU . 0.2 OUTLIER -60.15 -44.13 95.2 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.268 -0.895 . . . . 0.0 109.501 -179.992 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.538 ' HG ' HG21 ' A' ' 36' ' ' ILE . 4.3 mm? -56.15 -35.13 66.82 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.237 -0.914 . . . . 0.0 109.42 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 67.9 tttt -60.87 -62.07 2.12 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.25 -0.906 . . . . 0.0 109.491 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -62.82 -14.1 41.47 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.216 -0.928 . . . . 0.0 109.421 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.856 HD23 ' N ' ' A' ' 97' ' ' LEU . 4.7 tt -72.78 -62.08 1.58 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.231 -0.918 . . . . 0.0 109.473 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.856 ' N ' HD23 ' A' ' 96' ' ' LEU . 0.1 OUTLIER -61.78 -31.9 72.15 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.266 -0.896 . . . . 0.0 109.444 -179.983 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -71.86 -25.56 62.0 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.277 -0.889 . . . . 0.0 109.506 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -68.79 -26.82 65.4 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.209 -0.932 . . . . 0.0 109.474 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -85.78 -39.31 17.25 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.244 -0.91 . . . . 0.0 109.504 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 117.65 14.46 6.82 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' MET . . . . . 0.413 ' HB2' HD23 ' A' ' 97' ' ' LEU . 19.0 mtp -96.62 154.12 17.46 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.293 -1.122 . . . . 0.0 109.451 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 11.1 mptt -81.19 118.94 22.99 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.282 -0.886 . . . . 0.0 109.512 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.773 ' HB ' HD22 ' A' ' 97' ' ' LEU . 12.1 p -115.32 135.06 56.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.265 -0.897 . . . . 0.0 109.456 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 71.6 tttt -102.28 97.56 7.82 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.273 -0.892 . . . . 0.0 109.465 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.459 ' O ' ' HB3' ' A' ' 107' ' ' ALA . 23.9 tp -45.59 -30.35 1.47 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.285 -0.884 . . . . 0.0 109.497 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.459 ' HB3' ' O ' ' A' ' 106' ' ' LEU . . . . . . . . 0 N--CA 1.49 1.55 0 O-C-N 121.232 -0.918 . . . . 0.0 109.48 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.586 ' HA3' HD21 ' A' ' 56' ' ' LEU . . . -122.94 145.45 16.21 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.673 HG12 ' HB2' ' A' ' 103' ' ' LYS . 16.3 m -132.21 137.71 53.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.29 -1.124 . . . . 0.0 109.45 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.761 ' HB ' HD21 ' A' ' 97' ' ' LEU . 60.3 t -106.6 162.29 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.196 -0.94 . . . . 0.0 109.478 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.53 ' N ' HG12 ' A' ' 34' ' ' VAL . 4.4 ttt180 -135.62 108.07 7.37 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.243 -0.911 . . . . 0.0 109.48 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.739 HG12 HD22 ' A' ' 93' ' ' LEU . 3.2 mt -116.53 128.11 73.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.208 -0.933 . . . . 0.0 109.429 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.745 ' HB3' ' HB3' ' A' ' 107' ' ' ALA . 4.0 pt20 -156.07 153.88 30.1 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.258 -0.901 . . . . 0.0 109.477 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.1 143.14 34.66 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.248 -0.908 . . . . 0.0 109.487 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 20.2 tt0 -109.55 71.2 0.76 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.203 -0.936 . . . . 0.0 109.47 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 3.3 t . . . . . 0 N--CA 1.491 1.579 0 O-C-N 121.29 -0.881 . . . . 0.0 109.485 179.954 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 12.3 tttt . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -96.16 123.27 7.64 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 15.6 m -121.44 143.31 34.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.239 -1.154 . . . . 0.0 109.328 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -125.37 133.92 52.36 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.211 -0.93 . . . . 0.0 109.53 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.425 ' HG ' ' O ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -123.29 120.52 33.34 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.264 -0.898 . . . . 0.0 109.41 179.951 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.452 HD13 ' N ' ' A' ' 51' ' ' ILE . 3.2 mm -90.91 119.61 38.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.232 -0.917 . . . . 0.0 109.441 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.92 159.4 44.58 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.273 -0.892 . . . . 0.0 109.455 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 108.05 -31.21 8.13 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.54 HG22 HG22 ' A' ' 34' ' ' VAL . 57.0 t -45.02 113.05 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.221 -1.164 . . . . 0.0 109.419 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -114.34 76.8 1.01 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.234 -0.916 . . . . 0.0 109.478 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.586 HD21 ' HA3' ' A' ' 32' ' ' GLY . 31.3 mt -130.06 -156.33 0.75 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.255 -0.903 . . . . 0.0 109.439 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.598 ' O ' HD12 ' A' ' 61' ' ' LEU . 4.4 m-20 -67.34 143.28 56.46 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.278 -0.889 . . . . 0.0 109.446 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -58.08 -36.02 72.24 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.248 -0.907 . . . . 0.0 109.66 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -75.25 -32.55 61.12 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.182 -0.949 . . . . 0.0 109.531 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -71.95 -26.3 62.22 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.278 -0.889 . . . . 0.0 109.534 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.598 HD12 ' O ' ' A' ' 57' ' ' ASP . 0.2 OUTLIER -71.87 -56.87 4.94 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.219 -0.925 . . . . 0.0 109.549 -179.962 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 4.5 t -56.45 -24.36 44.96 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.266 -0.896 . . . . 0.0 109.453 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 79.2 mttt -75.54 -46.17 33.66 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.259 -0.9 . . . . 0.0 109.515 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.415 ' HA ' HD22 ' A' ' 64' ' ' LEU . 0.4 OUTLIER -60.73 -46.02 92.04 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.188 -0.945 . . . . 0.0 109.359 179.939 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.41 ' CB ' HG13 ' A' ' 78' ' ' VAL . . . -65.78 -38.09 88.08 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.271 -0.893 . . . . 0.0 109.381 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.82 -36.98 75.39 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.227 -0.921 . . . . 0.0 109.413 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -75.55 -35.99 60.53 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.231 -0.918 . . . . 0.0 109.445 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.433 HD13 ' HA ' ' A' ' 68' ' ' LEU . 0.1 OUTLIER -56.55 -53.17 60.65 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.347 -0.846 . . . . 0.0 109.605 -179.932 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 15.4 pttp -66.16 -34.02 77.1 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.277 -0.889 . . . . 0.0 109.494 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -59.7 -21.83 61.16 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.316 -0.865 . . . . 0.0 109.71 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -85.07 -36.72 21.01 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.221 -0.925 . . . . 0.0 109.75 -179.655 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.2 m -94.42 -64.95 1.02 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.219 -0.925 . . . . 0.0 109.574 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 118.23 5.2 13.33 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 -179.726 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 46.8 t -160.15 121.87 3.19 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.307 -1.114 . . . . 0.0 109.258 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -129.35 -106.81 1.25 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 -179.732 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -172.84 -47.07 0.04 OUTLIER Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -178.55 119.52 0.08 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.291 -1.123 . . . . 0.0 109.56 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.416 HG22 HG23 ' A' ' 83' ' ' ILE . 77.9 t -100.98 97.82 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.312 -0.868 . . . . 0.0 109.292 179.837 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -106.34 141.34 37.82 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.213 -0.929 . . . . 0.0 109.814 -179.698 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -57.82 96.16 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.329 -0.857 . . . . 0.0 109.44 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 127.45 -40.78 1.7 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 23.5 t -132.93 122.51 46.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.179 -1.189 . . . . 0.0 109.58 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.416 HG23 HG22 ' A' ' 78' ' ' VAL . 2.9 mp -120.6 132.33 70.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.316 -0.865 . . . . 0.0 109.241 179.829 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -110.25 137.14 48.39 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.236 -0.915 . . . . 0.0 109.583 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 31.2 mm -132.59 123.18 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.299 -0.876 . . . . 0.0 109.563 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -91.78 104.95 17.34 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.204 -0.935 . . . . 0.0 109.438 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 178.6 -162.9 30.42 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -153.5 70.78 0.86 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.243 -1.151 . . . . 0.0 109.47 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 77.3 mttt -136.57 50.0 2.05 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.263 -0.898 . . . . 0.0 109.578 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 24.5 ptt180 -60.21 -34.04 73.09 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.227 -0.92 . . . . 0.0 109.478 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 30.5 t0 -55.74 -56.14 23.97 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.242 -0.911 . . . . 0.0 109.416 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.38 -31.03 71.63 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.249 -0.907 . . . . 0.0 109.398 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.739 HD22 HG12 ' A' ' 36' ' ' ILE . 0.4 OUTLIER -58.9 -45.16 90.96 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.31 -0.868 . . . . 0.0 109.442 179.961 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -61.91 -31.86 72.2 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.28 -0.887 . . . . 0.0 109.562 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.415 ' O ' ' C ' ' A' ' 96' ' ' LEU . 1.5 t -68.9 -69.76 0.31 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.216 -0.928 . . . . 0.0 109.499 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.961 HD12 ' N ' ' A' ' 97' ' ' LEU . 4.1 pp -43.78 -37.56 2.8 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.272 -0.892 . . . . 0.0 109.532 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.961 ' N ' HD12 ' A' ' 96' ' ' LEU . 10.6 tp -63.04 -47.24 83.87 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.213 -0.929 . . . . 0.0 109.46 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -69.2 -15.62 63.43 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.285 -0.884 . . . . 0.0 109.481 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -69.99 -28.34 65.44 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.22 -0.925 . . . . 0.0 109.472 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.446 ' HD3' ' N ' ' A' ' 100' ' ' LYS . 0.3 OUTLIER -85.77 -16.24 39.49 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.23 -0.919 . . . . 0.0 109.466 -179.951 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 84.94 14.38 69.8 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' MET . . . . . 0.481 ' HE3' HG23 ' A' ' 34' ' ' VAL . 1.4 mtm -87.29 171.89 10.28 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.243 -1.151 . . . . 0.0 109.43 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.673 ' HB2' HG12 ' A' ' 33' ' ' VAL . 0.1 OUTLIER -80.43 164.93 22.68 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.238 -0.913 . . . . 0.0 109.452 179.974 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.848 HG13 HD23 ' A' ' 97' ' ' LEU . 4.8 t -139.49 125.88 23.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.215 -0.928 . . . . 0.0 109.48 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.427 ' O ' ' C ' ' A' ' 106' ' ' LEU . 2.5 mttt -106.5 64.46 0.66 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.189 -0.944 . . . . 0.0 109.491 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.43 HD12 ' HA ' ' A' ' 106' ' ' LEU . 3.6 tp -43.93 102.55 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.28 -0.887 . . . . 0.0 109.494 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.745 ' HB3' ' HB3' ' A' ' 37' ' ' GLN . . . . . . . . 0 N--CA 1.49 1.568 0 O-C-N 121.23 -0.919 . . . . 0.0 109.456 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 65.9 t0 . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -99.53 139.33 14.37 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 33' ' ' VAL . 18.8 m -143.89 121.56 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.213 -1.169 . . . . 0.0 109.459 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.446 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 2.4 t -98.94 152.8 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.281 -0.887 . . . . 0.0 109.474 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.421 ' HG2' ' C ' ' A' ' 34' ' ' VAL . 4.4 mtt180 -139.01 118.56 12.95 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.314 -0.866 . . . . 0.0 109.461 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.907 HG21 ' HG ' ' A' ' 93' ' ' LEU . 2.6 mp -125.64 116.91 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.218 -0.926 . . . . 0.0 109.45 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.518 ' HB3' ' HB3' ' A' ' 107' ' ' ALA . 12.7 pt20 -146.96 174.24 11.7 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.186 -0.946 . . . . 0.0 109.504 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.401 ' HB2' ' HD2' ' A' ' 90' ' ' ARG . 9.1 ttm180 -102.1 149.74 23.96 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.221 -0.924 . . . . 0.0 109.469 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -136.27 108.04 7.05 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.233 -0.917 . . . . 0.0 109.405 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 40.5 p . . . . . 0 N--CA 1.489 1.518 0 O-C-N 121.264 -0.898 . . . . 0.0 109.493 179.96 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -107.28 135.09 12.55 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 18.6 m -133.06 168.75 23.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.252 -1.146 . . . . 0.0 109.461 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -119.83 116.98 26.97 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.184 -0.947 . . . . 0.0 109.54 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -92.69 129.51 38.59 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.254 -0.904 . . . . 0.0 109.425 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.727 HG12 HG23 ' A' ' 36' ' ' ILE . 21.9 mt -110.07 111.62 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.256 -0.903 . . . . 0.0 109.562 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 60.2 p -137.98 176.25 8.86 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.243 -0.91 . . . . 0.0 109.452 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.89 -15.11 59.81 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 18.6 t -56.67 122.01 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.248 -1.148 . . . . 0.0 109.466 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -124.45 72.12 1.18 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.255 -0.903 . . . . 0.0 109.486 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.643 HD13 ' HB3' ' A' ' 60' ' ' GLU . 8.3 mt -113.15 -173.36 2.24 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.28 -0.887 . . . . 0.0 109.466 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.61 -83.6 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.269 -0.895 . . . . 0.0 109.536 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -156.24 -61.09 0.1 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.22 -0.925 . . . . 0.0 109.452 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.442 ' O ' HG22 ' A' ' 62' ' ' THR . . . -65.33 -26.6 68.11 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.235 -0.916 . . . . 0.0 109.45 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.643 ' HB3' HD13 ' A' ' 56' ' ' LEU . 5.4 mt-10 -62.58 -42.5 99.6 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.253 -0.904 . . . . 0.0 109.481 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -56.03 -59.15 5.32 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.212 -0.93 . . . . 0.0 109.403 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.442 HG22 ' O ' ' A' ' 59' ' ' ALA . 8.8 t -59.46 -20.6 56.43 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.281 -0.887 . . . . 0.0 109.506 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.2 tttt -70.94 -71.06 0.27 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.215 -0.928 . . . . 0.0 109.522 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.635 HD13 ' O ' ' A' ' 64' ' ' LEU . 0.2 OUTLIER -48.25 -32.24 6.95 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.3 -0.875 . . . . 0.0 109.761 -179.869 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.42 -49.86 61.91 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.123 -0.986 . . . . 0.0 109.902 -179.715 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.421 ' O ' ' HG3' ' A' ' 70' ' ' LYS . . . -60.01 -28.99 68.18 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.089 -1.007 . . . . 0.0 109.891 -179.652 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.45 ' O ' ' HB2' ' A' ' 70' ' ' LYS . 2.6 tt0 -76.71 -33.83 58.18 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.127 -0.983 . . . . 0.0 109.835 -179.709 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.468 ' HA ' HD23 ' A' ' 68' ' ' LEU . 29.7 mt -71.62 -42.79 67.2 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.155 -0.965 . . . . 0.0 109.624 -179.788 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 18.7 mtmt -72.34 -4.51 30.32 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.171 -0.956 . . . . 0.0 109.461 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.45 ' HB2' ' O ' ' A' ' 67' ' ' GLU . 4.3 mttt -74.0 -21.8 59.84 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.131 -0.981 . . . . 0.0 109.955 -179.509 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.93 59.3 1.54 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.12 -0.988 . . . . 0.0 109.579 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 4.9 t -134.31 -3.76 2.71 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.17 -0.956 . . . . 0.0 110.029 -179.663 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.13 2.68 54.13 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -163.54 -169.12 1.84 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.157 -1.202 . . . . 0.0 109.512 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -140.81 -116.18 1.27 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 144.1 -172.36 25.26 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -87.26 126.14 34.64 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.231 -1.158 . . . . 0.0 109.464 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.581 ' O ' HG23 ' A' ' 78' ' ' VAL . 18.8 m -99.39 88.43 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.186 -0.946 . . . . 0.0 109.565 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.47 148.23 22.45 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.208 -0.933 . . . . 0.0 109.351 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -70.83 89.89 0.78 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.193 -0.942 . . . . 0.0 109.555 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.453 ' O ' HG23 ' A' ' 82' ' ' VAL . . . 123.85 -11.19 8.34 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 81' ' ' GLY . 73.2 t -156.18 121.41 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.299 -1.118 . . . . 0.0 109.356 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 11.3 mt -119.45 126.61 75.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.203 -0.935 . . . . 0.0 109.659 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -92.5 120.73 33.26 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.277 -0.889 . . . . 0.0 109.318 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.431 HG22 ' O ' ' A' ' 85' ' ' ILE . 48.1 mm -127.45 70.72 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.28 -0.887 . . . . 0.0 109.561 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -50.43 160.92 0.35 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.256 -0.902 . . . . 0.0 109.416 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 126.59 -159.81 20.88 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -151.82 93.82 1.9 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.239 -1.153 . . . . 0.0 109.539 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 63.5 mttt -152.55 29.03 0.54 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.278 -0.889 . . . . 0.0 109.437 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.7 ' HB3' HD21 ' A' ' 106' ' ' LEU . 26.4 mtp180 -49.53 -38.42 30.59 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.219 -0.926 . . . . 0.0 109.465 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -55.36 -57.19 12.87 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.228 -0.92 . . . . 0.0 109.477 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.77 -21.48 65.88 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.285 -0.884 . . . . 0.0 109.467 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.907 ' HG ' HG21 ' A' ' 36' ' ' ILE . 0.9 OUTLIER -68.94 -42.4 76.77 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.248 -0.907 . . . . 0.0 109.472 179.995 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 18.3 tttt -68.84 -23.67 64.27 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.282 -0.886 . . . . 0.0 109.482 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -74.68 -62.44 1.53 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.173 -0.955 . . . . 0.0 109.437 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.659 HD12 ' N ' ' A' ' 97' ' ' LEU . 2.6 pp -53.92 -35.88 62.15 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.235 -0.916 . . . . 0.0 109.439 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.659 ' N ' HD12 ' A' ' 96' ' ' LEU . 0.2 OUTLIER -63.23 -52.58 61.6 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.281 -0.887 . . . . 0.0 109.483 179.976 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -63.04 -16.54 60.19 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.276 -0.89 . . . . 0.0 109.441 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.453 ' HB3' ' O ' ' A' ' 96' ' ' LEU . . . -65.76 -35.92 82.09 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.248 -0.908 . . . . 0.0 109.505 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.426 ' HE3' HD21 ' A' ' 64' ' ' LEU . 2.7 mptp? -81.05 -38.5 27.3 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.245 -0.909 . . . . 0.0 109.508 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 108.99 14.58 14.73 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 8.1 mtm -89.77 158.83 17.34 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.25 -1.147 . . . . 0.0 109.466 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 20.4 mttt -80.93 120.04 24.23 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.269 -0.895 . . . . 0.0 109.428 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.446 ' HA ' ' O ' ' A' ' 34' ' ' VAL . 3.0 p -115.82 143.11 26.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.218 -0.926 . . . . 0.0 109.455 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.418 ' O ' ' C ' ' A' ' 106' ' ' LEU . 26.6 tttt -114.1 83.19 1.83 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.263 -0.898 . . . . 0.0 109.481 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.7 HD21 ' HB3' ' A' ' 90' ' ' ARG . 0.6 OUTLIER -44.67 -26.81 0.42 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.207 -0.933 . . . . 0.0 109.473 179.993 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.524 ' HB3' ' O ' ' A' ' 106' ' ' LEU . . . . . . . . 0 N--CA 1.49 1.55 0 O-C-N 121.249 -0.907 . . . . 0.0 109.48 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 19.1 p-10 . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.408 ' C ' HG13 ' A' ' 33' ' ' VAL . . . 178.02 130.21 1.37 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.663 HG23 ' O ' ' A' ' 33' ' ' VAL . 19.3 m -152.1 115.12 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.259 -1.142 . . . . 0.0 109.5 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.689 ' HB ' HD11 ' A' ' 97' ' ' LEU . 4.7 t -90.81 142.32 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.253 -0.904 . . . . 0.0 109.486 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 67.8 ttt180 -117.6 109.55 16.82 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.236 -0.915 . . . . 0.0 109.496 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 1.026 HG21 HD13 ' A' ' 93' ' ' LEU . 2.4 mp -108.22 93.7 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.266 -0.896 . . . . 0.0 109.473 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.79 179.96 7.44 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.273 -0.892 . . . . 0.0 109.425 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.71 102.67 3.96 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.254 -0.904 . . . . 0.0 109.446 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.6 ' O ' HG22 ' A' ' 48' ' ' VAL . 7.7 tt0 -88.44 128.83 35.54 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.285 -0.885 . . . . 0.0 109.478 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 74.1 p . . . . . 0 N--CA 1.49 1.554 0 O-C-N 121.279 -0.888 . . . . 0.0 109.481 179.965 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 41.6 pttt . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -161.49 145.1 10.46 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.6 HG22 ' O ' ' A' ' 39' ' ' GLN . 34.1 m -137.08 153.01 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.229 -1.159 . . . . 0.0 109.444 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -130.63 130.53 44.08 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.212 -0.93 . . . . 0.0 109.52 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 4.2 mp -118.74 109.51 16.17 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.235 -0.916 . . . . 0.0 109.468 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.577 HG13 HG23 ' A' ' 36' ' ' ILE . 4.0 mp -99.58 122.25 51.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.192 -0.943 . . . . 0.0 109.492 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.535 ' HB ' HG13 ' A' ' 82' ' ' VAL . 8.8 t -158.47 167.59 29.23 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.289 -0.882 . . . . 0.0 109.496 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 83.44 48.09 5.45 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.652 ' HB ' HD21 ' A' ' 61' ' ' LEU . 18.3 t -103.57 117.45 49.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.22 -1.165 . . . . 0.0 109.506 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -83.55 81.13 8.87 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.178 -0.951 . . . . 0.0 109.437 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.457 HD23 ' HA ' ' A' ' 56' ' ' LEU . 19.0 mt -151.35 174.02 13.82 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.256 -0.902 . . . . 0.0 109.467 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -56.85 166.5 0.97 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.245 -0.91 . . . . 0.0 109.509 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -73.74 -35.87 65.09 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.283 -0.885 . . . . 0.0 109.422 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.03 -29.43 58.07 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.256 -0.903 . . . . 0.0 109.395 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -67.43 -34.66 77.67 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.24 -0.912 . . . . 0.0 109.388 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.652 HD21 ' HB ' ' A' ' 54' ' ' VAL . 0.2 OUTLIER -66.79 -44.62 80.82 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.229 -0.919 . . . . 0.0 109.286 179.89 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 54.9 m -60.82 -44.31 97.09 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.319 -0.863 . . . . 0.0 109.206 179.773 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 74.4 tttt -57.52 -49.54 76.0 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.342 -0.849 . . . . 0.0 109.363 179.827 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -55.95 -41.03 74.05 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.256 -0.902 . . . . 0.0 109.505 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.503 ' HB1' HG13 ' A' ' 78' ' ' VAL . . . -62.55 -37.01 84.46 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.242 -0.911 . . . . 0.0 109.578 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -70.81 -31.59 68.4 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.272 -0.893 . . . . 0.0 109.548 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 82.8 mt-10 -71.66 -37.67 70.78 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.181 -0.95 . . . . 0.0 109.433 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.522 HD21 HD22 ' A' ' 96' ' ' LEU . 11.2 mt -68.48 -55.45 11.74 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.253 -0.904 . . . . 0.0 109.531 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 19.8 ttmt -52.84 -40.18 63.13 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.258 -0.902 . . . . 0.0 109.41 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 61.4 tttt -47.81 -47.77 30.92 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.177 -0.952 . . . . 0.0 109.322 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 14.7 mttt -108.09 57.86 0.62 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.372 -0.83 . . . . 0.0 109.301 179.742 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.5 m -129.69 -75.97 0.55 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.265 -0.897 . . . . 0.0 109.736 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.658 ' O ' ' CB ' ' A' ' 74' ' ' CYS . . . 125.95 49.77 0.18 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.07 -1.612 . . . . 0.0 109.07 -179.582 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.658 ' CB ' ' O ' ' A' ' 73' ' ' GLY . 49.3 t 112.44 104.57 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.237 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -179.499 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -83.8 142.54 20.92 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -86.54 -80.71 1.18 Allowed Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -129.62 124.16 33.03 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.133 -1.216 . . . . 0.0 109.6 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.503 HG13 ' HB1' ' A' ' 65' ' ' ALA . 95.1 t -125.81 95.44 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.303 -0.873 . . . . 0.0 109.298 179.828 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 18.0 mttt -122.27 142.12 50.8 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.239 -0.913 . . . . 0.0 109.705 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -54.21 94.82 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.283 -0.886 . . . . 0.0 109.491 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 148.02 -46.24 0.71 Allowed Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.535 HG13 ' HB ' ' A' ' 52' ' ' THR . 42.7 t -143.13 160.94 17.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.233 -1.157 . . . . 0.0 109.47 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.478 ' N ' HG12 ' A' ' 82' ' ' VAL . 4.8 mp -138.32 149.43 24.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.246 -0.909 . . . . 0.0 109.43 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -147.14 120.25 8.85 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.252 -0.905 . . . . 0.0 109.473 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 36.3 mm -119.53 117.75 54.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.171 -0.956 . . . . 0.0 109.443 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.57 114.37 10.63 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.234 -0.916 . . . . 0.0 109.481 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 172.2 -137.97 4.54 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.556 -1.417 . . . . 0.0 109.556 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -177.08 53.24 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.238 -1.154 . . . . 0.0 109.452 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 19.8 mttt -106.14 39.45 1.8 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.234 -0.916 . . . . 0.0 109.499 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.85 ' HA ' HD12 ' A' ' 93' ' ' LEU . 5.4 ttm180 -49.59 -35.28 20.28 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.205 -0.934 . . . . 0.0 109.501 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.93 -43.96 91.26 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.241 -0.912 . . . . 0.0 109.439 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.84 -20.32 58.23 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.231 -0.918 . . . . 0.0 109.427 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 1.026 HD13 HG21 ' A' ' 36' ' ' ILE . 19.5 mt -69.33 -43.46 73.66 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.234 -0.916 . . . . 0.0 109.45 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -67.69 -24.07 65.36 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.274 -0.892 . . . . 0.0 109.446 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -74.98 -60.86 2.1 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.205 -0.935 . . . . 0.0 109.491 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.714 HD12 ' N ' ' A' ' 97' ' ' LEU . 3.6 pp -54.08 -34.53 60.41 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.254 -0.904 . . . . 0.0 109.505 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.917 HD13 ' CG2' ' A' ' 104' ' ' VAL . 0.4 OUTLIER -67.33 -47.04 71.68 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.315 -0.866 . . . . 0.0 109.453 179.981 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -65.91 -16.42 63.84 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.29 -0.881 . . . . 0.0 109.466 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -67.3 -36.37 81.38 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.264 -0.897 . . . . 0.0 109.437 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.94 -37.78 23.65 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.266 -0.896 . . . . 0.0 109.48 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 106.19 21.5 8.43 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.96 158.92 16.0 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.253 -1.145 . . . . 0.0 109.485 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.466 ' HB2' HG12 ' A' ' 33' ' ' VAL . 11.5 mttm -82.85 107.28 15.35 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.249 -0.907 . . . . 0.0 109.469 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.917 ' CG2' HD13 ' A' ' 97' ' ' LEU . 7.5 p -84.65 144.47 9.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.226 -0.921 . . . . 0.0 109.471 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 11.0 mttt -113.92 83.76 1.92 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.25 -0.906 . . . . 0.0 109.462 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.502 HD12 ' HA ' ' A' ' 106' ' ' LEU . 1.1 tp -45.09 -27.98 0.66 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.235 -0.916 . . . . 0.0 109.425 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.552 0 O-C-N 121.276 -0.89 . . . . 0.0 109.492 -179.959 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 7.5 tttt . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -166.61 -62.74 0.03 OUTLIER Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 65.84 73.29 0.39 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.302 -1.116 . . . . 0.0 109.53 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.467 ' HA2' ' HB3' ' A' ' 55' ' ' ASP . . . 147.67 126.45 1.64 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.585 HG23 ' O ' ' A' ' 33' ' ' VAL . 19.1 m -133.8 121.26 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.318 -1.107 . . . . 0.0 109.42 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.954 HG22 HG22 ' A' ' 54' ' ' VAL . 77.9 t -96.42 135.78 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.218 -0.926 . . . . 0.0 109.493 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.471 ' O ' ' HG3' ' A' ' 35' ' ' ARG . 0.1 OUTLIER -130.08 124.45 32.82 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.187 -0.946 . . . . 0.0 109.519 -179.992 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.877 HG21 ' HG ' ' A' ' 93' ' ' LEU . 3.9 mp -110.08 126.11 67.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.233 -0.917 . . . . 0.0 109.449 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -121.69 160.65 24.05 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.272 -0.892 . . . . 0.0 109.502 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.405 ' O ' ' HG3' ' A' ' 38' ' ' ARG . 12.0 ptt180 -131.87 104.75 7.04 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.292 -0.88 . . . . 0.0 109.402 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -88.33 80.72 7.43 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.226 -0.921 . . . . 0.0 109.49 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 43.6 p -77.75 -173.24 2.95 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.245 -0.909 . . . . 0.0 109.463 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 22.6 t -139.12 22.65 2.59 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.226 -0.921 . . . . 0.0 109.484 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 158.15 -157.03 27.92 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 19.2 mtt-85 -71.24 -74.08 0.16 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.25 -1.147 . . . . 0.0 109.495 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 76.3 mttt -139.48 115.78 10.49 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.251 -0.906 . . . . 0.0 109.413 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -173.04 -39.83 0.04 OUTLIER Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -168.37 110.48 0.56 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.205 -1.174 . . . . 0.0 109.572 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -118.99 149.61 18.13 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 27.6 m -126.43 158.13 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.232 -1.158 . . . . 0.0 109.487 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -129.42 124.23 33.6 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.267 -0.896 . . . . 0.0 109.48 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.1 mt -115.34 124.26 50.81 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.233 -0.917 . . . . 0.0 109.39 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.49 ' HB ' ' HB ' ' A' ' 83' ' ' ILE . 6.7 mm -107.28 119.28 56.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.231 -0.918 . . . . 0.0 109.595 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.987 HG23 ' O ' ' A' ' 81' ' ' GLY . 1.3 m -158.86 158.72 33.99 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.267 -0.896 . . . . 0.0 109.426 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.487 ' O ' ' N ' ' A' ' 55' ' ' ASP . . . 109.09 -23.86 22.37 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.954 HG22 HG22 ' A' ' 34' ' ' VAL . 21.3 t -49.02 94.17 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.311 -1.111 . . . . 0.0 109.424 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.487 ' N ' ' O ' ' A' ' 53' ' ' GLY . 13.3 t0 -79.78 85.92 5.4 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.234 -0.916 . . . . 0.0 109.527 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.493 HD13 ' OE1' ' A' ' 60' ' ' GLU . 35.2 mt -146.16 167.52 23.24 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.322 -0.861 . . . . 0.0 109.355 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.402 ' C ' ' O ' ' A' ' 56' ' ' LEU . 0.2 OUTLIER -45.47 150.47 0.47 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.224 -0.923 . . . . 0.0 109.392 179.888 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -60.33 -53.35 58.62 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.187 -0.945 . . . . 0.0 109.656 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.12 -39.02 71.59 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.283 -0.886 . . . . 0.0 109.733 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.493 ' OE1' HD13 ' A' ' 56' ' ' LEU . 0.3 OUTLIER -62.41 -39.41 93.19 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.174 -0.954 . . . . 0.0 109.671 -179.801 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.531 HD21 ' HB ' ' A' ' 54' ' ' VAL . 0.2 OUTLIER -58.9 -42.95 90.81 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.213 -0.929 . . . . 0.0 109.602 -179.894 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -61.36 -33.44 73.64 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.309 -0.87 . . . . 0.0 109.638 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -71.58 -34.89 70.31 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.235 -0.915 . . . . 0.0 109.605 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.49 ' HA ' HD22 ' A' ' 64' ' ' LEU . 0.2 OUTLIER -65.99 -59.77 3.5 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.189 -0.944 . . . . 0.0 109.577 -179.973 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -56.99 -34.17 67.86 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.278 -0.889 . . . . 0.0 109.628 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.477 ' HA ' ' HG2' ' A' ' 69' ' ' LYS . . . -66.36 -33.82 76.58 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.274 -0.891 . . . . 0.0 109.768 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -70.17 -44.31 69.05 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.204 -0.935 . . . . 0.0 109.723 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.645 ' CD2' HD22 ' A' ' 96' ' ' LEU . 9.7 mt -63.99 -39.85 95.07 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.231 -0.918 . . . . 0.0 109.629 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.485 ' HB2' ' HA2' ' A' ' 75' ' ' GLY . 12.9 ptmt -75.23 -2.11 26.47 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.321 -0.862 . . . . 0.0 109.854 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 10.3 tttt -76.83 -49.22 16.3 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.096 -1.003 . . . . 0.0 109.993 -179.569 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.54 64.63 1.43 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.079 -1.013 . . . . 0.0 109.768 -179.586 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' CYS . . . . . 0.437 ' HB2' ' O ' ' A' ' 68' ' ' LEU . 5.7 m -128.64 -15.36 4.47 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.192 -0.942 . . . . 0.0 110.078 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.672 ' O ' ' CB ' ' A' ' 74' ' ' CYS . . . 96.35 78.29 1.4 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.672 ' CB ' ' O ' ' A' ' 73' ' ' GLY . 34.7 t 112.02 110.62 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.19 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 -179.527 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.485 ' HA2' ' HB2' ' A' ' 69' ' ' LYS . . . -67.06 111.61 4.25 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -84.1 148.93 24.74 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -107.25 168.34 9.29 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.194 -1.18 . . . . 0.0 109.783 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.947 HG22 HG12 ' A' ' 83' ' ' ILE . 85.0 t -106.46 162.26 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.42 -0.8 . . . . 0.0 109.347 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.541 ' N ' HG12 ' A' ' 78' ' ' VAL . 6.6 mttt -149.27 82.27 1.42 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.222 -0.924 . . . . 0.0 109.521 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 46.15 66.87 0.85 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.373 -0.829 . . . . 0.0 109.728 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.987 ' O ' HG23 ' A' ' 52' ' ' THR . . . 74.84 8.88 82.91 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 179.608 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.459 ' O ' ' HB2' ' A' ' 79' ' ' LYS . 3.3 t -124.62 98.57 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.084 -1.245 . . . . 0.0 109.585 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.947 HG12 HG22 ' A' ' 78' ' ' VAL . 6.2 mt -93.15 124.37 45.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.228 -0.92 . . . . 0.0 109.481 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -91.87 124.55 36.07 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.324 -0.86 . . . . 0.0 109.578 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.413 HD13 ' HA ' ' A' ' 85' ' ' ILE . 34.1 mm -127.76 115.1 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.268 -0.895 . . . . 0.0 109.221 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.73 105.46 16.97 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.254 -0.904 . . . . 0.0 109.619 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 162.2 137.69 2.25 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -97.01 64.36 1.98 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.174 -1.192 . . . . 0.0 109.429 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 76.2 mttt -112.06 36.48 3.32 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.278 -0.889 . . . . 0.0 109.471 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 17.7 ttm180 -44.27 -35.8 2.46 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.261 -0.9 . . . . 0.0 109.476 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -56.39 -52.28 65.2 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.242 -0.911 . . . . 0.0 109.498 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.43 -26.88 68.17 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.291 -0.881 . . . . 0.0 109.47 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.877 ' HG ' HG21 ' A' ' 36' ' ' ILE . 3.2 mm? -63.23 -46.08 88.61 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.309 -0.869 . . . . 0.0 109.459 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 72.3 tttt -61.67 -29.95 70.41 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.228 -0.92 . . . . 0.0 109.534 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 17.5 t -69.83 -68.7 0.4 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.253 -0.905 . . . . 0.0 109.449 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.827 HD21 HD13 ' A' ' 93' ' ' LEU . 2.5 pp -44.86 -35.36 2.75 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.242 -0.911 . . . . 0.0 109.42 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.881 HD22 HG22 ' A' ' 104' ' ' VAL . 0.5 OUTLIER -64.63 -47.94 76.69 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.23 -0.919 . . . . 0.0 109.487 179.939 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -67.18 -9.26 38.21 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.234 -0.916 . . . . 0.0 109.488 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.417 ' HB3' ' O ' ' A' ' 96' ' ' LEU . . . -70.44 -33.16 70.99 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.233 -0.917 . . . . 0.0 109.482 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 4.8 mtmm -84.98 -25.87 27.48 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.209 -0.932 . . . . 0.0 109.506 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 92.5 16.01 50.99 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 4.2 mtm -87.69 -174.42 4.76 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.266 -1.138 . . . . 0.0 109.464 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 24.5 mttt -91.42 163.5 14.16 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.262 -0.899 . . . . 0.0 109.487 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.881 HG22 HD22 ' A' ' 97' ' ' LEU . 19.2 t -139.82 158.99 27.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.245 -0.909 . . . . 0.0 109.456 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.452 ' O ' ' N ' ' A' ' 107' ' ' ALA . 17.3 tttt -130.25 61.42 1.59 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.215 -0.928 . . . . 0.0 109.474 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.41 ' C ' ' O ' ' A' ' 105' ' ' LYS . 3.7 tp -44.9 98.49 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.26 -0.9 . . . . 0.0 109.494 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.452 ' N ' ' O ' ' A' ' 105' ' ' LYS . . . -69.06 164.94 21.29 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.206 -0.934 . . . . 0.0 109.488 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 178.2 -168.68 40.07 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 151.65 161.69 10.28 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -110.77 124.4 51.93 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.27 -1.135 . . . . 0.0 109.467 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 117.994 -1.003 . . . . 0.0 109.452 -179.957 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 93.3 mttt . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -178.44 78.57 0.07 OUTLIER Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -92.72 130.32 38.38 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.302 -1.117 . . . . 0.0 109.453 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -86.37 161.08 33.75 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.806 HG12 ' HB3' ' A' ' 103' ' ' LYS . 18.9 m -142.98 97.51 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.189 -1.183 . . . . 0.0 109.506 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.634 ' HB ' HD21 ' A' ' 97' ' ' LEU . 38.6 t -97.06 145.45 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.186 -0.946 . . . . 0.0 109.444 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 58.5 mtt180 -127.45 131.13 50.26 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.265 -0.897 . . . . 0.0 109.493 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.773 ' CD1' HD22 ' A' ' 97' ' ' LEU . 3.0 mp -125.68 106.31 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.293 -0.879 . . . . 0.0 109.476 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.66 ' HA ' ' HB2' ' A' ' 107' ' ' ALA . 20.4 pt20 -113.49 -175.01 2.57 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.265 -0.897 . . . . 0.0 109.443 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.413 ' O ' ' CG ' ' A' ' 38' ' ' ARG . 3.9 ptt180 -133.22 117.85 17.9 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.237 -0.914 . . . . 0.0 109.498 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -95.05 132.63 39.73 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.237 -0.915 . . . . 0.0 109.47 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -117.45 150.79 38.33 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.248 -0.908 . . . . 0.0 109.523 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.35 23.57 14.31 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.246 -0.909 . . . . 0.0 109.449 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 139.47 177.47 15.64 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 61.8 mtt180 -68.79 116.17 8.98 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.202 -1.175 . . . . 0.0 109.522 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 55.2 pttt -168.3 161.04 11.9 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.254 -0.904 . . . . 0.0 109.445 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -78.11 -39.07 24.53 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -57.08 158.59 4.94 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.26 -1.141 . . . . 0.0 109.48 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -166.12 156.86 29.06 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -130.22 165.01 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.276 -1.132 . . . . 0.0 109.454 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 3.5 m -133.82 134.59 43.01 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.245 -0.91 . . . . 0.0 109.515 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -111.18 139.25 46.71 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.261 -0.899 . . . . 0.0 109.489 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.481 HG12 ' CG1' ' A' ' 36' ' ' ILE . 15.3 mt -127.95 107.8 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.246 -0.909 . . . . 0.0 109.468 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 15.8 m -152.47 158.82 43.13 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.237 -0.914 . . . . 0.0 109.426 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 104.36 16.42 18.31 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.781 ' HB ' HD21 ' A' ' 61' ' ' LEU . 21.8 t -74.6 130.42 36.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.198 -1.177 . . . . 0.0 109.46 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -104.44 86.85 2.59 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.232 -0.918 . . . . 0.0 109.45 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.628 ' HB2' HD11 ' A' ' 61' ' ' LEU . 5.1 mt -133.38 -170.63 2.52 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.247 -0.908 . . . . 0.0 109.537 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -73.89 -69.89 0.41 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.191 -0.943 . . . . 0.0 109.481 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 174.12 -63.13 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.171 -0.956 . . . . 0.0 109.521 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.68 -30.89 71.92 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.242 -0.911 . . . . 0.0 109.583 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -66.01 -35.49 80.71 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.182 -0.949 . . . . 0.0 109.478 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.781 HD21 ' HB ' ' A' ' 54' ' ' VAL . 0.3 OUTLIER -63.95 -38.61 91.7 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.27 -0.894 . . . . 0.0 109.548 179.995 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 23.8 m -59.75 -49.64 76.92 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.234 -0.916 . . . . 0.0 109.47 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 58.5 tttt -59.7 -36.88 77.41 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.255 -0.903 . . . . 0.0 109.492 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.46 ' CD1' HD23 ' A' ' 68' ' ' LEU . 0.1 OUTLIER -59.29 -53.69 55.37 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.209 -0.932 . . . . 0.0 109.527 -179.926 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.559 ' HB1' HG11 ' A' ' 78' ' ' VAL . . . -59.15 -32.28 69.73 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.271 -0.893 . . . . 0.0 109.541 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.88 -42.29 94.93 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.238 -0.914 . . . . 0.0 109.401 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -75.64 -19.83 58.93 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.273 -0.892 . . . . 0.0 109.403 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.463 ' HA ' HD13 ' A' ' 68' ' ' LEU . 0.7 OUTLIER -72.17 -53.69 11.93 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.32 -0.863 . . . . 0.0 109.548 -179.956 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.496 ' HA ' ' HB2' ' A' ' 72' ' ' CYS . 1.3 ptpt -65.8 -21.41 66.49 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.323 -0.861 . . . . 0.0 109.694 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 9.3 mttt -58.57 -34.61 71.25 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.321 -0.862 . . . . 0.0 110.042 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 59.7 tttt -120.12 24.03 10.67 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.045 -1.034 . . . . 0.0 110.066 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' CYS . . . . . 0.496 ' HB2' ' HA ' ' A' ' 69' ' ' LYS . 0.5 OUTLIER -107.37 -27.13 10.65 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.069 -1.019 . . . . 0.0 109.548 179.827 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.424 ' O ' ' HB3' ' A' ' 74' ' ' CYS . . . 61.38 54.09 38.95 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.646 -1.381 . . . . 0.0 109.646 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.424 ' HB3' ' O ' ' A' ' 73' ' ' GLY . 27.0 p 177.66 125.33 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.283 -1.128 . . . . 0.0 109.49 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -114.06 82.27 0.31 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.479 ' O ' ' HB2' ' A' ' 77' ' ' ALA . . . -75.91 -52.88 6.08 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.774 -1.331 . . . . 0.0 109.774 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.479 ' HB2' ' O ' ' A' ' 76' ' ' GLY . . . 176.78 124.42 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.171 -1.194 . . . . 0.0 109.508 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.559 HG11 ' HB1' ' A' ' 65' ' ' ALA . 38.5 t -127.29 122.53 59.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.261 -0.9 . . . . 0.0 109.554 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -131.5 143.81 50.67 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.24 -0.912 . . . . 0.0 109.593 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.63 109.72 0.85 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.157 -0.964 . . . . 0.0 109.36 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 119.68 -38.39 2.81 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 87.8 t -140.26 133.13 33.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.329 -1.1 . . . . 0.0 109.412 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.414 HG12 HG13 ' A' ' 78' ' ' VAL . 12.1 mt -122.55 148.4 26.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.247 -0.908 . . . . 0.0 109.4 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.458 ' O ' HD13 ' A' ' 85' ' ' ILE . 6.9 tt0 -135.41 134.96 40.23 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.175 -0.953 . . . . 0.0 109.686 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.458 HD13 ' O ' ' A' ' 84' ' ' GLU . 27.8 mm -118.15 148.52 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.236 -0.915 . . . . 0.0 109.332 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -109.38 122.06 46.55 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.204 -0.935 . . . . 0.0 109.478 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 130.43 161.28 10.32 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -103.66 108.93 20.42 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.231 -1.159 . . . . 0.0 109.458 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 30.6 mttt -158.73 31.39 0.22 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.235 -0.916 . . . . 0.0 109.462 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.589 ' HA ' HD12 ' A' ' 93' ' ' LEU . 50.8 ttp180 -53.48 -27.78 27.09 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.249 -0.907 . . . . 0.0 109.485 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 50.0 t0 -60.05 -51.77 68.2 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.259 -0.901 . . . . 0.0 109.456 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.621 HD23 HD23 ' A' ' 96' ' ' LEU . 1.7 tt -70.75 -23.95 62.52 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.21 -0.931 . . . . 0.0 109.438 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.769 HD22 HG21 ' A' ' 36' ' ' ILE . 1.3 mt -63.51 -47.87 79.93 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.193 -0.942 . . . . 0.0 109.424 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.946 ' HD2' HD21 ' A' ' 106' ' ' LEU . 78.2 tttt -61.98 -23.07 66.17 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.244 -0.91 . . . . 0.0 109.451 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 6.6 t -76.56 -65.37 0.94 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.277 -0.889 . . . . 0.0 109.491 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.848 HD12 ' N ' ' A' ' 97' ' ' LEU . 2.9 pp -47.73 -36.04 10.74 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.256 -0.903 . . . . 0.0 109.419 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.848 ' N ' HD12 ' A' ' 96' ' ' LEU . 1.4 tp -69.52 -44.25 71.41 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.225 -0.922 . . . . 0.0 109.456 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 68.4 tt0 -61.21 -20.26 62.58 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.285 -0.884 . . . . 0.0 109.477 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -62.77 -32.28 73.4 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.229 -0.919 . . . . 0.0 109.476 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -84.36 -18.07 37.37 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.229 -0.919 . . . . 0.0 109.495 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 75.47 24.66 69.98 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 1.1 mtm -79.07 179.34 7.41 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.29 -1.124 . . . . 0.0 109.495 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.806 ' HB3' HG12 ' A' ' 33' ' ' VAL . 13.0 mttt -97.21 88.32 4.43 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.308 -0.87 . . . . 0.0 109.447 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.693 ' CG2' HD23 ' A' ' 97' ' ' LEU . 2.1 t -81.62 165.08 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.227 -0.92 . . . . 0.0 109.494 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.401 ' O ' ' C ' ' A' ' 106' ' ' LEU . 41.7 tttt -128.88 28.2 5.37 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.263 -0.898 . . . . 0.0 109.446 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.946 HD21 ' HD2' ' A' ' 94' ' ' LYS . 0.2 OUTLIER 44.24 -157.82 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.243 -0.911 . . . . 0.0 109.456 179.954 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.66 ' HB2' ' HA ' ' A' ' 37' ' ' GLN . . . -98.46 -32.88 11.25 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.213 -0.929 . . . . 0.0 109.479 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -132.93 127.22 4.69 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -113.52 -23.93 4.9 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.4 mt -140.33 112.69 7.85 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.272 -1.134 . . . . 0.0 109.472 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 . . . . . 0 N--CA 1.489 1.52 0 CA-C-O 118.025 -0.988 . . . . 0.0 109.519 -179.975 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 176.09 66.58 0.06 OUTLIER Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -116.45 -63.78 1.4 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.28 -1.13 . . . . 0.0 109.434 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.4 ' C ' ' CG2' ' A' ' 33' ' ' VAL . . . 163.2 128.12 0.93 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.4 ' CG2' ' C ' ' A' ' 32' ' ' GLY . 1.9 t -149.61 151.64 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.248 -1.149 . . . . 0.0 109.546 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.547 ' HB ' HD11 ' A' ' 97' ' ' LEU . 72.7 t -138.1 121.68 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.312 -0.867 . . . . 0.0 109.392 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.436 ' CG ' ' HA3' ' A' ' 53' ' ' GLY . 62.3 mtt180 -88.11 111.22 21.34 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.244 -0.91 . . . . 0.0 109.516 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.93 HD11 HD13 ' A' ' 97' ' ' LEU . 7.5 mt -115.66 108.51 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.263 -0.898 . . . . 0.0 109.408 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.758 ' HB3' ' HB3' ' A' ' 107' ' ' ALA . 3.4 pt20 -131.72 -160.12 1.02 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.21 -0.931 . . . . 0.0 109.548 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 11.9 ptm180 -130.79 132.09 45.06 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.297 -0.877 . . . . 0.0 109.447 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -125.81 77.47 1.67 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.254 -0.904 . . . . 0.0 109.484 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -106.05 17.23 23.88 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.3 -0.875 . . . . 0.0 109.472 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.88 150.38 7.72 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.28 -0.888 . . . . 0.0 109.481 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 68.32 159.65 1.55 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 45.8 mtt180 -95.7 111.5 23.44 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.312 -1.111 . . . . 0.0 109.468 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 50.7 tttt -174.09 31.66 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.244 -0.91 . . . . 0.0 109.51 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 153.34 158.31 8.5 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -71.07 -45.58 63.52 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.269 -1.136 . . . . 0.0 109.447 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 176.96 144.52 5.31 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 16.0 m -135.02 159.05 41.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.275 -1.132 . . . . 0.0 109.373 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -111.9 110.02 20.13 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.247 -0.908 . . . . 0.0 109.531 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.899 HD12 ' HG3' ' A' ' 84' ' ' GLU . 8.5 tp -93.83 129.29 40.28 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.225 -0.922 . . . . 0.0 109.44 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.402 HG23 HD12 ' A' ' 51' ' ' ILE . 11.1 mm -120.91 114.74 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.295 -0.878 . . . . 0.0 109.439 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.444 ' O ' HG22 ' A' ' 52' ' ' THR . 8.6 m -141.6 13.28 2.13 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.307 -0.871 . . . . 0.0 109.496 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.436 ' HA3' ' CG ' ' A' ' 35' ' ' ARG . . . -97.41 19.02 56.37 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.579 -1.409 . . . . 0.0 109.579 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.639 HG11 ' HG ' ' A' ' 61' ' ' LEU . 60.0 t -82.95 105.65 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.267 -1.137 . . . . 0.0 109.452 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -100.19 87.73 3.52 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.187 -0.946 . . . . 0.0 109.522 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.594 HD12 ' CG1' ' A' ' 54' ' ' VAL . 19.2 mt -129.15 -169.23 2.05 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.269 -0.894 . . . . 0.0 109.403 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -81.87 -65.33 1.02 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.235 -0.916 . . . . 0.0 109.446 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.4 t0 179.76 -50.34 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.23 -0.918 . . . . 0.0 109.402 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.6 -34.71 65.18 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.24 -0.913 . . . . 0.0 109.437 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -70.2 -28.15 65.06 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.261 -0.899 . . . . 0.0 109.413 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.639 ' HG ' HG11 ' A' ' 54' ' ' VAL . 0.4 OUTLIER -66.55 -55.46 15.38 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.263 -0.898 . . . . 0.0 109.476 179.951 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.449 HG23 ' N ' ' A' ' 63' ' ' LYS . 8.2 t -59.81 -37.73 79.99 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.26 -0.9 . . . . 0.0 109.551 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.449 ' N ' HG23 ' A' ' 62' ' ' THR . 0.7 OUTLIER -57.74 -62.39 1.83 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.206 -0.934 . . . . 0.0 109.535 -179.947 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.5 tt -49.82 -48.43 50.81 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.258 -0.901 . . . . 0.0 109.612 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -50.08 -41.61 48.47 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.29 -0.881 . . . . 0.0 109.659 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.8 -34.92 76.34 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.213 -0.93 . . . . 0.0 109.657 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -67.18 -30.26 70.17 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.222 -0.924 . . . . 0.0 109.584 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -79.62 -33.93 41.06 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.293 -0.88 . . . . 0.0 109.454 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.476 ' HA ' ' HB3' ' A' ' 72' ' ' CYS . 6.8 ttpt -77.04 -9.58 58.81 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.267 -0.895 . . . . 0.0 109.377 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -68.51 -41.58 79.77 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.187 -0.946 . . . . 0.0 109.46 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 39.6 mttt -103.83 5.44 35.91 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.267 -0.896 . . . . 0.0 109.493 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' CYS . . . . . 0.476 ' HB3' ' HA ' ' A' ' 69' ' ' LYS . 31.9 t -81.4 -64.44 1.19 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.217 -0.927 . . . . 0.0 109.615 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 91.38 19.65 41.02 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.291 -1.524 . . . . 0.0 109.291 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 17.4 t -174.92 90.95 0.06 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.364 -1.08 . . . . 0.0 109.304 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -95.89 157.99 21.81 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -117.98 -87.57 1.21 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -134.07 127.99 33.33 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.187 -1.184 . . . . 0.0 109.288 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.701 HG22 HG23 ' A' ' 83' ' ' ILE . 84.0 t -128.03 82.64 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.152 -0.967 . . . . 0.0 109.682 -179.723 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 65.4 mttt -94.09 155.69 16.96 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.268 -0.895 . . . . 0.0 109.255 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -63.72 104.97 0.73 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.24 -0.912 . . . . 0.0 109.575 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 129.67 -26.32 4.32 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 90.9 t -149.79 151.9 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.207 -1.172 . . . . 0.0 109.726 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.701 HG23 HG22 ' A' ' 78' ' ' VAL . 15.8 mt -143.7 120.58 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.389 -0.819 . . . . 0.0 109.249 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.899 ' HG3' HD12 ' A' ' 50' ' ' LEU . 1.7 tt0 -112.56 130.28 56.07 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.219 -0.925 . . . . 0.0 109.638 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.402 HD13 ' HA ' ' A' ' 85' ' ' ILE . 25.7 mm -126.39 145.85 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.262 -0.899 . . . . 0.0 109.335 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.53 112.23 24.47 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.231 -0.918 . . . . 0.0 109.543 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -161.03 -40.07 0.02 OUTLIER Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 27.7 t70 53.36 60.83 3.46 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.314 -1.11 . . . . 0.0 109.478 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 16.8 mttt -152.15 65.98 0.84 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.288 -0.883 . . . . 0.0 109.466 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 4.1 ptt-85 -56.79 -28.92 62.15 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.218 -0.927 . . . . 0.0 109.478 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -55.28 -52.63 62.82 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.242 -0.911 . . . . 0.0 109.455 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.5 tt -70.02 -42.07 73.45 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.25 -0.906 . . . . 0.0 109.511 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.653 HD13 ' CG2' ' A' ' 36' ' ' ILE . 2.3 mt -54.28 -26.27 28.16 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.196 -0.94 . . . . 0.0 109.484 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -64.48 -64.33 0.91 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.259 -0.901 . . . . 0.0 109.412 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -63.51 -13.93 45.98 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.276 -0.89 . . . . 0.0 109.435 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.827 HD23 ' N ' ' A' ' 97' ' ' LEU . 4.1 tt -71.16 -56.9 5.13 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.287 -0.883 . . . . 0.0 109.429 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.956 HD22 HG22 ' A' ' 104' ' ' VAL . 0.2 OUTLIER -70.91 -30.54 66.91 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.306 -0.871 . . . . 0.0 109.437 -179.966 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -64.71 -18.09 64.7 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.261 -0.899 . . . . 0.0 109.458 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.95 -37.24 86.99 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.292 -0.88 . . . . 0.0 109.484 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 11.2 mtpp -82.63 -34.91 27.39 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.266 -0.896 . . . . 0.0 109.444 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 107.99 17.85 10.54 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 1.5 mtm -91.28 167.85 12.01 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.261 -1.141 . . . . 0.0 109.45 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.14 157.76 22.65 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.245 -0.91 . . . . 0.0 109.44 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.956 HG22 HD22 ' A' ' 97' ' ' LEU . 87.3 t -136.19 123.0 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.312 -0.867 . . . . 0.0 109.423 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.84 88.63 4.34 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.239 -0.913 . . . . 0.0 109.49 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.556 ' O ' ' HB3' ' A' ' 107' ' ' ALA . 30.9 mt -44.24 -36.11 2.57 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.339 -0.85 . . . . 0.0 109.465 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.758 ' HB3' ' HB3' ' A' ' 37' ' ' GLN . . . 68.1 83.6 0.16 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.248 -0.908 . . . . 0.0 109.455 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -173.53 102.54 0.17 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.569 -1.413 . . . . 0.0 109.569 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 72.01 174.46 22.48 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.3 pp -149.48 144.97 26.64 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.305 -1.115 . . . . 0.0 109.469 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.507 -180.0 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 56.3 mttp . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -132.76 165.59 23.8 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -178.68 110.5 0.05 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.275 -1.132 . . . . 0.0 109.455 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.581 ' CA ' HD21 ' A' ' 56' ' ' LEU . . . 76.92 117.58 0.16 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.976 HG13 ' O ' ' A' ' 103' ' ' LYS . 82.2 t -143.68 122.55 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.261 -1.14 . . . . 0.0 109.483 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.778 ' O ' HG23 ' A' ' 104' ' ' VAL . 44.5 t -101.77 135.17 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.257 -0.902 . . . . 0.0 109.462 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 13.4 ttt180 -102.89 123.35 46.36 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.231 -0.918 . . . . 0.0 109.521 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.772 HG21 HD13 ' A' ' 93' ' ' LEU . 4.0 mt -128.87 112.49 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.195 -0.94 . . . . 0.0 109.537 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.704 ' HB3' ' HB3' ' A' ' 107' ' ' ALA . 3.3 pm0 -136.3 110.9 8.61 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.277 -0.889 . . . . 0.0 109.49 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.412 ' O ' ' HG3' ' A' ' 38' ' ' ARG . 0.0 OUTLIER -69.83 109.64 4.54 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.277 -0.89 . . . . 0.0 109.433 -179.949 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -96.17 138.99 32.97 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.304 -0.872 . . . . 0.0 109.507 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.401 HG22 ' N ' ' A' ' 41' ' ' SER . 8.9 m -111.24 163.34 14.04 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.25 -0.906 . . . . 0.0 109.446 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.401 ' N ' HG22 ' A' ' 40' ' ' THR . 4.5 t -119.99 -29.3 4.96 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.275 -0.891 . . . . 0.0 109.438 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.418 ' O ' ' CB ' ' A' ' 43' ' ' ARG . . . 169.65 150.56 6.87 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.418 ' CB ' ' O ' ' A' ' 42' ' ' GLY . 4.6 ttm180 70.32 160.02 0.2 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.274 -1.133 . . . . 0.0 109.45 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -99.9 27.29 5.59 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.22 -0.925 . . . . 0.0 109.468 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -116.39 -25.95 3.31 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 12.5 tttt -86.62 162.16 18.11 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.3 -1.118 . . . . 0.0 109.48 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 169.26 139.53 2.74 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 16.0 m -146.71 151.16 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.201 -1.176 . . . . 0.0 109.475 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -111.04 126.01 54.36 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.302 -0.874 . . . . 0.0 109.444 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.2 mp -112.99 104.77 12.73 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.254 -0.904 . . . . 0.0 109.578 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.454 ' HB ' ' HB ' ' A' ' 83' ' ' ILE . 8.2 mm -82.83 119.67 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.251 -0.905 . . . . 0.0 109.39 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 9.8 t -159.93 169.59 23.17 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.211 -0.93 . . . . 0.0 109.5 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 84.33 24.13 48.56 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.559 ' HB ' HD21 ' A' ' 61' ' ' LEU . 3.3 t -91.59 126.68 44.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.25 -1.147 . . . . 0.0 109.495 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -113.55 78.73 1.17 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.271 -0.893 . . . . 0.0 109.43 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.581 HD21 ' CA ' ' A' ' 32' ' ' GLY . 84.7 mt -137.21 -170.44 2.72 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.244 -0.91 . . . . 0.0 109.429 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.491 ' HB3' ' HB2' ' A' ' 60' ' ' GLU . 6.7 t0 -57.92 151.42 18.26 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.257 -0.902 . . . . 0.0 109.484 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.87 -54.25 49.25 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.237 -0.914 . . . . 0.0 109.513 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.57 -21.76 62.65 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.191 -0.943 . . . . 0.0 109.604 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.491 ' HB2' ' HB3' ' A' ' 57' ' ' ASP . 19.0 tt0 -61.99 -41.74 98.38 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.201 -0.937 . . . . 0.0 109.597 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.559 HD21 ' HB ' ' A' ' 54' ' ' VAL . 1.8 mp -61.08 -56.7 17.82 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.225 -0.922 . . . . 0.0 109.579 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 86.6 m -47.87 -36.69 12.51 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.15 -0.969 . . . . 0.0 109.492 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.408 ' O ' ' C ' ' A' ' 64' ' ' LEU . 15.4 tttt -61.84 -64.76 0.84 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.265 -0.897 . . . . 0.0 109.437 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.421 HD23 HD23 ' A' ' 68' ' ' LEU . 0.5 OUTLIER -44.55 -41.51 6.53 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.281 -0.887 . . . . 0.0 109.751 -179.862 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -56.83 -59.09 5.55 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.242 -0.911 . . . . 0.0 109.702 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.3 -17.08 17.01 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.292 -0.88 . . . . 0.0 109.81 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -76.65 -44.16 35.13 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.162 -0.961 . . . . 0.0 110.042 -179.606 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.481 ' N ' HD22 ' A' ' 68' ' ' LEU . 4.4 mm? -79.58 -26.52 41.28 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.073 -1.017 . . . . 0.0 110.201 -179.413 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.1 ttmt -71.18 -5.84 34.92 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.056 -1.028 . . . . 0.0 109.593 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -60.22 -42.23 94.72 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.251 -0.905 . . . . 0.0 109.196 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.52 43.48 0.75 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.313 -0.867 . . . . 0.0 109.688 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -77.78 -28.35 50.48 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.345 -0.847 . . . . 0.0 108.944 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.488 ' O ' ' HB2' ' A' ' 74' ' ' CYS . . . 124.75 -27.98 5.31 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 108.839 -1.705 . . . . 0.0 108.839 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.488 ' HB2' ' O ' ' A' ' 73' ' ' GLY . 4.5 t 165.36 97.42 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.554 -0.968 . . . . 0.0 108.695 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -76.52 116.29 4.64 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.444 -1.463 . . . . 0.0 109.444 -179.696 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -63.4 -88.47 0.04 OUTLIER Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.496 -1.441 . . . . 0.0 109.496 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -133.09 160.6 36.71 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.341 -1.093 . . . . 0.0 109.559 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 39.5 t -132.0 140.75 47.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.277 -0.89 . . . . 0.0 109.413 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 48.5 mttt -148.18 141.68 25.38 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.287 -0.883 . . . . 0.0 109.414 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -60.71 91.49 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.153 -0.967 . . . . 0.0 109.516 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 134.93 -37.33 1.95 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 90.8 t -139.86 135.18 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.266 -1.138 . . . . 0.0 109.341 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.454 ' HB ' ' HB ' ' A' ' 51' ' ' ILE . 41.4 mt -130.99 133.92 62.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.227 -0.92 . . . . 0.0 109.612 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 -104.33 120.62 41.59 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.263 -0.898 . . . . 0.0 109.43 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.438 HD13 ' HA ' ' A' ' 85' ' ' ILE . 20.4 mm -122.44 91.4 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.209 -0.932 . . . . 0.0 109.46 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -55.2 129.99 40.4 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.211 -0.931 . . . . 0.0 109.505 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 161.74 -155.16 26.32 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -177.79 70.38 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.203 -1.175 . . . . 0.0 109.475 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 55.1 mttt -143.51 49.44 1.41 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.276 -0.89 . . . . 0.0 109.537 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -48.44 -28.76 3.48 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.27 -0.894 . . . . 0.0 109.426 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -60.77 -55.16 36.48 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.196 -0.94 . . . . 0.0 109.433 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.506 HD23 HD23 ' A' ' 96' ' ' LEU . 2.7 tt -64.49 -29.2 70.24 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.24 -0.913 . . . . 0.0 109.477 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.772 HD13 HG21 ' A' ' 36' ' ' ILE . 0.3 OUTLIER -61.86 -44.04 97.64 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.21 -0.931 . . . . 0.0 109.474 -179.979 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -63.21 -30.31 71.48 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.291 -0.881 . . . . 0.0 109.438 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.404 ' O ' ' C ' ' A' ' 96' ' ' LEU . 46.8 t -70.32 -68.95 0.39 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.284 -0.885 . . . . 0.0 109.469 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.719 HD12 ' N ' ' A' ' 97' ' ' LEU . 3.8 pp -45.42 -35.39 3.67 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.224 -0.923 . . . . 0.0 109.493 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.719 ' N ' HD12 ' A' ' 96' ' ' LEU . 2.5 tt -62.54 -52.67 62.51 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.292 -0.88 . . . . 0.0 109.431 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -62.25 -17.52 58.66 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.248 -0.908 . . . . 0.0 109.441 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.488 ' HB3' ' O ' ' A' ' 96' ' ' LEU . . . -62.18 -37.2 84.38 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.303 -0.873 . . . . 0.0 109.466 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -84.23 -23.47 30.43 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.196 -0.94 . . . . 0.0 109.477 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 93.58 14.8 52.31 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' MET . . . . . 0.606 ' CE ' HG23 ' A' ' 34' ' ' VAL . 2.6 mtm -85.42 152.79 22.96 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.194 -1.18 . . . . 0.0 109.49 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.976 ' O ' HG13 ' A' ' 33' ' ' VAL . 16.2 mttt -81.31 149.35 28.97 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.264 -0.898 . . . . 0.0 109.436 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.778 HG23 ' O ' ' A' ' 34' ' ' VAL . 12.9 p -136.87 153.59 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.259 -0.901 . . . . 0.0 109.454 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 69.6 mttt -120.93 85.83 2.47 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.248 -0.907 . . . . 0.0 109.431 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -50.52 101.33 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.263 -0.898 . . . . 0.0 109.521 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.704 ' HB3' ' HB3' ' A' ' 37' ' ' GLN . . . -89.16 175.4 7.39 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.236 -0.915 . . . . 0.0 109.493 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 156.81 -146.86 14.52 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 159.58 118.97 0.53 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -101.45 -27.35 13.18 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.249 -1.148 . . . . 0.0 109.463 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.441 ' HG2' ' O ' ' A' ' 111' ' ' GLU . 77.7 tt0 . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 118.0 -1.0 . . . . 0.0 109.418 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 23.8 mtpt . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -136.49 58.11 0.66 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -106.64 104.87 14.66 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.286 -1.126 . . . . 0.0 109.515 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.444 ' O ' HG13 ' A' ' 33' ' ' VAL . . . -117.09 133.43 10.62 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.444 HG13 ' O ' ' A' ' 32' ' ' GLY . 5.8 m -154.43 145.48 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.217 -1.166 . . . . 0.0 109.493 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.518 HG13 HG22 ' A' ' 54' ' ' VAL . 45.0 t -127.73 147.36 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.286 -0.884 . . . . 0.0 109.436 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.481 ' HB2' ' HA3' ' A' ' 53' ' ' GLY . 3.2 ttm180 -103.18 99.56 9.43 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.224 -0.922 . . . . 0.0 109.487 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.8 ' CG2' HD13 ' A' ' 93' ' ' LEU . 11.0 mt -104.87 107.58 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.236 -0.915 . . . . 0.0 109.457 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.923 ' HB3' ' HB3' ' A' ' 107' ' ' ALA . 1.5 pt20 -137.64 138.44 39.47 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.255 -0.903 . . . . 0.0 109.47 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 10.1 ptt85 -92.63 127.63 38.2 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.232 -0.917 . . . . 0.0 109.532 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -115.06 81.88 1.65 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.266 -0.896 . . . . 0.0 109.384 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 4.2 p -50.57 162.14 0.27 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.215 -0.928 . . . . 0.0 109.504 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -148.92 37.55 0.8 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.28 -0.888 . . . . 0.0 109.458 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 152.55 169.52 17.96 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -105.73 49.0 0.82 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.272 -1.134 . . . . 0.0 109.391 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 74.1 mttt -130.83 49.43 2.32 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.279 -0.888 . . . . 0.0 109.531 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 54.75 42.17 77.46 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 12.7 tttt -100.07 87.35 3.45 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.244 -1.15 . . . . 0.0 109.424 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -103.29 130.35 10.21 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 35.2 m -144.09 154.08 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.312 -1.111 . . . . 0.0 109.459 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -125.65 125.31 42.89 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.166 -0.959 . . . . 0.0 109.54 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.5 mp -106.29 111.07 23.51 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.253 -0.904 . . . . 0.0 109.485 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.458 ' HB ' ' HB ' ' A' ' 83' ' ' ILE . 5.4 mm -98.64 117.76 44.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.233 -0.917 . . . . 0.0 109.481 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.0 m -154.82 25.89 0.44 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.207 -0.933 . . . . 0.0 109.491 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.481 ' HA3' ' HB2' ' A' ' 35' ' ' ARG . . . -119.68 28.51 6.43 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.758 ' HB ' HD21 ' A' ' 61' ' ' LEU . 17.5 t -88.28 127.83 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.224 -1.162 . . . . 0.0 109.462 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -115.95 82.71 1.82 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.262 -0.899 . . . . 0.0 109.442 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.6 mt -146.21 -172.65 3.98 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.247 -0.908 . . . . 0.0 109.465 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.464 ' HB2' ' HB2' ' A' ' 60' ' ' GLU . 2.9 m-20 -59.37 167.04 2.02 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.265 -0.897 . . . . 0.0 109.396 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -76.16 -50.58 14.2 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.251 -0.906 . . . . 0.0 109.329 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.24 -27.9 65.86 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.294 -0.879 . . . . 0.0 109.301 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.464 ' HB2' ' HB2' ' A' ' 57' ' ' ASP . 18.3 tt0 -70.47 -37.07 74.21 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.274 -0.891 . . . . 0.0 109.391 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.758 HD21 ' HB ' ' A' ' 54' ' ' VAL . 0.0 OUTLIER -66.27 -35.41 80.33 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.301 -0.874 . . . . 0.0 109.49 179.957 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.5 m -66.85 -31.05 71.41 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.294 -0.879 . . . . 0.0 109.583 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 43.8 mttt -72.5 -49.31 33.93 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.274 -0.891 . . . . 0.0 109.616 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.441 HD11 ' HE2' ' A' ' 100' ' ' LYS . 1.4 tp -55.24 -48.34 74.11 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.244 -0.91 . . . . 0.0 109.419 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.828 ' HA ' HD12 ' A' ' 68' ' ' LEU . . . -61.74 -36.13 80.1 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.309 -0.869 . . . . 0.0 109.394 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.08 -47.44 85.89 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.274 -0.891 . . . . 0.0 109.528 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -72.24 -19.77 61.65 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.215 -0.928 . . . . 0.0 109.545 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.828 HD12 ' HA ' ' A' ' 65' ' ' ALA . 7.1 mt -70.29 -63.88 1.0 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.201 -0.937 . . . . 0.0 109.12 179.563 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.31 -12.0 12.04 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.457 -0.777 . . . . 0.0 109.631 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.5 -50.79 62.09 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.15 -0.969 . . . . 0.0 109.369 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -111.36 31.43 6.11 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.195 -0.941 . . . . 0.0 109.724 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 42.5 t -96.7 -12.31 23.96 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.106 -0.996 . . . . 0.0 109.657 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 90.51 -32.96 4.77 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 9.9 t 179.15 112.07 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.981 -1.305 . . . . 0.0 109.537 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -91.77 -150.15 25.1 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 110.034 -1.227 . . . . 0.0 110.034 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -157.94 -83.3 0.04 OUTLIER Glycine 0 N--CA 1.493 2.456 0 O-C-N 121.228 -1.16 . . . . 0.0 110.257 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -113.9 118.0 32.96 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.06 -1.259 . . . . 0.0 109.851 -179.48 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 97.7 t -109.69 120.35 60.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.256 -0.903 . . . . 0.0 109.731 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.6 mtmt -154.16 149.96 27.61 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.299 -0.876 . . . . 0.0 109.239 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -70.58 97.03 1.26 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.156 -0.965 . . . . 0.0 109.523 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.501 ' O ' HG23 ' A' ' 82' ' ' VAL . . . 125.52 -11.42 7.54 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.501 HG23 ' O ' ' A' ' 81' ' ' GLY . 57.3 t -156.88 108.33 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.055 -1.262 . . . . 0.0 109.413 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.458 ' HB ' ' HB ' ' A' ' 51' ' ' ILE . 4.1 mt -118.74 104.85 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.208 -0.932 . . . . 0.0 109.52 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -92.92 112.28 24.18 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.295 -0.878 . . . . 0.0 109.615 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 49.5 mm -99.07 89.95 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.229 -0.919 . . . . 0.0 109.29 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -60.13 104.69 0.33 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.224 -0.922 . . . . 0.0 109.548 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 156.57 152.27 6.23 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -112.05 96.83 6.27 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.288 -1.124 . . . . 0.0 109.515 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 16.2 mttt -141.3 48.37 1.67 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.296 -0.878 . . . . 0.0 109.5 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.947 ' HA ' HD12 ' A' ' 93' ' ' LEU . 39.2 ptt180 -49.38 -32.01 10.67 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.231 -0.918 . . . . 0.0 109.659 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.425 ' N ' ' HG3' ' A' ' 90' ' ' ARG . 67.8 t0 -62.21 -60.39 3.65 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.228 -0.92 . . . . 0.0 109.572 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.1 tp -59.25 -22.67 61.47 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.167 -0.958 . . . . 0.0 109.351 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.947 HD12 ' HA ' ' A' ' 90' ' ' ARG . 35.4 mt -69.11 -46.29 68.07 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.312 -0.868 . . . . 0.0 109.471 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 77.0 tttt -61.73 -25.76 67.64 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.196 -0.94 . . . . 0.0 109.46 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 8.7 t -76.05 -61.05 2.07 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.229 -0.919 . . . . 0.0 109.564 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.902 HD12 ' N ' ' A' ' 97' ' ' LEU . 4.2 pp -52.91 -29.72 30.13 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.246 -0.909 . . . . 0.0 109.537 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.902 ' N ' HD12 ' A' ' 96' ' ' LEU . 0.2 OUTLIER -72.34 -48.55 41.08 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.22 -0.925 . . . . 0.0 109.491 -179.955 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -68.74 -12.74 61.81 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.244 -0.91 . . . . 0.0 109.465 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -61.97 -33.11 73.7 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.226 -0.921 . . . . 0.0 109.469 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.441 ' HE2' HD11 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -85.73 -22.04 27.97 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.22 -0.925 . . . . 0.0 109.491 179.986 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 77.89 24.6 64.1 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -99.09 -158.88 0.7 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.255 -1.144 . . . . 0.0 109.479 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 23.3 mttt -104.06 165.06 11.29 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.206 -0.934 . . . . 0.0 109.492 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.418 HG22 ' N ' ' A' ' 105' ' ' LYS . 11.4 p -145.03 158.25 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.24 -0.912 . . . . 0.0 109.458 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.422 ' O ' ' N ' ' A' ' 107' ' ' ALA . 33.9 tttt -119.61 68.47 0.82 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.262 -0.899 . . . . 0.0 109.471 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -50.39 96.61 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.212 -0.93 . . . . 0.0 109.478 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.923 ' HB3' ' HB3' ' A' ' 37' ' ' GLN . . . -89.05 140.06 29.83 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.325 -0.86 . . . . 0.0 109.509 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 117.73 174.62 16.75 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -168.94 -177.82 40.0 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -77.6 115.58 17.47 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.253 -1.146 . . . . 0.0 109.469 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.438 ' HG2' ' O ' ' A' ' 111' ' ' GLU . 74.0 tt0 . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.442 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 88.3 mttt . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -171.57 130.32 1.93 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -142.64 72.43 1.37 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.209 -1.171 . . . . 0.0 109.512 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 125.61 59.67 0.16 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.474 HG22 ' HB2' ' A' ' 103' ' ' LYS . 73.3 t -108.89 111.29 35.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.263 -1.139 . . . . 0.0 109.423 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.913 HG13 HG22 ' A' ' 54' ' ' VAL . 39.8 t -87.65 145.13 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.275 -0.891 . . . . 0.0 109.522 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 31.9 ttm180 -111.55 103.53 11.86 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.228 -0.92 . . . . 0.0 109.437 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.976 HD11 HD23 ' A' ' 97' ' ' LEU . 4.7 mt -102.07 106.22 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.196 -0.94 . . . . 0.0 109.538 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.872 ' HB3' ' HB3' ' A' ' 107' ' ' ALA . 1.7 pp0? -142.66 136.58 29.22 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.227 -0.921 . . . . 0.0 109.412 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.65 167.03 11.37 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.235 -0.915 . . . . 0.0 109.501 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -150.17 154.29 37.75 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.243 -0.91 . . . . 0.0 109.467 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.46 76.79 1.03 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.298 -0.876 . . . . 0.0 109.468 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -147.13 104.01 3.64 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.247 -0.908 . . . . 0.0 109.465 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 153.61 138.25 2.63 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.536 -1.425 . . . . 0.0 109.536 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 91.2 mtt180 -96.34 23.35 6.79 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.253 -1.146 . . . . 0.0 109.497 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 25.3 mttt -129.05 29.35 5.19 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.287 -0.883 . . . . 0.0 109.441 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 159.71 137.5 2.24 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -113.0 120.01 39.9 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.219 -1.166 . . . . 0.0 109.485 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.62 85.85 0.65 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 27.7 m -123.69 168.33 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.242 -1.152 . . . . 0.0 109.452 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 2.1 t -140.72 132.51 27.43 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.223 -0.923 . . . . 0.0 109.429 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.668 ' O ' HD13 ' A' ' 51' ' ' ILE . 0.2 OUTLIER -124.09 154.56 39.78 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.265 -0.897 . . . . 0.0 109.449 -179.979 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.697 ' HB ' HD12 ' A' ' 83' ' ' ILE . 4.5 mm -122.15 117.83 53.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.246 -0.909 . . . . 0.0 109.463 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.1 m -141.84 14.01 2.1 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.261 -0.9 . . . . 0.0 109.525 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.442 ' O ' ' N ' ' A' ' 55' ' ' ASP . . . -105.5 -16.69 15.27 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.913 HG22 HG13 ' A' ' 34' ' ' VAL . 18.6 t -44.93 98.9 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.214 -1.168 . . . . 0.0 109.494 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.442 ' N ' ' O ' ' A' ' 53' ' ' GLY . 41.0 t0 -87.34 88.28 7.64 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.201 -0.937 . . . . 0.0 109.459 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.495 HD23 ' HA ' ' A' ' 56' ' ' LEU . 12.9 mt -151.42 -169.95 3.52 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.281 -0.887 . . . . 0.0 109.487 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -74.76 178.49 5.43 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.259 -0.901 . . . . 0.0 109.441 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.53 -30.31 46.95 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.286 -0.884 . . . . 0.0 109.444 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -75.79 -48.66 20.77 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.213 -0.929 . . . . 0.0 109.464 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -62.06 -32.16 72.66 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.276 -0.89 . . . . 0.0 109.466 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.525 HD23 ' HA2' ' A' ' 81' ' ' GLY . 0.2 OUTLIER -65.36 -45.83 82.55 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.225 -0.922 . . . . 0.0 109.435 -179.994 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 51.5 p -63.78 -33.88 76.65 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.218 -0.926 . . . . 0.0 109.47 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 32.6 mttp -65.65 -46.73 78.06 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.29 -0.882 . . . . 0.0 109.469 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.29 -57.65 12.08 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.339 -0.851 . . . . 0.0 109.527 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.789 ' HA ' HD12 ' A' ' 68' ' ' LEU . . . -58.55 -23.63 58.87 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.273 -0.892 . . . . 0.0 109.534 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -69.72 -41.49 75.26 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.241 -0.912 . . . . 0.0 109.582 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -76.99 -29.21 55.4 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.203 -0.936 . . . . 0.0 109.566 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.789 HD12 ' HA ' ' A' ' 65' ' ' ALA . 9.8 mt -67.7 -52.22 40.32 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.242 -0.911 . . . . 0.0 109.47 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.414 ' HB3' ' HA3' ' A' ' 76' ' ' GLY . 0.0 OUTLIER -66.46 -12.55 57.85 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.295 -0.878 . . . . 0.0 109.504 -179.929 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -74.97 -42.11 58.26 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.197 -0.939 . . . . 0.0 109.507 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 5.7 tttp -67.1 -19.86 65.7 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.304 -0.873 . . . . 0.0 109.654 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 43.7 t -88.14 -43.52 11.59 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.193 -0.942 . . . . 0.0 109.552 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.403 ' O ' ' HB2' ' A' ' 74' ' ' CYS . . . 100.62 -19.87 50.63 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.403 ' HB2' ' O ' ' A' ' 73' ' ' GLY . 0.1 OUTLIER 172.08 134.97 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.169 -1.195 . . . . 0.0 109.532 -179.981 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 126.73 -34.45 3.15 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.414 ' HA3' ' HB3' ' A' ' 69' ' ' LYS . . . -69.31 98.76 0.59 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -108.9 134.52 51.46 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.305 -1.114 . . . . 0.0 109.17 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.455 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 26.8 m -101.02 160.49 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.269 -0.894 . . . . 0.0 109.817 -179.617 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.443 ' HB2' ' O ' ' A' ' 82' ' ' VAL . 0.2 OUTLIER -142.05 65.82 1.36 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.362 -0.836 . . . . 0.0 109.208 179.747 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 25.4 t70 50.76 68.7 0.73 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.362 -0.836 . . . . 0.0 109.545 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.525 ' HA2' HD23 ' A' ' 61' ' ' LEU . . . 90.3 -28.57 7.32 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.443 ' O ' ' HB2' ' A' ' 79' ' ' LYS . 40.2 t -91.59 90.74 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.161 -1.199 . . . . 0.0 109.559 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.697 HD12 ' HB ' ' A' ' 51' ' ' ILE . 11.7 mt -82.04 155.86 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.276 -0.89 . . . . 0.0 109.437 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -149.56 113.33 5.07 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.2 -0.937 . . . . 0.0 109.436 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.403 HG12 ' HA2' ' A' ' 76' ' ' GLY . 23.8 mt -130.9 107.62 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.215 -0.928 . . . . 0.0 109.511 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -53.74 148.52 9.84 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.235 -0.916 . . . . 0.0 109.397 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 143.55 152.84 5.73 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -133.91 84.14 2.1 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.252 -1.146 . . . . 0.0 109.429 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 84.7 mttt -148.21 52.22 1.02 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.282 -0.886 . . . . 0.0 109.478 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 11.8 ptt-85 -46.58 -31.95 3.13 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.25 -0.906 . . . . 0.0 109.472 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -55.78 -55.21 35.03 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.236 -0.915 . . . . 0.0 109.465 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.556 HD23 ' C ' ' A' ' 92' ' ' LEU . 8.2 tt -63.16 -49.32 74.77 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.176 -0.952 . . . . 0.0 109.491 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.649 ' HB3' HG21 ' A' ' 36' ' ' ILE . 3.7 mm? -47.87 -31.04 4.61 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.229 -0.919 . . . . 0.0 109.481 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 34.4 tttt -60.63 -62.77 1.62 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.241 -0.912 . . . . 0.0 109.53 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.57 -16.83 58.28 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.247 -0.908 . . . . 0.0 109.495 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.587 ' C ' HD23 ' A' ' 96' ' ' LEU . 5.4 tt -72.62 -43.92 62.64 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.287 -0.883 . . . . 0.0 109.513 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.976 HD23 HD11 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -74.1 -38.41 63.86 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.287 -0.883 . . . . 0.0 109.484 179.959 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -69.73 -20.9 63.51 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.281 -0.887 . . . . 0.0 109.475 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -55.62 -29.93 60.03 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.262 -0.899 . . . . 0.0 109.497 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.43 -25.37 21.54 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.281 -0.887 . . . . 0.0 109.492 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 95.26 28.44 9.81 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 31.4 mtm -109.5 179.93 4.0 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.226 -1.161 . . . . 0.0 109.471 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.474 ' HB2' HG22 ' A' ' 33' ' ' VAL . 8.7 mmtt -88.85 162.16 16.31 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.259 -0.901 . . . . 0.0 109.456 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.463 ' CG2' HD12 ' A' ' 36' ' ' ILE . 3.2 p -154.39 135.79 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.218 -0.926 . . . . 0.0 109.464 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 12.5 mttt -108.56 104.41 13.72 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.253 -0.904 . . . . 0.0 109.464 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.442 ' O ' ' HB3' ' A' ' 37' ' ' GLN . 1.1 tp -47.86 -24.45 1.01 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.25 -0.906 . . . . 0.0 109.453 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.872 ' HB3' ' HB3' ' A' ' 37' ' ' GLN . . . 44.74 67.23 0.73 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.215 -0.928 . . . . 0.0 109.475 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -109.38 -170.57 20.51 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 142.9 166.06 10.91 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.434 ' O ' ' HB2' ' A' ' 111' ' ' GLU . 13.4 mt 59.48 86.42 0.09 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.276 -1.132 . . . . 0.0 109.469 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.434 ' HB2' ' O ' ' A' ' 110' ' ' LEU . 81.5 tt0 . . . . . 0 N--CA 1.49 1.525 0 CA-C-O 117.99 -1.005 . . . . 0.0 109.489 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.7 mttt . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -178.94 154.51 14.25 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -152.23 50.82 0.78 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.232 -1.158 . . . . 0.0 109.484 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.429 ' HA3' ' SD ' ' A' ' 102' ' ' MET . . . 112.61 125.9 4.53 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.624 HG13 ' O ' ' A' ' 103' ' ' LYS . 93.7 t -143.16 93.95 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.252 -1.146 . . . . 0.0 109.478 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.933 ' O ' HG23 ' A' ' 104' ' ' VAL . 70.5 t -93.23 109.46 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.289 -0.882 . . . . 0.0 109.454 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.522 ' O ' HG23 ' A' ' 51' ' ' ILE . 71.9 mtt180 -92.34 131.8 37.24 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.24 -0.913 . . . . 0.0 109.545 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.744 HG21 HD22 ' A' ' 93' ' ' LEU . 7.0 mt -125.55 127.22 71.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.219 -0.926 . . . . 0.0 109.421 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.673 ' HA ' ' HB2' ' A' ' 107' ' ' ALA . 1.7 pt20 -151.03 -167.89 2.94 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.176 -0.953 . . . . 0.0 109.526 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.419 ' O ' ' HG3' ' A' ' 38' ' ' ARG . 5.4 ptt180 -137.11 118.8 14.99 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.229 -0.919 . . . . 0.0 109.504 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.513 ' OE1' HD13 ' A' ' 50' ' ' LEU . 8.6 tt0 -91.36 118.63 30.69 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.183 -0.948 . . . . 0.0 109.442 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 29.0 p -106.13 -171.05 1.83 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.263 -0.898 . . . . 0.0 109.428 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -177.63 -51.0 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.185 -0.947 . . . . 0.0 109.54 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -110.68 -173.61 20.12 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -139.5 55.25 1.68 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.246 -1.15 . . . . 0.0 109.445 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 31.4 pttt -161.11 30.31 0.14 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.284 -0.885 . . . . 0.0 109.481 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -158.1 -123.85 0.75 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 51.9 mttt -132.98 -153.36 0.54 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.206 -1.173 . . . . 0.0 109.478 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -141.93 -163.93 9.83 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.586 -1.405 . . . . 0.0 109.586 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 22.9 m -154.58 146.11 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.269 -1.136 . . . . 0.0 109.521 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -90.04 131.27 36.01 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.288 -0.883 . . . . 0.0 109.435 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.513 HD13 ' OE1' ' A' ' 39' ' ' GLN . 0.0 OUTLIER -118.1 115.86 25.68 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.255 -0.903 . . . . 0.0 109.46 -179.917 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.522 HG23 ' O ' ' A' ' 35' ' ' ARG . 8.1 mt -120.37 110.5 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.212 -0.93 . . . . 0.0 109.458 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 9.8 t -142.95 162.89 34.27 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.238 -0.914 . . . . 0.0 109.637 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.49 22.24 13.09 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.611 -1.395 . . . . 0.0 109.611 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.577 ' HB ' HD21 ' A' ' 61' ' ' LEU . 61.7 t -78.41 112.71 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.22 -1.165 . . . . 0.0 109.443 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -97.15 70.48 2.37 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.294 -0.879 . . . . 0.0 109.541 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.549 HD22 ' OE2' ' A' ' 60' ' ' GLU . 10.3 mt -136.87 172.7 12.62 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.167 -0.958 . . . . 0.0 109.524 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -47.75 170.71 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.218 -0.926 . . . . 0.0 109.45 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -76.55 -39.8 51.73 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.232 -0.917 . . . . 0.0 109.468 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.09 -31.01 72.04 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.243 -0.91 . . . . 0.0 109.496 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.549 ' OE2' HD22 ' A' ' 56' ' ' LEU . 2.9 mt-10 -62.03 -45.92 91.47 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.269 -0.894 . . . . 0.0 109.543 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.577 HD21 ' HB ' ' A' ' 54' ' ' VAL . 8.4 mt -53.04 -42.69 65.98 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.249 -0.907 . . . . 0.0 109.472 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 52.2 m -71.9 -26.28 62.26 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.264 -0.898 . . . . 0.0 109.425 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.2 tttt -63.49 -59.91 4.04 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.256 -0.902 . . . . 0.0 109.393 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.9 mt -64.7 -31.55 72.82 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.281 -0.887 . . . . 0.0 109.538 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.506 ' HB1' ' CG2' ' A' ' 78' ' ' VAL . . . -57.5 -49.63 75.68 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.272 -0.892 . . . . 0.0 109.662 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -71.81 -28.04 63.33 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.244 -0.91 . . . . 0.0 109.628 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -64.45 -33.08 75.05 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.219 -0.926 . . . . 0.0 109.907 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 6.0 mt -88.04 -34.52 17.96 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.102 -0.999 . . . . 0.0 109.921 -179.669 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.8 mttt -63.24 -16.9 61.66 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.139 -0.975 . . . . 0.0 109.778 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 13.5 tttt -75.28 -28.15 59.67 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.18 -0.95 . . . . 0.0 109.707 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 7.2 mtpp -72.42 -67.84 0.52 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.169 -0.957 . . . . 0.0 109.243 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -64.63 -56.72 12.03 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.19 -0.944 . . . . 0.0 109.195 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.482 ' O ' ' HB2' ' A' ' 74' ' ' CYS . . . 84.31 12.88 75.07 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.482 ' HB2' ' O ' ' A' ' 73' ' ' GLY . 4.7 t 166.46 126.73 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.478 -1.013 . . . . 0.0 108.994 -179.733 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 113.86 -5.95 24.02 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -110.08 125.63 7.61 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.194 -1.563 . . . . 0.0 109.194 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -110.15 121.41 45.21 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.169 -1.194 . . . . 0.0 109.939 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.506 ' CG2' ' HB1' ' A' ' 65' ' ' ALA . 36.9 t -86.92 124.34 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.276 -0.89 . . . . 0.0 109.122 179.534 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -120.41 145.7 46.94 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.209 -0.932 . . . . 0.0 109.201 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.0 101.17 1.08 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.289 -0.882 . . . . 0.0 109.493 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 103.53 -11.53 54.03 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 65.0 t -142.85 121.29 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.323 -1.104 . . . . 0.0 109.426 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 26.8 mm -104.3 121.18 55.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.226 -0.921 . . . . 0.0 109.589 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -105.68 120.33 41.41 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.315 -0.866 . . . . 0.0 109.401 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.494 HG13 HD12 ' A' ' 51' ' ' ILE . 14.8 mm -117.6 164.4 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.176 -0.952 . . . . 0.0 109.517 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.478 ' N ' HG22 ' A' ' 85' ' ' ILE . 5.4 mt-30 -124.69 132.89 53.36 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.311 -0.868 . . . . 0.0 109.583 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 136.87 168.31 11.37 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -135.62 82.11 1.93 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.29 -1.124 . . . . 0.0 109.559 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 43.7 mttt -142.88 51.68 1.41 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.217 -0.927 . . . . 0.0 109.478 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.64 -25.95 0.81 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.24 -0.912 . . . . 0.0 109.447 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -64.85 -58.33 6.47 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.244 -0.91 . . . . 0.0 109.373 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.0 tt -58.13 -49.08 78.24 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.245 -0.909 . . . . 0.0 109.308 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.744 HD22 HG21 ' A' ' 36' ' ' ILE . 3.4 mt -52.1 -33.63 40.53 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.278 -0.889 . . . . 0.0 109.408 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.594 ' CG ' HD11 ' A' ' 106' ' ' LEU . 0.1 OUTLIER -60.53 -58.49 8.25 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.292 -0.88 . . . . 0.0 109.388 179.923 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 3.2 t -65.79 -11.76 48.63 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.213 -0.929 . . . . 0.0 109.447 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.609 HD23 ' N ' ' A' ' 97' ' ' LEU . 3.1 tt -74.9 -59.2 2.84 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.24 -0.913 . . . . 0.0 109.423 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.683 HD23 HD11 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -69.56 -23.29 63.54 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.286 -0.883 . . . . 0.0 109.49 179.975 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -73.39 -26.46 61.0 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.282 -0.886 . . . . 0.0 109.516 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -71.03 -22.26 62.17 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.252 -0.905 . . . . 0.0 109.489 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 4.0 mtmt -94.29 8.0 43.37 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.231 -0.918 . . . . 0.0 109.508 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 46.32 33.29 5.65 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' MET . . . . . 0.519 ' HB2' ' CD1' ' A' ' 97' ' ' LEU . 0.1 OUTLIER -86.93 -173.43 4.46 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.268 -1.137 . . . . 0.0 109.471 -179.993 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.624 ' O ' HG13 ' A' ' 33' ' ' VAL . 16.8 mttt -101.16 72.06 1.43 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.262 -0.899 . . . . 0.0 109.459 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.933 HG23 ' O ' ' A' ' 34' ' ' VAL . 8.3 p -88.68 145.69 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.232 -0.918 . . . . 0.0 109.532 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.403 ' O ' ' C ' ' A' ' 106' ' ' LEU . 21.5 tttt -110.79 30.27 7.0 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.277 -0.889 . . . . 0.0 109.446 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.594 HD11 ' CG ' ' A' ' 94' ' ' LYS . 3.5 tp 44.6 -154.28 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.251 -0.905 . . . . 0.0 109.487 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.673 ' HB2' ' HA ' ' A' ' 37' ' ' GLN . . . -105.26 63.61 0.7 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.221 -0.924 . . . . 0.0 109.463 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -68.72 168.65 43.07 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -170.53 162.5 35.6 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -177.05 67.62 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.292 -1.122 . . . . 0.0 109.416 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.427 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 85.7 mttt . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -77.01 111.68 3.33 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -119.04 -35.67 3.58 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.22 -1.165 . . . . 0.0 109.531 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -160.33 148.1 15.95 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.504 HG12 ' HB2' ' A' ' 103' ' ' LYS . 34.8 m -131.68 145.41 35.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.271 -1.135 . . . . 0.0 109.491 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.576 HG11 HD21 ' A' ' 97' ' ' LEU . 5.4 t -111.28 164.71 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.23 -0.919 . . . . 0.0 109.442 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.424 ' N ' HG12 ' A' ' 34' ' ' VAL . 0.1 OUTLIER -141.57 112.24 7.14 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.237 -0.915 . . . . 0.0 109.444 -179.985 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.715 HG21 HD13 ' A' ' 93' ' ' LEU . 4.5 mt -125.78 117.1 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.259 -0.901 . . . . 0.0 109.483 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.71 98.16 2.93 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.303 -0.873 . . . . 0.0 109.449 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.2 ptt180 -56.38 125.68 23.04 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.284 -0.885 . . . . 0.0 109.515 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -110.78 79.14 1.17 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.208 -0.932 . . . . 0.0 109.494 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 33.7 p -50.28 149.22 3.06 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.209 -0.932 . . . . 0.0 109.476 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.2 t -103.34 -12.56 17.15 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.265 -0.897 . . . . 0.0 109.449 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -135.4 160.35 24.41 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -61.36 119.36 8.36 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.194 -1.18 . . . . 0.0 109.456 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 27.4 tttt 53.73 -175.9 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.232 -0.918 . . . . 0.0 109.474 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 97.49 -143.41 16.71 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 10.8 tttt -88.26 161.54 17.13 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.29 -1.124 . . . . 0.0 109.506 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -144.75 152.58 24.54 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 34.5 m -106.01 167.88 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.233 -1.157 . . . . 0.0 109.428 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -128.88 113.1 14.83 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.187 -0.946 . . . . 0.0 109.477 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.783 ' O ' HD13 ' A' ' 51' ' ' ILE . 0.8 OUTLIER -89.04 143.78 26.61 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.198 -0.939 . . . . 0.0 109.528 179.955 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.783 HD13 ' O ' ' A' ' 50' ' ' LEU . 6.4 mm -127.33 108.32 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.207 -0.933 . . . . 0.0 109.414 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.403 ' HB ' HG12 ' A' ' 82' ' ' VAL . 0.0 OUTLIER -155.14 154.58 32.55 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.274 -0.891 . . . . 0.0 109.494 179.995 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 115.5 -28.72 7.67 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.452 HG12 HD23 ' A' ' 56' ' ' LEU . 24.2 t -45.76 109.84 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.311 -1.111 . . . . 0.0 109.457 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -90.73 75.89 6.49 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.284 -0.885 . . . . 0.0 109.466 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.486 ' HA ' HD13 ' A' ' 56' ' ' LEU . 1.4 mm? -114.12 -171.5 1.92 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.259 -0.9 . . . . 0.0 109.485 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -72.5 -69.72 0.39 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.258 -0.901 . . . . 0.0 109.473 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -178.93 -43.03 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.256 -0.903 . . . . 0.0 109.465 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.92 -30.58 56.18 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.247 -0.908 . . . . 0.0 109.525 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -59.1 -45.48 90.75 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.223 -0.923 . . . . 0.0 109.523 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.566 HD23 HD11 ' A' ' 83' ' ' ILE . 0.1 OUTLIER -50.89 -52.8 38.35 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.238 -0.914 . . . . 0.0 109.42 179.988 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 34.0 p -57.57 -40.66 79.46 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.304 -0.872 . . . . 0.0 109.405 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 7.7 tttt -54.57 -45.04 73.44 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.3 -0.875 . . . . 0.0 109.536 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.472 ' HA ' HD22 ' A' ' 64' ' ' LEU . 0.1 OUTLIER -64.0 -46.01 86.44 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.24 -0.912 . . . . 0.0 109.509 -179.945 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -49.72 -43.83 47.9 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.199 -0.938 . . . . 0.0 109.548 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -69.37 -35.96 76.35 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.272 -0.892 . . . . 0.0 109.577 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -65.44 -21.61 66.67 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.211 -0.931 . . . . 0.0 109.627 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 5.4 mt -87.25 -44.4 11.47 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.305 -0.872 . . . . 0.0 109.673 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.446 ' O ' ' HG2' ' A' ' 69' ' ' LYS . 10.0 tttt -64.59 -22.7 67.04 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.259 -0.901 . . . . 0.0 109.801 -179.686 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.24 -15.52 47.58 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.178 -0.951 . . . . 0.0 110.004 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.8 23.87 1.09 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.057 -1.027 . . . . 0.0 109.656 -179.589 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -105.39 -24.56 12.63 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.303 -0.873 . . . . 0.0 109.551 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.43 ' O ' ' SG ' ' A' ' 74' ' ' CYS . . . 94.03 -10.74 71.65 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 -179.621 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.43 ' SG ' ' O ' ' A' ' 73' ' ' GLY . 0.7 OUTLIER 174.07 134.86 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.325 -1.103 . . . . 0.0 109.281 179.983 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -72.66 -80.49 0.41 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 120.66 -109.34 1.54 Allowed Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -106.0 131.39 53.35 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.153 -1.204 . . . . 0.0 109.417 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 90.4 t -136.33 97.37 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.23 -0.919 . . . . 0.0 109.83 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.2 146.71 27.59 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.194 -0.941 . . . . 0.0 108.761 179.321 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -63.27 94.43 0.08 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.112 -0.992 . . . . 0.0 109.609 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 129.88 -25.95 4.33 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.433 ' O ' HG13 ' A' ' 83' ' ' ILE . 1.6 m -143.59 157.79 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.182 -1.187 . . . . 0.0 109.673 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.566 HD11 HD23 ' A' ' 61' ' ' LEU . 4.2 mp -143.71 146.74 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.223 -0.923 . . . . 0.0 109.467 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -130.28 125.96 36.08 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.238 -0.914 . . . . 0.0 109.423 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.432 HG22 ' N ' ' A' ' 86' ' ' GLN . 28.1 mm -114.69 157.18 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.215 -0.928 . . . . 0.0 109.5 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.432 ' N ' HG22 ' A' ' 85' ' ' ILE . 0.0 OUTLIER -115.9 86.02 2.4 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.206 -0.934 . . . . 0.0 109.469 -179.963 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -164.48 166.85 38.07 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -119.38 49.22 1.38 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.246 -1.149 . . . . 0.0 109.482 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 31.4 mttt -105.52 37.0 2.32 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.211 -0.931 . . . . 0.0 109.459 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.413 ' HA ' HD12 ' A' ' 93' ' ' LEU . 7.3 ttt180 -46.81 -36.85 7.83 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.26 -0.9 . . . . 0.0 109.474 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -58.03 -53.66 55.75 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.242 -0.912 . . . . 0.0 109.547 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.11 -17.8 64.94 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.231 -0.918 . . . . 0.0 109.526 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.715 HD13 HG21 ' A' ' 36' ' ' ILE . 2.1 mt -72.56 -44.85 61.53 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.302 -0.874 . . . . 0.0 109.494 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 61.6 tttt -65.96 -32.98 74.78 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.224 -0.923 . . . . 0.0 109.477 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 14.3 t -67.54 -62.69 1.3 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.25 -0.906 . . . . 0.0 109.448 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.939 HD12 ' N ' ' A' ' 97' ' ' LEU . 4.2 pp -51.64 -31.61 26.1 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.195 -0.941 . . . . 0.0 109.471 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.939 ' N ' HD12 ' A' ' 96' ' ' LEU . 0.2 OUTLIER -65.14 -47.01 78.6 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.223 -0.923 . . . . 0.0 109.494 179.968 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 72.4 tt0 -69.19 -14.26 62.88 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.298 -0.876 . . . . 0.0 109.455 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -73.42 -13.93 61.17 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.212 -0.93 . . . . 0.0 109.434 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.35 -31.28 11.4 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.262 -0.899 . . . . 0.0 109.441 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 100.68 15.8 28.25 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 1.5 mtm -88.2 156.12 19.4 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.192 -1.181 . . . . 0.0 109.49 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.504 ' HB2' HG12 ' A' ' 33' ' ' VAL . 27.2 mttt -86.17 97.61 10.44 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.285 -0.885 . . . . 0.0 109.468 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 12.5 p -81.43 140.66 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.226 -0.921 . . . . 0.0 109.46 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.47 ' O ' ' N ' ' A' ' 107' ' ' ALA . 0.7 OUTLIER -111.41 77.41 1.04 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.224 -0.923 . . . . 0.0 109.469 -179.994 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.5 mp -46.54 96.44 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.185 -0.947 . . . . 0.0 109.471 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.47 ' N ' ' O ' ' A' ' 105' ' ' LYS . . . -90.2 97.36 11.14 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.265 -0.897 . . . . 0.0 109.488 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -178.71 161.91 28.7 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -157.82 168.86 34.51 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.512 HD22 ' HA ' ' A' ' 110' ' ' LEU . 0.2 OUTLIER -81.7 98.87 8.61 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.217 -1.167 . . . . 0.0 109.458 179.957 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 118.016 -0.993 . . . . 0.0 109.428 -179.987 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 23.3 mttt . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -96.52 -62.49 0.94 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -133.03 86.51 2.31 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.266 -1.138 . . . . 0.0 109.462 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.425 ' O ' ' HB2' ' A' ' 103' ' ' LYS . . . -138.64 123.45 2.61 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.403 HG22 ' CB ' ' A' ' 103' ' ' LYS . 73.2 t -146.91 104.5 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.242 -1.152 . . . . 0.0 109.454 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.745 HG13 ' CG2' ' A' ' 54' ' ' VAL . 21.4 t -92.88 151.09 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.253 -0.904 . . . . 0.0 109.432 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 2.0 ttt180 -121.82 112.4 18.3 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.25 -0.906 . . . . 0.0 109.487 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.785 HG21 ' HB3' ' A' ' 93' ' ' LEU . 2.2 mp -123.44 114.54 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.266 -0.896 . . . . 0.0 109.406 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.5 ' CD ' ' HB3' ' A' ' 107' ' ' ALA . 7.0 pt20 -150.59 -162.13 1.49 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.212 -0.93 . . . . 0.0 109.446 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 30.8 mtm180 -123.77 139.19 54.22 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.233 -0.917 . . . . 0.0 109.452 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.694 ' HB2' HD13 ' A' ' 50' ' ' LEU . 13.5 tt0 -116.05 60.17 0.72 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.247 -0.908 . . . . 0.0 109.472 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.6 p -60.05 142.51 53.91 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.261 -0.9 . . . . 0.0 109.438 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 20.0 m -114.28 -73.59 0.65 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.245 -0.909 . . . . 0.0 109.47 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 149.36 75.85 0.02 OUTLIER Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 5.1 ttt180 179.52 -58.28 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.314 -1.109 . . . . 0.0 109.491 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -60.42 -57.12 14.12 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.296 -0.878 . . . . 0.0 109.451 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 119.96 -54.6 0.64 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.561 -1.415 . . . . 0.0 109.561 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 19.6 mttt -69.17 -174.41 0.63 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.274 -1.133 . . . . 0.0 109.547 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -109.11 149.05 17.06 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.9 m -119.57 145.74 25.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.307 -1.113 . . . . 0.0 109.468 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 2.3 t -111.46 139.79 46.59 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.269 -0.894 . . . . 0.0 109.437 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.694 HD13 ' HB2' ' A' ' 39' ' ' GLN . 2.1 mp -130.35 119.91 23.51 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.246 -0.909 . . . . 0.0 109.516 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.801 ' HB ' HD12 ' A' ' 83' ' ' ILE . 3.1 mm -101.19 124.7 55.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.229 -0.919 . . . . 0.0 109.379 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -159.63 159.52 33.2 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.199 -0.938 . . . . 0.0 109.491 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.412 ' O ' ' C ' ' A' ' 54' ' ' VAL . . . 105.76 -29.06 11.93 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.745 ' CG2' HG13 ' A' ' 34' ' ' VAL . 62.5 t -45.22 117.75 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.213 -1.169 . . . . 0.0 109.421 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -111.95 72.24 0.77 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.26 -0.9 . . . . 0.0 109.511 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.503 HD11 ' SD ' ' A' ' 102' ' ' MET . 2.7 mt -126.04 -170.31 2.17 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.216 -0.928 . . . . 0.0 109.456 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -56.03 147.77 19.19 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.242 -0.911 . . . . 0.0 109.475 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.94 -33.49 73.25 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.274 -0.891 . . . . 0.0 109.518 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -77.27 -29.06 53.69 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.231 -0.918 . . . . 0.0 109.385 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -69.27 -30.51 68.64 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.303 -0.873 . . . . 0.0 109.45 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.416 HD21 ' HB ' ' A' ' 54' ' ' VAL . 1.7 mt -66.21 -58.35 5.59 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.271 -0.893 . . . . 0.0 109.496 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -57.68 -19.4 26.71 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.197 -0.939 . . . . 0.0 109.376 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 9.3 mttt -76.68 -44.33 34.16 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.309 -0.869 . . . . 0.0 109.558 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.409 HD22 ' HA ' ' A' ' 64' ' ' LEU . 0.3 OUTLIER -70.88 -29.0 64.98 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.209 -0.932 . . . . 0.0 109.508 -179.997 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.451 ' HB1' HG13 ' A' ' 78' ' ' VAL . . . -72.25 -52.38 16.67 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.245 -0.909 . . . . 0.0 109.382 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.9 -48.78 80.21 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.237 -0.915 . . . . 0.0 109.551 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -54.0 -46.27 71.72 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.196 -0.94 . . . . 0.0 109.331 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -59.5 -36.54 76.24 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.277 -0.889 . . . . 0.0 109.238 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 7.9 tmtt? -61.54 -37.96 85.68 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.333 -0.855 . . . . 0.0 109.286 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 11.3 mttt -58.05 -25.46 61.24 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.234 -0.916 . . . . 0.0 108.955 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 1.7 mtmp? -122.0 50.19 1.48 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.513 -0.742 . . . . 0.0 109.217 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 23.4 t -133.72 -63.51 0.74 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.178 -0.951 . . . . 0.0 109.686 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.482 ' O ' ' HB2' ' A' ' 74' ' ' CYS . . . 120.17 10.25 7.53 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -179.701 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.482 ' HB2' ' O ' ' A' ' 73' ' ' GLY . 4.6 t 168.3 127.92 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.325 -1.103 . . . . 0.0 109.193 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -94.53 101.58 2.75 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -66.99 -109.01 0.02 OUTLIER Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -111.75 121.77 46.0 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.205 -1.173 . . . . 0.0 109.302 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.451 HG13 ' HB1' ' A' ' 65' ' ' ALA . 22.9 t -116.43 78.12 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.21 -0.931 . . . . 0.0 109.808 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -88.28 145.62 25.76 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.243 -0.911 . . . . 0.0 109.201 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -65.0 91.42 0.09 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.201 -0.937 . . . . 0.0 109.507 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 129.07 -24.34 4.79 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.0 t -139.04 137.86 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.152 -1.205 . . . . 0.0 109.582 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.801 HD12 ' HB ' ' A' ' 51' ' ' ILE . 4.2 mt -132.01 135.34 58.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.353 -0.842 . . . . 0.0 109.55 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 68.1 mt-10 -132.25 116.47 16.97 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.302 -0.874 . . . . 0.0 109.207 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 56.1 mt -148.36 146.72 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.225 -0.922 . . . . 0.0 109.621 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -72.74 141.58 48.14 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.24 -0.912 . . . . 0.0 109.309 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 167.7 122.33 0.61 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -106.96 51.61 0.74 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.321 -1.105 . . . . 0.0 109.538 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 85.5 mttt -131.9 53.42 2.0 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.252 -0.905 . . . . 0.0 109.478 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 32.5 ptt180 -53.13 -27.48 21.1 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.24 -0.912 . . . . 0.0 109.358 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 48.1 t0 -65.41 -53.33 44.76 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.29 -0.881 . . . . 0.0 109.393 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.9 tt -58.71 -48.35 81.43 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.274 -0.891 . . . . 0.0 109.424 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.785 ' HB3' HG21 ' A' ' 36' ' ' ILE . 5.9 mt -53.93 -38.97 65.45 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.252 -0.905 . . . . 0.0 109.429 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.521 ' HE3' HD11 ' A' ' 106' ' ' LEU . 3.1 ttmt -68.26 -31.26 70.6 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.253 -0.904 . . . . 0.0 109.494 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 21.8 t -67.54 -64.03 0.94 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.236 -0.915 . . . . 0.0 109.471 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.796 HD12 ' N ' ' A' ' 97' ' ' LEU . 2.6 pp -50.62 -38.27 44.98 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.277 -0.889 . . . . 0.0 109.499 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.796 ' N ' HD12 ' A' ' 96' ' ' LEU . 0.2 OUTLIER -59.44 -45.13 92.46 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.218 -0.926 . . . . 0.0 109.485 179.978 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -69.68 -17.07 63.46 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.257 -0.902 . . . . 0.0 109.444 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -67.98 -27.47 66.6 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.251 -0.905 . . . . 0.0 109.459 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.494 ' HD2' ' N ' ' A' ' 100' ' ' LYS . 6.7 mptt -85.13 -16.35 40.77 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.228 -0.92 . . . . 0.0 109.442 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 88.73 23.96 34.4 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' MET . . . . . 0.503 ' SD ' HD11 ' A' ' 56' ' ' LEU . 1.2 mtm -97.77 171.17 8.49 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.265 -1.138 . . . . 0.0 109.467 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.425 ' HB2' ' O ' ' A' ' 32' ' ' GLY . 8.7 mttt -84.62 165.74 17.71 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.231 -0.918 . . . . 0.0 109.484 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.8 t -147.91 124.16 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.275 -0.891 . . . . 0.0 109.485 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 5.9 mttt -109.38 79.07 1.18 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.256 -0.903 . . . . 0.0 109.468 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.521 HD11 ' HE3' ' A' ' 94' ' ' LYS . 6.2 mt -46.18 105.53 0.06 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.297 -0.877 . . . . 0.0 109.482 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.5 ' HB3' ' CD ' ' A' ' 37' ' ' GLN . . . -102.5 163.5 12.19 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.277 -0.89 . . . . 0.0 109.466 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -178.46 -150.04 8.5 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -63.71 -145.96 0.02 OUTLIER Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 13.4 mt -127.78 -65.39 0.92 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.263 -1.14 . . . . 0.0 109.473 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 117.956 -1.021 . . . . 0.0 109.426 -179.974 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 92.9 mttt . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 142.79 164.41 10.15 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -135.71 51.77 2.03 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.208 -1.172 . . . . 0.0 109.454 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 149.54 130.98 1.89 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.5 p -160.03 131.26 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.265 -1.138 . . . . 0.0 109.449 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.629 HG23 ' CE ' ' A' ' 102' ' ' MET . 75.6 t -105.54 153.65 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.261 -0.899 . . . . 0.0 109.468 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.431 ' HB3' ' O ' ' A' ' 52' ' ' THR . 24.6 ttt180 -129.65 100.89 5.68 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.192 -0.942 . . . . 0.0 109.513 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.85 HG23 HG13 ' A' ' 51' ' ' ILE . 1.2 mp -102.81 125.75 57.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.232 -0.918 . . . . 0.0 109.397 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -122.63 -166.81 1.48 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.235 -0.916 . . . . 0.0 109.468 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 14.1 ptt180 -152.54 132.7 13.51 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.197 -0.939 . . . . 0.0 109.476 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -118.13 110.37 17.52 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.23 -0.919 . . . . 0.0 109.488 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 5.7 t -109.18 166.5 10.8 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.275 -0.89 . . . . 0.0 109.453 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -148.99 21.24 0.98 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.251 -0.906 . . . . 0.0 109.471 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 179.33 -147.97 7.92 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 39.4 ptt180 -150.87 -177.36 5.96 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.238 -1.154 . . . . 0.0 109.469 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 77.2 tttt 62.27 25.68 15.36 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.23 -0.919 . . . . 0.0 109.442 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.456 ' O ' ' O ' ' A' ' 46' ' ' LYS . . . 129.93 -158.43 22.29 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.456 ' O ' ' O ' ' A' ' 45' ' ' GLY . 12.4 ttmt 58.15 112.2 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.248 -1.148 . . . . 0.0 109.515 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -178.35 131.26 1.71 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.2 m -131.49 147.26 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.245 -1.15 . . . . 0.0 109.528 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 1.8 m -125.01 118.34 26.0 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.269 -0.895 . . . . 0.0 109.494 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.563 ' C ' HD12 ' A' ' 51' ' ' ILE . 0.4 OUTLIER -113.1 138.93 49.19 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.218 -0.926 . . . . 0.0 109.503 -179.94 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.85 HG13 HG23 ' A' ' 36' ' ' ILE . 2.7 mp -108.37 122.62 63.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.234 -0.916 . . . . 0.0 109.394 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.431 ' O ' ' HB3' ' A' ' 35' ' ' ARG . 0.5 OUTLIER -146.25 156.53 43.45 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.287 -0.883 . . . . 0.0 109.534 -179.898 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 93.89 23.14 23.81 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.438 HG12 HD12 ' A' ' 56' ' ' LEU . 10.1 t -80.55 115.38 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.304 -1.115 . . . . 0.0 109.552 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -94.14 76.91 4.05 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.265 -0.897 . . . . 0.0 109.443 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.438 HD12 HG12 ' A' ' 54' ' ' VAL . 0.4 OUTLIER -144.9 177.75 8.51 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.263 -0.898 . . . . 0.0 109.409 179.955 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -56.97 158.35 4.97 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.216 -0.927 . . . . 0.0 109.519 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.72 -48.35 59.82 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.32 -0.862 . . . . 0.0 109.495 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.92 -33.69 70.85 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.279 -0.888 . . . . 0.0 109.411 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.421 ' O ' ' C ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -59.47 -54.05 51.05 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.232 -0.917 . . . . 0.0 109.418 179.951 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.421 ' C ' ' O ' ' A' ' 60' ' ' GLU . 0.3 OUTLIER -44.58 -42.75 7.59 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.239 -0.913 . . . . 0.0 109.196 179.844 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 60.9 m -58.54 -50.63 73.08 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.263 -0.898 . . . . 0.0 109.166 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -52.5 -30.39 29.96 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.26 -0.9 . . . . 0.0 109.137 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -68.81 -53.48 21.31 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.344 -0.847 . . . . 0.0 109.485 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -52.68 -33.76 48.88 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.242 -0.911 . . . . 0.0 109.308 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -71.98 -41.88 67.16 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.278 -0.889 . . . . 0.0 109.284 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -65.11 -19.79 66.15 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.22 -0.925 . . . . 0.0 109.357 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.463 ' HA ' HD13 ' A' ' 68' ' ' LEU . 3.3 mm? -84.02 -57.3 3.25 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.229 -0.919 . . . . 0.0 109.447 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 6.2 mttt -60.11 -22.75 63.19 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.281 -0.887 . . . . 0.0 109.412 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.8 -42.67 47.44 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.262 -0.899 . . . . 0.0 109.496 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 2.1 ptmt -129.14 70.17 1.41 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.271 -0.893 . . . . 0.0 109.332 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -144.33 -42.7 0.26 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.311 -0.868 . . . . 0.0 109.424 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.474 ' O ' ' HB2' ' A' ' 74' ' ' CYS . . . 119.49 -62.09 0.48 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.474 ' HB2' ' O ' ' A' ' 73' ' ' GLY . 17.0 t 172.31 107.49 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.344 -1.092 . . . . 0.0 109.323 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 160.38 50.77 0.01 OUTLIER Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -117.97 116.92 3.58 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.501 ' HB3' ' HB3' ' A' ' 84' ' ' GLU . . . -104.05 110.25 22.35 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.337 -1.096 . . . . 0.0 109.004 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.2 t -85.16 84.22 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.214 -0.929 . . . . 0.0 109.814 -179.544 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.476 ' HB3' ' HB ' ' A' ' 82' ' ' VAL . 20.3 mmtt -90.9 169.18 11.13 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.287 -0.883 . . . . 0.0 108.955 179.505 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -60.63 112.75 2.12 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.113 -0.992 . . . . 0.0 109.578 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 51.99 27.78 22.92 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.494 ' O ' HG12 ' A' ' 82' ' ' VAL . 43.4 t -141.65 88.19 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.152 -1.205 . . . . 0.0 109.536 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.494 ' N ' HD13 ' A' ' 83' ' ' ILE . 4.7 mm -83.53 102.12 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.246 -0.908 . . . . 0.0 109.306 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.501 ' HB3' ' HB3' ' A' ' 77' ' ' ALA . 0.5 OUTLIER -82.92 126.66 32.73 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.284 -0.885 . . . . 0.0 109.73 -179.845 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 18.6 mm -133.96 110.62 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.265 -0.897 . . . . 0.0 109.406 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -72.77 128.95 37.06 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.263 -0.898 . . . . 0.0 109.573 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 145.04 136.56 3.03 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -95.89 89.56 5.29 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.251 -1.147 . . . . 0.0 109.445 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 3.1 mttt -144.55 53.23 1.25 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.205 -0.934 . . . . 0.0 109.5 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.842 ' HA ' HD12 ' A' ' 93' ' ' LEU . 51.2 ttt180 -64.02 -40.73 96.98 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.251 -0.906 . . . . 0.0 109.483 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -53.82 -44.06 69.92 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.211 -0.931 . . . . 0.0 109.46 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 3.6 tt -75.11 -26.63 59.4 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.267 -0.896 . . . . 0.0 109.532 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.842 HD12 ' HA ' ' A' ' 90' ' ' ARG . 22.8 mt -61.63 -42.86 99.47 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.263 -0.898 . . . . 0.0 109.474 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 17.3 tttt -67.03 -26.74 66.92 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.24 -0.913 . . . . 0.0 109.592 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 1.2 t -70.72 -62.34 1.43 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.224 -0.922 . . . . 0.0 109.534 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.865 HD12 ' N ' ' A' ' 97' ' ' LEU . 4.6 pp -54.93 -31.43 60.3 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.228 -0.92 . . . . 0.0 109.534 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.865 ' N ' HD12 ' A' ' 96' ' ' LEU . 0.2 OUTLIER -67.64 -47.4 69.69 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.183 -0.948 . . . . 0.0 109.559 -179.917 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.53 -15.36 63.23 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.223 -0.923 . . . . 0.0 109.589 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -69.79 -12.75 61.87 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.222 -0.924 . . . . 0.0 109.464 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.19 -37.49 20.07 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.246 -0.908 . . . . 0.0 109.497 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 101.45 22.96 9.89 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' MET . . . . . 0.629 ' CE ' HG23 ' A' ' 34' ' ' VAL . 0.3 OUTLIER -119.6 -172.89 2.41 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.198 -1.177 . . . . 0.0 109.466 -179.996 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 6.6 tttt -86.54 162.01 18.26 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.252 -0.905 . . . . 0.0 109.484 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.582 ' HB ' HD12 ' A' ' 97' ' ' LEU . 12.7 p -152.32 153.47 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.262 -0.899 . . . . 0.0 109.429 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 6.0 mttt -131.64 90.12 2.8 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.212 -0.93 . . . . 0.0 109.494 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.68 ' O ' ' HB3' ' A' ' 107' ' ' ALA . 4.6 mm? -54.85 -30.13 56.93 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.259 -0.901 . . . . 0.0 109.476 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.68 ' HB3' ' O ' ' A' ' 106' ' ' LEU . . . 75.25 86.23 0.09 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.265 -0.897 . . . . 0.0 109.433 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -115.04 70.39 0.25 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -84.57 -168.03 43.7 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.466 HD23 ' H ' ' A' ' 111' ' ' GLU . 0.3 OUTLIER -156.54 153.66 29.05 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.239 -1.154 . . . . 0.0 109.456 179.959 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.466 ' H ' HD23 ' A' ' 110' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 118.028 -0.986 . . . . 0.0 109.483 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.6 mttt . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 179.82 164.71 32.58 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -160.17 69.48 0.4 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.26 -1.141 . . . . 0.0 109.483 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 171.72 120.36 0.55 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.595 HG23 ' O ' ' A' ' 33' ' ' VAL . 35.5 m -132.17 115.48 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.307 -1.114 . . . . 0.0 109.463 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.729 HG22 HG22 ' A' ' 54' ' ' VAL . 97.0 t -80.62 159.84 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.273 -0.892 . . . . 0.0 109.513 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.484 ' N ' HG12 ' A' ' 34' ' ' VAL . 4.5 mtp180 -145.59 127.76 15.7 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.282 -0.887 . . . . 0.0 109.441 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.833 HG21 HD13 ' A' ' 93' ' ' LEU . 2.7 mp -132.48 109.18 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.274 -0.891 . . . . 0.0 109.497 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.878 ' HB3' ' HB3' ' A' ' 107' ' ' ALA . 2.6 pt20 -140.02 157.39 45.74 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.294 -0.879 . . . . 0.0 109.467 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.44 ' HG2' ' HD3' ' A' ' 90' ' ' ARG . 7.8 ptt180 -96.15 135.96 37.24 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.249 -0.907 . . . . 0.0 109.433 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -108.39 95.41 5.65 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.26 -0.9 . . . . 0.0 109.458 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.25 171.01 14.41 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.226 -0.921 . . . . 0.0 109.461 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -176.33 82.87 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.297 -0.877 . . . . 0.0 109.479 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 129.71 -168.19 21.26 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 1.4 mtt180 -111.79 -69.25 0.88 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.254 -1.145 . . . . 0.0 109.474 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 66.9 mttt -94.9 86.66 4.73 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.226 -0.921 . . . . 0.0 109.501 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -152.49 -164.0 12.05 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 21.8 mttt -107.7 158.77 17.0 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.201 -1.176 . . . . 0.0 109.481 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -95.03 177.13 35.09 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.7 m -151.46 154.36 8.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.258 -1.142 . . . . 0.0 109.477 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 6.9 t -119.34 110.64 17.21 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.261 -0.9 . . . . 0.0 109.493 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -97.12 131.7 43.63 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.29 -0.881 . . . . 0.0 109.411 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 63.6 mt -125.36 114.95 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.229 -0.919 . . . . 0.0 109.533 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -151.84 170.35 20.02 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.252 -0.905 . . . . 0.0 109.435 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.19 -15.91 58.66 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.729 HG22 HG22 ' A' ' 34' ' ' VAL . 53.4 t -56.92 108.47 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.269 -1.136 . . . . 0.0 109.474 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.468 ' O ' HD22 ' A' ' 56' ' ' LEU . 18.3 t0 -86.16 78.16 9.43 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.296 -0.878 . . . . 0.0 109.471 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.468 HD22 ' O ' ' A' ' 55' ' ' ASP . 0.2 OUTLIER -134.53 159.03 42.42 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.247 -0.908 . . . . 0.0 109.46 179.986 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.448 ' O ' ' O ' ' A' ' 58' ' ' ASP . 0.2 OUTLIER -76.61 157.02 32.27 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.203 -0.936 . . . . 0.0 109.501 179.963 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.709 ' O ' ' HB3' ' A' ' 59' ' ' ALA . 0.2 OUTLIER -50.73 -179.48 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.298 -0.876 . . . . 0.0 109.523 -179.963 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.709 ' HB3' ' O ' ' A' ' 58' ' ' ASP . . . 76.98 -78.9 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.313 -0.867 . . . . 0.0 109.501 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -55.1 -36.77 66.03 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.236 -0.915 . . . . 0.0 109.543 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -58.76 -48.29 81.73 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.181 -0.95 . . . . 0.0 109.478 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -61.85 -28.11 69.26 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.211 -0.931 . . . . 0.0 109.463 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -68.67 -51.54 40.79 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.276 -0.89 . . . . 0.0 109.388 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.59 -33.59 72.95 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.218 -0.926 . . . . 0.0 109.309 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -64.17 -52.1 60.6 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.262 -0.899 . . . . 0.0 109.371 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.67 -22.31 66.95 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.238 -0.914 . . . . 0.0 109.322 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.99 -55.19 13.58 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.256 -0.902 . . . . 0.0 109.425 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.3 mp -69.36 -22.47 63.74 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.186 -0.946 . . . . 0.0 109.415 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.93 -37.38 72.87 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.275 -0.891 . . . . 0.0 109.504 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 19.7 tttt -68.82 -12.85 61.97 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.248 -0.907 . . . . 0.0 109.414 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 20.3 mttm -75.47 -22.47 57.22 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.318 -0.864 . . . . 0.0 109.818 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -103.66 -34.39 8.63 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.185 -0.947 . . . . 0.0 110.008 -179.428 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.446 ' O ' ' CB ' ' A' ' 74' ' ' CYS . . . 76.21 32.09 53.17 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 108.764 -1.734 . . . . 0.0 108.764 -179.437 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.446 ' CB ' ' O ' ' A' ' 73' ' ' GLY . 0.0 OUTLIER 167.35 152.05 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.475 -1.015 . . . . 0.0 109.126 -179.695 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 67.6 123.94 0.02 OUTLIER Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -173.89 92.59 0.09 OUTLIER Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -104.07 123.31 47.02 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.221 -1.164 . . . . 0.0 109.081 179.603 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 33.7 m -110.49 170.24 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.141 -0.974 . . . . 0.0 109.541 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.423 ' CB ' ' HB ' ' A' ' 82' ' ' VAL . 11.4 mttp -159.19 166.74 30.77 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.299 -0.876 . . . . 0.0 109.352 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -64.13 100.8 0.35 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.202 -0.936 . . . . 0.0 109.567 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 74.7 2.97 65.78 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.423 ' HB ' ' CB ' ' A' ' 79' ' ' LYS . 87.5 t -129.6 141.71 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.116 -1.226 . . . . 0.0 109.595 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.431 HG22 ' N ' ' A' ' 84' ' ' GLU . 58.1 mt -131.89 158.69 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.326 -0.859 . . . . 0.0 109.456 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.431 ' N ' HG22 ' A' ' 83' ' ' ILE . 19.1 tt0 -148.03 139.14 23.35 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.217 -0.927 . . . . 0.0 109.548 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 53.6 mt -149.69 102.7 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.218 -0.926 . . . . 0.0 109.377 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -52.8 110.07 0.48 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.214 -0.929 . . . . 0.0 109.506 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -154.85 -175.75 26.3 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -154.39 47.82 0.59 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.267 -1.137 . . . . 0.0 109.446 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 60.3 mttt -137.82 45.95 2.12 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.283 -0.886 . . . . 0.0 109.467 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.59 ' HA ' HD12 ' A' ' 93' ' ' LEU . 36.1 ptt180 -50.93 -40.15 56.43 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.246 -0.909 . . . . 0.0 109.467 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.486 ' N ' ' HG3' ' A' ' 90' ' ' ARG . 8.1 p-10 -51.05 -45.54 61.37 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.27 -0.894 . . . . 0.0 109.467 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.404 HD23 ' N ' ' A' ' 93' ' ' LEU . 4.4 tt -68.4 -47.18 68.0 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.267 -0.896 . . . . 0.0 109.495 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.833 HD13 HG21 ' A' ' 36' ' ' ILE . 17.9 mt -54.32 -24.67 20.08 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.223 -0.923 . . . . 0.0 109.477 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -61.39 -65.42 0.7 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.297 -0.877 . . . . 0.0 109.465 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 11.4 t -64.48 -17.38 63.81 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.272 -0.893 . . . . 0.0 109.465 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.636 HD23 ' N ' ' A' ' 97' ' ' LEU . 3.1 tt -66.42 -55.83 13.91 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.288 -0.883 . . . . 0.0 109.482 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.636 ' N ' HD23 ' A' ' 96' ' ' LEU . 0.2 OUTLIER -69.97 -38.24 76.02 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.293 -0.879 . . . . 0.0 109.504 -179.979 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -64.27 -19.11 65.18 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.243 -0.91 . . . . 0.0 109.497 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -66.53 -31.74 72.64 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.273 -0.892 . . . . 0.0 109.441 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? -80.21 -14.9 58.07 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.239 -0.913 . . . . 0.0 109.474 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 101.44 -13.16 58.37 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 2.7 mtm -65.64 147.89 52.65 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.278 -1.13 . . . . 0.0 109.431 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 16.6 mttt -81.85 115.79 21.22 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.284 -0.885 . . . . 0.0 109.473 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.418 HG22 ' N ' ' A' ' 105' ' ' LYS . 4.6 p -109.72 155.0 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.221 -0.924 . . . . 0.0 109.523 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.429 ' O ' ' N ' ' A' ' 107' ' ' ALA . 0.5 OUTLIER -122.18 90.39 3.3 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.212 -0.93 . . . . 0.0 109.468 -179.958 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 19.5 tp -54.2 93.09 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.253 -0.904 . . . . 0.0 109.486 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.878 ' HB3' ' HB3' ' A' ' 37' ' ' GLN . . . -73.87 -161.93 0.12 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.28 -0.887 . . . . 0.0 109.475 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 88.79 108.44 1.1 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 69.3 66.24 2.32 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -171.91 -59.89 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.212 -1.169 . . . . 0.0 109.471 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 118.055 -0.974 . . . . 0.0 109.48 -179.983 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 83.5 mttt . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 155.33 151.23 5.8 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.45 ' N ' ' OD1' ' A' ' 31' ' ' ASP . 18.8 p30 -55.81 98.21 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.251 -1.146 . . . . 0.0 109.414 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -60.3 153.24 35.96 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.708 HG23 ' O ' ' A' ' 33' ' ' VAL . 34.7 m -142.39 101.17 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.279 -1.13 . . . . 0.0 109.452 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.571 HG13 HG22 ' A' ' 54' ' ' VAL . 9.7 t -88.85 150.04 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.268 -0.895 . . . . 0.0 109.501 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 53.0 mtt180 -127.05 119.25 26.13 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.231 -0.918 . . . . 0.0 109.458 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.511 HD11 HD13 ' A' ' 97' ' ' LEU . 1.5 mp -118.1 118.41 58.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.237 -0.914 . . . . 0.0 109.507 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -153.89 175.54 13.23 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.258 -0.901 . . . . 0.0 109.479 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.78 140.04 38.68 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.223 -0.923 . . . . 0.0 109.453 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -124.91 57.6 1.27 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.282 -0.886 . . . . 0.0 109.486 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 15.1 t -76.05 165.21 25.28 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.246 -0.909 . . . . 0.0 109.448 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -176.53 138.37 0.3 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.265 -0.897 . . . . 0.0 109.486 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.61 -53.59 0.73 Allowed Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 22.0 ttt180 -168.18 159.07 10.63 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.23 -1.159 . . . . 0.0 109.515 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 30.0 tttt -83.08 125.39 31.43 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.275 -0.891 . . . . 0.0 109.422 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 168.23 -44.79 0.23 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.4 ptmt -129.27 179.51 5.74 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.209 -1.171 . . . . 0.0 109.539 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -171.16 147.75 10.62 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.405 HG12 ' HG3' ' A' ' 86' ' ' GLN . 14.1 m -119.77 158.03 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.205 -1.173 . . . . 0.0 109.504 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 1.4 t -121.11 120.51 35.52 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.229 -0.919 . . . . 0.0 109.422 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -111.58 149.25 31.72 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.234 -0.916 . . . . 0.0 109.539 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.493 ' CG1' HG23 ' A' ' 36' ' ' ILE . 16.7 mt -134.26 126.43 49.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.269 -0.895 . . . . 0.0 109.46 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.463 HG23 ' O ' ' A' ' 81' ' ' GLY . 0.2 OUTLIER -151.59 166.67 30.5 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.228 -0.92 . . . . 0.0 109.48 179.98 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 92.57 15.57 52.43 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.571 HG22 HG13 ' A' ' 34' ' ' VAL . 8.8 t -75.86 106.9 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.231 -1.158 . . . . 0.0 109.489 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -94.62 84.57 4.3 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.279 -0.888 . . . . 0.0 109.476 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -144.95 -172.87 3.93 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.194 -0.941 . . . . 0.0 109.483 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -68.67 150.22 48.19 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.262 -0.899 . . . . 0.0 109.464 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.418 ' O ' ' HB2' ' A' ' 61' ' ' LEU . 19.6 m-20 -52.72 -46.26 67.3 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.246 -0.909 . . . . 0.0 109.549 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.808 ' O ' HG22 ' A' ' 62' ' ' THR . . . -58.72 -44.73 90.48 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.23 -0.919 . . . . 0.0 109.558 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -51.36 -34.73 35.31 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.151 -0.968 . . . . 0.0 109.488 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.461 HD23 ' HA ' ' A' ' 61' ' ' LEU . 39.7 mt -56.8 -54.81 42.11 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.233 -0.917 . . . . 0.0 109.505 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.808 HG22 ' O ' ' A' ' 59' ' ' ALA . 9.5 t -63.66 -17.82 63.32 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.233 -0.917 . . . . 0.0 109.588 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.65 -68.76 0.48 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.265 -0.897 . . . . 0.0 109.459 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -51.77 -34.61 40.3 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.273 -0.892 . . . . 0.0 109.371 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.48 -59.47 5.19 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.267 -0.896 . . . . 0.0 109.426 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -55.07 -24.93 27.66 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.279 -0.888 . . . . 0.0 109.447 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -66.68 -62.46 1.44 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.256 -0.903 . . . . 0.0 109.482 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -67.33 -13.5 62.06 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.193 -0.942 . . . . 0.0 109.545 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 17.8 tttt -69.77 -36.35 75.68 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.189 -0.944 . . . . 0.0 109.428 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -73.27 -19.74 60.99 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.279 -0.888 . . . . 0.0 109.276 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 63.7 mttt -66.29 -29.88 70.19 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.3 -0.875 . . . . 0.0 109.319 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 62.7 m -89.17 -30.06 18.85 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.315 -0.866 . . . . 0.0 109.316 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.457 ' O ' ' HB2' ' A' ' 74' ' ' CYS . . . 91.87 -19.74 46.78 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.457 ' HB2' ' O ' ' A' ' 73' ' ' GLY . 52.8 t 177.55 94.41 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.232 -1.158 . . . . 0.0 109.364 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 148.83 151.03 5.36 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.394 -1.483 . . . . 0.0 109.394 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 159.41 -176.46 36.19 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -179.36 114.12 0.06 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.252 -1.146 . . . . 0.0 109.624 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.5 p -120.01 148.59 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.256 -0.903 . . . . 0.0 109.136 179.669 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.448 ' CB ' ' HB ' ' A' ' 82' ' ' VAL . 0.0 OUTLIER -150.21 77.7 1.31 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.17 -0.956 . . . . 0.0 109.774 -179.735 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 60.3 t0 49.25 69.03 0.63 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.336 -0.852 . . . . 0.0 109.956 179.527 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.463 ' O ' HG23 ' A' ' 52' ' ' THR . . . 83.27 -11.56 54.65 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 179.514 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.448 ' HB ' ' CB ' ' A' ' 79' ' ' LYS . 58.5 t -97.97 89.79 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.094 -1.239 . . . . 0.0 109.523 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 52.3 mt -99.68 154.15 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.228 -0.92 . . . . 0.0 109.374 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -149.26 104.11 3.37 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.242 -0.911 . . . . 0.0 109.612 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 62.2 mt -125.76 125.04 67.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.334 -0.853 . . . . 0.0 109.357 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.405 ' HG3' HG12 ' A' ' 48' ' ' VAL . 8.3 tt0 -66.8 155.98 36.79 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.261 -0.899 . . . . 0.0 109.462 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 141.7 140.32 3.78 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -112.61 52.28 0.78 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.19 -1.182 . . . . 0.0 109.511 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 6.6 mttp -121.13 41.37 3.34 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.208 -0.933 . . . . 0.0 109.452 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.48 HH11 HD21 ' A' ' 106' ' ' LEU . 7.6 ptt85 -56.44 -27.76 57.59 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.251 -0.906 . . . . 0.0 109.494 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -57.89 -47.09 83.81 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.209 -0.932 . . . . 0.0 109.481 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 4.2 tt -74.28 -33.38 63.24 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.199 -0.938 . . . . 0.0 109.511 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.482 ' HG ' HG21 ' A' ' 36' ' ' ILE . 1.5 mm? -55.9 -38.72 70.6 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.272 -0.892 . . . . 0.0 109.458 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 13.1 tttt -53.41 -49.29 67.61 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.205 -0.934 . . . . 0.0 109.451 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 3.2 t -68.35 -29.36 68.07 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.28 -0.888 . . . . 0.0 109.437 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.558 HD23 ' N ' ' A' ' 97' ' ' LEU . 4.1 tt -58.06 -51.85 67.96 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.238 -0.914 . . . . 0.0 109.434 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.558 ' N ' HD23 ' A' ' 96' ' ' LEU . 0.4 OUTLIER -72.19 -32.35 66.74 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.261 -0.899 . . . . 0.0 109.428 179.983 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -71.69 -14.49 62.05 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.232 -0.918 . . . . 0.0 109.456 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.08 -31.42 72.6 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.213 -0.929 . . . . 0.0 109.422 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 7.3 mttm -94.0 -19.83 20.52 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.266 -0.896 . . . . 0.0 109.473 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 100.17 13.1 37.34 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 4.0 mtm -79.3 156.99 27.8 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.287 -1.125 . . . . 0.0 109.5 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.697 ' HB3' HG12 ' A' ' 33' ' ' VAL . 28.3 tttt -81.98 132.55 35.26 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.224 -0.923 . . . . 0.0 109.472 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.476 ' HB ' ' CD2' ' A' ' 97' ' ' LEU . 11.6 p -133.86 141.5 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.248 -0.908 . . . . 0.0 109.457 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 2.1 tttt -115.85 98.13 6.49 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.238 -0.914 . . . . 0.0 109.488 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.521 ' O ' ' HB3' ' A' ' 107' ' ' ALA . 25.5 tp -45.92 -26.59 0.72 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.238 -0.914 . . . . 0.0 109.477 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.521 ' HB3' ' O ' ' A' ' 106' ' ' LEU . . . 65.66 68.52 0.47 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.223 -0.923 . . . . 0.0 109.5 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -50.38 -62.28 5.24 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.44 ' O ' ' CB ' ' A' ' 110' ' ' LEU . . . 78.04 167.1 29.76 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.44 ' CB ' ' O ' ' A' ' 109' ' ' GLY . 0.4 OUTLIER 72.0 161.58 0.24 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.241 -1.152 . . . . 0.0 109.485 179.99 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.463 -179.99 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 66.5 mttt . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 174.71 164.24 29.22 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -179.61 85.81 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.242 -1.152 . . . . 0.0 109.449 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 140.48 119.33 1.59 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.544 -1.423 . . . . 0.0 109.544 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 18.2 t -123.84 94.6 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.211 -1.17 . . . . 0.0 109.458 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.467 HG12 ' N ' ' A' ' 35' ' ' ARG . 22.0 t -86.54 162.39 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.23 -0.919 . . . . 0.0 109.491 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.467 ' N ' HG12 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -144.91 140.56 28.38 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.206 -0.934 . . . . 0.0 109.491 179.928 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.903 HG21 ' HG ' ' A' ' 93' ' ' LEU . 3.8 mp -141.52 124.4 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.233 -0.917 . . . . 0.0 109.491 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.862 ' HB3' ' HB2' ' A' ' 107' ' ' ALA . 5.5 pt20 -147.59 118.98 7.86 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.25 -0.906 . . . . 0.0 109.471 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 5.4 tmm_? -45.81 116.0 1.1 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.249 -0.907 . . . . 0.0 109.426 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 2.1 tm0? -85.01 126.95 33.97 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.253 -0.904 . . . . 0.0 109.465 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.416 ' O ' ' CB ' ' A' ' 41' ' ' SER . 8.8 t -96.25 173.66 7.28 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.243 -0.911 . . . . 0.0 109.459 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.416 ' CB ' ' O ' ' A' ' 40' ' ' THR . 1.4 t 169.57 81.53 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.271 -0.893 . . . . 0.0 109.436 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.41 161.04 30.23 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 10.6 ptt180 -123.15 59.42 1.08 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.214 -1.168 . . . . 0.0 109.495 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 85.8 mttt -147.17 27.78 1.03 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.25 -0.906 . . . . 0.0 109.512 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -177.86 -176.31 45.76 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 31.0 mttt -83.05 177.44 8.6 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.275 -1.132 . . . . 0.0 109.469 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.456 ' C ' HG13 ' A' ' 48' ' ' VAL . . . -103.54 -156.96 24.63 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.456 HG13 ' C ' ' A' ' 47' ' ' GLY . 35.9 m -156.5 160.34 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.281 -1.129 . . . . 0.0 109.481 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.4 ' HB2' ' O ' ' A' ' 85' ' ' ILE . 0.1 OUTLIER -95.35 117.56 30.54 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.191 -0.943 . . . . 0.0 109.494 179.989 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -103.56 98.17 8.09 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.27 -0.894 . . . . 0.0 109.471 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.694 HG13 HG23 ' A' ' 36' ' ' ILE . 3.1 mp -96.05 125.87 48.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.232 -0.918 . . . . 0.0 109.485 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.7 -152.82 0.43 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.224 -0.923 . . . . 0.0 109.538 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 52.07 51.44 40.85 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.441 ' O ' ' N ' ' A' ' 56' ' ' LEU . 2.1 t -115.72 46.33 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.212 -1.17 . . . . 0.0 109.477 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -55.71 90.89 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.229 -0.919 . . . . 0.0 109.423 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.441 ' N ' ' O ' ' A' ' 54' ' ' VAL . 0.4 OUTLIER -149.98 157.07 42.79 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.283 -0.886 . . . . 0.0 109.509 -179.925 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.34 157.75 19.05 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.286 -0.884 . . . . 0.0 109.452 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.719 ' O ' ' HB3' ' A' ' 59' ' ' ALA . 0.4 OUTLIER -56.17 172.46 0.21 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.183 -0.948 . . . . 0.0 109.455 179.995 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.719 ' HB3' ' O ' ' A' ' 58' ' ' ASP . . . 83.05 -43.03 0.11 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.676 -0.64 . . . . 0.0 109.83 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.41 -63.14 1.35 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.08 -1.012 . . . . 0.0 109.52 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -56.63 -27.92 59.4 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.233 -0.917 . . . . 0.0 109.476 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 46.0 p -72.72 -33.4 66.41 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.232 -0.918 . . . . 0.0 109.421 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 44.4 mttt -73.87 -51.73 15.25 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.269 -0.894 . . . . 0.0 109.469 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.693 ' O ' HD12 ' A' ' 68' ' ' LEU . 1.0 OUTLIER -56.69 -48.38 77.8 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.315 -0.866 . . . . 0.0 109.526 179.995 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.696 ' HB1' HG22 ' A' ' 78' ' ' VAL . . . -59.13 -61.02 2.95 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.323 -0.861 . . . . 0.0 109.686 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.415 ' C ' ' O ' ' A' ' 65' ' ' ALA . . . -43.26 -40.58 3.53 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.307 -0.871 . . . . 0.0 109.722 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -60.78 -52.22 66.0 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.21 -0.931 . . . . 0.0 109.542 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.693 HD12 ' O ' ' A' ' 64' ' ' LEU . 0.9 OUTLIER -60.72 -21.43 62.94 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.214 -0.929 . . . . 0.0 109.652 -179.879 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -65.44 -40.06 92.81 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.176 -0.952 . . . . 0.0 109.478 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 45.7 mttt -69.11 -23.29 63.98 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.209 -0.932 . . . . 0.0 109.444 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 15.7 mtpt -64.28 -29.07 70.18 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.406 -0.808 . . . . 0.0 110.032 -179.547 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.2 m -99.05 -43.03 6.83 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.049 -1.032 . . . . 0.0 109.672 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.474 ' O ' ' HB2' ' A' ' 74' ' ' CYS . . . 103.08 -22.68 35.92 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.474 ' HB2' ' O ' ' A' ' 73' ' ' GLY . 30.2 t 173.62 104.17 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.279 -1.13 . . . . 0.0 109.499 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 155.18 -61.4 0.37 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -47.49 119.38 4.83 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -110.41 150.35 28.95 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.26 -1.141 . . . . 0.0 109.234 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.696 HG22 ' HB1' ' A' ' 65' ' ' ALA . 41.8 t -102.38 152.22 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.253 -0.904 . . . . 0.0 109.715 -179.779 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -138.77 151.97 47.53 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.331 -0.856 . . . . 0.0 109.243 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.429 ' N ' ' OD1' ' A' ' 80' ' ' ASP . 1.0 OUTLIER -69.91 90.97 0.64 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.242 -0.911 . . . . 0.0 109.626 -179.817 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 109.07 -8.46 33.39 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.771 -1.331 . . . . 0.0 109.771 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.913 ' O ' HD13 ' A' ' 83' ' ' ILE . 75.9 t -142.26 153.02 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.129 -1.218 . . . . 0.0 109.566 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.913 HD13 ' O ' ' A' ' 82' ' ' VAL . 2.0 mm -136.53 129.25 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.289 -0.882 . . . . 0.0 109.226 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.515 ' O ' HD13 ' A' ' 85' ' ' ILE . 2.2 mt-10 -117.4 125.68 51.38 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.211 -0.931 . . . . 0.0 109.66 -179.844 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.515 HD13 ' O ' ' A' ' 84' ' ' GLU . 17.8 mm -137.42 116.65 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.269 -0.894 . . . . 0.0 109.417 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -69.77 157.56 37.1 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.247 -0.908 . . . . 0.0 109.521 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 148.74 -39.22 0.96 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.504 -1.439 . . . . 0.0 109.504 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 21.1 t0 57.33 53.77 7.3 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.223 -1.163 . . . . 0.0 109.452 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 19.8 mttt -134.96 54.52 1.94 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.24 -0.913 . . . . 0.0 109.451 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.414 ' HA ' ' HB2' ' A' ' 93' ' ' LEU . 38.5 ptt180 -47.31 -27.14 1.46 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.244 -0.91 . . . . 0.0 109.54 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -61.2 -58.61 7.62 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.248 -0.907 . . . . 0.0 109.464 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.484 HD23 ' O ' ' A' ' 92' ' ' LEU . 0.7 OUTLIER -64.87 -20.72 66.57 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.265 -0.897 . . . . 0.0 109.494 -179.975 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.903 ' HG ' HG21 ' A' ' 36' ' ' ILE . 2.1 mm? -65.81 -52.76 48.0 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.213 -0.93 . . . . 0.0 109.462 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.441 ' HG2' ' CG1' ' A' ' 104' ' ' VAL . 0.0 OUTLIER -62.83 -19.76 64.41 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.27 -0.893 . . . . 0.0 109.439 -179.98 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.94 -55.25 6.39 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.299 -0.876 . . . . 0.0 109.446 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.676 HD21 HD13 ' A' ' 93' ' ' LEU . 2.6 pp -64.82 -27.82 69.14 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.204 -0.935 . . . . 0.0 109.473 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.529 ' HB3' ' CG1' ' A' ' 104' ' ' VAL . 0.8 OUTLIER -68.12 -51.71 43.2 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.228 -0.92 . . . . 0.0 109.468 179.996 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -70.08 -16.65 63.16 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.267 -0.895 . . . . 0.0 109.44 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -67.22 -21.28 65.76 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.296 -0.878 . . . . 0.0 109.506 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -99.08 -17.18 18.36 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.269 -0.894 . . . . 0.0 109.453 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 103.59 -11.13 53.71 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 2.2 mtp -65.9 145.59 55.75 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.263 -1.14 . . . . 0.0 109.439 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.8 mttt -86.53 92.79 8.99 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.246 -0.908 . . . . 0.0 109.456 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.542 ' CG2' HD12 ' A' ' 36' ' ' ILE . 9.3 p -88.99 147.79 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.266 -0.896 . . . . 0.0 109.49 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 1.5 mttt -116.29 111.41 20.09 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.227 -0.92 . . . . 0.0 109.476 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.684 ' O ' ' HB2' ' A' ' 107' ' ' ALA . 2.8 mt -45.69 -84.6 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.194 -0.941 . . . . 0.0 109.48 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.862 ' HB2' ' HB3' ' A' ' 37' ' ' GLN . . . 165.33 -49.63 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.282 -0.886 . . . . 0.0 109.486 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 112.08 -127.34 8.03 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 126.72 168.04 12.49 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.511 -1.435 . . . . 0.0 109.511 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -175.88 -175.79 0.77 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.229 -1.159 . . . . 0.0 109.495 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 118.009 -0.996 . . . . 0.0 109.504 179.965 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 15.1 mttm . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 171.25 178.1 41.49 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -177.69 -37.88 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.254 -1.145 . . . . 0.0 109.511 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.499 ' O ' HG13 ' A' ' 33' ' ' VAL . . . -120.21 152.16 17.07 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.678 HG12 ' CB ' ' A' ' 103' ' ' LYS . 4.6 m -156.14 106.52 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.255 -1.144 . . . . 0.0 109.482 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.556 HG23 ' HE3' ' A' ' 102' ' ' MET . 3.0 t -89.75 140.66 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.221 -0.924 . . . . 0.0 109.48 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 17.0 ttm180 -106.71 108.01 19.31 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.262 -0.899 . . . . 0.0 109.435 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.761 ' CG2' HD13 ' A' ' 93' ' ' LEU . 22.2 mt -101.36 126.23 55.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.203 -0.935 . . . . 0.0 109.473 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.967 ' HB3' ' HB3' ' A' ' 107' ' ' ALA . 18.1 pt20 -146.59 -178.37 6.13 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.239 -0.913 . . . . 0.0 109.475 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 10.9 ttm180 -134.89 114.34 12.46 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.246 -0.909 . . . . 0.0 109.462 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.538 ' HB2' ' CD1' ' A' ' 50' ' ' LEU . 5.5 tp60 -87.78 127.5 35.32 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.245 -0.909 . . . . 0.0 109.438 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -87.64 159.63 18.46 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.267 -0.896 . . . . 0.0 109.518 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 45.2 t -153.58 30.69 0.47 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.193 -0.942 . . . . 0.0 109.475 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 148.9 141.93 3.53 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.42 79.87 9.27 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.276 -1.132 . . . . 0.0 109.473 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 2.3 mttp -172.55 -54.78 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.259 -0.9 . . . . 0.0 109.463 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -171.77 -131.02 1.3 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 51.28 74.53 0.24 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.229 -1.16 . . . . 0.0 109.443 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -109.15 144.52 16.51 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 29.5 m -144.45 151.99 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.258 -1.142 . . . . 0.0 109.458 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -109.52 116.66 32.2 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.226 -0.921 . . . . 0.0 109.483 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.691 ' O ' HD13 ' A' ' 51' ' ' ILE . 1.3 mp -96.99 147.73 23.7 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.251 -0.906 . . . . 0.0 109.53 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.691 HD13 ' O ' ' A' ' 50' ' ' LEU . 3.8 mm -136.08 125.87 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.293 -0.879 . . . . 0.0 109.387 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.406 ' HB ' HG13 ' A' ' 82' ' ' VAL . 1.4 t -158.16 168.46 26.99 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.186 -0.946 . . . . 0.0 109.508 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.35 -24.78 25.75 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.658 HG13 ' O ' ' A' ' 54' ' ' VAL . 8.0 p -49.55 106.97 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.255 -1.144 . . . . 0.0 109.496 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -100.48 78.85 2.05 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.195 -0.941 . . . . 0.0 109.462 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.456 HD23 ' HA ' ' A' ' 56' ' ' LEU . 16.4 mt -137.73 -173.57 3.53 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.231 -0.918 . . . . 0.0 109.455 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -68.0 138.26 55.74 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.24 -0.913 . . . . 0.0 109.446 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -50.08 -31.3 12.85 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.277 -0.89 . . . . 0.0 109.493 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.74 -43.42 93.44 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.249 -0.907 . . . . 0.0 109.5 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -66.18 -35.22 79.89 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.273 -0.892 . . . . 0.0 109.528 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.94 HD23 HD11 ' A' ' 83' ' ' ILE . 0.1 OUTLIER -59.63 -46.27 89.49 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.203 -0.935 . . . . 0.0 109.454 -179.955 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 39.5 p -71.06 -22.2 62.15 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.268 -0.895 . . . . 0.0 109.426 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.5 mmtp -71.77 -42.26 67.37 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.296 -0.877 . . . . 0.0 109.41 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -74.81 -34.64 62.41 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.203 -0.936 . . . . 0.0 109.285 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.63 -54.47 42.38 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.277 -0.889 . . . . 0.0 109.271 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.7 -39.2 93.24 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.274 -0.891 . . . . 0.0 109.213 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -54.89 -38.35 67.46 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.296 -0.878 . . . . 0.0 109.367 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 13.2 mt -82.17 -23.03 35.75 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.302 -0.874 . . . . 0.0 109.435 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 42.2 tttt -70.44 -22.93 62.65 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.22 -0.925 . . . . 0.0 109.268 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 4.6 mmtt -76.95 1.12 18.63 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.257 -0.902 . . . . 0.0 109.572 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 11.2 tttt -118.02 16.44 14.19 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.224 -0.922 . . . . 0.0 109.484 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -113.78 -33.04 5.93 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.201 -0.937 . . . . 0.0 109.544 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 87.72 -43.52 3.18 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 7.5 t -157.05 113.33 2.97 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.207 -1.172 . . . . 0.0 109.544 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 126.0 177.55 14.94 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 115.56 111.5 2.79 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -123.16 121.01 34.91 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.218 -1.166 . . . . 0.0 109.704 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.5 p -109.48 139.59 31.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.266 -0.896 . . . . 0.0 109.199 179.744 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.472 ' O ' ' N ' ' A' ' 81' ' ' GLY . 50.1 mttt -130.01 136.26 49.21 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.163 -0.961 . . . . 0.0 109.716 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -55.22 89.52 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.287 -0.883 . . . . 0.0 109.437 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.472 ' N ' ' O ' ' A' ' 79' ' ' LYS . . . 137.45 -44.78 1.11 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.406 HG13 ' HB ' ' A' ' 52' ' ' THR . 2.3 t -137.18 151.79 27.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.179 -1.189 . . . . 0.0 109.488 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.94 HD11 HD23 ' A' ' 61' ' ' LEU . 2.4 mp -124.66 140.63 47.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.209 -0.932 . . . . 0.0 109.555 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -128.92 139.0 52.32 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.315 -0.866 . . . . 0.0 109.372 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 17.8 mt -155.08 135.18 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.215 -0.928 . . . . 0.0 109.55 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -82.3 112.27 19.13 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.304 -0.872 . . . . 0.0 109.552 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -136.29 -39.78 0.14 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.461 -1.455 . . . . 0.0 109.461 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 46.28 36.61 3.42 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.227 -1.161 . . . . 0.0 109.521 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 5.4 mttp -137.91 53.7 1.82 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.261 -0.9 . . . . 0.0 109.473 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.562 ' HA ' HD12 ' A' ' 93' ' ' LEU . 1.9 mtm105 -49.64 -25.68 3.06 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.26 -0.9 . . . . 0.0 109.434 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -57.31 -53.34 59.17 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.255 -0.903 . . . . 0.0 109.443 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.6 tt -72.63 -33.4 66.62 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.262 -0.899 . . . . 0.0 109.471 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.761 HD13 ' CG2' ' A' ' 36' ' ' ILE . 48.0 mt -60.35 -27.42 67.36 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.263 -0.898 . . . . 0.0 109.406 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 75.4 tttt -64.65 -65.2 0.71 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.261 -0.9 . . . . 0.0 109.507 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -63.07 -15.42 56.52 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.228 -0.92 . . . . 0.0 109.468 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.766 HD23 ' N ' ' A' ' 97' ' ' LEU . 5.0 tt -71.22 -57.57 4.36 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.261 -0.899 . . . . 0.0 109.431 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.766 ' N ' HD23 ' A' ' 96' ' ' LEU . 0.1 OUTLIER -65.29 -32.38 74.0 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.252 -0.905 . . . . 0.0 109.469 179.993 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 56.5 mm-40 -67.8 -27.97 67.19 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.275 -0.891 . . . . 0.0 109.465 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.38 -32.21 73.73 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.295 -0.878 . . . . 0.0 109.441 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 17.2 mttt -80.52 -14.68 58.03 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.19 -0.944 . . . . 0.0 109.476 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 79.55 11.66 84.56 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' MET . . . . . 0.556 ' HE3' HG23 ' A' ' 34' ' ' VAL . 4.5 mtm -86.64 156.73 19.89 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.221 -1.164 . . . . 0.0 109.499 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.678 ' CB ' HG12 ' A' ' 33' ' ' VAL . 2.1 mmtt -80.69 108.44 14.34 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.242 -0.911 . . . . 0.0 109.445 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 34' ' ' VAL . 13.1 p -102.39 151.73 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.281 -0.887 . . . . 0.0 109.496 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.401 ' O ' ' N ' ' A' ' 107' ' ' ALA . 0.3 OUTLIER -115.32 79.21 1.25 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.243 -0.91 . . . . 0.0 109.472 179.993 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.488 HD23 ' C ' ' A' ' 106' ' ' LEU . 5.2 tt -46.74 100.45 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.247 -0.908 . . . . 0.0 109.463 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.967 ' HB3' ' HB3' ' A' ' 37' ' ' GLN . . . -98.71 130.93 45.21 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.259 -0.901 . . . . 0.0 109.494 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -128.28 -80.4 0.28 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.489 ' O ' ' CB ' ' A' ' 110' ' ' LEU . . . 106.05 -81.68 0.31 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.489 ' CB ' ' O ' ' A' ' 109' ' ' GLY . 6.8 tp 74.83 38.91 0.44 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.233 -1.157 . . . . 0.0 109.483 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 76.9 tt0 . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 117.981 -1.009 . . . . 0.0 109.451 -179.951 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 92.7 mttt . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 176.25 67.09 0.06 OUTLIER Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -94.4 46.83 1.16 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.247 -1.149 . . . . 0.0 109.507 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -169.46 107.4 0.27 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.546 HG12 ' HB2' ' A' ' 103' ' ' LYS . 27.0 m -121.86 144.96 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.281 -1.129 . . . . 0.0 109.426 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.54 ' O ' HG23 ' A' ' 104' ' ' VAL . 72.2 t -119.88 133.32 67.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.264 -0.898 . . . . 0.0 109.5 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 5.5 mtt180 -108.17 98.05 7.65 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.202 -0.937 . . . . 0.0 109.474 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.649 HG12 HD22 ' A' ' 93' ' ' LEU . 3.9 mt -98.63 145.42 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.251 -0.905 . . . . 0.0 109.432 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.425 ' O ' ' HG3' ' A' ' 37' ' ' GLN . 0.0 OUTLIER -179.46 122.46 0.08 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.253 -0.905 . . . . 0.0 109.473 179.977 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.5 132.51 44.78 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.23 -0.919 . . . . 0.0 109.462 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -121.45 149.21 43.36 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.279 -0.888 . . . . 0.0 109.506 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 11.2 p -86.45 143.06 27.96 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.269 -0.894 . . . . 0.0 109.444 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.3 m -102.98 -57.35 2.06 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.218 -0.926 . . . . 0.0 109.437 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 113.4 -19.69 19.38 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 46.7 mtt180 -105.19 -76.31 0.61 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.255 -1.144 . . . . 0.0 109.422 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 47.7 mttt -123.65 98.34 5.78 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.237 -0.914 . . . . 0.0 109.469 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 152.52 -57.98 0.42 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 25.3 mttt 55.18 31.42 16.38 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.214 -1.168 . . . . 0.0 109.513 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 127.39 83.99 0.46 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 28.1 m -113.69 157.02 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.225 -1.162 . . . . 0.0 109.434 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.518 ' SG ' HD11 ' A' ' 51' ' ' ILE . 5.4 t -105.71 123.56 48.13 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.237 -0.914 . . . . 0.0 109.485 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.41 ' C ' HD13 ' A' ' 51' ' ' ILE . 1.4 mt -116.39 108.61 16.27 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.237 -0.914 . . . . 0.0 109.433 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.518 HD11 ' SG ' ' A' ' 49' ' ' CYS . 3.5 mm -96.13 121.22 46.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.268 -0.895 . . . . 0.0 109.533 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.505 HG22 ' H ' ' A' ' 53' ' ' GLY . 0.2 OUTLIER -135.6 -169.32 2.37 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.264 -0.897 . . . . 0.0 109.497 179.938 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.505 ' H ' HG22 ' A' ' 52' ' ' THR . . . 63.35 46.42 92.82 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.8 t -95.94 122.63 47.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.216 -1.167 . . . . 0.0 109.491 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -105.24 77.61 1.32 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.218 -0.926 . . . . 0.0 109.496 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 37.7 mt -135.89 165.93 24.49 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.24 -0.912 . . . . 0.0 109.481 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -65.79 -73.59 0.13 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.303 -0.873 . . . . 0.0 109.454 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -173.45 -52.09 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.229 -0.919 . . . . 0.0 109.479 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.41 -33.42 74.75 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.221 -0.924 . . . . 0.0 109.495 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -69.73 -30.15 67.7 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.222 -0.924 . . . . 0.0 109.434 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.5 tt -70.54 -45.95 64.51 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.225 -0.922 . . . . 0.0 109.4 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -61.35 -43.97 97.97 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.255 -0.903 . . . . 0.0 109.45 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 76.8 tttt -60.56 -52.14 66.46 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.273 -0.892 . . . . 0.0 109.433 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.47 ' HA ' HD22 ' A' ' 64' ' ' LEU . 0.2 OUTLIER -48.01 -47.48 33.33 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.169 -0.957 . . . . 0.0 109.316 179.96 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.03 -42.14 84.69 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.293 -0.879 . . . . 0.0 109.297 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.35 -24.26 67.2 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.289 -0.882 . . . . 0.0 109.343 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -75.39 -38.62 59.83 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.34 -0.85 . . . . 0.0 109.431 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 9.5 mt -68.17 -42.57 79.79 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.246 -0.909 . . . . 0.0 109.314 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 17.2 tttt -56.81 -43.9 81.44 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.281 -0.887 . . . . 0.0 109.341 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 10.5 mttt -52.66 -33.19 45.99 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.21 -0.931 . . . . 0.0 109.459 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 34.4 mttt -116.61 54.78 0.84 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.169 -0.957 . . . . 0.0 109.836 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -140.36 -37.95 0.45 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.091 -1.006 . . . . 0.0 109.559 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.487 ' O ' ' CB ' ' A' ' 74' ' ' CYS . . . 91.28 -24.1 21.03 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 -179.843 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.487 ' CB ' ' O ' ' A' ' 73' ' ' GLY . 1.6 p 165.62 133.14 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.3 -1.117 . . . . 0.0 109.392 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.7 114.31 3.63 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 178.25 76.22 0.06 OUTLIER Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.564 ' HB3' ' HB2' ' A' ' 84' ' ' GLU . . . -83.95 151.33 25.12 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.297 -1.119 . . . . 0.0 109.473 -179.833 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 37.5 t -119.6 142.95 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.263 -0.898 . . . . 0.0 109.269 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.422 ' HB2' ' O ' ' A' ' 82' ' ' VAL . 16.3 mttt -147.33 171.18 15.84 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.267 -0.896 . . . . 0.0 109.496 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -63.8 102.62 0.48 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.344 -0.848 . . . . 0.0 109.718 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 63.18 25.9 68.73 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 179.725 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.422 ' O ' ' HB2' ' A' ' 79' ' ' LYS . 40.8 t -146.21 123.26 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.232 -1.158 . . . . 0.0 109.414 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 34.9 mt -117.86 139.59 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.223 -0.923 . . . . 0.0 109.508 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.564 ' HB2' ' HB3' ' A' ' 77' ' ' ALA . 1.3 mt-10 -115.09 131.2 57.0 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.195 -0.94 . . . . 0.0 109.325 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.415 HD13 ' HA ' ' A' ' 85' ' ' ILE . 47.3 mm -128.82 137.33 57.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.203 -0.935 . . . . 0.0 109.583 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -96.39 109.35 21.89 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.28 -0.888 . . . . 0.0 109.449 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 165.68 166.96 25.55 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -129.2 62.8 1.51 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.266 -1.138 . . . . 0.0 109.47 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 76.0 mttt -127.27 52.19 1.83 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.214 -0.929 . . . . 0.0 109.473 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.431 ' HG3' ' N ' ' A' ' 91' ' ' ASP . 6.6 ptt180 -52.25 -36.11 51.67 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.32 -0.863 . . . . 0.0 109.442 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.431 ' N ' ' HG3' ' A' ' 90' ' ' ARG . 21.9 m-20 -60.21 -43.22 96.15 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.274 -0.891 . . . . 0.0 109.519 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.45 -34.6 77.51 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.23 -0.919 . . . . 0.0 109.484 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.681 ' HA ' HD21 ' A' ' 96' ' ' LEU . 0.3 OUTLIER -62.15 -39.83 93.94 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.286 -0.884 . . . . 0.0 109.504 179.983 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 76.1 tttt -63.76 -27.07 68.94 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.242 -0.911 . . . . 0.0 109.427 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 20.7 t -75.61 -60.67 2.21 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.273 -0.892 . . . . 0.0 109.504 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.999 HD12 ' N ' ' A' ' 97' ' ' LEU . 4.0 pp -52.36 -33.16 41.79 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.271 -0.893 . . . . 0.0 109.479 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.999 ' N ' HD12 ' A' ' 96' ' ' LEU . 0.1 OUTLIER -68.89 -54.15 17.18 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.276 -0.89 . . . . 0.0 109.508 179.978 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -64.78 -12.52 48.46 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.286 -0.884 . . . . 0.0 109.523 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.28 -28.32 69.24 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.238 -0.914 . . . . 0.0 109.469 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 33.6 mttm -95.86 -24.92 16.22 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.263 -0.898 . . . . 0.0 109.445 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 103.04 13.92 27.88 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -76.62 147.98 37.22 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.254 -1.144 . . . . 0.0 109.488 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.546 ' HB2' HG12 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -80.47 87.16 5.7 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.254 -0.904 . . . . 0.0 109.434 -179.999 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.54 HG23 ' O ' ' A' ' 34' ' ' VAL . 11.7 p -85.88 133.19 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.225 -0.922 . . . . 0.0 109.475 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.417 ' O ' ' N ' ' A' ' 107' ' ' ALA . 5.3 mttt -102.33 86.18 2.77 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.285 -0.885 . . . . 0.0 109.469 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 4.7 tp -52.27 95.89 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.192 -0.942 . . . . 0.0 109.483 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.417 ' N ' ' O ' ' A' ' 105' ' ' LYS . . . -95.37 144.73 25.67 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.281 -0.887 . . . . 0.0 109.468 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -146.96 -79.86 0.03 OUTLIER Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -86.9 -157.85 31.33 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -172.61 168.42 5.26 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.203 -1.175 . . . . 0.0 109.459 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 118.051 -0.976 . . . . 0.0 109.459 179.995 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -178.32 78.0 0.07 OUTLIER Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -93.95 114.82 27.1 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.307 -1.113 . . . . 0.0 109.518 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -108.4 167.3 13.16 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.941 HG23 ' O ' ' A' ' 103' ' ' LYS . 3.3 p -150.41 94.47 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.233 -1.157 . . . . 0.0 109.504 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.91 ' HB ' HD21 ' A' ' 97' ' ' LEU . 69.6 t -85.14 107.42 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.251 -0.905 . . . . 0.0 109.484 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 82.6 mtt180 -83.45 120.81 26.36 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.268 -0.895 . . . . 0.0 109.445 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.767 HG21 HD13 ' A' ' 93' ' ' LEU . 5.6 mt -120.14 116.31 49.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.196 -0.94 . . . . 0.0 109.524 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.934 ' HB3' ' HB3' ' A' ' 107' ' ' ALA . 28.2 pt20 -143.76 151.25 39.75 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.207 -0.933 . . . . 0.0 109.454 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.455 ' O ' ' HG3' ' A' ' 38' ' ' ARG . 11.9 ptt180 -95.47 122.59 38.36 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.221 -0.924 . . . . 0.0 109.439 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 7.2 tp60 -83.04 -37.2 24.22 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.3 -0.875 . . . . 0.0 109.484 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 55.05 54.65 8.64 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.234 -0.916 . . . . 0.0 109.448 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 30.2 t -113.1 118.01 33.58 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.201 -0.937 . . . . 0.0 109.481 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 118.37 178.19 17.02 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 2.4 ttp180 -144.11 38.25 1.29 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.277 -1.131 . . . . 0.0 109.422 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.73 23.09 13.85 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.254 -0.904 . . . . 0.0 109.524 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -172.9 -83.44 0.05 OUTLIER Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 12.6 mttt -179.09 -60.8 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.25 -1.147 . . . . 0.0 109.492 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.7 173.32 31.02 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 16.0 m -143.22 156.92 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.261 -1.14 . . . . 0.0 109.416 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -118.21 110.89 18.11 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.241 -0.912 . . . . 0.0 109.471 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.453 ' C ' HD13 ' A' ' 51' ' ' ILE . 56.5 mt -93.79 123.83 37.39 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.273 -0.892 . . . . 0.0 109.514 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.453 HD13 ' C ' ' A' ' 50' ' ' LEU . 4.7 mm -109.4 110.94 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.28 -0.888 . . . . 0.0 109.453 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -158.48 152.68 24.03 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.269 -0.894 . . . . 0.0 109.448 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.443 ' O ' HG13 ' A' ' 33' ' ' VAL . . . 100.36 51.8 1.2 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 6.1 t -116.53 100.17 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.255 -1.144 . . . . 0.0 109.497 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -77.36 102.49 6.81 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.223 -0.923 . . . . 0.0 109.505 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.439 HD23 ' H ' ' A' ' 57' ' ' ASP . 0.1 OUTLIER -150.8 -157.43 0.81 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.252 -0.905 . . . . 0.0 109.481 179.991 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.439 ' H ' HD23 ' A' ' 56' ' ' LEU . 5.5 m-20 -76.58 -86.56 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.27 -0.894 . . . . 0.0 109.473 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -177.84 -47.33 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.307 -0.87 . . . . 0.0 109.36 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.8 -23.12 52.84 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.289 -0.882 . . . . 0.0 109.364 179.866 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.402 ' CB ' HD22 ' A' ' 56' ' ' LEU . 1.9 mm-40 -68.25 -28.07 66.89 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.267 -0.895 . . . . 0.0 109.437 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.95 -32.94 74.52 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.215 -0.928 . . . . 0.0 109.348 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -71.14 -40.7 71.22 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.275 -0.89 . . . . 0.0 109.391 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -66.79 -37.55 84.78 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.201 -0.937 . . . . 0.0 109.365 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.489 HD21 HG21 ' A' ' 34' ' ' VAL . 53.4 tp -65.35 -50.96 63.6 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.267 -0.896 . . . . 0.0 109.356 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.95 -26.96 69.07 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.306 -0.871 . . . . 0.0 109.295 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -74.21 -34.51 63.73 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.328 -0.858 . . . . 0.0 109.34 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -76.75 -26.71 54.86 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.254 -0.904 . . . . 0.0 109.39 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.489 ' HA ' HD13 ' A' ' 68' ' ' LEU . 0.5 OUTLIER -77.9 -37.01 48.91 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.267 -0.895 . . . . 0.0 109.437 -179.978 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 7.3 ttpt -67.61 -24.04 65.43 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.283 -0.886 . . . . 0.0 109.422 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.9 -29.71 60.43 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.288 -0.883 . . . . 0.0 109.536 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 4.0 mtmt -132.08 52.63 2.06 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.257 -0.902 . . . . 0.0 109.492 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' CYS . . . . . 0.581 ' SG ' HG23 ' A' ' 85' ' ' ILE . 9.1 t -110.13 -28.68 8.55 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.274 -0.891 . . . . 0.0 109.49 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.408 ' O ' ' HB2' ' A' ' 74' ' ' CYS . . . 77.73 6.19 86.82 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.408 ' HB2' ' O ' ' A' ' 73' ' ' GLY . 23.2 t 177.37 125.31 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.241 -1.152 . . . . 0.0 109.455 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -102.85 139.11 14.29 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -114.5 -100.86 2.37 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -117.78 133.36 56.01 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.211 -1.17 . . . . 0.0 109.333 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.0 t -124.85 99.13 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.19 -0.944 . . . . 0.0 109.669 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 61.4 mttm -115.29 141.47 47.99 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.272 -0.893 . . . . 0.0 109.322 179.822 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -60.39 99.84 0.09 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.207 -0.933 . . . . 0.0 109.391 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 121.17 -33.03 4.51 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 30.9 t -132.84 117.53 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.294 -1.121 . . . . 0.0 109.361 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 7.6 mt -123.13 123.71 68.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.291 -0.881 . . . . 0.0 109.556 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 53.6 tt0 -106.1 124.79 50.13 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.166 -0.959 . . . . 0.0 109.422 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.581 HG23 ' SG ' ' A' ' 72' ' ' CYS . 45.2 mm -115.2 143.44 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.228 -0.92 . . . . 0.0 109.555 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -112.68 113.64 25.86 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.301 -0.874 . . . . 0.0 109.501 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 178.74 -140.37 4.45 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.544 -1.423 . . . . 0.0 109.544 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.464 ' O ' ' CG ' ' A' ' 89' ' ' LYS . 17.6 t0 -177.35 79.9 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.261 -1.141 . . . . 0.0 109.514 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.464 ' CG ' ' O ' ' A' ' 88' ' ' ASP . 90.4 mttt -156.89 40.27 0.33 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.291 -0.881 . . . . 0.0 109.473 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 68.4 ttt180 -47.55 -31.5 4.46 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.282 -0.886 . . . . 0.0 109.527 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -57.46 -53.56 56.72 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.243 -0.91 . . . . 0.0 109.493 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 3.3 tp -63.82 -31.71 72.97 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.218 -0.926 . . . . 0.0 109.502 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.767 HD13 HG21 ' A' ' 36' ' ' ILE . 0.6 OUTLIER -59.09 -41.68 88.65 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.242 -0.911 . . . . 0.0 109.493 179.964 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -64.72 -27.04 68.64 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.272 -0.893 . . . . 0.0 109.519 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 1.1 t -73.94 -62.42 1.51 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.228 -0.92 . . . . 0.0 109.487 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.943 HD12 ' N ' ' A' ' 97' ' ' LEU . 4.1 pp -51.96 -31.11 27.66 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.237 -0.914 . . . . 0.0 109.526 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.943 ' N ' HD12 ' A' ' 96' ' ' LEU . 0.2 OUTLIER -70.03 -50.1 44.65 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.235 -0.916 . . . . 0.0 109.459 -179.927 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -65.49 -14.48 61.09 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.189 -0.945 . . . . 0.0 109.505 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -73.19 -27.94 61.92 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.252 -0.905 . . . . 0.0 109.489 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.8 mptt -87.65 -13.13 43.46 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.284 -0.885 . . . . 0.0 109.484 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 74.13 31.17 59.92 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 2.0 mtm -98.06 167.02 11.15 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.265 -1.138 . . . . 0.0 109.468 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.941 ' O ' HG23 ' A' ' 33' ' ' VAL . 2.3 mttm -86.53 93.34 9.15 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.292 -0.88 . . . . 0.0 109.457 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.641 ' HB ' HD12 ' A' ' 97' ' ' LEU . 7.5 p -83.31 136.43 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.241 -0.912 . . . . 0.0 109.5 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.9 90.25 3.33 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.302 -0.874 . . . . 0.0 109.456 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 45.3 mt -57.04 94.02 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.238 -0.914 . . . . 0.0 109.509 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.934 ' HB3' ' HB3' ' A' ' 37' ' ' GLN . . . -82.72 118.47 23.38 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.277 -0.889 . . . . 0.0 109.454 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -155.75 -166.44 15.8 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 162.53 161.48 12.24 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.559 -1.417 . . . . 0.0 109.559 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 2.0 pp -168.02 152.56 6.45 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.266 -1.138 . . . . 0.0 109.45 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.468 -179.998 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 98.9 mttt . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 152.09 -174.24 31.12 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -177.51 143.13 0.35 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.267 -1.137 . . . . 0.0 109.443 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -126.86 119.06 3.2 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 33' ' ' VAL . 5.2 m -125.65 90.62 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.273 -1.134 . . . . 0.0 109.443 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.506 HG12 ' N ' ' A' ' 35' ' ' ARG . 44.9 t -97.59 163.21 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.241 -0.912 . . . . 0.0 109.459 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.506 ' N ' HG12 ' A' ' 34' ' ' VAL . 69.5 mtt180 -147.79 121.66 9.34 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.248 -0.908 . . . . 0.0 109.458 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.776 HD11 HD13 ' A' ' 97' ' ' LEU . 1.1 mp -116.21 94.54 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.24 -0.913 . . . . 0.0 109.493 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.415 ' HB3' ' HB3' ' A' ' 107' ' ' ALA . 7.8 pt20 -106.97 -176.02 2.96 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.258 -0.901 . . . . 0.0 109.473 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 18.4 mtp180 -122.02 142.12 50.65 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.291 -0.881 . . . . 0.0 109.464 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -105.62 102.54 11.99 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.185 -0.947 . . . . 0.0 109.473 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 3.0 t -126.23 139.34 53.41 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.247 -0.908 . . . . 0.0 109.444 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -171.3 143.01 1.8 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.191 -0.943 . . . . 0.0 109.461 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 69.73 -175.14 34.73 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.408 ' O ' ' CB ' ' A' ' 44' ' ' LYS . 40.9 ptt180 -104.65 178.36 4.58 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.247 -1.149 . . . . 0.0 109.512 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.408 ' CB ' ' O ' ' A' ' 43' ' ' ARG . 56.0 tttt 69.0 67.08 0.28 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.244 -0.91 . . . . 0.0 109.497 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 179.4 146.4 6.75 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -99.43 -26.84 14.0 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.228 -1.16 . . . . 0.0 109.475 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 114.76 146.34 9.05 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 5.6 m -138.71 162.75 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.241 -1.152 . . . . 0.0 109.581 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 92.2 m -112.37 138.22 49.42 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.277 -0.889 . . . . 0.0 109.39 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.415 HD23 ' N ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -132.26 113.36 13.15 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.243 -0.91 . . . . 0.0 109.493 -179.972 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.682 HG13 HG23 ' A' ' 36' ' ' ILE . 3.7 mp -85.91 131.01 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.208 -0.933 . . . . 0.0 109.503 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.0 p -142.15 -174.54 4.13 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.236 -0.915 . . . . 0.0 109.453 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 52.04 51.36 41.08 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.6 t -97.13 110.69 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.289 -1.124 . . . . 0.0 109.41 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -97.43 78.18 2.67 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.258 -0.901 . . . . 0.0 109.488 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.647 HD12 ' CB ' ' A' ' 60' ' ' GLU . 1.8 mm? -115.86 -167.7 1.3 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.228 -0.92 . . . . 0.0 109.49 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -96.57 -61.03 1.48 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.257 -0.902 . . . . 0.0 109.47 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 175.74 -54.59 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.308 -0.87 . . . . 0.0 109.394 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -75.55 -23.05 56.57 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.252 -0.905 . . . . 0.0 109.435 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.647 ' CB ' HD12 ' A' ' 56' ' ' LEU . 0.4 OUTLIER -75.29 -33.48 61.21 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.289 -0.882 . . . . 0.0 109.441 179.986 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.0 -44.42 84.86 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.266 -0.897 . . . . 0.0 109.374 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 57.2 m -69.02 -29.77 68.01 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.266 -0.896 . . . . 0.0 109.514 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -70.67 -35.48 72.85 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.232 -0.918 . . . . 0.0 109.49 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.419 HD22 ' HA ' ' A' ' 64' ' ' LEU . 0.1 OUTLIER -72.45 -59.83 2.53 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.214 -0.929 . . . . 0.0 109.494 179.986 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -48.39 -45.39 35.84 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.278 -0.889 . . . . 0.0 109.473 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.18 -41.37 99.21 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.262 -0.899 . . . . 0.0 109.465 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -59.35 -32.62 70.27 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.212 -0.93 . . . . 0.0 109.534 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.533 HD21 ' CD1' ' A' ' 96' ' ' LEU . 3.5 mt -82.89 -22.28 33.99 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.265 -0.897 . . . . 0.0 109.405 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.98 -21.08 59.37 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.302 -0.873 . . . . 0.0 109.758 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.6 -14.18 61.14 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.274 -0.891 . . . . 0.0 110.264 -179.412 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.02 37.88 1.17 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.053 -1.029 . . . . 0.0 109.584 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' CYS . . . . . 0.638 ' SG ' HD12 ' A' ' 85' ' ' ILE . 0.1 OUTLIER -99.06 -64.79 1.01 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.269 -0.894 . . . . 0.0 109.566 -179.958 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.479 ' O ' ' CB ' ' A' ' 74' ' ' CYS . . . 116.21 18.81 5.72 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.479 ' CB ' ' O ' ' A' ' 73' ' ' GLY . 0.5 OUTLIER 164.93 93.06 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.275 -1.132 . . . . 0.0 109.438 -179.961 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -57.27 100.71 0.13 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -77.38 -159.09 10.44 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -74.2 146.57 43.27 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.128 -1.219 . . . . 0.0 109.314 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 57.9 t -135.18 93.77 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.176 -0.952 . . . . 0.0 109.695 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.04 156.35 18.85 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.332 -0.855 . . . . 0.0 109.333 179.821 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -71.58 101.45 2.5 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.173 -0.954 . . . . 0.0 109.54 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.404 ' C ' ' CG2' ' A' ' 82' ' ' VAL . . . 117.44 -11.93 14.06 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.404 ' CG2' ' C ' ' A' ' 81' ' ' GLY . 3.3 t -152.72 117.75 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.297 -1.12 . . . . 0.0 109.357 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 15.2 mt -122.76 123.68 68.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.189 -0.944 . . . . 0.0 109.744 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -92.14 136.06 33.49 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.308 -0.87 . . . . 0.0 109.27 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.638 HD12 ' SG ' ' A' ' 72' ' ' CYS . 13.1 mm -131.9 95.93 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.171 -0.956 . . . . 0.0 109.521 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -56.56 133.85 53.84 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.296 -0.877 . . . . 0.0 109.407 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 143.9 173.72 15.59 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -139.92 81.32 1.81 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.28 -1.13 . . . . 0.0 109.419 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 13.7 pttt -145.55 49.03 1.24 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.261 -0.9 . . . . 0.0 109.456 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 7.1 ptt180 -47.69 -37.53 13.21 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.258 -0.901 . . . . 0.0 109.516 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -56.15 -49.66 73.33 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.261 -0.899 . . . . 0.0 109.438 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.498 ' HA ' HD22 ' A' ' 92' ' ' LEU . 0.2 OUTLIER -60.15 -44.13 95.2 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.268 -0.895 . . . . 0.0 109.501 -179.992 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.538 ' HG ' HG21 ' A' ' 36' ' ' ILE . 4.3 mm? -56.15 -35.13 66.82 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.237 -0.914 . . . . 0.0 109.42 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 67.9 tttt -60.87 -62.07 2.12 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.25 -0.906 . . . . 0.0 109.491 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -62.82 -14.1 41.47 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.216 -0.928 . . . . 0.0 109.421 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.856 HD23 ' N ' ' A' ' 97' ' ' LEU . 4.7 tt -72.78 -62.08 1.58 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.231 -0.918 . . . . 0.0 109.473 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.856 ' N ' HD23 ' A' ' 96' ' ' LEU . 0.1 OUTLIER -61.78 -31.9 72.15 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.266 -0.896 . . . . 0.0 109.444 -179.983 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -71.86 -25.56 62.0 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.277 -0.889 . . . . 0.0 109.506 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -68.79 -26.82 65.4 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.209 -0.932 . . . . 0.0 109.474 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -85.78 -39.31 17.25 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.244 -0.91 . . . . 0.0 109.504 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 117.65 14.46 6.82 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' MET . . . . . 0.413 ' HB2' HD23 ' A' ' 97' ' ' LEU . 19.0 mtp -96.62 154.12 17.46 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.293 -1.122 . . . . 0.0 109.451 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 11.1 mptt -81.19 118.94 22.99 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.282 -0.886 . . . . 0.0 109.512 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.773 ' HB ' HD22 ' A' ' 97' ' ' LEU . 12.1 p -115.32 135.06 56.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.265 -0.897 . . . . 0.0 109.456 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 71.6 tttt -102.28 97.56 7.82 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.273 -0.892 . . . . 0.0 109.465 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.459 ' O ' ' HB3' ' A' ' 107' ' ' ALA . 23.9 tp -45.59 -30.35 1.47 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.285 -0.884 . . . . 0.0 109.497 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.459 ' HB3' ' O ' ' A' ' 106' ' ' LEU . . . 62.67 -178.39 0.14 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.232 -0.918 . . . . 0.0 109.48 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.404 ' O ' ' C ' ' A' ' 109' ' ' GLY . . . 148.25 -139.36 7.61 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.404 ' C ' ' O ' ' A' ' 108' ' ' GLY . . . -44.83 129.66 7.77 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.0 tt -174.03 119.65 0.27 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.281 -1.129 . . . . 0.0 109.47 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 118.017 -0.992 . . . . 0.0 109.483 179.979 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 57.6 tttt . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 177.57 -71.77 0.08 OUTLIER Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -92.86 149.33 21.34 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.239 -1.154 . . . . 0.0 109.453 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.586 ' HA3' HD21 ' A' ' 56' ' ' LEU . . . -122.94 145.45 16.21 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.673 HG12 ' HB2' ' A' ' 103' ' ' LYS . 16.3 m -132.21 137.71 53.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.29 -1.124 . . . . 0.0 109.45 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.761 ' HB ' HD21 ' A' ' 97' ' ' LEU . 60.3 t -106.6 162.29 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.196 -0.94 . . . . 0.0 109.478 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.53 ' N ' HG12 ' A' ' 34' ' ' VAL . 4.4 ttt180 -135.62 108.07 7.37 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.243 -0.911 . . . . 0.0 109.48 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.739 HG12 HD22 ' A' ' 93' ' ' LEU . 3.2 mt -116.53 128.11 73.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.208 -0.933 . . . . 0.0 109.429 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.745 ' HB3' ' HB3' ' A' ' 107' ' ' ALA . 4.0 pt20 -156.07 153.88 30.1 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.258 -0.901 . . . . 0.0 109.477 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.1 143.14 34.66 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.248 -0.908 . . . . 0.0 109.487 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 20.2 tt0 -109.55 71.2 0.76 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.203 -0.936 . . . . 0.0 109.47 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 3.3 t -56.5 151.87 12.68 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.29 -0.881 . . . . 0.0 109.485 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -152.52 56.29 0.81 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.3 -0.875 . . . . 0.0 109.509 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 153.43 163.49 11.83 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 27.9 mtp85 -84.22 113.64 21.24 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.215 -1.167 . . . . 0.0 109.452 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 81.8 tttt 47.94 63.7 1.93 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.201 -0.937 . . . . 0.0 109.436 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -116.88 -55.48 0.31 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 12.3 tttt -174.18 131.5 0.39 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.193 -1.18 . . . . 0.0 109.406 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -96.16 123.27 7.64 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 15.6 m -121.44 143.31 34.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.239 -1.154 . . . . 0.0 109.328 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -125.37 133.92 52.36 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.211 -0.93 . . . . 0.0 109.53 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.425 ' HG ' ' O ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -123.29 120.52 33.34 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.264 -0.898 . . . . 0.0 109.41 179.951 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.452 HD13 ' N ' ' A' ' 51' ' ' ILE . 3.2 mm -90.91 119.61 38.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.232 -0.917 . . . . 0.0 109.441 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.92 159.4 44.58 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.273 -0.892 . . . . 0.0 109.455 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 108.05 -31.21 8.13 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.54 HG22 HG22 ' A' ' 34' ' ' VAL . 57.0 t -45.02 113.05 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.221 -1.164 . . . . 0.0 109.419 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -114.34 76.8 1.01 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.234 -0.916 . . . . 0.0 109.478 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.586 HD21 ' HA3' ' A' ' 32' ' ' GLY . 31.3 mt -130.06 -156.33 0.75 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.255 -0.903 . . . . 0.0 109.439 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.598 ' O ' HD12 ' A' ' 61' ' ' LEU . 4.4 m-20 -67.34 143.28 56.46 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.278 -0.889 . . . . 0.0 109.446 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -58.08 -36.02 72.24 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.248 -0.907 . . . . 0.0 109.66 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -75.25 -32.55 61.12 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.182 -0.949 . . . . 0.0 109.531 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -71.95 -26.3 62.22 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.278 -0.889 . . . . 0.0 109.534 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.598 HD12 ' O ' ' A' ' 57' ' ' ASP . 0.2 OUTLIER -71.87 -56.87 4.94 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.219 -0.925 . . . . 0.0 109.549 -179.962 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 4.5 t -56.45 -24.36 44.96 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.266 -0.896 . . . . 0.0 109.453 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 79.2 mttt -75.54 -46.17 33.66 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.259 -0.9 . . . . 0.0 109.515 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.415 ' HA ' HD22 ' A' ' 64' ' ' LEU . 0.4 OUTLIER -60.73 -46.02 92.04 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.188 -0.945 . . . . 0.0 109.359 179.939 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.41 ' CB ' HG13 ' A' ' 78' ' ' VAL . . . -65.78 -38.09 88.08 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.271 -0.893 . . . . 0.0 109.381 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.82 -36.98 75.39 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.227 -0.921 . . . . 0.0 109.413 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -75.55 -35.99 60.53 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.231 -0.918 . . . . 0.0 109.445 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.433 HD13 ' HA ' ' A' ' 68' ' ' LEU . 0.1 OUTLIER -56.55 -53.17 60.65 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.347 -0.846 . . . . 0.0 109.605 -179.932 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 15.4 pttp -66.16 -34.02 77.1 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.277 -0.889 . . . . 0.0 109.494 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -59.7 -21.83 61.16 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.316 -0.865 . . . . 0.0 109.71 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -85.07 -36.72 21.01 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.221 -0.925 . . . . 0.0 109.75 -179.655 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.2 m -94.42 -64.95 1.02 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.219 -0.925 . . . . 0.0 109.574 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 118.23 5.2 13.33 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 -179.726 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 46.8 t -160.15 121.87 3.19 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.307 -1.114 . . . . 0.0 109.258 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -129.35 -106.81 1.25 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 -179.732 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -172.84 -47.07 0.04 OUTLIER Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -178.55 119.52 0.08 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.291 -1.123 . . . . 0.0 109.56 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.416 HG22 HG23 ' A' ' 83' ' ' ILE . 77.9 t -100.98 97.82 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.312 -0.868 . . . . 0.0 109.292 179.837 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -106.34 141.34 37.82 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.213 -0.929 . . . . 0.0 109.814 -179.698 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -57.82 96.16 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.329 -0.857 . . . . 0.0 109.44 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 127.45 -40.78 1.7 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 23.5 t -132.93 122.51 46.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.179 -1.189 . . . . 0.0 109.58 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.416 HG23 HG22 ' A' ' 78' ' ' VAL . 2.9 mp -120.6 132.33 70.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.316 -0.865 . . . . 0.0 109.241 179.829 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -110.25 137.14 48.39 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.236 -0.915 . . . . 0.0 109.583 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 31.2 mm -132.59 123.18 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.299 -0.876 . . . . 0.0 109.563 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -91.78 104.95 17.34 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.204 -0.935 . . . . 0.0 109.438 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 178.6 -162.9 30.42 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -153.5 70.78 0.86 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.243 -1.151 . . . . 0.0 109.47 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 77.3 mttt -136.57 50.0 2.05 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.263 -0.898 . . . . 0.0 109.578 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 24.5 ptt180 -60.21 -34.04 73.09 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.227 -0.92 . . . . 0.0 109.478 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 30.5 t0 -55.74 -56.14 23.97 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.242 -0.911 . . . . 0.0 109.416 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.38 -31.03 71.63 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.249 -0.907 . . . . 0.0 109.398 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.739 HD22 HG12 ' A' ' 36' ' ' ILE . 0.4 OUTLIER -58.9 -45.16 90.96 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.31 -0.868 . . . . 0.0 109.442 179.961 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -61.91 -31.86 72.2 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.28 -0.887 . . . . 0.0 109.562 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.415 ' O ' ' C ' ' A' ' 96' ' ' LEU . 1.5 t -68.9 -69.76 0.31 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.216 -0.928 . . . . 0.0 109.499 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.961 HD12 ' N ' ' A' ' 97' ' ' LEU . 4.1 pp -43.78 -37.56 2.8 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.272 -0.892 . . . . 0.0 109.532 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.961 ' N ' HD12 ' A' ' 96' ' ' LEU . 10.6 tp -63.04 -47.24 83.87 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.213 -0.929 . . . . 0.0 109.46 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -69.2 -15.62 63.43 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.285 -0.884 . . . . 0.0 109.481 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -69.99 -28.34 65.44 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.22 -0.925 . . . . 0.0 109.472 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.446 ' HD3' ' N ' ' A' ' 100' ' ' LYS . 0.3 OUTLIER -85.77 -16.24 39.49 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.23 -0.919 . . . . 0.0 109.466 -179.951 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 84.94 14.38 69.8 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' MET . . . . . 0.481 ' HE3' HG23 ' A' ' 34' ' ' VAL . 1.4 mtm -87.29 171.89 10.28 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.243 -1.151 . . . . 0.0 109.43 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.673 ' HB2' HG12 ' A' ' 33' ' ' VAL . 0.1 OUTLIER -80.43 164.93 22.68 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.238 -0.913 . . . . 0.0 109.452 179.974 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.848 HG13 HD23 ' A' ' 97' ' ' LEU . 4.8 t -139.49 125.88 23.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.215 -0.928 . . . . 0.0 109.48 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.427 ' O ' ' C ' ' A' ' 106' ' ' LEU . 2.5 mttt -106.5 64.46 0.66 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.189 -0.944 . . . . 0.0 109.491 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.43 HD12 ' HA ' ' A' ' 106' ' ' LEU . 3.6 tp -43.93 102.55 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.28 -0.887 . . . . 0.0 109.494 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.745 ' HB3' ' HB3' ' A' ' 37' ' ' GLN . . . -96.0 -11.65 26.18 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.23 -0.919 . . . . 0.0 109.456 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -102.72 137.27 13.3 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 146.74 148.68 4.81 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -102.41 157.41 16.93 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.267 -1.137 . . . . 0.0 109.445 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 117.996 -1.002 . . . . 0.0 109.479 179.952 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 36.8 tttt . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -176.18 -59.31 0.06 OUTLIER Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 65.9 t0 50.45 68.3 0.79 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.201 -1.176 . . . . 0.0 109.477 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -99.53 139.33 14.37 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 33' ' ' VAL . 18.8 m -143.89 121.56 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.213 -1.169 . . . . 0.0 109.459 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.446 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 2.4 t -98.94 152.8 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.281 -0.887 . . . . 0.0 109.474 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.421 ' HG2' ' C ' ' A' ' 34' ' ' VAL . 4.4 mtt180 -139.01 118.56 12.95 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.314 -0.866 . . . . 0.0 109.461 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.907 HG21 ' HG ' ' A' ' 93' ' ' LEU . 2.6 mp -125.64 116.91 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.218 -0.926 . . . . 0.0 109.45 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.518 ' HB3' ' HB3' ' A' ' 107' ' ' ALA . 12.7 pt20 -146.96 174.24 11.7 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.186 -0.946 . . . . 0.0 109.504 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.401 ' HB2' ' HD2' ' A' ' 90' ' ' ARG . 9.1 ttm180 -102.1 149.74 23.96 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.221 -0.924 . . . . 0.0 109.469 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -136.27 108.04 7.05 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.233 -0.917 . . . . 0.0 109.405 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 40.5 p -69.15 -179.47 1.57 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.264 -0.898 . . . . 0.0 109.493 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -149.15 -54.29 0.18 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.221 -0.924 . . . . 0.0 109.463 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -89.08 -110.51 1.19 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 86.7 mtt180 -127.31 -47.9 1.45 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.288 -1.124 . . . . 0.0 109.468 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 30.0 pttt -138.55 156.47 47.46 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.285 -0.884 . . . . 0.0 109.484 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 60.55 -173.3 5.7 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 58.29 49.01 11.68 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.235 -1.156 . . . . 0.0 109.432 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -107.28 135.09 12.55 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 18.6 m -133.06 168.75 23.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.252 -1.146 . . . . 0.0 109.461 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -119.83 116.98 26.97 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.184 -0.947 . . . . 0.0 109.54 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -92.69 129.51 38.59 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.254 -0.904 . . . . 0.0 109.425 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.727 HG12 HG23 ' A' ' 36' ' ' ILE . 21.9 mt -110.07 111.62 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.256 -0.903 . . . . 0.0 109.562 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 60.2 p -137.98 176.25 8.86 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.243 -0.91 . . . . 0.0 109.452 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.89 -15.11 59.81 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 18.6 t -56.67 122.01 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.248 -1.148 . . . . 0.0 109.466 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -124.45 72.12 1.18 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.255 -0.903 . . . . 0.0 109.486 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.643 HD13 ' HB3' ' A' ' 60' ' ' GLU . 8.3 mt -113.15 -173.36 2.24 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.28 -0.887 . . . . 0.0 109.466 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.61 -83.6 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.269 -0.895 . . . . 0.0 109.536 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -156.24 -61.09 0.1 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.22 -0.925 . . . . 0.0 109.452 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.442 ' O ' HG22 ' A' ' 62' ' ' THR . . . -65.33 -26.6 68.11 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.235 -0.916 . . . . 0.0 109.45 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.643 ' HB3' HD13 ' A' ' 56' ' ' LEU . 5.4 mt-10 -62.58 -42.5 99.6 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.253 -0.904 . . . . 0.0 109.481 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -56.03 -59.15 5.32 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.212 -0.93 . . . . 0.0 109.403 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.442 HG22 ' O ' ' A' ' 59' ' ' ALA . 8.8 t -59.46 -20.6 56.43 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.281 -0.887 . . . . 0.0 109.506 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.2 tttt -70.94 -71.06 0.27 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.215 -0.928 . . . . 0.0 109.522 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.635 HD13 ' O ' ' A' ' 64' ' ' LEU . 0.2 OUTLIER -48.25 -32.24 6.95 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.3 -0.875 . . . . 0.0 109.761 -179.869 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.42 -49.86 61.91 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.123 -0.986 . . . . 0.0 109.902 -179.715 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.421 ' O ' ' HG3' ' A' ' 70' ' ' LYS . . . -60.01 -28.99 68.18 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.089 -1.007 . . . . 0.0 109.891 -179.652 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.45 ' O ' ' HB2' ' A' ' 70' ' ' LYS . 2.6 tt0 -76.71 -33.83 58.18 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.127 -0.983 . . . . 0.0 109.835 -179.709 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.468 ' HA ' HD23 ' A' ' 68' ' ' LEU . 29.7 mt -71.62 -42.79 67.2 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.155 -0.965 . . . . 0.0 109.624 -179.788 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 18.7 mtmt -72.34 -4.51 30.32 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.171 -0.956 . . . . 0.0 109.461 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.45 ' HB2' ' O ' ' A' ' 67' ' ' GLU . 4.3 mttt -74.0 -21.8 59.84 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.131 -0.981 . . . . 0.0 109.955 -179.509 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.93 59.3 1.54 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.12 -0.988 . . . . 0.0 109.579 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 4.9 t -134.31 -3.76 2.71 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.17 -0.956 . . . . 0.0 110.029 -179.663 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.13 2.68 54.13 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -163.54 -169.12 1.84 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.157 -1.202 . . . . 0.0 109.512 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -140.81 -116.18 1.27 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 144.1 -172.36 25.26 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -87.26 126.14 34.64 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.231 -1.158 . . . . 0.0 109.464 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.581 ' O ' HG23 ' A' ' 78' ' ' VAL . 18.8 m -99.39 88.43 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.186 -0.946 . . . . 0.0 109.565 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.47 148.23 22.45 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.208 -0.933 . . . . 0.0 109.351 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -70.83 89.89 0.78 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.193 -0.942 . . . . 0.0 109.555 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.453 ' O ' HG23 ' A' ' 82' ' ' VAL . . . 123.85 -11.19 8.34 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 81' ' ' GLY . 73.2 t -156.18 121.41 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.299 -1.118 . . . . 0.0 109.356 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 11.3 mt -119.45 126.61 75.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.203 -0.935 . . . . 0.0 109.659 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -92.5 120.73 33.26 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.277 -0.889 . . . . 0.0 109.318 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.431 HG22 ' O ' ' A' ' 85' ' ' ILE . 48.1 mm -127.45 70.72 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.28 -0.887 . . . . 0.0 109.561 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -50.43 160.92 0.35 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.256 -0.902 . . . . 0.0 109.416 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 126.59 -159.81 20.88 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -151.82 93.82 1.9 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.239 -1.153 . . . . 0.0 109.539 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 63.5 mttt -152.55 29.03 0.54 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.278 -0.889 . . . . 0.0 109.437 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.7 ' HB3' HD21 ' A' ' 106' ' ' LEU . 26.4 mtp180 -49.53 -38.42 30.59 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.219 -0.926 . . . . 0.0 109.465 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -55.36 -57.19 12.87 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.228 -0.92 . . . . 0.0 109.477 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.77 -21.48 65.88 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.285 -0.884 . . . . 0.0 109.467 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.907 ' HG ' HG21 ' A' ' 36' ' ' ILE . 0.9 OUTLIER -68.94 -42.4 76.77 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.248 -0.907 . . . . 0.0 109.472 179.995 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 18.3 tttt -68.84 -23.67 64.27 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.282 -0.886 . . . . 0.0 109.482 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -74.68 -62.44 1.53 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.173 -0.955 . . . . 0.0 109.437 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.659 HD12 ' N ' ' A' ' 97' ' ' LEU . 2.6 pp -53.92 -35.88 62.15 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.235 -0.916 . . . . 0.0 109.439 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.659 ' N ' HD12 ' A' ' 96' ' ' LEU . 0.2 OUTLIER -63.23 -52.58 61.6 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.281 -0.887 . . . . 0.0 109.483 179.976 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -63.04 -16.54 60.19 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.276 -0.89 . . . . 0.0 109.441 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.453 ' HB3' ' O ' ' A' ' 96' ' ' LEU . . . -65.76 -35.92 82.09 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.248 -0.908 . . . . 0.0 109.505 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.426 ' HE3' HD21 ' A' ' 64' ' ' LEU . 2.7 mptp? -81.05 -38.5 27.3 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.245 -0.909 . . . . 0.0 109.508 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 108.99 14.58 14.73 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 8.1 mtm -89.77 158.83 17.34 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.25 -1.147 . . . . 0.0 109.466 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 20.4 mttt -80.93 120.04 24.23 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.269 -0.895 . . . . 0.0 109.428 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.446 ' HA ' ' O ' ' A' ' 34' ' ' VAL . 3.0 p -115.82 143.11 26.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.218 -0.926 . . . . 0.0 109.455 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.418 ' O ' ' C ' ' A' ' 106' ' ' LEU . 26.6 tttt -114.1 83.19 1.83 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.263 -0.898 . . . . 0.0 109.481 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.7 HD21 ' HB3' ' A' ' 90' ' ' ARG . 0.6 OUTLIER -44.67 -26.81 0.42 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.207 -0.933 . . . . 0.0 109.473 179.993 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.524 ' HB3' ' O ' ' A' ' 106' ' ' LEU . . . 66.21 -169.89 0.2 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.249 -0.907 . . . . 0.0 109.48 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 116.94 -166.21 12.42 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 160.38 -171.39 36.58 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.4 tp -53.94 102.14 0.05 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.312 -1.11 . . . . 0.0 109.436 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 63.8 tt0 . . . . . 0 N--CA 1.489 1.52 0 CA-C-O 117.986 -1.007 . . . . 0.0 109.502 179.976 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 75.0 mttt . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -149.26 141.7 9.16 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 19.1 p-10 -174.92 -171.51 0.54 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.222 -1.163 . . . . 0.0 109.458 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.408 ' C ' HG13 ' A' ' 33' ' ' VAL . . . 178.02 130.21 1.37 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.663 HG23 ' O ' ' A' ' 33' ' ' VAL . 19.3 m -152.1 115.12 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.259 -1.142 . . . . 0.0 109.5 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.689 ' HB ' HD11 ' A' ' 97' ' ' LEU . 4.7 t -90.81 142.32 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.253 -0.904 . . . . 0.0 109.486 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 67.8 ttt180 -117.6 109.55 16.82 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.236 -0.915 . . . . 0.0 109.496 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 1.026 HG21 HD13 ' A' ' 93' ' ' LEU . 2.4 mp -108.22 93.7 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.266 -0.896 . . . . 0.0 109.473 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.79 179.96 7.44 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.273 -0.892 . . . . 0.0 109.425 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.71 102.67 3.96 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.254 -0.904 . . . . 0.0 109.446 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.6 ' O ' HG22 ' A' ' 48' ' ' VAL . 7.7 tt0 -88.44 128.83 35.54 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.285 -0.885 . . . . 0.0 109.478 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 74.1 p -130.49 147.75 52.22 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.279 -0.888 . . . . 0.0 109.481 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.3 t -113.2 144.19 43.11 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.284 -0.885 . . . . 0.0 109.467 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 49.32 -158.75 1.13 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -95.52 118.42 32.19 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.259 -1.142 . . . . 0.0 109.438 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 21.7 tttt 45.97 -165.89 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.292 -0.88 . . . . 0.0 109.463 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 104.46 -29.87 11.14 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 41.6 pttt -173.11 174.52 3.41 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.302 -1.116 . . . . 0.0 109.472 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -161.49 145.1 10.46 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.6 HG22 ' O ' ' A' ' 39' ' ' GLN . 34.1 m -137.08 153.01 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.229 -1.159 . . . . 0.0 109.444 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -130.63 130.53 44.08 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.212 -0.93 . . . . 0.0 109.52 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 4.2 mp -118.74 109.51 16.17 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.235 -0.916 . . . . 0.0 109.468 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.577 HG13 HG23 ' A' ' 36' ' ' ILE . 4.0 mp -99.58 122.25 51.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.192 -0.943 . . . . 0.0 109.492 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.535 ' HB ' HG13 ' A' ' 82' ' ' VAL . 8.8 t -158.47 167.59 29.23 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.289 -0.882 . . . . 0.0 109.496 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 83.44 48.09 5.45 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.652 ' HB ' HD21 ' A' ' 61' ' ' LEU . 18.3 t -103.57 117.45 49.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.22 -1.165 . . . . 0.0 109.506 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -83.55 81.13 8.87 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.178 -0.951 . . . . 0.0 109.437 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.457 HD23 ' HA ' ' A' ' 56' ' ' LEU . 19.0 mt -151.35 174.02 13.82 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.256 -0.902 . . . . 0.0 109.467 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -56.85 166.5 0.97 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.245 -0.91 . . . . 0.0 109.509 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -73.74 -35.87 65.09 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.283 -0.885 . . . . 0.0 109.422 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.03 -29.43 58.07 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.256 -0.903 . . . . 0.0 109.395 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -67.43 -34.66 77.67 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.24 -0.912 . . . . 0.0 109.388 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.652 HD21 ' HB ' ' A' ' 54' ' ' VAL . 0.2 OUTLIER -66.79 -44.62 80.82 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.229 -0.919 . . . . 0.0 109.286 179.89 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 54.9 m -60.82 -44.31 97.09 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.319 -0.863 . . . . 0.0 109.206 179.773 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 74.4 tttt -57.52 -49.54 76.0 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.342 -0.849 . . . . 0.0 109.363 179.827 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -55.95 -41.03 74.05 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.256 -0.902 . . . . 0.0 109.505 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.503 ' HB1' HG13 ' A' ' 78' ' ' VAL . . . -62.55 -37.01 84.46 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.242 -0.911 . . . . 0.0 109.578 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -70.81 -31.59 68.4 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.272 -0.893 . . . . 0.0 109.548 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 82.8 mt-10 -71.66 -37.67 70.78 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.181 -0.95 . . . . 0.0 109.433 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.522 HD21 HD22 ' A' ' 96' ' ' LEU . 11.2 mt -68.48 -55.45 11.74 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.253 -0.904 . . . . 0.0 109.531 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 19.8 ttmt -52.84 -40.18 63.13 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.258 -0.902 . . . . 0.0 109.41 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 61.4 tttt -47.81 -47.77 30.92 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.177 -0.952 . . . . 0.0 109.322 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 14.7 mttt -108.09 57.86 0.62 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.372 -0.83 . . . . 0.0 109.301 179.742 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.5 m -129.69 -75.97 0.55 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.265 -0.897 . . . . 0.0 109.736 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.658 ' O ' ' CB ' ' A' ' 74' ' ' CYS . . . 125.95 49.77 0.18 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.07 -1.612 . . . . 0.0 109.07 -179.582 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.658 ' CB ' ' O ' ' A' ' 73' ' ' GLY . 49.3 t 112.44 104.57 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.237 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -179.499 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -83.8 142.54 20.92 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -86.54 -80.71 1.18 Allowed Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -129.62 124.16 33.03 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.133 -1.216 . . . . 0.0 109.6 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.503 HG13 ' HB1' ' A' ' 65' ' ' ALA . 95.1 t -125.81 95.44 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.303 -0.873 . . . . 0.0 109.298 179.828 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 18.0 mttt -122.27 142.12 50.8 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.239 -0.913 . . . . 0.0 109.705 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -54.21 94.82 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.283 -0.886 . . . . 0.0 109.491 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 148.02 -46.24 0.71 Allowed Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.535 HG13 ' HB ' ' A' ' 52' ' ' THR . 42.7 t -143.13 160.94 17.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.233 -1.157 . . . . 0.0 109.47 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.478 ' N ' HG12 ' A' ' 82' ' ' VAL . 4.8 mp -138.32 149.43 24.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.246 -0.909 . . . . 0.0 109.43 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -147.14 120.25 8.85 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.252 -0.905 . . . . 0.0 109.473 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 36.3 mm -119.53 117.75 54.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.171 -0.956 . . . . 0.0 109.443 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.57 114.37 10.63 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.234 -0.916 . . . . 0.0 109.481 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 172.2 -137.97 4.54 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.556 -1.417 . . . . 0.0 109.556 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -177.08 53.24 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.238 -1.154 . . . . 0.0 109.452 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 19.8 mttt -106.14 39.45 1.8 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.234 -0.916 . . . . 0.0 109.499 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.85 ' HA ' HD12 ' A' ' 93' ' ' LEU . 5.4 ttm180 -49.59 -35.28 20.28 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.205 -0.934 . . . . 0.0 109.501 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.93 -43.96 91.26 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.241 -0.912 . . . . 0.0 109.439 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.84 -20.32 58.23 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.231 -0.918 . . . . 0.0 109.427 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 1.026 HD13 HG21 ' A' ' 36' ' ' ILE . 19.5 mt -69.33 -43.46 73.66 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.234 -0.916 . . . . 0.0 109.45 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -67.69 -24.07 65.36 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.274 -0.892 . . . . 0.0 109.446 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -74.98 -60.86 2.1 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.205 -0.935 . . . . 0.0 109.491 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.714 HD12 ' N ' ' A' ' 97' ' ' LEU . 3.6 pp -54.08 -34.53 60.41 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.254 -0.904 . . . . 0.0 109.505 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.917 HD13 ' CG2' ' A' ' 104' ' ' VAL . 0.4 OUTLIER -67.33 -47.04 71.68 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.315 -0.866 . . . . 0.0 109.453 179.981 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -65.91 -16.42 63.84 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.29 -0.881 . . . . 0.0 109.466 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -67.3 -36.37 81.38 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.264 -0.897 . . . . 0.0 109.437 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.94 -37.78 23.65 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.266 -0.896 . . . . 0.0 109.48 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 106.19 21.5 8.43 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.96 158.92 16.0 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.253 -1.145 . . . . 0.0 109.485 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.466 ' HB2' HG12 ' A' ' 33' ' ' VAL . 11.5 mttm -82.85 107.28 15.35 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.249 -0.907 . . . . 0.0 109.469 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.917 ' CG2' HD13 ' A' ' 97' ' ' LEU . 7.5 p -84.65 144.47 9.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.226 -0.921 . . . . 0.0 109.471 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 11.0 mttt -113.92 83.76 1.92 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.25 -0.906 . . . . 0.0 109.462 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.502 HD12 ' HA ' ' A' ' 106' ' ' LEU . 1.1 tp -45.09 -27.98 0.66 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.235 -0.916 . . . . 0.0 109.425 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . 59.05 77.89 0.29 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.276 -0.89 . . . . 0.0 109.492 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -159.59 175.9 36.41 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 167.88 -169.6 41.4 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 5.0 mt -62.49 143.56 57.0 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.276 -1.132 . . . . 0.0 109.485 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 50.4 tt0 . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.486 -179.983 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 121.298 0.571 . . . . 0.0 109.53 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.467 ' HA2' ' HB3' ' A' ' 55' ' ' ASP . . . 147.67 126.45 1.64 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.585 ' O ' HG23 ' A' ' 33' ' ' VAL . 19.1 m -133.8 121.26 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.318 -1.107 . . . . 0.0 109.42 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.954 HG22 HG22 ' A' ' 54' ' ' VAL . 77.9 t -96.42 135.78 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.218 -0.926 . . . . 0.0 109.493 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.471 ' O ' ' HG3' ' A' ' 35' ' ' ARG . 0.1 OUTLIER -130.08 124.45 32.82 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.187 -0.946 . . . . 0.0 109.519 -179.992 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.877 HG21 ' HG ' ' A' ' 93' ' ' LEU . 3.9 mp -110.08 126.11 67.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.233 -0.917 . . . . 0.0 109.449 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -121.69 160.65 24.05 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.272 -0.892 . . . . 0.0 109.502 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.405 ' O ' ' HG3' ' A' ' 38' ' ' ARG . 12.0 ptt180 -131.87 104.75 7.04 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.292 -0.88 . . . . 0.0 109.402 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -88.33 80.72 7.43 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.226 -0.921 . . . . 0.0 109.49 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 43.6 p . . . . . 0 N--CA 1.489 1.523 0 O-C-N 121.245 -0.909 . . . . 0.0 109.463 179.994 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 79.1 tttt . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 121.283 0.563 . . . . 0.0 109.572 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -118.99 149.61 18.13 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 27.6 m -126.43 158.13 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.232 -1.158 . . . . 0.0 109.487 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -129.42 124.23 33.6 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.267 -0.896 . . . . 0.0 109.48 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.1 mt -115.34 124.26 50.81 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.233 -0.917 . . . . 0.0 109.39 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.49 ' HB ' ' HB ' ' A' ' 83' ' ' ILE . 6.7 mm -107.28 119.28 56.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.231 -0.918 . . . . 0.0 109.595 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.987 HG23 ' O ' ' A' ' 81' ' ' GLY . 1.3 m -158.86 158.72 33.99 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.267 -0.896 . . . . 0.0 109.426 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.487 ' O ' ' N ' ' A' ' 55' ' ' ASP . . . 109.09 -23.86 22.37 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.954 HG22 HG22 ' A' ' 34' ' ' VAL . 21.3 t -49.02 94.17 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.311 -1.111 . . . . 0.0 109.424 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.487 ' N ' ' O ' ' A' ' 53' ' ' GLY . 13.3 t0 -79.78 85.92 5.4 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.234 -0.916 . . . . 0.0 109.527 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.493 HD13 ' OE1' ' A' ' 60' ' ' GLU . 35.2 mt -146.16 167.52 23.24 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.322 -0.861 . . . . 0.0 109.355 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.402 ' C ' ' O ' ' A' ' 56' ' ' LEU . 0.2 OUTLIER -45.47 150.47 0.47 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.224 -0.923 . . . . 0.0 109.392 179.888 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -60.33 -53.35 58.62 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.187 -0.945 . . . . 0.0 109.656 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.12 -39.02 71.59 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.283 -0.886 . . . . 0.0 109.733 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.493 ' OE1' HD13 ' A' ' 56' ' ' LEU . 0.3 OUTLIER -62.41 -39.41 93.19 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.174 -0.954 . . . . 0.0 109.671 -179.801 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.531 HD21 ' HB ' ' A' ' 54' ' ' VAL . 0.2 OUTLIER -58.9 -42.95 90.81 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.213 -0.929 . . . . 0.0 109.602 -179.894 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -61.36 -33.44 73.64 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.309 -0.87 . . . . 0.0 109.638 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -71.58 -34.89 70.31 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.235 -0.915 . . . . 0.0 109.605 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.49 ' HA ' HD22 ' A' ' 64' ' ' LEU . 0.2 OUTLIER -65.99 -59.77 3.5 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.189 -0.944 . . . . 0.0 109.577 -179.973 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -56.99 -34.17 67.86 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.278 -0.889 . . . . 0.0 109.628 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.477 ' HA ' ' HG2' ' A' ' 69' ' ' LYS . . . -66.36 -33.82 76.58 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.274 -0.891 . . . . 0.0 109.768 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -70.17 -44.31 69.05 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.204 -0.935 . . . . 0.0 109.723 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.645 ' CD2' HD22 ' A' ' 96' ' ' LEU . 9.7 mt -63.99 -39.85 95.07 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.231 -0.918 . . . . 0.0 109.629 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.485 ' HB2' ' HA2' ' A' ' 75' ' ' GLY . 12.9 ptmt -75.23 -2.11 26.47 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.321 -0.862 . . . . 0.0 109.854 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 10.3 tttt -76.83 -49.22 16.3 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.096 -1.003 . . . . 0.0 109.993 -179.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.54 64.63 1.43 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.079 -1.013 . . . . 0.0 109.768 -179.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . 0.437 ' HB2' ' O ' ' A' ' 68' ' ' LEU . 5.7 m -128.64 -15.36 4.47 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.192 -0.942 . . . . 0.0 110.078 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.672 ' O ' ' CB ' ' A' ' 74' ' ' CYS . . . 96.35 78.29 1.4 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.672 ' CB ' ' O ' ' A' ' 73' ' ' GLY . 34.7 t 112.02 110.62 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.19 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 -179.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.485 ' HA2' ' HB2' ' A' ' 69' ' ' LYS . . . -67.06 111.61 4.25 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -84.1 148.93 24.74 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -107.25 168.34 9.29 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.194 -1.18 . . . . 0.0 109.783 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.947 HG22 HG12 ' A' ' 83' ' ' ILE . 85.0 t -106.46 162.26 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.42 -0.8 . . . . 0.0 109.347 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.541 ' N ' HG12 ' A' ' 78' ' ' VAL . 6.6 mttt -149.27 82.27 1.42 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.222 -0.924 . . . . 0.0 109.521 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 46.15 66.87 0.85 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.373 -0.829 . . . . 0.0 109.728 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.987 ' O ' HG23 ' A' ' 52' ' ' THR . . . 74.84 8.88 82.91 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 179.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.459 ' O ' ' HB2' ' A' ' 79' ' ' LYS . 3.3 t -124.62 98.57 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.084 -1.245 . . . . 0.0 109.585 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.947 HG12 HG22 ' A' ' 78' ' ' VAL . 6.2 mt -93.15 124.37 45.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.228 -0.92 . . . . 0.0 109.481 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -91.87 124.55 36.07 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.324 -0.86 . . . . 0.0 109.578 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.413 HD13 ' HA ' ' A' ' 85' ' ' ILE . 34.1 mm -127.76 115.1 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.268 -0.895 . . . . 0.0 109.221 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.73 105.46 16.97 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.254 -0.904 . . . . 0.0 109.619 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 162.2 137.69 2.25 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -97.01 64.36 1.98 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.174 -1.192 . . . . 0.0 109.429 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 76.2 mttt -112.06 36.48 3.32 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.278 -0.889 . . . . 0.0 109.471 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 17.7 ttm180 -44.27 -35.8 2.46 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.261 -0.9 . . . . 0.0 109.476 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -56.39 -52.28 65.2 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.242 -0.911 . . . . 0.0 109.498 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.43 -26.88 68.17 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.291 -0.881 . . . . 0.0 109.47 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.877 ' HG ' HG21 ' A' ' 36' ' ' ILE . 3.2 mm? -63.23 -46.08 88.61 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.309 -0.869 . . . . 0.0 109.459 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 72.3 tttt -61.67 -29.95 70.41 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.228 -0.92 . . . . 0.0 109.534 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 17.5 t -69.83 -68.7 0.4 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.253 -0.905 . . . . 0.0 109.449 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.827 HD21 HD13 ' A' ' 93' ' ' LEU . 2.5 pp -44.86 -35.36 2.75 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.242 -0.911 . . . . 0.0 109.42 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.881 HD22 HG22 ' A' ' 104' ' ' VAL . 0.5 OUTLIER -64.63 -47.94 76.69 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.23 -0.919 . . . . 0.0 109.487 179.939 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -67.18 -9.26 38.21 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.234 -0.916 . . . . 0.0 109.488 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.417 ' HB3' ' O ' ' A' ' 96' ' ' LEU . . . -70.44 -33.16 70.99 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.233 -0.917 . . . . 0.0 109.482 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 4.8 mtmm -84.98 -25.87 27.48 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.209 -0.932 . . . . 0.0 109.506 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 92.5 16.01 50.99 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 4.2 mtm -87.69 -174.42 4.76 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.266 -1.138 . . . . 0.0 109.464 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 24.5 mttt -91.42 163.5 14.16 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.262 -0.899 . . . . 0.0 109.487 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.881 HG22 HD22 ' A' ' 97' ' ' LEU . 19.2 t -139.82 158.99 27.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.245 -0.909 . . . . 0.0 109.456 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.452 ' O ' ' N ' ' A' ' 107' ' ' ALA . 17.3 tttt -130.25 61.42 1.59 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.215 -0.928 . . . . 0.0 109.474 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.41 ' C ' ' O ' ' A' ' 105' ' ' LYS . 3.7 tp -44.9 98.49 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.26 -0.9 . . . . 0.0 109.494 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.452 ' N ' ' O ' ' A' ' 105' ' ' LYS . . . . . . . . 0 N--CA 1.49 1.526 0 O-C-N 121.206 -0.934 . . . . 0.0 109.488 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 14.9 t70 . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -86.37 161.08 33.75 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.806 HG12 ' HB3' ' A' ' 103' ' ' LYS . 18.9 m -142.98 97.51 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.189 -1.183 . . . . 0.0 109.506 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.634 ' HB ' HD21 ' A' ' 97' ' ' LEU . 38.6 t -97.06 145.45 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.186 -0.946 . . . . 0.0 109.444 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 58.5 mtt180 -127.45 131.13 50.26 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.265 -0.897 . . . . 0.0 109.493 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.773 ' CD1' HD22 ' A' ' 97' ' ' LEU . 3.0 mp -125.68 106.31 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.293 -0.879 . . . . 0.0 109.476 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.66 ' HA ' ' HB2' ' A' ' 107' ' ' ALA . 20.4 pt20 -113.49 -175.01 2.57 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.265 -0.897 . . . . 0.0 109.443 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.413 ' O ' ' CG ' ' A' ' 38' ' ' ARG . 3.9 ptt180 -133.22 117.85 17.9 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.237 -0.914 . . . . 0.0 109.498 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -95.05 132.63 39.73 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.237 -0.915 . . . . 0.0 109.47 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.537 0 O-C-N 121.248 -0.908 . . . . 0.0 109.523 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 90.1 mttt . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -166.12 156.86 29.06 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -130.22 165.01 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.276 -1.132 . . . . 0.0 109.454 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 3.5 m -133.82 134.59 43.01 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.245 -0.91 . . . . 0.0 109.515 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -111.18 139.25 46.71 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.261 -0.899 . . . . 0.0 109.489 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.481 HG12 ' CG1' ' A' ' 36' ' ' ILE . 15.3 mt -127.95 107.8 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.246 -0.909 . . . . 0.0 109.468 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 15.8 m -152.47 158.82 43.13 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.237 -0.914 . . . . 0.0 109.426 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 104.36 16.42 18.31 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.781 ' HB ' HD21 ' A' ' 61' ' ' LEU . 21.8 t -74.6 130.42 36.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.198 -1.177 . . . . 0.0 109.46 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -104.44 86.85 2.59 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.232 -0.918 . . . . 0.0 109.45 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.628 ' HB2' HD11 ' A' ' 61' ' ' LEU . 5.1 mt -133.38 -170.63 2.52 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.247 -0.908 . . . . 0.0 109.537 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -73.89 -69.89 0.41 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.191 -0.943 . . . . 0.0 109.481 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 174.12 -63.13 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.171 -0.956 . . . . 0.0 109.521 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.68 -30.89 71.92 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.242 -0.911 . . . . 0.0 109.583 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -66.01 -35.49 80.71 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.182 -0.949 . . . . 0.0 109.478 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.781 HD21 ' HB ' ' A' ' 54' ' ' VAL . 0.3 OUTLIER -63.95 -38.61 91.7 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.27 -0.894 . . . . 0.0 109.548 179.995 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 23.8 m -59.75 -49.64 76.92 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.234 -0.916 . . . . 0.0 109.47 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 58.5 tttt -59.7 -36.88 77.41 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.255 -0.903 . . . . 0.0 109.492 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.46 ' CD1' HD23 ' A' ' 68' ' ' LEU . 0.1 OUTLIER -59.29 -53.69 55.37 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.209 -0.932 . . . . 0.0 109.527 -179.926 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.559 ' HB1' HG11 ' A' ' 78' ' ' VAL . . . -59.15 -32.28 69.73 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.271 -0.893 . . . . 0.0 109.541 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.88 -42.29 94.93 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.238 -0.914 . . . . 0.0 109.401 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -75.64 -19.83 58.93 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.273 -0.892 . . . . 0.0 109.403 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.463 HD13 ' HA ' ' A' ' 68' ' ' LEU . 0.7 OUTLIER -72.17 -53.69 11.93 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.32 -0.863 . . . . 0.0 109.548 -179.956 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.496 ' HA ' ' HB2' ' A' ' 72' ' ' CYS . 1.3 ptpt -65.8 -21.41 66.49 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.323 -0.861 . . . . 0.0 109.694 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 9.3 mttt -58.57 -34.61 71.25 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.321 -0.862 . . . . 0.0 110.042 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 59.7 tttt -120.12 24.03 10.67 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.045 -1.034 . . . . 0.0 110.066 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . 0.496 ' HB2' ' HA ' ' A' ' 69' ' ' LYS . 0.5 OUTLIER -107.37 -27.13 10.65 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.069 -1.019 . . . . 0.0 109.548 179.827 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.424 ' O ' ' HB3' ' A' ' 74' ' ' CYS . . . 61.38 54.09 38.95 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.646 -1.381 . . . . 0.0 109.646 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.424 ' HB3' ' O ' ' A' ' 73' ' ' GLY . 27.0 p 177.66 125.33 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.283 -1.128 . . . . 0.0 109.49 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -114.06 82.27 0.31 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.479 ' O ' ' HB2' ' A' ' 77' ' ' ALA . . . -75.91 -52.88 6.08 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.774 -1.331 . . . . 0.0 109.774 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.479 ' HB2' ' O ' ' A' ' 76' ' ' GLY . . . 176.78 124.42 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.171 -1.194 . . . . 0.0 109.508 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.559 HG11 ' HB1' ' A' ' 65' ' ' ALA . 38.5 t -127.29 122.53 59.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.261 -0.9 . . . . 0.0 109.554 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -131.5 143.81 50.67 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.24 -0.912 . . . . 0.0 109.593 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.63 109.72 0.85 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.157 -0.964 . . . . 0.0 109.36 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 119.68 -38.39 2.81 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 87.8 t -140.26 133.13 33.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.329 -1.1 . . . . 0.0 109.412 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.414 HG12 HG13 ' A' ' 78' ' ' VAL . 12.1 mt -122.55 148.4 26.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.247 -0.908 . . . . 0.0 109.4 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.458 ' O ' HD13 ' A' ' 85' ' ' ILE . 6.9 tt0 -135.41 134.96 40.23 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.175 -0.953 . . . . 0.0 109.686 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.458 HD13 ' O ' ' A' ' 84' ' ' GLU . 27.8 mm -118.15 148.52 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.236 -0.915 . . . . 0.0 109.332 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.38 122.06 46.55 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.204 -0.935 . . . . 0.0 109.478 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 130.43 161.28 10.32 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -103.66 108.93 20.42 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.231 -1.159 . . . . 0.0 109.458 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 30.6 mttt -158.73 31.39 0.22 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.235 -0.916 . . . . 0.0 109.462 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.589 ' HA ' HD12 ' A' ' 93' ' ' LEU . 50.8 ttp180 -53.48 -27.78 27.09 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.249 -0.907 . . . . 0.0 109.485 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 50.0 t0 -60.05 -51.77 68.2 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.259 -0.901 . . . . 0.0 109.456 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.621 HD23 HD23 ' A' ' 96' ' ' LEU . 1.7 tt -70.75 -23.95 62.52 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.21 -0.931 . . . . 0.0 109.438 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.769 HD22 HG21 ' A' ' 36' ' ' ILE . 1.3 mt -63.51 -47.87 79.93 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.193 -0.942 . . . . 0.0 109.424 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.946 ' HD2' HD21 ' A' ' 106' ' ' LEU . 78.2 tttt -61.98 -23.07 66.17 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.244 -0.91 . . . . 0.0 109.451 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 6.6 t -76.56 -65.37 0.94 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.277 -0.889 . . . . 0.0 109.491 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.848 HD12 ' N ' ' A' ' 97' ' ' LEU . 2.9 pp -47.73 -36.04 10.74 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.256 -0.903 . . . . 0.0 109.419 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.848 ' N ' HD12 ' A' ' 96' ' ' LEU . 1.4 tp -69.52 -44.25 71.41 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.225 -0.922 . . . . 0.0 109.456 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 68.4 tt0 -61.21 -20.26 62.58 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.285 -0.884 . . . . 0.0 109.477 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -62.77 -32.28 73.4 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.229 -0.919 . . . . 0.0 109.476 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -84.36 -18.07 37.37 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.229 -0.919 . . . . 0.0 109.495 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 75.47 24.66 69.98 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 1.1 mtm -79.07 179.34 7.41 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.29 -1.124 . . . . 0.0 109.495 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.806 ' HB3' HG12 ' A' ' 33' ' ' VAL . 13.0 mttt -97.21 88.32 4.43 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.308 -0.87 . . . . 0.0 109.447 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.693 ' CG2' HD23 ' A' ' 97' ' ' LEU . 2.1 t -81.62 165.08 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.227 -0.92 . . . . 0.0 109.494 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.401 ' O ' ' C ' ' A' ' 106' ' ' LEU . 41.7 tttt -128.88 28.2 5.37 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.263 -0.898 . . . . 0.0 109.446 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.946 HD21 ' HD2' ' A' ' 94' ' ' LYS . 0.2 OUTLIER 44.24 -157.82 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.243 -0.911 . . . . 0.0 109.456 179.954 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.66 ' HB2' ' HA ' ' A' ' 37' ' ' GLN . . . . . . . . 0 N--CA 1.49 1.541 0 O-C-N 121.213 -0.929 . . . . 0.0 109.479 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.4 ' C ' ' CG2' ' A' ' 33' ' ' VAL . . . 163.2 128.12 0.93 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.4 ' CG2' ' C ' ' A' ' 32' ' ' GLY . 1.9 t -149.61 151.64 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.248 -1.149 . . . . 0.0 109.546 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.547 ' HB ' HD11 ' A' ' 97' ' ' LEU . 72.7 t -138.1 121.68 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.312 -0.867 . . . . 0.0 109.392 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.436 ' CG ' ' HA3' ' A' ' 53' ' ' GLY . 62.3 mtt180 -88.11 111.22 21.34 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.244 -0.91 . . . . 0.0 109.516 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.93 HD11 HD13 ' A' ' 97' ' ' LEU . 7.5 mt -115.66 108.51 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.263 -0.898 . . . . 0.0 109.408 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.758 ' HB3' ' HB3' ' A' ' 107' ' ' ALA . 3.4 pt20 -131.72 -160.12 1.02 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.21 -0.931 . . . . 0.0 109.548 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 11.9 ptm180 -130.79 132.09 45.06 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.297 -0.877 . . . . 0.0 109.447 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -125.81 77.47 1.67 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.254 -0.904 . . . . 0.0 109.484 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.576 0 O-C-N 121.3 -0.875 . . . . 0.0 109.472 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 93.3 mttt . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 176.96 144.52 5.31 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 16.0 m -135.02 159.05 41.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.275 -1.132 . . . . 0.0 109.373 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -111.9 110.02 20.13 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.247 -0.908 . . . . 0.0 109.531 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.899 HD12 ' HG3' ' A' ' 84' ' ' GLU . 8.5 tp -93.83 129.29 40.28 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.225 -0.922 . . . . 0.0 109.44 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.402 HG23 HD12 ' A' ' 51' ' ' ILE . 11.1 mm -120.91 114.74 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.295 -0.878 . . . . 0.0 109.439 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.444 HG22 ' O ' ' A' ' 52' ' ' THR . 8.6 m -141.6 13.28 2.13 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.307 -0.871 . . . . 0.0 109.496 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.436 ' HA3' ' CG ' ' A' ' 35' ' ' ARG . . . -97.41 19.02 56.37 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.579 -1.409 . . . . 0.0 109.579 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.639 HG11 ' HG ' ' A' ' 61' ' ' LEU . 60.0 t -82.95 105.65 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.267 -1.137 . . . . 0.0 109.452 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -100.19 87.73 3.52 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.187 -0.946 . . . . 0.0 109.522 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.594 HD12 ' CG1' ' A' ' 54' ' ' VAL . 19.2 mt -129.15 -169.23 2.05 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.269 -0.894 . . . . 0.0 109.403 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -81.87 -65.33 1.02 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.235 -0.916 . . . . 0.0 109.446 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.4 t0 179.76 -50.34 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.23 -0.918 . . . . 0.0 109.402 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.6 -34.71 65.18 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.24 -0.913 . . . . 0.0 109.437 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -70.2 -28.15 65.06 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.261 -0.899 . . . . 0.0 109.413 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.639 ' HG ' HG11 ' A' ' 54' ' ' VAL . 0.4 OUTLIER -66.55 -55.46 15.38 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.263 -0.898 . . . . 0.0 109.476 179.951 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.449 HG23 ' N ' ' A' ' 63' ' ' LYS . 8.2 t -59.81 -37.73 79.99 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.26 -0.9 . . . . 0.0 109.551 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.449 ' N ' HG23 ' A' ' 62' ' ' THR . 0.7 OUTLIER -57.74 -62.39 1.83 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.206 -0.934 . . . . 0.0 109.535 -179.947 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.5 tt -49.82 -48.43 50.81 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.258 -0.901 . . . . 0.0 109.612 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -50.08 -41.61 48.47 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.29 -0.881 . . . . 0.0 109.659 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.8 -34.92 76.34 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.213 -0.93 . . . . 0.0 109.657 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -67.18 -30.26 70.17 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.222 -0.924 . . . . 0.0 109.584 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -79.62 -33.93 41.06 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.293 -0.88 . . . . 0.0 109.454 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.476 ' HA ' ' HB3' ' A' ' 72' ' ' CYS . 6.8 ttpt -77.04 -9.58 58.81 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.267 -0.895 . . . . 0.0 109.377 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -68.51 -41.58 79.77 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.187 -0.946 . . . . 0.0 109.46 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 39.6 mttt -103.83 5.44 35.91 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.267 -0.896 . . . . 0.0 109.493 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . 0.476 ' HB3' ' HA ' ' A' ' 69' ' ' LYS . 31.9 t -81.4 -64.44 1.19 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.217 -0.927 . . . . 0.0 109.615 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 91.38 19.65 41.02 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.291 -1.524 . . . . 0.0 109.291 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 17.4 t -174.92 90.95 0.06 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.364 -1.08 . . . . 0.0 109.304 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -95.89 157.99 21.81 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -117.98 -87.57 1.21 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -134.07 127.99 33.33 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.187 -1.184 . . . . 0.0 109.288 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.701 HG22 HG23 ' A' ' 83' ' ' ILE . 84.0 t -128.03 82.64 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.152 -0.967 . . . . 0.0 109.682 -179.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 65.4 mttt -94.09 155.69 16.96 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.268 -0.895 . . . . 0.0 109.255 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -63.72 104.97 0.73 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.24 -0.912 . . . . 0.0 109.575 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 129.67 -26.32 4.32 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 90.9 t -149.79 151.9 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.207 -1.172 . . . . 0.0 109.726 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.701 HG23 HG22 ' A' ' 78' ' ' VAL . 15.8 mt -143.7 120.58 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.389 -0.819 . . . . 0.0 109.249 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.899 ' HG3' HD12 ' A' ' 50' ' ' LEU . 1.7 tt0 -112.56 130.28 56.07 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.219 -0.925 . . . . 0.0 109.638 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.402 HD13 ' HA ' ' A' ' 85' ' ' ILE . 25.7 mm -126.39 145.85 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.262 -0.899 . . . . 0.0 109.335 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.53 112.23 24.47 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.231 -0.918 . . . . 0.0 109.543 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -161.03 -40.07 0.02 OUTLIER Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 27.7 t70 53.36 60.83 3.46 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.314 -1.11 . . . . 0.0 109.478 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 16.8 mttt -152.15 65.98 0.84 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.288 -0.883 . . . . 0.0 109.466 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 4.1 ptt-85 -56.79 -28.92 62.15 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.218 -0.927 . . . . 0.0 109.478 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -55.28 -52.63 62.82 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.242 -0.911 . . . . 0.0 109.455 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.5 tt -70.02 -42.07 73.45 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.25 -0.906 . . . . 0.0 109.511 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.653 HD13 ' CG2' ' A' ' 36' ' ' ILE . 2.3 mt -54.28 -26.27 28.16 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.196 -0.94 . . . . 0.0 109.484 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -64.48 -64.33 0.91 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.259 -0.901 . . . . 0.0 109.412 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -63.51 -13.93 45.98 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.276 -0.89 . . . . 0.0 109.435 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.827 HD23 ' N ' ' A' ' 97' ' ' LEU . 4.1 tt -71.16 -56.9 5.13 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.287 -0.883 . . . . 0.0 109.429 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.956 HD22 HG22 ' A' ' 104' ' ' VAL . 0.2 OUTLIER -70.91 -30.54 66.91 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.306 -0.871 . . . . 0.0 109.437 -179.966 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -64.71 -18.09 64.7 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.261 -0.899 . . . . 0.0 109.458 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.95 -37.24 86.99 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.292 -0.88 . . . . 0.0 109.484 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 11.2 mtpp -82.63 -34.91 27.39 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.266 -0.896 . . . . 0.0 109.444 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 107.99 17.85 10.54 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 1.5 mtm -91.28 167.85 12.01 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.261 -1.141 . . . . 0.0 109.45 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.14 157.76 22.65 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.245 -0.91 . . . . 0.0 109.44 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.956 HG22 HD22 ' A' ' 97' ' ' LEU . 87.3 t -136.19 123.0 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.312 -0.867 . . . . 0.0 109.423 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.84 88.63 4.34 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.239 -0.913 . . . . 0.0 109.49 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.556 ' O ' ' HB3' ' A' ' 107' ' ' ALA . 30.9 mt -44.24 -36.11 2.57 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.339 -0.85 . . . . 0.0 109.465 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.758 ' HB3' ' HB3' ' A' ' 37' ' ' GLN . . . . . . . . 0 N--CA 1.49 1.54 0 O-C-N 121.248 -0.908 . . . . 0.0 109.455 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.581 ' CA ' HD21 ' A' ' 56' ' ' LEU . . . 76.92 117.58 0.16 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.976 HG13 ' O ' ' A' ' 103' ' ' LYS . 82.2 t -143.68 122.55 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.261 -1.14 . . . . 0.0 109.483 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.778 ' O ' HG23 ' A' ' 104' ' ' VAL . 44.5 t -101.77 135.17 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.257 -0.902 . . . . 0.0 109.462 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 13.4 ttt180 -102.89 123.35 46.36 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.231 -0.918 . . . . 0.0 109.521 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.772 HG21 HD13 ' A' ' 93' ' ' LEU . 4.0 mt -128.87 112.49 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.195 -0.94 . . . . 0.0 109.537 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.704 ' HB3' ' HB3' ' A' ' 107' ' ' ALA . 3.3 pm0 -136.3 110.9 8.61 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.277 -0.889 . . . . 0.0 109.49 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.412 ' HG3' ' O ' ' A' ' 38' ' ' ARG . 0.0 OUTLIER -69.83 109.64 4.54 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.277 -0.89 . . . . 0.0 109.433 -179.949 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -96.17 138.99 32.97 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.304 -0.872 . . . . 0.0 109.507 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 8.9 m . . . . . 0 N--CA 1.49 1.547 0 O-C-N 121.25 -0.906 . . . . 0.0 109.446 -179.989 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 12.5 tttt . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 169.26 139.53 2.74 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 16.0 m -146.71 151.16 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.201 -1.176 . . . . 0.0 109.475 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -111.04 126.01 54.36 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.302 -0.874 . . . . 0.0 109.444 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.2 mp -112.99 104.77 12.73 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.254 -0.904 . . . . 0.0 109.578 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.454 ' HB ' ' HB ' ' A' ' 83' ' ' ILE . 8.2 mm -82.83 119.67 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.251 -0.905 . . . . 0.0 109.39 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 9.8 t -159.93 169.59 23.17 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.211 -0.93 . . . . 0.0 109.5 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 84.33 24.13 48.56 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.559 ' HB ' HD21 ' A' ' 61' ' ' LEU . 3.3 t -91.59 126.68 44.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.25 -1.147 . . . . 0.0 109.495 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -113.55 78.73 1.17 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.271 -0.893 . . . . 0.0 109.43 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.581 HD21 ' CA ' ' A' ' 32' ' ' GLY . 84.7 mt -137.21 -170.44 2.72 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.244 -0.91 . . . . 0.0 109.429 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.491 ' HB3' ' HB2' ' A' ' 60' ' ' GLU . 6.7 t0 -57.92 151.42 18.26 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.257 -0.902 . . . . 0.0 109.484 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.87 -54.25 49.25 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.237 -0.914 . . . . 0.0 109.513 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.57 -21.76 62.65 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.191 -0.943 . . . . 0.0 109.604 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.491 ' HB2' ' HB3' ' A' ' 57' ' ' ASP . 19.0 tt0 -61.99 -41.74 98.38 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.201 -0.937 . . . . 0.0 109.597 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.559 HD21 ' HB ' ' A' ' 54' ' ' VAL . 1.8 mp -61.08 -56.7 17.82 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.225 -0.922 . . . . 0.0 109.579 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 86.6 m -47.87 -36.69 12.51 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.15 -0.969 . . . . 0.0 109.492 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.408 ' O ' ' C ' ' A' ' 64' ' ' LEU . 15.4 tttt -61.84 -64.76 0.84 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.265 -0.897 . . . . 0.0 109.437 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.421 HD23 HD23 ' A' ' 68' ' ' LEU . 0.5 OUTLIER -44.55 -41.51 6.53 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.281 -0.887 . . . . 0.0 109.751 -179.862 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -56.83 -59.09 5.55 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.242 -0.911 . . . . 0.0 109.702 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.3 -17.08 17.01 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.292 -0.88 . . . . 0.0 109.81 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -76.65 -44.16 35.13 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.162 -0.961 . . . . 0.0 110.042 -179.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.481 HD22 ' N ' ' A' ' 68' ' ' LEU . 4.4 mm? -79.58 -26.52 41.28 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.073 -1.017 . . . . 0.0 110.201 -179.413 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.1 ttmt -71.18 -5.84 34.92 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.056 -1.028 . . . . 0.0 109.593 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -60.22 -42.23 94.72 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.251 -0.905 . . . . 0.0 109.196 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.52 43.48 0.75 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.313 -0.867 . . . . 0.0 109.688 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -77.78 -28.35 50.48 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.345 -0.847 . . . . 0.0 108.944 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.488 ' O ' ' HB2' ' A' ' 74' ' ' CYS . . . 124.75 -27.98 5.31 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 108.839 -1.705 . . . . 0.0 108.839 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.488 ' HB2' ' O ' ' A' ' 73' ' ' GLY . 4.5 t 165.36 97.42 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.554 -0.968 . . . . 0.0 108.695 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -76.52 116.29 4.64 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.444 -1.463 . . . . 0.0 109.444 -179.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -63.4 -88.47 0.04 OUTLIER Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.496 -1.441 . . . . 0.0 109.496 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -133.09 160.6 36.71 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.341 -1.093 . . . . 0.0 109.559 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 39.5 t -132.0 140.75 47.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.277 -0.89 . . . . 0.0 109.413 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 48.5 mttt -148.18 141.68 25.38 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.287 -0.883 . . . . 0.0 109.414 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -60.71 91.49 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.153 -0.967 . . . . 0.0 109.516 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 134.93 -37.33 1.95 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 90.8 t -139.86 135.18 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.266 -1.138 . . . . 0.0 109.341 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.454 ' HB ' ' HB ' ' A' ' 51' ' ' ILE . 41.4 mt -130.99 133.92 62.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.227 -0.92 . . . . 0.0 109.612 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 -104.33 120.62 41.59 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.263 -0.898 . . . . 0.0 109.43 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.438 HD13 ' HA ' ' A' ' 85' ' ' ILE . 20.4 mm -122.44 91.4 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.209 -0.932 . . . . 0.0 109.46 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -55.2 129.99 40.4 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.211 -0.931 . . . . 0.0 109.505 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 161.74 -155.16 26.32 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -177.79 70.38 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.203 -1.175 . . . . 0.0 109.475 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 55.1 mttt -143.51 49.44 1.41 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.276 -0.89 . . . . 0.0 109.537 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -48.44 -28.76 3.48 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.27 -0.894 . . . . 0.0 109.426 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -60.77 -55.16 36.48 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.196 -0.94 . . . . 0.0 109.433 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.506 HD23 HD23 ' A' ' 96' ' ' LEU . 2.7 tt -64.49 -29.2 70.24 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.24 -0.913 . . . . 0.0 109.477 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.772 HD13 HG21 ' A' ' 36' ' ' ILE . 0.3 OUTLIER -61.86 -44.04 97.64 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.21 -0.931 . . . . 0.0 109.474 -179.979 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -63.21 -30.31 71.48 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.291 -0.881 . . . . 0.0 109.438 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.404 ' O ' ' C ' ' A' ' 96' ' ' LEU . 46.8 t -70.32 -68.95 0.39 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.284 -0.885 . . . . 0.0 109.469 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.719 HD12 ' N ' ' A' ' 97' ' ' LEU . 3.8 pp -45.42 -35.39 3.67 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.224 -0.923 . . . . 0.0 109.493 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.719 ' N ' HD12 ' A' ' 96' ' ' LEU . 2.5 tt -62.54 -52.67 62.51 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.292 -0.88 . . . . 0.0 109.431 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -62.25 -17.52 58.66 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.248 -0.908 . . . . 0.0 109.441 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.488 ' HB3' ' O ' ' A' ' 96' ' ' LEU . . . -62.18 -37.2 84.38 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.303 -0.873 . . . . 0.0 109.466 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -84.23 -23.47 30.43 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.196 -0.94 . . . . 0.0 109.477 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 93.58 14.8 52.31 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' MET . . . . . 0.606 ' CE ' HG23 ' A' ' 34' ' ' VAL . 2.6 mtm -85.42 152.79 22.96 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.194 -1.18 . . . . 0.0 109.49 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.976 ' O ' HG13 ' A' ' 33' ' ' VAL . 16.2 mttt -81.31 149.35 28.97 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.264 -0.898 . . . . 0.0 109.436 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.778 HG23 ' O ' ' A' ' 34' ' ' VAL . 12.9 p -136.87 153.59 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.259 -0.901 . . . . 0.0 109.454 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 69.6 mttt -120.93 85.83 2.47 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.248 -0.907 . . . . 0.0 109.431 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -50.52 101.33 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.263 -0.898 . . . . 0.0 109.521 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.704 ' HB3' ' HB3' ' A' ' 37' ' ' GLN . . . . . . . . 0 N--CA 1.49 1.546 0 O-C-N 121.236 -0.915 . . . . 0.0 109.493 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 121.274 0.559 . . . . 0.0 109.515 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.444 ' O ' HG13 ' A' ' 33' ' ' VAL . . . -117.09 133.43 10.62 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.444 HG13 ' O ' ' A' ' 32' ' ' GLY . 5.8 m -154.43 145.48 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.217 -1.166 . . . . 0.0 109.493 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.518 HG13 HG22 ' A' ' 54' ' ' VAL . 45.0 t -127.73 147.36 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.286 -0.884 . . . . 0.0 109.436 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.481 ' HB2' ' HA3' ' A' ' 53' ' ' GLY . 3.2 ttm180 -103.18 99.56 9.43 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.224 -0.922 . . . . 0.0 109.487 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.8 ' CG2' HD13 ' A' ' 93' ' ' LEU . 11.0 mt -104.87 107.58 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.236 -0.915 . . . . 0.0 109.457 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.923 ' HB3' ' HB3' ' A' ' 107' ' ' ALA . 1.5 pt20 -137.64 138.44 39.47 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.255 -0.903 . . . . 0.0 109.47 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 10.1 ptt85 -92.63 127.63 38.2 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.232 -0.917 . . . . 0.0 109.532 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -115.06 81.88 1.65 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.266 -0.896 . . . . 0.0 109.384 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 4.2 p . . . . . 0 N--CA 1.49 1.559 0 O-C-N 121.215 -0.928 . . . . 0.0 109.504 -179.955 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 12.7 tttt . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -103.29 130.35 10.21 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 35.2 m -144.09 154.08 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.312 -1.111 . . . . 0.0 109.459 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -125.65 125.31 42.89 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.166 -0.959 . . . . 0.0 109.54 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.5 mp -106.29 111.07 23.51 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.253 -0.904 . . . . 0.0 109.485 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.458 ' HB ' ' HB ' ' A' ' 83' ' ' ILE . 5.4 mm -98.64 117.76 44.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.233 -0.917 . . . . 0.0 109.481 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.0 m -154.82 25.89 0.44 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.207 -0.933 . . . . 0.0 109.491 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.481 ' HA3' ' HB2' ' A' ' 35' ' ' ARG . . . -119.68 28.51 6.43 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.758 ' HB ' HD21 ' A' ' 61' ' ' LEU . 17.5 t -88.28 127.83 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.224 -1.162 . . . . 0.0 109.462 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -115.95 82.71 1.82 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.262 -0.899 . . . . 0.0 109.442 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.6 mt -146.21 -172.65 3.98 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.247 -0.908 . . . . 0.0 109.465 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.464 ' HB2' ' HB2' ' A' ' 60' ' ' GLU . 2.9 m-20 -59.37 167.04 2.02 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.265 -0.897 . . . . 0.0 109.396 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -76.16 -50.58 14.2 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.251 -0.906 . . . . 0.0 109.329 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.24 -27.9 65.86 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.294 -0.879 . . . . 0.0 109.301 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.464 ' HB2' ' HB2' ' A' ' 57' ' ' ASP . 18.3 tt0 -70.47 -37.07 74.21 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.274 -0.891 . . . . 0.0 109.391 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.758 HD21 ' HB ' ' A' ' 54' ' ' VAL . 0.0 OUTLIER -66.27 -35.41 80.33 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.301 -0.874 . . . . 0.0 109.49 179.957 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.5 m -66.85 -31.05 71.41 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.294 -0.879 . . . . 0.0 109.583 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 43.8 mttt -72.5 -49.31 33.93 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.274 -0.891 . . . . 0.0 109.616 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.441 HD11 ' HE2' ' A' ' 100' ' ' LYS . 1.4 tp -55.24 -48.34 74.11 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.244 -0.91 . . . . 0.0 109.419 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.828 ' HA ' HD12 ' A' ' 68' ' ' LEU . . . -61.74 -36.13 80.1 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.309 -0.869 . . . . 0.0 109.394 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.08 -47.44 85.89 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.274 -0.891 . . . . 0.0 109.528 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -72.24 -19.77 61.65 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.215 -0.928 . . . . 0.0 109.545 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.828 HD12 ' HA ' ' A' ' 65' ' ' ALA . 7.1 mt -70.29 -63.88 1.0 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.201 -0.937 . . . . 0.0 109.12 179.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.31 -12.0 12.04 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.457 -0.777 . . . . 0.0 109.631 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.5 -50.79 62.09 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.15 -0.969 . . . . 0.0 109.369 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -111.36 31.43 6.11 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.195 -0.941 . . . . 0.0 109.724 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 42.5 t -96.7 -12.31 23.96 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.106 -0.996 . . . . 0.0 109.657 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 90.51 -32.96 4.77 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 9.9 t 179.15 112.07 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.981 -1.305 . . . . 0.0 109.537 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -91.77 -150.15 25.1 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 110.034 -1.227 . . . . 0.0 110.034 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -157.94 -83.3 0.04 OUTLIER Glycine 0 N--CA 1.493 2.456 0 O-C-N 121.228 -1.16 . . . . 0.0 110.257 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -113.9 118.0 32.96 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.06 -1.259 . . . . 0.0 109.851 -179.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 97.7 t -109.69 120.35 60.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.256 -0.903 . . . . 0.0 109.731 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.6 mtmt -154.16 149.96 27.61 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.299 -0.876 . . . . 0.0 109.239 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -70.58 97.03 1.26 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.156 -0.965 . . . . 0.0 109.523 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.501 ' O ' HG23 ' A' ' 82' ' ' VAL . . . 125.52 -11.42 7.54 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.501 HG23 ' O ' ' A' ' 81' ' ' GLY . 57.3 t -156.88 108.33 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.055 -1.262 . . . . 0.0 109.413 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.458 ' HB ' ' HB ' ' A' ' 51' ' ' ILE . 4.1 mt -118.74 104.85 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.208 -0.932 . . . . 0.0 109.52 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -92.92 112.28 24.18 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.295 -0.878 . . . . 0.0 109.615 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 49.5 mm -99.07 89.95 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.229 -0.919 . . . . 0.0 109.29 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -60.13 104.69 0.33 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.224 -0.922 . . . . 0.0 109.548 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 156.57 152.27 6.23 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -112.05 96.83 6.27 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.288 -1.124 . . . . 0.0 109.515 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 16.2 mttt -141.3 48.37 1.67 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.296 -0.878 . . . . 0.0 109.5 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.947 ' HA ' HD12 ' A' ' 93' ' ' LEU . 39.2 ptt180 -49.38 -32.01 10.67 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.231 -0.918 . . . . 0.0 109.659 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.425 ' N ' ' HG3' ' A' ' 90' ' ' ARG . 67.8 t0 -62.21 -60.39 3.65 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.228 -0.92 . . . . 0.0 109.572 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.1 tp -59.25 -22.67 61.47 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.167 -0.958 . . . . 0.0 109.351 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.947 HD12 ' HA ' ' A' ' 90' ' ' ARG . 35.4 mt -69.11 -46.29 68.07 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.312 -0.868 . . . . 0.0 109.471 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 77.0 tttt -61.73 -25.76 67.64 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.196 -0.94 . . . . 0.0 109.46 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 8.7 t -76.05 -61.05 2.07 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.229 -0.919 . . . . 0.0 109.564 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.902 HD12 ' N ' ' A' ' 97' ' ' LEU . 4.2 pp -52.91 -29.72 30.13 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.246 -0.909 . . . . 0.0 109.537 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.902 ' N ' HD12 ' A' ' 96' ' ' LEU . 0.2 OUTLIER -72.34 -48.55 41.08 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.22 -0.925 . . . . 0.0 109.491 -179.955 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -68.74 -12.74 61.81 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.244 -0.91 . . . . 0.0 109.465 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -61.97 -33.11 73.7 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.226 -0.921 . . . . 0.0 109.469 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.441 ' HE2' HD11 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -85.73 -22.04 27.97 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.22 -0.925 . . . . 0.0 109.491 179.986 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 77.89 24.6 64.1 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -99.09 -158.88 0.7 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.255 -1.144 . . . . 0.0 109.479 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 23.3 mttt -104.06 165.06 11.29 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.206 -0.934 . . . . 0.0 109.492 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.418 HG22 ' N ' ' A' ' 105' ' ' LYS . 11.4 p -145.03 158.25 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.24 -0.912 . . . . 0.0 109.458 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.422 ' O ' ' N ' ' A' ' 107' ' ' ALA . 33.9 tttt -119.61 68.47 0.82 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.262 -0.899 . . . . 0.0 109.471 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -50.39 96.61 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.212 -0.93 . . . . 0.0 109.478 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.923 ' HB3' ' HB3' ' A' ' 37' ' ' GLN . . . . . . . . 0 N--CA 1.49 1.568 0 O-C-N 121.325 -0.86 . . . . 0.0 109.509 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 125.61 59.67 0.16 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.474 HG22 ' HB2' ' A' ' 103' ' ' LYS . 73.3 t -108.89 111.29 35.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.263 -1.139 . . . . 0.0 109.423 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.913 HG13 HG22 ' A' ' 54' ' ' VAL . 39.8 t -87.65 145.13 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.275 -0.891 . . . . 0.0 109.522 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 31.9 ttm180 -111.55 103.53 11.86 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.228 -0.92 . . . . 0.0 109.437 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.976 HD11 HD23 ' A' ' 97' ' ' LEU . 4.7 mt -102.07 106.22 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.196 -0.94 . . . . 0.0 109.538 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.872 ' HB3' ' HB3' ' A' ' 107' ' ' ALA . 1.7 pp0? -142.66 136.58 29.22 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.227 -0.921 . . . . 0.0 109.412 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.65 167.03 11.37 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.235 -0.915 . . . . 0.0 109.501 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -150.17 154.29 37.75 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.243 -0.91 . . . . 0.0 109.467 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.555 0 O-C-N 121.298 -0.876 . . . . 0.0 109.468 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 90.7 mttt . . . . . 0 N--CA 1.489 1.513 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.62 85.85 0.65 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 27.7 m -123.69 168.33 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.242 -1.152 . . . . 0.0 109.452 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 2.1 t -140.72 132.51 27.43 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.223 -0.923 . . . . 0.0 109.429 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.668 ' O ' HD13 ' A' ' 51' ' ' ILE . 0.2 OUTLIER -124.09 154.56 39.78 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.265 -0.897 . . . . 0.0 109.449 -179.979 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.697 ' HB ' HD12 ' A' ' 83' ' ' ILE . 4.5 mm -122.15 117.83 53.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.246 -0.909 . . . . 0.0 109.463 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.1 m -141.84 14.01 2.1 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.261 -0.9 . . . . 0.0 109.525 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.442 ' O ' ' N ' ' A' ' 55' ' ' ASP . . . -105.5 -16.69 15.27 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.913 HG22 HG13 ' A' ' 34' ' ' VAL . 18.6 t -44.93 98.9 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.214 -1.168 . . . . 0.0 109.494 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.442 ' N ' ' O ' ' A' ' 53' ' ' GLY . 41.0 t0 -87.34 88.28 7.64 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.201 -0.937 . . . . 0.0 109.459 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.495 ' HA ' HD23 ' A' ' 56' ' ' LEU . 12.9 mt -151.42 -169.95 3.52 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.281 -0.887 . . . . 0.0 109.487 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -74.76 178.49 5.43 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.259 -0.901 . . . . 0.0 109.441 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.53 -30.31 46.95 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.286 -0.884 . . . . 0.0 109.444 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -75.79 -48.66 20.77 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.213 -0.929 . . . . 0.0 109.464 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -62.06 -32.16 72.66 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.276 -0.89 . . . . 0.0 109.466 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.525 HD23 ' HA2' ' A' ' 81' ' ' GLY . 0.2 OUTLIER -65.36 -45.83 82.55 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.225 -0.922 . . . . 0.0 109.435 -179.994 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 51.5 p -63.78 -33.88 76.65 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.218 -0.926 . . . . 0.0 109.47 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 32.6 mttp -65.65 -46.73 78.06 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.29 -0.882 . . . . 0.0 109.469 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.29 -57.65 12.08 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.339 -0.851 . . . . 0.0 109.527 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.789 ' HA ' HD12 ' A' ' 68' ' ' LEU . . . -58.55 -23.63 58.87 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.273 -0.892 . . . . 0.0 109.534 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -69.72 -41.49 75.26 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.241 -0.912 . . . . 0.0 109.582 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -76.99 -29.21 55.4 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.203 -0.936 . . . . 0.0 109.566 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.789 HD12 ' HA ' ' A' ' 65' ' ' ALA . 9.8 mt -67.7 -52.22 40.32 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.242 -0.911 . . . . 0.0 109.47 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.414 ' HB3' ' HA3' ' A' ' 76' ' ' GLY . 0.0 OUTLIER -66.46 -12.55 57.85 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.295 -0.878 . . . . 0.0 109.504 -179.929 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -74.97 -42.11 58.26 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.197 -0.939 . . . . 0.0 109.507 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 5.7 tttp -67.1 -19.86 65.7 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.304 -0.873 . . . . 0.0 109.654 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 43.7 t -88.14 -43.52 11.59 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.193 -0.942 . . . . 0.0 109.552 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.403 ' O ' ' HB2' ' A' ' 74' ' ' CYS . . . 100.62 -19.87 50.63 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.403 ' HB2' ' O ' ' A' ' 73' ' ' GLY . 0.1 OUTLIER 172.08 134.97 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.169 -1.195 . . . . 0.0 109.532 -179.981 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 126.73 -34.45 3.15 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.414 ' HA3' ' HB3' ' A' ' 69' ' ' LYS . . . -69.31 98.76 0.59 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -108.9 134.52 51.46 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.305 -1.114 . . . . 0.0 109.17 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.455 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 26.8 m -101.02 160.49 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.269 -0.894 . . . . 0.0 109.817 -179.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.443 ' HB2' ' O ' ' A' ' 82' ' ' VAL . 0.2 OUTLIER -142.05 65.82 1.36 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.362 -0.836 . . . . 0.0 109.208 179.747 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 25.4 t70 50.76 68.7 0.73 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.362 -0.836 . . . . 0.0 109.545 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.525 ' HA2' HD23 ' A' ' 61' ' ' LEU . . . 90.3 -28.57 7.32 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.443 ' O ' ' HB2' ' A' ' 79' ' ' LYS . 40.2 t -91.59 90.74 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.161 -1.199 . . . . 0.0 109.559 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.697 HD12 ' HB ' ' A' ' 51' ' ' ILE . 11.7 mt -82.04 155.86 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.276 -0.89 . . . . 0.0 109.437 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -149.56 113.33 5.07 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.2 -0.937 . . . . 0.0 109.436 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.403 HG12 ' HA2' ' A' ' 76' ' ' GLY . 23.8 mt -130.9 107.62 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.215 -0.928 . . . . 0.0 109.511 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -53.74 148.52 9.84 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.235 -0.916 . . . . 0.0 109.397 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 143.55 152.84 5.73 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -133.91 84.14 2.1 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.252 -1.146 . . . . 0.0 109.429 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 84.7 mttt -148.21 52.22 1.02 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.282 -0.886 . . . . 0.0 109.478 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 11.8 ptt-85 -46.58 -31.95 3.13 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.25 -0.906 . . . . 0.0 109.472 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -55.78 -55.21 35.03 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.236 -0.915 . . . . 0.0 109.465 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.556 ' C ' HD23 ' A' ' 92' ' ' LEU . 8.2 tt -63.16 -49.32 74.77 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.176 -0.952 . . . . 0.0 109.491 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.649 ' HB3' HG21 ' A' ' 36' ' ' ILE . 3.7 mm? -47.87 -31.04 4.61 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.229 -0.919 . . . . 0.0 109.481 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 34.4 tttt -60.63 -62.77 1.62 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.241 -0.912 . . . . 0.0 109.53 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.57 -16.83 58.28 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.247 -0.908 . . . . 0.0 109.495 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.587 ' C ' HD23 ' A' ' 96' ' ' LEU . 5.4 tt -72.62 -43.92 62.64 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.287 -0.883 . . . . 0.0 109.513 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.976 HD23 HD11 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -74.1 -38.41 63.86 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.287 -0.883 . . . . 0.0 109.484 179.959 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -69.73 -20.9 63.51 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.281 -0.887 . . . . 0.0 109.475 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -55.62 -29.93 60.03 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.262 -0.899 . . . . 0.0 109.497 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.43 -25.37 21.54 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.281 -0.887 . . . . 0.0 109.492 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 95.26 28.44 9.81 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 31.4 mtm -109.5 179.93 4.0 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.226 -1.161 . . . . 0.0 109.471 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.474 ' HB2' HG22 ' A' ' 33' ' ' VAL . 8.7 mmtt -88.85 162.16 16.31 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.259 -0.901 . . . . 0.0 109.456 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.463 ' CG2' HD12 ' A' ' 36' ' ' ILE . 3.2 p -154.39 135.79 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.218 -0.926 . . . . 0.0 109.464 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 12.5 mttt -108.56 104.41 13.72 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.253 -0.904 . . . . 0.0 109.464 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.442 ' O ' ' HB3' ' A' ' 37' ' ' GLN . 1.1 tp -47.86 -24.45 1.01 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.25 -0.906 . . . . 0.0 109.453 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.872 ' HB3' ' HB3' ' A' ' 37' ' ' GLN . . . . . . . . 0 N--CA 1.489 1.511 0 O-C-N 121.215 -0.928 . . . . 0.0 109.475 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 19.0 t70 . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.429 ' HA3' ' SD ' ' A' ' 102' ' ' MET . . . 112.61 125.9 4.53 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.624 HG13 ' O ' ' A' ' 103' ' ' LYS . 93.7 t -143.16 93.95 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.252 -1.146 . . . . 0.0 109.478 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.933 ' O ' HG23 ' A' ' 104' ' ' VAL . 70.5 t -93.23 109.46 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.289 -0.882 . . . . 0.0 109.454 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.522 ' O ' HG23 ' A' ' 51' ' ' ILE . 71.9 mtt180 -92.34 131.8 37.24 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.24 -0.913 . . . . 0.0 109.545 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.744 HG21 HD22 ' A' ' 93' ' ' LEU . 7.0 mt -125.55 127.22 71.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.219 -0.926 . . . . 0.0 109.421 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.673 ' HA ' ' HB2' ' A' ' 107' ' ' ALA . 1.7 pt20 -151.03 -167.89 2.94 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.176 -0.953 . . . . 0.0 109.526 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.419 ' HG3' ' O ' ' A' ' 38' ' ' ARG . 5.4 ptt180 -137.11 118.8 14.99 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.229 -0.919 . . . . 0.0 109.504 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.513 ' OE1' HD13 ' A' ' 50' ' ' LEU . 8.6 tt0 -91.36 118.63 30.69 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.183 -0.948 . . . . 0.0 109.442 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 29.0 p . . . . . 0 N--CA 1.49 1.533 0 O-C-N 121.263 -0.898 . . . . 0.0 109.428 179.922 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 51.9 mttt . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -141.93 -163.93 9.83 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.586 -1.405 . . . . 0.0 109.586 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 22.9 m -154.58 146.11 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.269 -1.136 . . . . 0.0 109.521 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -90.04 131.27 36.01 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.288 -0.883 . . . . 0.0 109.435 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.513 HD13 ' OE1' ' A' ' 39' ' ' GLN . 0.0 OUTLIER -118.1 115.86 25.68 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.255 -0.903 . . . . 0.0 109.46 -179.917 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.522 HG23 ' O ' ' A' ' 35' ' ' ARG . 8.1 mt -120.37 110.5 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.212 -0.93 . . . . 0.0 109.458 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 9.8 t -142.95 162.89 34.27 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.238 -0.914 . . . . 0.0 109.637 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.49 22.24 13.09 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.611 -1.395 . . . . 0.0 109.611 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.577 ' HB ' HD21 ' A' ' 61' ' ' LEU . 61.7 t -78.41 112.71 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.22 -1.165 . . . . 0.0 109.443 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -97.15 70.48 2.37 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.294 -0.879 . . . . 0.0 109.541 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.549 HD22 ' OE2' ' A' ' 60' ' ' GLU . 10.3 mt -136.87 172.7 12.62 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.167 -0.958 . . . . 0.0 109.524 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -47.75 170.71 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.218 -0.926 . . . . 0.0 109.45 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -76.55 -39.8 51.73 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.232 -0.917 . . . . 0.0 109.468 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.09 -31.01 72.04 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.243 -0.91 . . . . 0.0 109.496 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.549 ' OE2' HD22 ' A' ' 56' ' ' LEU . 2.9 mt-10 -62.03 -45.92 91.47 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.269 -0.894 . . . . 0.0 109.543 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.577 HD21 ' HB ' ' A' ' 54' ' ' VAL . 8.4 mt -53.04 -42.69 65.98 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.249 -0.907 . . . . 0.0 109.472 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 52.2 m -71.9 -26.28 62.26 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.264 -0.898 . . . . 0.0 109.425 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.2 tttt -63.49 -59.91 4.04 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.256 -0.902 . . . . 0.0 109.393 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.9 mt -64.7 -31.55 72.82 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.281 -0.887 . . . . 0.0 109.538 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.506 ' HB1' ' CG2' ' A' ' 78' ' ' VAL . . . -57.5 -49.63 75.68 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.272 -0.892 . . . . 0.0 109.662 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -71.81 -28.04 63.33 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.244 -0.91 . . . . 0.0 109.628 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -64.45 -33.08 75.05 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.219 -0.926 . . . . 0.0 109.907 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 6.0 mt -88.04 -34.52 17.96 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.102 -0.999 . . . . 0.0 109.921 -179.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.8 mttt -63.24 -16.9 61.66 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.139 -0.975 . . . . 0.0 109.778 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 13.5 tttt -75.28 -28.15 59.67 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.18 -0.95 . . . . 0.0 109.707 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 7.2 mtpp -72.42 -67.84 0.52 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.169 -0.957 . . . . 0.0 109.243 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -64.63 -56.72 12.03 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.19 -0.944 . . . . 0.0 109.195 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.482 ' O ' ' HB2' ' A' ' 74' ' ' CYS . . . 84.31 12.88 75.07 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.482 ' HB2' ' O ' ' A' ' 73' ' ' GLY . 4.7 t 166.46 126.73 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.478 -1.013 . . . . 0.0 108.994 -179.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 113.86 -5.95 24.02 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -110.08 125.63 7.61 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.194 -1.563 . . . . 0.0 109.194 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -110.15 121.41 45.21 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.169 -1.194 . . . . 0.0 109.939 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.506 ' CG2' ' HB1' ' A' ' 65' ' ' ALA . 36.9 t -86.92 124.34 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.276 -0.89 . . . . 0.0 109.122 179.534 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -120.41 145.7 46.94 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.209 -0.932 . . . . 0.0 109.201 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.0 101.17 1.08 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.289 -0.882 . . . . 0.0 109.493 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 103.53 -11.53 54.03 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 65.0 t -142.85 121.29 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.323 -1.104 . . . . 0.0 109.426 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 26.8 mm -104.3 121.18 55.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.226 -0.921 . . . . 0.0 109.589 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -105.68 120.33 41.41 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.315 -0.866 . . . . 0.0 109.401 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.494 HG13 HD12 ' A' ' 51' ' ' ILE . 14.8 mm -117.6 164.4 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.176 -0.952 . . . . 0.0 109.517 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.478 ' N ' HG22 ' A' ' 85' ' ' ILE . 5.4 mt-30 -124.69 132.89 53.36 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.311 -0.868 . . . . 0.0 109.583 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 136.87 168.31 11.37 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -135.62 82.11 1.93 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.29 -1.124 . . . . 0.0 109.559 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 43.7 mttt -142.88 51.68 1.41 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.217 -0.927 . . . . 0.0 109.478 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.64 -25.95 0.81 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.24 -0.912 . . . . 0.0 109.447 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -64.85 -58.33 6.47 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.244 -0.91 . . . . 0.0 109.373 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.0 tt -58.13 -49.08 78.24 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.245 -0.909 . . . . 0.0 109.308 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.744 HD22 HG21 ' A' ' 36' ' ' ILE . 3.4 mt -52.1 -33.63 40.53 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.278 -0.889 . . . . 0.0 109.408 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.594 ' CG ' HD11 ' A' ' 106' ' ' LEU . 0.1 OUTLIER -60.53 -58.49 8.25 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.292 -0.88 . . . . 0.0 109.388 179.923 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 3.2 t -65.79 -11.76 48.63 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.213 -0.929 . . . . 0.0 109.447 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.609 HD23 ' N ' ' A' ' 97' ' ' LEU . 3.1 tt -74.9 -59.2 2.84 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.24 -0.913 . . . . 0.0 109.423 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.683 HD23 HD11 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -69.56 -23.29 63.54 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.286 -0.883 . . . . 0.0 109.49 179.975 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -73.39 -26.46 61.0 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.282 -0.886 . . . . 0.0 109.516 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -71.03 -22.26 62.17 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.252 -0.905 . . . . 0.0 109.489 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 4.0 mtmt -94.29 8.0 43.37 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.231 -0.918 . . . . 0.0 109.508 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 46.32 33.29 5.65 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' MET . . . . . 0.519 ' HB2' ' CD1' ' A' ' 97' ' ' LEU . 0.1 OUTLIER -86.93 -173.43 4.46 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.268 -1.137 . . . . 0.0 109.471 -179.993 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.624 ' O ' HG13 ' A' ' 33' ' ' VAL . 16.8 mttt -101.16 72.06 1.43 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.262 -0.899 . . . . 0.0 109.459 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.933 HG23 ' O ' ' A' ' 34' ' ' VAL . 8.3 p -88.68 145.69 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.232 -0.918 . . . . 0.0 109.532 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.403 ' O ' ' C ' ' A' ' 106' ' ' LEU . 21.5 tttt -110.79 30.27 7.0 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.277 -0.889 . . . . 0.0 109.446 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.594 HD11 ' CG ' ' A' ' 94' ' ' LYS . 3.5 tp 44.6 -154.28 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.251 -0.905 . . . . 0.0 109.487 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.673 ' HB2' ' HA ' ' A' ' 37' ' ' GLN . . . . . . . . 0 N--CA 1.49 1.545 0 O-C-N 121.221 -0.924 . . . . 0.0 109.463 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 16.1 t0 . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 121.252 0.549 . . . . 0.0 109.531 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -160.33 148.1 15.95 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.504 HG12 ' HB2' ' A' ' 103' ' ' LYS . 34.8 m -131.68 145.41 35.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.271 -1.135 . . . . 0.0 109.491 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.576 HG11 HD21 ' A' ' 97' ' ' LEU . 5.4 t -111.28 164.71 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.23 -0.919 . . . . 0.0 109.442 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.424 ' N ' HG12 ' A' ' 34' ' ' VAL . 0.1 OUTLIER -141.57 112.24 7.14 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.237 -0.915 . . . . 0.0 109.444 -179.985 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.715 HG21 HD13 ' A' ' 93' ' ' LEU . 4.5 mt -125.78 117.1 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.259 -0.901 . . . . 0.0 109.483 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.71 98.16 2.93 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.303 -0.873 . . . . 0.0 109.449 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.2 ptt180 -56.38 125.68 23.04 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.284 -0.885 . . . . 0.0 109.515 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -110.78 79.14 1.17 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.208 -0.932 . . . . 0.0 109.494 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 33.7 p . . . . . 0 N--CA 1.49 1.552 0 O-C-N 121.209 -0.932 . . . . 0.0 109.476 -179.96 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 10.8 tttt . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -144.75 152.58 24.54 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 34.5 m -106.01 167.88 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.233 -1.157 . . . . 0.0 109.428 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -128.88 113.1 14.83 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.187 -0.946 . . . . 0.0 109.477 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.783 ' O ' HD13 ' A' ' 51' ' ' ILE . 0.8 OUTLIER -89.04 143.78 26.61 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.198 -0.939 . . . . 0.0 109.528 179.955 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.783 HD13 ' O ' ' A' ' 50' ' ' LEU . 6.4 mm -127.33 108.32 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.207 -0.933 . . . . 0.0 109.414 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.403 ' HB ' HG12 ' A' ' 82' ' ' VAL . 0.0 OUTLIER -155.14 154.58 32.55 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.274 -0.891 . . . . 0.0 109.494 179.995 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 115.5 -28.72 7.67 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.452 HG12 HD23 ' A' ' 56' ' ' LEU . 24.2 t -45.76 109.84 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.311 -1.111 . . . . 0.0 109.457 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -90.73 75.89 6.49 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.284 -0.885 . . . . 0.0 109.466 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.486 HD13 ' HA ' ' A' ' 56' ' ' LEU . 1.4 mm? -114.12 -171.5 1.92 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.259 -0.9 . . . . 0.0 109.485 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -72.5 -69.72 0.39 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.258 -0.901 . . . . 0.0 109.473 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -178.93 -43.03 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.256 -0.903 . . . . 0.0 109.465 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.92 -30.58 56.18 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.247 -0.908 . . . . 0.0 109.525 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -59.1 -45.48 90.75 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.223 -0.923 . . . . 0.0 109.523 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.566 HD23 HD11 ' A' ' 83' ' ' ILE . 0.1 OUTLIER -50.89 -52.8 38.35 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.238 -0.914 . . . . 0.0 109.42 179.988 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 34.0 p -57.57 -40.66 79.46 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.304 -0.872 . . . . 0.0 109.405 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 7.7 tttt -54.57 -45.04 73.44 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.3 -0.875 . . . . 0.0 109.536 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.472 ' HA ' HD22 ' A' ' 64' ' ' LEU . 0.1 OUTLIER -64.0 -46.01 86.44 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.24 -0.912 . . . . 0.0 109.509 -179.945 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -49.72 -43.83 47.9 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.199 -0.938 . . . . 0.0 109.548 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -69.37 -35.96 76.35 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.272 -0.892 . . . . 0.0 109.577 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -65.44 -21.61 66.67 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.211 -0.931 . . . . 0.0 109.627 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 5.4 mt -87.25 -44.4 11.47 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.305 -0.872 . . . . 0.0 109.673 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.446 ' O ' ' HG2' ' A' ' 69' ' ' LYS . 10.0 tttt -64.59 -22.7 67.04 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.259 -0.901 . . . . 0.0 109.801 -179.686 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.24 -15.52 47.58 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.178 -0.951 . . . . 0.0 110.004 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.8 23.87 1.09 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.057 -1.027 . . . . 0.0 109.656 -179.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -105.39 -24.56 12.63 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.303 -0.873 . . . . 0.0 109.551 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.43 ' O ' ' SG ' ' A' ' 74' ' ' CYS . . . 94.03 -10.74 71.65 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 -179.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.43 ' SG ' ' O ' ' A' ' 73' ' ' GLY . 0.7 OUTLIER 174.07 134.86 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.325 -1.103 . . . . 0.0 109.281 179.983 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -72.66 -80.49 0.41 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 120.66 -109.34 1.54 Allowed Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -106.0 131.39 53.35 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.153 -1.204 . . . . 0.0 109.417 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 90.4 t -136.33 97.37 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.23 -0.919 . . . . 0.0 109.83 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.2 146.71 27.59 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.194 -0.941 . . . . 0.0 108.761 179.321 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -63.27 94.43 0.08 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.112 -0.992 . . . . 0.0 109.609 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 129.88 -25.95 4.33 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.433 ' O ' HG13 ' A' ' 83' ' ' ILE . 1.6 m -143.59 157.79 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.182 -1.187 . . . . 0.0 109.673 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.566 HD11 HD23 ' A' ' 61' ' ' LEU . 4.2 mp -143.71 146.74 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.223 -0.923 . . . . 0.0 109.467 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -130.28 125.96 36.08 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.238 -0.914 . . . . 0.0 109.423 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.432 HG22 ' N ' ' A' ' 86' ' ' GLN . 28.1 mm -114.69 157.18 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.215 -0.928 . . . . 0.0 109.5 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.432 ' N ' HG22 ' A' ' 85' ' ' ILE . 0.0 OUTLIER -115.9 86.02 2.4 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.206 -0.934 . . . . 0.0 109.469 -179.963 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -164.48 166.85 38.07 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -119.38 49.22 1.38 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.246 -1.149 . . . . 0.0 109.482 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 31.4 mttt -105.52 37.0 2.32 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.211 -0.931 . . . . 0.0 109.459 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.413 ' HA ' HD12 ' A' ' 93' ' ' LEU . 7.3 ttt180 -46.81 -36.85 7.83 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.26 -0.9 . . . . 0.0 109.474 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -58.03 -53.66 55.75 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.242 -0.912 . . . . 0.0 109.547 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.11 -17.8 64.94 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.231 -0.918 . . . . 0.0 109.526 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.715 HD13 HG21 ' A' ' 36' ' ' ILE . 2.1 mt -72.56 -44.85 61.53 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.302 -0.874 . . . . 0.0 109.494 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 61.6 tttt -65.96 -32.98 74.78 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.224 -0.923 . . . . 0.0 109.477 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 14.3 t -67.54 -62.69 1.3 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.25 -0.906 . . . . 0.0 109.448 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.939 HD12 ' N ' ' A' ' 97' ' ' LEU . 4.2 pp -51.64 -31.61 26.1 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.195 -0.941 . . . . 0.0 109.471 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.939 ' N ' HD12 ' A' ' 96' ' ' LEU . 0.2 OUTLIER -65.14 -47.01 78.6 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.223 -0.923 . . . . 0.0 109.494 179.968 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 72.4 tt0 -69.19 -14.26 62.88 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.298 -0.876 . . . . 0.0 109.455 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -73.42 -13.93 61.17 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.212 -0.93 . . . . 0.0 109.434 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.35 -31.28 11.4 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.262 -0.899 . . . . 0.0 109.441 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 100.68 15.8 28.25 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 1.5 mtm -88.2 156.12 19.4 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.192 -1.181 . . . . 0.0 109.49 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.504 ' HB2' HG12 ' A' ' 33' ' ' VAL . 27.2 mttt -86.17 97.61 10.44 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.285 -0.885 . . . . 0.0 109.468 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 12.5 p -81.43 140.66 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.226 -0.921 . . . . 0.0 109.46 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.47 ' O ' ' N ' ' A' ' 107' ' ' ALA . 0.7 OUTLIER -111.41 77.41 1.04 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.224 -0.923 . . . . 0.0 109.469 -179.994 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.5 mp -46.54 96.44 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.185 -0.947 . . . . 0.0 109.471 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.47 ' N ' ' O ' ' A' ' 105' ' ' LYS . . . . . . . . 0 N--CA 1.49 1.552 0 O-C-N 121.265 -0.897 . . . . 0.0 109.488 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 23.0 t0 . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.425 ' O ' ' HB2' ' A' ' 103' ' ' LYS . . . -138.64 123.45 2.61 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.403 HG22 ' CB ' ' A' ' 103' ' ' LYS . 73.2 t -146.91 104.5 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.242 -1.152 . . . . 0.0 109.454 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.745 HG13 ' CG2' ' A' ' 54' ' ' VAL . 21.4 t -92.88 151.09 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.253 -0.904 . . . . 0.0 109.432 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 2.0 ttt180 -121.82 112.4 18.3 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.25 -0.906 . . . . 0.0 109.487 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.785 HG21 ' HB3' ' A' ' 93' ' ' LEU . 2.2 mp -123.44 114.54 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.266 -0.896 . . . . 0.0 109.406 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.5 ' CD ' ' HB3' ' A' ' 107' ' ' ALA . 7.0 pt20 -150.59 -162.13 1.49 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.212 -0.93 . . . . 0.0 109.446 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 30.8 mtm180 -123.77 139.19 54.22 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.233 -0.917 . . . . 0.0 109.452 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.694 ' HB2' HD13 ' A' ' 50' ' ' LEU . 13.5 tt0 -116.05 60.17 0.72 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.247 -0.908 . . . . 0.0 109.472 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.6 p . . . . . 0 N--CA 1.491 1.589 0 O-C-N 121.261 -0.9 . . . . 0.0 109.438 -179.965 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 19.6 mttt . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 121.265 0.555 . . . . 0.0 109.547 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -109.11 149.05 17.06 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.9 m -119.57 145.74 25.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.307 -1.113 . . . . 0.0 109.468 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 2.3 t -111.46 139.79 46.59 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.269 -0.894 . . . . 0.0 109.437 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.694 HD13 ' HB2' ' A' ' 39' ' ' GLN . 2.1 mp -130.35 119.91 23.51 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.246 -0.909 . . . . 0.0 109.516 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.801 ' HB ' HD12 ' A' ' 83' ' ' ILE . 3.1 mm -101.19 124.7 55.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.229 -0.919 . . . . 0.0 109.379 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -159.63 159.52 33.2 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.199 -0.938 . . . . 0.0 109.491 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.412 ' O ' ' C ' ' A' ' 54' ' ' VAL . . . 105.76 -29.06 11.93 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.745 ' CG2' HG13 ' A' ' 34' ' ' VAL . 62.5 t -45.22 117.75 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.213 -1.169 . . . . 0.0 109.421 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -111.95 72.24 0.77 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.26 -0.9 . . . . 0.0 109.511 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.503 HD11 ' SD ' ' A' ' 102' ' ' MET . 2.7 mt -126.04 -170.31 2.17 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.216 -0.928 . . . . 0.0 109.456 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -56.03 147.77 19.19 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.242 -0.911 . . . . 0.0 109.475 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.94 -33.49 73.25 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.274 -0.891 . . . . 0.0 109.518 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -77.27 -29.06 53.69 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.231 -0.918 . . . . 0.0 109.385 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -69.27 -30.51 68.64 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.303 -0.873 . . . . 0.0 109.45 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.416 HD21 ' HB ' ' A' ' 54' ' ' VAL . 1.7 mt -66.21 -58.35 5.59 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.271 -0.893 . . . . 0.0 109.496 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -57.68 -19.4 26.71 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.197 -0.939 . . . . 0.0 109.376 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 9.3 mttt -76.68 -44.33 34.16 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.309 -0.869 . . . . 0.0 109.558 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.409 HD22 ' HA ' ' A' ' 64' ' ' LEU . 0.3 OUTLIER -70.88 -29.0 64.98 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.209 -0.932 . . . . 0.0 109.508 -179.997 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.451 ' HB1' HG13 ' A' ' 78' ' ' VAL . . . -72.25 -52.38 16.67 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.245 -0.909 . . . . 0.0 109.382 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.9 -48.78 80.21 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.237 -0.915 . . . . 0.0 109.551 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -54.0 -46.27 71.72 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.196 -0.94 . . . . 0.0 109.331 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -59.5 -36.54 76.24 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.277 -0.889 . . . . 0.0 109.238 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 7.9 tmtt? -61.54 -37.96 85.68 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.333 -0.855 . . . . 0.0 109.286 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 11.3 mttt -58.05 -25.46 61.24 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.234 -0.916 . . . . 0.0 108.955 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 1.7 mtmp? -122.0 50.19 1.48 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.513 -0.742 . . . . 0.0 109.217 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 23.4 t -133.72 -63.51 0.74 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.178 -0.951 . . . . 0.0 109.686 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.482 ' O ' ' HB2' ' A' ' 74' ' ' CYS . . . 120.17 10.25 7.53 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -179.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.482 ' HB2' ' O ' ' A' ' 73' ' ' GLY . 4.6 t 168.3 127.92 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.325 -1.103 . . . . 0.0 109.193 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -94.53 101.58 2.75 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -66.99 -109.01 0.02 OUTLIER Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -111.75 121.77 46.0 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.205 -1.173 . . . . 0.0 109.302 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.451 HG13 ' HB1' ' A' ' 65' ' ' ALA . 22.9 t -116.43 78.12 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.21 -0.931 . . . . 0.0 109.808 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -88.28 145.62 25.76 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.243 -0.911 . . . . 0.0 109.201 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -65.0 91.42 0.09 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.201 -0.937 . . . . 0.0 109.507 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 129.07 -24.34 4.79 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.0 t -139.04 137.86 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.152 -1.205 . . . . 0.0 109.582 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.801 HD12 ' HB ' ' A' ' 51' ' ' ILE . 4.2 mt -132.01 135.34 58.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.353 -0.842 . . . . 0.0 109.55 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 68.1 mt-10 -132.25 116.47 16.97 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.302 -0.874 . . . . 0.0 109.207 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 56.1 mt -148.36 146.72 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.225 -0.922 . . . . 0.0 109.621 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -72.74 141.58 48.14 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.24 -0.912 . . . . 0.0 109.309 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 167.7 122.33 0.61 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -106.96 51.61 0.74 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.321 -1.105 . . . . 0.0 109.538 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 85.5 mttt -131.9 53.42 2.0 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.252 -0.905 . . . . 0.0 109.478 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 32.5 ptt180 -53.13 -27.48 21.1 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.24 -0.912 . . . . 0.0 109.358 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 48.1 t0 -65.41 -53.33 44.76 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.29 -0.881 . . . . 0.0 109.393 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.9 tt -58.71 -48.35 81.43 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.274 -0.891 . . . . 0.0 109.424 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.785 ' HB3' HG21 ' A' ' 36' ' ' ILE . 5.9 mt -53.93 -38.97 65.45 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.252 -0.905 . . . . 0.0 109.429 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.521 ' HE3' HD11 ' A' ' 106' ' ' LEU . 3.1 ttmt -68.26 -31.26 70.6 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.253 -0.904 . . . . 0.0 109.494 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 21.8 t -67.54 -64.03 0.94 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.236 -0.915 . . . . 0.0 109.471 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.796 HD12 ' N ' ' A' ' 97' ' ' LEU . 2.6 pp -50.62 -38.27 44.98 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.277 -0.889 . . . . 0.0 109.499 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.796 ' N ' HD12 ' A' ' 96' ' ' LEU . 0.2 OUTLIER -59.44 -45.13 92.46 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.218 -0.926 . . . . 0.0 109.485 179.978 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -69.68 -17.07 63.46 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.257 -0.902 . . . . 0.0 109.444 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -67.98 -27.47 66.6 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.251 -0.905 . . . . 0.0 109.459 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.494 ' HD2' ' N ' ' A' ' 100' ' ' LYS . 6.7 mptt -85.13 -16.35 40.77 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.228 -0.92 . . . . 0.0 109.442 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 88.73 23.96 34.4 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' MET . . . . . 0.503 ' SD ' HD11 ' A' ' 56' ' ' LEU . 1.2 mtm -97.77 171.17 8.49 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.265 -1.138 . . . . 0.0 109.467 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.425 ' HB2' ' O ' ' A' ' 32' ' ' GLY . 8.7 mttt -84.62 165.74 17.71 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.231 -0.918 . . . . 0.0 109.484 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.8 t -147.91 124.16 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.275 -0.891 . . . . 0.0 109.485 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 5.9 mttt -109.38 79.07 1.18 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.256 -0.903 . . . . 0.0 109.468 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.521 HD11 ' HE3' ' A' ' 94' ' ' LYS . 6.2 mt -46.18 105.53 0.06 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.297 -0.877 . . . . 0.0 109.482 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.5 ' HB3' ' CD ' ' A' ' 37' ' ' GLN . . . . . . . . 0 N--CA 1.49 1.56 0 O-C-N 121.277 -0.89 . . . . 0.0 109.466 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 149.54 130.98 1.89 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.5 p -160.03 131.26 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.265 -1.138 . . . . 0.0 109.449 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.629 HG23 ' CE ' ' A' ' 102' ' ' MET . 75.6 t -105.54 153.65 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.261 -0.899 . . . . 0.0 109.468 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.431 ' HB3' ' O ' ' A' ' 52' ' ' THR . 24.6 ttt180 -129.65 100.89 5.68 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.192 -0.942 . . . . 0.0 109.513 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.85 HG23 HG13 ' A' ' 51' ' ' ILE . 1.2 mp -102.81 125.75 57.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.232 -0.918 . . . . 0.0 109.397 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -122.63 -166.81 1.48 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.235 -0.916 . . . . 0.0 109.468 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 14.1 ptt180 -152.54 132.7 13.51 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.197 -0.939 . . . . 0.0 109.476 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -118.13 110.37 17.52 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.23 -0.919 . . . . 0.0 109.488 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 5.7 t . . . . . 0 N--CA 1.49 1.558 0 O-C-N 121.275 -0.89 . . . . 0.0 109.453 -179.962 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 12.4 ttmt . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 121.284 0.564 . . . . 0.0 109.515 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -178.35 131.26 1.71 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.2 m -131.49 147.26 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.245 -1.15 . . . . 0.0 109.528 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 1.8 m -125.01 118.34 26.0 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.269 -0.895 . . . . 0.0 109.494 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.563 ' C ' HD12 ' A' ' 51' ' ' ILE . 0.4 OUTLIER -113.1 138.93 49.19 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.218 -0.926 . . . . 0.0 109.503 -179.94 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.85 HG13 HG23 ' A' ' 36' ' ' ILE . 2.7 mp -108.37 122.62 63.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.234 -0.916 . . . . 0.0 109.394 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.431 ' O ' ' HB3' ' A' ' 35' ' ' ARG . 0.5 OUTLIER -146.25 156.53 43.45 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.287 -0.883 . . . . 0.0 109.534 -179.898 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 93.89 23.14 23.81 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.438 HG12 HD12 ' A' ' 56' ' ' LEU . 10.1 t -80.55 115.38 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.304 -1.115 . . . . 0.0 109.552 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -94.14 76.91 4.05 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.265 -0.897 . . . . 0.0 109.443 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.438 HD12 HG12 ' A' ' 54' ' ' VAL . 0.4 OUTLIER -144.9 177.75 8.51 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.263 -0.898 . . . . 0.0 109.409 179.955 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -56.97 158.35 4.97 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.216 -0.927 . . . . 0.0 109.519 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.72 -48.35 59.82 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.32 -0.862 . . . . 0.0 109.495 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.92 -33.69 70.85 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.279 -0.888 . . . . 0.0 109.411 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.421 ' O ' ' C ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -59.47 -54.05 51.05 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.232 -0.917 . . . . 0.0 109.418 179.951 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.421 ' C ' ' O ' ' A' ' 60' ' ' GLU . 0.3 OUTLIER -44.58 -42.75 7.59 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.239 -0.913 . . . . 0.0 109.196 179.844 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 60.9 m -58.54 -50.63 73.08 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.263 -0.898 . . . . 0.0 109.166 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -52.5 -30.39 29.96 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.26 -0.9 . . . . 0.0 109.137 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -68.81 -53.48 21.31 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.344 -0.847 . . . . 0.0 109.485 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -52.68 -33.76 48.88 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.242 -0.911 . . . . 0.0 109.308 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -71.98 -41.88 67.16 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.278 -0.889 . . . . 0.0 109.284 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -65.11 -19.79 66.15 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.22 -0.925 . . . . 0.0 109.357 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.463 HD13 ' HA ' ' A' ' 68' ' ' LEU . 3.3 mm? -84.02 -57.3 3.25 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.229 -0.919 . . . . 0.0 109.447 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 6.2 mttt -60.11 -22.75 63.19 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.281 -0.887 . . . . 0.0 109.412 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.8 -42.67 47.44 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.262 -0.899 . . . . 0.0 109.496 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 2.1 ptmt -129.14 70.17 1.41 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.271 -0.893 . . . . 0.0 109.332 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -144.33 -42.7 0.26 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.311 -0.868 . . . . 0.0 109.424 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.474 ' O ' ' HB2' ' A' ' 74' ' ' CYS . . . 119.49 -62.09 0.48 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.474 ' HB2' ' O ' ' A' ' 73' ' ' GLY . 17.0 t 172.31 107.49 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.344 -1.092 . . . . 0.0 109.323 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 160.38 50.77 0.01 OUTLIER Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -117.97 116.92 3.58 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.501 ' HB3' ' HB3' ' A' ' 84' ' ' GLU . . . -104.05 110.25 22.35 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.337 -1.096 . . . . 0.0 109.004 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.2 t -85.16 84.22 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.214 -0.929 . . . . 0.0 109.814 -179.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.476 ' HB3' ' HB ' ' A' ' 82' ' ' VAL . 20.3 mmtt -90.9 169.18 11.13 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.287 -0.883 . . . . 0.0 108.955 179.505 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -60.63 112.75 2.12 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.113 -0.992 . . . . 0.0 109.578 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 51.99 27.78 22.92 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.494 ' O ' HG12 ' A' ' 82' ' ' VAL . 43.4 t -141.65 88.19 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.152 -1.205 . . . . 0.0 109.536 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.494 ' N ' HD13 ' A' ' 83' ' ' ILE . 4.7 mm -83.53 102.12 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.246 -0.908 . . . . 0.0 109.306 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.501 ' HB3' ' HB3' ' A' ' 77' ' ' ALA . 0.5 OUTLIER -82.92 126.66 32.73 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.284 -0.885 . . . . 0.0 109.73 -179.845 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 18.6 mm -133.96 110.62 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.265 -0.897 . . . . 0.0 109.406 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -72.77 128.95 37.06 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.263 -0.898 . . . . 0.0 109.573 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 145.04 136.56 3.03 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -95.89 89.56 5.29 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.251 -1.147 . . . . 0.0 109.445 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 3.1 mttt -144.55 53.23 1.25 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.205 -0.934 . . . . 0.0 109.5 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.842 ' HA ' HD12 ' A' ' 93' ' ' LEU . 51.2 ttt180 -64.02 -40.73 96.98 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.251 -0.906 . . . . 0.0 109.483 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -53.82 -44.06 69.92 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.211 -0.931 . . . . 0.0 109.46 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 3.6 tt -75.11 -26.63 59.4 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.267 -0.896 . . . . 0.0 109.532 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.842 HD12 ' HA ' ' A' ' 90' ' ' ARG . 22.8 mt -61.63 -42.86 99.47 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.263 -0.898 . . . . 0.0 109.474 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 17.3 tttt -67.03 -26.74 66.92 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.24 -0.913 . . . . 0.0 109.592 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 1.2 t -70.72 -62.34 1.43 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.224 -0.922 . . . . 0.0 109.534 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.865 HD12 ' N ' ' A' ' 97' ' ' LEU . 4.6 pp -54.93 -31.43 60.3 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.228 -0.92 . . . . 0.0 109.534 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.865 ' N ' HD12 ' A' ' 96' ' ' LEU . 0.2 OUTLIER -67.64 -47.4 69.69 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.183 -0.948 . . . . 0.0 109.559 -179.917 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.53 -15.36 63.23 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.223 -0.923 . . . . 0.0 109.589 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -69.79 -12.75 61.87 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.222 -0.924 . . . . 0.0 109.464 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.19 -37.49 20.07 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.246 -0.908 . . . . 0.0 109.497 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 101.45 22.96 9.89 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' MET . . . . . 0.629 ' CE ' HG23 ' A' ' 34' ' ' VAL . 0.3 OUTLIER -119.6 -172.89 2.41 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.198 -1.177 . . . . 0.0 109.466 -179.996 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 6.6 tttt -86.54 162.01 18.26 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.252 -0.905 . . . . 0.0 109.484 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.582 ' HB ' HD12 ' A' ' 97' ' ' LEU . 12.7 p -152.32 153.47 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.262 -0.899 . . . . 0.0 109.429 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 6.0 mttt -131.64 90.12 2.8 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.212 -0.93 . . . . 0.0 109.494 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.68 ' O ' ' HB3' ' A' ' 107' ' ' ALA . 4.6 mm? -54.85 -30.13 56.93 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.259 -0.901 . . . . 0.0 109.476 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.68 ' HB3' ' O ' ' A' ' 106' ' ' LEU . . . . . . . . 0 N--CA 1.49 1.555 0 O-C-N 121.265 -0.897 . . . . 0.0 109.433 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 27.4 t0 . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 171.72 120.36 0.55 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.595 ' O ' HG23 ' A' ' 33' ' ' VAL . 35.5 m -132.17 115.48 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.307 -1.114 . . . . 0.0 109.463 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.729 HG22 HG22 ' A' ' 54' ' ' VAL . 97.0 t -80.62 159.84 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.273 -0.892 . . . . 0.0 109.513 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.484 ' N ' HG12 ' A' ' 34' ' ' VAL . 4.5 mtp180 -145.59 127.76 15.7 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.282 -0.887 . . . . 0.0 109.441 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.833 HG21 HD13 ' A' ' 93' ' ' LEU . 2.7 mp -132.48 109.18 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.274 -0.891 . . . . 0.0 109.497 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.878 ' HB3' ' HB3' ' A' ' 107' ' ' ALA . 2.6 pt20 -140.02 157.39 45.74 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.294 -0.879 . . . . 0.0 109.467 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.44 ' HG2' ' HD3' ' A' ' 90' ' ' ARG . 7.8 ptt180 -96.15 135.96 37.24 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.249 -0.907 . . . . 0.0 109.433 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -108.39 95.41 5.65 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.26 -0.9 . . . . 0.0 109.458 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.565 0 O-C-N 121.226 -0.921 . . . . 0.0 109.461 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 21.8 mttt . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -95.03 177.13 35.09 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.7 m -151.46 154.36 8.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.258 -1.142 . . . . 0.0 109.477 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 6.9 t -119.34 110.64 17.21 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.261 -0.9 . . . . 0.0 109.493 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -97.12 131.7 43.63 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.29 -0.881 . . . . 0.0 109.411 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 63.6 mt -125.36 114.95 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.229 -0.919 . . . . 0.0 109.533 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -151.84 170.35 20.02 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.252 -0.905 . . . . 0.0 109.435 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.19 -15.91 58.66 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.729 HG22 HG22 ' A' ' 34' ' ' VAL . 53.4 t -56.92 108.47 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.269 -1.136 . . . . 0.0 109.474 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.468 ' O ' HD22 ' A' ' 56' ' ' LEU . 18.3 t0 -86.16 78.16 9.43 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.296 -0.878 . . . . 0.0 109.471 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.468 HD22 ' O ' ' A' ' 55' ' ' ASP . 0.2 OUTLIER -134.53 159.03 42.42 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.247 -0.908 . . . . 0.0 109.46 179.986 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.448 ' O ' ' O ' ' A' ' 58' ' ' ASP . 0.2 OUTLIER -76.61 157.02 32.27 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.203 -0.936 . . . . 0.0 109.501 179.963 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.709 ' O ' ' HB3' ' A' ' 59' ' ' ALA . 0.2 OUTLIER -50.73 -179.48 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.298 -0.876 . . . . 0.0 109.523 -179.963 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.709 ' HB3' ' O ' ' A' ' 58' ' ' ASP . . . 76.98 -78.9 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.313 -0.867 . . . . 0.0 109.501 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -55.1 -36.77 66.03 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.236 -0.915 . . . . 0.0 109.543 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -58.76 -48.29 81.73 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.181 -0.95 . . . . 0.0 109.478 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -61.85 -28.11 69.26 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.211 -0.931 . . . . 0.0 109.463 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -68.67 -51.54 40.79 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.276 -0.89 . . . . 0.0 109.388 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.59 -33.59 72.95 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.218 -0.926 . . . . 0.0 109.309 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -64.17 -52.1 60.6 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.262 -0.899 . . . . 0.0 109.371 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.67 -22.31 66.95 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.238 -0.914 . . . . 0.0 109.322 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.99 -55.19 13.58 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.256 -0.902 . . . . 0.0 109.425 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.3 mp -69.36 -22.47 63.74 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.186 -0.946 . . . . 0.0 109.415 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.93 -37.38 72.87 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.275 -0.891 . . . . 0.0 109.504 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 19.7 tttt -68.82 -12.85 61.97 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.248 -0.907 . . . . 0.0 109.414 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 20.3 mttm -75.47 -22.47 57.22 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.318 -0.864 . . . . 0.0 109.818 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -103.66 -34.39 8.63 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.185 -0.947 . . . . 0.0 110.008 -179.428 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.446 ' O ' ' CB ' ' A' ' 74' ' ' CYS . . . 76.21 32.09 53.17 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 108.764 -1.734 . . . . 0.0 108.764 -179.437 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.446 ' CB ' ' O ' ' A' ' 73' ' ' GLY . 0.0 OUTLIER 167.35 152.05 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.475 -1.015 . . . . 0.0 109.126 -179.695 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 67.6 123.94 0.02 OUTLIER Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -173.89 92.59 0.09 OUTLIER Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -104.07 123.31 47.02 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.221 -1.164 . . . . 0.0 109.081 179.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 33.7 m -110.49 170.24 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.141 -0.974 . . . . 0.0 109.541 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.423 ' CB ' ' HB ' ' A' ' 82' ' ' VAL . 11.4 mttp -159.19 166.74 30.77 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.299 -0.876 . . . . 0.0 109.352 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -64.13 100.8 0.35 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.202 -0.936 . . . . 0.0 109.567 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 74.7 2.97 65.78 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.423 ' HB ' ' CB ' ' A' ' 79' ' ' LYS . 87.5 t -129.6 141.71 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.116 -1.226 . . . . 0.0 109.595 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.431 HG22 ' N ' ' A' ' 84' ' ' GLU . 58.1 mt -131.89 158.69 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.326 -0.859 . . . . 0.0 109.456 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.431 ' N ' HG22 ' A' ' 83' ' ' ILE . 19.1 tt0 -148.03 139.14 23.35 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.217 -0.927 . . . . 0.0 109.548 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 53.6 mt -149.69 102.7 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.218 -0.926 . . . . 0.0 109.377 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -52.8 110.07 0.48 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.214 -0.929 . . . . 0.0 109.506 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -154.85 -175.75 26.3 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -154.39 47.82 0.59 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.267 -1.137 . . . . 0.0 109.446 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 60.3 mttt -137.82 45.95 2.12 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.283 -0.886 . . . . 0.0 109.467 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.59 ' HA ' HD12 ' A' ' 93' ' ' LEU . 36.1 ptt180 -50.93 -40.15 56.43 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.246 -0.909 . . . . 0.0 109.467 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.486 ' N ' ' HG3' ' A' ' 90' ' ' ARG . 8.1 p-10 -51.05 -45.54 61.37 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.27 -0.894 . . . . 0.0 109.467 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.404 HD23 ' N ' ' A' ' 93' ' ' LEU . 4.4 tt -68.4 -47.18 68.0 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.267 -0.896 . . . . 0.0 109.495 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.833 HD13 HG21 ' A' ' 36' ' ' ILE . 17.9 mt -54.32 -24.67 20.08 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.223 -0.923 . . . . 0.0 109.477 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -61.39 -65.42 0.7 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.297 -0.877 . . . . 0.0 109.465 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 11.4 t -64.48 -17.38 63.81 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.272 -0.893 . . . . 0.0 109.465 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.636 HD23 ' N ' ' A' ' 97' ' ' LEU . 3.1 tt -66.42 -55.83 13.91 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.288 -0.883 . . . . 0.0 109.482 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.636 ' N ' HD23 ' A' ' 96' ' ' LEU . 0.2 OUTLIER -69.97 -38.24 76.02 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.293 -0.879 . . . . 0.0 109.504 -179.979 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -64.27 -19.11 65.18 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.243 -0.91 . . . . 0.0 109.497 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -66.53 -31.74 72.64 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.273 -0.892 . . . . 0.0 109.441 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? -80.21 -14.9 58.07 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.239 -0.913 . . . . 0.0 109.474 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 101.44 -13.16 58.37 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 2.7 mtm -65.64 147.89 52.65 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.278 -1.13 . . . . 0.0 109.431 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 16.6 mttt -81.85 115.79 21.22 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.284 -0.885 . . . . 0.0 109.473 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.418 HG22 ' N ' ' A' ' 105' ' ' LYS . 4.6 p -109.72 155.0 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.221 -0.924 . . . . 0.0 109.523 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.429 ' O ' ' N ' ' A' ' 107' ' ' ALA . 0.5 OUTLIER -122.18 90.39 3.3 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.212 -0.93 . . . . 0.0 109.468 -179.958 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 19.5 tp -54.2 93.09 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.253 -0.904 . . . . 0.0 109.486 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.878 ' HB3' ' HB3' ' A' ' 37' ' ' GLN . . . . . . . . 0 N--CA 1.491 1.593 0 O-C-N 121.28 -0.887 . . . . 0.0 109.475 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.45 ' N ' ' OD1' ' A' ' 31' ' ' ASP . 18.8 p30 . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -60.3 153.24 35.96 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.708 ' O ' HG23 ' A' ' 33' ' ' VAL . 34.7 m -142.39 101.17 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.279 -1.13 . . . . 0.0 109.452 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.571 HG13 HG22 ' A' ' 54' ' ' VAL . 9.7 t -88.85 150.04 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.268 -0.895 . . . . 0.0 109.501 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 53.0 mtt180 -127.05 119.25 26.13 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.231 -0.918 . . . . 0.0 109.458 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.511 HD11 HD13 ' A' ' 97' ' ' LEU . 1.5 mp -118.1 118.41 58.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.237 -0.914 . . . . 0.0 109.507 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -153.89 175.54 13.23 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.258 -0.901 . . . . 0.0 109.479 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.78 140.04 38.68 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.223 -0.923 . . . . 0.0 109.453 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -124.91 57.6 1.27 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.282 -0.886 . . . . 0.0 109.486 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 15.1 t . . . . . 0 N--CA 1.49 1.546 0 O-C-N 121.246 -0.909 . . . . 0.0 109.448 -179.988 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.4 ptmt . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 121.325 0.583 . . . . 0.0 109.539 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -171.16 147.75 10.62 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.405 HG12 ' HG3' ' A' ' 86' ' ' GLN . 14.1 m -119.77 158.03 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.205 -1.173 . . . . 0.0 109.504 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 1.4 t -121.11 120.51 35.52 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.229 -0.919 . . . . 0.0 109.422 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -111.58 149.25 31.72 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.234 -0.916 . . . . 0.0 109.539 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.493 ' CG1' HG23 ' A' ' 36' ' ' ILE . 16.7 mt -134.26 126.43 49.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.269 -0.895 . . . . 0.0 109.46 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.463 HG23 ' O ' ' A' ' 81' ' ' GLY . 0.2 OUTLIER -151.59 166.67 30.5 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.228 -0.92 . . . . 0.0 109.48 179.98 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 92.57 15.57 52.43 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.571 HG22 HG13 ' A' ' 34' ' ' VAL . 8.8 t -75.86 106.9 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.231 -1.158 . . . . 0.0 109.489 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -94.62 84.57 4.3 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.279 -0.888 . . . . 0.0 109.476 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -144.95 -172.87 3.93 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.194 -0.941 . . . . 0.0 109.483 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -68.67 150.22 48.19 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.262 -0.899 . . . . 0.0 109.464 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.418 ' O ' ' HB2' ' A' ' 61' ' ' LEU . 19.6 m-20 -52.72 -46.26 67.3 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.246 -0.909 . . . . 0.0 109.549 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.808 ' O ' HG22 ' A' ' 62' ' ' THR . . . -58.72 -44.73 90.48 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.23 -0.919 . . . . 0.0 109.558 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -51.36 -34.73 35.31 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.151 -0.968 . . . . 0.0 109.488 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.461 HD23 ' HA ' ' A' ' 61' ' ' LEU . 39.7 mt -56.8 -54.81 42.11 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.233 -0.917 . . . . 0.0 109.505 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.808 HG22 ' O ' ' A' ' 59' ' ' ALA . 9.5 t -63.66 -17.82 63.32 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.233 -0.917 . . . . 0.0 109.588 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.65 -68.76 0.48 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.265 -0.897 . . . . 0.0 109.459 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -51.77 -34.61 40.3 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.273 -0.892 . . . . 0.0 109.371 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.48 -59.47 5.19 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.267 -0.896 . . . . 0.0 109.426 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -55.07 -24.93 27.66 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.279 -0.888 . . . . 0.0 109.447 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -66.68 -62.46 1.44 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.256 -0.903 . . . . 0.0 109.482 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -67.33 -13.5 62.06 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.193 -0.942 . . . . 0.0 109.545 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 17.8 tttt -69.77 -36.35 75.68 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.189 -0.944 . . . . 0.0 109.428 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -73.27 -19.74 60.99 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.279 -0.888 . . . . 0.0 109.276 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 63.7 mttt -66.29 -29.88 70.19 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.3 -0.875 . . . . 0.0 109.319 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 62.7 m -89.17 -30.06 18.85 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.315 -0.866 . . . . 0.0 109.316 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.457 ' O ' ' HB2' ' A' ' 74' ' ' CYS . . . 91.87 -19.74 46.78 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.457 ' HB2' ' O ' ' A' ' 73' ' ' GLY . 52.8 t 177.55 94.41 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.232 -1.158 . . . . 0.0 109.364 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 148.83 151.03 5.36 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.394 -1.483 . . . . 0.0 109.394 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 159.41 -176.46 36.19 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -179.36 114.12 0.06 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.252 -1.146 . . . . 0.0 109.624 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.5 p -120.01 148.59 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.256 -0.903 . . . . 0.0 109.136 179.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.448 ' CB ' ' HB ' ' A' ' 82' ' ' VAL . 0.0 OUTLIER -150.21 77.7 1.31 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.17 -0.956 . . . . 0.0 109.774 -179.735 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 60.3 t0 49.25 69.03 0.63 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.336 -0.852 . . . . 0.0 109.956 179.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.463 ' O ' HG23 ' A' ' 52' ' ' THR . . . 83.27 -11.56 54.65 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 179.514 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.448 ' HB ' ' CB ' ' A' ' 79' ' ' LYS . 58.5 t -97.97 89.79 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.094 -1.239 . . . . 0.0 109.523 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 52.3 mt -99.68 154.15 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.228 -0.92 . . . . 0.0 109.374 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -149.26 104.11 3.37 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.242 -0.911 . . . . 0.0 109.612 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 62.2 mt -125.76 125.04 67.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.334 -0.853 . . . . 0.0 109.357 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.405 ' HG3' HG12 ' A' ' 48' ' ' VAL . 8.3 tt0 -66.8 155.98 36.79 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.261 -0.899 . . . . 0.0 109.462 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 141.7 140.32 3.78 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -112.61 52.28 0.78 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.19 -1.182 . . . . 0.0 109.511 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 6.6 mttp -121.13 41.37 3.34 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.208 -0.933 . . . . 0.0 109.452 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.48 HH11 HD21 ' A' ' 106' ' ' LEU . 7.6 ptt85 -56.44 -27.76 57.59 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.251 -0.906 . . . . 0.0 109.494 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -57.89 -47.09 83.81 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.209 -0.932 . . . . 0.0 109.481 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 4.2 tt -74.28 -33.38 63.24 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.199 -0.938 . . . . 0.0 109.511 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.482 ' HG ' HG21 ' A' ' 36' ' ' ILE . 1.5 mm? -55.9 -38.72 70.6 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.272 -0.892 . . . . 0.0 109.458 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 13.1 tttt -53.41 -49.29 67.61 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.205 -0.934 . . . . 0.0 109.451 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 3.2 t -68.35 -29.36 68.07 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.28 -0.888 . . . . 0.0 109.437 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.558 HD23 ' N ' ' A' ' 97' ' ' LEU . 4.1 tt -58.06 -51.85 67.96 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.238 -0.914 . . . . 0.0 109.434 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.558 ' N ' HD23 ' A' ' 96' ' ' LEU . 0.4 OUTLIER -72.19 -32.35 66.74 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.261 -0.899 . . . . 0.0 109.428 179.983 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -71.69 -14.49 62.05 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.232 -0.918 . . . . 0.0 109.456 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.08 -31.42 72.6 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.213 -0.929 . . . . 0.0 109.422 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 7.3 mttm -94.0 -19.83 20.52 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.266 -0.896 . . . . 0.0 109.473 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 100.17 13.1 37.34 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 4.0 mtm -79.3 156.99 27.8 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.287 -1.125 . . . . 0.0 109.5 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.697 ' HB3' HG12 ' A' ' 33' ' ' VAL . 28.3 tttt -81.98 132.55 35.26 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.224 -0.923 . . . . 0.0 109.472 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.476 ' HB ' ' CD2' ' A' ' 97' ' ' LEU . 11.6 p -133.86 141.5 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.248 -0.908 . . . . 0.0 109.457 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 2.1 tttt -115.85 98.13 6.49 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.238 -0.914 . . . . 0.0 109.488 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.521 ' O ' ' HB3' ' A' ' 107' ' ' ALA . 25.5 tp -45.92 -26.59 0.72 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.238 -0.914 . . . . 0.0 109.477 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.521 ' HB3' ' O ' ' A' ' 106' ' ' LEU . . . . . . . . 0 N--CA 1.489 1.512 0 O-C-N 121.223 -0.923 . . . . 0.0 109.5 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 140.48 119.33 1.59 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.544 -1.423 . . . . 0.0 109.544 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 18.2 t -123.84 94.6 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.211 -1.17 . . . . 0.0 109.458 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.467 HG12 ' N ' ' A' ' 35' ' ' ARG . 22.0 t -86.54 162.39 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.23 -0.919 . . . . 0.0 109.491 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.467 ' N ' HG12 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -144.91 140.56 28.38 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.206 -0.934 . . . . 0.0 109.491 179.928 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.903 HG21 ' HG ' ' A' ' 93' ' ' LEU . 3.8 mp -141.52 124.4 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.233 -0.917 . . . . 0.0 109.491 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.862 ' HB3' ' HB2' ' A' ' 107' ' ' ALA . 5.5 pt20 -147.59 118.98 7.86 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.25 -0.906 . . . . 0.0 109.471 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 5.4 tmm_? -45.81 116.0 1.1 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.249 -0.907 . . . . 0.0 109.426 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 2.1 tm0? -85.01 126.95 33.97 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.253 -0.904 . . . . 0.0 109.465 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 8.8 t . . . . . 0 N--CA 1.49 1.558 0 O-C-N 121.243 -0.911 . . . . 0.0 109.459 -179.987 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 31.0 mttt . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.456 ' C ' HG13 ' A' ' 48' ' ' VAL . . . -103.54 -156.96 24.63 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.456 HG13 ' C ' ' A' ' 47' ' ' GLY . 35.9 m -156.5 160.34 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.281 -1.129 . . . . 0.0 109.481 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.4 ' HB2' ' O ' ' A' ' 85' ' ' ILE . 0.1 OUTLIER -95.35 117.56 30.54 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.191 -0.943 . . . . 0.0 109.494 179.989 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -103.56 98.17 8.09 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.27 -0.894 . . . . 0.0 109.471 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.694 HG13 HG23 ' A' ' 36' ' ' ILE . 3.1 mp -96.05 125.87 48.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.232 -0.918 . . . . 0.0 109.485 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.7 -152.82 0.43 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.224 -0.923 . . . . 0.0 109.538 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 52.07 51.44 40.85 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.441 ' O ' ' N ' ' A' ' 56' ' ' LEU . 2.1 t -115.72 46.33 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.212 -1.17 . . . . 0.0 109.477 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -55.71 90.89 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.229 -0.919 . . . . 0.0 109.423 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.441 ' N ' ' O ' ' A' ' 54' ' ' VAL . 0.4 OUTLIER -149.98 157.07 42.79 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.283 -0.886 . . . . 0.0 109.509 -179.925 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.34 157.75 19.05 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.286 -0.884 . . . . 0.0 109.452 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.719 ' O ' ' HB3' ' A' ' 59' ' ' ALA . 0.4 OUTLIER -56.17 172.46 0.21 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.183 -0.948 . . . . 0.0 109.455 179.995 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.719 ' HB3' ' O ' ' A' ' 58' ' ' ASP . . . 83.05 -43.03 0.11 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.676 -0.64 . . . . 0.0 109.83 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.41 -63.14 1.35 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.08 -1.012 . . . . 0.0 109.52 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -56.63 -27.92 59.4 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.233 -0.917 . . . . 0.0 109.476 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 46.0 p -72.72 -33.4 66.41 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.232 -0.918 . . . . 0.0 109.421 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 44.4 mttt -73.87 -51.73 15.25 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.269 -0.894 . . . . 0.0 109.469 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.693 ' O ' HD12 ' A' ' 68' ' ' LEU . 1.0 OUTLIER -56.69 -48.38 77.8 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.315 -0.866 . . . . 0.0 109.526 179.995 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.696 ' HB1' HG22 ' A' ' 78' ' ' VAL . . . -59.13 -61.02 2.95 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.323 -0.861 . . . . 0.0 109.686 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.415 ' C ' ' O ' ' A' ' 65' ' ' ALA . . . -43.26 -40.58 3.53 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.307 -0.871 . . . . 0.0 109.722 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -60.78 -52.22 66.0 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.21 -0.931 . . . . 0.0 109.542 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.693 HD12 ' O ' ' A' ' 64' ' ' LEU . 0.9 OUTLIER -60.72 -21.43 62.94 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.214 -0.929 . . . . 0.0 109.652 -179.879 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -65.44 -40.06 92.81 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.176 -0.952 . . . . 0.0 109.478 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 45.7 mttt -69.11 -23.29 63.98 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.209 -0.932 . . . . 0.0 109.444 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 15.7 mtpt -64.28 -29.07 70.18 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.406 -0.808 . . . . 0.0 110.032 -179.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.2 m -99.05 -43.03 6.83 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.049 -1.032 . . . . 0.0 109.672 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.474 ' O ' ' HB2' ' A' ' 74' ' ' CYS . . . 103.08 -22.68 35.92 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.474 ' HB2' ' O ' ' A' ' 73' ' ' GLY . 30.2 t 173.62 104.17 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.279 -1.13 . . . . 0.0 109.499 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 155.18 -61.4 0.37 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -47.49 119.38 4.83 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -110.41 150.35 28.95 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.26 -1.141 . . . . 0.0 109.234 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.696 HG22 ' HB1' ' A' ' 65' ' ' ALA . 41.8 t -102.38 152.22 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.253 -0.904 . . . . 0.0 109.715 -179.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -138.77 151.97 47.53 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.331 -0.856 . . . . 0.0 109.243 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.429 ' N ' ' OD1' ' A' ' 80' ' ' ASP . 1.0 OUTLIER -69.91 90.97 0.64 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.242 -0.911 . . . . 0.0 109.626 -179.817 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 109.07 -8.46 33.39 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.771 -1.331 . . . . 0.0 109.771 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.913 ' O ' HD13 ' A' ' 83' ' ' ILE . 75.9 t -142.26 153.02 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.129 -1.218 . . . . 0.0 109.566 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.913 HD13 ' O ' ' A' ' 82' ' ' VAL . 2.0 mm -136.53 129.25 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.289 -0.882 . . . . 0.0 109.226 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.515 ' O ' HD13 ' A' ' 85' ' ' ILE . 2.2 mt-10 -117.4 125.68 51.38 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.211 -0.931 . . . . 0.0 109.66 -179.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.515 HD13 ' O ' ' A' ' 84' ' ' GLU . 17.8 mm -137.42 116.65 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.269 -0.894 . . . . 0.0 109.417 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -69.77 157.56 37.1 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.247 -0.908 . . . . 0.0 109.521 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 148.74 -39.22 0.96 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.504 -1.439 . . . . 0.0 109.504 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 21.1 t0 57.33 53.77 7.3 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.223 -1.163 . . . . 0.0 109.452 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 19.8 mttt -134.96 54.52 1.94 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.24 -0.913 . . . . 0.0 109.451 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.414 ' HA ' ' HB2' ' A' ' 93' ' ' LEU . 38.5 ptt180 -47.31 -27.14 1.46 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.244 -0.91 . . . . 0.0 109.54 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -61.2 -58.61 7.62 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.248 -0.907 . . . . 0.0 109.464 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.484 ' O ' HD23 ' A' ' 92' ' ' LEU . 0.7 OUTLIER -64.87 -20.72 66.57 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.265 -0.897 . . . . 0.0 109.494 -179.975 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.903 ' HG ' HG21 ' A' ' 36' ' ' ILE . 2.1 mm? -65.81 -52.76 48.0 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.213 -0.93 . . . . 0.0 109.462 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.441 ' HG2' ' CG1' ' A' ' 104' ' ' VAL . 0.0 OUTLIER -62.83 -19.76 64.41 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.27 -0.893 . . . . 0.0 109.439 -179.98 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.94 -55.25 6.39 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.299 -0.876 . . . . 0.0 109.446 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.676 HD21 HD13 ' A' ' 93' ' ' LEU . 2.6 pp -64.82 -27.82 69.14 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.204 -0.935 . . . . 0.0 109.473 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.529 ' HB3' ' CG1' ' A' ' 104' ' ' VAL . 0.8 OUTLIER -68.12 -51.71 43.2 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.228 -0.92 . . . . 0.0 109.468 179.996 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -70.08 -16.65 63.16 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.267 -0.895 . . . . 0.0 109.44 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -67.22 -21.28 65.76 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.296 -0.878 . . . . 0.0 109.506 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -99.08 -17.18 18.36 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.269 -0.894 . . . . 0.0 109.453 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 103.59 -11.13 53.71 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 2.2 mtp -65.9 145.59 55.75 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.263 -1.14 . . . . 0.0 109.439 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.8 mttt -86.53 92.79 8.99 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.246 -0.908 . . . . 0.0 109.456 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.542 ' CG2' HD12 ' A' ' 36' ' ' ILE . 9.3 p -88.99 147.79 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.266 -0.896 . . . . 0.0 109.49 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 1.5 mttt -116.29 111.41 20.09 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.227 -0.92 . . . . 0.0 109.476 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.684 ' O ' ' HB2' ' A' ' 107' ' ' ALA . 2.8 mt -45.69 -84.6 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.194 -0.941 . . . . 0.0 109.48 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.862 ' HB2' ' HB3' ' A' ' 37' ' ' GLN . . . . . . . . 0 N--CA 1.49 1.547 0 O-C-N 121.282 -0.886 . . . . 0.0 109.486 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.3 t70 . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.499 ' O ' HG13 ' A' ' 33' ' ' VAL . . . -120.21 152.16 17.07 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.678 HG12 ' CB ' ' A' ' 103' ' ' LYS . 4.6 m -156.14 106.52 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.255 -1.144 . . . . 0.0 109.482 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.556 HG23 ' HE3' ' A' ' 102' ' ' MET . 3.0 t -89.75 140.66 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.221 -0.924 . . . . 0.0 109.48 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 17.0 ttm180 -106.71 108.01 19.31 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.262 -0.899 . . . . 0.0 109.435 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.761 ' CG2' HD13 ' A' ' 93' ' ' LEU . 22.2 mt -101.36 126.23 55.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.203 -0.935 . . . . 0.0 109.473 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.967 ' HB3' ' HB3' ' A' ' 107' ' ' ALA . 18.1 pt20 -146.59 -178.37 6.13 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.239 -0.913 . . . . 0.0 109.475 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 10.9 ttm180 -134.89 114.34 12.46 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.246 -0.909 . . . . 0.0 109.462 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.538 ' HB2' ' CD1' ' A' ' 50' ' ' LEU . 5.5 tp60 -87.78 127.5 35.32 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.245 -0.909 . . . . 0.0 109.438 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.523 0 O-C-N 121.267 -0.896 . . . . 0.0 109.518 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -109.15 144.52 16.51 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 29.5 m -144.45 151.99 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.258 -1.142 . . . . 0.0 109.458 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -109.52 116.66 32.2 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.226 -0.921 . . . . 0.0 109.483 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.691 ' O ' HD13 ' A' ' 51' ' ' ILE . 1.3 mp -96.99 147.73 23.7 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.251 -0.906 . . . . 0.0 109.53 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.691 HD13 ' O ' ' A' ' 50' ' ' LEU . 3.8 mm -136.08 125.87 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.293 -0.879 . . . . 0.0 109.387 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.406 ' HB ' HG13 ' A' ' 82' ' ' VAL . 1.4 t -158.16 168.46 26.99 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.186 -0.946 . . . . 0.0 109.508 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.35 -24.78 25.75 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.658 ' O ' HG13 ' A' ' 54' ' ' VAL . 8.0 p -49.55 106.97 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.255 -1.144 . . . . 0.0 109.496 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -100.48 78.85 2.05 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.195 -0.941 . . . . 0.0 109.462 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.456 HD23 ' HA ' ' A' ' 56' ' ' LEU . 16.4 mt -137.73 -173.57 3.53 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.231 -0.918 . . . . 0.0 109.455 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -68.0 138.26 55.74 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.24 -0.913 . . . . 0.0 109.446 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -50.08 -31.3 12.85 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.277 -0.89 . . . . 0.0 109.493 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.74 -43.42 93.44 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.249 -0.907 . . . . 0.0 109.5 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -66.18 -35.22 79.89 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.273 -0.892 . . . . 0.0 109.528 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.94 HD23 HD11 ' A' ' 83' ' ' ILE . 0.1 OUTLIER -59.63 -46.27 89.49 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.203 -0.935 . . . . 0.0 109.454 -179.955 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 39.5 p -71.06 -22.2 62.15 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.268 -0.895 . . . . 0.0 109.426 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.5 mmtp -71.77 -42.26 67.37 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.296 -0.877 . . . . 0.0 109.41 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -74.81 -34.64 62.41 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.203 -0.936 . . . . 0.0 109.285 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.63 -54.47 42.38 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.277 -0.889 . . . . 0.0 109.271 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.7 -39.2 93.24 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.274 -0.891 . . . . 0.0 109.213 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -54.89 -38.35 67.46 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.296 -0.878 . . . . 0.0 109.367 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 13.2 mt -82.17 -23.03 35.75 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.302 -0.874 . . . . 0.0 109.435 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 42.2 tttt -70.44 -22.93 62.65 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.22 -0.925 . . . . 0.0 109.268 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 4.6 mmtt -76.95 1.12 18.63 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.257 -0.902 . . . . 0.0 109.572 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 11.2 tttt -118.02 16.44 14.19 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.224 -0.922 . . . . 0.0 109.484 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -113.78 -33.04 5.93 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.201 -0.937 . . . . 0.0 109.544 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 87.72 -43.52 3.18 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 7.5 t -157.05 113.33 2.97 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.207 -1.172 . . . . 0.0 109.544 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 126.0 177.55 14.94 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 115.56 111.5 2.79 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -123.16 121.01 34.91 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.218 -1.166 . . . . 0.0 109.704 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.5 p -109.48 139.59 31.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.266 -0.896 . . . . 0.0 109.199 179.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.472 ' O ' ' N ' ' A' ' 81' ' ' GLY . 50.1 mttt -130.01 136.26 49.21 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.163 -0.961 . . . . 0.0 109.716 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -55.22 89.52 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.287 -0.883 . . . . 0.0 109.437 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.472 ' N ' ' O ' ' A' ' 79' ' ' LYS . . . 137.45 -44.78 1.11 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.406 HG13 ' HB ' ' A' ' 52' ' ' THR . 2.3 t -137.18 151.79 27.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.179 -1.189 . . . . 0.0 109.488 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.94 HD11 HD23 ' A' ' 61' ' ' LEU . 2.4 mp -124.66 140.63 47.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.209 -0.932 . . . . 0.0 109.555 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -128.92 139.0 52.32 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.315 -0.866 . . . . 0.0 109.372 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 17.8 mt -155.08 135.18 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.215 -0.928 . . . . 0.0 109.55 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -82.3 112.27 19.13 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.304 -0.872 . . . . 0.0 109.552 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -136.29 -39.78 0.14 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.461 -1.455 . . . . 0.0 109.461 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 46.28 36.61 3.42 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.227 -1.161 . . . . 0.0 109.521 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 5.4 mttp -137.91 53.7 1.82 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.261 -0.9 . . . . 0.0 109.473 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.562 ' HA ' HD12 ' A' ' 93' ' ' LEU . 1.9 mtm105 -49.64 -25.68 3.06 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.26 -0.9 . . . . 0.0 109.434 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -57.31 -53.34 59.17 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.255 -0.903 . . . . 0.0 109.443 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.6 tt -72.63 -33.4 66.62 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.262 -0.899 . . . . 0.0 109.471 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.761 HD13 ' CG2' ' A' ' 36' ' ' ILE . 48.0 mt -60.35 -27.42 67.36 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.263 -0.898 . . . . 0.0 109.406 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 75.4 tttt -64.65 -65.2 0.71 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.261 -0.9 . . . . 0.0 109.507 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -63.07 -15.42 56.52 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.228 -0.92 . . . . 0.0 109.468 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.766 HD23 ' N ' ' A' ' 97' ' ' LEU . 5.0 tt -71.22 -57.57 4.36 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.261 -0.899 . . . . 0.0 109.431 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.766 ' N ' HD23 ' A' ' 96' ' ' LEU . 0.1 OUTLIER -65.29 -32.38 74.0 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.252 -0.905 . . . . 0.0 109.469 179.993 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 56.5 mm-40 -67.8 -27.97 67.19 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.275 -0.891 . . . . 0.0 109.465 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.38 -32.21 73.73 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.295 -0.878 . . . . 0.0 109.441 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 17.2 mttt -80.52 -14.68 58.03 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.19 -0.944 . . . . 0.0 109.476 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 79.55 11.66 84.56 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' MET . . . . . 0.556 ' HE3' HG23 ' A' ' 34' ' ' VAL . 4.5 mtm -86.64 156.73 19.89 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.221 -1.164 . . . . 0.0 109.499 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.678 ' CB ' HG12 ' A' ' 33' ' ' VAL . 2.1 mmtt -80.69 108.44 14.34 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.242 -0.911 . . . . 0.0 109.445 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 34' ' ' VAL . 13.1 p -102.39 151.73 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.281 -0.887 . . . . 0.0 109.496 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.401 ' O ' ' N ' ' A' ' 107' ' ' ALA . 0.3 OUTLIER -115.32 79.21 1.25 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.243 -0.91 . . . . 0.0 109.472 179.993 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.488 ' C ' HD23 ' A' ' 106' ' ' LEU . 5.2 tt -46.74 100.45 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.247 -0.908 . . . . 0.0 109.463 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.967 ' HB3' ' HB3' ' A' ' 37' ' ' GLN . . . . . . . . 0 N--CA 1.491 1.581 0 O-C-N 121.259 -0.901 . . . . 0.0 109.494 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 16.6 t0 . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -169.46 107.4 0.27 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.546 HG12 ' HB2' ' A' ' 103' ' ' LYS . 27.0 m -121.86 144.96 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.281 -1.129 . . . . 0.0 109.426 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.54 ' O ' HG23 ' A' ' 104' ' ' VAL . 72.2 t -119.88 133.32 67.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.264 -0.898 . . . . 0.0 109.5 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 5.5 mtt180 -108.17 98.05 7.65 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.202 -0.937 . . . . 0.0 109.474 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.649 HG12 HD22 ' A' ' 93' ' ' LEU . 3.9 mt -98.63 145.42 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.251 -0.905 . . . . 0.0 109.432 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.425 ' HG3' ' O ' ' A' ' 37' ' ' GLN . 0.0 OUTLIER -179.46 122.46 0.08 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.253 -0.905 . . . . 0.0 109.473 179.977 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.5 132.51 44.78 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.23 -0.919 . . . . 0.0 109.462 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -121.45 149.21 43.36 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.279 -0.888 . . . . 0.0 109.506 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 11.2 p . . . . . 0 N--CA 1.49 1.572 0 O-C-N 121.269 -0.894 . . . . 0.0 109.444 -179.988 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 25.3 mttt . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 127.39 83.99 0.46 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 28.1 m -113.69 157.02 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.225 -1.162 . . . . 0.0 109.434 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.518 ' SG ' HD11 ' A' ' 51' ' ' ILE . 5.4 t -105.71 123.56 48.13 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.237 -0.914 . . . . 0.0 109.485 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.41 ' C ' HD13 ' A' ' 51' ' ' ILE . 1.4 mt -116.39 108.61 16.27 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.237 -0.914 . . . . 0.0 109.433 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.518 HD11 ' SG ' ' A' ' 49' ' ' CYS . 3.5 mm -96.13 121.22 46.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.268 -0.895 . . . . 0.0 109.533 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.505 HG22 ' H ' ' A' ' 53' ' ' GLY . 0.2 OUTLIER -135.6 -169.32 2.37 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.264 -0.897 . . . . 0.0 109.497 179.938 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.505 ' H ' HG22 ' A' ' 52' ' ' THR . . . 63.35 46.42 92.82 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.8 t -95.94 122.63 47.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.216 -1.167 . . . . 0.0 109.491 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -105.24 77.61 1.32 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.218 -0.926 . . . . 0.0 109.496 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 37.7 mt -135.89 165.93 24.49 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.24 -0.912 . . . . 0.0 109.481 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -65.79 -73.59 0.13 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.303 -0.873 . . . . 0.0 109.454 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -173.45 -52.09 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.229 -0.919 . . . . 0.0 109.479 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.41 -33.42 74.75 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.221 -0.924 . . . . 0.0 109.495 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -69.73 -30.15 67.7 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.222 -0.924 . . . . 0.0 109.434 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.5 tt -70.54 -45.95 64.51 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.225 -0.922 . . . . 0.0 109.4 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -61.35 -43.97 97.97 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.255 -0.903 . . . . 0.0 109.45 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 76.8 tttt -60.56 -52.14 66.46 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.273 -0.892 . . . . 0.0 109.433 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.47 ' HA ' HD22 ' A' ' 64' ' ' LEU . 0.2 OUTLIER -48.01 -47.48 33.33 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.169 -0.957 . . . . 0.0 109.316 179.96 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.03 -42.14 84.69 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.293 -0.879 . . . . 0.0 109.297 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.35 -24.26 67.2 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.289 -0.882 . . . . 0.0 109.343 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -75.39 -38.62 59.83 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.34 -0.85 . . . . 0.0 109.431 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 9.5 mt -68.17 -42.57 79.79 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.246 -0.909 . . . . 0.0 109.314 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 17.2 tttt -56.81 -43.9 81.44 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.281 -0.887 . . . . 0.0 109.341 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 10.5 mttt -52.66 -33.19 45.99 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.21 -0.931 . . . . 0.0 109.459 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 34.4 mttt -116.61 54.78 0.84 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.169 -0.957 . . . . 0.0 109.836 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -140.36 -37.95 0.45 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.091 -1.006 . . . . 0.0 109.559 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.487 ' O ' ' CB ' ' A' ' 74' ' ' CYS . . . 91.28 -24.1 21.03 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 -179.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.487 ' CB ' ' O ' ' A' ' 73' ' ' GLY . 1.6 p 165.62 133.14 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.3 -1.117 . . . . 0.0 109.392 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.7 114.31 3.63 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 178.25 76.22 0.06 OUTLIER Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.564 ' HB3' ' HB2' ' A' ' 84' ' ' GLU . . . -83.95 151.33 25.12 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.297 -1.119 . . . . 0.0 109.473 -179.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 37.5 t -119.6 142.95 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.263 -0.898 . . . . 0.0 109.269 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.422 ' HB2' ' O ' ' A' ' 82' ' ' VAL . 16.3 mttt -147.33 171.18 15.84 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.267 -0.896 . . . . 0.0 109.496 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -63.8 102.62 0.48 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.344 -0.848 . . . . 0.0 109.718 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 63.18 25.9 68.73 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 179.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.422 ' O ' ' HB2' ' A' ' 79' ' ' LYS . 40.8 t -146.21 123.26 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.232 -1.158 . . . . 0.0 109.414 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 34.9 mt -117.86 139.59 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.223 -0.923 . . . . 0.0 109.508 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.564 ' HB2' ' HB3' ' A' ' 77' ' ' ALA . 1.3 mt-10 -115.09 131.2 57.0 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.195 -0.94 . . . . 0.0 109.325 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.415 HD13 ' HA ' ' A' ' 85' ' ' ILE . 47.3 mm -128.82 137.33 57.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.203 -0.935 . . . . 0.0 109.583 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -96.39 109.35 21.89 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.28 -0.888 . . . . 0.0 109.449 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 165.68 166.96 25.55 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -129.2 62.8 1.51 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.266 -1.138 . . . . 0.0 109.47 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 76.0 mttt -127.27 52.19 1.83 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.214 -0.929 . . . . 0.0 109.473 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.431 ' HG3' ' N ' ' A' ' 91' ' ' ASP . 6.6 ptt180 -52.25 -36.11 51.67 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.32 -0.863 . . . . 0.0 109.442 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.431 ' N ' ' HG3' ' A' ' 90' ' ' ARG . 21.9 m-20 -60.21 -43.22 96.15 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.274 -0.891 . . . . 0.0 109.519 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.45 -34.6 77.51 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.23 -0.919 . . . . 0.0 109.484 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.681 ' HA ' HD21 ' A' ' 96' ' ' LEU . 0.3 OUTLIER -62.15 -39.83 93.94 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.286 -0.884 . . . . 0.0 109.504 179.983 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 76.1 tttt -63.76 -27.07 68.94 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.242 -0.911 . . . . 0.0 109.427 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 20.7 t -75.61 -60.67 2.21 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.273 -0.892 . . . . 0.0 109.504 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.999 HD12 ' N ' ' A' ' 97' ' ' LEU . 4.0 pp -52.36 -33.16 41.79 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.271 -0.893 . . . . 0.0 109.479 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.999 ' N ' HD12 ' A' ' 96' ' ' LEU . 0.1 OUTLIER -68.89 -54.15 17.18 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.276 -0.89 . . . . 0.0 109.508 179.978 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -64.78 -12.52 48.46 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.286 -0.884 . . . . 0.0 109.523 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.28 -28.32 69.24 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.238 -0.914 . . . . 0.0 109.469 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 33.6 mttm -95.86 -24.92 16.22 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.263 -0.898 . . . . 0.0 109.445 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 103.04 13.92 27.88 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -76.62 147.98 37.22 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.254 -1.144 . . . . 0.0 109.488 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.546 ' HB2' HG12 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -80.47 87.16 5.7 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.254 -0.904 . . . . 0.0 109.434 -179.999 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.54 HG23 ' O ' ' A' ' 34' ' ' VAL . 11.7 p -85.88 133.19 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.225 -0.922 . . . . 0.0 109.475 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.417 ' O ' ' N ' ' A' ' 107' ' ' ALA . 5.3 mttt -102.33 86.18 2.77 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.285 -0.885 . . . . 0.0 109.469 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 4.7 tp -52.27 95.89 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.192 -0.942 . . . . 0.0 109.483 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.417 ' N ' ' O ' ' A' ' 105' ' ' LYS . . . . . . . . 0 N--CA 1.49 1.542 0 O-C-N 121.281 -0.887 . . . . 0.0 109.468 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -108.4 167.3 13.16 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.941 HG23 ' O ' ' A' ' 103' ' ' LYS . 3.3 p -150.41 94.47 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.233 -1.157 . . . . 0.0 109.504 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.91 ' HB ' HD21 ' A' ' 97' ' ' LEU . 69.6 t -85.14 107.42 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.251 -0.905 . . . . 0.0 109.484 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 82.6 mtt180 -83.45 120.81 26.36 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.268 -0.895 . . . . 0.0 109.445 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.767 HG21 HD13 ' A' ' 93' ' ' LEU . 5.6 mt -120.14 116.31 49.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.196 -0.94 . . . . 0.0 109.524 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.934 ' HB3' ' HB3' ' A' ' 107' ' ' ALA . 28.2 pt20 -143.76 151.25 39.75 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.207 -0.933 . . . . 0.0 109.454 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.455 ' HG3' ' O ' ' A' ' 38' ' ' ARG . 11.9 ptt180 -95.47 122.59 38.36 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.221 -0.924 . . . . 0.0 109.439 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 7.2 tp60 -83.04 -37.2 24.22 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.3 -0.875 . . . . 0.0 109.484 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.541 0 O-C-N 121.234 -0.916 . . . . 0.0 109.448 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 12.6 mttt . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.7 173.32 31.02 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 16.0 m -143.22 156.92 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.261 -1.14 . . . . 0.0 109.416 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -118.21 110.89 18.11 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.241 -0.912 . . . . 0.0 109.471 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.453 ' C ' HD13 ' A' ' 51' ' ' ILE . 56.5 mt -93.79 123.83 37.39 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.273 -0.892 . . . . 0.0 109.514 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.453 HD13 ' C ' ' A' ' 50' ' ' LEU . 4.7 mm -109.4 110.94 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.28 -0.888 . . . . 0.0 109.453 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -158.48 152.68 24.03 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.269 -0.894 . . . . 0.0 109.448 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.443 ' O ' HG13 ' A' ' 33' ' ' VAL . . . 100.36 51.8 1.2 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 6.1 t -116.53 100.17 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.255 -1.144 . . . . 0.0 109.497 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -77.36 102.49 6.81 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.223 -0.923 . . . . 0.0 109.505 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.439 HD23 ' H ' ' A' ' 57' ' ' ASP . 0.1 OUTLIER -150.8 -157.43 0.81 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.252 -0.905 . . . . 0.0 109.481 179.991 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.439 ' H ' HD23 ' A' ' 56' ' ' LEU . 5.5 m-20 -76.58 -86.56 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.27 -0.894 . . . . 0.0 109.473 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -177.84 -47.33 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.307 -0.87 . . . . 0.0 109.36 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.8 -23.12 52.84 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.289 -0.882 . . . . 0.0 109.364 179.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.402 ' CB ' HD22 ' A' ' 56' ' ' LEU . 1.9 mm-40 -68.25 -28.07 66.89 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.267 -0.895 . . . . 0.0 109.437 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.95 -32.94 74.52 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.215 -0.928 . . . . 0.0 109.348 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -71.14 -40.7 71.22 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.275 -0.89 . . . . 0.0 109.391 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -66.79 -37.55 84.78 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.201 -0.937 . . . . 0.0 109.365 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.489 HD21 HG21 ' A' ' 34' ' ' VAL . 53.4 tp -65.35 -50.96 63.6 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.267 -0.896 . . . . 0.0 109.356 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.95 -26.96 69.07 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.306 -0.871 . . . . 0.0 109.295 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -74.21 -34.51 63.73 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.328 -0.858 . . . . 0.0 109.34 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -76.75 -26.71 54.86 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.254 -0.904 . . . . 0.0 109.39 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.489 HD13 ' HA ' ' A' ' 68' ' ' LEU . 0.5 OUTLIER -77.9 -37.01 48.91 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.267 -0.895 . . . . 0.0 109.437 -179.978 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 7.3 ttpt -67.61 -24.04 65.43 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.283 -0.886 . . . . 0.0 109.422 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.9 -29.71 60.43 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.288 -0.883 . . . . 0.0 109.536 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 4.0 mtmt -132.08 52.63 2.06 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.257 -0.902 . . . . 0.0 109.492 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . 0.581 ' SG ' HG23 ' A' ' 85' ' ' ILE . 9.1 t -110.13 -28.68 8.55 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.274 -0.891 . . . . 0.0 109.49 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.408 ' O ' ' HB2' ' A' ' 74' ' ' CYS . . . 77.73 6.19 86.82 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.408 ' HB2' ' O ' ' A' ' 73' ' ' GLY . 23.2 t 177.37 125.31 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.241 -1.152 . . . . 0.0 109.455 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -102.85 139.11 14.29 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -114.5 -100.86 2.37 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -117.78 133.36 56.01 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.211 -1.17 . . . . 0.0 109.333 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.0 t -124.85 99.13 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.19 -0.944 . . . . 0.0 109.669 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 61.4 mttm -115.29 141.47 47.99 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.272 -0.893 . . . . 0.0 109.322 179.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -60.39 99.84 0.09 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.207 -0.933 . . . . 0.0 109.391 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 121.17 -33.03 4.51 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 30.9 t -132.84 117.53 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.294 -1.121 . . . . 0.0 109.361 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 7.6 mt -123.13 123.71 68.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.291 -0.881 . . . . 0.0 109.556 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 53.6 tt0 -106.1 124.79 50.13 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.166 -0.959 . . . . 0.0 109.422 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.581 HG23 ' SG ' ' A' ' 72' ' ' CYS . 45.2 mm -115.2 143.44 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.228 -0.92 . . . . 0.0 109.555 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -112.68 113.64 25.86 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.301 -0.874 . . . . 0.0 109.501 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 178.74 -140.37 4.45 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.544 -1.423 . . . . 0.0 109.544 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.464 ' O ' ' CG ' ' A' ' 89' ' ' LYS . 17.6 t0 -177.35 79.9 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.261 -1.141 . . . . 0.0 109.514 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.464 ' CG ' ' O ' ' A' ' 88' ' ' ASP . 90.4 mttt -156.89 40.27 0.33 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.291 -0.881 . . . . 0.0 109.473 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 68.4 ttt180 -47.55 -31.5 4.46 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.282 -0.886 . . . . 0.0 109.527 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -57.46 -53.56 56.72 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.243 -0.91 . . . . 0.0 109.493 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 3.3 tp -63.82 -31.71 72.97 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.218 -0.926 . . . . 0.0 109.502 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.767 HD13 HG21 ' A' ' 36' ' ' ILE . 0.6 OUTLIER -59.09 -41.68 88.65 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.242 -0.911 . . . . 0.0 109.493 179.964 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -64.72 -27.04 68.64 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.272 -0.893 . . . . 0.0 109.519 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 1.1 t -73.94 -62.42 1.51 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.228 -0.92 . . . . 0.0 109.487 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.943 HD12 ' N ' ' A' ' 97' ' ' LEU . 4.1 pp -51.96 -31.11 27.66 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.237 -0.914 . . . . 0.0 109.526 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.943 ' N ' HD12 ' A' ' 96' ' ' LEU . 0.2 OUTLIER -70.03 -50.1 44.65 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.235 -0.916 . . . . 0.0 109.459 -179.927 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -65.49 -14.48 61.09 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.189 -0.945 . . . . 0.0 109.505 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -73.19 -27.94 61.92 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.252 -0.905 . . . . 0.0 109.489 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.8 mptt -87.65 -13.13 43.46 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.284 -0.885 . . . . 0.0 109.484 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 74.13 31.17 59.92 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 2.0 mtm -98.06 167.02 11.15 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.265 -1.138 . . . . 0.0 109.468 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.941 ' O ' HG23 ' A' ' 33' ' ' VAL . 2.3 mttm -86.53 93.34 9.15 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.292 -0.88 . . . . 0.0 109.457 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.641 ' HB ' HD12 ' A' ' 97' ' ' LEU . 7.5 p -83.31 136.43 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.241 -0.912 . . . . 0.0 109.5 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.9 90.25 3.33 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.302 -0.874 . . . . 0.0 109.456 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 45.3 mt -57.04 94.02 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.238 -0.914 . . . . 0.0 109.509 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.934 ' HB3' ' HB3' ' A' ' 37' ' ' GLN . . . . . . . . 0 N--CA 1.49 1.555 0 O-C-N 121.277 -0.889 . . . . 0.0 109.454 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -126.86 119.06 3.2 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.408 ' O ' HG23 ' A' ' 33' ' ' VAL . 5.2 m -125.65 90.62 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.273 -1.134 . . . . 0.0 109.443 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.506 HG12 ' N ' ' A' ' 35' ' ' ARG . 44.9 t -97.59 163.21 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.241 -0.912 . . . . 0.0 109.459 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.506 ' N ' HG12 ' A' ' 34' ' ' VAL . 69.5 mtt180 -147.79 121.66 9.34 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.248 -0.908 . . . . 0.0 109.458 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.776 HD11 HD13 ' A' ' 97' ' ' LEU . 1.1 mp -116.21 94.54 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.24 -0.913 . . . . 0.0 109.493 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.415 ' HB3' ' HB3' ' A' ' 107' ' ' ALA . 7.8 pt20 -106.97 -176.02 2.96 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.258 -0.901 . . . . 0.0 109.473 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 18.4 mtp180 -122.02 142.12 50.65 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.291 -0.881 . . . . 0.0 109.464 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -105.62 102.54 11.99 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.185 -0.947 . . . . 0.0 109.473 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 3.0 t . . . . . 0 N--CA 1.491 1.584 0 O-C-N 121.247 -0.908 . . . . 0.0 109.444 -179.946 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 92.2 mttt . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 121.301 0.572 . . . . 0.0 109.475 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 114.76 146.34 9.05 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 5.6 m -138.71 162.75 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.241 -1.152 . . . . 0.0 109.581 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 92.2 m -112.37 138.22 49.42 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.277 -0.889 . . . . 0.0 109.39 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.415 ' N ' HD23 ' A' ' 50' ' ' LEU . 0.2 OUTLIER -132.26 113.36 13.15 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.243 -0.91 . . . . 0.0 109.493 -179.972 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.682 HG13 HG23 ' A' ' 36' ' ' ILE . 3.7 mp -85.91 131.01 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.208 -0.933 . . . . 0.0 109.503 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.0 p -142.15 -174.54 4.13 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.236 -0.915 . . . . 0.0 109.453 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 52.04 51.36 41.08 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.6 t -97.13 110.69 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.289 -1.124 . . . . 0.0 109.41 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -97.43 78.18 2.67 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.258 -0.901 . . . . 0.0 109.488 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.647 HD12 ' CB ' ' A' ' 60' ' ' GLU . 1.8 mm? -115.86 -167.7 1.3 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.228 -0.92 . . . . 0.0 109.49 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -96.57 -61.03 1.48 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.257 -0.902 . . . . 0.0 109.47 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 175.74 -54.59 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.308 -0.87 . . . . 0.0 109.394 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -75.55 -23.05 56.57 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.252 -0.905 . . . . 0.0 109.435 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.647 ' CB ' HD12 ' A' ' 56' ' ' LEU . 0.4 OUTLIER -75.29 -33.48 61.21 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.289 -0.882 . . . . 0.0 109.441 179.986 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.0 -44.42 84.86 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.266 -0.897 . . . . 0.0 109.374 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 57.2 m -69.02 -29.77 68.01 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.266 -0.896 . . . . 0.0 109.514 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -70.67 -35.48 72.85 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.232 -0.918 . . . . 0.0 109.49 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.419 HD22 ' HA ' ' A' ' 64' ' ' LEU . 0.1 OUTLIER -72.45 -59.83 2.53 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.214 -0.929 . . . . 0.0 109.494 179.986 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -48.39 -45.39 35.84 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.278 -0.889 . . . . 0.0 109.473 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.18 -41.37 99.21 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.262 -0.899 . . . . 0.0 109.465 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -59.35 -32.62 70.27 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.212 -0.93 . . . . 0.0 109.534 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.533 HD21 ' CD1' ' A' ' 96' ' ' LEU . 3.5 mt -82.89 -22.28 33.99 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.265 -0.897 . . . . 0.0 109.405 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.98 -21.08 59.37 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.302 -0.873 . . . . 0.0 109.758 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.6 -14.18 61.14 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.274 -0.891 . . . . 0.0 110.264 -179.412 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.02 37.88 1.17 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.053 -1.029 . . . . 0.0 109.584 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . 0.638 ' SG ' HD12 ' A' ' 85' ' ' ILE . 0.1 OUTLIER -99.06 -64.79 1.01 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.269 -0.894 . . . . 0.0 109.566 -179.958 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.479 ' O ' ' CB ' ' A' ' 74' ' ' CYS . . . 116.21 18.81 5.72 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.479 ' CB ' ' O ' ' A' ' 73' ' ' GLY . 0.5 OUTLIER 164.93 93.06 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.275 -1.132 . . . . 0.0 109.438 -179.961 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -57.27 100.71 0.13 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -77.38 -159.09 10.44 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -74.2 146.57 43.27 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.128 -1.219 . . . . 0.0 109.314 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 57.9 t -135.18 93.77 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.176 -0.952 . . . . 0.0 109.695 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.04 156.35 18.85 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.332 -0.855 . . . . 0.0 109.333 179.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -71.58 101.45 2.5 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.173 -0.954 . . . . 0.0 109.54 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.404 ' C ' ' CG2' ' A' ' 82' ' ' VAL . . . 117.44 -11.93 14.06 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.404 ' CG2' ' C ' ' A' ' 81' ' ' GLY . 3.3 t -152.72 117.75 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.297 -1.12 . . . . 0.0 109.357 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 15.2 mt -122.76 123.68 68.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.189 -0.944 . . . . 0.0 109.744 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -92.14 136.06 33.49 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.308 -0.87 . . . . 0.0 109.27 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.638 HD12 ' SG ' ' A' ' 72' ' ' CYS . 13.1 mm -131.9 95.93 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.171 -0.956 . . . . 0.0 109.521 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -56.56 133.85 53.84 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.296 -0.877 . . . . 0.0 109.407 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 143.9 173.72 15.59 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -139.92 81.32 1.81 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.28 -1.13 . . . . 0.0 109.419 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 13.7 pttt -145.55 49.03 1.24 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.261 -0.9 . . . . 0.0 109.456 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 7.1 ptt180 -47.69 -37.53 13.21 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.258 -0.901 . . . . 0.0 109.516 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -56.15 -49.66 73.33 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.261 -0.899 . . . . 0.0 109.438 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.498 ' HA ' HD22 ' A' ' 92' ' ' LEU . 0.2 OUTLIER -60.15 -44.13 95.2 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.268 -0.895 . . . . 0.0 109.501 -179.992 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.538 ' HG ' HG21 ' A' ' 36' ' ' ILE . 4.3 mm? -56.15 -35.13 66.82 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.237 -0.914 . . . . 0.0 109.42 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 67.9 tttt -60.87 -62.07 2.12 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.25 -0.906 . . . . 0.0 109.491 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -62.82 -14.1 41.47 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.216 -0.928 . . . . 0.0 109.421 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.856 HD23 ' N ' ' A' ' 97' ' ' LEU . 4.7 tt -72.78 -62.08 1.58 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.231 -0.918 . . . . 0.0 109.473 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.856 ' N ' HD23 ' A' ' 96' ' ' LEU . 0.1 OUTLIER -61.78 -31.9 72.15 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.266 -0.896 . . . . 0.0 109.444 -179.983 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -71.86 -25.56 62.0 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.277 -0.889 . . . . 0.0 109.506 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -68.79 -26.82 65.4 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.209 -0.932 . . . . 0.0 109.474 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -85.78 -39.31 17.25 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.244 -0.91 . . . . 0.0 109.504 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 117.65 14.46 6.82 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' MET . . . . . 0.413 ' HB2' HD23 ' A' ' 97' ' ' LEU . 19.0 mtp -96.62 154.12 17.46 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.293 -1.122 . . . . 0.0 109.451 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 11.1 mptt -81.19 118.94 22.99 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.282 -0.886 . . . . 0.0 109.512 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.773 ' HB ' HD22 ' A' ' 97' ' ' LEU . 12.1 p -115.32 135.06 56.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.265 -0.897 . . . . 0.0 109.456 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 71.6 tttt -102.28 97.56 7.82 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.273 -0.892 . . . . 0.0 109.465 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.459 ' O ' ' HB3' ' A' ' 107' ' ' ALA . 23.9 tp -45.59 -30.35 1.47 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.285 -0.884 . . . . 0.0 109.497 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.459 ' HB3' ' O ' ' A' ' 106' ' ' LEU . . . . . . . . 0 N--CA 1.49 1.55 0 O-C-N 121.232 -0.918 . . . . 0.0 109.48 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.586 ' HA3' HD21 ' A' ' 56' ' ' LEU . . . -122.94 145.45 16.21 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.673 HG12 ' HB2' ' A' ' 103' ' ' LYS . 16.3 m -132.21 137.71 53.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.29 -1.124 . . . . 0.0 109.45 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.761 ' HB ' HD21 ' A' ' 97' ' ' LEU . 60.3 t -106.6 162.29 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.196 -0.94 . . . . 0.0 109.478 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.53 ' N ' HG12 ' A' ' 34' ' ' VAL . 4.4 ttt180 -135.62 108.07 7.37 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.243 -0.911 . . . . 0.0 109.48 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.739 HG12 HD22 ' A' ' 93' ' ' LEU . 3.2 mt -116.53 128.11 73.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.208 -0.933 . . . . 0.0 109.429 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.745 ' HB3' ' HB3' ' A' ' 107' ' ' ALA . 4.0 pt20 -156.07 153.88 30.1 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.258 -0.901 . . . . 0.0 109.477 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.1 143.14 34.66 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.248 -0.908 . . . . 0.0 109.487 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 20.2 tt0 -109.55 71.2 0.76 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.203 -0.936 . . . . 0.0 109.47 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 3.3 t . . . . . 0 N--CA 1.491 1.579 0 O-C-N 121.29 -0.881 . . . . 0.0 109.485 179.954 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 12.3 tttt . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -96.16 123.27 7.64 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 15.6 m -121.44 143.31 34.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.239 -1.154 . . . . 0.0 109.328 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -125.37 133.92 52.36 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.211 -0.93 . . . . 0.0 109.53 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.425 ' HG ' ' O ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -123.29 120.52 33.34 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.264 -0.898 . . . . 0.0 109.41 179.951 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.452 ' N ' HD13 ' A' ' 51' ' ' ILE . 3.2 mm -90.91 119.61 38.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.232 -0.917 . . . . 0.0 109.441 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.92 159.4 44.58 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.273 -0.892 . . . . 0.0 109.455 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 108.05 -31.21 8.13 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.54 HG22 HG22 ' A' ' 34' ' ' VAL . 57.0 t -45.02 113.05 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.221 -1.164 . . . . 0.0 109.419 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -114.34 76.8 1.01 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.234 -0.916 . . . . 0.0 109.478 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.586 HD21 ' HA3' ' A' ' 32' ' ' GLY . 31.3 mt -130.06 -156.33 0.75 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.255 -0.903 . . . . 0.0 109.439 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.598 ' O ' HD12 ' A' ' 61' ' ' LEU . 4.4 m-20 -67.34 143.28 56.46 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.278 -0.889 . . . . 0.0 109.446 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -58.08 -36.02 72.24 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.248 -0.907 . . . . 0.0 109.66 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -75.25 -32.55 61.12 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.182 -0.949 . . . . 0.0 109.531 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -71.95 -26.3 62.22 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.278 -0.889 . . . . 0.0 109.534 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.598 HD12 ' O ' ' A' ' 57' ' ' ASP . 0.2 OUTLIER -71.87 -56.87 4.94 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.219 -0.925 . . . . 0.0 109.549 -179.962 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 4.5 t -56.45 -24.36 44.96 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.266 -0.896 . . . . 0.0 109.453 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 79.2 mttt -75.54 -46.17 33.66 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.259 -0.9 . . . . 0.0 109.515 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.415 ' HA ' HD22 ' A' ' 64' ' ' LEU . 0.4 OUTLIER -60.73 -46.02 92.04 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.188 -0.945 . . . . 0.0 109.359 179.939 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.41 ' CB ' HG13 ' A' ' 78' ' ' VAL . . . -65.78 -38.09 88.08 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.271 -0.893 . . . . 0.0 109.381 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.82 -36.98 75.39 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.227 -0.921 . . . . 0.0 109.413 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -75.55 -35.99 60.53 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.231 -0.918 . . . . 0.0 109.445 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.433 HD13 ' HA ' ' A' ' 68' ' ' LEU . 0.1 OUTLIER -56.55 -53.17 60.65 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.347 -0.846 . . . . 0.0 109.605 -179.932 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 15.4 pttp -66.16 -34.02 77.1 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.277 -0.889 . . . . 0.0 109.494 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -59.7 -21.83 61.16 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.316 -0.865 . . . . 0.0 109.71 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -85.07 -36.72 21.01 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.221 -0.925 . . . . 0.0 109.75 -179.655 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.2 m -94.42 -64.95 1.02 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.219 -0.925 . . . . 0.0 109.574 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 118.23 5.2 13.33 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 -179.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 46.8 t -160.15 121.87 3.19 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.307 -1.114 . . . . 0.0 109.258 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -129.35 -106.81 1.25 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 -179.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -172.84 -47.07 0.04 OUTLIER Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -178.55 119.52 0.08 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.291 -1.123 . . . . 0.0 109.56 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.416 HG22 HG23 ' A' ' 83' ' ' ILE . 77.9 t -100.98 97.82 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.312 -0.868 . . . . 0.0 109.292 179.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -106.34 141.34 37.82 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.213 -0.929 . . . . 0.0 109.814 -179.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -57.82 96.16 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.329 -0.857 . . . . 0.0 109.44 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 127.45 -40.78 1.7 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 23.5 t -132.93 122.51 46.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.179 -1.189 . . . . 0.0 109.58 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.416 HG23 HG22 ' A' ' 78' ' ' VAL . 2.9 mp -120.6 132.33 70.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.316 -0.865 . . . . 0.0 109.241 179.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -110.25 137.14 48.39 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.236 -0.915 . . . . 0.0 109.583 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 31.2 mm -132.59 123.18 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.299 -0.876 . . . . 0.0 109.563 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -91.78 104.95 17.34 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.204 -0.935 . . . . 0.0 109.438 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 178.6 -162.9 30.42 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -153.5 70.78 0.86 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.243 -1.151 . . . . 0.0 109.47 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 77.3 mttt -136.57 50.0 2.05 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.263 -0.898 . . . . 0.0 109.578 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 24.5 ptt180 -60.21 -34.04 73.09 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.227 -0.92 . . . . 0.0 109.478 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 30.5 t0 -55.74 -56.14 23.97 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.242 -0.911 . . . . 0.0 109.416 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.38 -31.03 71.63 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.249 -0.907 . . . . 0.0 109.398 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.739 HD22 HG12 ' A' ' 36' ' ' ILE . 0.4 OUTLIER -58.9 -45.16 90.96 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.31 -0.868 . . . . 0.0 109.442 179.961 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -61.91 -31.86 72.2 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.28 -0.887 . . . . 0.0 109.562 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.415 ' O ' ' C ' ' A' ' 96' ' ' LEU . 1.5 t -68.9 -69.76 0.31 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.216 -0.928 . . . . 0.0 109.499 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.961 HD12 ' N ' ' A' ' 97' ' ' LEU . 4.1 pp -43.78 -37.56 2.8 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.272 -0.892 . . . . 0.0 109.532 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.961 ' N ' HD12 ' A' ' 96' ' ' LEU . 10.6 tp -63.04 -47.24 83.87 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.213 -0.929 . . . . 0.0 109.46 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -69.2 -15.62 63.43 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.285 -0.884 . . . . 0.0 109.481 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -69.99 -28.34 65.44 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.22 -0.925 . . . . 0.0 109.472 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.446 ' HD3' ' N ' ' A' ' 100' ' ' LYS . 0.3 OUTLIER -85.77 -16.24 39.49 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.23 -0.919 . . . . 0.0 109.466 -179.951 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 84.94 14.38 69.8 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' MET . . . . . 0.481 ' HE3' HG23 ' A' ' 34' ' ' VAL . 1.4 mtm -87.29 171.89 10.28 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.243 -1.151 . . . . 0.0 109.43 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.673 ' HB2' HG12 ' A' ' 33' ' ' VAL . 0.1 OUTLIER -80.43 164.93 22.68 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.238 -0.913 . . . . 0.0 109.452 179.974 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.848 HG13 HD23 ' A' ' 97' ' ' LEU . 4.8 t -139.49 125.88 23.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.215 -0.928 . . . . 0.0 109.48 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.427 ' O ' ' C ' ' A' ' 106' ' ' LEU . 2.5 mttt -106.5 64.46 0.66 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.189 -0.944 . . . . 0.0 109.491 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.43 HD12 ' HA ' ' A' ' 106' ' ' LEU . 3.6 tp -43.93 102.55 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.28 -0.887 . . . . 0.0 109.494 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.745 ' HB3' ' HB3' ' A' ' 37' ' ' GLN . . . . . . . . 0 N--CA 1.49 1.568 0 O-C-N 121.23 -0.919 . . . . 0.0 109.456 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 65.9 t0 . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -99.53 139.33 14.37 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.444 ' O ' HG23 ' A' ' 33' ' ' VAL . 18.8 m -143.89 121.56 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.213 -1.169 . . . . 0.0 109.459 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.446 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 2.4 t -98.94 152.8 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.281 -0.887 . . . . 0.0 109.474 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.421 ' HG2' ' C ' ' A' ' 34' ' ' VAL . 4.4 mtt180 -139.01 118.56 12.95 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.314 -0.866 . . . . 0.0 109.461 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.907 HG21 ' HG ' ' A' ' 93' ' ' LEU . 2.6 mp -125.64 116.91 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.218 -0.926 . . . . 0.0 109.45 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.518 ' HB3' ' HB3' ' A' ' 107' ' ' ALA . 12.7 pt20 -146.96 174.24 11.7 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.186 -0.946 . . . . 0.0 109.504 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.401 ' HB2' ' HD2' ' A' ' 90' ' ' ARG . 9.1 ttm180 -102.1 149.74 23.96 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.221 -0.924 . . . . 0.0 109.469 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -136.27 108.04 7.05 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.233 -0.917 . . . . 0.0 109.405 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 40.5 p . . . . . 0 N--CA 1.489 1.518 0 O-C-N 121.264 -0.898 . . . . 0.0 109.493 179.96 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -107.28 135.09 12.55 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 18.6 m -133.06 168.75 23.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.252 -1.146 . . . . 0.0 109.461 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -119.83 116.98 26.97 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.184 -0.947 . . . . 0.0 109.54 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -92.69 129.51 38.59 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.254 -0.904 . . . . 0.0 109.425 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.727 HG12 HG23 ' A' ' 36' ' ' ILE . 21.9 mt -110.07 111.62 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.256 -0.903 . . . . 0.0 109.562 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 60.2 p -137.98 176.25 8.86 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.243 -0.91 . . . . 0.0 109.452 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.89 -15.11 59.81 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 18.6 t -56.67 122.01 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.248 -1.148 . . . . 0.0 109.466 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -124.45 72.12 1.18 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.255 -0.903 . . . . 0.0 109.486 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.643 HD13 ' HB3' ' A' ' 60' ' ' GLU . 8.3 mt -113.15 -173.36 2.24 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.28 -0.887 . . . . 0.0 109.466 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.61 -83.6 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.269 -0.895 . . . . 0.0 109.536 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -156.24 -61.09 0.1 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.22 -0.925 . . . . 0.0 109.452 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.442 ' O ' HG22 ' A' ' 62' ' ' THR . . . -65.33 -26.6 68.11 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.235 -0.916 . . . . 0.0 109.45 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.643 ' HB3' HD13 ' A' ' 56' ' ' LEU . 5.4 mt-10 -62.58 -42.5 99.6 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.253 -0.904 . . . . 0.0 109.481 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -56.03 -59.15 5.32 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.212 -0.93 . . . . 0.0 109.403 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.442 HG22 ' O ' ' A' ' 59' ' ' ALA . 8.8 t -59.46 -20.6 56.43 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.281 -0.887 . . . . 0.0 109.506 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.2 tttt -70.94 -71.06 0.27 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.215 -0.928 . . . . 0.0 109.522 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.635 ' O ' HD13 ' A' ' 64' ' ' LEU . 0.2 OUTLIER -48.25 -32.24 6.95 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.3 -0.875 . . . . 0.0 109.761 -179.869 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.42 -49.86 61.91 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.123 -0.986 . . . . 0.0 109.902 -179.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.421 ' O ' ' HG3' ' A' ' 70' ' ' LYS . . . -60.01 -28.99 68.18 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.089 -1.007 . . . . 0.0 109.891 -179.652 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.45 ' O ' ' HB2' ' A' ' 70' ' ' LYS . 2.6 tt0 -76.71 -33.83 58.18 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.127 -0.983 . . . . 0.0 109.835 -179.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.468 ' HA ' HD23 ' A' ' 68' ' ' LEU . 29.7 mt -71.62 -42.79 67.2 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.155 -0.965 . . . . 0.0 109.624 -179.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 18.7 mtmt -72.34 -4.51 30.32 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.171 -0.956 . . . . 0.0 109.461 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.45 ' HB2' ' O ' ' A' ' 67' ' ' GLU . 4.3 mttt -74.0 -21.8 59.84 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.131 -0.981 . . . . 0.0 109.955 -179.509 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.93 59.3 1.54 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.12 -0.988 . . . . 0.0 109.579 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 4.9 t -134.31 -3.76 2.71 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.17 -0.956 . . . . 0.0 110.029 -179.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.13 2.68 54.13 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -163.54 -169.12 1.84 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.157 -1.202 . . . . 0.0 109.512 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -140.81 -116.18 1.27 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 144.1 -172.36 25.26 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -87.26 126.14 34.64 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.231 -1.158 . . . . 0.0 109.464 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.581 HG23 ' O ' ' A' ' 78' ' ' VAL . 18.8 m -99.39 88.43 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.186 -0.946 . . . . 0.0 109.565 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.47 148.23 22.45 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.208 -0.933 . . . . 0.0 109.351 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -70.83 89.89 0.78 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.193 -0.942 . . . . 0.0 109.555 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.453 ' O ' HG23 ' A' ' 82' ' ' VAL . . . 123.85 -11.19 8.34 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 81' ' ' GLY . 73.2 t -156.18 121.41 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.299 -1.118 . . . . 0.0 109.356 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 11.3 mt -119.45 126.61 75.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.203 -0.935 . . . . 0.0 109.659 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -92.5 120.73 33.26 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.277 -0.889 . . . . 0.0 109.318 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.431 HG22 ' O ' ' A' ' 85' ' ' ILE . 48.1 mm -127.45 70.72 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.28 -0.887 . . . . 0.0 109.561 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -50.43 160.92 0.35 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.256 -0.902 . . . . 0.0 109.416 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 126.59 -159.81 20.88 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -151.82 93.82 1.9 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.239 -1.153 . . . . 0.0 109.539 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 63.5 mttt -152.55 29.03 0.54 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.278 -0.889 . . . . 0.0 109.437 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.7 ' HB3' HD21 ' A' ' 106' ' ' LEU . 26.4 mtp180 -49.53 -38.42 30.59 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.219 -0.926 . . . . 0.0 109.465 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -55.36 -57.19 12.87 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.228 -0.92 . . . . 0.0 109.477 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.77 -21.48 65.88 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.285 -0.884 . . . . 0.0 109.467 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.907 ' HG ' HG21 ' A' ' 36' ' ' ILE . 0.9 OUTLIER -68.94 -42.4 76.77 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.248 -0.907 . . . . 0.0 109.472 179.995 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 18.3 tttt -68.84 -23.67 64.27 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.282 -0.886 . . . . 0.0 109.482 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -74.68 -62.44 1.53 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.173 -0.955 . . . . 0.0 109.437 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.659 HD12 ' N ' ' A' ' 97' ' ' LEU . 2.6 pp -53.92 -35.88 62.15 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.235 -0.916 . . . . 0.0 109.439 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.659 ' N ' HD12 ' A' ' 96' ' ' LEU . 0.2 OUTLIER -63.23 -52.58 61.6 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.281 -0.887 . . . . 0.0 109.483 179.976 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -63.04 -16.54 60.19 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.276 -0.89 . . . . 0.0 109.441 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.453 ' HB3' ' O ' ' A' ' 96' ' ' LEU . . . -65.76 -35.92 82.09 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.248 -0.908 . . . . 0.0 109.505 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.426 ' HE3' HD21 ' A' ' 64' ' ' LEU . 2.7 mptp? -81.05 -38.5 27.3 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.245 -0.909 . . . . 0.0 109.508 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 108.99 14.58 14.73 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 8.1 mtm -89.77 158.83 17.34 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.25 -1.147 . . . . 0.0 109.466 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 20.4 mttt -80.93 120.04 24.23 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.269 -0.895 . . . . 0.0 109.428 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.446 ' HA ' ' O ' ' A' ' 34' ' ' VAL . 3.0 p -115.82 143.11 26.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.218 -0.926 . . . . 0.0 109.455 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.418 ' O ' ' C ' ' A' ' 106' ' ' LEU . 26.6 tttt -114.1 83.19 1.83 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.263 -0.898 . . . . 0.0 109.481 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.7 HD21 ' HB3' ' A' ' 90' ' ' ARG . 0.6 OUTLIER -44.67 -26.81 0.42 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.207 -0.933 . . . . 0.0 109.473 179.993 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.524 ' HB3' ' O ' ' A' ' 106' ' ' LEU . . . . . . . . 0 N--CA 1.49 1.55 0 O-C-N 121.249 -0.907 . . . . 0.0 109.48 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 19.1 p-10 . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.408 ' C ' HG13 ' A' ' 33' ' ' VAL . . . 178.02 130.21 1.37 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.663 ' O ' HG23 ' A' ' 33' ' ' VAL . 19.3 m -152.1 115.12 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.259 -1.142 . . . . 0.0 109.5 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.689 ' HB ' HD11 ' A' ' 97' ' ' LEU . 4.7 t -90.81 142.32 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.253 -0.904 . . . . 0.0 109.486 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 67.8 ttt180 -117.6 109.55 16.82 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.236 -0.915 . . . . 0.0 109.496 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 1.026 HG21 HD13 ' A' ' 93' ' ' LEU . 2.4 mp -108.22 93.7 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.266 -0.896 . . . . 0.0 109.473 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.79 179.96 7.44 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.273 -0.892 . . . . 0.0 109.425 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.71 102.67 3.96 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.254 -0.904 . . . . 0.0 109.446 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.6 ' O ' HG22 ' A' ' 48' ' ' VAL . 7.7 tt0 -88.44 128.83 35.54 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.285 -0.885 . . . . 0.0 109.478 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 74.1 p . . . . . 0 N--CA 1.49 1.554 0 O-C-N 121.279 -0.888 . . . . 0.0 109.481 179.965 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 41.6 pttt . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -161.49 145.1 10.46 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.6 HG22 ' O ' ' A' ' 39' ' ' GLN . 34.1 m -137.08 153.01 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.229 -1.159 . . . . 0.0 109.444 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -130.63 130.53 44.08 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.212 -0.93 . . . . 0.0 109.52 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 4.2 mp -118.74 109.51 16.17 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.235 -0.916 . . . . 0.0 109.468 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.577 HG13 HG23 ' A' ' 36' ' ' ILE . 4.0 mp -99.58 122.25 51.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.192 -0.943 . . . . 0.0 109.492 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.535 ' HB ' HG13 ' A' ' 82' ' ' VAL . 8.8 t -158.47 167.59 29.23 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.289 -0.882 . . . . 0.0 109.496 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 83.44 48.09 5.45 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.652 ' HB ' HD21 ' A' ' 61' ' ' LEU . 18.3 t -103.57 117.45 49.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.22 -1.165 . . . . 0.0 109.506 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -83.55 81.13 8.87 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.178 -0.951 . . . . 0.0 109.437 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.457 ' HA ' HD23 ' A' ' 56' ' ' LEU . 19.0 mt -151.35 174.02 13.82 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.256 -0.902 . . . . 0.0 109.467 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -56.85 166.5 0.97 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.245 -0.91 . . . . 0.0 109.509 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -73.74 -35.87 65.09 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.283 -0.885 . . . . 0.0 109.422 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.03 -29.43 58.07 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.256 -0.903 . . . . 0.0 109.395 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -67.43 -34.66 77.67 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.24 -0.912 . . . . 0.0 109.388 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.652 HD21 ' HB ' ' A' ' 54' ' ' VAL . 0.2 OUTLIER -66.79 -44.62 80.82 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.229 -0.919 . . . . 0.0 109.286 179.89 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 54.9 m -60.82 -44.31 97.09 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.319 -0.863 . . . . 0.0 109.206 179.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 74.4 tttt -57.52 -49.54 76.0 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.342 -0.849 . . . . 0.0 109.363 179.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -55.95 -41.03 74.05 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.256 -0.902 . . . . 0.0 109.505 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.503 ' HB1' HG13 ' A' ' 78' ' ' VAL . . . -62.55 -37.01 84.46 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.242 -0.911 . . . . 0.0 109.578 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -70.81 -31.59 68.4 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.272 -0.893 . . . . 0.0 109.548 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 82.8 mt-10 -71.66 -37.67 70.78 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.181 -0.95 . . . . 0.0 109.433 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.522 HD21 HD22 ' A' ' 96' ' ' LEU . 11.2 mt -68.48 -55.45 11.74 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.253 -0.904 . . . . 0.0 109.531 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 19.8 ttmt -52.84 -40.18 63.13 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.258 -0.902 . . . . 0.0 109.41 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 61.4 tttt -47.81 -47.77 30.92 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.177 -0.952 . . . . 0.0 109.322 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 14.7 mttt -108.09 57.86 0.62 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.372 -0.83 . . . . 0.0 109.301 179.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.5 m -129.69 -75.97 0.55 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.265 -0.897 . . . . 0.0 109.736 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.658 ' O ' ' CB ' ' A' ' 74' ' ' CYS . . . 125.95 49.77 0.18 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.07 -1.612 . . . . 0.0 109.07 -179.582 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.658 ' CB ' ' O ' ' A' ' 73' ' ' GLY . 49.3 t 112.44 104.57 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.237 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -179.499 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -83.8 142.54 20.92 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -86.54 -80.71 1.18 Allowed Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -129.62 124.16 33.03 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.133 -1.216 . . . . 0.0 109.6 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.503 HG13 ' HB1' ' A' ' 65' ' ' ALA . 95.1 t -125.81 95.44 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.303 -0.873 . . . . 0.0 109.298 179.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 18.0 mttt -122.27 142.12 50.8 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.239 -0.913 . . . . 0.0 109.705 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -54.21 94.82 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.283 -0.886 . . . . 0.0 109.491 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 148.02 -46.24 0.71 Allowed Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.535 HG13 ' HB ' ' A' ' 52' ' ' THR . 42.7 t -143.13 160.94 17.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.233 -1.157 . . . . 0.0 109.47 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.478 ' N ' HG12 ' A' ' 82' ' ' VAL . 4.8 mp -138.32 149.43 24.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.246 -0.909 . . . . 0.0 109.43 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -147.14 120.25 8.85 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.252 -0.905 . . . . 0.0 109.473 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 36.3 mm -119.53 117.75 54.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.171 -0.956 . . . . 0.0 109.443 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.57 114.37 10.63 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.234 -0.916 . . . . 0.0 109.481 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 172.2 -137.97 4.54 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.556 -1.417 . . . . 0.0 109.556 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -177.08 53.24 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.238 -1.154 . . . . 0.0 109.452 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 19.8 mttt -106.14 39.45 1.8 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.234 -0.916 . . . . 0.0 109.499 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.85 ' HA ' HD12 ' A' ' 93' ' ' LEU . 5.4 ttm180 -49.59 -35.28 20.28 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.205 -0.934 . . . . 0.0 109.501 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.93 -43.96 91.26 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.241 -0.912 . . . . 0.0 109.439 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.84 -20.32 58.23 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.231 -0.918 . . . . 0.0 109.427 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 1.026 HD13 HG21 ' A' ' 36' ' ' ILE . 19.5 mt -69.33 -43.46 73.66 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.234 -0.916 . . . . 0.0 109.45 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -67.69 -24.07 65.36 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.274 -0.892 . . . . 0.0 109.446 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -74.98 -60.86 2.1 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.205 -0.935 . . . . 0.0 109.491 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.714 HD12 ' N ' ' A' ' 97' ' ' LEU . 3.6 pp -54.08 -34.53 60.41 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.254 -0.904 . . . . 0.0 109.505 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.917 HD13 ' CG2' ' A' ' 104' ' ' VAL . 0.4 OUTLIER -67.33 -47.04 71.68 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.315 -0.866 . . . . 0.0 109.453 179.981 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -65.91 -16.42 63.84 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.29 -0.881 . . . . 0.0 109.466 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -67.3 -36.37 81.38 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.264 -0.897 . . . . 0.0 109.437 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.94 -37.78 23.65 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.266 -0.896 . . . . 0.0 109.48 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 106.19 21.5 8.43 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.96 158.92 16.0 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.253 -1.145 . . . . 0.0 109.485 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.466 ' HB2' HG12 ' A' ' 33' ' ' VAL . 11.5 mttm -82.85 107.28 15.35 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.249 -0.907 . . . . 0.0 109.469 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.917 ' CG2' HD13 ' A' ' 97' ' ' LEU . 7.5 p -84.65 144.47 9.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.226 -0.921 . . . . 0.0 109.471 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 11.0 mttt -113.92 83.76 1.92 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.25 -0.906 . . . . 0.0 109.462 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.502 HD12 ' HA ' ' A' ' 106' ' ' LEU . 1.1 tp -45.09 -27.98 0.66 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.235 -0.916 . . . . 0.0 109.425 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.552 0 O-C-N 121.276 -0.89 . . . . 0.0 109.492 -179.959 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 7.5 tttt . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -166.61 -62.74 0.03 OUTLIER Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 65.84 73.29 0.39 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.302 -1.116 . . . . 0.0 109.53 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.467 ' HA2' ' HB3' ' A' ' 55' ' ' ASP . . . 147.67 126.45 1.64 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.585 ' O ' HG23 ' A' ' 33' ' ' VAL . 19.1 m -133.8 121.26 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.318 -1.107 . . . . 0.0 109.42 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.954 HG22 HG22 ' A' ' 54' ' ' VAL . 77.9 t -96.42 135.78 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.218 -0.926 . . . . 0.0 109.493 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.471 ' O ' ' HG3' ' A' ' 35' ' ' ARG . 0.1 OUTLIER -130.08 124.45 32.82 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.187 -0.946 . . . . 0.0 109.519 -179.992 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.877 HG21 ' HG ' ' A' ' 93' ' ' LEU . 3.9 mp -110.08 126.11 67.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.233 -0.917 . . . . 0.0 109.449 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -121.69 160.65 24.05 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.272 -0.892 . . . . 0.0 109.502 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.405 ' O ' ' HG3' ' A' ' 38' ' ' ARG . 12.0 ptt180 -131.87 104.75 7.04 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.292 -0.88 . . . . 0.0 109.402 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -88.33 80.72 7.43 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.226 -0.921 . . . . 0.0 109.49 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 43.6 p -77.75 -173.24 2.95 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.245 -0.909 . . . . 0.0 109.463 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 22.6 t -139.12 22.65 2.59 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.226 -0.921 . . . . 0.0 109.484 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 158.15 -157.03 27.92 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 19.2 mtt-85 -71.24 -74.08 0.16 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.25 -1.147 . . . . 0.0 109.495 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 76.3 mttt -139.48 115.78 10.49 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.251 -0.906 . . . . 0.0 109.413 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -173.04 -39.83 0.04 OUTLIER Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -168.37 110.48 0.56 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.205 -1.174 . . . . 0.0 109.572 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -118.99 149.61 18.13 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 27.6 m -126.43 158.13 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.232 -1.158 . . . . 0.0 109.487 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -129.42 124.23 33.6 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.267 -0.896 . . . . 0.0 109.48 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.1 mt -115.34 124.26 50.81 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.233 -0.917 . . . . 0.0 109.39 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.49 ' HB ' ' HB ' ' A' ' 83' ' ' ILE . 6.7 mm -107.28 119.28 56.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.231 -0.918 . . . . 0.0 109.595 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.987 HG23 ' O ' ' A' ' 81' ' ' GLY . 1.3 m -158.86 158.72 33.99 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.267 -0.896 . . . . 0.0 109.426 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.487 ' O ' ' N ' ' A' ' 55' ' ' ASP . . . 109.09 -23.86 22.37 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.954 HG22 HG22 ' A' ' 34' ' ' VAL . 21.3 t -49.02 94.17 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.311 -1.111 . . . . 0.0 109.424 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.487 ' N ' ' O ' ' A' ' 53' ' ' GLY . 13.3 t0 -79.78 85.92 5.4 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.234 -0.916 . . . . 0.0 109.527 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.493 HD13 ' OE1' ' A' ' 60' ' ' GLU . 35.2 mt -146.16 167.52 23.24 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.322 -0.861 . . . . 0.0 109.355 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.402 ' C ' ' O ' ' A' ' 56' ' ' LEU . 0.2 OUTLIER -45.47 150.47 0.47 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.224 -0.923 . . . . 0.0 109.392 179.888 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -60.33 -53.35 58.62 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.187 -0.945 . . . . 0.0 109.656 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.12 -39.02 71.59 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.283 -0.886 . . . . 0.0 109.733 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.493 ' OE1' HD13 ' A' ' 56' ' ' LEU . 0.3 OUTLIER -62.41 -39.41 93.19 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.174 -0.954 . . . . 0.0 109.671 -179.801 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.531 HD21 ' HB ' ' A' ' 54' ' ' VAL . 0.2 OUTLIER -58.9 -42.95 90.81 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.213 -0.929 . . . . 0.0 109.602 -179.894 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -61.36 -33.44 73.64 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.309 -0.87 . . . . 0.0 109.638 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -71.58 -34.89 70.31 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.235 -0.915 . . . . 0.0 109.605 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.49 ' HA ' HD22 ' A' ' 64' ' ' LEU . 0.2 OUTLIER -65.99 -59.77 3.5 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.189 -0.944 . . . . 0.0 109.577 -179.973 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -56.99 -34.17 67.86 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.278 -0.889 . . . . 0.0 109.628 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.477 ' HA ' ' HG2' ' A' ' 69' ' ' LYS . . . -66.36 -33.82 76.58 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.274 -0.891 . . . . 0.0 109.768 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -70.17 -44.31 69.05 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.204 -0.935 . . . . 0.0 109.723 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.645 ' CD2' HD22 ' A' ' 96' ' ' LEU . 9.7 mt -63.99 -39.85 95.07 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.231 -0.918 . . . . 0.0 109.629 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.485 ' HB2' ' HA2' ' A' ' 75' ' ' GLY . 12.9 ptmt -75.23 -2.11 26.47 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.321 -0.862 . . . . 0.0 109.854 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 10.3 tttt -76.83 -49.22 16.3 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.096 -1.003 . . . . 0.0 109.993 -179.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.54 64.63 1.43 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.079 -1.013 . . . . 0.0 109.768 -179.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . 0.437 ' HB2' ' O ' ' A' ' 68' ' ' LEU . 5.7 m -128.64 -15.36 4.47 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.192 -0.942 . . . . 0.0 110.078 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.672 ' O ' ' CB ' ' A' ' 74' ' ' CYS . . . 96.35 78.29 1.4 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.672 ' CB ' ' O ' ' A' ' 73' ' ' GLY . 34.7 t 112.02 110.62 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.19 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 -179.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.485 ' HA2' ' HB2' ' A' ' 69' ' ' LYS . . . -67.06 111.61 4.25 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -84.1 148.93 24.74 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -107.25 168.34 9.29 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.194 -1.18 . . . . 0.0 109.783 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.947 HG22 HG12 ' A' ' 83' ' ' ILE . 85.0 t -106.46 162.26 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.42 -0.8 . . . . 0.0 109.347 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.541 ' N ' HG12 ' A' ' 78' ' ' VAL . 6.6 mttt -149.27 82.27 1.42 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.222 -0.924 . . . . 0.0 109.521 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 46.15 66.87 0.85 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.373 -0.829 . . . . 0.0 109.728 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.987 ' O ' HG23 ' A' ' 52' ' ' THR . . . 74.84 8.88 82.91 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 179.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.459 ' O ' ' HB2' ' A' ' 79' ' ' LYS . 3.3 t -124.62 98.57 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.084 -1.245 . . . . 0.0 109.585 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.947 HG12 HG22 ' A' ' 78' ' ' VAL . 6.2 mt -93.15 124.37 45.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.228 -0.92 . . . . 0.0 109.481 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -91.87 124.55 36.07 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.324 -0.86 . . . . 0.0 109.578 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.413 HD13 ' HA ' ' A' ' 85' ' ' ILE . 34.1 mm -127.76 115.1 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.268 -0.895 . . . . 0.0 109.221 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.73 105.46 16.97 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.254 -0.904 . . . . 0.0 109.619 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 162.2 137.69 2.25 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -97.01 64.36 1.98 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.174 -1.192 . . . . 0.0 109.429 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 76.2 mttt -112.06 36.48 3.32 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.278 -0.889 . . . . 0.0 109.471 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 17.7 ttm180 -44.27 -35.8 2.46 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.261 -0.9 . . . . 0.0 109.476 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -56.39 -52.28 65.2 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.242 -0.911 . . . . 0.0 109.498 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.43 -26.88 68.17 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.291 -0.881 . . . . 0.0 109.47 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.877 ' HG ' HG21 ' A' ' 36' ' ' ILE . 3.2 mm? -63.23 -46.08 88.61 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.309 -0.869 . . . . 0.0 109.459 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 72.3 tttt -61.67 -29.95 70.41 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.228 -0.92 . . . . 0.0 109.534 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 17.5 t -69.83 -68.7 0.4 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.253 -0.905 . . . . 0.0 109.449 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.827 HD21 HD13 ' A' ' 93' ' ' LEU . 2.5 pp -44.86 -35.36 2.75 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.242 -0.911 . . . . 0.0 109.42 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.881 HD22 HG22 ' A' ' 104' ' ' VAL . 0.5 OUTLIER -64.63 -47.94 76.69 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.23 -0.919 . . . . 0.0 109.487 179.939 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -67.18 -9.26 38.21 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.234 -0.916 . . . . 0.0 109.488 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.417 ' HB3' ' O ' ' A' ' 96' ' ' LEU . . . -70.44 -33.16 70.99 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.233 -0.917 . . . . 0.0 109.482 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 4.8 mtmm -84.98 -25.87 27.48 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.209 -0.932 . . . . 0.0 109.506 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 92.5 16.01 50.99 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 4.2 mtm -87.69 -174.42 4.76 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.266 -1.138 . . . . 0.0 109.464 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 24.5 mttt -91.42 163.5 14.16 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.262 -0.899 . . . . 0.0 109.487 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.881 HG22 HD22 ' A' ' 97' ' ' LEU . 19.2 t -139.82 158.99 27.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.245 -0.909 . . . . 0.0 109.456 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.452 ' O ' ' N ' ' A' ' 107' ' ' ALA . 17.3 tttt -130.25 61.42 1.59 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.215 -0.928 . . . . 0.0 109.474 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.41 ' C ' ' O ' ' A' ' 105' ' ' LYS . 3.7 tp -44.9 98.49 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.26 -0.9 . . . . 0.0 109.494 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.452 ' N ' ' O ' ' A' ' 105' ' ' LYS . . . -69.06 164.94 21.29 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.206 -0.934 . . . . 0.0 109.488 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 178.2 -168.68 40.07 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 151.65 161.69 10.28 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -110.77 124.4 51.93 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.27 -1.135 . . . . 0.0 109.467 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 117.994 -1.003 . . . . 0.0 109.452 -179.957 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 93.3 mttt . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -178.44 78.57 0.07 OUTLIER Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -92.72 130.32 38.38 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.302 -1.117 . . . . 0.0 109.453 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -86.37 161.08 33.75 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.806 HG12 ' HB3' ' A' ' 103' ' ' LYS . 18.9 m -142.98 97.51 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.189 -1.183 . . . . 0.0 109.506 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.634 ' HB ' HD21 ' A' ' 97' ' ' LEU . 38.6 t -97.06 145.45 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.186 -0.946 . . . . 0.0 109.444 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 58.5 mtt180 -127.45 131.13 50.26 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.265 -0.897 . . . . 0.0 109.493 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.773 ' CD1' HD22 ' A' ' 97' ' ' LEU . 3.0 mp -125.68 106.31 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.293 -0.879 . . . . 0.0 109.476 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.66 ' HA ' ' HB2' ' A' ' 107' ' ' ALA . 20.4 pt20 -113.49 -175.01 2.57 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.265 -0.897 . . . . 0.0 109.443 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.413 ' O ' ' CG ' ' A' ' 38' ' ' ARG . 3.9 ptt180 -133.22 117.85 17.9 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.237 -0.914 . . . . 0.0 109.498 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -95.05 132.63 39.73 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.237 -0.915 . . . . 0.0 109.47 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -117.45 150.79 38.33 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.248 -0.908 . . . . 0.0 109.523 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.35 23.57 14.31 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.246 -0.909 . . . . 0.0 109.449 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 139.47 177.47 15.64 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 61.8 mtt180 -68.79 116.17 8.98 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.202 -1.175 . . . . 0.0 109.522 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 55.2 pttt -168.3 161.04 11.9 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.254 -0.904 . . . . 0.0 109.445 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -78.11 -39.07 24.53 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -57.08 158.59 4.94 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.26 -1.141 . . . . 0.0 109.48 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -166.12 156.86 29.06 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -130.22 165.01 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.276 -1.132 . . . . 0.0 109.454 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 3.5 m -133.82 134.59 43.01 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.245 -0.91 . . . . 0.0 109.515 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -111.18 139.25 46.71 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.261 -0.899 . . . . 0.0 109.489 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.481 HG12 ' CG1' ' A' ' 36' ' ' ILE . 15.3 mt -127.95 107.8 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.246 -0.909 . . . . 0.0 109.468 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 15.8 m -152.47 158.82 43.13 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.237 -0.914 . . . . 0.0 109.426 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 104.36 16.42 18.31 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.781 ' HB ' HD21 ' A' ' 61' ' ' LEU . 21.8 t -74.6 130.42 36.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.198 -1.177 . . . . 0.0 109.46 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -104.44 86.85 2.59 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.232 -0.918 . . . . 0.0 109.45 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.628 ' HB2' HD11 ' A' ' 61' ' ' LEU . 5.1 mt -133.38 -170.63 2.52 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.247 -0.908 . . . . 0.0 109.537 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -73.89 -69.89 0.41 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.191 -0.943 . . . . 0.0 109.481 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 174.12 -63.13 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.171 -0.956 . . . . 0.0 109.521 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.68 -30.89 71.92 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.242 -0.911 . . . . 0.0 109.583 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -66.01 -35.49 80.71 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.182 -0.949 . . . . 0.0 109.478 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.781 HD21 ' HB ' ' A' ' 54' ' ' VAL . 0.3 OUTLIER -63.95 -38.61 91.7 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.27 -0.894 . . . . 0.0 109.548 179.995 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 23.8 m -59.75 -49.64 76.92 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.234 -0.916 . . . . 0.0 109.47 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 58.5 tttt -59.7 -36.88 77.41 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.255 -0.903 . . . . 0.0 109.492 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.46 ' CD1' HD23 ' A' ' 68' ' ' LEU . 0.1 OUTLIER -59.29 -53.69 55.37 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.209 -0.932 . . . . 0.0 109.527 -179.926 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.559 ' HB1' HG11 ' A' ' 78' ' ' VAL . . . -59.15 -32.28 69.73 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.271 -0.893 . . . . 0.0 109.541 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.88 -42.29 94.93 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.238 -0.914 . . . . 0.0 109.401 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -75.64 -19.83 58.93 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.273 -0.892 . . . . 0.0 109.403 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.463 HD13 ' HA ' ' A' ' 68' ' ' LEU . 0.7 OUTLIER -72.17 -53.69 11.93 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.32 -0.863 . . . . 0.0 109.548 -179.956 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.496 ' HA ' ' HB2' ' A' ' 72' ' ' CYS . 1.3 ptpt -65.8 -21.41 66.49 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.323 -0.861 . . . . 0.0 109.694 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 9.3 mttt -58.57 -34.61 71.25 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.321 -0.862 . . . . 0.0 110.042 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 59.7 tttt -120.12 24.03 10.67 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.045 -1.034 . . . . 0.0 110.066 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . 0.496 ' HB2' ' HA ' ' A' ' 69' ' ' LYS . 0.5 OUTLIER -107.37 -27.13 10.65 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.069 -1.019 . . . . 0.0 109.548 179.827 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.424 ' O ' ' HB3' ' A' ' 74' ' ' CYS . . . 61.38 54.09 38.95 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.646 -1.381 . . . . 0.0 109.646 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.424 ' HB3' ' O ' ' A' ' 73' ' ' GLY . 27.0 p 177.66 125.33 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.283 -1.128 . . . . 0.0 109.49 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -114.06 82.27 0.31 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.479 ' O ' ' HB2' ' A' ' 77' ' ' ALA . . . -75.91 -52.88 6.08 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.774 -1.331 . . . . 0.0 109.774 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.479 ' HB2' ' O ' ' A' ' 76' ' ' GLY . . . 176.78 124.42 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.171 -1.194 . . . . 0.0 109.508 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.559 HG11 ' HB1' ' A' ' 65' ' ' ALA . 38.5 t -127.29 122.53 59.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.261 -0.9 . . . . 0.0 109.554 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -131.5 143.81 50.67 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.24 -0.912 . . . . 0.0 109.593 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.63 109.72 0.85 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.157 -0.964 . . . . 0.0 109.36 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 119.68 -38.39 2.81 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 87.8 t -140.26 133.13 33.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.329 -1.1 . . . . 0.0 109.412 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.414 HG12 HG13 ' A' ' 78' ' ' VAL . 12.1 mt -122.55 148.4 26.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.247 -0.908 . . . . 0.0 109.4 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.458 ' O ' HD13 ' A' ' 85' ' ' ILE . 6.9 tt0 -135.41 134.96 40.23 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.175 -0.953 . . . . 0.0 109.686 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.458 HD13 ' O ' ' A' ' 84' ' ' GLU . 27.8 mm -118.15 148.52 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.236 -0.915 . . . . 0.0 109.332 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.38 122.06 46.55 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.204 -0.935 . . . . 0.0 109.478 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 130.43 161.28 10.32 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -103.66 108.93 20.42 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.231 -1.159 . . . . 0.0 109.458 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 30.6 mttt -158.73 31.39 0.22 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.235 -0.916 . . . . 0.0 109.462 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.589 ' HA ' HD12 ' A' ' 93' ' ' LEU . 50.8 ttp180 -53.48 -27.78 27.09 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.249 -0.907 . . . . 0.0 109.485 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 50.0 t0 -60.05 -51.77 68.2 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.259 -0.901 . . . . 0.0 109.456 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.621 HD23 HD23 ' A' ' 96' ' ' LEU . 1.7 tt -70.75 -23.95 62.52 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.21 -0.931 . . . . 0.0 109.438 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.769 HD22 HG21 ' A' ' 36' ' ' ILE . 1.3 mt -63.51 -47.87 79.93 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.193 -0.942 . . . . 0.0 109.424 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.946 ' HD2' HD21 ' A' ' 106' ' ' LEU . 78.2 tttt -61.98 -23.07 66.17 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.244 -0.91 . . . . 0.0 109.451 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 6.6 t -76.56 -65.37 0.94 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.277 -0.889 . . . . 0.0 109.491 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.848 HD12 ' N ' ' A' ' 97' ' ' LEU . 2.9 pp -47.73 -36.04 10.74 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.256 -0.903 . . . . 0.0 109.419 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.848 ' N ' HD12 ' A' ' 96' ' ' LEU . 1.4 tp -69.52 -44.25 71.41 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.225 -0.922 . . . . 0.0 109.456 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 68.4 tt0 -61.21 -20.26 62.58 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.285 -0.884 . . . . 0.0 109.477 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -62.77 -32.28 73.4 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.229 -0.919 . . . . 0.0 109.476 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -84.36 -18.07 37.37 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.229 -0.919 . . . . 0.0 109.495 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 75.47 24.66 69.98 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 1.1 mtm -79.07 179.34 7.41 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.29 -1.124 . . . . 0.0 109.495 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.806 ' HB3' HG12 ' A' ' 33' ' ' VAL . 13.0 mttt -97.21 88.32 4.43 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.308 -0.87 . . . . 0.0 109.447 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.693 ' CG2' HD23 ' A' ' 97' ' ' LEU . 2.1 t -81.62 165.08 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.227 -0.92 . . . . 0.0 109.494 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.401 ' O ' ' C ' ' A' ' 106' ' ' LEU . 41.7 tttt -128.88 28.2 5.37 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.263 -0.898 . . . . 0.0 109.446 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.946 HD21 ' HD2' ' A' ' 94' ' ' LYS . 0.2 OUTLIER 44.24 -157.82 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.243 -0.911 . . . . 0.0 109.456 179.954 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.66 ' HB2' ' HA ' ' A' ' 37' ' ' GLN . . . -98.46 -32.88 11.25 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.213 -0.929 . . . . 0.0 109.479 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -132.93 127.22 4.69 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -113.52 -23.93 4.9 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.4 mt -140.33 112.69 7.85 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.272 -1.134 . . . . 0.0 109.472 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 . . . . . 0 N--CA 1.489 1.52 0 CA-C-O 118.025 -0.988 . . . . 0.0 109.519 -179.975 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 176.09 66.58 0.06 OUTLIER Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -116.45 -63.78 1.4 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.28 -1.13 . . . . 0.0 109.434 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.4 ' C ' ' CG2' ' A' ' 33' ' ' VAL . . . 163.2 128.12 0.93 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.4 ' CG2' ' C ' ' A' ' 32' ' ' GLY . 1.9 t -149.61 151.64 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.248 -1.149 . . . . 0.0 109.546 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.547 ' HB ' HD11 ' A' ' 97' ' ' LEU . 72.7 t -138.1 121.68 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.312 -0.867 . . . . 0.0 109.392 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.436 ' CG ' ' HA3' ' A' ' 53' ' ' GLY . 62.3 mtt180 -88.11 111.22 21.34 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.244 -0.91 . . . . 0.0 109.516 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.93 HD11 HD13 ' A' ' 97' ' ' LEU . 7.5 mt -115.66 108.51 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.263 -0.898 . . . . 0.0 109.408 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.758 ' HB3' ' HB3' ' A' ' 107' ' ' ALA . 3.4 pt20 -131.72 -160.12 1.02 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.21 -0.931 . . . . 0.0 109.548 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 11.9 ptm180 -130.79 132.09 45.06 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.297 -0.877 . . . . 0.0 109.447 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -125.81 77.47 1.67 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.254 -0.904 . . . . 0.0 109.484 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -106.05 17.23 23.88 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.3 -0.875 . . . . 0.0 109.472 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.88 150.38 7.72 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.28 -0.888 . . . . 0.0 109.481 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 68.32 159.65 1.55 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 45.8 mtt180 -95.7 111.5 23.44 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.312 -1.111 . . . . 0.0 109.468 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 50.7 tttt -174.09 31.66 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.244 -0.91 . . . . 0.0 109.51 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 153.34 158.31 8.5 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -71.07 -45.58 63.52 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.269 -1.136 . . . . 0.0 109.447 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 176.96 144.52 5.31 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 16.0 m -135.02 159.05 41.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.275 -1.132 . . . . 0.0 109.373 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -111.9 110.02 20.13 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.247 -0.908 . . . . 0.0 109.531 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.899 HD12 ' HG3' ' A' ' 84' ' ' GLU . 8.5 tp -93.83 129.29 40.28 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.225 -0.922 . . . . 0.0 109.44 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.402 HG23 HD12 ' A' ' 51' ' ' ILE . 11.1 mm -120.91 114.74 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.295 -0.878 . . . . 0.0 109.439 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.444 HG22 ' O ' ' A' ' 52' ' ' THR . 8.6 m -141.6 13.28 2.13 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.307 -0.871 . . . . 0.0 109.496 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.436 ' HA3' ' CG ' ' A' ' 35' ' ' ARG . . . -97.41 19.02 56.37 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.579 -1.409 . . . . 0.0 109.579 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.639 HG11 ' HG ' ' A' ' 61' ' ' LEU . 60.0 t -82.95 105.65 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.267 -1.137 . . . . 0.0 109.452 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -100.19 87.73 3.52 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.187 -0.946 . . . . 0.0 109.522 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.594 HD12 ' CG1' ' A' ' 54' ' ' VAL . 19.2 mt -129.15 -169.23 2.05 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.269 -0.894 . . . . 0.0 109.403 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -81.87 -65.33 1.02 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.235 -0.916 . . . . 0.0 109.446 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.4 t0 179.76 -50.34 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.23 -0.918 . . . . 0.0 109.402 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -73.6 -34.71 65.18 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.24 -0.913 . . . . 0.0 109.437 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -70.2 -28.15 65.06 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.261 -0.899 . . . . 0.0 109.413 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.639 ' HG ' HG11 ' A' ' 54' ' ' VAL . 0.4 OUTLIER -66.55 -55.46 15.38 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.263 -0.898 . . . . 0.0 109.476 179.951 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.449 HG23 ' N ' ' A' ' 63' ' ' LYS . 8.2 t -59.81 -37.73 79.99 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.26 -0.9 . . . . 0.0 109.551 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.449 ' N ' HG23 ' A' ' 62' ' ' THR . 0.7 OUTLIER -57.74 -62.39 1.83 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.206 -0.934 . . . . 0.0 109.535 -179.947 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.5 tt -49.82 -48.43 50.81 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.258 -0.901 . . . . 0.0 109.612 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -50.08 -41.61 48.47 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.29 -0.881 . . . . 0.0 109.659 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.8 -34.92 76.34 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.213 -0.93 . . . . 0.0 109.657 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -67.18 -30.26 70.17 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.222 -0.924 . . . . 0.0 109.584 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -79.62 -33.93 41.06 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.293 -0.88 . . . . 0.0 109.454 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.476 ' HA ' ' HB3' ' A' ' 72' ' ' CYS . 6.8 ttpt -77.04 -9.58 58.81 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.267 -0.895 . . . . 0.0 109.377 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -68.51 -41.58 79.77 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.187 -0.946 . . . . 0.0 109.46 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 39.6 mttt -103.83 5.44 35.91 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.267 -0.896 . . . . 0.0 109.493 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . 0.476 ' HB3' ' HA ' ' A' ' 69' ' ' LYS . 31.9 t -81.4 -64.44 1.19 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.217 -0.927 . . . . 0.0 109.615 -179.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 91.38 19.65 41.02 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.291 -1.524 . . . . 0.0 109.291 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 17.4 t -174.92 90.95 0.06 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.364 -1.08 . . . . 0.0 109.304 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -95.89 157.99 21.81 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -117.98 -87.57 1.21 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -134.07 127.99 33.33 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.187 -1.184 . . . . 0.0 109.288 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.701 HG22 HG23 ' A' ' 83' ' ' ILE . 84.0 t -128.03 82.64 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.152 -0.967 . . . . 0.0 109.682 -179.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 65.4 mttt -94.09 155.69 16.96 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.268 -0.895 . . . . 0.0 109.255 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -63.72 104.97 0.73 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.24 -0.912 . . . . 0.0 109.575 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 129.67 -26.32 4.32 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 90.9 t -149.79 151.9 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.207 -1.172 . . . . 0.0 109.726 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.701 HG23 HG22 ' A' ' 78' ' ' VAL . 15.8 mt -143.7 120.58 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.389 -0.819 . . . . 0.0 109.249 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.899 ' HG3' HD12 ' A' ' 50' ' ' LEU . 1.7 tt0 -112.56 130.28 56.07 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.219 -0.925 . . . . 0.0 109.638 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.402 HD13 ' HA ' ' A' ' 85' ' ' ILE . 25.7 mm -126.39 145.85 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.262 -0.899 . . . . 0.0 109.335 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.53 112.23 24.47 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.231 -0.918 . . . . 0.0 109.543 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -161.03 -40.07 0.02 OUTLIER Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 27.7 t70 53.36 60.83 3.46 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.314 -1.11 . . . . 0.0 109.478 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 16.8 mttt -152.15 65.98 0.84 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.288 -0.883 . . . . 0.0 109.466 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 4.1 ptt-85 -56.79 -28.92 62.15 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.218 -0.927 . . . . 0.0 109.478 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -55.28 -52.63 62.82 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.242 -0.911 . . . . 0.0 109.455 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.5 tt -70.02 -42.07 73.45 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.25 -0.906 . . . . 0.0 109.511 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.653 HD13 ' CG2' ' A' ' 36' ' ' ILE . 2.3 mt -54.28 -26.27 28.16 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.196 -0.94 . . . . 0.0 109.484 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -64.48 -64.33 0.91 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.259 -0.901 . . . . 0.0 109.412 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -63.51 -13.93 45.98 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.276 -0.89 . . . . 0.0 109.435 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.827 HD23 ' N ' ' A' ' 97' ' ' LEU . 4.1 tt -71.16 -56.9 5.13 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.287 -0.883 . . . . 0.0 109.429 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.956 HD22 HG22 ' A' ' 104' ' ' VAL . 0.2 OUTLIER -70.91 -30.54 66.91 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.306 -0.871 . . . . 0.0 109.437 -179.966 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -64.71 -18.09 64.7 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.261 -0.899 . . . . 0.0 109.458 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.95 -37.24 86.99 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.292 -0.88 . . . . 0.0 109.484 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 11.2 mtpp -82.63 -34.91 27.39 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.266 -0.896 . . . . 0.0 109.444 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 107.99 17.85 10.54 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 1.5 mtm -91.28 167.85 12.01 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.261 -1.141 . . . . 0.0 109.45 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.14 157.76 22.65 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.245 -0.91 . . . . 0.0 109.44 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.956 HG22 HD22 ' A' ' 97' ' ' LEU . 87.3 t -136.19 123.0 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.312 -0.867 . . . . 0.0 109.423 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.84 88.63 4.34 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.239 -0.913 . . . . 0.0 109.49 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.556 ' O ' ' HB3' ' A' ' 107' ' ' ALA . 30.9 mt -44.24 -36.11 2.57 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.339 -0.85 . . . . 0.0 109.465 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.758 ' HB3' ' HB3' ' A' ' 37' ' ' GLN . . . 68.1 83.6 0.16 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.248 -0.908 . . . . 0.0 109.455 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -173.53 102.54 0.17 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.569 -1.413 . . . . 0.0 109.569 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 72.01 174.46 22.48 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.3 pp -149.48 144.97 26.64 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.305 -1.115 . . . . 0.0 109.469 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.507 -180.0 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 56.3 mttp . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -132.76 165.59 23.8 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -178.68 110.5 0.05 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.275 -1.132 . . . . 0.0 109.455 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.581 ' CA ' HD21 ' A' ' 56' ' ' LEU . . . 76.92 117.58 0.16 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.976 HG13 ' O ' ' A' ' 103' ' ' LYS . 82.2 t -143.68 122.55 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.261 -1.14 . . . . 0.0 109.483 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.778 ' O ' HG23 ' A' ' 104' ' ' VAL . 44.5 t -101.77 135.17 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.257 -0.902 . . . . 0.0 109.462 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 13.4 ttt180 -102.89 123.35 46.36 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.231 -0.918 . . . . 0.0 109.521 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.772 HG21 HD13 ' A' ' 93' ' ' LEU . 4.0 mt -128.87 112.49 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.195 -0.94 . . . . 0.0 109.537 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.704 ' HB3' ' HB3' ' A' ' 107' ' ' ALA . 3.3 pm0 -136.3 110.9 8.61 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.277 -0.889 . . . . 0.0 109.49 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.412 ' HG3' ' O ' ' A' ' 38' ' ' ARG . 0.0 OUTLIER -69.83 109.64 4.54 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.277 -0.89 . . . . 0.0 109.433 -179.949 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -96.17 138.99 32.97 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.304 -0.872 . . . . 0.0 109.507 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.401 HG22 ' N ' ' A' ' 41' ' ' SER . 8.9 m -111.24 163.34 14.04 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.25 -0.906 . . . . 0.0 109.446 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.401 ' N ' HG22 ' A' ' 40' ' ' THR . 4.5 t -119.99 -29.3 4.96 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.275 -0.891 . . . . 0.0 109.438 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.418 ' O ' ' CB ' ' A' ' 43' ' ' ARG . . . 169.65 150.56 6.87 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.418 ' CB ' ' O ' ' A' ' 42' ' ' GLY . 4.6 ttm180 70.32 160.02 0.2 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.274 -1.133 . . . . 0.0 109.45 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -99.9 27.29 5.59 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.22 -0.925 . . . . 0.0 109.468 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -116.39 -25.95 3.31 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 12.5 tttt -86.62 162.16 18.11 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.3 -1.118 . . . . 0.0 109.48 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 169.26 139.53 2.74 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 16.0 m -146.71 151.16 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.201 -1.176 . . . . 0.0 109.475 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -111.04 126.01 54.36 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.302 -0.874 . . . . 0.0 109.444 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.2 mp -112.99 104.77 12.73 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.254 -0.904 . . . . 0.0 109.578 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.454 ' HB ' ' HB ' ' A' ' 83' ' ' ILE . 8.2 mm -82.83 119.67 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.251 -0.905 . . . . 0.0 109.39 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 9.8 t -159.93 169.59 23.17 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.211 -0.93 . . . . 0.0 109.5 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 84.33 24.13 48.56 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.559 ' HB ' HD21 ' A' ' 61' ' ' LEU . 3.3 t -91.59 126.68 44.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.25 -1.147 . . . . 0.0 109.495 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -113.55 78.73 1.17 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.271 -0.893 . . . . 0.0 109.43 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.581 HD21 ' CA ' ' A' ' 32' ' ' GLY . 84.7 mt -137.21 -170.44 2.72 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.244 -0.91 . . . . 0.0 109.429 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.491 ' HB3' ' HB2' ' A' ' 60' ' ' GLU . 6.7 t0 -57.92 151.42 18.26 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.257 -0.902 . . . . 0.0 109.484 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.87 -54.25 49.25 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.237 -0.914 . . . . 0.0 109.513 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.57 -21.76 62.65 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.191 -0.943 . . . . 0.0 109.604 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.491 ' HB2' ' HB3' ' A' ' 57' ' ' ASP . 19.0 tt0 -61.99 -41.74 98.38 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.201 -0.937 . . . . 0.0 109.597 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.559 HD21 ' HB ' ' A' ' 54' ' ' VAL . 1.8 mp -61.08 -56.7 17.82 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.225 -0.922 . . . . 0.0 109.579 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 86.6 m -47.87 -36.69 12.51 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.15 -0.969 . . . . 0.0 109.492 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.408 ' O ' ' C ' ' A' ' 64' ' ' LEU . 15.4 tttt -61.84 -64.76 0.84 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.265 -0.897 . . . . 0.0 109.437 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.421 HD23 HD23 ' A' ' 68' ' ' LEU . 0.5 OUTLIER -44.55 -41.51 6.53 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.281 -0.887 . . . . 0.0 109.751 -179.862 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -56.83 -59.09 5.55 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.242 -0.911 . . . . 0.0 109.702 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.3 -17.08 17.01 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.292 -0.88 . . . . 0.0 109.81 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -76.65 -44.16 35.13 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.162 -0.961 . . . . 0.0 110.042 -179.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.481 HD22 ' N ' ' A' ' 68' ' ' LEU . 4.4 mm? -79.58 -26.52 41.28 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.073 -1.017 . . . . 0.0 110.201 -179.413 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.1 ttmt -71.18 -5.84 34.92 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.056 -1.028 . . . . 0.0 109.593 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -60.22 -42.23 94.72 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.251 -0.905 . . . . 0.0 109.196 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.52 43.48 0.75 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.313 -0.867 . . . . 0.0 109.688 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -77.78 -28.35 50.48 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.345 -0.847 . . . . 0.0 108.944 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.488 ' O ' ' HB2' ' A' ' 74' ' ' CYS . . . 124.75 -27.98 5.31 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 108.839 -1.705 . . . . 0.0 108.839 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.488 ' HB2' ' O ' ' A' ' 73' ' ' GLY . 4.5 t 165.36 97.42 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.554 -0.968 . . . . 0.0 108.695 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -76.52 116.29 4.64 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.444 -1.463 . . . . 0.0 109.444 -179.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -63.4 -88.47 0.04 OUTLIER Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.496 -1.441 . . . . 0.0 109.496 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -133.09 160.6 36.71 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.341 -1.093 . . . . 0.0 109.559 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 39.5 t -132.0 140.75 47.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.277 -0.89 . . . . 0.0 109.413 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 48.5 mttt -148.18 141.68 25.38 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.287 -0.883 . . . . 0.0 109.414 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -60.71 91.49 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.153 -0.967 . . . . 0.0 109.516 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 134.93 -37.33 1.95 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 90.8 t -139.86 135.18 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.266 -1.138 . . . . 0.0 109.341 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.454 ' HB ' ' HB ' ' A' ' 51' ' ' ILE . 41.4 mt -130.99 133.92 62.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.227 -0.92 . . . . 0.0 109.612 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 -104.33 120.62 41.59 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.263 -0.898 . . . . 0.0 109.43 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.438 HD13 ' HA ' ' A' ' 85' ' ' ILE . 20.4 mm -122.44 91.4 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.209 -0.932 . . . . 0.0 109.46 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -55.2 129.99 40.4 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.211 -0.931 . . . . 0.0 109.505 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 161.74 -155.16 26.32 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -177.79 70.38 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.203 -1.175 . . . . 0.0 109.475 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 55.1 mttt -143.51 49.44 1.41 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.276 -0.89 . . . . 0.0 109.537 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -48.44 -28.76 3.48 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.27 -0.894 . . . . 0.0 109.426 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -60.77 -55.16 36.48 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.196 -0.94 . . . . 0.0 109.433 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.506 HD23 HD23 ' A' ' 96' ' ' LEU . 2.7 tt -64.49 -29.2 70.24 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.24 -0.913 . . . . 0.0 109.477 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.772 HD13 HG21 ' A' ' 36' ' ' ILE . 0.3 OUTLIER -61.86 -44.04 97.64 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.21 -0.931 . . . . 0.0 109.474 -179.979 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -63.21 -30.31 71.48 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.291 -0.881 . . . . 0.0 109.438 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.404 ' O ' ' C ' ' A' ' 96' ' ' LEU . 46.8 t -70.32 -68.95 0.39 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.284 -0.885 . . . . 0.0 109.469 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.719 HD12 ' N ' ' A' ' 97' ' ' LEU . 3.8 pp -45.42 -35.39 3.67 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.224 -0.923 . . . . 0.0 109.493 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.719 ' N ' HD12 ' A' ' 96' ' ' LEU . 2.5 tt -62.54 -52.67 62.51 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.292 -0.88 . . . . 0.0 109.431 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -62.25 -17.52 58.66 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.248 -0.908 . . . . 0.0 109.441 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.488 ' HB3' ' O ' ' A' ' 96' ' ' LEU . . . -62.18 -37.2 84.38 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.303 -0.873 . . . . 0.0 109.466 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -84.23 -23.47 30.43 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.196 -0.94 . . . . 0.0 109.477 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 93.58 14.8 52.31 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' MET . . . . . 0.606 ' CE ' HG23 ' A' ' 34' ' ' VAL . 2.6 mtm -85.42 152.79 22.96 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.194 -1.18 . . . . 0.0 109.49 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.976 ' O ' HG13 ' A' ' 33' ' ' VAL . 16.2 mttt -81.31 149.35 28.97 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.264 -0.898 . . . . 0.0 109.436 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.778 HG23 ' O ' ' A' ' 34' ' ' VAL . 12.9 p -136.87 153.59 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.259 -0.901 . . . . 0.0 109.454 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 69.6 mttt -120.93 85.83 2.47 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.248 -0.907 . . . . 0.0 109.431 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -50.52 101.33 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.263 -0.898 . . . . 0.0 109.521 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.704 ' HB3' ' HB3' ' A' ' 37' ' ' GLN . . . -89.16 175.4 7.39 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.236 -0.915 . . . . 0.0 109.493 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 156.81 -146.86 14.52 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 159.58 118.97 0.53 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -101.45 -27.35 13.18 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.249 -1.148 . . . . 0.0 109.463 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.441 ' O ' ' HG2' ' A' ' 111' ' ' GLU . 77.7 tt0 . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 118.0 -1.0 . . . . 0.0 109.418 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 23.8 mtpt . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -136.49 58.11 0.66 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -106.64 104.87 14.66 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.286 -1.126 . . . . 0.0 109.515 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.444 ' O ' HG13 ' A' ' 33' ' ' VAL . . . -117.09 133.43 10.62 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.444 HG13 ' O ' ' A' ' 32' ' ' GLY . 5.8 m -154.43 145.48 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.217 -1.166 . . . . 0.0 109.493 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.518 HG13 HG22 ' A' ' 54' ' ' VAL . 45.0 t -127.73 147.36 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.286 -0.884 . . . . 0.0 109.436 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.481 ' HB2' ' HA3' ' A' ' 53' ' ' GLY . 3.2 ttm180 -103.18 99.56 9.43 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.224 -0.922 . . . . 0.0 109.487 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.8 ' CG2' HD13 ' A' ' 93' ' ' LEU . 11.0 mt -104.87 107.58 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.236 -0.915 . . . . 0.0 109.457 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.923 ' HB3' ' HB3' ' A' ' 107' ' ' ALA . 1.5 pt20 -137.64 138.44 39.47 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.255 -0.903 . . . . 0.0 109.47 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 10.1 ptt85 -92.63 127.63 38.2 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.232 -0.917 . . . . 0.0 109.532 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -115.06 81.88 1.65 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.266 -0.896 . . . . 0.0 109.384 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 4.2 p -50.57 162.14 0.27 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.215 -0.928 . . . . 0.0 109.504 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -148.92 37.55 0.8 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.28 -0.888 . . . . 0.0 109.458 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 152.55 169.52 17.96 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -105.73 49.0 0.82 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.272 -1.134 . . . . 0.0 109.391 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 74.1 mttt -130.83 49.43 2.32 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.279 -0.888 . . . . 0.0 109.531 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 54.75 42.17 77.46 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 12.7 tttt -100.07 87.35 3.45 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.244 -1.15 . . . . 0.0 109.424 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -103.29 130.35 10.21 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 35.2 m -144.09 154.08 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.312 -1.111 . . . . 0.0 109.459 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -125.65 125.31 42.89 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.166 -0.959 . . . . 0.0 109.54 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.5 mp -106.29 111.07 23.51 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.253 -0.904 . . . . 0.0 109.485 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.458 ' HB ' ' HB ' ' A' ' 83' ' ' ILE . 5.4 mm -98.64 117.76 44.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.233 -0.917 . . . . 0.0 109.481 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.0 m -154.82 25.89 0.44 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.207 -0.933 . . . . 0.0 109.491 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.481 ' HA3' ' HB2' ' A' ' 35' ' ' ARG . . . -119.68 28.51 6.43 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.758 ' HB ' HD21 ' A' ' 61' ' ' LEU . 17.5 t -88.28 127.83 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.224 -1.162 . . . . 0.0 109.462 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -115.95 82.71 1.82 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.262 -0.899 . . . . 0.0 109.442 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.6 mt -146.21 -172.65 3.98 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.247 -0.908 . . . . 0.0 109.465 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.464 ' HB2' ' HB2' ' A' ' 60' ' ' GLU . 2.9 m-20 -59.37 167.04 2.02 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.265 -0.897 . . . . 0.0 109.396 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -76.16 -50.58 14.2 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.251 -0.906 . . . . 0.0 109.329 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -69.24 -27.9 65.86 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.294 -0.879 . . . . 0.0 109.301 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.464 ' HB2' ' HB2' ' A' ' 57' ' ' ASP . 18.3 tt0 -70.47 -37.07 74.21 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.274 -0.891 . . . . 0.0 109.391 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.758 HD21 ' HB ' ' A' ' 54' ' ' VAL . 0.0 OUTLIER -66.27 -35.41 80.33 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.301 -0.874 . . . . 0.0 109.49 179.957 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.5 m -66.85 -31.05 71.41 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.294 -0.879 . . . . 0.0 109.583 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 43.8 mttt -72.5 -49.31 33.93 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.274 -0.891 . . . . 0.0 109.616 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.441 HD11 ' HE2' ' A' ' 100' ' ' LYS . 1.4 tp -55.24 -48.34 74.11 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.244 -0.91 . . . . 0.0 109.419 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.828 ' HA ' HD12 ' A' ' 68' ' ' LEU . . . -61.74 -36.13 80.1 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.309 -0.869 . . . . 0.0 109.394 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.08 -47.44 85.89 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.274 -0.891 . . . . 0.0 109.528 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -72.24 -19.77 61.65 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.215 -0.928 . . . . 0.0 109.545 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.828 HD12 ' HA ' ' A' ' 65' ' ' ALA . 7.1 mt -70.29 -63.88 1.0 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.201 -0.937 . . . . 0.0 109.12 179.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.31 -12.0 12.04 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.457 -0.777 . . . . 0.0 109.631 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.5 -50.79 62.09 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.15 -0.969 . . . . 0.0 109.369 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -111.36 31.43 6.11 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.195 -0.941 . . . . 0.0 109.724 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 42.5 t -96.7 -12.31 23.96 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.106 -0.996 . . . . 0.0 109.657 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 90.51 -32.96 4.77 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 9.9 t 179.15 112.07 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.981 -1.305 . . . . 0.0 109.537 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -91.77 -150.15 25.1 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 110.034 -1.227 . . . . 0.0 110.034 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -157.94 -83.3 0.04 OUTLIER Glycine 0 N--CA 1.493 2.456 0 O-C-N 121.228 -1.16 . . . . 0.0 110.257 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -113.9 118.0 32.96 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.06 -1.259 . . . . 0.0 109.851 -179.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 97.7 t -109.69 120.35 60.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.256 -0.903 . . . . 0.0 109.731 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.6 mtmt -154.16 149.96 27.61 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.299 -0.876 . . . . 0.0 109.239 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -70.58 97.03 1.26 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.156 -0.965 . . . . 0.0 109.523 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.501 ' O ' HG23 ' A' ' 82' ' ' VAL . . . 125.52 -11.42 7.54 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.501 HG23 ' O ' ' A' ' 81' ' ' GLY . 57.3 t -156.88 108.33 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.055 -1.262 . . . . 0.0 109.413 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.458 ' HB ' ' HB ' ' A' ' 51' ' ' ILE . 4.1 mt -118.74 104.85 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.208 -0.932 . . . . 0.0 109.52 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -92.92 112.28 24.18 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.295 -0.878 . . . . 0.0 109.615 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 49.5 mm -99.07 89.95 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.229 -0.919 . . . . 0.0 109.29 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -60.13 104.69 0.33 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.224 -0.922 . . . . 0.0 109.548 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 156.57 152.27 6.23 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -112.05 96.83 6.27 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.288 -1.124 . . . . 0.0 109.515 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 16.2 mttt -141.3 48.37 1.67 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.296 -0.878 . . . . 0.0 109.5 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.947 ' HA ' HD12 ' A' ' 93' ' ' LEU . 39.2 ptt180 -49.38 -32.01 10.67 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.231 -0.918 . . . . 0.0 109.659 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.425 ' N ' ' HG3' ' A' ' 90' ' ' ARG . 67.8 t0 -62.21 -60.39 3.65 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.228 -0.92 . . . . 0.0 109.572 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.1 tp -59.25 -22.67 61.47 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.167 -0.958 . . . . 0.0 109.351 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.947 HD12 ' HA ' ' A' ' 90' ' ' ARG . 35.4 mt -69.11 -46.29 68.07 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.312 -0.868 . . . . 0.0 109.471 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 77.0 tttt -61.73 -25.76 67.64 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.196 -0.94 . . . . 0.0 109.46 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 8.7 t -76.05 -61.05 2.07 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.229 -0.919 . . . . 0.0 109.564 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.902 HD12 ' N ' ' A' ' 97' ' ' LEU . 4.2 pp -52.91 -29.72 30.13 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.246 -0.909 . . . . 0.0 109.537 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.902 ' N ' HD12 ' A' ' 96' ' ' LEU . 0.2 OUTLIER -72.34 -48.55 41.08 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.22 -0.925 . . . . 0.0 109.491 -179.955 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -68.74 -12.74 61.81 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.244 -0.91 . . . . 0.0 109.465 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -61.97 -33.11 73.7 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.226 -0.921 . . . . 0.0 109.469 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.441 ' HE2' HD11 ' A' ' 64' ' ' LEU . 0.0 OUTLIER -85.73 -22.04 27.97 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.22 -0.925 . . . . 0.0 109.491 179.986 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 77.89 24.6 64.1 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -99.09 -158.88 0.7 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.255 -1.144 . . . . 0.0 109.479 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 23.3 mttt -104.06 165.06 11.29 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.206 -0.934 . . . . 0.0 109.492 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.418 HG22 ' N ' ' A' ' 105' ' ' LYS . 11.4 p -145.03 158.25 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.24 -0.912 . . . . 0.0 109.458 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.422 ' O ' ' N ' ' A' ' 107' ' ' ALA . 33.9 tttt -119.61 68.47 0.82 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.262 -0.899 . . . . 0.0 109.471 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -50.39 96.61 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.212 -0.93 . . . . 0.0 109.478 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.923 ' HB3' ' HB3' ' A' ' 37' ' ' GLN . . . -89.05 140.06 29.83 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.325 -0.86 . . . . 0.0 109.509 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 117.73 174.62 16.75 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -168.94 -177.82 40.0 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -77.6 115.58 17.47 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.253 -1.146 . . . . 0.0 109.469 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.438 ' O ' ' HG2' ' A' ' 111' ' ' GLU . 74.0 tt0 . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.442 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 88.3 mttt . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -171.57 130.32 1.93 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -142.64 72.43 1.37 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.209 -1.171 . . . . 0.0 109.512 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 125.61 59.67 0.16 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.474 HG22 ' HB2' ' A' ' 103' ' ' LYS . 73.3 t -108.89 111.29 35.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.263 -1.139 . . . . 0.0 109.423 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.913 HG13 HG22 ' A' ' 54' ' ' VAL . 39.8 t -87.65 145.13 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.275 -0.891 . . . . 0.0 109.522 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 31.9 ttm180 -111.55 103.53 11.86 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.228 -0.92 . . . . 0.0 109.437 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.976 HD11 HD23 ' A' ' 97' ' ' LEU . 4.7 mt -102.07 106.22 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.196 -0.94 . . . . 0.0 109.538 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.872 ' HB3' ' HB3' ' A' ' 107' ' ' ALA . 1.7 pp0? -142.66 136.58 29.22 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.227 -0.921 . . . . 0.0 109.412 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.65 167.03 11.37 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.235 -0.915 . . . . 0.0 109.501 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -150.17 154.29 37.75 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.243 -0.91 . . . . 0.0 109.467 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.46 76.79 1.03 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.298 -0.876 . . . . 0.0 109.468 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -147.13 104.01 3.64 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.247 -0.908 . . . . 0.0 109.465 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 153.61 138.25 2.63 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.536 -1.425 . . . . 0.0 109.536 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 91.2 mtt180 -96.34 23.35 6.79 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.253 -1.146 . . . . 0.0 109.497 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 25.3 mttt -129.05 29.35 5.19 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.287 -0.883 . . . . 0.0 109.441 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 159.71 137.5 2.24 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -113.0 120.01 39.9 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.219 -1.166 . . . . 0.0 109.485 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.62 85.85 0.65 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 27.7 m -123.69 168.33 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.242 -1.152 . . . . 0.0 109.452 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 2.1 t -140.72 132.51 27.43 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.223 -0.923 . . . . 0.0 109.429 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.668 ' O ' HD13 ' A' ' 51' ' ' ILE . 0.2 OUTLIER -124.09 154.56 39.78 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.265 -0.897 . . . . 0.0 109.449 -179.979 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.697 ' HB ' HD12 ' A' ' 83' ' ' ILE . 4.5 mm -122.15 117.83 53.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.246 -0.909 . . . . 0.0 109.463 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.1 m -141.84 14.01 2.1 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.261 -0.9 . . . . 0.0 109.525 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.442 ' O ' ' N ' ' A' ' 55' ' ' ASP . . . -105.5 -16.69 15.27 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.913 HG22 HG13 ' A' ' 34' ' ' VAL . 18.6 t -44.93 98.9 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.214 -1.168 . . . . 0.0 109.494 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.442 ' N ' ' O ' ' A' ' 53' ' ' GLY . 41.0 t0 -87.34 88.28 7.64 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.201 -0.937 . . . . 0.0 109.459 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.495 ' HA ' HD23 ' A' ' 56' ' ' LEU . 12.9 mt -151.42 -169.95 3.52 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.281 -0.887 . . . . 0.0 109.487 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -74.76 178.49 5.43 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.259 -0.901 . . . . 0.0 109.441 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.53 -30.31 46.95 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.286 -0.884 . . . . 0.0 109.444 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -75.79 -48.66 20.77 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.213 -0.929 . . . . 0.0 109.464 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -62.06 -32.16 72.66 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.276 -0.89 . . . . 0.0 109.466 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.525 HD23 ' HA2' ' A' ' 81' ' ' GLY . 0.2 OUTLIER -65.36 -45.83 82.55 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.225 -0.922 . . . . 0.0 109.435 -179.994 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 51.5 p -63.78 -33.88 76.65 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.218 -0.926 . . . . 0.0 109.47 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 32.6 mttp -65.65 -46.73 78.06 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.29 -0.882 . . . . 0.0 109.469 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.29 -57.65 12.08 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.339 -0.851 . . . . 0.0 109.527 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.789 ' HA ' HD12 ' A' ' 68' ' ' LEU . . . -58.55 -23.63 58.87 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.273 -0.892 . . . . 0.0 109.534 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -69.72 -41.49 75.26 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.241 -0.912 . . . . 0.0 109.582 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -76.99 -29.21 55.4 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.203 -0.936 . . . . 0.0 109.566 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.789 HD12 ' HA ' ' A' ' 65' ' ' ALA . 9.8 mt -67.7 -52.22 40.32 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.242 -0.911 . . . . 0.0 109.47 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.414 ' HB3' ' HA3' ' A' ' 76' ' ' GLY . 0.0 OUTLIER -66.46 -12.55 57.85 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.295 -0.878 . . . . 0.0 109.504 -179.929 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -74.97 -42.11 58.26 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.197 -0.939 . . . . 0.0 109.507 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 5.7 tttp -67.1 -19.86 65.7 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.304 -0.873 . . . . 0.0 109.654 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 43.7 t -88.14 -43.52 11.59 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.193 -0.942 . . . . 0.0 109.552 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.403 ' O ' ' HB2' ' A' ' 74' ' ' CYS . . . 100.62 -19.87 50.63 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.403 ' HB2' ' O ' ' A' ' 73' ' ' GLY . 0.1 OUTLIER 172.08 134.97 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.169 -1.195 . . . . 0.0 109.532 -179.981 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 126.73 -34.45 3.15 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.414 ' HA3' ' HB3' ' A' ' 69' ' ' LYS . . . -69.31 98.76 0.59 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -108.9 134.52 51.46 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.305 -1.114 . . . . 0.0 109.17 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.455 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 26.8 m -101.02 160.49 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.269 -0.894 . . . . 0.0 109.817 -179.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.443 ' HB2' ' O ' ' A' ' 82' ' ' VAL . 0.2 OUTLIER -142.05 65.82 1.36 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.362 -0.836 . . . . 0.0 109.208 179.747 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 25.4 t70 50.76 68.7 0.73 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.362 -0.836 . . . . 0.0 109.545 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.525 ' HA2' HD23 ' A' ' 61' ' ' LEU . . . 90.3 -28.57 7.32 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.443 ' O ' ' HB2' ' A' ' 79' ' ' LYS . 40.2 t -91.59 90.74 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.161 -1.199 . . . . 0.0 109.559 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.697 HD12 ' HB ' ' A' ' 51' ' ' ILE . 11.7 mt -82.04 155.86 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.276 -0.89 . . . . 0.0 109.437 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -149.56 113.33 5.07 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.2 -0.937 . . . . 0.0 109.436 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.403 HG12 ' HA2' ' A' ' 76' ' ' GLY . 23.8 mt -130.9 107.62 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.215 -0.928 . . . . 0.0 109.511 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -53.74 148.52 9.84 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.235 -0.916 . . . . 0.0 109.397 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 143.55 152.84 5.73 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -133.91 84.14 2.1 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.252 -1.146 . . . . 0.0 109.429 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 84.7 mttt -148.21 52.22 1.02 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.282 -0.886 . . . . 0.0 109.478 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 11.8 ptt-85 -46.58 -31.95 3.13 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.25 -0.906 . . . . 0.0 109.472 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -55.78 -55.21 35.03 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.236 -0.915 . . . . 0.0 109.465 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.556 ' C ' HD23 ' A' ' 92' ' ' LEU . 8.2 tt -63.16 -49.32 74.77 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.176 -0.952 . . . . 0.0 109.491 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.649 ' HB3' HG21 ' A' ' 36' ' ' ILE . 3.7 mm? -47.87 -31.04 4.61 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.229 -0.919 . . . . 0.0 109.481 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 34.4 tttt -60.63 -62.77 1.62 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.241 -0.912 . . . . 0.0 109.53 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.57 -16.83 58.28 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.247 -0.908 . . . . 0.0 109.495 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.587 ' C ' HD23 ' A' ' 96' ' ' LEU . 5.4 tt -72.62 -43.92 62.64 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.287 -0.883 . . . . 0.0 109.513 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.976 HD23 HD11 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -74.1 -38.41 63.86 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.287 -0.883 . . . . 0.0 109.484 179.959 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -69.73 -20.9 63.51 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.281 -0.887 . . . . 0.0 109.475 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -55.62 -29.93 60.03 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.262 -0.899 . . . . 0.0 109.497 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.43 -25.37 21.54 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.281 -0.887 . . . . 0.0 109.492 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 95.26 28.44 9.81 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 31.4 mtm -109.5 179.93 4.0 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.226 -1.161 . . . . 0.0 109.471 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.474 ' HB2' HG22 ' A' ' 33' ' ' VAL . 8.7 mmtt -88.85 162.16 16.31 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.259 -0.901 . . . . 0.0 109.456 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.463 ' CG2' HD12 ' A' ' 36' ' ' ILE . 3.2 p -154.39 135.79 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.218 -0.926 . . . . 0.0 109.464 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 12.5 mttt -108.56 104.41 13.72 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.253 -0.904 . . . . 0.0 109.464 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.442 ' O ' ' HB3' ' A' ' 37' ' ' GLN . 1.1 tp -47.86 -24.45 1.01 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.25 -0.906 . . . . 0.0 109.453 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.872 ' HB3' ' HB3' ' A' ' 37' ' ' GLN . . . 44.74 67.23 0.73 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.215 -0.928 . . . . 0.0 109.475 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -109.38 -170.57 20.51 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 142.9 166.06 10.91 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.434 ' O ' ' HB2' ' A' ' 111' ' ' GLU . 13.4 mt 59.48 86.42 0.09 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.276 -1.132 . . . . 0.0 109.469 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.434 ' HB2' ' O ' ' A' ' 110' ' ' LEU . 81.5 tt0 . . . . . 0 N--CA 1.49 1.525 0 CA-C-O 117.99 -1.005 . . . . 0.0 109.489 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.7 mttt . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -178.94 154.51 14.25 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -152.23 50.82 0.78 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.232 -1.158 . . . . 0.0 109.484 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.429 ' HA3' ' SD ' ' A' ' 102' ' ' MET . . . 112.61 125.9 4.53 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.624 HG13 ' O ' ' A' ' 103' ' ' LYS . 93.7 t -143.16 93.95 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.252 -1.146 . . . . 0.0 109.478 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.933 ' O ' HG23 ' A' ' 104' ' ' VAL . 70.5 t -93.23 109.46 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.289 -0.882 . . . . 0.0 109.454 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.522 ' O ' HG23 ' A' ' 51' ' ' ILE . 71.9 mtt180 -92.34 131.8 37.24 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.24 -0.913 . . . . 0.0 109.545 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.744 HG21 HD22 ' A' ' 93' ' ' LEU . 7.0 mt -125.55 127.22 71.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.219 -0.926 . . . . 0.0 109.421 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.673 ' HA ' ' HB2' ' A' ' 107' ' ' ALA . 1.7 pt20 -151.03 -167.89 2.94 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.176 -0.953 . . . . 0.0 109.526 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.419 ' HG3' ' O ' ' A' ' 38' ' ' ARG . 5.4 ptt180 -137.11 118.8 14.99 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.229 -0.919 . . . . 0.0 109.504 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.513 ' OE1' HD13 ' A' ' 50' ' ' LEU . 8.6 tt0 -91.36 118.63 30.69 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.183 -0.948 . . . . 0.0 109.442 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 29.0 p -106.13 -171.05 1.83 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.263 -0.898 . . . . 0.0 109.428 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -177.63 -51.0 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.185 -0.947 . . . . 0.0 109.54 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -110.68 -173.61 20.12 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -139.5 55.25 1.68 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.246 -1.15 . . . . 0.0 109.445 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 31.4 pttt -161.11 30.31 0.14 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.284 -0.885 . . . . 0.0 109.481 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -158.1 -123.85 0.75 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 51.9 mttt -132.98 -153.36 0.54 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.206 -1.173 . . . . 0.0 109.478 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -141.93 -163.93 9.83 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.586 -1.405 . . . . 0.0 109.586 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 22.9 m -154.58 146.11 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.269 -1.136 . . . . 0.0 109.521 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -90.04 131.27 36.01 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.288 -0.883 . . . . 0.0 109.435 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.513 HD13 ' OE1' ' A' ' 39' ' ' GLN . 0.0 OUTLIER -118.1 115.86 25.68 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.255 -0.903 . . . . 0.0 109.46 -179.917 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.522 HG23 ' O ' ' A' ' 35' ' ' ARG . 8.1 mt -120.37 110.5 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.212 -0.93 . . . . 0.0 109.458 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 9.8 t -142.95 162.89 34.27 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.238 -0.914 . . . . 0.0 109.637 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.49 22.24 13.09 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.611 -1.395 . . . . 0.0 109.611 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.577 ' HB ' HD21 ' A' ' 61' ' ' LEU . 61.7 t -78.41 112.71 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.22 -1.165 . . . . 0.0 109.443 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -97.15 70.48 2.37 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.294 -0.879 . . . . 0.0 109.541 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.549 HD22 ' OE2' ' A' ' 60' ' ' GLU . 10.3 mt -136.87 172.7 12.62 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.167 -0.958 . . . . 0.0 109.524 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -47.75 170.71 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.218 -0.926 . . . . 0.0 109.45 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -76.55 -39.8 51.73 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.232 -0.917 . . . . 0.0 109.468 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.09 -31.01 72.04 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.243 -0.91 . . . . 0.0 109.496 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.549 ' OE2' HD22 ' A' ' 56' ' ' LEU . 2.9 mt-10 -62.03 -45.92 91.47 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.269 -0.894 . . . . 0.0 109.543 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.577 HD21 ' HB ' ' A' ' 54' ' ' VAL . 8.4 mt -53.04 -42.69 65.98 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.249 -0.907 . . . . 0.0 109.472 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 52.2 m -71.9 -26.28 62.26 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.264 -0.898 . . . . 0.0 109.425 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.2 tttt -63.49 -59.91 4.04 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.256 -0.902 . . . . 0.0 109.393 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.9 mt -64.7 -31.55 72.82 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.281 -0.887 . . . . 0.0 109.538 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.506 ' HB1' ' CG2' ' A' ' 78' ' ' VAL . . . -57.5 -49.63 75.68 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.272 -0.892 . . . . 0.0 109.662 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -71.81 -28.04 63.33 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.244 -0.91 . . . . 0.0 109.628 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -64.45 -33.08 75.05 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.219 -0.926 . . . . 0.0 109.907 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 6.0 mt -88.04 -34.52 17.96 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.102 -0.999 . . . . 0.0 109.921 -179.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.8 mttt -63.24 -16.9 61.66 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.139 -0.975 . . . . 0.0 109.778 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 13.5 tttt -75.28 -28.15 59.67 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.18 -0.95 . . . . 0.0 109.707 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 7.2 mtpp -72.42 -67.84 0.52 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.169 -0.957 . . . . 0.0 109.243 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -64.63 -56.72 12.03 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.19 -0.944 . . . . 0.0 109.195 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.482 ' O ' ' HB2' ' A' ' 74' ' ' CYS . . . 84.31 12.88 75.07 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.482 ' HB2' ' O ' ' A' ' 73' ' ' GLY . 4.7 t 166.46 126.73 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.478 -1.013 . . . . 0.0 108.994 -179.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 113.86 -5.95 24.02 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -110.08 125.63 7.61 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.194 -1.563 . . . . 0.0 109.194 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -110.15 121.41 45.21 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.169 -1.194 . . . . 0.0 109.939 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.506 ' CG2' ' HB1' ' A' ' 65' ' ' ALA . 36.9 t -86.92 124.34 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.276 -0.89 . . . . 0.0 109.122 179.534 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -120.41 145.7 46.94 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.209 -0.932 . . . . 0.0 109.201 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.0 101.17 1.08 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.289 -0.882 . . . . 0.0 109.493 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 103.53 -11.53 54.03 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 65.0 t -142.85 121.29 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.323 -1.104 . . . . 0.0 109.426 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 26.8 mm -104.3 121.18 55.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.226 -0.921 . . . . 0.0 109.589 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -105.68 120.33 41.41 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.315 -0.866 . . . . 0.0 109.401 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.494 HG13 HD12 ' A' ' 51' ' ' ILE . 14.8 mm -117.6 164.4 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.176 -0.952 . . . . 0.0 109.517 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.478 ' N ' HG22 ' A' ' 85' ' ' ILE . 5.4 mt-30 -124.69 132.89 53.36 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.311 -0.868 . . . . 0.0 109.583 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 136.87 168.31 11.37 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -135.62 82.11 1.93 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.29 -1.124 . . . . 0.0 109.559 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 43.7 mttt -142.88 51.68 1.41 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.217 -0.927 . . . . 0.0 109.478 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.64 -25.95 0.81 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.24 -0.912 . . . . 0.0 109.447 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -64.85 -58.33 6.47 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.244 -0.91 . . . . 0.0 109.373 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.0 tt -58.13 -49.08 78.24 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.245 -0.909 . . . . 0.0 109.308 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.744 HD22 HG21 ' A' ' 36' ' ' ILE . 3.4 mt -52.1 -33.63 40.53 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.278 -0.889 . . . . 0.0 109.408 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.594 ' CG ' HD11 ' A' ' 106' ' ' LEU . 0.1 OUTLIER -60.53 -58.49 8.25 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.292 -0.88 . . . . 0.0 109.388 179.923 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 3.2 t -65.79 -11.76 48.63 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.213 -0.929 . . . . 0.0 109.447 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.609 HD23 ' N ' ' A' ' 97' ' ' LEU . 3.1 tt -74.9 -59.2 2.84 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.24 -0.913 . . . . 0.0 109.423 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.683 HD23 HD11 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -69.56 -23.29 63.54 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.286 -0.883 . . . . 0.0 109.49 179.975 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -73.39 -26.46 61.0 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.282 -0.886 . . . . 0.0 109.516 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -71.03 -22.26 62.17 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.252 -0.905 . . . . 0.0 109.489 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 4.0 mtmt -94.29 8.0 43.37 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.231 -0.918 . . . . 0.0 109.508 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 46.32 33.29 5.65 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' MET . . . . . 0.519 ' HB2' ' CD1' ' A' ' 97' ' ' LEU . 0.1 OUTLIER -86.93 -173.43 4.46 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.268 -1.137 . . . . 0.0 109.471 -179.993 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.624 ' O ' HG13 ' A' ' 33' ' ' VAL . 16.8 mttt -101.16 72.06 1.43 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.262 -0.899 . . . . 0.0 109.459 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.933 HG23 ' O ' ' A' ' 34' ' ' VAL . 8.3 p -88.68 145.69 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.232 -0.918 . . . . 0.0 109.532 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.403 ' O ' ' C ' ' A' ' 106' ' ' LEU . 21.5 tttt -110.79 30.27 7.0 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.277 -0.889 . . . . 0.0 109.446 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.594 HD11 ' CG ' ' A' ' 94' ' ' LYS . 3.5 tp 44.6 -154.28 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.251 -0.905 . . . . 0.0 109.487 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.673 ' HB2' ' HA ' ' A' ' 37' ' ' GLN . . . -105.26 63.61 0.7 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.221 -0.924 . . . . 0.0 109.463 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -68.72 168.65 43.07 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -170.53 162.5 35.6 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -177.05 67.62 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.292 -1.122 . . . . 0.0 109.416 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.427 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 85.7 mttt . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -77.01 111.68 3.33 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -119.04 -35.67 3.58 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.22 -1.165 . . . . 0.0 109.531 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -160.33 148.1 15.95 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.504 HG12 ' HB2' ' A' ' 103' ' ' LYS . 34.8 m -131.68 145.41 35.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.271 -1.135 . . . . 0.0 109.491 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.576 HG11 HD21 ' A' ' 97' ' ' LEU . 5.4 t -111.28 164.71 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.23 -0.919 . . . . 0.0 109.442 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.424 ' N ' HG12 ' A' ' 34' ' ' VAL . 0.1 OUTLIER -141.57 112.24 7.14 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.237 -0.915 . . . . 0.0 109.444 -179.985 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.715 HG21 HD13 ' A' ' 93' ' ' LEU . 4.5 mt -125.78 117.1 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.259 -0.901 . . . . 0.0 109.483 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.71 98.16 2.93 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.303 -0.873 . . . . 0.0 109.449 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.2 ptt180 -56.38 125.68 23.04 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.284 -0.885 . . . . 0.0 109.515 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -110.78 79.14 1.17 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.208 -0.932 . . . . 0.0 109.494 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 33.7 p -50.28 149.22 3.06 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.209 -0.932 . . . . 0.0 109.476 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.2 t -103.34 -12.56 17.15 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.265 -0.897 . . . . 0.0 109.449 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -135.4 160.35 24.41 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -61.36 119.36 8.36 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.194 -1.18 . . . . 0.0 109.456 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 27.4 tttt 53.73 -175.9 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.232 -0.918 . . . . 0.0 109.474 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 97.49 -143.41 16.71 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 10.8 tttt -88.26 161.54 17.13 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.29 -1.124 . . . . 0.0 109.506 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -144.75 152.58 24.54 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 34.5 m -106.01 167.88 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.233 -1.157 . . . . 0.0 109.428 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -128.88 113.1 14.83 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.187 -0.946 . . . . 0.0 109.477 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.783 ' O ' HD13 ' A' ' 51' ' ' ILE . 0.8 OUTLIER -89.04 143.78 26.61 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.198 -0.939 . . . . 0.0 109.528 179.955 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.783 HD13 ' O ' ' A' ' 50' ' ' LEU . 6.4 mm -127.33 108.32 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.207 -0.933 . . . . 0.0 109.414 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.403 ' HB ' HG12 ' A' ' 82' ' ' VAL . 0.0 OUTLIER -155.14 154.58 32.55 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.274 -0.891 . . . . 0.0 109.494 179.995 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 115.5 -28.72 7.67 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.452 HG12 HD23 ' A' ' 56' ' ' LEU . 24.2 t -45.76 109.84 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.311 -1.111 . . . . 0.0 109.457 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -90.73 75.89 6.49 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.284 -0.885 . . . . 0.0 109.466 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.486 HD13 ' HA ' ' A' ' 56' ' ' LEU . 1.4 mm? -114.12 -171.5 1.92 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.259 -0.9 . . . . 0.0 109.485 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -72.5 -69.72 0.39 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.258 -0.901 . . . . 0.0 109.473 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -178.93 -43.03 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.256 -0.903 . . . . 0.0 109.465 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.92 -30.58 56.18 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.247 -0.908 . . . . 0.0 109.525 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -59.1 -45.48 90.75 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.223 -0.923 . . . . 0.0 109.523 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.566 HD23 HD11 ' A' ' 83' ' ' ILE . 0.1 OUTLIER -50.89 -52.8 38.35 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.238 -0.914 . . . . 0.0 109.42 179.988 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 34.0 p -57.57 -40.66 79.46 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.304 -0.872 . . . . 0.0 109.405 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 7.7 tttt -54.57 -45.04 73.44 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.3 -0.875 . . . . 0.0 109.536 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.472 ' HA ' HD22 ' A' ' 64' ' ' LEU . 0.1 OUTLIER -64.0 -46.01 86.44 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.24 -0.912 . . . . 0.0 109.509 -179.945 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -49.72 -43.83 47.9 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.199 -0.938 . . . . 0.0 109.548 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -69.37 -35.96 76.35 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.272 -0.892 . . . . 0.0 109.577 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -65.44 -21.61 66.67 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.211 -0.931 . . . . 0.0 109.627 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 5.4 mt -87.25 -44.4 11.47 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.305 -0.872 . . . . 0.0 109.673 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.446 ' O ' ' HG2' ' A' ' 69' ' ' LYS . 10.0 tttt -64.59 -22.7 67.04 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.259 -0.901 . . . . 0.0 109.801 -179.686 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.24 -15.52 47.58 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.178 -0.951 . . . . 0.0 110.004 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.8 23.87 1.09 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.057 -1.027 . . . . 0.0 109.656 -179.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -105.39 -24.56 12.63 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.303 -0.873 . . . . 0.0 109.551 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.43 ' O ' ' SG ' ' A' ' 74' ' ' CYS . . . 94.03 -10.74 71.65 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 -179.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.43 ' SG ' ' O ' ' A' ' 73' ' ' GLY . 0.7 OUTLIER 174.07 134.86 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.325 -1.103 . . . . 0.0 109.281 179.983 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -72.66 -80.49 0.41 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 120.66 -109.34 1.54 Allowed Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -106.0 131.39 53.35 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.153 -1.204 . . . . 0.0 109.417 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 90.4 t -136.33 97.37 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.23 -0.919 . . . . 0.0 109.83 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.2 146.71 27.59 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.194 -0.941 . . . . 0.0 108.761 179.321 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -63.27 94.43 0.08 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.112 -0.992 . . . . 0.0 109.609 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 129.88 -25.95 4.33 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.433 ' O ' HG13 ' A' ' 83' ' ' ILE . 1.6 m -143.59 157.79 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.182 -1.187 . . . . 0.0 109.673 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.566 HD11 HD23 ' A' ' 61' ' ' LEU . 4.2 mp -143.71 146.74 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.223 -0.923 . . . . 0.0 109.467 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -130.28 125.96 36.08 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.238 -0.914 . . . . 0.0 109.423 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.432 HG22 ' N ' ' A' ' 86' ' ' GLN . 28.1 mm -114.69 157.18 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.215 -0.928 . . . . 0.0 109.5 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.432 ' N ' HG22 ' A' ' 85' ' ' ILE . 0.0 OUTLIER -115.9 86.02 2.4 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.206 -0.934 . . . . 0.0 109.469 -179.963 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -164.48 166.85 38.07 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -119.38 49.22 1.38 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.246 -1.149 . . . . 0.0 109.482 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 31.4 mttt -105.52 37.0 2.32 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.211 -0.931 . . . . 0.0 109.459 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.413 ' HA ' HD12 ' A' ' 93' ' ' LEU . 7.3 ttt180 -46.81 -36.85 7.83 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.26 -0.9 . . . . 0.0 109.474 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -58.03 -53.66 55.75 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.242 -0.912 . . . . 0.0 109.547 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.11 -17.8 64.94 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.231 -0.918 . . . . 0.0 109.526 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.715 HD13 HG21 ' A' ' 36' ' ' ILE . 2.1 mt -72.56 -44.85 61.53 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.302 -0.874 . . . . 0.0 109.494 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 61.6 tttt -65.96 -32.98 74.78 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.224 -0.923 . . . . 0.0 109.477 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 14.3 t -67.54 -62.69 1.3 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.25 -0.906 . . . . 0.0 109.448 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.939 HD12 ' N ' ' A' ' 97' ' ' LEU . 4.2 pp -51.64 -31.61 26.1 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.195 -0.941 . . . . 0.0 109.471 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.939 ' N ' HD12 ' A' ' 96' ' ' LEU . 0.2 OUTLIER -65.14 -47.01 78.6 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.223 -0.923 . . . . 0.0 109.494 179.968 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 72.4 tt0 -69.19 -14.26 62.88 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.298 -0.876 . . . . 0.0 109.455 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -73.42 -13.93 61.17 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.212 -0.93 . . . . 0.0 109.434 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.35 -31.28 11.4 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.262 -0.899 . . . . 0.0 109.441 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 100.68 15.8 28.25 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 1.5 mtm -88.2 156.12 19.4 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.192 -1.181 . . . . 0.0 109.49 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.504 ' HB2' HG12 ' A' ' 33' ' ' VAL . 27.2 mttt -86.17 97.61 10.44 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.285 -0.885 . . . . 0.0 109.468 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 12.5 p -81.43 140.66 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.226 -0.921 . . . . 0.0 109.46 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.47 ' O ' ' N ' ' A' ' 107' ' ' ALA . 0.7 OUTLIER -111.41 77.41 1.04 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.224 -0.923 . . . . 0.0 109.469 -179.994 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.5 mp -46.54 96.44 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.185 -0.947 . . . . 0.0 109.471 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.47 ' N ' ' O ' ' A' ' 105' ' ' LYS . . . -90.2 97.36 11.14 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.265 -0.897 . . . . 0.0 109.488 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -178.71 161.91 28.7 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -157.82 168.86 34.51 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.512 HD22 ' HA ' ' A' ' 110' ' ' LEU . 0.2 OUTLIER -81.7 98.87 8.61 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.217 -1.167 . . . . 0.0 109.458 179.957 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 118.016 -0.993 . . . . 0.0 109.428 -179.987 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 23.3 mttt . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -96.52 -62.49 0.94 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -133.03 86.51 2.31 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.266 -1.138 . . . . 0.0 109.462 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.425 ' O ' ' HB2' ' A' ' 103' ' ' LYS . . . -138.64 123.45 2.61 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.403 HG22 ' CB ' ' A' ' 103' ' ' LYS . 73.2 t -146.91 104.5 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.242 -1.152 . . . . 0.0 109.454 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.745 HG13 ' CG2' ' A' ' 54' ' ' VAL . 21.4 t -92.88 151.09 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.253 -0.904 . . . . 0.0 109.432 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 2.0 ttt180 -121.82 112.4 18.3 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.25 -0.906 . . . . 0.0 109.487 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.785 HG21 ' HB3' ' A' ' 93' ' ' LEU . 2.2 mp -123.44 114.54 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.266 -0.896 . . . . 0.0 109.406 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.5 ' CD ' ' HB3' ' A' ' 107' ' ' ALA . 7.0 pt20 -150.59 -162.13 1.49 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.212 -0.93 . . . . 0.0 109.446 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 30.8 mtm180 -123.77 139.19 54.22 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.233 -0.917 . . . . 0.0 109.452 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.694 ' HB2' HD13 ' A' ' 50' ' ' LEU . 13.5 tt0 -116.05 60.17 0.72 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.247 -0.908 . . . . 0.0 109.472 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.6 p -60.05 142.51 53.91 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.261 -0.9 . . . . 0.0 109.438 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 20.0 m -114.28 -73.59 0.65 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.245 -0.909 . . . . 0.0 109.47 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 149.36 75.85 0.02 OUTLIER Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 5.1 ttt180 179.52 -58.28 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.314 -1.109 . . . . 0.0 109.491 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -60.42 -57.12 14.12 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.296 -0.878 . . . . 0.0 109.451 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 119.96 -54.6 0.64 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.561 -1.415 . . . . 0.0 109.561 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 19.6 mttt -69.17 -174.41 0.63 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.274 -1.133 . . . . 0.0 109.547 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -109.11 149.05 17.06 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.9 m -119.57 145.74 25.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.307 -1.113 . . . . 0.0 109.468 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 2.3 t -111.46 139.79 46.59 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.269 -0.894 . . . . 0.0 109.437 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.694 HD13 ' HB2' ' A' ' 39' ' ' GLN . 2.1 mp -130.35 119.91 23.51 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.246 -0.909 . . . . 0.0 109.516 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.801 ' HB ' HD12 ' A' ' 83' ' ' ILE . 3.1 mm -101.19 124.7 55.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.229 -0.919 . . . . 0.0 109.379 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -159.63 159.52 33.2 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.199 -0.938 . . . . 0.0 109.491 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.412 ' O ' ' C ' ' A' ' 54' ' ' VAL . . . 105.76 -29.06 11.93 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.745 ' CG2' HG13 ' A' ' 34' ' ' VAL . 62.5 t -45.22 117.75 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.213 -1.169 . . . . 0.0 109.421 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -111.95 72.24 0.77 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.26 -0.9 . . . . 0.0 109.511 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.503 HD11 ' SD ' ' A' ' 102' ' ' MET . 2.7 mt -126.04 -170.31 2.17 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.216 -0.928 . . . . 0.0 109.456 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -56.03 147.77 19.19 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.242 -0.911 . . . . 0.0 109.475 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -60.94 -33.49 73.25 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.274 -0.891 . . . . 0.0 109.518 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -77.27 -29.06 53.69 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.231 -0.918 . . . . 0.0 109.385 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -69.27 -30.51 68.64 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.303 -0.873 . . . . 0.0 109.45 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.416 HD21 ' HB ' ' A' ' 54' ' ' VAL . 1.7 mt -66.21 -58.35 5.59 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.271 -0.893 . . . . 0.0 109.496 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -57.68 -19.4 26.71 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.197 -0.939 . . . . 0.0 109.376 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 9.3 mttt -76.68 -44.33 34.16 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.309 -0.869 . . . . 0.0 109.558 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.409 HD22 ' HA ' ' A' ' 64' ' ' LEU . 0.3 OUTLIER -70.88 -29.0 64.98 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.209 -0.932 . . . . 0.0 109.508 -179.997 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.451 ' HB1' HG13 ' A' ' 78' ' ' VAL . . . -72.25 -52.38 16.67 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.245 -0.909 . . . . 0.0 109.382 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.9 -48.78 80.21 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.237 -0.915 . . . . 0.0 109.551 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -54.0 -46.27 71.72 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.196 -0.94 . . . . 0.0 109.331 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -59.5 -36.54 76.24 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.277 -0.889 . . . . 0.0 109.238 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 7.9 tmtt? -61.54 -37.96 85.68 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.333 -0.855 . . . . 0.0 109.286 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 11.3 mttt -58.05 -25.46 61.24 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.234 -0.916 . . . . 0.0 108.955 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 1.7 mtmp? -122.0 50.19 1.48 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.513 -0.742 . . . . 0.0 109.217 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 23.4 t -133.72 -63.51 0.74 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.178 -0.951 . . . . 0.0 109.686 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.482 ' O ' ' HB2' ' A' ' 74' ' ' CYS . . . 120.17 10.25 7.53 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -179.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.482 ' HB2' ' O ' ' A' ' 73' ' ' GLY . 4.6 t 168.3 127.92 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.325 -1.103 . . . . 0.0 109.193 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -94.53 101.58 2.75 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -66.99 -109.01 0.02 OUTLIER Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -111.75 121.77 46.0 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.205 -1.173 . . . . 0.0 109.302 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.451 HG13 ' HB1' ' A' ' 65' ' ' ALA . 22.9 t -116.43 78.12 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.21 -0.931 . . . . 0.0 109.808 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -88.28 145.62 25.76 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.243 -0.911 . . . . 0.0 109.201 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -65.0 91.42 0.09 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.201 -0.937 . . . . 0.0 109.507 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 129.07 -24.34 4.79 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.0 t -139.04 137.86 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.152 -1.205 . . . . 0.0 109.582 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.801 HD12 ' HB ' ' A' ' 51' ' ' ILE . 4.2 mt -132.01 135.34 58.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.353 -0.842 . . . . 0.0 109.55 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 68.1 mt-10 -132.25 116.47 16.97 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.302 -0.874 . . . . 0.0 109.207 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 56.1 mt -148.36 146.72 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.225 -0.922 . . . . 0.0 109.621 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -72.74 141.58 48.14 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.24 -0.912 . . . . 0.0 109.309 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 167.7 122.33 0.61 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -106.96 51.61 0.74 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.321 -1.105 . . . . 0.0 109.538 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 85.5 mttt -131.9 53.42 2.0 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.252 -0.905 . . . . 0.0 109.478 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 32.5 ptt180 -53.13 -27.48 21.1 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.24 -0.912 . . . . 0.0 109.358 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 48.1 t0 -65.41 -53.33 44.76 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.29 -0.881 . . . . 0.0 109.393 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.9 tt -58.71 -48.35 81.43 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.274 -0.891 . . . . 0.0 109.424 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.785 ' HB3' HG21 ' A' ' 36' ' ' ILE . 5.9 mt -53.93 -38.97 65.45 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.252 -0.905 . . . . 0.0 109.429 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.521 ' HE3' HD11 ' A' ' 106' ' ' LEU . 3.1 ttmt -68.26 -31.26 70.6 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.253 -0.904 . . . . 0.0 109.494 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 21.8 t -67.54 -64.03 0.94 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.236 -0.915 . . . . 0.0 109.471 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.796 HD12 ' N ' ' A' ' 97' ' ' LEU . 2.6 pp -50.62 -38.27 44.98 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.277 -0.889 . . . . 0.0 109.499 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.796 ' N ' HD12 ' A' ' 96' ' ' LEU . 0.2 OUTLIER -59.44 -45.13 92.46 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.218 -0.926 . . . . 0.0 109.485 179.978 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -69.68 -17.07 63.46 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.257 -0.902 . . . . 0.0 109.444 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -67.98 -27.47 66.6 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.251 -0.905 . . . . 0.0 109.459 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.494 ' HD2' ' N ' ' A' ' 100' ' ' LYS . 6.7 mptt -85.13 -16.35 40.77 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.228 -0.92 . . . . 0.0 109.442 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 88.73 23.96 34.4 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' MET . . . . . 0.503 ' SD ' HD11 ' A' ' 56' ' ' LEU . 1.2 mtm -97.77 171.17 8.49 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.265 -1.138 . . . . 0.0 109.467 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.425 ' HB2' ' O ' ' A' ' 32' ' ' GLY . 8.7 mttt -84.62 165.74 17.71 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.231 -0.918 . . . . 0.0 109.484 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.8 t -147.91 124.16 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.275 -0.891 . . . . 0.0 109.485 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 5.9 mttt -109.38 79.07 1.18 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.256 -0.903 . . . . 0.0 109.468 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.521 HD11 ' HE3' ' A' ' 94' ' ' LYS . 6.2 mt -46.18 105.53 0.06 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.297 -0.877 . . . . 0.0 109.482 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.5 ' HB3' ' CD ' ' A' ' 37' ' ' GLN . . . -102.5 163.5 12.19 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.277 -0.89 . . . . 0.0 109.466 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -178.46 -150.04 8.5 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -63.71 -145.96 0.02 OUTLIER Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 13.4 mt -127.78 -65.39 0.92 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.263 -1.14 . . . . 0.0 109.473 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 117.956 -1.021 . . . . 0.0 109.426 -179.974 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 92.9 mttt . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 142.79 164.41 10.15 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -135.71 51.77 2.03 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.208 -1.172 . . . . 0.0 109.454 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 149.54 130.98 1.89 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.5 p -160.03 131.26 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.265 -1.138 . . . . 0.0 109.449 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.629 HG23 ' CE ' ' A' ' 102' ' ' MET . 75.6 t -105.54 153.65 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.261 -0.899 . . . . 0.0 109.468 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.431 ' HB3' ' O ' ' A' ' 52' ' ' THR . 24.6 ttt180 -129.65 100.89 5.68 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.192 -0.942 . . . . 0.0 109.513 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.85 HG23 HG13 ' A' ' 51' ' ' ILE . 1.2 mp -102.81 125.75 57.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.232 -0.918 . . . . 0.0 109.397 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -122.63 -166.81 1.48 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.235 -0.916 . . . . 0.0 109.468 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 14.1 ptt180 -152.54 132.7 13.51 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.197 -0.939 . . . . 0.0 109.476 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -118.13 110.37 17.52 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.23 -0.919 . . . . 0.0 109.488 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 5.7 t -109.18 166.5 10.8 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.275 -0.89 . . . . 0.0 109.453 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -148.99 21.24 0.98 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.251 -0.906 . . . . 0.0 109.471 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 179.33 -147.97 7.92 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 39.4 ptt180 -150.87 -177.36 5.96 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.238 -1.154 . . . . 0.0 109.469 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 77.2 tttt 62.27 25.68 15.36 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.23 -0.919 . . . . 0.0 109.442 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.456 ' O ' ' O ' ' A' ' 46' ' ' LYS . . . 129.93 -158.43 22.29 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.456 ' O ' ' O ' ' A' ' 45' ' ' GLY . 12.4 ttmt 58.15 112.2 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.248 -1.148 . . . . 0.0 109.515 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -178.35 131.26 1.71 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.2 m -131.49 147.26 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.245 -1.15 . . . . 0.0 109.528 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 1.8 m -125.01 118.34 26.0 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.269 -0.895 . . . . 0.0 109.494 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.563 ' C ' HD12 ' A' ' 51' ' ' ILE . 0.4 OUTLIER -113.1 138.93 49.19 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.218 -0.926 . . . . 0.0 109.503 -179.94 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.85 HG13 HG23 ' A' ' 36' ' ' ILE . 2.7 mp -108.37 122.62 63.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.234 -0.916 . . . . 0.0 109.394 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.431 ' O ' ' HB3' ' A' ' 35' ' ' ARG . 0.5 OUTLIER -146.25 156.53 43.45 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.287 -0.883 . . . . 0.0 109.534 -179.898 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 93.89 23.14 23.81 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.438 HG12 HD12 ' A' ' 56' ' ' LEU . 10.1 t -80.55 115.38 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.304 -1.115 . . . . 0.0 109.552 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -94.14 76.91 4.05 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.265 -0.897 . . . . 0.0 109.443 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.438 HD12 HG12 ' A' ' 54' ' ' VAL . 0.4 OUTLIER -144.9 177.75 8.51 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.263 -0.898 . . . . 0.0 109.409 179.955 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -56.97 158.35 4.97 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.216 -0.927 . . . . 0.0 109.519 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.72 -48.35 59.82 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.32 -0.862 . . . . 0.0 109.495 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.92 -33.69 70.85 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.279 -0.888 . . . . 0.0 109.411 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.421 ' O ' ' C ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -59.47 -54.05 51.05 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.232 -0.917 . . . . 0.0 109.418 179.951 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.421 ' C ' ' O ' ' A' ' 60' ' ' GLU . 0.3 OUTLIER -44.58 -42.75 7.59 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.239 -0.913 . . . . 0.0 109.196 179.844 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 60.9 m -58.54 -50.63 73.08 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.263 -0.898 . . . . 0.0 109.166 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -52.5 -30.39 29.96 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.26 -0.9 . . . . 0.0 109.137 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -68.81 -53.48 21.31 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.344 -0.847 . . . . 0.0 109.485 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -52.68 -33.76 48.88 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.242 -0.911 . . . . 0.0 109.308 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -71.98 -41.88 67.16 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.278 -0.889 . . . . 0.0 109.284 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -65.11 -19.79 66.15 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.22 -0.925 . . . . 0.0 109.357 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.463 HD13 ' HA ' ' A' ' 68' ' ' LEU . 3.3 mm? -84.02 -57.3 3.25 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.229 -0.919 . . . . 0.0 109.447 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 6.2 mttt -60.11 -22.75 63.19 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.281 -0.887 . . . . 0.0 109.412 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.8 -42.67 47.44 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.262 -0.899 . . . . 0.0 109.496 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 2.1 ptmt -129.14 70.17 1.41 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.271 -0.893 . . . . 0.0 109.332 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -144.33 -42.7 0.26 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.311 -0.868 . . . . 0.0 109.424 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.474 ' O ' ' HB2' ' A' ' 74' ' ' CYS . . . 119.49 -62.09 0.48 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.474 ' HB2' ' O ' ' A' ' 73' ' ' GLY . 17.0 t 172.31 107.49 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.344 -1.092 . . . . 0.0 109.323 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 160.38 50.77 0.01 OUTLIER Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -117.97 116.92 3.58 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.501 ' HB3' ' HB3' ' A' ' 84' ' ' GLU . . . -104.05 110.25 22.35 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.337 -1.096 . . . . 0.0 109.004 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.2 t -85.16 84.22 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.214 -0.929 . . . . 0.0 109.814 -179.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.476 ' HB3' ' HB ' ' A' ' 82' ' ' VAL . 20.3 mmtt -90.9 169.18 11.13 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.287 -0.883 . . . . 0.0 108.955 179.505 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -60.63 112.75 2.12 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.113 -0.992 . . . . 0.0 109.578 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 51.99 27.78 22.92 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.494 ' O ' HG12 ' A' ' 82' ' ' VAL . 43.4 t -141.65 88.19 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.152 -1.205 . . . . 0.0 109.536 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.494 ' N ' HD13 ' A' ' 83' ' ' ILE . 4.7 mm -83.53 102.12 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.246 -0.908 . . . . 0.0 109.306 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.501 ' HB3' ' HB3' ' A' ' 77' ' ' ALA . 0.5 OUTLIER -82.92 126.66 32.73 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.284 -0.885 . . . . 0.0 109.73 -179.845 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 18.6 mm -133.96 110.62 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.265 -0.897 . . . . 0.0 109.406 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -72.77 128.95 37.06 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.263 -0.898 . . . . 0.0 109.573 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 145.04 136.56 3.03 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -95.89 89.56 5.29 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.251 -1.147 . . . . 0.0 109.445 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 3.1 mttt -144.55 53.23 1.25 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.205 -0.934 . . . . 0.0 109.5 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.842 ' HA ' HD12 ' A' ' 93' ' ' LEU . 51.2 ttt180 -64.02 -40.73 96.98 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.251 -0.906 . . . . 0.0 109.483 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -53.82 -44.06 69.92 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.211 -0.931 . . . . 0.0 109.46 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 3.6 tt -75.11 -26.63 59.4 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.267 -0.896 . . . . 0.0 109.532 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.842 HD12 ' HA ' ' A' ' 90' ' ' ARG . 22.8 mt -61.63 -42.86 99.47 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.263 -0.898 . . . . 0.0 109.474 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 17.3 tttt -67.03 -26.74 66.92 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.24 -0.913 . . . . 0.0 109.592 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 1.2 t -70.72 -62.34 1.43 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.224 -0.922 . . . . 0.0 109.534 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.865 HD12 ' N ' ' A' ' 97' ' ' LEU . 4.6 pp -54.93 -31.43 60.3 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.228 -0.92 . . . . 0.0 109.534 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.865 ' N ' HD12 ' A' ' 96' ' ' LEU . 0.2 OUTLIER -67.64 -47.4 69.69 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.183 -0.948 . . . . 0.0 109.559 -179.917 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.53 -15.36 63.23 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.223 -0.923 . . . . 0.0 109.589 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -69.79 -12.75 61.87 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.222 -0.924 . . . . 0.0 109.464 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.19 -37.49 20.07 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.246 -0.908 . . . . 0.0 109.497 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 101.45 22.96 9.89 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' MET . . . . . 0.629 ' CE ' HG23 ' A' ' 34' ' ' VAL . 0.3 OUTLIER -119.6 -172.89 2.41 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.198 -1.177 . . . . 0.0 109.466 -179.996 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 6.6 tttt -86.54 162.01 18.26 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.252 -0.905 . . . . 0.0 109.484 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.582 ' HB ' HD12 ' A' ' 97' ' ' LEU . 12.7 p -152.32 153.47 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.262 -0.899 . . . . 0.0 109.429 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 6.0 mttt -131.64 90.12 2.8 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.212 -0.93 . . . . 0.0 109.494 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.68 ' O ' ' HB3' ' A' ' 107' ' ' ALA . 4.6 mm? -54.85 -30.13 56.93 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.259 -0.901 . . . . 0.0 109.476 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.68 ' HB3' ' O ' ' A' ' 106' ' ' LEU . . . 75.25 86.23 0.09 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.265 -0.897 . . . . 0.0 109.433 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -115.04 70.39 0.25 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -84.57 -168.03 43.7 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.466 HD23 ' H ' ' A' ' 111' ' ' GLU . 0.3 OUTLIER -156.54 153.66 29.05 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.239 -1.154 . . . . 0.0 109.456 179.959 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.466 ' H ' HD23 ' A' ' 110' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 118.028 -0.986 . . . . 0.0 109.483 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.6 mttt . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 179.82 164.71 32.58 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -160.17 69.48 0.4 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.26 -1.141 . . . . 0.0 109.483 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 171.72 120.36 0.55 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.595 ' O ' HG23 ' A' ' 33' ' ' VAL . 35.5 m -132.17 115.48 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.307 -1.114 . . . . 0.0 109.463 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.729 HG22 HG22 ' A' ' 54' ' ' VAL . 97.0 t -80.62 159.84 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.273 -0.892 . . . . 0.0 109.513 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.484 ' N ' HG12 ' A' ' 34' ' ' VAL . 4.5 mtp180 -145.59 127.76 15.7 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.282 -0.887 . . . . 0.0 109.441 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.833 HG21 HD13 ' A' ' 93' ' ' LEU . 2.7 mp -132.48 109.18 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.274 -0.891 . . . . 0.0 109.497 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.878 ' HB3' ' HB3' ' A' ' 107' ' ' ALA . 2.6 pt20 -140.02 157.39 45.74 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.294 -0.879 . . . . 0.0 109.467 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.44 ' HG2' ' HD3' ' A' ' 90' ' ' ARG . 7.8 ptt180 -96.15 135.96 37.24 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.249 -0.907 . . . . 0.0 109.433 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -108.39 95.41 5.65 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.26 -0.9 . . . . 0.0 109.458 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.25 171.01 14.41 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.226 -0.921 . . . . 0.0 109.461 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -176.33 82.87 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.297 -0.877 . . . . 0.0 109.479 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 129.71 -168.19 21.26 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 1.4 mtt180 -111.79 -69.25 0.88 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.254 -1.145 . . . . 0.0 109.474 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 66.9 mttt -94.9 86.66 4.73 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.226 -0.921 . . . . 0.0 109.501 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -152.49 -164.0 12.05 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 21.8 mttt -107.7 158.77 17.0 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.201 -1.176 . . . . 0.0 109.481 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -95.03 177.13 35.09 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.7 m -151.46 154.36 8.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.258 -1.142 . . . . 0.0 109.477 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 6.9 t -119.34 110.64 17.21 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.261 -0.9 . . . . 0.0 109.493 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -97.12 131.7 43.63 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.29 -0.881 . . . . 0.0 109.411 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 63.6 mt -125.36 114.95 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.229 -0.919 . . . . 0.0 109.533 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -151.84 170.35 20.02 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.252 -0.905 . . . . 0.0 109.435 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.19 -15.91 58.66 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.729 HG22 HG22 ' A' ' 34' ' ' VAL . 53.4 t -56.92 108.47 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.269 -1.136 . . . . 0.0 109.474 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.468 ' O ' HD22 ' A' ' 56' ' ' LEU . 18.3 t0 -86.16 78.16 9.43 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.296 -0.878 . . . . 0.0 109.471 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.468 HD22 ' O ' ' A' ' 55' ' ' ASP . 0.2 OUTLIER -134.53 159.03 42.42 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.247 -0.908 . . . . 0.0 109.46 179.986 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.448 ' O ' ' O ' ' A' ' 58' ' ' ASP . 0.2 OUTLIER -76.61 157.02 32.27 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.203 -0.936 . . . . 0.0 109.501 179.963 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.709 ' O ' ' HB3' ' A' ' 59' ' ' ALA . 0.2 OUTLIER -50.73 -179.48 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.298 -0.876 . . . . 0.0 109.523 -179.963 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.709 ' HB3' ' O ' ' A' ' 58' ' ' ASP . . . 76.98 -78.9 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.313 -0.867 . . . . 0.0 109.501 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -55.1 -36.77 66.03 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.236 -0.915 . . . . 0.0 109.543 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -58.76 -48.29 81.73 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.181 -0.95 . . . . 0.0 109.478 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -61.85 -28.11 69.26 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.211 -0.931 . . . . 0.0 109.463 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -68.67 -51.54 40.79 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.276 -0.89 . . . . 0.0 109.388 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.59 -33.59 72.95 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.218 -0.926 . . . . 0.0 109.309 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -64.17 -52.1 60.6 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.262 -0.899 . . . . 0.0 109.371 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.67 -22.31 66.95 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.238 -0.914 . . . . 0.0 109.322 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.99 -55.19 13.58 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.256 -0.902 . . . . 0.0 109.425 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.3 mp -69.36 -22.47 63.74 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.186 -0.946 . . . . 0.0 109.415 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.93 -37.38 72.87 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.275 -0.891 . . . . 0.0 109.504 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 19.7 tttt -68.82 -12.85 61.97 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.248 -0.907 . . . . 0.0 109.414 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 20.3 mttm -75.47 -22.47 57.22 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.318 -0.864 . . . . 0.0 109.818 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -103.66 -34.39 8.63 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.185 -0.947 . . . . 0.0 110.008 -179.428 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.446 ' O ' ' CB ' ' A' ' 74' ' ' CYS . . . 76.21 32.09 53.17 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 108.764 -1.734 . . . . 0.0 108.764 -179.437 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.446 ' CB ' ' O ' ' A' ' 73' ' ' GLY . 0.0 OUTLIER 167.35 152.05 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.475 -1.015 . . . . 0.0 109.126 -179.695 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 67.6 123.94 0.02 OUTLIER Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -173.89 92.59 0.09 OUTLIER Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -104.07 123.31 47.02 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.221 -1.164 . . . . 0.0 109.081 179.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 33.7 m -110.49 170.24 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.141 -0.974 . . . . 0.0 109.541 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.423 ' CB ' ' HB ' ' A' ' 82' ' ' VAL . 11.4 mttp -159.19 166.74 30.77 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.299 -0.876 . . . . 0.0 109.352 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -64.13 100.8 0.35 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.202 -0.936 . . . . 0.0 109.567 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 74.7 2.97 65.78 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.423 ' HB ' ' CB ' ' A' ' 79' ' ' LYS . 87.5 t -129.6 141.71 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.116 -1.226 . . . . 0.0 109.595 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.431 HG22 ' N ' ' A' ' 84' ' ' GLU . 58.1 mt -131.89 158.69 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.326 -0.859 . . . . 0.0 109.456 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.431 ' N ' HG22 ' A' ' 83' ' ' ILE . 19.1 tt0 -148.03 139.14 23.35 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.217 -0.927 . . . . 0.0 109.548 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 53.6 mt -149.69 102.7 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.218 -0.926 . . . . 0.0 109.377 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -52.8 110.07 0.48 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.214 -0.929 . . . . 0.0 109.506 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -154.85 -175.75 26.3 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -154.39 47.82 0.59 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.267 -1.137 . . . . 0.0 109.446 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 60.3 mttt -137.82 45.95 2.12 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.283 -0.886 . . . . 0.0 109.467 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.59 ' HA ' HD12 ' A' ' 93' ' ' LEU . 36.1 ptt180 -50.93 -40.15 56.43 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.246 -0.909 . . . . 0.0 109.467 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.486 ' N ' ' HG3' ' A' ' 90' ' ' ARG . 8.1 p-10 -51.05 -45.54 61.37 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.27 -0.894 . . . . 0.0 109.467 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.404 HD23 ' N ' ' A' ' 93' ' ' LEU . 4.4 tt -68.4 -47.18 68.0 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.267 -0.896 . . . . 0.0 109.495 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.833 HD13 HG21 ' A' ' 36' ' ' ILE . 17.9 mt -54.32 -24.67 20.08 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.223 -0.923 . . . . 0.0 109.477 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -61.39 -65.42 0.7 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.297 -0.877 . . . . 0.0 109.465 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 11.4 t -64.48 -17.38 63.81 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.272 -0.893 . . . . 0.0 109.465 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.636 HD23 ' N ' ' A' ' 97' ' ' LEU . 3.1 tt -66.42 -55.83 13.91 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.288 -0.883 . . . . 0.0 109.482 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.636 ' N ' HD23 ' A' ' 96' ' ' LEU . 0.2 OUTLIER -69.97 -38.24 76.02 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.293 -0.879 . . . . 0.0 109.504 -179.979 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -64.27 -19.11 65.18 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.243 -0.91 . . . . 0.0 109.497 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -66.53 -31.74 72.64 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.273 -0.892 . . . . 0.0 109.441 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? -80.21 -14.9 58.07 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.239 -0.913 . . . . 0.0 109.474 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 101.44 -13.16 58.37 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 2.7 mtm -65.64 147.89 52.65 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.278 -1.13 . . . . 0.0 109.431 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 16.6 mttt -81.85 115.79 21.22 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.284 -0.885 . . . . 0.0 109.473 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.418 HG22 ' N ' ' A' ' 105' ' ' LYS . 4.6 p -109.72 155.0 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.221 -0.924 . . . . 0.0 109.523 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.429 ' O ' ' N ' ' A' ' 107' ' ' ALA . 0.5 OUTLIER -122.18 90.39 3.3 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.212 -0.93 . . . . 0.0 109.468 -179.958 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 19.5 tp -54.2 93.09 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.253 -0.904 . . . . 0.0 109.486 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.878 ' HB3' ' HB3' ' A' ' 37' ' ' GLN . . . -73.87 -161.93 0.12 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.28 -0.887 . . . . 0.0 109.475 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 88.79 108.44 1.1 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 69.3 66.24 2.32 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -171.91 -59.89 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.212 -1.169 . . . . 0.0 109.471 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 118.055 -0.974 . . . . 0.0 109.48 -179.983 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 83.5 mttt . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 155.33 151.23 5.8 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.45 ' N ' ' OD1' ' A' ' 31' ' ' ASP . 18.8 p30 -55.81 98.21 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.251 -1.146 . . . . 0.0 109.414 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -60.3 153.24 35.96 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.708 ' O ' HG23 ' A' ' 33' ' ' VAL . 34.7 m -142.39 101.17 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.279 -1.13 . . . . 0.0 109.452 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.571 HG13 HG22 ' A' ' 54' ' ' VAL . 9.7 t -88.85 150.04 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.268 -0.895 . . . . 0.0 109.501 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 53.0 mtt180 -127.05 119.25 26.13 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.231 -0.918 . . . . 0.0 109.458 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.511 HD11 HD13 ' A' ' 97' ' ' LEU . 1.5 mp -118.1 118.41 58.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.237 -0.914 . . . . 0.0 109.507 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -153.89 175.54 13.23 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.258 -0.901 . . . . 0.0 109.479 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.78 140.04 38.68 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.223 -0.923 . . . . 0.0 109.453 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -124.91 57.6 1.27 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.282 -0.886 . . . . 0.0 109.486 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 15.1 t -76.05 165.21 25.28 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.246 -0.909 . . . . 0.0 109.448 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -176.53 138.37 0.3 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.265 -0.897 . . . . 0.0 109.486 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.61 -53.59 0.73 Allowed Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 22.0 ttt180 -168.18 159.07 10.63 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.23 -1.159 . . . . 0.0 109.515 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 30.0 tttt -83.08 125.39 31.43 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.275 -0.891 . . . . 0.0 109.422 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 168.23 -44.79 0.23 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.4 ptmt -129.27 179.51 5.74 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.209 -1.171 . . . . 0.0 109.539 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -171.16 147.75 10.62 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.405 HG12 ' HG3' ' A' ' 86' ' ' GLN . 14.1 m -119.77 158.03 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.205 -1.173 . . . . 0.0 109.504 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 1.4 t -121.11 120.51 35.52 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.229 -0.919 . . . . 0.0 109.422 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -111.58 149.25 31.72 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.234 -0.916 . . . . 0.0 109.539 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.493 ' CG1' HG23 ' A' ' 36' ' ' ILE . 16.7 mt -134.26 126.43 49.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.269 -0.895 . . . . 0.0 109.46 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.463 HG23 ' O ' ' A' ' 81' ' ' GLY . 0.2 OUTLIER -151.59 166.67 30.5 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.228 -0.92 . . . . 0.0 109.48 179.98 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 92.57 15.57 52.43 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.571 HG22 HG13 ' A' ' 34' ' ' VAL . 8.8 t -75.86 106.9 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.231 -1.158 . . . . 0.0 109.489 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -94.62 84.57 4.3 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.279 -0.888 . . . . 0.0 109.476 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -144.95 -172.87 3.93 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.194 -0.941 . . . . 0.0 109.483 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -68.67 150.22 48.19 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.262 -0.899 . . . . 0.0 109.464 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.418 ' O ' ' HB2' ' A' ' 61' ' ' LEU . 19.6 m-20 -52.72 -46.26 67.3 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.246 -0.909 . . . . 0.0 109.549 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.808 ' O ' HG22 ' A' ' 62' ' ' THR . . . -58.72 -44.73 90.48 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.23 -0.919 . . . . 0.0 109.558 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -51.36 -34.73 35.31 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.151 -0.968 . . . . 0.0 109.488 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.461 HD23 ' HA ' ' A' ' 61' ' ' LEU . 39.7 mt -56.8 -54.81 42.11 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.233 -0.917 . . . . 0.0 109.505 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.808 HG22 ' O ' ' A' ' 59' ' ' ALA . 9.5 t -63.66 -17.82 63.32 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.233 -0.917 . . . . 0.0 109.588 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.65 -68.76 0.48 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.265 -0.897 . . . . 0.0 109.459 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -51.77 -34.61 40.3 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.273 -0.892 . . . . 0.0 109.371 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.48 -59.47 5.19 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.267 -0.896 . . . . 0.0 109.426 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -55.07 -24.93 27.66 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.279 -0.888 . . . . 0.0 109.447 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -66.68 -62.46 1.44 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.256 -0.903 . . . . 0.0 109.482 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -67.33 -13.5 62.06 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.193 -0.942 . . . . 0.0 109.545 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 17.8 tttt -69.77 -36.35 75.68 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.189 -0.944 . . . . 0.0 109.428 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -73.27 -19.74 60.99 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.279 -0.888 . . . . 0.0 109.276 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 63.7 mttt -66.29 -29.88 70.19 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.3 -0.875 . . . . 0.0 109.319 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 62.7 m -89.17 -30.06 18.85 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.315 -0.866 . . . . 0.0 109.316 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.457 ' O ' ' HB2' ' A' ' 74' ' ' CYS . . . 91.87 -19.74 46.78 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.457 ' HB2' ' O ' ' A' ' 73' ' ' GLY . 52.8 t 177.55 94.41 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.232 -1.158 . . . . 0.0 109.364 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 148.83 151.03 5.36 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.394 -1.483 . . . . 0.0 109.394 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 159.41 -176.46 36.19 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -179.36 114.12 0.06 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.252 -1.146 . . . . 0.0 109.624 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.5 p -120.01 148.59 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.256 -0.903 . . . . 0.0 109.136 179.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.448 ' CB ' ' HB ' ' A' ' 82' ' ' VAL . 0.0 OUTLIER -150.21 77.7 1.31 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.17 -0.956 . . . . 0.0 109.774 -179.735 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 60.3 t0 49.25 69.03 0.63 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.336 -0.852 . . . . 0.0 109.956 179.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.463 ' O ' HG23 ' A' ' 52' ' ' THR . . . 83.27 -11.56 54.65 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 179.514 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.448 ' HB ' ' CB ' ' A' ' 79' ' ' LYS . 58.5 t -97.97 89.79 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.094 -1.239 . . . . 0.0 109.523 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 52.3 mt -99.68 154.15 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.228 -0.92 . . . . 0.0 109.374 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -149.26 104.11 3.37 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.242 -0.911 . . . . 0.0 109.612 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 62.2 mt -125.76 125.04 67.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.334 -0.853 . . . . 0.0 109.357 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.405 ' HG3' HG12 ' A' ' 48' ' ' VAL . 8.3 tt0 -66.8 155.98 36.79 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.261 -0.899 . . . . 0.0 109.462 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 141.7 140.32 3.78 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -112.61 52.28 0.78 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.19 -1.182 . . . . 0.0 109.511 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 6.6 mttp -121.13 41.37 3.34 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.208 -0.933 . . . . 0.0 109.452 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.48 HH11 HD21 ' A' ' 106' ' ' LEU . 7.6 ptt85 -56.44 -27.76 57.59 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.251 -0.906 . . . . 0.0 109.494 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -57.89 -47.09 83.81 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.209 -0.932 . . . . 0.0 109.481 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 4.2 tt -74.28 -33.38 63.24 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.199 -0.938 . . . . 0.0 109.511 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.482 ' HG ' HG21 ' A' ' 36' ' ' ILE . 1.5 mm? -55.9 -38.72 70.6 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.272 -0.892 . . . . 0.0 109.458 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 13.1 tttt -53.41 -49.29 67.61 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.205 -0.934 . . . . 0.0 109.451 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 3.2 t -68.35 -29.36 68.07 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.28 -0.888 . . . . 0.0 109.437 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.558 HD23 ' N ' ' A' ' 97' ' ' LEU . 4.1 tt -58.06 -51.85 67.96 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.238 -0.914 . . . . 0.0 109.434 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.558 ' N ' HD23 ' A' ' 96' ' ' LEU . 0.4 OUTLIER -72.19 -32.35 66.74 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.261 -0.899 . . . . 0.0 109.428 179.983 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -71.69 -14.49 62.05 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.232 -0.918 . . . . 0.0 109.456 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.08 -31.42 72.6 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.213 -0.929 . . . . 0.0 109.422 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 7.3 mttm -94.0 -19.83 20.52 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.266 -0.896 . . . . 0.0 109.473 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 100.17 13.1 37.34 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 4.0 mtm -79.3 156.99 27.8 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.287 -1.125 . . . . 0.0 109.5 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.697 ' HB3' HG12 ' A' ' 33' ' ' VAL . 28.3 tttt -81.98 132.55 35.26 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.224 -0.923 . . . . 0.0 109.472 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.476 ' HB ' ' CD2' ' A' ' 97' ' ' LEU . 11.6 p -133.86 141.5 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.248 -0.908 . . . . 0.0 109.457 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 2.1 tttt -115.85 98.13 6.49 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.238 -0.914 . . . . 0.0 109.488 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.521 ' O ' ' HB3' ' A' ' 107' ' ' ALA . 25.5 tp -45.92 -26.59 0.72 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.238 -0.914 . . . . 0.0 109.477 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.521 ' HB3' ' O ' ' A' ' 106' ' ' LEU . . . 65.66 68.52 0.47 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.223 -0.923 . . . . 0.0 109.5 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -50.38 -62.28 5.24 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.44 ' O ' ' CB ' ' A' ' 110' ' ' LEU . . . 78.04 167.1 29.76 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.44 ' CB ' ' O ' ' A' ' 109' ' ' GLY . 0.4 OUTLIER 72.0 161.58 0.24 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.241 -1.152 . . . . 0.0 109.485 179.99 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.463 -179.99 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 66.5 mttt . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 174.71 164.24 29.22 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -179.61 85.81 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.242 -1.152 . . . . 0.0 109.449 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 140.48 119.33 1.59 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.544 -1.423 . . . . 0.0 109.544 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 18.2 t -123.84 94.6 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.211 -1.17 . . . . 0.0 109.458 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.467 HG12 ' N ' ' A' ' 35' ' ' ARG . 22.0 t -86.54 162.39 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.23 -0.919 . . . . 0.0 109.491 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.467 ' N ' HG12 ' A' ' 34' ' ' VAL . 0.0 OUTLIER -144.91 140.56 28.38 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.206 -0.934 . . . . 0.0 109.491 179.928 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.903 HG21 ' HG ' ' A' ' 93' ' ' LEU . 3.8 mp -141.52 124.4 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.233 -0.917 . . . . 0.0 109.491 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.862 ' HB3' ' HB2' ' A' ' 107' ' ' ALA . 5.5 pt20 -147.59 118.98 7.86 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.25 -0.906 . . . . 0.0 109.471 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 5.4 tmm_? -45.81 116.0 1.1 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.249 -0.907 . . . . 0.0 109.426 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 2.1 tm0? -85.01 126.95 33.97 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.253 -0.904 . . . . 0.0 109.465 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.416 ' O ' ' CB ' ' A' ' 41' ' ' SER . 8.8 t -96.25 173.66 7.28 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.243 -0.911 . . . . 0.0 109.459 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.416 ' CB ' ' O ' ' A' ' 40' ' ' THR . 1.4 t 169.57 81.53 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.271 -0.893 . . . . 0.0 109.436 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.41 161.04 30.23 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 10.6 ptt180 -123.15 59.42 1.08 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.214 -1.168 . . . . 0.0 109.495 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 85.8 mttt -147.17 27.78 1.03 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.25 -0.906 . . . . 0.0 109.512 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -177.86 -176.31 45.76 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 31.0 mttt -83.05 177.44 8.6 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.275 -1.132 . . . . 0.0 109.469 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.456 ' C ' HG13 ' A' ' 48' ' ' VAL . . . -103.54 -156.96 24.63 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.456 HG13 ' C ' ' A' ' 47' ' ' GLY . 35.9 m -156.5 160.34 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.281 -1.129 . . . . 0.0 109.481 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.4 ' HB2' ' O ' ' A' ' 85' ' ' ILE . 0.1 OUTLIER -95.35 117.56 30.54 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.191 -0.943 . . . . 0.0 109.494 179.989 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -103.56 98.17 8.09 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.27 -0.894 . . . . 0.0 109.471 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.694 HG13 HG23 ' A' ' 36' ' ' ILE . 3.1 mp -96.05 125.87 48.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.232 -0.918 . . . . 0.0 109.485 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.7 -152.82 0.43 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.224 -0.923 . . . . 0.0 109.538 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 52.07 51.44 40.85 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.441 ' O ' ' N ' ' A' ' 56' ' ' LEU . 2.1 t -115.72 46.33 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.212 -1.17 . . . . 0.0 109.477 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -55.71 90.89 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.229 -0.919 . . . . 0.0 109.423 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.441 ' N ' ' O ' ' A' ' 54' ' ' VAL . 0.4 OUTLIER -149.98 157.07 42.79 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.283 -0.886 . . . . 0.0 109.509 -179.925 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.34 157.75 19.05 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.286 -0.884 . . . . 0.0 109.452 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.719 ' O ' ' HB3' ' A' ' 59' ' ' ALA . 0.4 OUTLIER -56.17 172.46 0.21 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.183 -0.948 . . . . 0.0 109.455 179.995 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.719 ' HB3' ' O ' ' A' ' 58' ' ' ASP . . . 83.05 -43.03 0.11 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.676 -0.64 . . . . 0.0 109.83 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.41 -63.14 1.35 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.08 -1.012 . . . . 0.0 109.52 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -56.63 -27.92 59.4 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.233 -0.917 . . . . 0.0 109.476 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 46.0 p -72.72 -33.4 66.41 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.232 -0.918 . . . . 0.0 109.421 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 44.4 mttt -73.87 -51.73 15.25 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.269 -0.894 . . . . 0.0 109.469 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.693 ' O ' HD12 ' A' ' 68' ' ' LEU . 1.0 OUTLIER -56.69 -48.38 77.8 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.315 -0.866 . . . . 0.0 109.526 179.995 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.696 ' HB1' HG22 ' A' ' 78' ' ' VAL . . . -59.13 -61.02 2.95 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.323 -0.861 . . . . 0.0 109.686 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.415 ' C ' ' O ' ' A' ' 65' ' ' ALA . . . -43.26 -40.58 3.53 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.307 -0.871 . . . . 0.0 109.722 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -60.78 -52.22 66.0 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.21 -0.931 . . . . 0.0 109.542 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.693 HD12 ' O ' ' A' ' 64' ' ' LEU . 0.9 OUTLIER -60.72 -21.43 62.94 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.214 -0.929 . . . . 0.0 109.652 -179.879 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -65.44 -40.06 92.81 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.176 -0.952 . . . . 0.0 109.478 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 45.7 mttt -69.11 -23.29 63.98 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.209 -0.932 . . . . 0.0 109.444 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 15.7 mtpt -64.28 -29.07 70.18 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.406 -0.808 . . . . 0.0 110.032 -179.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.2 m -99.05 -43.03 6.83 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.049 -1.032 . . . . 0.0 109.672 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.474 ' O ' ' HB2' ' A' ' 74' ' ' CYS . . . 103.08 -22.68 35.92 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.474 ' HB2' ' O ' ' A' ' 73' ' ' GLY . 30.2 t 173.62 104.17 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.279 -1.13 . . . . 0.0 109.499 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 155.18 -61.4 0.37 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -47.49 119.38 4.83 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -110.41 150.35 28.95 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.26 -1.141 . . . . 0.0 109.234 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.696 HG22 ' HB1' ' A' ' 65' ' ' ALA . 41.8 t -102.38 152.22 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.253 -0.904 . . . . 0.0 109.715 -179.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -138.77 151.97 47.53 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.331 -0.856 . . . . 0.0 109.243 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.429 ' N ' ' OD1' ' A' ' 80' ' ' ASP . 1.0 OUTLIER -69.91 90.97 0.64 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.242 -0.911 . . . . 0.0 109.626 -179.817 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 109.07 -8.46 33.39 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.771 -1.331 . . . . 0.0 109.771 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.913 ' O ' HD13 ' A' ' 83' ' ' ILE . 75.9 t -142.26 153.02 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.129 -1.218 . . . . 0.0 109.566 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.913 HD13 ' O ' ' A' ' 82' ' ' VAL . 2.0 mm -136.53 129.25 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.289 -0.882 . . . . 0.0 109.226 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.515 ' O ' HD13 ' A' ' 85' ' ' ILE . 2.2 mt-10 -117.4 125.68 51.38 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.211 -0.931 . . . . 0.0 109.66 -179.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.515 HD13 ' O ' ' A' ' 84' ' ' GLU . 17.8 mm -137.42 116.65 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.269 -0.894 . . . . 0.0 109.417 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -69.77 157.56 37.1 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.247 -0.908 . . . . 0.0 109.521 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 148.74 -39.22 0.96 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.504 -1.439 . . . . 0.0 109.504 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 21.1 t0 57.33 53.77 7.3 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.223 -1.163 . . . . 0.0 109.452 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 19.8 mttt -134.96 54.52 1.94 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.24 -0.913 . . . . 0.0 109.451 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.414 ' HA ' ' HB2' ' A' ' 93' ' ' LEU . 38.5 ptt180 -47.31 -27.14 1.46 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.244 -0.91 . . . . 0.0 109.54 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -61.2 -58.61 7.62 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.248 -0.907 . . . . 0.0 109.464 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.484 ' O ' HD23 ' A' ' 92' ' ' LEU . 0.7 OUTLIER -64.87 -20.72 66.57 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.265 -0.897 . . . . 0.0 109.494 -179.975 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.903 ' HG ' HG21 ' A' ' 36' ' ' ILE . 2.1 mm? -65.81 -52.76 48.0 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.213 -0.93 . . . . 0.0 109.462 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.441 ' HG2' ' CG1' ' A' ' 104' ' ' VAL . 0.0 OUTLIER -62.83 -19.76 64.41 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.27 -0.893 . . . . 0.0 109.439 -179.98 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.94 -55.25 6.39 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.299 -0.876 . . . . 0.0 109.446 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.676 HD21 HD13 ' A' ' 93' ' ' LEU . 2.6 pp -64.82 -27.82 69.14 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.204 -0.935 . . . . 0.0 109.473 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.529 ' HB3' ' CG1' ' A' ' 104' ' ' VAL . 0.8 OUTLIER -68.12 -51.71 43.2 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.228 -0.92 . . . . 0.0 109.468 179.996 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -70.08 -16.65 63.16 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.267 -0.895 . . . . 0.0 109.44 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -67.22 -21.28 65.76 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.296 -0.878 . . . . 0.0 109.506 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -99.08 -17.18 18.36 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.269 -0.894 . . . . 0.0 109.453 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 103.59 -11.13 53.71 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 2.2 mtp -65.9 145.59 55.75 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.263 -1.14 . . . . 0.0 109.439 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.8 mttt -86.53 92.79 8.99 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.246 -0.908 . . . . 0.0 109.456 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.542 ' CG2' HD12 ' A' ' 36' ' ' ILE . 9.3 p -88.99 147.79 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.266 -0.896 . . . . 0.0 109.49 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 1.5 mttt -116.29 111.41 20.09 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.227 -0.92 . . . . 0.0 109.476 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.684 ' O ' ' HB2' ' A' ' 107' ' ' ALA . 2.8 mt -45.69 -84.6 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.194 -0.941 . . . . 0.0 109.48 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.862 ' HB2' ' HB3' ' A' ' 37' ' ' GLN . . . 165.33 -49.63 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.282 -0.886 . . . . 0.0 109.486 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 112.08 -127.34 8.03 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 126.72 168.04 12.49 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.511 -1.435 . . . . 0.0 109.511 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -175.88 -175.79 0.77 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.229 -1.159 . . . . 0.0 109.495 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 118.009 -0.996 . . . . 0.0 109.504 179.965 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 15.1 mttm . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 171.25 178.1 41.49 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -177.69 -37.88 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.254 -1.145 . . . . 0.0 109.511 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.499 ' O ' HG13 ' A' ' 33' ' ' VAL . . . -120.21 152.16 17.07 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.678 HG12 ' CB ' ' A' ' 103' ' ' LYS . 4.6 m -156.14 106.52 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.255 -1.144 . . . . 0.0 109.482 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.556 HG23 ' HE3' ' A' ' 102' ' ' MET . 3.0 t -89.75 140.66 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.221 -0.924 . . . . 0.0 109.48 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 17.0 ttm180 -106.71 108.01 19.31 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.262 -0.899 . . . . 0.0 109.435 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.761 ' CG2' HD13 ' A' ' 93' ' ' LEU . 22.2 mt -101.36 126.23 55.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.203 -0.935 . . . . 0.0 109.473 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.967 ' HB3' ' HB3' ' A' ' 107' ' ' ALA . 18.1 pt20 -146.59 -178.37 6.13 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.239 -0.913 . . . . 0.0 109.475 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 10.9 ttm180 -134.89 114.34 12.46 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.246 -0.909 . . . . 0.0 109.462 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.538 ' HB2' ' CD1' ' A' ' 50' ' ' LEU . 5.5 tp60 -87.78 127.5 35.32 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.245 -0.909 . . . . 0.0 109.438 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -87.64 159.63 18.46 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.267 -0.896 . . . . 0.0 109.518 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 45.2 t -153.58 30.69 0.47 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.193 -0.942 . . . . 0.0 109.475 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 148.9 141.93 3.53 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.42 79.87 9.27 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.276 -1.132 . . . . 0.0 109.473 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 2.3 mttp -172.55 -54.78 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.259 -0.9 . . . . 0.0 109.463 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -171.77 -131.02 1.3 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 51.28 74.53 0.24 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.229 -1.16 . . . . 0.0 109.443 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -109.15 144.52 16.51 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 29.5 m -144.45 151.99 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.258 -1.142 . . . . 0.0 109.458 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -109.52 116.66 32.2 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.226 -0.921 . . . . 0.0 109.483 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.691 ' O ' HD13 ' A' ' 51' ' ' ILE . 1.3 mp -96.99 147.73 23.7 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.251 -0.906 . . . . 0.0 109.53 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.691 HD13 ' O ' ' A' ' 50' ' ' LEU . 3.8 mm -136.08 125.87 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.293 -0.879 . . . . 0.0 109.387 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.406 ' HB ' HG13 ' A' ' 82' ' ' VAL . 1.4 t -158.16 168.46 26.99 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.186 -0.946 . . . . 0.0 109.508 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.35 -24.78 25.75 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.658 ' O ' HG13 ' A' ' 54' ' ' VAL . 8.0 p -49.55 106.97 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.255 -1.144 . . . . 0.0 109.496 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -100.48 78.85 2.05 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.195 -0.941 . . . . 0.0 109.462 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.456 HD23 ' HA ' ' A' ' 56' ' ' LEU . 16.4 mt -137.73 -173.57 3.53 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.231 -0.918 . . . . 0.0 109.455 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -68.0 138.26 55.74 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.24 -0.913 . . . . 0.0 109.446 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -50.08 -31.3 12.85 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.277 -0.89 . . . . 0.0 109.493 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.74 -43.42 93.44 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.249 -0.907 . . . . 0.0 109.5 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -66.18 -35.22 79.89 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.273 -0.892 . . . . 0.0 109.528 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.94 HD23 HD11 ' A' ' 83' ' ' ILE . 0.1 OUTLIER -59.63 -46.27 89.49 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.203 -0.935 . . . . 0.0 109.454 -179.955 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 39.5 p -71.06 -22.2 62.15 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.268 -0.895 . . . . 0.0 109.426 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.5 mmtp -71.77 -42.26 67.37 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.296 -0.877 . . . . 0.0 109.41 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -74.81 -34.64 62.41 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.203 -0.936 . . . . 0.0 109.285 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.63 -54.47 42.38 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.277 -0.889 . . . . 0.0 109.271 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.7 -39.2 93.24 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.274 -0.891 . . . . 0.0 109.213 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -54.89 -38.35 67.46 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.296 -0.878 . . . . 0.0 109.367 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 13.2 mt -82.17 -23.03 35.75 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.302 -0.874 . . . . 0.0 109.435 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 42.2 tttt -70.44 -22.93 62.65 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.22 -0.925 . . . . 0.0 109.268 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 4.6 mmtt -76.95 1.12 18.63 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.257 -0.902 . . . . 0.0 109.572 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 11.2 tttt -118.02 16.44 14.19 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.224 -0.922 . . . . 0.0 109.484 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -113.78 -33.04 5.93 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.201 -0.937 . . . . 0.0 109.544 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 87.72 -43.52 3.18 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 7.5 t -157.05 113.33 2.97 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.207 -1.172 . . . . 0.0 109.544 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 126.0 177.55 14.94 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 115.56 111.5 2.79 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -123.16 121.01 34.91 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.218 -1.166 . . . . 0.0 109.704 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.5 p -109.48 139.59 31.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.266 -0.896 . . . . 0.0 109.199 179.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.472 ' O ' ' N ' ' A' ' 81' ' ' GLY . 50.1 mttt -130.01 136.26 49.21 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.163 -0.961 . . . . 0.0 109.716 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -55.22 89.52 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.287 -0.883 . . . . 0.0 109.437 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.472 ' N ' ' O ' ' A' ' 79' ' ' LYS . . . 137.45 -44.78 1.11 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.406 HG13 ' HB ' ' A' ' 52' ' ' THR . 2.3 t -137.18 151.79 27.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.179 -1.189 . . . . 0.0 109.488 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.94 HD11 HD23 ' A' ' 61' ' ' LEU . 2.4 mp -124.66 140.63 47.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.209 -0.932 . . . . 0.0 109.555 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -128.92 139.0 52.32 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.315 -0.866 . . . . 0.0 109.372 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 17.8 mt -155.08 135.18 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.215 -0.928 . . . . 0.0 109.55 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -82.3 112.27 19.13 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.304 -0.872 . . . . 0.0 109.552 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -136.29 -39.78 0.14 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.461 -1.455 . . . . 0.0 109.461 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 46.28 36.61 3.42 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.227 -1.161 . . . . 0.0 109.521 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 5.4 mttp -137.91 53.7 1.82 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.261 -0.9 . . . . 0.0 109.473 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.562 ' HA ' HD12 ' A' ' 93' ' ' LEU . 1.9 mtm105 -49.64 -25.68 3.06 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.26 -0.9 . . . . 0.0 109.434 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -57.31 -53.34 59.17 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.255 -0.903 . . . . 0.0 109.443 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.6 tt -72.63 -33.4 66.62 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.262 -0.899 . . . . 0.0 109.471 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.761 HD13 ' CG2' ' A' ' 36' ' ' ILE . 48.0 mt -60.35 -27.42 67.36 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.263 -0.898 . . . . 0.0 109.406 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 75.4 tttt -64.65 -65.2 0.71 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.261 -0.9 . . . . 0.0 109.507 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -63.07 -15.42 56.52 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.228 -0.92 . . . . 0.0 109.468 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.766 HD23 ' N ' ' A' ' 97' ' ' LEU . 5.0 tt -71.22 -57.57 4.36 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.261 -0.899 . . . . 0.0 109.431 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.766 ' N ' HD23 ' A' ' 96' ' ' LEU . 0.1 OUTLIER -65.29 -32.38 74.0 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.252 -0.905 . . . . 0.0 109.469 179.993 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 56.5 mm-40 -67.8 -27.97 67.19 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.275 -0.891 . . . . 0.0 109.465 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -64.38 -32.21 73.73 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.295 -0.878 . . . . 0.0 109.441 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 17.2 mttt -80.52 -14.68 58.03 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.19 -0.944 . . . . 0.0 109.476 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 79.55 11.66 84.56 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' MET . . . . . 0.556 ' HE3' HG23 ' A' ' 34' ' ' VAL . 4.5 mtm -86.64 156.73 19.89 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.221 -1.164 . . . . 0.0 109.499 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.678 ' CB ' HG12 ' A' ' 33' ' ' VAL . 2.1 mmtt -80.69 108.44 14.34 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.242 -0.911 . . . . 0.0 109.445 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 34' ' ' VAL . 13.1 p -102.39 151.73 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.281 -0.887 . . . . 0.0 109.496 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.401 ' O ' ' N ' ' A' ' 107' ' ' ALA . 0.3 OUTLIER -115.32 79.21 1.25 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.243 -0.91 . . . . 0.0 109.472 179.993 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.488 ' C ' HD23 ' A' ' 106' ' ' LEU . 5.2 tt -46.74 100.45 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.247 -0.908 . . . . 0.0 109.463 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.967 ' HB3' ' HB3' ' A' ' 37' ' ' GLN . . . -98.71 130.93 45.21 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.259 -0.901 . . . . 0.0 109.494 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -128.28 -80.4 0.28 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.489 ' O ' ' CB ' ' A' ' 110' ' ' LEU . . . 106.05 -81.68 0.31 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.489 ' CB ' ' O ' ' A' ' 109' ' ' GLY . 6.8 tp 74.83 38.91 0.44 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.233 -1.157 . . . . 0.0 109.483 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 76.9 tt0 . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 117.981 -1.009 . . . . 0.0 109.451 -179.951 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 92.7 mttt . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 176.25 67.09 0.06 OUTLIER Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -94.4 46.83 1.16 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.247 -1.149 . . . . 0.0 109.507 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -169.46 107.4 0.27 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.546 HG12 ' HB2' ' A' ' 103' ' ' LYS . 27.0 m -121.86 144.96 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.281 -1.129 . . . . 0.0 109.426 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.54 ' O ' HG23 ' A' ' 104' ' ' VAL . 72.2 t -119.88 133.32 67.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.264 -0.898 . . . . 0.0 109.5 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 5.5 mtt180 -108.17 98.05 7.65 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.202 -0.937 . . . . 0.0 109.474 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.649 HG12 HD22 ' A' ' 93' ' ' LEU . 3.9 mt -98.63 145.42 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.251 -0.905 . . . . 0.0 109.432 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.425 ' HG3' ' O ' ' A' ' 37' ' ' GLN . 0.0 OUTLIER -179.46 122.46 0.08 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.253 -0.905 . . . . 0.0 109.473 179.977 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.5 132.51 44.78 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.23 -0.919 . . . . 0.0 109.462 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -121.45 149.21 43.36 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.279 -0.888 . . . . 0.0 109.506 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 11.2 p -86.45 143.06 27.96 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.269 -0.894 . . . . 0.0 109.444 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.3 m -102.98 -57.35 2.06 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.218 -0.926 . . . . 0.0 109.437 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 113.4 -19.69 19.38 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 46.7 mtt180 -105.19 -76.31 0.61 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.255 -1.144 . . . . 0.0 109.422 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 47.7 mttt -123.65 98.34 5.78 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.237 -0.914 . . . . 0.0 109.469 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 152.52 -57.98 0.42 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 25.3 mttt 55.18 31.42 16.38 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.214 -1.168 . . . . 0.0 109.513 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 127.39 83.99 0.46 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 28.1 m -113.69 157.02 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.225 -1.162 . . . . 0.0 109.434 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.518 ' SG ' HD11 ' A' ' 51' ' ' ILE . 5.4 t -105.71 123.56 48.13 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.237 -0.914 . . . . 0.0 109.485 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.41 ' C ' HD13 ' A' ' 51' ' ' ILE . 1.4 mt -116.39 108.61 16.27 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.237 -0.914 . . . . 0.0 109.433 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.518 HD11 ' SG ' ' A' ' 49' ' ' CYS . 3.5 mm -96.13 121.22 46.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.268 -0.895 . . . . 0.0 109.533 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.505 HG22 ' H ' ' A' ' 53' ' ' GLY . 0.2 OUTLIER -135.6 -169.32 2.37 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.264 -0.897 . . . . 0.0 109.497 179.938 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.505 ' H ' HG22 ' A' ' 52' ' ' THR . . . 63.35 46.42 92.82 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.8 t -95.94 122.63 47.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.216 -1.167 . . . . 0.0 109.491 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -105.24 77.61 1.32 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.218 -0.926 . . . . 0.0 109.496 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 37.7 mt -135.89 165.93 24.49 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.24 -0.912 . . . . 0.0 109.481 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -65.79 -73.59 0.13 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.303 -0.873 . . . . 0.0 109.454 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -173.45 -52.09 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.229 -0.919 . . . . 0.0 109.479 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.41 -33.42 74.75 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.221 -0.924 . . . . 0.0 109.495 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -69.73 -30.15 67.7 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.222 -0.924 . . . . 0.0 109.434 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.5 tt -70.54 -45.95 64.51 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.225 -0.922 . . . . 0.0 109.4 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -61.35 -43.97 97.97 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.255 -0.903 . . . . 0.0 109.45 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 76.8 tttt -60.56 -52.14 66.46 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.273 -0.892 . . . . 0.0 109.433 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.47 ' HA ' HD22 ' A' ' 64' ' ' LEU . 0.2 OUTLIER -48.01 -47.48 33.33 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.169 -0.957 . . . . 0.0 109.316 179.96 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.03 -42.14 84.69 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.293 -0.879 . . . . 0.0 109.297 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.35 -24.26 67.2 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.289 -0.882 . . . . 0.0 109.343 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -75.39 -38.62 59.83 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.34 -0.85 . . . . 0.0 109.431 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 9.5 mt -68.17 -42.57 79.79 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.246 -0.909 . . . . 0.0 109.314 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 17.2 tttt -56.81 -43.9 81.44 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.281 -0.887 . . . . 0.0 109.341 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 10.5 mttt -52.66 -33.19 45.99 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.21 -0.931 . . . . 0.0 109.459 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 34.4 mttt -116.61 54.78 0.84 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.169 -0.957 . . . . 0.0 109.836 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -140.36 -37.95 0.45 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.091 -1.006 . . . . 0.0 109.559 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.487 ' O ' ' CB ' ' A' ' 74' ' ' CYS . . . 91.28 -24.1 21.03 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 -179.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.487 ' CB ' ' O ' ' A' ' 73' ' ' GLY . 1.6 p 165.62 133.14 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.3 -1.117 . . . . 0.0 109.392 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.7 114.31 3.63 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 178.25 76.22 0.06 OUTLIER Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.564 ' HB3' ' HB2' ' A' ' 84' ' ' GLU . . . -83.95 151.33 25.12 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.297 -1.119 . . . . 0.0 109.473 -179.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 37.5 t -119.6 142.95 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.263 -0.898 . . . . 0.0 109.269 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.422 ' HB2' ' O ' ' A' ' 82' ' ' VAL . 16.3 mttt -147.33 171.18 15.84 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.267 -0.896 . . . . 0.0 109.496 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -63.8 102.62 0.48 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.344 -0.848 . . . . 0.0 109.718 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 63.18 25.9 68.73 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 179.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.422 ' O ' ' HB2' ' A' ' 79' ' ' LYS . 40.8 t -146.21 123.26 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.232 -1.158 . . . . 0.0 109.414 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 34.9 mt -117.86 139.59 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.223 -0.923 . . . . 0.0 109.508 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.564 ' HB2' ' HB3' ' A' ' 77' ' ' ALA . 1.3 mt-10 -115.09 131.2 57.0 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.195 -0.94 . . . . 0.0 109.325 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.415 HD13 ' HA ' ' A' ' 85' ' ' ILE . 47.3 mm -128.82 137.33 57.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.203 -0.935 . . . . 0.0 109.583 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -96.39 109.35 21.89 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.28 -0.888 . . . . 0.0 109.449 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 165.68 166.96 25.55 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -129.2 62.8 1.51 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.266 -1.138 . . . . 0.0 109.47 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 76.0 mttt -127.27 52.19 1.83 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.214 -0.929 . . . . 0.0 109.473 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.431 ' HG3' ' N ' ' A' ' 91' ' ' ASP . 6.6 ptt180 -52.25 -36.11 51.67 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.32 -0.863 . . . . 0.0 109.442 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.431 ' N ' ' HG3' ' A' ' 90' ' ' ARG . 21.9 m-20 -60.21 -43.22 96.15 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.274 -0.891 . . . . 0.0 109.519 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.45 -34.6 77.51 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.23 -0.919 . . . . 0.0 109.484 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.681 ' HA ' HD21 ' A' ' 96' ' ' LEU . 0.3 OUTLIER -62.15 -39.83 93.94 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.286 -0.884 . . . . 0.0 109.504 179.983 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 76.1 tttt -63.76 -27.07 68.94 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.242 -0.911 . . . . 0.0 109.427 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 20.7 t -75.61 -60.67 2.21 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.273 -0.892 . . . . 0.0 109.504 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.999 HD12 ' N ' ' A' ' 97' ' ' LEU . 4.0 pp -52.36 -33.16 41.79 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.271 -0.893 . . . . 0.0 109.479 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.999 ' N ' HD12 ' A' ' 96' ' ' LEU . 0.1 OUTLIER -68.89 -54.15 17.18 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.276 -0.89 . . . . 0.0 109.508 179.978 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -64.78 -12.52 48.46 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.286 -0.884 . . . . 0.0 109.523 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -65.28 -28.32 69.24 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.238 -0.914 . . . . 0.0 109.469 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 33.6 mttm -95.86 -24.92 16.22 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.263 -0.898 . . . . 0.0 109.445 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 103.04 13.92 27.88 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -76.62 147.98 37.22 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.254 -1.144 . . . . 0.0 109.488 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.546 ' HB2' HG12 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -80.47 87.16 5.7 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.254 -0.904 . . . . 0.0 109.434 -179.999 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.54 HG23 ' O ' ' A' ' 34' ' ' VAL . 11.7 p -85.88 133.19 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.225 -0.922 . . . . 0.0 109.475 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.417 ' O ' ' N ' ' A' ' 107' ' ' ALA . 5.3 mttt -102.33 86.18 2.77 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.285 -0.885 . . . . 0.0 109.469 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 4.7 tp -52.27 95.89 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.192 -0.942 . . . . 0.0 109.483 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.417 ' N ' ' O ' ' A' ' 105' ' ' LYS . . . -95.37 144.73 25.67 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.281 -0.887 . . . . 0.0 109.468 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -146.96 -79.86 0.03 OUTLIER Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -86.9 -157.85 31.33 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -172.61 168.42 5.26 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.203 -1.175 . . . . 0.0 109.459 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 118.051 -0.976 . . . . 0.0 109.459 179.995 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -178.32 78.0 0.07 OUTLIER Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -93.95 114.82 27.1 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.307 -1.113 . . . . 0.0 109.518 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -108.4 167.3 13.16 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.941 HG23 ' O ' ' A' ' 103' ' ' LYS . 3.3 p -150.41 94.47 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.233 -1.157 . . . . 0.0 109.504 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.91 ' HB ' HD21 ' A' ' 97' ' ' LEU . 69.6 t -85.14 107.42 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.251 -0.905 . . . . 0.0 109.484 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 82.6 mtt180 -83.45 120.81 26.36 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.268 -0.895 . . . . 0.0 109.445 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.767 HG21 HD13 ' A' ' 93' ' ' LEU . 5.6 mt -120.14 116.31 49.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.196 -0.94 . . . . 0.0 109.524 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.934 ' HB3' ' HB3' ' A' ' 107' ' ' ALA . 28.2 pt20 -143.76 151.25 39.75 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.207 -0.933 . . . . 0.0 109.454 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.455 ' HG3' ' O ' ' A' ' 38' ' ' ARG . 11.9 ptt180 -95.47 122.59 38.36 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.221 -0.924 . . . . 0.0 109.439 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 7.2 tp60 -83.04 -37.2 24.22 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.3 -0.875 . . . . 0.0 109.484 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 55.05 54.65 8.64 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.234 -0.916 . . . . 0.0 109.448 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 30.2 t -113.1 118.01 33.58 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.201 -0.937 . . . . 0.0 109.481 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 118.37 178.19 17.02 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 2.4 ttp180 -144.11 38.25 1.29 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.277 -1.131 . . . . 0.0 109.422 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.73 23.09 13.85 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.254 -0.904 . . . . 0.0 109.524 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -172.9 -83.44 0.05 OUTLIER Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 12.6 mttt -179.09 -60.8 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.25 -1.147 . . . . 0.0 109.492 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.7 173.32 31.02 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 16.0 m -143.22 156.92 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.261 -1.14 . . . . 0.0 109.416 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -118.21 110.89 18.11 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.241 -0.912 . . . . 0.0 109.471 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.453 ' C ' HD13 ' A' ' 51' ' ' ILE . 56.5 mt -93.79 123.83 37.39 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.273 -0.892 . . . . 0.0 109.514 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.453 HD13 ' C ' ' A' ' 50' ' ' LEU . 4.7 mm -109.4 110.94 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.28 -0.888 . . . . 0.0 109.453 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -158.48 152.68 24.03 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.269 -0.894 . . . . 0.0 109.448 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.443 ' O ' HG13 ' A' ' 33' ' ' VAL . . . 100.36 51.8 1.2 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 6.1 t -116.53 100.17 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.255 -1.144 . . . . 0.0 109.497 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -77.36 102.49 6.81 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.223 -0.923 . . . . 0.0 109.505 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.439 HD23 ' H ' ' A' ' 57' ' ' ASP . 0.1 OUTLIER -150.8 -157.43 0.81 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.252 -0.905 . . . . 0.0 109.481 179.991 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.439 ' H ' HD23 ' A' ' 56' ' ' LEU . 5.5 m-20 -76.58 -86.56 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.27 -0.894 . . . . 0.0 109.473 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -177.84 -47.33 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.307 -0.87 . . . . 0.0 109.36 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.8 -23.12 52.84 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.289 -0.882 . . . . 0.0 109.364 179.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.402 ' CB ' HD22 ' A' ' 56' ' ' LEU . 1.9 mm-40 -68.25 -28.07 66.89 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.267 -0.895 . . . . 0.0 109.437 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.95 -32.94 74.52 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.215 -0.928 . . . . 0.0 109.348 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -71.14 -40.7 71.22 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.275 -0.89 . . . . 0.0 109.391 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -66.79 -37.55 84.78 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.201 -0.937 . . . . 0.0 109.365 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.489 HD21 HG21 ' A' ' 34' ' ' VAL . 53.4 tp -65.35 -50.96 63.6 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.267 -0.896 . . . . 0.0 109.356 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.95 -26.96 69.07 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.306 -0.871 . . . . 0.0 109.295 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -74.21 -34.51 63.73 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.328 -0.858 . . . . 0.0 109.34 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -76.75 -26.71 54.86 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.254 -0.904 . . . . 0.0 109.39 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.489 HD13 ' HA ' ' A' ' 68' ' ' LEU . 0.5 OUTLIER -77.9 -37.01 48.91 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.267 -0.895 . . . . 0.0 109.437 -179.978 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 7.3 ttpt -67.61 -24.04 65.43 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.283 -0.886 . . . . 0.0 109.422 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.9 -29.71 60.43 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.288 -0.883 . . . . 0.0 109.536 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 4.0 mtmt -132.08 52.63 2.06 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.257 -0.902 . . . . 0.0 109.492 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . 0.581 ' SG ' HG23 ' A' ' 85' ' ' ILE . 9.1 t -110.13 -28.68 8.55 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.274 -0.891 . . . . 0.0 109.49 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.408 ' O ' ' HB2' ' A' ' 74' ' ' CYS . . . 77.73 6.19 86.82 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.408 ' HB2' ' O ' ' A' ' 73' ' ' GLY . 23.2 t 177.37 125.31 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.241 -1.152 . . . . 0.0 109.455 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -102.85 139.11 14.29 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -114.5 -100.86 2.37 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -117.78 133.36 56.01 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.211 -1.17 . . . . 0.0 109.333 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.0 t -124.85 99.13 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.19 -0.944 . . . . 0.0 109.669 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 61.4 mttm -115.29 141.47 47.99 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.272 -0.893 . . . . 0.0 109.322 179.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -60.39 99.84 0.09 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.207 -0.933 . . . . 0.0 109.391 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 121.17 -33.03 4.51 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 30.9 t -132.84 117.53 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.294 -1.121 . . . . 0.0 109.361 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 7.6 mt -123.13 123.71 68.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.291 -0.881 . . . . 0.0 109.556 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 53.6 tt0 -106.1 124.79 50.13 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.166 -0.959 . . . . 0.0 109.422 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.581 HG23 ' SG ' ' A' ' 72' ' ' CYS . 45.2 mm -115.2 143.44 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.228 -0.92 . . . . 0.0 109.555 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -112.68 113.64 25.86 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.301 -0.874 . . . . 0.0 109.501 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 178.74 -140.37 4.45 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.544 -1.423 . . . . 0.0 109.544 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.464 ' O ' ' CG ' ' A' ' 89' ' ' LYS . 17.6 t0 -177.35 79.9 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.261 -1.141 . . . . 0.0 109.514 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.464 ' CG ' ' O ' ' A' ' 88' ' ' ASP . 90.4 mttt -156.89 40.27 0.33 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.291 -0.881 . . . . 0.0 109.473 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 68.4 ttt180 -47.55 -31.5 4.46 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.282 -0.886 . . . . 0.0 109.527 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -57.46 -53.56 56.72 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.243 -0.91 . . . . 0.0 109.493 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 3.3 tp -63.82 -31.71 72.97 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.218 -0.926 . . . . 0.0 109.502 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.767 HD13 HG21 ' A' ' 36' ' ' ILE . 0.6 OUTLIER -59.09 -41.68 88.65 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.242 -0.911 . . . . 0.0 109.493 179.964 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -64.72 -27.04 68.64 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.272 -0.893 . . . . 0.0 109.519 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 1.1 t -73.94 -62.42 1.51 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.228 -0.92 . . . . 0.0 109.487 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.943 HD12 ' N ' ' A' ' 97' ' ' LEU . 4.1 pp -51.96 -31.11 27.66 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.237 -0.914 . . . . 0.0 109.526 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.943 ' N ' HD12 ' A' ' 96' ' ' LEU . 0.2 OUTLIER -70.03 -50.1 44.65 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.235 -0.916 . . . . 0.0 109.459 -179.927 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -65.49 -14.48 61.09 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.189 -0.945 . . . . 0.0 109.505 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -73.19 -27.94 61.92 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.252 -0.905 . . . . 0.0 109.489 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.8 mptt -87.65 -13.13 43.46 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.284 -0.885 . . . . 0.0 109.484 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 74.13 31.17 59.92 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 2.0 mtm -98.06 167.02 11.15 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.265 -1.138 . . . . 0.0 109.468 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.941 ' O ' HG23 ' A' ' 33' ' ' VAL . 2.3 mttm -86.53 93.34 9.15 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.292 -0.88 . . . . 0.0 109.457 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.641 ' HB ' HD12 ' A' ' 97' ' ' LEU . 7.5 p -83.31 136.43 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.241 -0.912 . . . . 0.0 109.5 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.9 90.25 3.33 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.302 -0.874 . . . . 0.0 109.456 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 45.3 mt -57.04 94.02 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.238 -0.914 . . . . 0.0 109.509 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.934 ' HB3' ' HB3' ' A' ' 37' ' ' GLN . . . -82.72 118.47 23.38 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.277 -0.889 . . . . 0.0 109.454 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -155.75 -166.44 15.8 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 162.53 161.48 12.24 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.559 -1.417 . . . . 0.0 109.559 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 2.0 pp -168.02 152.56 6.45 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.266 -1.138 . . . . 0.0 109.45 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.468 -179.998 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 98.9 mttt . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 152.09 -174.24 31.12 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -177.51 143.13 0.35 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.267 -1.137 . . . . 0.0 109.443 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -126.86 119.06 3.2 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.408 ' O ' HG23 ' A' ' 33' ' ' VAL . 5.2 m -125.65 90.62 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.273 -1.134 . . . . 0.0 109.443 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.506 HG12 ' N ' ' A' ' 35' ' ' ARG . 44.9 t -97.59 163.21 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.241 -0.912 . . . . 0.0 109.459 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.506 ' N ' HG12 ' A' ' 34' ' ' VAL . 69.5 mtt180 -147.79 121.66 9.34 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.248 -0.908 . . . . 0.0 109.458 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.776 HD11 HD13 ' A' ' 97' ' ' LEU . 1.1 mp -116.21 94.54 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.24 -0.913 . . . . 0.0 109.493 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.415 ' HB3' ' HB3' ' A' ' 107' ' ' ALA . 7.8 pt20 -106.97 -176.02 2.96 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.258 -0.901 . . . . 0.0 109.473 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 18.4 mtp180 -122.02 142.12 50.65 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.291 -0.881 . . . . 0.0 109.464 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -105.62 102.54 11.99 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.185 -0.947 . . . . 0.0 109.473 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 3.0 t -126.23 139.34 53.41 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.247 -0.908 . . . . 0.0 109.444 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -171.3 143.01 1.8 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.191 -0.943 . . . . 0.0 109.461 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 69.73 -175.14 34.73 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.408 ' O ' ' CB ' ' A' ' 44' ' ' LYS . 40.9 ptt180 -104.65 178.36 4.58 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.247 -1.149 . . . . 0.0 109.512 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.408 ' CB ' ' O ' ' A' ' 43' ' ' ARG . 56.0 tttt 69.0 67.08 0.28 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.244 -0.91 . . . . 0.0 109.497 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 179.4 146.4 6.75 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -99.43 -26.84 14.0 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.228 -1.16 . . . . 0.0 109.475 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 114.76 146.34 9.05 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 5.6 m -138.71 162.75 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.241 -1.152 . . . . 0.0 109.581 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 92.2 m -112.37 138.22 49.42 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.277 -0.889 . . . . 0.0 109.39 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.415 ' N ' HD23 ' A' ' 50' ' ' LEU . 0.2 OUTLIER -132.26 113.36 13.15 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.243 -0.91 . . . . 0.0 109.493 -179.972 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.682 HG13 HG23 ' A' ' 36' ' ' ILE . 3.7 mp -85.91 131.01 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.208 -0.933 . . . . 0.0 109.503 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.0 p -142.15 -174.54 4.13 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.236 -0.915 . . . . 0.0 109.453 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 52.04 51.36 41.08 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.6 t -97.13 110.69 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.289 -1.124 . . . . 0.0 109.41 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -97.43 78.18 2.67 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.258 -0.901 . . . . 0.0 109.488 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.647 HD12 ' CB ' ' A' ' 60' ' ' GLU . 1.8 mm? -115.86 -167.7 1.3 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.228 -0.92 . . . . 0.0 109.49 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -96.57 -61.03 1.48 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.257 -0.902 . . . . 0.0 109.47 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 175.74 -54.59 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.308 -0.87 . . . . 0.0 109.394 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -75.55 -23.05 56.57 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.252 -0.905 . . . . 0.0 109.435 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.647 ' CB ' HD12 ' A' ' 56' ' ' LEU . 0.4 OUTLIER -75.29 -33.48 61.21 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.289 -0.882 . . . . 0.0 109.441 179.986 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.0 -44.42 84.86 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.266 -0.897 . . . . 0.0 109.374 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 57.2 m -69.02 -29.77 68.01 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.266 -0.896 . . . . 0.0 109.514 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -70.67 -35.48 72.85 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.232 -0.918 . . . . 0.0 109.49 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.419 HD22 ' HA ' ' A' ' 64' ' ' LEU . 0.1 OUTLIER -72.45 -59.83 2.53 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.214 -0.929 . . . . 0.0 109.494 179.986 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -48.39 -45.39 35.84 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.278 -0.889 . . . . 0.0 109.473 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.18 -41.37 99.21 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.262 -0.899 . . . . 0.0 109.465 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -59.35 -32.62 70.27 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.212 -0.93 . . . . 0.0 109.534 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.533 HD21 ' CD1' ' A' ' 96' ' ' LEU . 3.5 mt -82.89 -22.28 33.99 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.265 -0.897 . . . . 0.0 109.405 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.98 -21.08 59.37 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.302 -0.873 . . . . 0.0 109.758 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.6 -14.18 61.14 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.274 -0.891 . . . . 0.0 110.264 -179.412 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.02 37.88 1.17 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.053 -1.029 . . . . 0.0 109.584 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . 0.638 ' SG ' HD12 ' A' ' 85' ' ' ILE . 0.1 OUTLIER -99.06 -64.79 1.01 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.269 -0.894 . . . . 0.0 109.566 -179.958 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.479 ' O ' ' CB ' ' A' ' 74' ' ' CYS . . . 116.21 18.81 5.72 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.479 ' CB ' ' O ' ' A' ' 73' ' ' GLY . 0.5 OUTLIER 164.93 93.06 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.275 -1.132 . . . . 0.0 109.438 -179.961 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -57.27 100.71 0.13 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -77.38 -159.09 10.44 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -74.2 146.57 43.27 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.128 -1.219 . . . . 0.0 109.314 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 57.9 t -135.18 93.77 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.176 -0.952 . . . . 0.0 109.695 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.04 156.35 18.85 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.332 -0.855 . . . . 0.0 109.333 179.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -71.58 101.45 2.5 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.173 -0.954 . . . . 0.0 109.54 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.404 ' C ' ' CG2' ' A' ' 82' ' ' VAL . . . 117.44 -11.93 14.06 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.404 ' CG2' ' C ' ' A' ' 81' ' ' GLY . 3.3 t -152.72 117.75 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.297 -1.12 . . . . 0.0 109.357 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 15.2 mt -122.76 123.68 68.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.189 -0.944 . . . . 0.0 109.744 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -92.14 136.06 33.49 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.308 -0.87 . . . . 0.0 109.27 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.638 HD12 ' SG ' ' A' ' 72' ' ' CYS . 13.1 mm -131.9 95.93 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.171 -0.956 . . . . 0.0 109.521 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -56.56 133.85 53.84 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.296 -0.877 . . . . 0.0 109.407 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 143.9 173.72 15.59 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -139.92 81.32 1.81 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.28 -1.13 . . . . 0.0 109.419 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 13.7 pttt -145.55 49.03 1.24 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.261 -0.9 . . . . 0.0 109.456 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 7.1 ptt180 -47.69 -37.53 13.21 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.258 -0.901 . . . . 0.0 109.516 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -56.15 -49.66 73.33 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.261 -0.899 . . . . 0.0 109.438 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.498 ' HA ' HD22 ' A' ' 92' ' ' LEU . 0.2 OUTLIER -60.15 -44.13 95.2 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.268 -0.895 . . . . 0.0 109.501 -179.992 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.538 ' HG ' HG21 ' A' ' 36' ' ' ILE . 4.3 mm? -56.15 -35.13 66.82 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.237 -0.914 . . . . 0.0 109.42 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 67.9 tttt -60.87 -62.07 2.12 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.25 -0.906 . . . . 0.0 109.491 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -62.82 -14.1 41.47 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.216 -0.928 . . . . 0.0 109.421 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.856 HD23 ' N ' ' A' ' 97' ' ' LEU . 4.7 tt -72.78 -62.08 1.58 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.231 -0.918 . . . . 0.0 109.473 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.856 ' N ' HD23 ' A' ' 96' ' ' LEU . 0.1 OUTLIER -61.78 -31.9 72.15 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.266 -0.896 . . . . 0.0 109.444 -179.983 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -71.86 -25.56 62.0 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.277 -0.889 . . . . 0.0 109.506 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -68.79 -26.82 65.4 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.209 -0.932 . . . . 0.0 109.474 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -85.78 -39.31 17.25 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.244 -0.91 . . . . 0.0 109.504 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 117.65 14.46 6.82 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' MET . . . . . 0.413 ' HB2' HD23 ' A' ' 97' ' ' LEU . 19.0 mtp -96.62 154.12 17.46 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.293 -1.122 . . . . 0.0 109.451 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 11.1 mptt -81.19 118.94 22.99 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.282 -0.886 . . . . 0.0 109.512 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.773 ' HB ' HD22 ' A' ' 97' ' ' LEU . 12.1 p -115.32 135.06 56.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.265 -0.897 . . . . 0.0 109.456 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 71.6 tttt -102.28 97.56 7.82 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.273 -0.892 . . . . 0.0 109.465 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.459 ' O ' ' HB3' ' A' ' 107' ' ' ALA . 23.9 tp -45.59 -30.35 1.47 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.285 -0.884 . . . . 0.0 109.497 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.459 ' HB3' ' O ' ' A' ' 106' ' ' LEU . . . 62.67 -178.39 0.14 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.232 -0.918 . . . . 0.0 109.48 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.404 ' O ' ' C ' ' A' ' 109' ' ' GLY . . . 148.25 -139.36 7.61 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.404 ' C ' ' O ' ' A' ' 108' ' ' GLY . . . -44.83 129.66 7.77 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.0 tt -174.03 119.65 0.27 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.281 -1.129 . . . . 0.0 109.47 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 118.017 -0.992 . . . . 0.0 109.483 179.979 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 57.6 tttt . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 177.57 -71.77 0.08 OUTLIER Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -92.86 149.33 21.34 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.239 -1.154 . . . . 0.0 109.453 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.586 ' HA3' HD21 ' A' ' 56' ' ' LEU . . . -122.94 145.45 16.21 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.673 HG12 ' HB2' ' A' ' 103' ' ' LYS . 16.3 m -132.21 137.71 53.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.29 -1.124 . . . . 0.0 109.45 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.761 ' HB ' HD21 ' A' ' 97' ' ' LEU . 60.3 t -106.6 162.29 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.196 -0.94 . . . . 0.0 109.478 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.53 ' N ' HG12 ' A' ' 34' ' ' VAL . 4.4 ttt180 -135.62 108.07 7.37 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.243 -0.911 . . . . 0.0 109.48 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.739 HG12 HD22 ' A' ' 93' ' ' LEU . 3.2 mt -116.53 128.11 73.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.208 -0.933 . . . . 0.0 109.429 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.745 ' HB3' ' HB3' ' A' ' 107' ' ' ALA . 4.0 pt20 -156.07 153.88 30.1 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.258 -0.901 . . . . 0.0 109.477 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.1 143.14 34.66 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.248 -0.908 . . . . 0.0 109.487 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 20.2 tt0 -109.55 71.2 0.76 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.203 -0.936 . . . . 0.0 109.47 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 3.3 t -56.5 151.87 12.68 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.29 -0.881 . . . . 0.0 109.485 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -152.52 56.29 0.81 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.3 -0.875 . . . . 0.0 109.509 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 153.43 163.49 11.83 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 27.9 mtp85 -84.22 113.64 21.24 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.215 -1.167 . . . . 0.0 109.452 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 81.8 tttt 47.94 63.7 1.93 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.201 -0.937 . . . . 0.0 109.436 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -116.88 -55.48 0.31 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 12.3 tttt -174.18 131.5 0.39 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.193 -1.18 . . . . 0.0 109.406 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -96.16 123.27 7.64 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 15.6 m -121.44 143.31 34.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.239 -1.154 . . . . 0.0 109.328 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -125.37 133.92 52.36 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.211 -0.93 . . . . 0.0 109.53 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.425 ' HG ' ' O ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -123.29 120.52 33.34 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.264 -0.898 . . . . 0.0 109.41 179.951 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.452 ' N ' HD13 ' A' ' 51' ' ' ILE . 3.2 mm -90.91 119.61 38.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.232 -0.917 . . . . 0.0 109.441 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.92 159.4 44.58 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.273 -0.892 . . . . 0.0 109.455 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 108.05 -31.21 8.13 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.54 HG22 HG22 ' A' ' 34' ' ' VAL . 57.0 t -45.02 113.05 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.221 -1.164 . . . . 0.0 109.419 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -114.34 76.8 1.01 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.234 -0.916 . . . . 0.0 109.478 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.586 HD21 ' HA3' ' A' ' 32' ' ' GLY . 31.3 mt -130.06 -156.33 0.75 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.255 -0.903 . . . . 0.0 109.439 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.598 ' O ' HD12 ' A' ' 61' ' ' LEU . 4.4 m-20 -67.34 143.28 56.46 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.278 -0.889 . . . . 0.0 109.446 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -58.08 -36.02 72.24 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.248 -0.907 . . . . 0.0 109.66 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -75.25 -32.55 61.12 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.182 -0.949 . . . . 0.0 109.531 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -71.95 -26.3 62.22 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.278 -0.889 . . . . 0.0 109.534 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.598 HD12 ' O ' ' A' ' 57' ' ' ASP . 0.2 OUTLIER -71.87 -56.87 4.94 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.219 -0.925 . . . . 0.0 109.549 -179.962 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 4.5 t -56.45 -24.36 44.96 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.266 -0.896 . . . . 0.0 109.453 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 79.2 mttt -75.54 -46.17 33.66 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.259 -0.9 . . . . 0.0 109.515 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.415 ' HA ' HD22 ' A' ' 64' ' ' LEU . 0.4 OUTLIER -60.73 -46.02 92.04 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.188 -0.945 . . . . 0.0 109.359 179.939 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.41 ' CB ' HG13 ' A' ' 78' ' ' VAL . . . -65.78 -38.09 88.08 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.271 -0.893 . . . . 0.0 109.381 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.82 -36.98 75.39 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.227 -0.921 . . . . 0.0 109.413 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -75.55 -35.99 60.53 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.231 -0.918 . . . . 0.0 109.445 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.433 HD13 ' HA ' ' A' ' 68' ' ' LEU . 0.1 OUTLIER -56.55 -53.17 60.65 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.347 -0.846 . . . . 0.0 109.605 -179.932 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 15.4 pttp -66.16 -34.02 77.1 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.277 -0.889 . . . . 0.0 109.494 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -59.7 -21.83 61.16 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.316 -0.865 . . . . 0.0 109.71 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -85.07 -36.72 21.01 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.221 -0.925 . . . . 0.0 109.75 -179.655 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.2 m -94.42 -64.95 1.02 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.219 -0.925 . . . . 0.0 109.574 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 118.23 5.2 13.33 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 -179.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 46.8 t -160.15 121.87 3.19 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.307 -1.114 . . . . 0.0 109.258 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -129.35 -106.81 1.25 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 -179.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -172.84 -47.07 0.04 OUTLIER Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -178.55 119.52 0.08 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.291 -1.123 . . . . 0.0 109.56 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.416 HG22 HG23 ' A' ' 83' ' ' ILE . 77.9 t -100.98 97.82 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.312 -0.868 . . . . 0.0 109.292 179.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -106.34 141.34 37.82 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.213 -0.929 . . . . 0.0 109.814 -179.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -57.82 96.16 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.329 -0.857 . . . . 0.0 109.44 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 127.45 -40.78 1.7 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 23.5 t -132.93 122.51 46.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.179 -1.189 . . . . 0.0 109.58 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.416 HG23 HG22 ' A' ' 78' ' ' VAL . 2.9 mp -120.6 132.33 70.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.316 -0.865 . . . . 0.0 109.241 179.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -110.25 137.14 48.39 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.236 -0.915 . . . . 0.0 109.583 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 31.2 mm -132.59 123.18 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.299 -0.876 . . . . 0.0 109.563 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -91.78 104.95 17.34 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.204 -0.935 . . . . 0.0 109.438 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 178.6 -162.9 30.42 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -153.5 70.78 0.86 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.243 -1.151 . . . . 0.0 109.47 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 77.3 mttt -136.57 50.0 2.05 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.263 -0.898 . . . . 0.0 109.578 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 24.5 ptt180 -60.21 -34.04 73.09 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.227 -0.92 . . . . 0.0 109.478 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 30.5 t0 -55.74 -56.14 23.97 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.242 -0.911 . . . . 0.0 109.416 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.38 -31.03 71.63 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.249 -0.907 . . . . 0.0 109.398 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.739 HD22 HG12 ' A' ' 36' ' ' ILE . 0.4 OUTLIER -58.9 -45.16 90.96 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.31 -0.868 . . . . 0.0 109.442 179.961 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -61.91 -31.86 72.2 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.28 -0.887 . . . . 0.0 109.562 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.415 ' O ' ' C ' ' A' ' 96' ' ' LEU . 1.5 t -68.9 -69.76 0.31 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.216 -0.928 . . . . 0.0 109.499 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.961 HD12 ' N ' ' A' ' 97' ' ' LEU . 4.1 pp -43.78 -37.56 2.8 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.272 -0.892 . . . . 0.0 109.532 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.961 ' N ' HD12 ' A' ' 96' ' ' LEU . 10.6 tp -63.04 -47.24 83.87 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.213 -0.929 . . . . 0.0 109.46 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -69.2 -15.62 63.43 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.285 -0.884 . . . . 0.0 109.481 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -69.99 -28.34 65.44 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.22 -0.925 . . . . 0.0 109.472 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.446 ' HD3' ' N ' ' A' ' 100' ' ' LYS . 0.3 OUTLIER -85.77 -16.24 39.49 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.23 -0.919 . . . . 0.0 109.466 -179.951 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 84.94 14.38 69.8 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' MET . . . . . 0.481 ' HE3' HG23 ' A' ' 34' ' ' VAL . 1.4 mtm -87.29 171.89 10.28 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.243 -1.151 . . . . 0.0 109.43 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.673 ' HB2' HG12 ' A' ' 33' ' ' VAL . 0.1 OUTLIER -80.43 164.93 22.68 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.238 -0.913 . . . . 0.0 109.452 179.974 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.848 HG13 HD23 ' A' ' 97' ' ' LEU . 4.8 t -139.49 125.88 23.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.215 -0.928 . . . . 0.0 109.48 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.427 ' O ' ' C ' ' A' ' 106' ' ' LEU . 2.5 mttt -106.5 64.46 0.66 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.189 -0.944 . . . . 0.0 109.491 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.43 HD12 ' HA ' ' A' ' 106' ' ' LEU . 3.6 tp -43.93 102.55 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.28 -0.887 . . . . 0.0 109.494 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.745 ' HB3' ' HB3' ' A' ' 37' ' ' GLN . . . -96.0 -11.65 26.18 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.23 -0.919 . . . . 0.0 109.456 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -102.72 137.27 13.3 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 146.74 148.68 4.81 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -102.41 157.41 16.93 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.267 -1.137 . . . . 0.0 109.445 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 117.996 -1.002 . . . . 0.0 109.479 179.952 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 36.8 tttt . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -176.18 -59.31 0.06 OUTLIER Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 65.9 t0 50.45 68.3 0.79 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.201 -1.176 . . . . 0.0 109.477 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -99.53 139.33 14.37 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.444 ' O ' HG23 ' A' ' 33' ' ' VAL . 18.8 m -143.89 121.56 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.213 -1.169 . . . . 0.0 109.459 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.446 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 2.4 t -98.94 152.8 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.281 -0.887 . . . . 0.0 109.474 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.421 ' HG2' ' C ' ' A' ' 34' ' ' VAL . 4.4 mtt180 -139.01 118.56 12.95 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.314 -0.866 . . . . 0.0 109.461 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.907 HG21 ' HG ' ' A' ' 93' ' ' LEU . 2.6 mp -125.64 116.91 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.218 -0.926 . . . . 0.0 109.45 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.518 ' HB3' ' HB3' ' A' ' 107' ' ' ALA . 12.7 pt20 -146.96 174.24 11.7 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.186 -0.946 . . . . 0.0 109.504 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.401 ' HB2' ' HD2' ' A' ' 90' ' ' ARG . 9.1 ttm180 -102.1 149.74 23.96 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.221 -0.924 . . . . 0.0 109.469 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -136.27 108.04 7.05 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.233 -0.917 . . . . 0.0 109.405 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 40.5 p -69.15 -179.47 1.57 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.264 -0.898 . . . . 0.0 109.493 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -149.15 -54.29 0.18 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.221 -0.924 . . . . 0.0 109.463 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -89.08 -110.51 1.19 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 86.7 mtt180 -127.31 -47.9 1.45 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.288 -1.124 . . . . 0.0 109.468 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 30.0 pttt -138.55 156.47 47.46 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.285 -0.884 . . . . 0.0 109.484 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 60.55 -173.3 5.7 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 58.29 49.01 11.68 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.235 -1.156 . . . . 0.0 109.432 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -107.28 135.09 12.55 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 18.6 m -133.06 168.75 23.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.252 -1.146 . . . . 0.0 109.461 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -119.83 116.98 26.97 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.184 -0.947 . . . . 0.0 109.54 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -92.69 129.51 38.59 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.254 -0.904 . . . . 0.0 109.425 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.727 HG12 HG23 ' A' ' 36' ' ' ILE . 21.9 mt -110.07 111.62 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.256 -0.903 . . . . 0.0 109.562 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 60.2 p -137.98 176.25 8.86 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.243 -0.91 . . . . 0.0 109.452 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.89 -15.11 59.81 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 18.6 t -56.67 122.01 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.248 -1.148 . . . . 0.0 109.466 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -124.45 72.12 1.18 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.255 -0.903 . . . . 0.0 109.486 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.643 HD13 ' HB3' ' A' ' 60' ' ' GLU . 8.3 mt -113.15 -173.36 2.24 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.28 -0.887 . . . . 0.0 109.466 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.61 -83.6 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.269 -0.895 . . . . 0.0 109.536 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -156.24 -61.09 0.1 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.22 -0.925 . . . . 0.0 109.452 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.442 ' O ' HG22 ' A' ' 62' ' ' THR . . . -65.33 -26.6 68.11 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.235 -0.916 . . . . 0.0 109.45 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.643 ' HB3' HD13 ' A' ' 56' ' ' LEU . 5.4 mt-10 -62.58 -42.5 99.6 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.253 -0.904 . . . . 0.0 109.481 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -56.03 -59.15 5.32 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.212 -0.93 . . . . 0.0 109.403 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.442 HG22 ' O ' ' A' ' 59' ' ' ALA . 8.8 t -59.46 -20.6 56.43 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.281 -0.887 . . . . 0.0 109.506 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.2 tttt -70.94 -71.06 0.27 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.215 -0.928 . . . . 0.0 109.522 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.635 ' O ' HD13 ' A' ' 64' ' ' LEU . 0.2 OUTLIER -48.25 -32.24 6.95 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.3 -0.875 . . . . 0.0 109.761 -179.869 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.42 -49.86 61.91 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.123 -0.986 . . . . 0.0 109.902 -179.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.421 ' O ' ' HG3' ' A' ' 70' ' ' LYS . . . -60.01 -28.99 68.18 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.089 -1.007 . . . . 0.0 109.891 -179.652 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.45 ' O ' ' HB2' ' A' ' 70' ' ' LYS . 2.6 tt0 -76.71 -33.83 58.18 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.127 -0.983 . . . . 0.0 109.835 -179.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.468 ' HA ' HD23 ' A' ' 68' ' ' LEU . 29.7 mt -71.62 -42.79 67.2 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.155 -0.965 . . . . 0.0 109.624 -179.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 18.7 mtmt -72.34 -4.51 30.32 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.171 -0.956 . . . . 0.0 109.461 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.45 ' HB2' ' O ' ' A' ' 67' ' ' GLU . 4.3 mttt -74.0 -21.8 59.84 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.131 -0.981 . . . . 0.0 109.955 -179.509 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.93 59.3 1.54 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.12 -0.988 . . . . 0.0 109.579 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 4.9 t -134.31 -3.76 2.71 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.17 -0.956 . . . . 0.0 110.029 -179.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.13 2.68 54.13 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -163.54 -169.12 1.84 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.157 -1.202 . . . . 0.0 109.512 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -140.81 -116.18 1.27 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 144.1 -172.36 25.26 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -87.26 126.14 34.64 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.231 -1.158 . . . . 0.0 109.464 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.581 HG23 ' O ' ' A' ' 78' ' ' VAL . 18.8 m -99.39 88.43 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.186 -0.946 . . . . 0.0 109.565 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.47 148.23 22.45 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.208 -0.933 . . . . 0.0 109.351 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -70.83 89.89 0.78 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.193 -0.942 . . . . 0.0 109.555 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.453 ' O ' HG23 ' A' ' 82' ' ' VAL . . . 123.85 -11.19 8.34 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 81' ' ' GLY . 73.2 t -156.18 121.41 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.299 -1.118 . . . . 0.0 109.356 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 11.3 mt -119.45 126.61 75.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.203 -0.935 . . . . 0.0 109.659 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -92.5 120.73 33.26 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.277 -0.889 . . . . 0.0 109.318 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.431 HG22 ' O ' ' A' ' 85' ' ' ILE . 48.1 mm -127.45 70.72 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.28 -0.887 . . . . 0.0 109.561 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -50.43 160.92 0.35 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.256 -0.902 . . . . 0.0 109.416 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 126.59 -159.81 20.88 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -151.82 93.82 1.9 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.239 -1.153 . . . . 0.0 109.539 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 63.5 mttt -152.55 29.03 0.54 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.278 -0.889 . . . . 0.0 109.437 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.7 ' HB3' HD21 ' A' ' 106' ' ' LEU . 26.4 mtp180 -49.53 -38.42 30.59 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.219 -0.926 . . . . 0.0 109.465 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -55.36 -57.19 12.87 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.228 -0.92 . . . . 0.0 109.477 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.77 -21.48 65.88 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.285 -0.884 . . . . 0.0 109.467 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.907 ' HG ' HG21 ' A' ' 36' ' ' ILE . 0.9 OUTLIER -68.94 -42.4 76.77 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.248 -0.907 . . . . 0.0 109.472 179.995 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 18.3 tttt -68.84 -23.67 64.27 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.282 -0.886 . . . . 0.0 109.482 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -74.68 -62.44 1.53 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.173 -0.955 . . . . 0.0 109.437 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.659 HD12 ' N ' ' A' ' 97' ' ' LEU . 2.6 pp -53.92 -35.88 62.15 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.235 -0.916 . . . . 0.0 109.439 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.659 ' N ' HD12 ' A' ' 96' ' ' LEU . 0.2 OUTLIER -63.23 -52.58 61.6 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.281 -0.887 . . . . 0.0 109.483 179.976 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -63.04 -16.54 60.19 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.276 -0.89 . . . . 0.0 109.441 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.453 ' HB3' ' O ' ' A' ' 96' ' ' LEU . . . -65.76 -35.92 82.09 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.248 -0.908 . . . . 0.0 109.505 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.426 ' HE3' HD21 ' A' ' 64' ' ' LEU . 2.7 mptp? -81.05 -38.5 27.3 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.245 -0.909 . . . . 0.0 109.508 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 108.99 14.58 14.73 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 8.1 mtm -89.77 158.83 17.34 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.25 -1.147 . . . . 0.0 109.466 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 20.4 mttt -80.93 120.04 24.23 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.269 -0.895 . . . . 0.0 109.428 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.446 ' HA ' ' O ' ' A' ' 34' ' ' VAL . 3.0 p -115.82 143.11 26.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.218 -0.926 . . . . 0.0 109.455 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.418 ' O ' ' C ' ' A' ' 106' ' ' LEU . 26.6 tttt -114.1 83.19 1.83 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.263 -0.898 . . . . 0.0 109.481 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.7 HD21 ' HB3' ' A' ' 90' ' ' ARG . 0.6 OUTLIER -44.67 -26.81 0.42 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.207 -0.933 . . . . 0.0 109.473 179.993 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.524 ' HB3' ' O ' ' A' ' 106' ' ' LEU . . . 66.21 -169.89 0.2 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.249 -0.907 . . . . 0.0 109.48 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 116.94 -166.21 12.42 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 160.38 -171.39 36.58 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.4 tp -53.94 102.14 0.05 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.312 -1.11 . . . . 0.0 109.436 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 63.8 tt0 . . . . . 0 N--CA 1.489 1.52 0 CA-C-O 117.986 -1.007 . . . . 0.0 109.502 179.976 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 75.0 mttt . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -149.26 141.7 9.16 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 19.1 p-10 -174.92 -171.51 0.54 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.222 -1.163 . . . . 0.0 109.458 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.408 ' C ' HG13 ' A' ' 33' ' ' VAL . . . 178.02 130.21 1.37 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.663 ' O ' HG23 ' A' ' 33' ' ' VAL . 19.3 m -152.1 115.12 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.259 -1.142 . . . . 0.0 109.5 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.689 ' HB ' HD11 ' A' ' 97' ' ' LEU . 4.7 t -90.81 142.32 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.253 -0.904 . . . . 0.0 109.486 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 67.8 ttt180 -117.6 109.55 16.82 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.236 -0.915 . . . . 0.0 109.496 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 1.026 HG21 HD13 ' A' ' 93' ' ' LEU . 2.4 mp -108.22 93.7 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.266 -0.896 . . . . 0.0 109.473 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.79 179.96 7.44 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.273 -0.892 . . . . 0.0 109.425 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.71 102.67 3.96 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.254 -0.904 . . . . 0.0 109.446 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.6 ' O ' HG22 ' A' ' 48' ' ' VAL . 7.7 tt0 -88.44 128.83 35.54 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.285 -0.885 . . . . 0.0 109.478 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 74.1 p -130.49 147.75 52.22 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.279 -0.888 . . . . 0.0 109.481 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.3 t -113.2 144.19 43.11 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.284 -0.885 . . . . 0.0 109.467 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 49.32 -158.75 1.13 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -95.52 118.42 32.19 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.259 -1.142 . . . . 0.0 109.438 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 21.7 tttt 45.97 -165.89 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.292 -0.88 . . . . 0.0 109.463 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 104.46 -29.87 11.14 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 41.6 pttt -173.11 174.52 3.41 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.302 -1.116 . . . . 0.0 109.472 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -161.49 145.1 10.46 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.6 HG22 ' O ' ' A' ' 39' ' ' GLN . 34.1 m -137.08 153.01 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.229 -1.159 . . . . 0.0 109.444 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -130.63 130.53 44.08 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.212 -0.93 . . . . 0.0 109.52 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 4.2 mp -118.74 109.51 16.17 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.235 -0.916 . . . . 0.0 109.468 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.577 HG13 HG23 ' A' ' 36' ' ' ILE . 4.0 mp -99.58 122.25 51.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.192 -0.943 . . . . 0.0 109.492 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.535 ' HB ' HG13 ' A' ' 82' ' ' VAL . 8.8 t -158.47 167.59 29.23 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.289 -0.882 . . . . 0.0 109.496 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 83.44 48.09 5.45 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.652 ' HB ' HD21 ' A' ' 61' ' ' LEU . 18.3 t -103.57 117.45 49.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.22 -1.165 . . . . 0.0 109.506 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -83.55 81.13 8.87 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.178 -0.951 . . . . 0.0 109.437 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.457 ' HA ' HD23 ' A' ' 56' ' ' LEU . 19.0 mt -151.35 174.02 13.82 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.256 -0.902 . . . . 0.0 109.467 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -56.85 166.5 0.97 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.245 -0.91 . . . . 0.0 109.509 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -73.74 -35.87 65.09 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.283 -0.885 . . . . 0.0 109.422 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.03 -29.43 58.07 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.256 -0.903 . . . . 0.0 109.395 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -67.43 -34.66 77.67 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.24 -0.912 . . . . 0.0 109.388 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.652 HD21 ' HB ' ' A' ' 54' ' ' VAL . 0.2 OUTLIER -66.79 -44.62 80.82 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.229 -0.919 . . . . 0.0 109.286 179.89 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 54.9 m -60.82 -44.31 97.09 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.319 -0.863 . . . . 0.0 109.206 179.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 74.4 tttt -57.52 -49.54 76.0 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.342 -0.849 . . . . 0.0 109.363 179.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -55.95 -41.03 74.05 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.256 -0.902 . . . . 0.0 109.505 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.503 ' HB1' HG13 ' A' ' 78' ' ' VAL . . . -62.55 -37.01 84.46 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.242 -0.911 . . . . 0.0 109.578 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -70.81 -31.59 68.4 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.272 -0.893 . . . . 0.0 109.548 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 82.8 mt-10 -71.66 -37.67 70.78 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.181 -0.95 . . . . 0.0 109.433 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.522 HD21 HD22 ' A' ' 96' ' ' LEU . 11.2 mt -68.48 -55.45 11.74 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.253 -0.904 . . . . 0.0 109.531 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 19.8 ttmt -52.84 -40.18 63.13 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.258 -0.902 . . . . 0.0 109.41 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 61.4 tttt -47.81 -47.77 30.92 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.177 -0.952 . . . . 0.0 109.322 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 14.7 mttt -108.09 57.86 0.62 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.372 -0.83 . . . . 0.0 109.301 179.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.5 m -129.69 -75.97 0.55 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.265 -0.897 . . . . 0.0 109.736 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.658 ' O ' ' CB ' ' A' ' 74' ' ' CYS . . . 125.95 49.77 0.18 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.07 -1.612 . . . . 0.0 109.07 -179.582 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.658 ' CB ' ' O ' ' A' ' 73' ' ' GLY . 49.3 t 112.44 104.57 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.237 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -179.499 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -83.8 142.54 20.92 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -86.54 -80.71 1.18 Allowed Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -129.62 124.16 33.03 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.133 -1.216 . . . . 0.0 109.6 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.503 HG13 ' HB1' ' A' ' 65' ' ' ALA . 95.1 t -125.81 95.44 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.303 -0.873 . . . . 0.0 109.298 179.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 18.0 mttt -122.27 142.12 50.8 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.239 -0.913 . . . . 0.0 109.705 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -54.21 94.82 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.283 -0.886 . . . . 0.0 109.491 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 148.02 -46.24 0.71 Allowed Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.535 HG13 ' HB ' ' A' ' 52' ' ' THR . 42.7 t -143.13 160.94 17.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.233 -1.157 . . . . 0.0 109.47 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.478 ' N ' HG12 ' A' ' 82' ' ' VAL . 4.8 mp -138.32 149.43 24.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.246 -0.909 . . . . 0.0 109.43 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -147.14 120.25 8.85 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.252 -0.905 . . . . 0.0 109.473 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 36.3 mm -119.53 117.75 54.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.171 -0.956 . . . . 0.0 109.443 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.57 114.37 10.63 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.234 -0.916 . . . . 0.0 109.481 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 172.2 -137.97 4.54 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.556 -1.417 . . . . 0.0 109.556 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -177.08 53.24 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.238 -1.154 . . . . 0.0 109.452 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 19.8 mttt -106.14 39.45 1.8 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.234 -0.916 . . . . 0.0 109.499 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.85 ' HA ' HD12 ' A' ' 93' ' ' LEU . 5.4 ttm180 -49.59 -35.28 20.28 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.205 -0.934 . . . . 0.0 109.501 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.93 -43.96 91.26 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.241 -0.912 . . . . 0.0 109.439 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.84 -20.32 58.23 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.231 -0.918 . . . . 0.0 109.427 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 1.026 HD13 HG21 ' A' ' 36' ' ' ILE . 19.5 mt -69.33 -43.46 73.66 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.234 -0.916 . . . . 0.0 109.45 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -67.69 -24.07 65.36 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.274 -0.892 . . . . 0.0 109.446 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -74.98 -60.86 2.1 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.205 -0.935 . . . . 0.0 109.491 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.714 HD12 ' N ' ' A' ' 97' ' ' LEU . 3.6 pp -54.08 -34.53 60.41 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.254 -0.904 . . . . 0.0 109.505 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.917 HD13 ' CG2' ' A' ' 104' ' ' VAL . 0.4 OUTLIER -67.33 -47.04 71.68 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.315 -0.866 . . . . 0.0 109.453 179.981 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -65.91 -16.42 63.84 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.29 -0.881 . . . . 0.0 109.466 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -67.3 -36.37 81.38 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.264 -0.897 . . . . 0.0 109.437 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.94 -37.78 23.65 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.266 -0.896 . . . . 0.0 109.48 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 106.19 21.5 8.43 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.96 158.92 16.0 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.253 -1.145 . . . . 0.0 109.485 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.466 ' HB2' HG12 ' A' ' 33' ' ' VAL . 11.5 mttm -82.85 107.28 15.35 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.249 -0.907 . . . . 0.0 109.469 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.917 ' CG2' HD13 ' A' ' 97' ' ' LEU . 7.5 p -84.65 144.47 9.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.226 -0.921 . . . . 0.0 109.471 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 11.0 mttt -113.92 83.76 1.92 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.25 -0.906 . . . . 0.0 109.462 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.502 HD12 ' HA ' ' A' ' 106' ' ' LEU . 1.1 tp -45.09 -27.98 0.66 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.235 -0.916 . . . . 0.0 109.425 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . 59.05 77.89 0.29 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.276 -0.89 . . . . 0.0 109.492 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -159.59 175.9 36.41 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 167.88 -169.6 41.4 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 5.0 mt -62.49 143.56 57.0 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.276 -1.132 . . . . 0.0 109.485 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 50.4 tt0 . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.486 -179.983 . . . . . . . . 0 0 . 1 stop_ save_